Citrus Sinensis ID: 006664
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 636 | 2.2.26 [Sep-21-2011] | |||||||
| Q551H4 | 1028 | Serine/threonine-protein | yes | no | 0.487 | 0.301 | 0.554 | 1e-101 | |
| Q863I2 | 529 | Serine/threonine-protein | yes | no | 0.468 | 0.563 | 0.501 | 2e-89 | |
| Q5R495 | 527 | Serine/threonine-protein | yes | no | 0.468 | 0.565 | 0.498 | 2e-88 | |
| Q9Z1W9 | 556 | STE20/SPS1-related prolin | yes | no | 0.468 | 0.535 | 0.508 | 2e-88 | |
| Q9UEW8 | 545 | STE20/SPS1-related prolin | yes | no | 0.468 | 0.546 | 0.508 | 3e-88 | |
| O95747 | 527 | Serine/threonine-protein | no | no | 0.468 | 0.565 | 0.498 | 3e-88 | |
| O88506 | 553 | STE20/SPS1-related prolin | no | no | 0.468 | 0.538 | 0.508 | 4e-88 | |
| Q6P9R2 | 527 | Serine/threonine-protein | no | no | 0.468 | 0.565 | 0.498 | 4e-88 | |
| Q54XL6 | 574 | Serine/threonine-protein | no | no | 0.457 | 0.506 | 0.459 | 6e-70 | |
| O61122 | 478 | Serine/threonine-protein | no | no | 0.404 | 0.537 | 0.455 | 1e-63 |
| >sp|Q551H4|FRAY2_DICDI Serine/threonine-protein kinase fray2 OS=Dictyostelium discoideum GN=fray2 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 368 bits (945), Expect = e-101, Method: Compositional matrix adjust.
Identities = 174/314 (55%), Positives = 219/314 (69%), Gaps = 4/314 (1%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQ 61
+K YP A+ Y L E +G+G S V RA+C+PF E VA+KI+D E N L I +E Q
Sbjct: 61 RKNYPNSADQYELKETIGKGGSGLVQRAICLPFQENVAIKIIDLEHCKNVSLEEIRKEIQ 120
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
M L HPNV+ H SFV + +LWV+M F+S GSC I++ ++P GFEE VIATIL+E L
Sbjct: 121 AMSLCHHPNVVAYHTSFVYNESLWVIMDFLSAGSCSDIMRFSFPQGFEEHVIATILKEAL 180
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
K + Y H G IHRD+KSGNILID G I+L DFGVSA L D+G+ R NTFVGTPCWM
Sbjct: 181 KAICYFHKTGRIHRDIKSGNILIDSNGNIQLSDFGVSATLIDTGETSR--NTFVGTPCWM 238
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
APE+MEQ++ YD+ DIWSFGITALELA G APF++YPPMKVLL+TLQN PP L+ + +
Sbjct: 239 APEIMEQVN-YDYAVDIWSFGITALELARGKAPFAEYPPMKVLLLTLQNPPPSLEGDGES 297
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKAL 301
K+S SFK ++ CL KDPSKRP KLL+H FFKQA+ +Y+ + +L LP LG R + L
Sbjct: 298 KWSHSFKDLVEKCLQKDPSKRPLPSKLLEHRFFKQAKKPDYLVQHILAKLPPLGQRYQML 357
Query: 302 KKKEEDMLAQKKMP 315
+ ML P
Sbjct: 358 SEDSFAMLRNTSSP 371
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q863I2|OXSR1_PIG Serine/threonine-protein kinase OSR1 OS=Sus scrofa GN=OXSR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 330 bits (845), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 156/311 (50%), Positives = 211/311 (67%), Gaps = 13/311 (4%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+ I + Y L E +G G +A V A C P E VA+K ++ E+ + + + +E Q M
Sbjct: 10 WSINKDDYELQEVIGSGATAVVQAAYCTPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG------FEEVVIATILRE 119
HPN++ + SFV LW+VM +SGGS L I+K G +E IATILRE
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEATIATILRE 129
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD--RQRMRNTFVGT 177
VL+GL+YLH +G IHRDVK+GNIL+ G++++ DFGVSA L GD R ++R TFVGT
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 235
PCWMAPEVMEQ+ GYDFKADIWSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 236 ---DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
D E +K+ KSF++MI+ CL KDP KRP+A +LL+H FF++A++ EY+ +L+ P
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEYLQEKILQRAP 309
Query: 293 ALGDRIKALKK 303
+ +R K +++
Sbjct: 310 TISERAKKVRR 320
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Sus scrofa (taxid: 9823) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R495|OXSR1_PONAB Serine/threonine-protein kinase OSR1 OS=Pongo abelii GN=OXSR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (838), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 155/311 (49%), Positives = 211/311 (67%), Gaps = 13/311 (4%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+ I + Y L E +G G +A V A C P E VA+K ++ E+ + + + +E Q M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG------FEEVVIATILRE 119
HPN++ + SFV LW+VM +SGGS L I+K G +E IATILRE
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD--RQRMRNTFVGT 177
VL+GL+YLH +G IHRDVK+GNIL+ G++++ DFGVSA L GD R ++R TFVGT
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 235
PCWMAPEVMEQ+ GYDFKADIWSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 236 ---DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
D E +K+ KSF++MI+ CL KDP KRP+A +LL+H FF++A++ E++ +L+ P
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQRAP 309
Query: 293 ALGDRIKALKK 303
+ +R K +++
Sbjct: 310 TISERAKKVRR 320
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Z1W9|STK39_MOUSE STE20/SPS1-related proline-alanine-rich protein kinase OS=Mus musculus GN=Stk39 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (837), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 158/311 (50%), Positives = 212/311 (68%), Gaps = 13/311 (4%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+PI + Y L E +G G +A V ALC P E VA+K ++ E+ + + + +E Q M
Sbjct: 68 WPICRDAYELQEVIGSGATAVVQAALCKPRQERVAIKRINLEKCQTSMDELLKEIQAMSQ 127
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG------FEEVVIATILRE 119
HPNV+ + SFV LW+VM +SGGS L I+K G EE +IATIL+E
Sbjct: 128 CSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYIVNRGEHKNGVLEEAIIATILKE 187
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD--RQRMRNTFVGT 177
VL+GLDYLH +G IHRD+K+GNIL+ G++++ DFGVSA L GD R ++R TFVGT
Sbjct: 188 VLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGVSAFLATGGDVTRNKVRKTFVGT 247
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 235
PCWMAPEVMEQ+ GYDFKAD+WSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 248 PCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPTLET 307
Query: 236 ---DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
D E +K+ KSF+++++ CL KDPSKRP+A +LLK FF++A++ EY+ LL P
Sbjct: 308 GVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLKCKFFQKAKNREYLIEKLLTRTP 367
Query: 293 ALGDRIKALKK 303
+ R K +++
Sbjct: 368 DIAQRAKKVRR 378
|
May act as a mediator of stress-activated signals. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9UEW8|STK39_HUMAN STE20/SPS1-related proline-alanine-rich protein kinase OS=Homo sapiens GN=STK39 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 327 bits (837), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 158/311 (50%), Positives = 212/311 (68%), Gaps = 13/311 (4%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+PI + Y L E +G G +A V ALC P E VA+K ++ E+ + + + +E Q M
Sbjct: 56 WPICRDAYELQEVIGSGATAVVQAALCKPRQERVAIKRINLEKCQTSMDELLKEIQAMSQ 115
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG------FEEVVIATILRE 119
HPNV+ + SFV LW+VM +SGGS L I+K G EE +IATIL+E
Sbjct: 116 CSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYIVNRGEHKNGVLEEAIIATILKE 175
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD--RQRMRNTFVGT 177
VL+GLDYLH +G IHRD+K+GNIL+ G++++ DFGVSA L GD R ++R TFVGT
Sbjct: 176 VLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGVSAFLATGGDVTRNKVRKTFVGT 235
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 235
PCWMAPEVMEQ+ GYDFKAD+WSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 236 PCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPTLET 295
Query: 236 ---DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
D E +K+ KSF+++++ CL KDPSKRP+A +LLK FF++A++ EY+ LL P
Sbjct: 296 GVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLKCKFFQKAKNREYLIEKLLTRTP 355
Query: 293 ALGDRIKALKK 303
+ R K +++
Sbjct: 356 DIAQRAKKVRR 366
|
May act as a mediator of stress-activated signals. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O95747|OXSR1_HUMAN Serine/threonine-protein kinase OSR1 OS=Homo sapiens GN=OXSR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 155/311 (49%), Positives = 210/311 (67%), Gaps = 13/311 (4%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+ I + Y L E +G G +A V A C P E VA+K ++ E+ + + + +E Q M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG------FEEVVIATILRE 119
HPN++ + SFV LW+VM +SGGS L I+K G +E IATILRE
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD--RQRMRNTFVGT 177
VL+GL+YLH +G IHRDVK+GNIL+ G++++ DFGVSA L GD R ++R TFVGT
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 235
PCWMAPEVMEQ+ GYDFKADIWSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 236 ---DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
D E +K+ KSF++MI+ CL KDP KRP+A +LL+H FF++A++ E++ L+ P
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKTLQRAP 309
Query: 293 ALGDRIKALKK 303
+ +R K +++
Sbjct: 310 TISERAKKVRR 320
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O88506|STK39_RAT STE20/SPS1-related proline-alanine-rich protein kinase OS=Rattus norvegicus GN=Stk39 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 326 bits (835), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 158/311 (50%), Positives = 212/311 (68%), Gaps = 13/311 (4%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+PI + Y L E +G G +A V ALC P E VA+K ++ E+ + + + +E Q M
Sbjct: 65 WPICRDAYELQEVIGSGATAVVQAALCKPRQERVAIKRINLEKCQTSMDELLKEIQAMSQ 124
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG------FEEVVIATILRE 119
HPNV+ + SFV LW+VM +SGGS L I+K G EE +IATIL+E
Sbjct: 125 CSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYIVNRGEHKNGVLEEAIIATILKE 184
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD--RQRMRNTFVGT 177
VL+GLDYLH +G IHRD+K+GNIL+ G++++ DFGVSA L GD R ++R TFVGT
Sbjct: 185 VLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGVSAFLATGGDVTRNKVRKTFVGT 244
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 235
PCWMAPEVMEQ+ GYDFKAD+WSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 245 PCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPTLET 304
Query: 236 ---DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
D E +K+ KSF+++++ CL KDPSKRP+A +LLK FF++A++ EY+ LL P
Sbjct: 305 GVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLKCKFFQKAKNREYLIEKLLTRTP 364
Query: 293 ALGDRIKALKK 303
+ R K +++
Sbjct: 365 DIAQRAKKVRR 375
|
May act as a mediator of stress-activated signals. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P9R2|OXSR1_MOUSE Serine/threonine-protein kinase OSR1 OS=Mus musculus GN=Oxsr1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (835), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 155/311 (49%), Positives = 211/311 (67%), Gaps = 13/311 (4%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+ I + Y L E +G G +A V A C P E VA+K ++ E+ + + + +E Q M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKERVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG------FEEVVIATILRE 119
HPN++ + SFV LW+VM +SGGS L I+K G +E IATILRE
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEPTIATILRE 129
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD--RQRMRNTFVGT 177
VL+GL+YLH +G IHRDVK+GNIL+ G++++ DFGVSA L GD R ++R TFVGT
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 235
PCWMAPEVMEQ+ GYDFKADIWSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 236 ---DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
D E +K+ KSF++MI+ CL KDP KRP+A +LL+H FF++A++ E++ +L+ P
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQRAP 309
Query: 293 ALGDRIKALKK 303
+ +R K +++
Sbjct: 310 TISERSKKVRR 320
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XL6|FRAY1_DICDI Serine/threonine-protein kinase fray1 OS=Dictyostelium discoideum GN=fray1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 265 bits (678), Expect = 6e-70, Method: Compositional matrix adjust.
Identities = 136/296 (45%), Positives = 185/296 (62%), Gaps = 5/296 (1%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMI 64
YP A Y L E +G+G V +A CIP E VA+K+++ ++ D + ++ +E + M
Sbjct: 90 YPSQANQYNLIEPIGEGTEGRVFKAYCIPLKENVAIKVVELDKMDPQFVKDVIKEVKVMN 149
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGL 124
+HPN++ H SF+ ++ LW+VM ++ GGS I+K YPDG EV+ T+L+ +LKGL
Sbjct: 150 GNNHPNLIHYHTSFLENNQLWLVMDYLGGGSLADIMKFKYPDGIPEVLAVTVLKSLLKGL 209
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
+YLH H IHRD+KS NILI GAI+L DFGVSA +F+ + R T VGTPCWMAPE
Sbjct: 210 EYLHSHQRIHRDLKSDNILIGEDGAIELADFGVSA-MFEK-NTCCSRKTIVGTPCWMAPE 267
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF- 243
++ + GY+ DIWSFGITA+EL G P PP KV + L P L E D+
Sbjct: 268 IISE-RGYNQGVDIWSFGITAIELIRGKPPGYDLPPSKVFMNLLFGNSPSLQEEEDKGVC 326
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIK 299
S +K ++ CL K+PSKRP+A KLL+H FKQA+ N YI LL GL DR +
Sbjct: 327 SHLYKDLVDKCLQKEPSKRPNASKLLEHKVFKQAKKNNYIVSHLLHGLTPCEDRYR 382
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O61122|SVKA_DICDI Serine/threonine-protein kinase svkA OS=Dictyostelium discoideum GN=svkA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 244 bits (624), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 122/268 (45%), Positives = 167/268 (62%), Gaps = 11/268 (4%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E Y E++G+G V + + NE +A+K +D E ++ +I +E + + P
Sbjct: 10 ELYVRQEKIGKGSFGEVFKGINKKTNETIAIKTIDLEDAEDEIEDIQQEINVLSQCESPF 69
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
V K SF+ LW++M +++GGS L ++K P F+E IA ILRE+LKGL+YLH
Sbjct: 70 VTKYFGSFLKGSKLWIIMEYLAGGSVLDLMK---PGPFDEGYIAIILRELLKGLEYLHSE 126
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
G IHRD+K+ N+L+ G +KL DFGVS L D+ RNTFVGTP WMAPEV++Q
Sbjct: 127 GKIHRDIKAANVLLSASGDVKLADFGVSGQL---TDQMTKRNTFVGTPFWMAPEVIKQ-T 182
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
GYD KADIWS GITALE+A G P + PM+ L + ++ PP L + FSK FK+
Sbjct: 183 GYDSKADIWSMGITALEMAKGEPPRADLHPMRALFLIPKDPPPTL----EGNFSKGFKEF 238
Query: 251 IASCLVKDPSKRPSAKKLLKHSFFKQAR 278
A CL KDP++RP+AK LLKH F K A+
Sbjct: 239 CALCLNKDPNQRPTAKDLLKHKFIKAAK 266
|
Involved in regulation of actin cytoskeleton organization during cell motility; F-actin fragmenting and capping protein allowing dynamic rearrangements of the actin cytoskeleton. Also part of a regulatory pathway from the centrosome to the midzone, thus regulating the completion of cell division. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 636 | ||||||
| 255543419 | 701 | serine/threonine protein kinase, putativ | 0.976 | 0.885 | 0.673 | 0.0 | |
| 356522149 | 730 | PREDICTED: uncharacterized protein LOC10 | 0.988 | 0.861 | 0.660 | 0.0 | |
| 356523463 | 715 | PREDICTED: uncharacterized protein LOC10 | 0.990 | 0.881 | 0.662 | 0.0 | |
| 240254403 | 687 | protein kinase domain-containing protein | 0.987 | 0.914 | 0.654 | 0.0 | |
| 334184021 | 680 | protein kinase domain-containing protein | 0.987 | 0.923 | 0.654 | 0.0 | |
| 359483196 | 680 | PREDICTED: STE20/SPS1-related proline-al | 0.982 | 0.919 | 0.677 | 0.0 | |
| 297842759 | 678 | kinase [Arabidopsis lyrata subsp. lyrata | 0.985 | 0.924 | 0.650 | 0.0 | |
| 357467681 | 761 | Serine/threonine protein kinase [Medicag | 0.979 | 0.818 | 0.616 | 0.0 | |
| 449440215 | 625 | PREDICTED: uncharacterized protein LOC10 | 0.930 | 0.947 | 0.628 | 0.0 | |
| 449501623 | 625 | PREDICTED: LOW QUALITY PROTEIN: uncharac | 0.930 | 0.947 | 0.626 | 0.0 |
| >gi|255543419|ref|XP_002512772.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547783|gb|EEF49275.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 905 bits (2339), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/705 (67%), Positives = 536/705 (76%), Gaps = 84/705 (11%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
M+KKKYPIGAE Y LYEEVGQGVSASV+RALCIPF+EIVA+KILDFER+NSDLSNISRE
Sbjct: 1 MEKKKYPIGAEFYMLYEEVGQGVSASVYRALCIPFDEIVAIKILDFERNNSDLSNISREV 60
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
QTMILVDHPN+LKSHCSFVSDHNLWVVMPFMSGGSCLHILKA YPDGFEEVVIATILREV
Sbjct: 61 QTMILVDHPNILKSHCSFVSDHNLWVVMPFMSGGSCLHILKAVYPDGFEEVVIATILREV 120
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
L+GL+YLHHHGHIHRDVK+GNILID G IKLGDFGVSACLFDSGDRQRMRNTFVGTPCW
Sbjct: 121 LRGLEYLHHHGHIHRDVKAGNILIDSHGTIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD
Sbjct: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA 300
+KFSKSFKQMIASCLVKDPSKRPSA+KLLKHSFFKQARSN+YIAR LLEGLPALGDRIKA
Sbjct: 241 KKFSKSFKQMIASCLVKDPSKRPSARKLLKHSFFKQARSNDYIARKLLEGLPALGDRIKA 300
Query: 301 LKKKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQDEDMISESNHG 360
LK+KEEDMLAQKKMPDG+KEEISQNEYKRGISGWNFNLED+KAQASLI DED+I+ +N G
Sbjct: 301 LKRKEEDMLAQKKMPDGEKEEISQNEYKRGISGWNFNLEDMKAQASLIHDEDLIANNNLG 360
Query: 361 GSSSTLSSLEMQGKQSECQVAVLNQL------------PPHI-LVESTMNITKLRCDKSD 407
GSSS+LS+++ KQ E Q + L Q+ P H+ L S++NI+K +KSD
Sbjct: 361 GSSSSLSTIDSLEKQLESQHSSLGQVPEMDENDLMQYQPTHLQLGNSSVNISKAGYEKSD 420
Query: 408 DDSSVASPCFEQYTQLSSPCH-DDRNQNNPSEKPSLEGTASPSHQRA----------GST 456
DDS+ SP +Q+ SS + DD +NN +EK E P A GS
Sbjct: 421 DDSNTTSPSSDQHVLHSSSHYLDDNVENNVTEKSMFEINGKPVEDIALQQKTRDPSNGSN 480
Query: 457 ALSESIIAPVNKE---------------------------------SVTVAANSDELDEK 483
L I P +KE ++ A N+DELDEK
Sbjct: 481 TLEN--IVPSDKEESDKLQNQSQNNSSSEDDDVVSEMPSKASKILGNILTARNNDELDEK 538
Query: 484 AKPPVIQQKGRFKVTSENVCLEKVVPPTLQKSHSMQVLSQSPAISSLVPSDTALSNLSGN 543
AKPPV+QQ+GRFKVTSENV +EKV+ HS L +P +S P SG+
Sbjct: 539 AKPPVVQQRGRFKVTSENVGIEKVL-----HQHSGLSLPATPDSTSSTP--------SGH 585
Query: 544 SLFPMLCNVLQTNILQRESILNLMKQVSVGDCTANRLVDGGGTPANTVTTEKSL------ 597
SLFP+L +VLQ NI+QR++ILNLMKQV D A+R +DGG + +TE SL
Sbjct: 586 SLFPLLNSVLQNNIVQRDNILNLMKQVCGCDTPASRAIDGGSILSIAGSTENSLMINEST 645
Query: 598 ------LEAAHDREKDLLHEITDLQWRLMCAQDELQKYKTENPQV 636
LEAAHDREKDLLHEIT+LQWRL+CAQ+EL+KY+TEN Q+
Sbjct: 646 SGFLDRLEAAHDREKDLLHEITELQWRLLCAQEELKKYRTENAQI 690
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522149|ref|XP_003529711.1| PREDICTED: uncharacterized protein LOC100819537 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2335), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/703 (66%), Positives = 537/703 (76%), Gaps = 74/703 (10%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQ 61
+KKKYPIG+EHY LYEE+GQGVSASVHRALC+PFNE+VA+KILDFERDN DL+N+SREAQ
Sbjct: 32 EKKKYPIGSEHYLLYEEIGQGVSASVHRALCVPFNEVVAIKILDFERDNCDLNNVSREAQ 91
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
TM LVDHPNVLKS CSFVS+HNLWVVMPFMSGGSCLHILK+++PDGF EVVI+TIL+EVL
Sbjct: 92 TMFLVDHPNVLKSLCSFVSEHNLWVVMPFMSGGSCLHILKSSHPDGFVEVVISTILKEVL 151
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
K L+YLHHHGHIHRDVK+GNILID RG +KLGDFGVSACLFDSGDRQR RNTFVGTPCWM
Sbjct: 152 KALEYLHHHGHIHRDVKAGNILIDSRGTVKLGDFGVSACLFDSGDRQRTRNTFVGTPCWM 211
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
APEVMEQLHGY+FKADIWSFGITALELAHGHAPFSK+PPMKVLLMTLQNAPPGLDYERDR
Sbjct: 212 APEVMEQLHGYNFKADIWSFGITALELAHGHAPFSKFPPMKVLLMTLQNAPPGLDYERDR 271
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKAL 301
KFSKSFKQMIASCLVKDPSKRPSA KLLKHSFFKQARS++ I + LLEGLPALGDR++AL
Sbjct: 272 KFSKSFKQMIASCLVKDPSKRPSASKLLKHSFFKQARSSDIIVKKLLEGLPALGDRMEAL 331
Query: 302 KKKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQD-EDMISESNHG 360
K+KEEDMLAQKKMPD + EE+SQNEYKRGISGWNFNL+D+KAQASLI D +D +S++NH
Sbjct: 332 KRKEEDMLAQKKMPDVKMEELSQNEYKRGISGWNFNLDDMKAQASLIHDFDDAMSDTNHA 391
Query: 361 GSSSTLSSLEMQGKQSECQV-------------AVLNQLPPHILVESTMNITKLRCDKSD 407
GSS +LS+L+ Q KQ + + N ++V+S +N K R +KSD
Sbjct: 392 GSSISLSTLDSQDKQLPSAIHKPSRSADMEENDEMQNLSASVLVVDSAVNDAKFRFEKSD 451
Query: 408 DDSSVASPCFEQYTQLSSPCHDDRNQNNPSEKP-------SLEGTASPSHQRAG--STAL 458
D SS+ C Q SS C DD NN EKP S+EG A+ + R+G S+ L
Sbjct: 452 DHSSIT--CSSHEPQTSSSCLDDHVDNNLGEKPDMENGGRSVEGMATHYYHRSGCSSSIL 509
Query: 459 SESIIAPVNKESVTV---------------------------------AANSDELDEKAK 485
E + P+ ES + +ANSD+ DEK+K
Sbjct: 510 PEVTLPPIPPESEKLQNLHPNVSSCNATSFPQTGEDVLTELPSRVSKSSANSDDTDEKSK 569
Query: 486 PPVIQQKGRFKVTSENVCLEKVV------PPTLQKSHSMQVLSQSPAISS-----LVP-S 533
PV+QQ+GRFKVTSENV EKV+ PP LQKSHS+QV SQ A S+ L+P S
Sbjct: 570 VPVVQQRGRFKVTSENVDPEKVIFFQVAPPPVLQKSHSVQVFSQHNAASTHPTLPLLPAS 629
Query: 534 DTALSNLSGNSLFPMLCNVLQTNILQRESILNLMKQVSVGDCTANRLVDGGGTPANTVTT 593
D SNLSG S+FP+L +VLQ NILQRESIL+LMKQ++ GD +A DG PA T
Sbjct: 630 DATPSNLSGCSVFPVLHSVLQINILQRESILSLMKQITAGDSSA----DGTCNPAQIAIT 685
Query: 594 EKSLLEAAHDREKDLLHEITDLQWRLMCAQDELQKYKTENPQV 636
EKSLLEAAH+REK+LLHEIT+LQWRL+C Q+ELQK KTEN QV
Sbjct: 686 EKSLLEAAHEREKELLHEITELQWRLICTQEELQKLKTENAQV 728
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523463|ref|XP_003530358.1| PREDICTED: uncharacterized protein LOC100780339 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 891 bits (2303), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/721 (66%), Positives = 543/721 (75%), Gaps = 91/721 (12%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
M+KKKYPIG EHY LYEE+GQGVSASVHRALC+PFNE+VA+KILDFERDN DL+N+SREA
Sbjct: 1 MEKKKYPIGEEHYLLYEEIGQGVSASVHRALCLPFNEVVAIKILDFERDNCDLNNVSREA 60
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAA+PDGFEEVVIAT+L+EV
Sbjct: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAHPDGFEEVVIATVLKEV 120
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
LKGL+YLHHHGHIHRDVK+GNILID RGA+KLGDFGVSACLFDSGDRQR RNTFVGTPCW
Sbjct: 121 LKGLEYLHHHGHIHRDVKAGNILIDSRGAVKLGDFGVSACLFDSGDRQRTRNTFVGTPCW 180
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
MAPEVMEQLHGY+FKADIWSFGITALELAHGHAPFSK+PPMKVLLMTLQNAPPGLDYERD
Sbjct: 181 MAPEVMEQLHGYNFKADIWSFGITALELAHGHAPFSKFPPMKVLLMTLQNAPPGLDYERD 240
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA 300
RKFSKSFKQMIASCLVKDPSKRPSA KLLKHSFFKQARS++ I + LLEGLPALGDR++A
Sbjct: 241 RKFSKSFKQMIASCLVKDPSKRPSASKLLKHSFFKQARSSDTIVKKLLEGLPALGDRMEA 300
Query: 301 LKKKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQD-EDMISESNH 359
LK+KEEDMLAQKKMPDG+ EE+SQNEYKRGISGWNFNL+D+KAQASLI D +D +S+ NH
Sbjct: 301 LKRKEEDMLAQKKMPDGKMEELSQNEYKRGISGWNFNLDDMKAQASLIHDFDDAMSDINH 360
Query: 360 GGSSSTLSSLEMQGKQSECQV-------------AVLNQLPPHILVESTMN--------- 397
GSSS+LS+L+ KQ + + QL +LV+S +N
Sbjct: 361 AGSSSSLSTLDSLDKQLPSAIHKPSRSADMEENDEMRRQLASALLVDSAVNDAKYAPKMH 420
Query: 398 --------ITKLRCDKSDDDSSVASPCFEQYTQLSSPCHDDRNQNNPSEKP-------SL 442
I++ R +KSDDDSS+AS E Q SS C DD N+ EK S+
Sbjct: 421 LMPDLCVAISRTRFEKSDDDSSIASSSHE--PQTSSSCPDDHVNNHLGEKSDMENGGRSV 478
Query: 443 EGTASPSHQRAG--STALSESIIAPVNKES------------------------------ 470
EG A+ + R G S+ L E+ + P+ ES
Sbjct: 479 EGMATHYYHRRGCSSSILPEATLLPIRAESEKPQNLPHNVSSCNATSVPQTGEDVLTELP 538
Query: 471 ---VTVAANSDELDEKAKPPVIQQKGRFKVTSENVCLEKVV------PPTLQKSHSMQVL 521
+ANSD+ DEK+K PV+QQ+GRFKVTSENV EKV+ P LQKSHSMQV
Sbjct: 539 SRVSKSSANSDDTDEKSKVPVVQQRGRFKVTSENVDPEKVIFFQVAPSPLLQKSHSMQVF 598
Query: 522 SQ------SPAISSLVPSDTALSNLSGNSLFPMLCNVLQTNILQRESILNLMKQVSVGDC 575
SQ P + L SD SNLSG SLFP+L +VLQTNILQRE IL+LMKQ++VGD
Sbjct: 599 SQHNTASIHPTLPLLPASDATSSNLSGYSLFPVLHSVLQTNILQREGILSLMKQITVGDS 658
Query: 576 TANRLVDGGGTPANTVTTEKSLLEAAHDREKDLLHEITDLQWRLMCAQDELQKYKTENPQ 635
+A DG PA TEKSLLEAAH+REK+LLHEITDLQWRL+C Q+ELQK KTEN Q
Sbjct: 659 SA----DGTCNPAQVAATEKSLLEAAHEREKELLHEITDLQWRLICTQEELQKLKTENAQ 714
Query: 636 V 636
V
Sbjct: 715 V 715
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|240254403|ref|NP_178082.6| protein kinase domain-containing protein [Arabidopsis thaliana] gi|332198156|gb|AEE36277.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2284), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/688 (65%), Positives = 537/688 (78%), Gaps = 60/688 (8%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
M+KKKYPIG EHYTLYE +GQGVSA VHRALCIPF+E+VA+KILDFERDN DL+NISREA
Sbjct: 4 MEKKKYPIGPEHYTLYEFIGQGVSALVHRALCIPFDEVVAIKILDFERDNCDLNNISREA 63
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
QTM+LVDHPNVLKSHCSFVSDHNLWV+MP+MSGGSCLHILKAAYPDGFEE +IATILRE
Sbjct: 64 QTMMLVDHPNVLKSHCSFVSDHNLWVIMPYMSGGSCLHILKAAYPDGFEEAIIATILREA 123
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
LKGLDYLH HGHIHRDVK+GNIL+ RGA+KLGDFGVSACLFDSGDRQR RNTFVGTPCW
Sbjct: 124 LKGLDYLHQHGHIHRDVKAGNILLGARGAVKLGDFGVSACLFDSGDRQRTRNTFVGTPCW 183
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
MAPEVMEQLHGYDFKADIWSFGIT LELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD
Sbjct: 184 MAPEVMEQLHGYDFKADIWSFGITGLELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA 300
+KFS+SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS++YIAR LL+GLP L +R++A
Sbjct: 244 KKFSRSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSSDYIARKLLDGLPDLVNRVQA 303
Query: 301 LKKKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQDEDMISESNHG 360
+K+KEEDMLAQ+KM DG+KEE+SQNEYKRGISGWNFNL+D+KAQASLIQD D +
Sbjct: 304 IKRKEEDMLAQEKMADGEKEELSQNEYKRGISGWNFNLDDMKAQASLIQDMDCGFSDSLS 363
Query: 361 GSSSTLSSLEMQGKQSECQV---AVLNQ-LPPHILVESTMNITKLRCDKSDDDSSVASPC 416
GS+++L +L+ Q QSE Q + N+ L P L+ +++I + DKSDDDSS+ASP
Sbjct: 364 GSATSLQALDSQDTQSEIQEDTGQITNKYLQP--LIHRSLSIAR---DKSDDDSSLASPS 418
Query: 417 FEQYTQLSSPCHDDRNQNN------------PSEKPSLEGTASPSHQRAGSTALSESIIA 464
++ Y SSP H+D + NN P++ S+ T P+ AGS+ L++ A
Sbjct: 419 YDSYV-YSSPRHEDLSLNNTHVGSTHANNGKPTDATSIP-TNQPTEIIAGSSVLADGNGA 476
Query: 465 PVNKES---------------------------------VTVAANSDELDEKAKPPVIQQ 491
P ES A++ DE D+K+KPPV+QQ
Sbjct: 477 PNKGESDKTQEQLQNGSNCNGTHPTVGGDDVPTEMAVKPPKAASSLDESDDKSKPPVVQQ 536
Query: 492 KGRFKVTSENVCLEKVVPPT--LQKSHSMQVLSQSPAISSLVPSDTALSNLSGNSLFPML 549
+GRFKVTSEN+ +EKVV P+ LQKSHSMQVL Q + +SL SD L NL+ + ++P++
Sbjct: 537 RGRFKVTSENLDIEKVVAPSPILQKSHSMQVLCQHSS-ASLPHSDVTLPNLTSSYVYPLV 595
Query: 550 CNVLQTNILQRESILNLMKQVSVGDCTANRLVDGGGTPANTV-TTEKSLLEAAHDREKDL 608
VLQTNIL+R++IL++MK ++ + T R V+ G TV TEKS+LEAAH+REK+L
Sbjct: 596 YPVLQTNILERDNILHMMKVLTNRELTDGRAVEQGSIQQPTVPPTEKSMLEAAHEREKEL 655
Query: 609 LHEITDLQWRLMCAQDELQKYKTENPQV 636
LH+ITDLQWRL+CA++ELQKYKTE+ QV
Sbjct: 656 LHDITDLQWRLICAEEELQKYKTEHAQV 683
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334184021|ref|NP_001185438.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|332198157|gb|AEE36278.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2283), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/688 (65%), Positives = 537/688 (78%), Gaps = 60/688 (8%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
M+KKKYPIG EHYTLYE +GQGVSA VHRALCIPF+E+VA+KILDFERDN DL+NISREA
Sbjct: 1 MEKKKYPIGPEHYTLYEFIGQGVSALVHRALCIPFDEVVAIKILDFERDNCDLNNISREA 60
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
QTM+LVDHPNVLKSHCSFVSDHNLWV+MP+MSGGSCLHILKAAYPDGFEE +IATILRE
Sbjct: 61 QTMMLVDHPNVLKSHCSFVSDHNLWVIMPYMSGGSCLHILKAAYPDGFEEAIIATILREA 120
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
LKGLDYLH HGHIHRDVK+GNIL+ RGA+KLGDFGVSACLFDSGDRQR RNTFVGTPCW
Sbjct: 121 LKGLDYLHQHGHIHRDVKAGNILLGARGAVKLGDFGVSACLFDSGDRQRTRNTFVGTPCW 180
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
MAPEVMEQLHGYDFKADIWSFGIT LELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD
Sbjct: 181 MAPEVMEQLHGYDFKADIWSFGITGLELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA 300
+KFS+SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS++YIAR LL+GLP L +R++A
Sbjct: 241 KKFSRSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSSDYIARKLLDGLPDLVNRVQA 300
Query: 301 LKKKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQDEDMISESNHG 360
+K+KEEDMLAQ+KM DG+KEE+SQNEYKRGISGWNFNL+D+KAQASLIQD D +
Sbjct: 301 IKRKEEDMLAQEKMADGEKEELSQNEYKRGISGWNFNLDDMKAQASLIQDMDCGFSDSLS 360
Query: 361 GSSSTLSSLEMQGKQSECQV---AVLNQ-LPPHILVESTMNITKLRCDKSDDDSSVASPC 416
GS+++L +L+ Q QSE Q + N+ L P L+ +++I + DKSDDDSS+ASP
Sbjct: 361 GSATSLQALDSQDTQSEIQEDTGQITNKYLQP--LIHRSLSIAR---DKSDDDSSLASPS 415
Query: 417 FEQYTQLSSPCHDDRNQNN------------PSEKPSLEGTASPSHQRAGSTALSESIIA 464
++ Y SSP H+D + NN P++ S+ T P+ AGS+ L++ A
Sbjct: 416 YDSYV-YSSPRHEDLSLNNTHVGSTHANNGKPTDATSIP-TNQPTEIIAGSSVLADGNGA 473
Query: 465 PVNKES---------------------------------VTVAANSDELDEKAKPPVIQQ 491
P ES A++ DE D+K+KPPV+QQ
Sbjct: 474 PNKGESDKTQEQLQNGSNCNGTHPTVGGDDVPTEMAVKPPKAASSLDESDDKSKPPVVQQ 533
Query: 492 KGRFKVTSENVCLEKVVPPT--LQKSHSMQVLSQSPAISSLVPSDTALSNLSGNSLFPML 549
+GRFKVTSEN+ +EKVV P+ LQKSHSMQVL Q + +SL SD L NL+ + ++P++
Sbjct: 534 RGRFKVTSENLDIEKVVAPSPILQKSHSMQVLCQHSS-ASLPHSDVTLPNLTSSYVYPLV 592
Query: 550 CNVLQTNILQRESILNLMKQVSVGDCTANRLVDGGGTPANTV-TTEKSLLEAAHDREKDL 608
VLQTNIL+R++IL++MK ++ + T R V+ G TV TEKS+LEAAH+REK+L
Sbjct: 593 YPVLQTNILERDNILHMMKVLTNRELTDGRAVEQGSIQQPTVPPTEKSMLEAAHEREKEL 652
Query: 609 LHEITDLQWRLMCAQDELQKYKTENPQV 636
LH+ITDLQWRL+CA++ELQKYKTE+ QV
Sbjct: 653 LHDITDLQWRLICAEEELQKYKTEHAQV 680
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483196|ref|XP_002271299.2| PREDICTED: STE20/SPS1-related proline-alanine-rich protein kinase-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 881 bits (2277), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/691 (67%), Positives = 535/691 (77%), Gaps = 66/691 (9%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
M+KKKYPIG E YTLYEE+GQGVSASV RALC+P NEIVA+KILDFERDN DL+NISREA
Sbjct: 1 MEKKKYPIGPEFYTLYEEIGQGVSASVLRALCVPLNEIVAIKILDFERDNCDLNNISREA 60
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
QTM LVDHPNVLKSHCSFVS+HNLWVVMP+M+GGSCL+ILKAAYPDG EEVVIATILREV
Sbjct: 61 QTMNLVDHPNVLKSHCSFVSEHNLWVVMPYMAGGSCLNILKAAYPDGLEEVVIATILREV 120
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
LKGL+YLHHHGHIHRDVK+GNILID RGAIKLGDFGVSACLFDSGDRQR RNTFVGTPCW
Sbjct: 121 LKGLEYLHHHGHIHRDVKAGNILIDARGAIKLGDFGVSACLFDSGDRQRSRNTFVGTPCW 180
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD
Sbjct: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA 300
RKFSKSFKQMIASCLVKDPSKRPSAKKLLKH FFKQARS++YI RTLLEGLP LG+RIK
Sbjct: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHPFFKQARSSDYIGRTLLEGLPDLGERIKE 300
Query: 301 LKKKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQD-EDMISESNH 359
LK+KEEDMLAQKKMPDG+KEE+SQNEYKRGISGWNFNLEDVKAQASLI D ED S S+
Sbjct: 301 LKRKEEDMLAQKKMPDGEKEELSQNEYKRGISGWNFNLEDVKAQASLIPDVED--SGSDL 358
Query: 360 GGSSSTLSSLEMQGKQSE----CQVA-----VLNQLP-PHILVESTMNITKLRCDKSDDD 409
GGSS++LS L++ KQS QVA ++ LP P V+S +N +++ KSDD+
Sbjct: 359 GGSSNSLSGLDVHEKQSSMGHLSQVAEEGSDLMQNLPVPLPSVDSAINNIRVQSYKSDDE 418
Query: 410 SSVASPCFEQY-TQLSSPCHDDRNQNNPSEKPSLEGT-----ASPSHQRAGSTALSESII 463
SS+AS E + +Q SSP HDD+ +NN +EKP E + + Q+ GS++ S S +
Sbjct: 419 SSIASSSHEHHISQGSSPRHDDQIENNLAEKPDPEISEKLLDMAIQSQKVGSSSDSTSSL 478
Query: 464 ---APVNKES------------------VTV---------------AANSDELDEKAKPP 487
PV ES VTV +ANSDE DE+AK P
Sbjct: 479 EVNCPVKGESGNLQNQLRKMSSCNGTTVVTVVDEAPSEIISRTSKSSANSDEPDERAKMP 538
Query: 488 VIQQKGRFKVTSENVCLEKVV--PPTLQKSHSMQVLSQSPAISSLVPSDTALSNLSGNSL 545
V+QQ+GRFKVTSENV LEKV+ PPT+ S + S S A SN G+ L
Sbjct: 539 VVQQRGRFKVTSENVDLEKVLNQPPTISLSSPLPSPSPSEATP---------SNHQGHFL 589
Query: 546 FPMLCNVLQTNILQRESILNLMKQVSVGDCTANRLVDGGGTPANTVTTEKSLLEAAHDRE 605
F +L +VLQ+NILQR++IL +M+ +S + AN DGG P T EKS+LEAAH+RE
Sbjct: 590 FSLLNSVLQSNILQRDTILGIMRHLSSSEFIANCAADGGCMPMYTSVAEKSMLEAAHERE 649
Query: 606 KDLLHEITDLQWRLMCAQDELQKYKTENPQV 636
KDLLHE+ +LQWRL+CAQ+E+QK+KTEN QV
Sbjct: 650 KDLLHEVAELQWRLICAQEEIQKFKTENAQV 680
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297842759|ref|XP_002889261.1| kinase [Arabidopsis lyrata subsp. lyrata] gi|297335102|gb|EFH65520.1| kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2267), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/683 (65%), Positives = 531/683 (77%), Gaps = 56/683 (8%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
M+KKKYPIG EHY+LYE +GQGVSA VHRALCIPF+E+VA+KILDFERDN DL+NISREA
Sbjct: 1 MEKKKYPIGPEHYSLYEVIGQGVSALVHRALCIPFDEVVAIKILDFERDNCDLNNISREA 60
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
QTM+LVDHPNVLKSHCSFVSDHNLWV+MP+MSGGSCLHILKAAYPDGFEE +IATILRE
Sbjct: 61 QTMMLVDHPNVLKSHCSFVSDHNLWVIMPYMSGGSCLHILKAAYPDGFEEAIIATILREA 120
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
LKGLDYLH HGHIHRDVK+GNIL+ RGA+KLGDFGVSACLFDSGDRQR RNTFVGTPCW
Sbjct: 121 LKGLDYLHQHGHIHRDVKAGNILLGARGAVKLGDFGVSACLFDSGDRQRTRNTFVGTPCW 180
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
MAPEVMEQLHGYDFKADIWSFGIT LELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD
Sbjct: 181 MAPEVMEQLHGYDFKADIWSFGITGLELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA 300
+KFS+SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS++YIAR LL+GLP L +R++A
Sbjct: 241 KKFSRSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSSDYIARKLLDGLPDLVNRVQA 300
Query: 301 LKKKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQDEDMISESNHG 360
+KKKEEDMLAQ+KM DG+KEE+SQNEYKRGISGWNFNL+D+KAQASLIQD D +
Sbjct: 301 IKKKEEDMLAQEKMADGEKEELSQNEYKRGISGWNFNLDDMKAQASLIQDMDCGFSDSLS 360
Query: 361 GSSSTLSSLEMQGKQSECQ--VAVLNQLPPHILVESTMNITKLRCDKSDDDSSVASPCFE 418
GS+++L +L+ Q QSE Q V + L+ +++I + DKSDDDSS+ASP ++
Sbjct: 361 GSTTSLQALDSQDTQSETQEDVGQITNKYLQPLIHRSLSIAR---DKSDDDSSLASPSYD 417
Query: 419 QYTQLSSPCHDDRNQNN------------PSEKPSLEGTASPSHQRAGSTALSESIIAPV 466
Y SSP H+D + NN P++ S+ T P+ AG++AL++ P
Sbjct: 418 SYV-YSSPRHEDLSLNNTTVGSNHAINGKPTDSTSIP-TNQPTEILAGNSALADRNGIPN 475
Query: 467 NKES---------------------------------VTVAANSDELDEKAKPPVIQQKG 493
ES A++ DE D+K+KPPV+QQ+G
Sbjct: 476 KGESDKTQDHLQNGSNCNGAHPTVGGDEVPTELAVKPPKAASSLDESDDKSKPPVVQQRG 535
Query: 494 RFKVTSENVCLEKVVPPT--LQKSHSMQVLSQSPAISSLVPSDTALSNLSGNSLFPMLCN 551
RFKVTSEN+ +EKVV P+ LQKSHSMQVL Q + + L SD L NL+ + ++P++
Sbjct: 536 RFKVTSENLDIEKVVAPSPILQKSHSMQVLCQHSS-APLPHSDVTLPNLTSSYVYPLVYP 594
Query: 552 VLQTNILQRESILNLMKQVSVGDCTANRLVDGGGTPANTV-TTEKSLLEAAHDREKDLLH 610
VLQTNIL+R++IL++MK ++ + T R V+ G TV TEKS+LEAAH+REK+LLH
Sbjct: 595 VLQTNILERDNILHMMKVLTNRELTDGRAVEQGSVQQPTVPPTEKSMLEAAHEREKELLH 654
Query: 611 EITDLQWRLMCAQDELQKYKTEN 633
+ITDLQWRL+CA++ELQKYKTE+
Sbjct: 655 DITDLQWRLICAEEELQKYKTEH 677
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357467681|ref|XP_003604125.1| Serine/threonine protein kinase [Medicago truncatula] gi|355505180|gb|AES86322.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2162), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/753 (61%), Positives = 529/753 (70%), Gaps = 130/753 (17%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER----------------- 48
YPIGAEHY LYEE+GQGVSASVHRALC+ FNEIVA+KILDFER
Sbjct: 17 YPIGAEHYQLYEEIGQGVSASVHRALCVSFNEIVAIKILDFERDNCDLDKRFVNRRHCVL 76
Query: 49 ---------------DNSDLS----------------------NISREAQTMILVDHPNV 71
DN+ ++ NISREAQTM+LVDHPNV
Sbjct: 77 SSCPHKNEEDASCSEDNNTMTTINKPHTLYYYSRKRPRTNAANNISREAQTMVLVDHPNV 136
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAA+PDGFEEVVIAT+LREVLKGL+YLHHHG
Sbjct: 137 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAHPDGFEEVVIATVLREVLKGLEYLHHHG 196
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG 191
HIHRDVK+GN+LID RGA+KLGDFGVSACLFDSGDRQR RNTFVGTPCWMAPEVMEQLHG
Sbjct: 197 HIHRDVKAGNVLIDSRGAVKLGDFGVSACLFDSGDRQRSRNTFVGTPCWMAPEVMEQLHG 256
Query: 192 YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251
Y+FKADIWSFGITALELAHGHAPFSKYPP+KVLLMTLQNAPPGLDYERD+KFSKSFKQMI
Sbjct: 257 YNFKADIWSFGITALELAHGHAPFSKYPPLKVLLMTLQNAPPGLDYERDKKFSKSFKQMI 316
Query: 252 ASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKEEDMLAQ 311
A CLVKDPSKRPSA KLLKHSFFKQARS++YI RTLLEGLPALGDR++ LK+K EDMLAQ
Sbjct: 317 ACCLVKDPSKRPSASKLLKHSFFKQARSSDYITRTLLEGLPALGDRMEILKRK-EDMLAQ 375
Query: 312 KKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQD-EDMISESNHGGSSSTLSSLE 370
KKMPDGQ EE+SQNEYKRGISGWNFNLED+KAQASLI D +D +S+ +H S+ +L++L+
Sbjct: 376 KKMPDGQMEELSQNEYKRGISGWNFNLEDMKAQASLINDFDDAMSDISHVSSACSLTNLD 435
Query: 371 MQGKQ------SECQVAVL-------NQLPPHILVESTMNITKLRCDKSDDDSSVASPCF 417
Q KQ S Q A + NQL V+ST+N K R +KSDDDSS+ S
Sbjct: 436 AQDKQLPSSSHSRSQTADMEESDEMHNQLASVPEVDSTINDVKTRIEKSDDDSSITSSSH 495
Query: 418 EQYTQLSSPCHDDR-------NQNNPSEKPSLEGTASPSHQRAGSTA-LSESIIAPVNKE 469
E T S C DD +N + T P H+R S++ L E + P+ E
Sbjct: 496 EPQT---SSCLDDHVDHSLGDMENVGRAAEVVVATHPPLHRRGCSSSILPEVTLPPIRAE 552
Query: 470 S-----------------VT----------------VAANSDELDEKAKPPVIQQKGRFK 496
S VT +ANSD+ D+KAK PV+QQ+GRFK
Sbjct: 553 SEKLQNLSTNVSSANAILVTHTGDDVLTELPSRASKTSANSDDTDDKAKVPVVQQRGRFK 612
Query: 497 VTSENVCLEKVVP-PTLQKSHSMQ-----VLSQSPA--ISSLVP-----SDTALSNLSGN 543
VTSENV EK P P LQKSHSMQ V+SQ A + S +P SD SN+S
Sbjct: 613 VTSENVDPEKATPSPVLQKSHSMQVGCLEVMSQHNATPLHSPLPLLSPISDATPSNISCC 672
Query: 544 SLFPMLCNVLQTNILQRESILNLMKQVSVGDCTANRLVDGGGTPANTVTTEKSLLEAAHD 603
SLFP+L +VLQTNILQRE+IL LMKQ++VG+ A D PA EKSLLE+AH+
Sbjct: 673 SLFPVLHSVLQTNILQRETILTLMKQITVGESAA----DNTNAPAQIAAMEKSLLESAHE 728
Query: 604 REKDLLHEITDLQWRLMCAQDELQKYKTENPQV 636
REK+LLHEITDLQWRL+C Q+ELQK KT+N QV
Sbjct: 729 REKELLHEITDLQWRLICTQEELQKLKTDNAQV 761
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440215|ref|XP_004137880.1| PREDICTED: uncharacterized protein LOC101211076 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 814 bits (2102), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/664 (62%), Positives = 501/664 (75%), Gaps = 72/664 (10%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
M+KK YPIG + Y LYEEVGQGVSASVHRALC NEIVA+KILDFER+N DL++I RE
Sbjct: 1 MEKKTYPIGEDSYILYEEVGQGVSASVHRALCKSLNEIVAIKILDFERENCDLASIYREV 60
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
QTMILVDHPNVLKSHCSFV+ H+LW+VMP+MSGGSCLHILKAAYPDGFEEVVIAT+LREV
Sbjct: 61 QTMILVDHPNVLKSHCSFVNGHDLWIVMPYMSGGSCLHILKAAYPDGFEEVVIATVLREV 120
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
LKG++YLH+HGHIHRD+K+GN+LID RG IKLGDFGVSACLFDSGDRQR+RNTFVGTPCW
Sbjct: 121 LKGVEYLHNHGHIHRDIKAGNVLIDSRGGIKLGDFGVSACLFDSGDRQRVRNTFVGTPCW 180
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
MAPEVMEQL+GYDFKADIWSF IT LELAHGHAPFSKYPPMKVL+MTLQNAPPGLDYERD
Sbjct: 181 MAPEVMEQLNGYDFKADIWSFAITGLELAHGHAPFSKYPPMKVLMMTLQNAPPGLDYERD 240
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA 300
+KFSKSFKQMIASCLVKDPSKRPSA KLLKHSFF+QARSN+YIAR LLEGLP LGDRIKA
Sbjct: 241 KKFSKSFKQMIASCLVKDPSKRPSASKLLKHSFFRQARSNDYIARALLEGLPVLGDRIKA 300
Query: 301 LKKKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQD-EDMISESNH 359
LK+KEEDMLAQKK+ DG+KEE+SQNEYKRGISGWNFNL+D+KAQASLIQ+ E+ ISE +
Sbjct: 301 LKRKEEDMLAQKKISDGKKEELSQNEYKRGISGWNFNLDDLKAQASLIQEFEESISEMSE 360
Query: 360 GGSSSTLSSLEMQGKQSECQ----------VAVLNQLPPHILVESTMNITKLRCDKSDDD 409
GSS++L++L++Q K+ + Q A+L + P ++ I K +
Sbjct: 361 VGSSNSLNALDVQEKKLQGQNSSEISDVEENAMLRRQPSMKANDTVYEIEK--------N 412
Query: 410 SSVASPCFEQYTQLSSPCHDDRNQNNPSEKPSLEGTASPSHQRAGSTALSESIIAPVNKE 469
+ SP ++S DD ++ S+ P K
Sbjct: 413 GANGSPAM----GVTSQAVDDALSDSQSKDP---------------------------KS 441
Query: 470 SVTVAANSDELDEKAKPPVIQQKGRFKVTSENVCLEKVVP-PTLQKSHSMQVLSQSPAIS 528
S++ A +E DEKAK PVIQQKGRFKVTSE+V LEK P LQKSHSMQV + S
Sbjct: 442 SLSPAITEEEQDEKAKAPVIQQKGRFKVTSESVDLEKAAASPILQKSHSMQVGNFEVITS 501
Query: 529 SL---VPSDT----------------ALSNLSGNSLFPMLCNVLQTNILQRESILNLMKQ 569
+ +PS+ A+ + +S+FP+L +VLQTNI+QR+ IL LM+Q
Sbjct: 502 NCATPLPSNLPTPLLTPLLTPLPSSDAIPINTRSSMFPVLHSVLQTNIVQRDDILTLMRQ 561
Query: 570 VSVGDCTANRLVDGGGTPANTVTTEKSLLEAAHDREKDLLHEITDLQWRLMCAQDELQKY 629
+S G+ +A+ +VD + A+ TEKSLLEAAH+REKDLL+E+T+LQWR++ A+DE+Q+
Sbjct: 562 ISTGEFSADGVVD--VSAAHITATEKSLLEAAHEREKDLLNEVTELQWRILRARDEIQRL 619
Query: 630 KTEN 633
K N
Sbjct: 620 KLNN 623
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449501623|ref|XP_004161419.1| PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC101229525 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 812 bits (2097), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/664 (62%), Positives = 500/664 (75%), Gaps = 72/664 (10%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
M+KK YPIG + Y LYEEVGQGVSASVHRALC NEIVA+KILDFER+N DL++I RE
Sbjct: 1 MEKKTYPIGEDSYILYEEVGQGVSASVHRALCKSLNEIVAIKILDFERENCDLASIYREV 60
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
QTMILVDHPNVLKSHCSFV+ H+LW+VMP+MSGGSCLHILKAAYPDGFEEVVIAT+LREV
Sbjct: 61 QTMILVDHPNVLKSHCSFVNGHDLWIVMPYMSGGSCLHILKAAYPDGFEEVVIATVLREV 120
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
LKG++YLH+HGHIHRD+K+GN+LID RG IKLGDFGVSACLFDSGDRQR+RNTFVGTPCW
Sbjct: 121 LKGVEYLHNHGHIHRDIKAGNVLIDSRGGIKLGDFGVSACLFDSGDRQRVRNTFVGTPCW 180
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
MAPEVMEQL+GYDFKADIWSF IT LELAHGHAPFSKYPPMKVL+MTLQNAPPGLDYERD
Sbjct: 181 MAPEVMEQLNGYDFKADIWSFAITGLELAHGHAPFSKYPPMKVLMMTLQNAPPGLDYERD 240
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA 300
+KFSKSFKQMIASCLVKDPSKRPSA KLLKH FF+QARSN+YIAR LLEGLP LGDRIKA
Sbjct: 241 KKFSKSFKQMIASCLVKDPSKRPSASKLLKHXFFRQARSNDYIARALLEGLPVLGDRIKA 300
Query: 301 LKKKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQD-EDMISESNH 359
LK+KEEDMLAQKK+ DG+KEE+SQNEYKRGISGWNFNL+D+KAQASLIQ+ E+ ISE +
Sbjct: 301 LKRKEEDMLAQKKISDGKKEELSQNEYKRGISGWNFNLDDLKAQASLIQEFEESISEMSE 360
Query: 360 GGSSSTLSSLEMQGKQSECQ----------VAVLNQLPPHILVESTMNITKLRCDKSDDD 409
GSS++L++L++Q K+ + Q A+L + P ++ I K +
Sbjct: 361 VGSSNSLNALDVQEKKLQGQNSSEISDVEENAMLRRQPSMKANDTVYEIEK--------N 412
Query: 410 SSVASPCFEQYTQLSSPCHDDRNQNNPSEKPSLEGTASPSHQRAGSTALSESIIAPVNKE 469
+ SP ++S DD ++ S+ P K
Sbjct: 413 GANGSPAM----GVTSQAVDDALSDSQSKDP---------------------------KS 441
Query: 470 SVTVAANSDELDEKAKPPVIQQKGRFKVTSENVCLEKVVP-PTLQKSHSMQVLSQSPAIS 528
S++ A +E DEKAK PVIQQKGRFKVTSE+V LEK P LQKSHSMQV + S
Sbjct: 442 SLSPAITEEEQDEKAKAPVIQQKGRFKVTSESVDLEKAAASPILQKSHSMQVGNFEVITS 501
Query: 529 SL---VPSDT----------------ALSNLSGNSLFPMLCNVLQTNILQRESILNLMKQ 569
+ +PS+ A+ + +S+FP+L +VLQTNI+QR+ IL LM+Q
Sbjct: 502 NCATPLPSNLPTPLLTPLLTPLPSSDAIPINTRSSMFPVLHSVLQTNIVQRDDILTLMRQ 561
Query: 570 VSVGDCTANRLVDGGGTPANTVTTEKSLLEAAHDREKDLLHEITDLQWRLMCAQDELQKY 629
+S G+ +A+ +VD + A+ TEKSLLEAAH+REKDLL+E+T+LQWR++ A+DE+Q+
Sbjct: 562 ISTGEFSADGVVD--VSAAHITATEKSLLEAAHEREKDLLNEVTELQWRILRARDEIQRL 619
Query: 630 KTEN 633
K N
Sbjct: 620 KLNN 623
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 636 | ||||||
| TAIR|locus:2019878 | 687 | AT1G79640 [Arabidopsis thalian | 0.727 | 0.673 | 0.720 | 5.9e-231 | |
| TAIR|locus:2185440 | 674 | AT5G14720 [Arabidopsis thalian | 0.547 | 0.516 | 0.708 | 5.1e-151 | |
| TAIR|locus:2132716 | 711 | AT4G10730 [Arabidopsis thalian | 0.718 | 0.642 | 0.549 | 6.6e-149 | |
| TAIR|locus:2135016 | 709 | AT4G24100 [Arabidopsis thalian | 0.550 | 0.493 | 0.645 | 3.4e-141 | |
| TAIR|locus:2016164 | 594 | AT1G70430 [Arabidopsis thalian | 0.520 | 0.557 | 0.637 | 2.1e-124 | |
| DICTYBASE|DDB_G0276577 | 1028 | fray2 "FRAY subfamily protein | 0.487 | 0.301 | 0.554 | 1.3e-94 | |
| TAIR|locus:2034888 | 473 | AT1G23700 [Arabidopsis thalian | 0.479 | 0.644 | 0.524 | 1.5e-89 | |
| FB|FBgn0023083 | 552 | fray "frayed" [Drosophila mela | 0.476 | 0.548 | 0.511 | 3.7e-80 | |
| UNIPROTKB|Q863I2 | 529 | OXSR1 "Serine/threonine-protei | 0.504 | 0.606 | 0.483 | 1.2e-79 | |
| UNIPROTKB|E1C6W3 | 533 | OXSR1 "Uncharacterized protein | 0.490 | 0.585 | 0.489 | 1.6e-79 |
| TAIR|locus:2019878 AT1G79640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1781 (632.0 bits), Expect = 5.9e-231, Sum P(2) = 5.9e-231
Identities = 350/486 (72%), Positives = 399/486 (82%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
M+KKKYPIG EHYTLYE +GQGVSA VHRALCIPF+E+VA+KILDFERDN DL+NISREA
Sbjct: 4 MEKKKYPIGPEHYTLYEFIGQGVSALVHRALCIPFDEVVAIKILDFERDNCDLNNISREA 63
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
QTM+LVDHPNVLKSHCSFVSDHNLWV+MP+MSGGSCLHILKAAYPDGFEE +IATILRE
Sbjct: 64 QTMMLVDHPNVLKSHCSFVSDHNLWVIMPYMSGGSCLHILKAAYPDGFEEAIIATILREA 123
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
LKGLDYLH HGHIHRDVK+GNIL+ RGA+KLGDFGVSACLFDSGDRQR RNTFVGTPCW
Sbjct: 124 LKGLDYLHQHGHIHRDVKAGNILLGARGAVKLGDFGVSACLFDSGDRQRTRNTFVGTPCW 183
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
MAPEVMEQLHGYDFKADIWSFGIT LELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD
Sbjct: 184 MAPEVMEQLHGYDFKADIWSFGITGLELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA 300
+KFS+SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS++YIAR LL+GLP L +R++A
Sbjct: 244 KKFSRSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSSDYIARKLLDGLPDLVNRVQA 303
Query: 301 LKKKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQDEDMIXXXXXX 360
+K+KEEDMLAQ+KM DG+KEE+SQNEYKRGISGWNFNL+D+KAQASLIQD D
Sbjct: 304 IKRKEEDMLAQEKMADGEKEELSQNEYKRGISGWNFNLDDMKAQASLIQDMDCGFSDSLS 363
Query: 361 XXXXXXXXXXMQGKQSECQV---AVLNQ-LPPHILVESTMNITKLRCDKSDDDSSVASPC 416
Q QSE Q + N+ L P L+ +++I + DKSDDDSS+ASP
Sbjct: 364 GSATSLQALDSQDTQSEIQEDTGQITNKYLQP--LIHRSLSIAR---DKSDDDSSLASPS 418
Query: 417 FEQYTQLSSPCHDDRNQNNP--------SEKPSLEGTASPSHQR----AGSTALSESIIA 464
++ Y SSP H+D + NN + KP+ + T+ P++Q AGS+ L++ A
Sbjct: 419 YDSYVY-SSPRHEDLSLNNTHVGSTHANNGKPT-DATSIPTNQPTEIIAGSSVLADGNGA 476
Query: 465 PVNKES 470
P ES
Sbjct: 477 PNKGES 482
|
|
| TAIR|locus:2185440 AT5G14720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1397 (496.8 bits), Expect = 5.1e-151, Sum P(2) = 5.1e-151
Identities = 248/350 (70%), Positives = 298/350 (85%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT 62
+KK+P+ A+ Y LYEE+G GVSA+VHRALCIP N +VA+K+LD E+ N+DL I RE QT
Sbjct: 6 EKKFPLNAKDYKLYEEIGDGVSATVHRALCIPLNVVVAIKVLDLEKCNNDLDGIRREVQT 65
Query: 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
M L++HPNVL++HCSF + H LWVVMP+M+GGSCLHI+K++YPDGFEE VIAT+LRE LK
Sbjct: 66 MSLINHPNVLQAHCSFTTGHQLWVVMPYMAGGSCLHIIKSSYPDGFEEPVIATLLRETLK 125
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
L YLH HGHIHRDVK+GNIL+D GA+KL DFGVSAC+FD+GDRQR RNTFVGTPCWMA
Sbjct: 126 ALVYLHAHGHIHRDVKAGNILLDSNGAVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 185
Query: 183 PEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242
PEVM+QLHGYDFKAD+WSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD++
Sbjct: 186 PEVMQQLHGYDFKADVWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
Query: 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALK 302
FSK+FK+M+ +CLVKDP KRP+++KLLKH FFK AR +Y+ +T+L GLP LGDR + +K
Sbjct: 246 FSKAFKEMVGTCLVKDPKKRPTSEKLLKHPFFKHARPADYLVKTILNGLPPLGDRYRQIK 305
Query: 303 KKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQDED 352
KE D+L Q K + +SQ EY RGIS WNFNLED+K QA+LI D+D
Sbjct: 306 SKEADLLMQNKSE--YEAHLSQQEYIRGISAWNFNLEDLKTQAALISDDD 353
|
|
| TAIR|locus:2132716 AT4G10730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1304 (464.1 bits), Expect = 6.6e-149, Sum P(2) = 6.6e-149
Identities = 259/471 (54%), Positives = 327/471 (69%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT 62
KK + + + Y L EEVG G SA VHRA+ +P NE+VA+K LD +R NS+L +I REAQT
Sbjct: 37 KKGFSVNPKDYKLMEEVGYGASAVVHRAIYLPTNEVVAIKSLDLDRCNSNLDDIRREAQT 96
Query: 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
M L+DHPNV+KS CSF DH+LWVVMPFM+ GSCLH++KAAYPDGFEE I ++L+E LK
Sbjct: 97 MTLIDHPNVIKSFCSFAVDHHLWVVMPFMAQGSCLHLMKAAYPDGFEEAAICSMLKETLK 156
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
LDYLH GHIHRDVK+GNIL+D G IKLGDFGVSACLFD+GDRQR RNTFVGTPCWMA
Sbjct: 157 ALDYLHRQGHIHRDVKAGNILLDDTGEIKLGDFGVSACLFDNGDRQRARNTFVGTPCWMA 216
Query: 183 PEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242
PEV++ GY+ KADIWSFGITALELAHGHAPFSKYPPMKVLLMT+QNAPPGLDY+RD+K
Sbjct: 217 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 276
Query: 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALK 302
FSKSFK+++A CLVKD +KRP+A+KLLKHSFFK + E + L LP L R+KAL+
Sbjct: 277 FSKSFKELVALCLVKDQTKRPTAEKLLKHSFFKNVKPPEICVKKLFVDLPPLWTRVKALQ 336
Query: 303 KKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQDEDMIXXXXXXXX 362
K+ LA K M ++ ISQ+EY+RG+S WNFN+ED+K QASL+ D+D++
Sbjct: 337 AKDAAQLALKGMASADQDAISQSEYQRGVSAWNFNIEDLKEQASLLDDDDILTESREEEE 396
Query: 363 XXXXXXXXMQGKQSECQVAVLNQLPPHILVESTMNITKLRCDKSDDDSSVASPCFEQYTQ 422
G+Q +V Q+ L+ MN K +K+ D + V P E+ +
Sbjct: 397 SF--------GEQLHNKVNDRGQVSGSQLLSENMN-GK---EKASD-TEVVEPICEEKST 443
Query: 423 LSSPCHDDRNQNNPSEKPSLEGTASPSHQRAGSTALSESIIAPVNKESVTV 473
L+S + SE+ + P + S LS ++ +N +S V
Sbjct: 444 LNSTTSSVEQPASSSEQDVPQAKGKPVRLQTHSGPLSSGVVL-INSDSEKV 493
|
|
| TAIR|locus:2135016 AT4G24100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1242 (442.3 bits), Expect = 3.4e-141, Sum P(2) = 3.4e-141
Identities = 226/350 (64%), Positives = 280/350 (80%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT 62
++ + + + Y L EE+G G SA V+RA+ +P NE+VA+K LD +R NS+L +I RE+QT
Sbjct: 23 QRGFSMNPKDYKLMEEIGHGASAVVYRAIYLPTNEVVAIKCLDLDRCNSNLDDIRRESQT 82
Query: 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
M L+DHPNV+KS CSF DH+LWVVMPFM+ GSCLH++K AY DGFEE I +L+E LK
Sbjct: 83 MSLIDHPNVIKSFCSFSVDHSLWVVMPFMAQGSCLHLMKTAYSDGFEESAICCVLKETLK 142
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
LDYLH GHIHRDVK+GNIL+D G IKLGDFGVSACLFD+GDRQR RNTFVGTPCWMA
Sbjct: 143 ALDYLHRQGHIHRDVKAGNILLDDNGEIKLGDFGVSACLFDNGDRQRARNTFVGTPCWMA 202
Query: 183 PEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242
PEV++ +GY+ KADIWSFGITALELAHGHAPFSKYPPMKVLLMT+QNAPPGLDY+RD+K
Sbjct: 203 PEVLQPGNGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 262
Query: 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALK 302
FSKSFK+M+A CLVKD +KRP+A+KLLKHS FK + E + L LP L R+K+L+
Sbjct: 263 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSCFKHTKPPEQTVKILFSDLPPLWTRVKSLQ 322
Query: 303 KKEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQDED 352
K+ LA K+M +E ISQ+EY+RG+S WNF++ D+K QASL+ D+D
Sbjct: 323 DKDAQQLALKRMATADEEAISQSEYQRGVSAWNFDVRDLKTQASLLIDDD 372
|
|
| TAIR|locus:2016164 AT1G70430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1191 (424.3 bits), Expect = 2.1e-124, Sum P(2) = 2.1e-124
Identities = 220/345 (63%), Positives = 275/345 (79%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM 63
K++P+ A+ Y L+EEVG+GVSA+V+RA CI NEIVAVKILD E+ +DL I +E M
Sbjct: 7 KRFPLYAKDYELFEEVGEGVSATVYRARCIALNEIVAVKILDLEKCRNDLETIRKEVHIM 66
Query: 64 ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
L+DHPN+LK+HCSF+ +LW+VMP+MSGGSC H++K+ YP+G E+ +IAT+LREVLK
Sbjct: 67 SLIDHPNLLKAHCSFIDSSSLWIVMPYMSGGSCFHLMKSVYPEGLEQPIIATLLREVLKA 126
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
L YLH GHIHRDVK+GNILI +G +KLGDFGVSAC+FDSG+R + RNTFVGTPCWMAP
Sbjct: 127 LVYLHRQGHIHRDVKAGNILIHSKGVVKLGDFGVSACMFDSGERMQTRNTFVGTPCWMAP 186
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243
EVM+QL GYDFK LAHGHAPFSKYPPMKVLLMTLQNAPP LDY+RD+KF
Sbjct: 187 EVMQQLDGYDFKY-----------LAHGHAPFSKYPPMKVLLMTLQNAPPRLDYDRDKKF 235
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKK 303
SKSF+++IA+CLVKDP KRP+A KLLKH FFK ARS +Y++R +L GL LG+R K LK+
Sbjct: 236 SKSFRELIAACLVKDPKKRPTAAKLLKHPFFKHARSTDYLSRKILHGLSPLGERFKKLKE 295
Query: 304 KEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLI 348
E ++ K +G KE++SQ+EY RGIS WNF+LE ++ QASL+
Sbjct: 296 AEAELF---KGINGDKEQLSQHEYMRGISAWNFDLEALRRQASLV 337
|
|
| DICTYBASE|DDB_G0276577 fray2 "FRAY subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 901 (322.2 bits), Expect = 1.3e-94, Sum P(2) = 1.3e-94
Identities = 174/314 (55%), Positives = 219/314 (69%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQ 61
+K YP A+ Y L E +G+G S V RA+C+PF E VA+KI+D E N L I +E Q
Sbjct: 61 RKNYPNSADQYELKETIGKGGSGLVQRAICLPFQENVAIKIIDLEHCKNVSLEEIRKEIQ 120
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
M L HPNV+ H SFV + +LWV+M F+S GSC I++ ++P GFEE VIATIL+E L
Sbjct: 121 AMSLCHHPNVVAYHTSFVYNESLWVIMDFLSAGSCSDIMRFSFPQGFEEHVIATILKEAL 180
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
K + Y H G IHRD+KSGNILID G I+L DFGVSA L D+G+ R NTFVGTPCWM
Sbjct: 181 KAICYFHKTGRIHRDIKSGNILIDSNGNIQLSDFGVSATLIDTGETSR--NTFVGTPCWM 238
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
APE+MEQ++ YD+ DIWSFGITALELA G APF++YPPMKVLL+TLQN PP L+ + +
Sbjct: 239 APEIMEQVN-YDYAVDIWSFGITALELARGKAPFAEYPPMKVLLLTLQNPPPSLEGDGES 297
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKAL 301
K+S SFK ++ CL KDPSKRP KLL+H FFKQA+ +Y+ + +L LP LG R + L
Sbjct: 298 KWSHSFKDLVEKCLQKDPSKRPLPSKLLEHRFFKQAKKPDYLVQHILAKLPPLGQRYQML 357
Query: 302 KKKEEDMLAQKKMP 315
+ ML P
Sbjct: 358 SEDSFAMLRNTSSP 371
|
|
| TAIR|locus:2034888 AT1G23700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 1.5e-89, Sum P(2) = 1.5e-89
Identities = 170/324 (52%), Positives = 234/324 (72%)
Query: 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI 64
++P+ A+ Y + EE+G GV +RA CI +EIVA+KI + E+ +DL I +E +
Sbjct: 8 RFPLVAKDYEILEEIGDGV----YRARCILLDEIVAIKIWNLEKCTNDLETIRKEVHRLS 63
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGL 124
L+DHPN+L+ HCSF+ +LW+VMPFMS GS L+I+K+ YP+G EE VIA +LRE+LK L
Sbjct: 64 LIDHPNLLRVHCSFIDSSSLWIVMPFMSCGSSLNIMKSVYPNGLEEPVIAILLREILKAL 123
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM--RNTFVGTPCWMA 182
YLH GHIHR+VK+GN+L+D G +KLGDF VSA +FDS +R R NTFVG P MA
Sbjct: 124 VYLHGLGHIHRNVKAGNVLVDSEGTVKLGDFEVSASMFDSVERMRTSSENTFVGNPRRMA 183
Query: 183 PEV-MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-PGLDYERD 240
PE M+Q+ GYDFK DIWSFG+TALELAHGH+P + VL + LQN+P P +YE D
Sbjct: 184 PEKDMQQVDGYDFKVDIWSFGMTALELAHGHSPTT------VLPLNLQNSPFP--NYEED 235
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA 300
KFSKSF++++A+CL++DP KRP+A +LL++ F +Q S EY+A T L+GL LG+R +
Sbjct: 236 TKFSKSFRELVAACLIEDPEKRPTASQLLEYPFLQQTLSTEYLASTFLDGLSPLGERYRK 295
Query: 301 LKKKEEDMLAQKKMPDGQKEEISQ 324
LK+++ ++ K DG KE++SQ
Sbjct: 296 LKEEKAKLV---KGVDGNKEKVSQ 316
|
|
| FB|FBgn0023083 fray "frayed" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 3.7e-80, P = 3.7e-80
Identities = 162/317 (51%), Positives = 218/317 (68%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQ 61
+K +P + Y L + +G G +A VH A CIP NE A+K ++ E+ N+ + + +E Q
Sbjct: 27 EKYTWPNSKDDYELRDVIGVGATAVVHGAYCIPRNEKCAIKRINLEKWNTSMDELLKEIQ 86
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILK-----AAYPDG-FEEVVIAT 115
M H NV+ H SFV LW+V+ + GGS L I+K + G F+E IAT
Sbjct: 87 AMSSCFHENVVTYHTSFVVREELWLVLRLLEGGSLLDIIKHKMRTSNCKQGVFDEATIAT 146
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD--RQRMRNT 173
+L+EVLKGL+Y H +G IHRD+K+GNILI G I++ DFGVSA L D RQ++R+T
Sbjct: 147 VLKEVLKGLEYFHSNGQIHRDIKAGNILIGDDGTIQIADFGVSAWLATGRDLSRQKVRHT 206
Query: 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233
FVGTPCWMAPEVMEQ HGYDFKADIWSFGITA+E+A G AP+ KYPPMKVL++TLQN PP
Sbjct: 207 FVGTPCWMAPEVMEQDHGYDFKADIWSFGITAIEMATGTAPYHKYPPMKVLMLTLQNDPP 266
Query: 234 GLDYERDRK-----FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLL 288
LD D K + K+F++MI CL K+PSKRP+A +LLKH+FFK+A+ +Y+ +TLL
Sbjct: 267 TLDTGADDKDQYKAYGKTFRKMIVECLQKEPSKRPTASELLKHAFFKKAKDRKYLTQTLL 326
Query: 289 EGLPALGDRI-KALKKK 304
+ P++ R+ KA K++
Sbjct: 327 QSGPSMETRVHKAAKRQ 343
|
|
| UNIPROTKB|Q863I2 OXSR1 "Serine/threonine-protein kinase OSR1" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.2e-79, P = 1.2e-79
Identities = 162/335 (48%), Positives = 219/335 (65%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+ I + Y L E +G G +A V A C P E VA+K ++ E+ + + + +E Q M
Sbjct: 10 WSINKDDYELQEVIGSGATAVVQAAYCTPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG------FEEVVIATILRE 119
HPN++ + SFV LW+VM +SGGS L I+K G +E IATILRE
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEATIATILRE 129
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD--RQRMRNTFVGT 177
VL+GL+YLH +G IHRDVK+GNIL+ G++++ DFGVSA L GD R ++R TFVGT
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 235
PCWMAPEVMEQ+ GYDFKADIWSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 236 ---DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
D E +K+ KSF++MI+ CL KDP KRP+A +LL+H FF++A++ EY+ +L+ P
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEYLQEKILQRAP 309
Query: 293 ALGDRIKALKKKEEDMLAQKKMPDGQKEEISQNEY 327
+ +R K +++ K DG E S +E+
Sbjct: 310 TISERAKKVRRVPGSSGRLHKTEDGGWEW-SDDEF 343
|
|
| UNIPROTKB|E1C6W3 OXSR1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 799 (286.3 bits), Expect = 1.6e-79, P = 1.6e-79
Identities = 159/325 (48%), Positives = 215/325 (66%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+ I + Y L E +G G +A V A C+P E VA+K ++ E+ + + + +E Q M
Sbjct: 10 WSINKDDYELQEVIGSGATAVVQAAFCVPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG------FEEVVIATILRE 119
HPN++ + SFV LW+VM +SGGS L I+K G +E IATIL+E
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKTGVLDEPCIATILKE 129
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD--RQRMRNTFVGT 177
VL+GLDYLH +G IHRDVK+GNIL+ G++++ DFGVSA L GD R ++R TFVGT
Sbjct: 130 VLEGLDYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 235
PCWMAPEVMEQ+ GYDFKADIWSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 236 ---DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
D E +K+ KSF++MI+SCL KDP KRP+A +LL+H FF +A++ E++ +L+ P
Sbjct: 250 GVQDKEMLKKYGKSFRKMISSCLQKDPEKRPTAAELLRHKFFTKAKNKEFLQEKMLQRAP 309
Query: 293 ALGDRIKALKKKEEDMLAQKKMPDG 317
+ +R K +++ K DG
Sbjct: 310 TITERSKKVRRVPGSSGRLHKTEDG 334
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | AT1G79640 | ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein tyrosine kinase; ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein tyrosine kinase; FUNCTIONS IN- protein serine/threonine kinase activity, protein tyrosine kinase activity, protein kinase activity, kinase activity, ATP binding; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- cellular_component unknown; EXPRESSED IN- 23 plant structures; EXPRESSED DURING- 14 growth stages; CONTAINS InterPro DOMAIN/s- Protein kinase, ATP binding site (InterPro-IPR017441), Protein kina [...] (687 aa) | |||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 636 | |||
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-165 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-106 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-99 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-89 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-88 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-80 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-79 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-76 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-75 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-74 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-74 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-72 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-72 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-68 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-67 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-66 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-63 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-63 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-61 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-61 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-56 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-54 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-53 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-53 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-52 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-52 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-51 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-51 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-51 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-51 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-50 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-49 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-49 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-49 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-48 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-47 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-47 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-47 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-47 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-47 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-46 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-46 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-46 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-45 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-44 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-43 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-43 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-42 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-42 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-41 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-41 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-40 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-39 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-39 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-38 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-38 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-37 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-37 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-37 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-37 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-37 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-36 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-35 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-35 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-35 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-35 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-34 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-34 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-34 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-33 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-32 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-32 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-30 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-30 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-30 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-30 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-29 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-29 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-29 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-28 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-28 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-28 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-28 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-27 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-25 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-24 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-24 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-24 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-23 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-23 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-23 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-23 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-22 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-22 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-22 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-22 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-22 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-22 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-22 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-21 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-21 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-21 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-21 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-21 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-21 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-20 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-20 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-19 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-19 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-18 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-18 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-18 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-17 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-16 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-12 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 7e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 473 bits (1219), Expect = e-165
Identities = 159/267 (59%), Positives = 209/267 (78%), Gaps = 3/267 (1%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ Y L E +G G +A V+ A+C+P NE VA+K +D E+ + + + +E Q M +HPN
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYP-DGFEEVVIATILREVLKGLDYLHH 129
V+K + SFV LW+VMP++SGGS L I+K++YP G +E +IAT+L+EVLKGL+YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ-RMRNTFVGTPCWMAPEVMEQ 188
+G IHRD+K+GNIL+ G++K+ DFGVSA L D GDR ++R TFVGTPCWMAPEVMEQ
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD-RKFSKSF 247
+HGYDFKADIWSFGITA+ELA G AP+SKYPPMKVL++TLQN PP L+ D +K+SKSF
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240
Query: 248 KQMIASCLVKDPSKRPSAKKLLKHSFF 274
++MI+ CL KDPSKRP+A++LLKH FF
Sbjct: 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 320 bits (823), Expect = e-106
Identities = 129/271 (47%), Positives = 174/271 (64%), Gaps = 10/271 (3%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
+TL E +G+G V++A+ N++VA+K++D E ++ +I +E Q + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH 132
K + SF+ LW++M + GGSCL +LK P +E IA ILREVL GL+YLH G
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLK---PGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 133 IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGY 192
IHRD+K+ NIL+ G +KL DFGVS L + + RNTFVGTP WMAPEV++Q GY
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK---RNTFVGTPFWMAPEVIKQS-GY 175
Query: 193 DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIA 252
D KADIWS GITA+ELA G P S PM+VL + +N PP L+ KFSK FK ++
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE---GNKFSKPFKDFVS 232
Query: 253 SCLVKDPSKRPSAKKLLKHSFFKQARSNEYI 283
CL KDP +RPSAK+LLKH F K+A+ Y+
Sbjct: 233 LCLNKDPKERPSAKELLKHKFIKKAKKTSYL 263
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 302 bits (777), Expect = 3e-99
Identities = 116/262 (44%), Positives = 158/262 (60%), Gaps = 9/262 (3%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNV 71
+ + E++G+G V++A + VA+K++ E I E Q + HPN+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNI 59
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
+K + S++ LW+VM F SGGS +LK+ E IA + +E+LKGL+YLH +G
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG 191
IHRD+K+ NIL+ G +KL DFG+SA L D+ RNT VGTP WMAPEV+
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----RNTMVGTPYWMAPEVINGKP- 173
Query: 192 YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251
YD+KADIWS GITA+ELA G P+S+ PPMK L N PPGL K+S FK +
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR--NPEKWSDEFKDFL 231
Query: 252 ASCLVKDPSKRPSAKKLLKHSF 273
CL K+P KRP+A++LLKH F
Sbjct: 232 KKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 277 bits (712), Expect = 2e-89
Identities = 109/264 (41%), Positives = 157/264 (59%), Gaps = 10/264 (3%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E + + E++G+G SV++A+ ++VA+K++ DL I +E + D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPY 59
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++K + S+ + +LW+VM + GS I+K E IA IL + LKGL+YLH +
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
IHRD+K+GNIL++ G KL DFGVS L D+ RNT +GTP WMAPEV++++
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---MAKRNTVIGTPFWMAPEVIQEI- 174
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
GY+ KADIWS GITA+E+A G P+S PM+ + M PP L K+S F
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTL--SDPEKWSPEFNDF 232
Query: 251 IASCLVKDPSKRPSAKKLLKHSFF 274
+ CLVKDP +RPSA +LL+H F
Sbjct: 233 VKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 274 bits (703), Expect = 4e-88
Identities = 89/262 (33%), Positives = 132/262 (50%), Gaps = 8/262 (3%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
Y + E++G+G V+ A ++VA+K++ ++ D I RE + + + HPN++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH 132
+ + F + L++VM + GG +LK E LR++L L+YLH G
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSKGI 118
Query: 133 IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGY 192
+HRD+K NIL+D G +KL DFG++ L D TFVGTP +MAPEV+ GY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQL----DPGEKLTTFVGTPEYMAPEVLLG-KGY 173
Query: 193 DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIA 252
DIWS G+ EL G PF + L + P S K +I
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEW-DISPEAKDLIR 232
Query: 253 SCLVKDPSKRPSAKKLLKHSFF 274
LVKDP KR +A++ L+H FF
Sbjct: 233 KLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 3e-80
Identities = 111/266 (41%), Positives = 149/266 (56%), Gaps = 9/266 (3%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E Y L + +G G V++A I E+VA+K++ E D I +E + HPN
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-PGDDFEIIQQEISMLKECRHPN 61
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ S++ LW+VM + GGS I + E+ IA + RE LKGL YLH
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET 120
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM--EQ 188
G IHRD+K NIL+ G +KL DFGVSA L + + R +F+GTP WMAPEV E+
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK---RKSFIGTPYWMAPEVAAVER 177
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL-LMTLQNAPPGLDYERDRKFSKSF 247
GYD K DIW+ GITA+ELA P PM+ L L++ N PP +++ K+S F
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE-KWSPVF 236
Query: 248 KQMIASCLVKDPSKRPSAKKLLKHSF 273
I CL KDP KRP+A KLL+H F
Sbjct: 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 253 bits (649), Expect = 1e-79
Identities = 110/278 (39%), Positives = 153/278 (55%), Gaps = 9/278 (3%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
E Y E++G+G S V++A + VA+K + + N I E M HP
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEILIMKDCKHP 75
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N++ + S++ LWVVM +M GGS I+ E IA + REVL+GL+YLH
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
IHRD+KS NIL+ G++KL DFG +A L + RN+ VGTP WMAPEV+++
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL---TKEKSKRNSVVGTPYWMAPEVIKR- 190
Query: 190 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249
Y K DIWS GI +E+A G P+ + PP++ L + P L K+S FK
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP--EKWSPEFKD 248
Query: 250 MIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTL 287
+ CLVKDP KRPSA++LL+H F K+A E A +
Sbjct: 249 FLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEFAPLI 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 4e-76
Identities = 102/267 (38%), Positives = 159/267 (59%), Gaps = 12/267 (4%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQ---TMILVDHP 69
Y E +G+G +V+R +P +VA+KI++ + + D+S+I RE + P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N+ K + S++ LW++M + GGS ++KA E I+ I+REVL L Y+H
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK 119
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
G IHRD+K+ NIL+ G +KL DFGV+A L + +R +TFVGTP WMAPEV+ +
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAA-LLNQNSSKR--STFVGTPYWMAPEVITEG 176
Query: 190 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249
YD KADIWS GIT E+A G+ P+S + +++ ++ PP L+ D +SK ++
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE---DNGYSKLLRE 233
Query: 250 MIASCLVKDPSKRPSAKKLLKHSFFKQ 276
+A+CL ++P +R SA++LLK + K
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKWIKA 260
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 243 bits (620), Expect = 1e-75
Identities = 122/263 (46%), Positives = 170/263 (64%), Gaps = 11/263 (4%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E +T E +G+G V++ + E+VA+KI+D E ++ +I +E + D P
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
+ + + S++ LW++M ++ GGS L +LK P EE IATILRE+LKGLDYLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSE 120
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
IHRD+K+ N+L+ +G +KL DFGV+ L D+ Q RNTFVGTP WMAPEV++Q
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAPEVIKQ-S 176
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
YDFKADIWS GITA+ELA G P S PM+VL + +N+PP L + ++SK FK+
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL----EGQYSKPFKEF 232
Query: 251 IASCLVKDPSKRPSAKKLLKHSF 273
+ +CL KDP RP+AK+LLKH F
Sbjct: 233 VEACLNKDPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 239 bits (613), Expect = 1e-74
Identities = 108/275 (39%), Positives = 149/275 (54%), Gaps = 22/275 (8%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM-ILVDHPNV 71
+ L E +G+G V++A ++VA+KI+D D + I E + +HPN+
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE--EIKEEYNILRKYSNHPNI 65
Query: 72 LKSHCSF------VSDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVLKG 123
+ +F +D LW+VM GGS ++K G +E IA ILRE L+G
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM-RNTFVGTPCWMA 182
L YLH + IHRD+K NIL+ +KL DFGVSA L D RNTF+GTP WMA
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DSTLGRRNTFIGTPYWMA 181
Query: 183 PEV---MEQLH-GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238
PEV EQ YD ++D+WS GITA+ELA G P PM+ L +N PP L +
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL--K 239
Query: 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
+SK F I+ CL+K+ +RP ++LL+H F
Sbjct: 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 6e-74
Identities = 112/308 (36%), Positives = 154/308 (50%), Gaps = 43/308 (13%)
Query: 14 TLYEEVGQGVS--ASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPN 70
L +G+ VH A P N +VAVK ++ + DL + +E T + HPN
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
+L SF+ D L+VV P M+ GSC +LK +P+G E+ IA IL++VL LDY+H
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-------WMAP 183
G IHR VK+ +IL+ G + L S + G RQR P W++P
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR---VVHDFPKSSVKNLPWLSP 177
Query: 184 EVMEQ-LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL------- 235
EV++Q L GY+ K+DI+S GITA ELA+GH PF P ++LL ++ P L
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237
Query: 236 DYERD----------------------RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
YE R FS+ F Q + CL +DP RPSA +LL HSF
Sbjct: 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297
Query: 274 FKQARSNE 281
FKQ +
Sbjct: 298 FKQCKRRN 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 234 bits (597), Expect = 2e-72
Identities = 126/278 (45%), Positives = 174/278 (62%), Gaps = 12/278 (4%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E +T E +G+G V + + ++VA+KI+D E ++ +I +E + D P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
V K + S++ LW++M ++ GGS L +L+A F+E IAT+L+E+LKGLDYLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE 120
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
IHRD+K+ N+L+ +G +KL DFGV+ L D+ Q RNTFVGTP WMAPEV++Q
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAPEVIQQ-S 176
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
YD KADIWS GITA+ELA G P S PM+VL + +N PP L E FSK FK+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE----FSKPFKEF 232
Query: 251 IASCLVKDPSKRPSAKKLLKHSFF-KQARSNEYIARTL 287
I +CL KDPS RP+AK+LLKH F K A+ Y+ +
Sbjct: 233 IDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELI 270
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 233 bits (594), Expect = 7e-72
Identities = 123/278 (44%), Positives = 174/278 (62%), Gaps = 12/278 (4%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E +T E++G+G V + + ++VA+KI+D E ++ +I +E + D P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
V K + S++ D LW++M ++ GGS L +L+ P +E IATILRE+LKGLDYLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE 120
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
IHRD+K+ N+L+ G +KL DFGV+ L D+ Q RNTFVGTP WMAPEV++Q
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAPEVIKQ-S 176
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
YD KADIWS GITA+ELA G P S+ PMKVL + +N PP L + +SK K+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTL----EGNYSKPLKEF 232
Query: 251 IASCLVKDPSKRPSAKKLLKHSF-FKQARSNEYIARTL 287
+ +CL K+PS RP+AK+LLKH F + A+ Y+ +
Sbjct: 233 VEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELI 270
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 223 bits (569), Expect = 5e-68
Identities = 108/284 (38%), Positives = 160/284 (56%), Gaps = 11/284 (3%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
+ + + E+G G V++A A KI+ E +L + E + HP
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHP 62
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N++ + ++ ++ LW+++ F GG+ L + G E I + R++L+ L++LH
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGA-LDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM--- 186
H IHRD+K+GNIL+ + G +KL DFGVSA + Q+ R+TF+GTP WMAPEV+
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQK-RDTFIGTPYWMAPEVVACE 178
Query: 187 -EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
+ + YD+KADIWS GIT +ELA P + PM+VLL L++ PP LD + K+S
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD--QPSKWSS 236
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLE 289
SF + SCLVKDP RP+A +LLKH F N+ I L E
Sbjct: 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLLAE 280
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 3e-67
Identities = 94/265 (35%), Positives = 139/265 (52%), Gaps = 8/265 (3%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-FERDNSDLSNISREAQTMILVDHPNV 71
Y L ++G G +V++A +IVAVKIL + RE + + + HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
++ +F +L++VM + GG L P E I ++L+GL+YLH +G
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNG 118
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG 191
IHRD+K NIL+D G +K+ DFG++ L S TFVGTP +MAPEV+ +G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKS---SSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 192 YDFKADIWSFGITALELAHGHAPFS--KYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249
Y K D+WS G+ EL G PFS L+ + P D + S+ K
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 250 MIASCLVKDPSKRPSAKKLLKHSFF 274
+I CL KDPSKRP+A+++L+H +F
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 2e-66
Identities = 102/264 (38%), Positives = 147/264 (55%), Gaps = 17/264 (6%)
Query: 20 GQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV 79
GQG S V++ P +I A+K + + D + RE +T+ + P V+K + +F
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 80 SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH-IHRDVK 138
+ + +V+ +M GGS L L E V+A I R++LKGLDYLH H IHRD+K
Sbjct: 70 KEGEISIVLEYMDGGS-LADLLKKVG-KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIK 127
Query: 139 SGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG--YDFKA 196
N+LI+ +G +K+ DFG+S L ++ D NTFVGT +M+P E++ G Y + A
Sbjct: 128 PSNLLINSKGEVKIADFGISKVLENTLD---QCNTFVGTVTYMSP---ERIQGESYSYAA 181
Query: 197 DIWSFGITALELAHGHAPFSK---YPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253
DIWS G+T LE A G PF +++ PP L E FS F+ I++
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEE---FSPEFRDFISA 238
Query: 254 CLVKDPSKRPSAKKLLKHSFFKQA 277
CL KDP KRPSA +LL+H F K+A
Sbjct: 239 CLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 2e-63
Identities = 90/268 (33%), Positives = 138/268 (51%), Gaps = 15/268 (5%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSN-ISREAQTMILVDHPNV 71
+T E +G+G SV+ AL E++AVK ++ D+ + + RE + + + HPN+
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 72 LK--SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
++ + L + + ++SGGS +LK E VI R++L+GL YLH
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHS 119
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
+G +HRD+K NIL+D G +KL DFG + + + GTP WMAPEV+
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEVIRG- 177
Query: 190 HGYDFKADIWSFGITALELAHGHAPFSKYP-PMKVLL--MTLQNAPPGLDYERDRKFSKS 246
Y ADIWS G T +E+A G P+S+ PM L + P ++ S+
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH-----LSEE 232
Query: 247 FKQMIASCLVKDPSKRPSAKKLLKHSFF 274
K + CL +DP KRP+A +LL+H F
Sbjct: 233 AKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 3e-63
Identities = 87/254 (34%), Positives = 128/254 (50%), Gaps = 41/254 (16%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSF 78
+G+G +V+ A + VA+KI+ E +S L + RE + + ++HPN++K + F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 79 VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVK 138
+++L++VM + GGS +LK E I IL ++L+GL+YLH +G IHRD+K
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 139 SGNILID-VRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKAD 197
NIL+D G +KL DFG+S L + T VGTP +MAPEV+ Y K+D
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 198 IWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVK 257
IWS G+ EL K +I L K
Sbjct: 177 IWSLGVILYEL------------------------------------PELKDLIRKMLQK 200
Query: 258 DPSKRPSAKKLLKH 271
DP KRPSAK++L+H
Sbjct: 201 DPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 6e-61
Identities = 93/264 (35%), Positives = 141/264 (53%), Gaps = 11/264 (4%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPN 70
+Y L + +G+G V++ L + + VA+K + E+ L +I +E + + HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++K S + +L++++ + GS I+K F E ++A + +VL+GL YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
G IHRD+K+ NIL G +KL DFGV+ L D + VGTP WMAPEV+E +
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---DASVVGTPYWMAPEVIE-MS 174
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
G +DIWS G T +EL G+ P+ PM L +Q+ P L S K
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL----PEGISPELKDF 230
Query: 251 IASCLVKDPSKRPSAKKLLKHSFF 274
+ C KDP+ RP+AK+LLKH +
Sbjct: 231 LMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 7e-61
Identities = 103/268 (38%), Positives = 146/268 (54%), Gaps = 16/268 (5%)
Query: 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCS 77
E+G G S V + L P +I+AVK + E + + I RE + + P ++ + +
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRD 136
F ++ ++ + M +M GGS ILK E ++ I VLKGL YLH H IHRD
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126
Query: 137 VKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKA 196
VK NIL++ RG IKL DFGVS L +S + TFVGT +MAPE ++ Y K+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVNS-----LAKTFVGTSSYMAPERIQGND-YSVKS 180
Query: 197 DIWSFGITALELAHGHAPFSK--YPPMKVL-LMT--LQNAPPGLDYERDRKFSKSFKQMI 251
DIWS G++ +ELA G P+ PP + L+ + PP L KFS F+ +
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG---KFSPDFQDFV 237
Query: 252 ASCLVKDPSKRPSAKKLLKHSFFKQARS 279
CL+KDP +RPS K+LL+H F K+ S
Sbjct: 238 NLCLIKDPRERPSYKELLEHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 4e-56
Identities = 106/283 (37%), Positives = 150/283 (53%), Gaps = 22/283 (7%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDF--ERDNSDLSNISREAQTMILVDHPN 70
+T E+G G +V+ A + NE+VA+K + + ++ N +I +E + + + HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ ++ +H W+VM + G S IL+ + +EV IA I L+GL YLH H
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLG-SASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV---ME 187
IHRD+K+GNIL+ G +KL DFG SA L N+FVGTP WMAPEV M+
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFG-SASLVSPA------NSFVGTPYWMAPEVILAMD 187
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247
+ YD K D+WS GIT +ELA P M L QN P L +S F
Sbjct: 188 EGQ-YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL---SSNDWSDYF 243
Query: 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN----EYIART 286
+ + SCL K P RPS+++LLKH F + R + I RT
Sbjct: 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRT 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 5e-54
Identities = 104/272 (38%), Positives = 148/272 (54%), Gaps = 19/272 (6%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI-LVDHPNV 71
+ L E VG G V++ + ++ A+K++D D + I E + H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE--EIKLEINMLKKYSHHRNI 75
Query: 72 LKSHCSFVS------DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
+ +F+ D LW+VM F GS ++K + +E IA I RE+L+GL
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
+LH H IHRD+K N+L+ +KL DFGVSA L + R RNTF+GTP WMAPEV
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWMAPEV 192
Query: 186 MEQLHG----YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
+ YD+++DIWS GITA+E+A G P PM+ L + +N PP L + +
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL---KSK 249
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
K+SK F I CLVK+ RPS ++LLKH F
Sbjct: 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 2e-53
Identities = 104/272 (38%), Positives = 152/272 (55%), Gaps = 19/272 (6%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI-LVDHPNV 71
+ L E VG G V++ + ++ A+K++D D + I +E + H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE--EIKQEINMLKKYSHHRNI 65
Query: 72 LKSHCSFVS------DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
+ +F+ D LW+VM F GS ++K + +E IA I RE+L+GL
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
+LH H IHRD+K N+L+ +KL DFGVSA L + R RNTF+GTP WMAPEV
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWMAPEV 182
Query: 186 MEQLHG----YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
+ YDFK+D+WS GITA+E+A G P PM+ L + +N P L + +
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL---KSK 239
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
K+SK F+ I SCLVK+ S+RP+ ++L+KH F
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 9e-53
Identities = 105/308 (34%), Positives = 154/308 (50%), Gaps = 53/308 (17%)
Query: 34 PFNEIVAVKILDFERDNSDLSN-ISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMS 92
P E V V+ ++ E +++ + E L +HPN++ +F++D+ LWVV FM+
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 93 GGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152
GS ++ + DG E+ IA IL+ VLK LDY+HH G++HR VK+ +ILI V G + L
Sbjct: 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL 142
Query: 153 GDFGVSACLFDSGDRQRMRNTF----VGTPCWMAPEVMEQ-LHGYDFKADIWSFGITALE 207
+ + + G R R+ + F V W++PEV++Q L GYD K+DI+S GITA E
Sbjct: 143 SGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 202
Query: 208 LAHGHAPFSKYPPMKVLL--------------------MTLQNAPPGLDY---------- 237
LA+GH PF P ++LL +T++ + G +
Sbjct: 203 LANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVST 262
Query: 238 -----------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIART 286
+R FS F + CL ++P RPSA LL HSFFKQ I R
Sbjct: 263 PRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ------IKRR 316
Query: 287 LLEGLPAL 294
E LP L
Sbjct: 317 ASEALPEL 324
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 2e-52
Identities = 95/282 (33%), Positives = 143/282 (50%), Gaps = 20/282 (7%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA---QTMILVD 67
+ + ++G+G + V A VAVK +D + RE + +I+ D
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR------RELLFNEVVIMRD 72
Query: 68 --HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
HPN+++ + S++ LWVVM F+ GG+ I+ + E IAT+ VLK L
Sbjct: 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMN---EEQIATVCLAVLKALS 129
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
+LH G IHRD+KS +IL+ G +KL DFG A + R R + VGTP WMAPEV
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR---RKSLVGTPYWMAPEV 186
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
+ +L Y + DIWS GI +E+ G P+ PP++ + N PP L + K S
Sbjct: 187 ISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL--KNLHKVSP 243
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTL 287
+ + LV+DP++R +A +LL H F +A I +
Sbjct: 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVPLM 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 182 bits (462), Expect = 2e-52
Identities = 98/266 (36%), Positives = 147/266 (55%), Gaps = 10/266 (3%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
YT +E++GQG S +V+ A+ + + VA+K ++ + I E M HPN++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIV 79
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH 132
S++ LWVVM +++GGS ++ +E IA + RE L+ L++LH +
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQV 136
Query: 133 IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGY 192
IHRD+KS NIL+ + G++KL DFG A + Q R+T VGTP WMAPEV+ + Y
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTR-KAY 192
Query: 193 DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIA 252
K DIWS GI A+E+ G P+ P++ L + N P + + K S F+ +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--ELQNPEKLSAIFRDFLN 250
Query: 253 SCLVKDPSKRPSAKKLLKHSFFKQAR 278
CL D KR SAK+LL+H F K A+
Sbjct: 251 RCLEMDVEKRGSAKELLQHPFLKIAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 1e-51
Identities = 111/280 (39%), Positives = 148/280 (52%), Gaps = 19/280 (6%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM-I 64
+P ++ + + E +G+G V + L AVKILD D + I E +
Sbjct: 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE--EIEAEYNILKA 70
Query: 65 LVDHPNVLKSHCSF-----VSDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATIL 117
L DHPNV+K + + + LW+V+ +GGS ++K G EE +IA IL
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177
E L GL +LH + IHRDVK NIL+ G +KL DFGVSA L + R RNT VGT
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR---RNTSVGT 187
Query: 178 PCWMAPEVM---EQLHG-YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233
P WMAPEV+ +QL YD + D+WS GITA+EL G P + PM+ L +N PP
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247
Query: 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
L + +S F I CL KD KRP+ LL+H F
Sbjct: 248 TL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 90/263 (34%), Positives = 134/263 (50%), Gaps = 17/263 (6%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD----LSNISREAQTMILVDHPNVL 72
E +G G SV+ L + + AVK + D + + +E + + HPN++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH 132
+ + + NL++ + + GGS L L Y F E VI R++L GL+YLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGS-LAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 133 IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGY 192
+HRD+K NIL+D G +KL DFG++ + + +F G+P WMAPEV+ Q GY
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVE----FSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 193 DFKADIWSFGITALELAHGHAPFSKYPPMKVLLM--TLQNAPPGLDYERDRKFSKSFKQM 250
ADIWS G T LE+A G P+S+ + + + PP D+ S K
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH-----LSDEAKDF 234
Query: 251 IASCLVKDPSKRPSAKKLLKHSF 273
I CL +DPS RP+A +LL+H F
Sbjct: 235 ILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 179 bits (454), Expect = 2e-51
Identities = 110/278 (39%), Positives = 151/278 (54%), Gaps = 19/278 (6%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM-ILVDH 68
+ + + E +G+G V++ + AVKILD D + I E + L +H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE--EIEAEYNILQSLPNH 78
Query: 69 PNVLKSHCSFV-SDH----NLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVL 121
PNV+K + F +D LW+V+ +GGS ++K G +E +I+ IL L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
GL +LH++ IHRDVK NIL+ G +KL DFGVSA L + R R RNT VGTP WM
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLR-RNTSVGTPFWM 195
Query: 182 APEVM--EQLH--GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237
APEV+ EQ + YD + D+WS GITA+EL G P P+K L +N PP L +
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH 255
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275
K+ +SF I+ CL+KD RPS LL+H F K
Sbjct: 256 P--EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 3e-51
Identities = 105/268 (39%), Positives = 148/268 (55%), Gaps = 14/268 (5%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E + L + +G G V++A + E+ A+K++ E D + + +E M H N
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKHSN 67
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ S++ LW+ M F GGS I P E IA + RE L+GL YLH
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSK 125
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV--MEQ 188
G +HRD+K NIL+ G +KL DFGVSA + + + R +F+GTP WMAPEV +E+
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIGTPYWMAPEVAAVER 182
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL-LMTLQN-APPGLDYERDR-KFSK 245
GY+ DIW+ GITA+ELA P PM+ L LMT N PP L +D+ K+S
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL---KDKMKWSN 239
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSF 273
SF + L K+P KRP+A+KLL+H F
Sbjct: 240 SFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-50
Identities = 104/265 (39%), Positives = 147/265 (55%), Gaps = 12/265 (4%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
Y L + VG G V++A + E+ AVKI+ E + D S I +E + H N++
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIV 69
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH 132
S++S LW+ M + GGS I P E+ IA + RE L+GL YLH G
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYLHSKGK 127
Query: 133 IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV--MEQLH 190
+HRD+K NIL+ G +KL DFGV+A + + + R +F+GTP WMAPEV +E+
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIGTPYWMAPEVAAVEKNG 184
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVL-LMTLQN-APPGLDYERDRKFSKSFK 248
GY+ DIW+ GITA+ELA P PM+ L LM+ N PP L + K+S +F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL--KDKTKWSSTFH 242
Query: 249 QMIASCLVKDPSKRPSAKKLLKHSF 273
+ L K+P KRP+A++LL H F
Sbjct: 243 NFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 91/268 (33%), Positives = 131/268 (48%), Gaps = 19/268 (7%)
Query: 20 GQGVSASVHRALCIPFNEIVAVKILDFERDNSDL-SNISREAQTMILVDHPNVLKSHCSF 78
G+G SV + I A+K + N DL I RE + P ++K + +F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 79 VSDH--NLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVLKGLDYLHHHGHIH 134
+ + ++ + M + GGS I K G E V+ I VLKGL YLH IH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIH 128
Query: 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDF 194
RD+K NIL+ +G +KL DFGVS L +S TF GT +MAPE + Q Y
Sbjct: 129 RDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-----GTFTGTSFYMAPERI-QGKPYSI 182
Query: 195 KADIWSFGITALELAHGHAPF-----SKYPPMKVLLMTLQNAPPGL--DYERDRKFSKSF 247
+D+WS G+T LE+A PF P+++L + P L + K+S+ F
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEF 242
Query: 248 KQMIASCLVKDPSKRPSAKKLLKHSFFK 275
K I CL KDP++RP+ +L+H + K
Sbjct: 243 KDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 105/328 (32%), Positives = 158/328 (48%), Gaps = 52/328 (15%)
Query: 15 LYEEVGQGVS--ASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI-LVDHPNV 71
L E+G+G SV+ A P +V V+I D E + + + HPN+
Sbjct: 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
+ S F + LWV+ PFM+ GS +LK +P+G E +I IL L+GL+YLH +G
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF----VGTPCWMAPEVME 187
+IHR++K+ +ILI G + L L +G + ++ F W++PE++
Sbjct: 122 YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLR 181
Query: 188 Q-LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL------------------ 228
Q L+GY+ K+DI+S GITA ELA G PF ++LL L
Sbjct: 182 QDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241
Query: 229 --QNAPPGLD-----------------YER-----DRKFSKSFKQMIASCLVKDPSKRPS 264
+N+ G+D ER + FS +F+ ++ CL +DP KRPS
Sbjct: 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS 301
Query: 265 AKKLLKHSFFKQARSNEYIARTLLEGLP 292
A LL H+FFKQ + E ++L LP
Sbjct: 302 ASSLLSHAFFKQVK--EQTQGSILSLLP 327
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 6e-49
Identities = 74/262 (28%), Positives = 130/262 (49%), Gaps = 11/262 (4%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPN 70
Y + +++G+G V+ ++ +K +D + + + E + + ++HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVLKGLDYLH 128
++K + SF L +VM + GG +K +G F E I ++ L YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
+HRD+K NI + G +KLGDFG+S L + D + T VGTP +++PE+ +
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD---LAKTVVGTPYYLSPELCQN 177
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
Y++K+DIWS G EL PF +++ L L+ P + ++S +
Sbjct: 178 K-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI----PSQYSSELR 232
Query: 249 QMIASCLVKDPSKRPSAKKLLK 270
+++S L KDP +RPS ++L+
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 99/268 (36%), Positives = 148/268 (55%), Gaps = 11/268 (4%)
Query: 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCS 77
E+G G V++A + A K+++ + +L + E + + +HP ++K +
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDV 137
F D LW+++ F GG+ I+ G E I I R++L+ L YLH IHRD+
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIM-LELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 138 KSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM--EQLHG--YD 193
K+GN+L+ + G IKL DFGVSA + R R++F+GTP WMAPEV+ E + YD
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQR---RDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 194 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253
+KADIWS GIT +E+A P + PM+VLL ++ PP L + K+S F+ + +
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS--QPSKWSMEFRDFLKT 251
Query: 254 CLVKDPSKRPSAKKLLKHSFFKQARSNE 281
L K P RPSA +LL+H F SN
Sbjct: 252 ALDKHPETRPSAAQLLEHPFVSSVTSNR 279
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 169 bits (428), Expect = 1e-47
Identities = 99/268 (36%), Positives = 149/268 (55%), Gaps = 10/268 (3%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ YT +E++GQG S +V+ A+ I + VA+K ++ ++ I E M +PN
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK-ELIINEILVMRENKNPN 77
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ S++ LWVVM +++GGS ++ D E IA + RE L+ LD+LH +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALDFLHSN 134
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
IHRD+KS NIL+ + G++KL DFG A + Q R+T VGTP WMAPEV+ +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTR-K 190
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
Y K DIWS GI A+E+ G P+ P++ L + N P L + + S F+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL--QNPERLSAVFRDF 248
Query: 251 IASCLVKDPSKRPSAKKLLKHSFFKQAR 278
+ CL D +R SAK+LL+H F K A+
Sbjct: 249 LNRCLEMDVDRRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 87/261 (33%), Positives = 138/261 (52%), Gaps = 11/261 (4%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCS 77
+G G V+ A+ + E++AVK + + D + I+ E + + L+ HPN++K +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDV 137
V +++ M + SGG+ +L+ + +E VI ++L+GL YLH HG +HRD+
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 138 KSGNILIDVRGAIKLGDFGVSACLFDSGDRQR-MRNTFVGTPCWMAPEVM--EQLHGYDF 194
K NI +D G IKLGDFG + L ++ + GTP +MAPEV+ + G+
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGR 185
Query: 195 KADIWSFGITALELAHGHAPFSKYPPMKVLLMTL--QNAPPGLDYERDRKFSKSFKQMIA 252
ADIWS G LE+A G P+S+ ++ + + PP D + K F +
Sbjct: 186 AADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF---LD 242
Query: 253 SCLVKDPSKRPSAKKLLKHSF 273
CL DP KRP+A +LL+H F
Sbjct: 243 RCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 3e-47
Identities = 98/277 (35%), Positives = 147/277 (53%), Gaps = 20/277 (7%)
Query: 18 EVGQGVSASVHRALCIPFNEIVAVKILDF--ERDNSDLSNISREAQTMILVDHPNVLKSH 75
E+G G +V+ A + +E+VA+K + + ++ N +I +E + + + HPN ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 76 CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHR 135
++ +H W+VM + G + L + +EV IA + L+GL YLH H IHR
Sbjct: 82 GCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 136 DVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH--GYD 193
DVK+GNIL+ G +KLGDFG ++ + + N FVGTP WMAPEV+ + YD
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPA-------NXFVGTPYWMAPEVILAMDEGQYD 192
Query: 194 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253
K D+WS GIT +ELA P M L QN P L + +S+ F+ + S
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---QSGHWSEYFRNFVDS 249
Query: 254 CLVKDPSKRPSAKKLLKHSFFKQARSN----EYIART 286
CL K P RP+++ LLKH F + R + I RT
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRT 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 3e-47
Identities = 104/301 (34%), Positives = 157/301 (52%), Gaps = 25/301 (8%)
Query: 18 EVGQGVSASVHRALCIPFNEIVAVKILDF--ERDNSDLSNISREAQTMILVDHPNVLKSH 75
E+G G +V+ A NE+VAVK + + ++ N +I +E + + + HPN ++
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 76 CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHR 135
++ +H W+VM + G + L + +EV IA I L+GL YLH H IHR
Sbjct: 88 GCYLKEHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 136 DVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH--GYD 193
D+K+GNIL+ G +KL DFG S + N+FVGTP WMAPEV+ + YD
Sbjct: 146 DIKAGNILLTEPGQVKLADFG-------SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 194 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253
K D+WS GIT +ELA P M L QN P L + +++ SF+ +
Sbjct: 199 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL---QSNEWTDSFRGFVDY 255
Query: 254 CLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKEEDMLAQKK 313
CL K P +RP++ +LL+H F ++ R AR L++ + D ++ L D L +K
Sbjct: 256 CLQKIPQERPASAELLRHDFVRRDRP----ARVLIDLIQRTKDAVREL-----DNLQYRK 306
Query: 314 M 314
M
Sbjct: 307 M 307
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 4e-47
Identities = 98/292 (33%), Positives = 137/292 (46%), Gaps = 36/292 (12%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
+D +KYP E+G G V++ ++AVK + R + R
Sbjct: 5 IDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKR-- 59
Query: 61 QTMILVDHPNVLKSHCS---------FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEV 111
IL+D VLKSH F++D ++++ M MS +CL L E
Sbjct: 60 ---ILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPED 114
Query: 112 VIATILREVLKGLDYL-HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170
++ + ++K L YL HG IHRDVK NIL+D G +KL DFG+S L DS + R
Sbjct: 115 ILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS 174
Query: 171 RNTFVGTPCWMAPEVME---QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK----V 223
G +MAPE ++ YD +AD+WS GI+ +ELA G P Y K V
Sbjct: 175 ----AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP---YKNCKTEFEV 227
Query: 224 LLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275
L LQ PP L + FS F + CL KD KRP ++LL+H F +
Sbjct: 228 LTKILQEEPPSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 99/268 (36%), Positives = 149/268 (55%), Gaps = 10/268 (3%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ YT YE++GQG S +V A+ + + VA+K ++ ++ I E M + +PN
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK-ELIINEILVMKELKNPN 77
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ SF+ L+VVM +++GGS ++ D E IA + RE L+ L++LH +
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD---EAQIAAVCRECLQALEFLHAN 134
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
IHRD+KS N+L+ + G++KL DFG A + Q R+T VGTP WMAPEV+ +
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTR-K 190
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
Y K DIWS GI A+E+ G P+ P++ L + N P L + K S F+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSPIFRDF 248
Query: 251 IASCLVKDPSKRPSAKKLLKHSFFKQAR 278
+ CL D KR SAK+LL+H F K A+
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 5e-46
Identities = 92/272 (33%), Positives = 143/272 (52%), Gaps = 23/272 (8%)
Query: 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCS 77
++G G SV + IP ++A K++ +S I RE Q M P ++ + +
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHI-HRD 136
F++++N+ + M FM GS I K P ++ I V++GL YL++ I HRD
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIYKKGGP--IPVEILGKIAVAVVEGLTYLYNVHRIMHRD 129
Query: 137 VKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKA 196
+K NIL++ RG IKL DFGVS L +S + +TFVGT +M+PE + Q Y K+
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSGELINS-----IADTFVGTSTYMSPERI-QGGKYTVKS 183
Query: 197 DIWSFGITALELAHGHAPFSKYP--------PMKVLLM---TLQNAPPGLDYERDRKFSK 245
D+WS GI+ +ELA G PF+ PM +L + +Q PP L F +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD---FPE 240
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277
+ + +CL+KDP++RP+ ++L F QA
Sbjct: 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 6e-46
Identities = 96/268 (35%), Positives = 152/268 (56%), Gaps = 13/268 (4%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E + + E+G G V++A + A K++D + +L + E + DHPN
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVID-TKSEEELEDYMVEIDILASCDHPN 63
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHI-LKAAYPDGFEEVVIATILREVLKGLDYLHH 129
++K +F ++NLW+++ F +GG+ + L+ P E I + ++ L+ L+YLH
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHE 121
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM--- 186
+ IHRD+K+GNIL + G IKL DFGVSA ++ QR R++F+GTP WMAPEV+
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQR-RDSFIGTPYWMAPEVVMCE 178
Query: 187 -EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
+ YD+KAD+WS GIT +E+A P + PM+VLL ++ PP L + ++S
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL--AQPSRWSS 236
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSF 273
FK + CL K+ R + +LL+H F
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 2e-45
Identities = 98/268 (36%), Positives = 149/268 (55%), Gaps = 10/268 (3%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ YT +E++GQG S +V+ A+ + + VA++ ++ ++ I E M +PN
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-ELIINEILVMRENKNPN 78
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ S++ LWVVM +++GGS ++ D E IA + RE L+ L++LH +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLHSN 135
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
IHRD+KS NIL+ + G++KL DFG A + Q R+T VGTP WMAPEV+ +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTR-K 191
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
Y K DIWS GI A+E+ G P+ P++ L + N P L + K S F+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIFRDF 249
Query: 251 IASCLVKDPSKRPSAKKLLKHSFFKQAR 278
+ CL D KR SAK+LL+H F K A+
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 161 bits (407), Expect = 2e-44
Identities = 96/270 (35%), Positives = 145/270 (53%), Gaps = 16/270 (5%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDF--ERDNSDLSNISREAQTMILVDHPN 70
+T E+G G +V+ A + NE+VA+K + + ++ N +I +E + + + HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ ++ +H W+VM + G + L + +EV IA I L+GL YLH H
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
IHRD+K+GNIL+ G +KL DFG ++ + N+FVGTP WMAPEV+ +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-------NSFVGTPYWMAPEVILAMD 197
Query: 191 --GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
YD K D+WS GIT +ELA P M L QN P L + ++S F+
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL---QSNEWSDYFR 254
Query: 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278
+ SCL K P RP++++LLKH F + R
Sbjct: 255 NFVDSCLQKIPQDRPTSEELLKHMFVLRER 284
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 73/244 (29%), Positives = 116/244 (47%), Gaps = 16/244 (6%)
Query: 36 NEIVAVKILD--FERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93
++ A+K+L ++ + E + ++HP ++K H +F ++ L++V+ + G
Sbjct: 18 GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77
Query: 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLG 153
G L F E E++ L+YLH G I+RD+K NIL+D G IKL
Sbjct: 78 GELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLT 135
Query: 154 DFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHA 213
DFG++ L G R NTF GTP ++APEV+ GY D WS G+ E+ G
Sbjct: 136 DFGLAKELSSEGSR---TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKP 191
Query: 214 PFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR---PSAKKLLK 270
PF ++ L++ S + +I+ L KDP+KR A+++
Sbjct: 192 PFYAEDRKEIYEKILKD-----PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246
Query: 271 HSFF 274
H FF
Sbjct: 247 HPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 97/262 (37%), Positives = 139/262 (53%), Gaps = 10/262 (3%)
Query: 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSH 75
+ ++G+G + V A ++VAVK +D R + E M H NV++ +
Sbjct: 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDL-RKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 76 CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHR 135
S++ LWVVM F+ GG+ I+ E IA + VLK L LH G IHR
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 136 DVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFK 195
D+KS +IL+ G +KL DFG A + S + R R + VGTP WMAPE++ +L Y +
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPR-RKSLVGTPYWMAPELISRL-PYGPE 196
Query: 196 ADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCL 255
DIWS GI +E+ G P+ PP+K + M N PP L + K S S K + L
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL--KNLHKVSPSLKGFLDRLL 254
Query: 256 VKDPSKRPSAKKLLKHSFFKQA 277
V+DP++R +A +LLKH F +A
Sbjct: 255 VRDPAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 4e-42
Identities = 98/301 (32%), Positives = 139/301 (46%), Gaps = 46/301 (15%)
Query: 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCS 77
E+G G V + L P I+A K++ E + + I RE + + + P ++ + +
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRD 136
F SD + + M M GGS +LK A E ++ I VL+GL YL H +HRD
Sbjct: 68 FYSDGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRD 125
Query: 137 VKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKA 196
VK NIL++ RG IKL DFGVS L DS M N+FVGT +M+PE ++ H Y ++
Sbjct: 126 VKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YTVQS 179
Query: 197 DIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG---------------------- 234
DIWS G++ +E+A G P PP L + P
Sbjct: 180 DIWSLGLSLVEMAIGRYPIP--PPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237
Query: 235 -----LDY--------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
LDY FS F+ + CL K+P +R K+L KH F K+A E
Sbjct: 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEE 297
Query: 282 Y 282
Sbjct: 298 V 298
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 156 bits (393), Expect = 5e-42
Identities = 90/288 (31%), Positives = 134/288 (46%), Gaps = 21/288 (7%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKIL--DFERDNSDLSNISREAQTMILVDHP 69
Y + ++G+G V+ A ++VA+K+L E + ++ RE Q + ++HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 70 -NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG-FEEVVIATILREVLKGLDYL 127
N++K + F + +L++VM ++ GGS +LK G E IL ++L L+YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 128 HHHGHIHRDVKSGNILID-VRGAIKLGDFGVSACLFDSGDRQ---RMRNTFVGTPCWMAP 183
H G IHRD+K NIL+D +KL DFG++ L D G + +T VGTP +MAP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 184 EVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN--------APP 233
EV+ L +DIWS GIT EL G PF TL+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
L SK+ ++ L KDP R S+ L H + E
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285
|
Length = 384 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 96/285 (33%), Positives = 136/285 (47%), Gaps = 14/285 (4%)
Query: 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQ-TMILVD 67
AE E+G+G +V++ L P I+AVK + D + + + M D
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG---FEEVVIATILREVLKGL 124
P ++K + + + + W+ M M S K Y E ++ I +K L
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 125 DYLHHHGHI-HRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
+YL I HRDVK NIL+D G IKL DFG+S L DS + R G +MAP
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD----AGCRPYMAP 176
Query: 184 EVM--EQLHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGLDYERD 240
E + GYD ++D+WS GIT E+A G P+ K+ L ++ PP L +
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ-ARSNEYIA 284
R+FS SF I CL+KD SKRP K+LL+H F K N +A
Sbjct: 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVA 281
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 6e-41
Identities = 83/270 (30%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKIL---DFERDNSDLSNISREAQTMILVDHPNVLKSH 75
+ +G V A +I A+K++ D R N + + E + P V+K +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQ-VDQVLTERDILSQAQSPYVVKLY 59
Query: 76 CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHR 135
SF NL++VM ++ GG +L+ +E V + E++ L+YLH +G IHR
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHR 117
Query: 136 DVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN-------TFVGTPCWMAPEVMEQ 188
D+K NILID G +KL DFG+S RQ N VGTP ++APEV+
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLS--KVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL- 174
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
G+ D WS G E G PF P ++ L +++ D + S
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK---IEWPEDVEVSDEAI 231
Query: 249 QMIASCLVKDPSKRP---SAKKLLKHSFFK 275
+I+ LV DP KR S +++ H FFK
Sbjct: 232 DLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 77/241 (31%), Positives = 119/241 (49%), Gaps = 12/241 (4%)
Query: 39 VAVKILDFERDNSDLSN----ISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGG 94
+AVK + F+ D+ + + E Q + + H +++ + D L + M +M GG
Sbjct: 30 LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGG 89
Query: 95 SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGD 154
S LKA E V R++L+G++YLH + +HRD+K NIL D G +KLGD
Sbjct: 90 SVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGD 147
Query: 155 FGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAP 214
FG S L + GTP WM+PEV+ GY KAD+WS G T +E+ P
Sbjct: 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPP 206
Query: 215 FSKYPPMKVLL-MTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
++++ M + + Q P L S + + V++ KRPSA++LL+H F
Sbjct: 207 WAEFEAMAAIFKIATQPTNPQLPSH----VSPDARNFLRRTFVENAKKRPSAEELLRHFF 262
Query: 274 F 274
Sbjct: 263 V 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 93/260 (35%), Positives = 136/260 (52%), Gaps = 10/260 (3%)
Query: 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCS 77
++G+G + V A + VAVK +D R + E M H NV+ + S
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDL-RKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDV 137
++ LWVVM F+ GG+ I+ E IAT+ VL+ L YLH+ G IHRD+
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQGVIHRDI 144
Query: 138 KSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKAD 197
KS +IL+ G IKL DFG A + + R + VGTP WMAPEV+ +L Y + D
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKSLVGTPYWMAPEVISRL-PYGTEVD 200
Query: 198 IWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVK 257
IWS GI +E+ G P+ PP++ + N PP + + K S + + LV+
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV--KDSHKVSSVLRGFLDLMLVR 258
Query: 258 DPSKRPSAKKLLKHSFFKQA 277
+PS+R +A++LL+H F K A
Sbjct: 259 EPSQRATAQELLQHPFLKLA 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 43/281 (15%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPN 70
+ + +G G V + A+KIL + + ++ E + + + HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ + SF D NL++VM ++ GG L+ + F E V +V+ L+YLH
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL 120
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN---TFVGTPCWMAPEVME 187
++RD+K N+L+D G IK+ DFG F +R++ T GTP ++APE++
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFG-----FA----KRVKGRTYTLCGTPEYLAPEII- 170
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER-------- 239
GY D W+ GI E+ G+ PF P+++ YE+
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-------------YEKILEGKVRF 217
Query: 240 DRKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFFK 275
FS K +I + L D +KR + H +F
Sbjct: 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 82/265 (30%), Positives = 132/265 (49%), Gaps = 14/265 (5%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLS-----NISREAQTMILVDHPNV 71
E +G+G +V+ L +++AVK ++ + N + + E + + H N+
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
++ + + D+ + + M F+ GGS IL P E V +++L G+ YLH++
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNC 122
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVS---ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
+HRD+K N+++ G IKL DFG + A + G M + GTP WMAPEV+ +
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
GY K+DIWS G T E+A G P + + + A GL FS +
Sbjct: 183 -SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--GAHRGLMPRLPDSFSAAAI 239
Query: 249 QMIASCLVKDPSKRPSAKKLLKHSF 273
+ SCL +D +RPSA +LL+H F
Sbjct: 240 DFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 66/269 (24%), Positives = 115/269 (42%), Gaps = 28/269 (10%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTMILVDHP 69
L +++G+G V++ E VAVK L + EA M + HP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N+++ L++V +M GG L L+ + + + + ++ KG++YL
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
+HRD+ + N L+ +K+ DFG+S +++ D R R WMAPE ++
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-DYYRKRGGGKLPIKWMAPESLKDG 179
Query: 190 HGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVL--------LMTLQNAPPGLDYERD 240
+ K+D+WSFG+ E+ G P+ +VL L +N P L
Sbjct: 180 K-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDEL----- 233
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLL 269
+++ C DP RP+ +L+
Sbjct: 234 -------YELMLQCWAYDPEDRPTFSELV 255
|
Length = 258 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 7e-38
Identities = 88/269 (32%), Positives = 135/269 (50%), Gaps = 26/269 (9%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHC 76
E +G G +V++A + I+AVK++ + I E + + D P ++ +
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 77 SFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRD 136
+F ++ + + FM GGS L + + E V+ I V+KGL YL +HRD
Sbjct: 67 AFFVENRISICTEFMDGGS-LDVYRK-----IPEHVLGRIAVAVVKGLTYLWSLKILHRD 120
Query: 137 VKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM--EQLHGYDF 194
VK N+L++ RG +KL DFGVS L +S + T+VGT +MAPE + EQ Y
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLVNS-----IAKTYVGTNAYMAPERISGEQ---YGI 172
Query: 195 KADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ-------NAPPGLDYERDRKFSKSF 247
+D+WS GI+ +ELA G P+ + + LM LQ PP L +FS+ F
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP---VGQFSEKF 229
Query: 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
I C+ K P +RP+ + L+ H F Q
Sbjct: 230 VHFITQCMRKQPKERPAPENLMDHPFIVQ 258
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 87/266 (32%), Positives = 135/266 (50%), Gaps = 18/266 (6%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDF--------ERDNSDLSNISREAQTMILVDHPN 70
+G G SV+ + E++AVK ++ +R S L ++RE + + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
+++ S + +L + + ++ GGS +L FEE ++ +R++LKGL+YLH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR 125
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACL---FDSGDRQRMRNTFVGTPCWMAPEVME 187
G IHRD+K NIL+D +G IK+ DFG+S L S R + G+ WMAPEV++
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247
Q Y KADIWS G +E+ G PF ++ + +NA P E S
Sbjct: 186 QT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP----EIPSNISSEA 240
Query: 248 KQMIASCLVKDPSKRPSAKKLLKHSF 273
+ D +KRP+A +LLKH F
Sbjct: 241 IDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 44/292 (15%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER----DNSDLSNISREAQTMILVDH 68
+ + +G+G ++V A N+ A+KILD + I +E T L H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTR-LNGH 61
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
P ++K + +F + NL+ V+ + G L ++ +E E+L L+YLH
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH 119
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD------------------RQRM 170
G IHRD+K NIL+D IK+ DFG +A + D +R
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFG-TAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 171 RNTFVGTPCWMAPEVM-EQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLM 226
+FVGT +++PE++ E+ G +D+W+ G ++ G PF ++Y +
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGK--SSDLWALGCIIYQMLTGKPPFRGSNEY-------L 229
Query: 227 TLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKK----LLKHSFF 274
T Q L+Y F K +I LV DP R + L H FF
Sbjct: 230 TFQKILK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 81/272 (29%), Positives = 135/272 (49%), Gaps = 22/272 (8%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVKIL---------DFERDNSDLSNISREAQTMILVD 67
E +G+G V+ AL + E++AVK + R + + E +T+ +D
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYL 127
H N+++ ++ L + + ++ GGS L+ FEE ++ +VL+GL YL
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYL 124
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGV---SACLFDSGDRQRMRNTFVGTPCWMAPE 184
H G +HRD+K+ N+L+D G K+ DFG+ S ++D+ M+ G+ WMAPE
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ----GSVFWMAPE 180
Query: 185 VMEQLH-GYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYERDR 241
V+ GY K DIWS G LE+ G P+S + + L ++APP + +
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP-IPPDVSM 239
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
S + +C +P RP+A++LL+H F
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 91/276 (32%), Positives = 145/276 (52%), Gaps = 32/276 (11%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSF 78
+G G +V++ + P + A+K++ +++ I RE + + V+HPNV+K H F
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 79 VSDHN--LWVVMPFMSGGSC--LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIH 134
DHN + V++ FM GGS HI + +A + R++L G+ YLH +H
Sbjct: 142 --DHNGEIQVLLEFMDGGSLEGTHIADEQF--------LADVARQILSGIAYLHRRHIVH 191
Query: 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR--NTFVGTPCWMAPEVM--EQLH 190
RD+K N+LI+ +K+ DFGVS L Q M N+ VGT +M+PE + + H
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRIL-----AQTMDPCNSSVGTIAYMSPERINTDLNH 246
Query: 191 G-YD-FKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTL-QNAPPGLDYERDRKFSK 245
G YD + DIWS G++ LE G PF + L+ + + PP E S+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP----EAPATASR 302
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
F+ I+ CL ++P+KR SA +LL+H F +A+ +
Sbjct: 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ 338
|
Length = 353 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 90/266 (33%), Positives = 135/266 (50%), Gaps = 10/266 (3%)
Query: 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSH 75
Y ++G+G + V A VAVK++D R + E M H NV++ +
Sbjct: 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDL-RKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 76 CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHR 135
S++ LWV+M F+ GG+ I+ E IAT+ VL+ L YLH G IHR
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 136 DVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFK 195
D+KS +IL+ + G +KL DFG A + S D + R + VGTP WMAPEV+ + Y +
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPK-RKSLVGTPYWMAPEVISRTP-YGTE 197
Query: 196 ADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCL 255
DIWS GI +E+ G P+ P++ + + PP L + K S + + L
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL--KNAHKISPVLRDFLERML 255
Query: 256 VKDPSKRPSAKKLLKHSFFKQARSNE 281
++P +R +A++LL H F Q E
Sbjct: 256 TREPQERATAQELLDHPFLLQTGLPE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 80/279 (28%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDF----ERDNSDLS---NISREAQTMI 64
Y + E +G+G +V + +I+ K +D+ E++ L NI RE +
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK--- 57
Query: 65 LVDHPNVLKSHCSFV--SDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREV 120
HPN+++ + + S+ L++VM + GG +++ + EE I IL ++
Sbjct: 58 ---HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 121 LKGLDYLHHHGH-----IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175
L L H+ +HRD+K NI +D +KLGDFG++ L G T+V
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---GHDSSFAKTYV 171
Query: 176 GTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-PG 234
GTP +M+PE + YD K+DIWS G EL PF+ L ++
Sbjct: 172 GTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFRR 229
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
+ Y +S ++I S L DP KRPS ++LL+
Sbjct: 230 IPYR----YSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 40/276 (14%)
Query: 14 TLYEEVGQGVSASVHRALCIPFN----EIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
TL +++G+G V++ VAVK L + + REA+ M +DHP
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 70 NVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYL 127
N++K C+ + L +VM +M GG L L+ P + + ++ +G++YL
Sbjct: 62 NIVKLLGVCT--EEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVM 186
IHRD+ + N L+ +K+ DFG+S D +++ + P WMAPE +
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLS-RDLYDDDYYKVKGGKL--PIRWMAPESL 176
Query: 187 EQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKV-----------LLMTLQNAPPG 234
+ + K+D+WSFG+ E+ G P YP M L N PP
Sbjct: 177 -KEGKFTSKSDVWSFGVLLWEIFTLGEEP---YPGMSNAEVLEYLKKGYRLPKPPNCPPE 232
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
L Y +++ C +DP RP+ +L++
Sbjct: 233 L-Y-----------KLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 74/259 (28%), Positives = 131/259 (50%), Gaps = 13/259 (5%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-FER-DNSDLSNISREAQTMILVDHPN 70
+ + +++G+G + V++A+C+ +VA+K + FE D + +E + +DHPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVLKGLDYLH 128
V+K SF+ ++ L +V+ G ++K E I ++ L+++H
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
+HRD+K N+ I G +KLGD G+ F S + ++ VGTP +M+PE + +
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGR-FFSS--KTTAAHSLVGTPYYMSPERIHE 180
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE--RDRKFSKS 246
+GY+FK+DIWS G E+A +PF K+ L +L DY +S+
Sbjct: 181 -NGYNFKSDIWSLGCLLYEMAALQSPFYG---DKMNLYSLCKKIEKCDYPPLPADHYSEE 236
Query: 247 FKQMIASCLVKDPSKRPSA 265
+ +++ C+ DP KRP
Sbjct: 237 LRDLVSRCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 93/279 (33%), Positives = 138/279 (49%), Gaps = 32/279 (11%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVKIL-------DFERDNSDLSNISREAQTMILVDHP 69
EE+G+G V + +P I+AVK + + +R DL +IS M VD P
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDL-DIS-----MRSVDCP 60
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHIL-KAAYPDG--FEEVVIATILREVLKGLDY 126
+ + + + ++W+ M M + L K Y G E ++ I ++K L+Y
Sbjct: 61 YTVTFYGALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 127 LHHHGH-IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF-VGTPCWMAPE 184
LH IHRDVK N+LI+ G +KL DFG+S L DS + T G +MAPE
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-----VAKTIDAGCKPYMAPE 173
Query: 185 VME---QLHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGLDYERD 240
+ GYD K+D+WS GIT +ELA G P+ + P + L ++ P L E
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAE-- 231
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279
KFS F+ + CL K+ +RP+ +LL+H FF+ S
Sbjct: 232 -KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 72/265 (27%), Positives = 122/265 (46%), Gaps = 19/265 (7%)
Query: 14 TLYEEVGQGVSASVHRAL---CIPFNEI-VAVKILDFERDNSDLSNISREAQTMILVDHP 69
TL +++G+G V++ ++ VAVK L + + REA+ M +DHP
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 70 NVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYL 127
NV+K C+ + L++VM +M GG L L+ + + ++ +G++YL
Sbjct: 62 NVVKLLGVCT--EEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYL 118
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVM 186
IHRD+ + N L+ +K+ DFG+S D R R + P WMAPE +
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLS-RDLYDDDYYRKRGGKL--PIRWMAPESL 175
Query: 187 EQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
+ + K+D+WSFG+ E+ G P YP M + L+ G +
Sbjct: 176 -KEGKFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEV-LEYLKNGYRLPQPPNCPP 230
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLK 270
++ C +DP RP+ +L++
Sbjct: 231 ELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 83/278 (29%), Positives = 134/278 (48%), Gaps = 25/278 (8%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHC 76
+E+G+G SV++ L P +A+K + E D S + I E + P ++ +
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 77 SFVSDHNLWVVMPFMSGGSCLHIL-KAAYPDGFEEVVIATILREVLKGLDYL-HHHGHIH 134
+F + +++ M +M GS + +G E V+ I V+KGL +L H IH
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE-----VMEQL 189
RDVK N+L++ G +KL DFGVS L S + T +G +MAPE Q
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 190 HGYDFKADIWSFGITALELAHGHAPFSKYPP------MKVLLMTLQNAPPGLDYERDRKF 243
Y ++D+WS G++ LE+A G P YPP L + PP L +
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIFAQLSAIVDGDPPTLPSG----Y 234
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
S + +A CL K P++RP+ +LL+H + + ++ +
Sbjct: 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 5e-35
Identities = 97/308 (31%), Positives = 145/308 (47%), Gaps = 54/308 (17%)
Query: 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCS 77
E+G G V + P I+A K++ E + + I RE Q + + P ++ + +
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRD 136
F SD + + M M GGS +LK A E ++ + V+KGL YL H +HRD
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 129
Query: 137 VKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKA 196
VK NIL++ RG IKL DFGVS L DS M N+FVGT +M+PE ++ H Y ++
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSVQS 183
Query: 197 DIWSFGITALELAHGH------------------------------------APFSKY-- 218
DIWS G++ +E+A G P S Y
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGP 243
Query: 219 ---PPMKV--LLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
PPM + LL + N PP F F+ + CL+K+P++R K+L+ H+F
Sbjct: 244 DSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301
Query: 274 FKQARSNE 281
K++ + E
Sbjct: 302 IKRSEAEE 309
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 1e-34
Identities = 97/310 (31%), Positives = 146/310 (47%), Gaps = 56/310 (18%)
Query: 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCS 77
E+G G V + P I+A K++ E + + I RE Q + + P ++ + +
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRD 136
F SD + + M M GGS +LK A E ++ + VL+GL YL H +HRD
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRD 129
Query: 137 VKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKA 196
VK NIL++ RG IKL DFGVS L DS M N+FVGT +M+PE ++ H Y ++
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSVQS 183
Query: 197 DIWSFGITALELAHGHAPFSKYPPMKVLL------------------MTLQNAPPG---- 234
DIWS G++ +ELA G P PP L ++ + PPG
Sbjct: 184 DIWSMGLSLVELAIGRYPIP--PPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS 241
Query: 235 ---------------LDYERDRK--------FSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
LDY + F+ F++ + CL+K+P++R K L+ H
Sbjct: 242 GHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301
Query: 272 SFFKQARSNE 281
+F K++ E
Sbjct: 302 TFIKRSEVEE 311
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 69/261 (26%), Positives = 125/261 (47%), Gaps = 9/261 (3%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNIS-REAQTMILVDHPNV 71
+ + ++G+G V + + + A+K +D + N + EA+ + +D +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
++ + SF+ L +VM + G +LK E + ++L GL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG 191
+HRD+KS N+ +D +K+GD GV+ L D NT VGTP +++PE+ E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELCED-KP 177
Query: 192 YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251
Y+ K+D+W+ G+ E G PF ++L ++ P + + +S+ Q+I
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV----SQMYSQQLAQLI 233
Query: 252 ASCLVKDPSKRPSAKKLLKHS 272
CL KD +RP +LL++
Sbjct: 234 DQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 64/269 (23%), Positives = 120/269 (44%), Gaps = 23/269 (8%)
Query: 17 EEVGQGVSASVHRALCIPFNE---IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLK 73
+++G+G V++ + VAVK L + + + +EA+ M + HPNV++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 74 S-HCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT-------ILREVLKGLD 125
+ L++V+ +M GG L L+ + P ++ KG++
Sbjct: 61 LLGVC-TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
YL +HRD+ + N L+ +K+ DFG+S ++D ++ + WMAPE
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPES 178
Query: 186 MEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKV--LLMTLQNAPPGLDYERDRK 242
++ + K+D+WSFG+ E+ G P YP + +L L+ G +
Sbjct: 179 LKDGI-FTSKSDVWSFGVLLWEIFTLGATP---YPGLSNEEVLEYLRK---GYRLPKPEY 231
Query: 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+++ SC DP RP+ +L++
Sbjct: 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 51/282 (18%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDF------ERDNSDLSNISREAQTMILV 66
+ + +++G+G SV++ + N+ A+K +D ER+++ E + + V
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDA-----VNEIRILASV 56
Query: 67 DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILK--AAYPDGFEEVVIATILREVLKGL 124
+HPN++ +F+ + L +VM + G + E I I ++L+GL
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
LH +HRD+KS NIL+ +K+GD G+S L ++ M T +GTP +MAPE
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL-----KKNMAKTQIGTPHYMAPE 171
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFS--------------KYPPMKVLLMTLQN 230
V + Y +K+DIWS G E+A PF KYPP+
Sbjct: 172 VW-KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI--------- 221
Query: 231 APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHS 272
PP +S+ + I S L P RP+ K+L
Sbjct: 222 -PP--------IYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 69/231 (29%), Positives = 109/231 (47%), Gaps = 25/231 (10%)
Query: 55 NISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIA 114
+I E + + +HP ++K + +F ++++M + GG IL+ F+E
Sbjct: 39 HIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR--GLFDEYTAR 96
Query: 115 TILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF 174
+ V+ +YLH+ G I+RD+K N+L+D G +KL DFG + L Q+ TF
Sbjct: 97 FYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTW-TF 152
Query: 175 VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS--KYPPMKV----LLMTL 228
GTP ++APE++ GYDF D WS GI EL G PF PM++ L
Sbjct: 153 CGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG 211
Query: 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFF 274
+ P K+ K +I L ++P +R K + KH +F
Sbjct: 212 KLEFP-------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 32/288 (11%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNIS-REAQTMILVDHPNV 71
Y E++G+G V++A EIVA+K + + + + + + RE + + HPN+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
+K ++ L++V + L P +I +I+ ++L+GL Y H H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCD--MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVS-ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
+HRD+K NILI+ G +KL DFG++ A + + V T + APE++
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL---RTYTHEVV-TLWYRAPEILLGSK 174
Query: 191 GYDFKADIWSFGITALELAHGHAPF---------------------SKYP---PMKVLLM 226
Y DIWS G E+ G F +P +
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234
Query: 227 TLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274
T PP + + +++ L +P+KR SAK+ LKH +F
Sbjct: 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 41/293 (13%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHPNV 71
Y ++G+G V++A EIVA+K I RE + + ++HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
+K F +L++V FM ++K G E +I + L ++L+GL + H HG
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLY-KLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG 191
+HRD+K N+LI+ G +KL DFG A F S R +V T + APE++ G
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFG-LARSFGS--PVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 192 YDFKADIWSFGITALELAHGHAPFSKYP-----------------PMKVLLMTLQNAPPG 234
Y DIWS G EL F P P + +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLF---PGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR- 231
Query: 235 LDYERDRK------FSKSF-------KQMIASCLVKDPSKRPSAKKLLKHSFF 274
+Y+ K F +++ L DP KR +A++ L H +F
Sbjct: 232 -NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 81/267 (30%), Positives = 128/267 (47%), Gaps = 20/267 (7%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFERDNSD--LSNISREAQTMILVDHPNVLKSHC 76
VG+G V +I A+K++ + +S E + + + P + +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 77 SFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRD 136
+F NL++VM + GG L +L Y D F+E + L E++ + +H G++HRD
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLL-NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 137 VKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF--VGTPCWMAPEVMEQLHG--- 191
+K N+LID G IKL DFG +A L +M N+ VGTP ++APEV+ ++G
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARL----TANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 192 --YDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYERDRKFSKSF 247
Y + D WS G+ A E+ +G +PF + K +M Q L + D K S F
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF---LKFPEDPKVSSDF 240
Query: 248 KQMIASCLVKDPSKRPSAKKLLKHSFF 274
+I S L+ +R + L H FF
Sbjct: 241 LDLIQS-LLCGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 77/275 (28%), Positives = 137/275 (49%), Gaps = 18/275 (6%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD-----LSNISREAQTMILV 66
+ +++G G +S ++A + ++AVK + + R+ S + + +E + M +
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 67 DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDY 126
+HP++++ + D + + + +M+GGS H+L F+E VI ++L+GL Y
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSY 118
Query: 127 LHHHGHIHRDVKSGNILIDVRGA-IKLGDFGVSACLFDSGDRQ-RMRNTFVGTPCWMAPE 184
LH + IHRDVK N+LID G +++ DFG +A L G + +GT +MAPE
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFS--KYPPMKVLLMTLQNA--PPGLDYERD 240
V+ Y D+WS G +E+A P++ K+ L+ + +A P +
Sbjct: 179 VLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI----P 233
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275
S + + CL P RP +++LLKH F+
Sbjct: 234 EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 79/297 (26%), Positives = 131/297 (44%), Gaps = 53/297 (17%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNISREAQTMILVDHPNVLKS 74
++G+G V++A E+VA+K ++ E++ ++ I RE + + + HPN+++
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI-REIKLLQKLRHPNIVRL 63
Query: 75 HCSFVSDH--NLWVVMPFMSGGSCLHILK--AAYPDG-FEEVVIATILREVLKGLDYLHH 129
S ++++V +M H L P+ F E I ++++L+GL YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMD-----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
+G +HRD+K NILI+ G +KL DFG+ A + + N + T + PE+ L
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVI-TLWYRPPEL---L 173
Query: 190 HG---YDFKADIWSFGITALELAHGHAPF---------------------SKYPPMKVLL 225
G Y + D+WS G EL G F +P + L
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233
Query: 226 MTLQNAPPGLDYERDRKFSKSFKQMI---ASCLVK-----DPSKRPSAKKLLKHSFF 274
P R+ + FK +I A L+ DP KR SA + L+H +F
Sbjct: 234 WFENLKPK---KPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 82/267 (30%), Positives = 134/267 (50%), Gaps = 23/267 (8%)
Query: 12 HYTLYEEVGQGV--SASVHRALCIPFNEIVAVKILDFERDNSDLS-NISREAQTMI---- 64
HY +G+G A+++R + +V K E + + LS R+A I
Sbjct: 1 HYIPIRVLGKGAFGEATLYRR--TEDDSLVVWK----EVNLTRLSEKERRDALNEIVILS 54
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGL 124
L+ HPN++ + F+ D+ L + M + +GG+ + FEE ++ L +++ +
Sbjct: 55 LLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
Y+H G +HRD+K+ NI + G IKLGDFG+S L G M T VGTP +M+PE
Sbjct: 115 SYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEYSMAETVVGTPYYMSPE 171
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ-NAPPGLDYERDRKF 243
+ Q Y+FK+DIW+ G EL F P+ +++ +Q N P + +
Sbjct: 172 -LCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVS-----VY 225
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLK 270
S ++ S L +DP KRP+A ++L
Sbjct: 226 SSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 23/228 (10%)
Query: 55 NISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC-LHILKAAYPDGFEEVVI 113
N+ E + + ++HP ++ SF + N+++V+ + GG H+ + F E +
Sbjct: 46 NVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK---FSEEQV 102
Query: 114 ATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173
+ E++ L+YLH G IHRD+K NIL+D +G + + DF + A + +
Sbjct: 103 KFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNI-ATKV---TPDTLTTS 158
Query: 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQN 230
GTP +MAPEV+ GY D WS G+TA E G P+ S+ ++
Sbjct: 159 TSGTPGYMAPEVL-CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA 217
Query: 231 AP--PGLDYERDRKFSKSFKQMIASCLVKDPSKRPS--AKKLLKHSFF 274
P S I L +DP KR K L H +F
Sbjct: 218 DVLYPATW-------STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 83/265 (31%), Positives = 121/265 (45%), Gaps = 17/265 (6%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVKIL---DFERDNSDLSNISREAQTMILVDHPNVLK 73
+ + +G SV+ A + A+K+L D N + + A MI + P V K
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 74 SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHI 133
+ SF S L++VM +++GG C ++K G E + EV+ G++ LH G I
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGII 119
Query: 134 HRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYD 193
HRD+K N+LID G +KL DFG+S ++ FVGTP ++APE + + G D
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-------FVGTPDYLAPETILGV-GDD 171
Query: 194 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253
+D WS G E G+ PF P V L E S +I
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-INWPEEVKEFCSPEAVDLINR 230
Query: 254 CLVKDPSKRPSAK---KLLKHSFFK 275
L DP+KR A ++ H FFK
Sbjct: 231 LLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 6e-30
Identities = 84/271 (30%), Positives = 130/271 (47%), Gaps = 33/271 (12%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFERDN----SDLSNISREAQTMILVDHPNVLKS 74
+GQG V+ + +A K + F+ ++ ++S + E Q + + H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 75 HCSFVSDH---NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
+ + D L + M +M GGS LKA E V R++L+G+ YLH +
Sbjct: 70 Y-GCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM 126
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVSA-----CLFDSGDRQRMRNTFVGTPCWMAPEVM 186
+HRD+K NIL D G +KLGDFG S C+ +G R + GTP WM+PEV+
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR-----SVTGTPYWMSPEVI 181
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAP--PGLDYERDRK 242
GY KAD+WS G T +E+ P+++Y M + + T P P E R
Sbjct: 182 SG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240
Query: 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
F C+ + RPSA++LL+H F
Sbjct: 241 FLG--------CIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 9e-30
Identities = 78/257 (30%), Positives = 128/257 (49%), Gaps = 15/257 (5%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSN-ISREAQTMILVDHPNVLKSHCS 77
VG+G VH ++V +K + E+ D E Q + L+ HPN+++ + +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDV 137
F+ D L +VM + GG+ ++ +E I ++L L ++H +HRD+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127
Query: 138 KSGNILIDVRGAI-KLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKA 196
K+ NIL+D + K+GDFG+S L + T VGTPC+++PE+ E Y+ K+
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKIL----SSKSKAYTVVGTPCYISPELCEG-KPYNQKS 182
Query: 197 DIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASC 254
DIW+ G ELA F + P + + +M+ AP DR +S +Q+I S
Sbjct: 183 DIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS-----DR-YSPDLRQLILSM 236
Query: 255 LVKDPSKRPSAKKLLKH 271
L DPSKRP +++
Sbjct: 237 LNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 77/273 (28%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 37 EIVAVKILDFERD---NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93
++ A+K+L + D + ++++ E + D P ++K + SF + +L++VM +M G
Sbjct: 27 QVYAMKVLR-KSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85
Query: 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLG 153
G +++L D F E + E++ LD +H G IHRD+K NILID G IKL
Sbjct: 86 GDLMNLL--IRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLA 143
Query: 154 DFGVSACLFDSGD--------------------------RQRMRNTFVGTPCWMAPEVME 187
DFG+ + + D R+ N+ VGTP ++APEV+
Sbjct: 144 DFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR 203
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPM----KVLLMTLQNAPPGLDYERDRKF 243
Y + D WS G+ E+ +G PF K++ N L + D
Sbjct: 204 G-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKII-----NWKESLRFPPDPPV 257
Query: 244 SKSFKQMIASCLVKDPSKR-PSAKKLLKHSFFK 275
S +I L DP R S +++ H FFK
Sbjct: 258 SPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 80/299 (26%), Positives = 124/299 (41%), Gaps = 42/299 (14%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD---FERDNSDLSNISREAQTMILVDH 68
H+ + +G+G V ++ A+K+LD + N + + E + + +DH
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLDH 60
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG-FEEVVIATILREVLKGLDYL 127
P + + SF ++ L +VM + GG L L P E V EVL L+YL
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGE-LFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR---------------- 171
H G ++RD+K NIL+ G I L DF +S D +
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLS-KQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 172 -----------NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP 220
N+FVGT ++APEV+ G+ D W+ GI E+ +G PF K
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPF-KGSN 236
Query: 221 MKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKK----LLKHSFFK 275
+ + S S + +I LVKDPSKR +K+ + +H FF+
Sbjct: 237 RDETFSNILKKEV--TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 11/217 (5%)
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATI 116
EAQ + +DHP ++K H SF+ ++ + G L+ G E +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 117 LREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176
++L G+ Y+H +HRD+K+ NI + +K+GDFGVS L S D + TF G
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCD---LATTFTG 167
Query: 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 236
TP +M+PE ++ GYD K+DIWS G E+ F + V+L ++ P L
Sbjct: 168 TPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL- 225
Query: 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
+S+ ++ S L KDPS RPSA ++L++ F
Sbjct: 226 ---PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 79/289 (27%), Positives = 126/289 (43%), Gaps = 32/289 (11%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSN-ISREAQTMILVDHPNV 71
Y + +G+G V +A E VA+K + R + N RE + + HP V
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
+K F +VM +M S L + E + + +R +LKG+ Y+H +G
Sbjct: 62 VKLLDVFPHGSGFVLVMEYM--PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG 191
+HRD+K N+LI G +K+ DFG++ LF + + + V T + APE++
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQ-VATRWYRAPELLYGARK 177
Query: 192 YDFKADIWSFGITALELAHGHAPFSKYPPM-------KVLLMTLQNAPPGL----DYERD 240
YD D+W+ G EL +G F + + L + PGL DY +
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237
Query: 241 RKFSKS----FKQMIASC-----------LVKDPSKRPSAKKLLKHSFF 274
F +S +++ LV DPSKR SA + L+H +F
Sbjct: 238 T-FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 32/292 (10%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNIS-REAQTMILVDHP 69
Y + VG+G V + EIVA+K D+ D+ + RE + + + H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N++ +F L++V ++ + L +L+A P G + + + ++L+ + Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
H IHRD+K NIL+ G +KL DFG + L +V T + APE++
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARAL--RARPASPLTDYVATRWYRAPELLVGD 176
Query: 190 HGYDFKADIWSFGITALELAHGHAPFSK-------YPPMKVL--------LMTLQNA--- 231
Y D+W+ G EL G F Y K L + N
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 232 ----PPGLDYE-RDRKFSKSFK----QMIASCLVKDPSKRPSAKKLLKHSFF 274
P E +R++ + +CL DP +R + +LL+H +F
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 75/259 (28%), Positives = 131/259 (50%), Gaps = 15/259 (5%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVK---ILDFERDNSDLSNISREAQTMILVDH 68
++ + +++G+G + V+RA C+ VA+K I D D ++ +E + ++H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNH 61
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVLKGLDY 126
PNV+K + SF+ D+ L +V+ G ++K E + ++ L++
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM 186
+H +HRD+K N+ I G +KLGD G+ F S + ++ VGTP +M+PE +
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE--RDRKFS 244
+ +GY+FK+DIWS G E+A +PF K+ L +L DY +S
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFYG---DKMNLYSLCKKIEQCDYPPLPSDHYS 234
Query: 245 KSFKQMIASCLVKDPSKRP 263
+ +Q++ C+ DP KRP
Sbjct: 235 EELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 73/310 (23%), Positives = 126/310 (40%), Gaps = 75/310 (24%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNIS-----REAQTMI-LV 66
Y + +++G G SV+ A E+VA+K + + RE +++ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIK-----KMKKKFYSWEECMNLREVKSLRKLN 55
Query: 67 DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDY 126
+HPN++K F + L+ V +M G + ++K F E VI +I+ ++L+GL +
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN-----TFVGTPCWM 181
+H HG HRD+K N+L+ +K+ DFG++ + +R+ +V T +
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLA---------REIRSRPPYTDYVSTRWYR 165
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPFS------------------------- 216
APE++ + Y DIW+ G EL F
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225
Query: 217 ----------KYPPMKVLLMT--LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
++P + + NA P +I L DP KRP+
Sbjct: 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEA------------IDLIKDMLRWDPKKRPT 273
Query: 265 AKKLLKHSFF 274
A + L+H +F
Sbjct: 274 ASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 75/270 (27%), Positives = 135/270 (50%), Gaps = 15/270 (5%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-FER-DNSDLSNISREAQTMILVDHPN 70
+ + +++G+G + V+RA C+ + VA+K + FE D + +E + ++HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVLKGLDYLH 128
V+K SF+ D+ L +V+ G ++K E + ++ ++++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
+HRD+K N+ I G +KLGD G+ F S + ++ VGTP +M+PE + +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSS--KTTAAHSLVGTPYYMSPERIHE 180
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE--RDRKFSKS 246
+GY+FK+DIWS G E+A +PF K+ L +L DY +S+
Sbjct: 181 -NGYNFKSDIWSLGCLLYEMAALQSPFYG---DKMNLFSLCQKIEQCDYPPLPTEHYSEK 236
Query: 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
+++++ C+ DP +RP + H KQ
Sbjct: 237 LRELVSMCIYPDPDQRPDIGYV--HQIAKQ 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 79/267 (29%), Positives = 126/267 (47%), Gaps = 22/267 (8%)
Query: 13 YTLYEEVGQGVSASVHRALCIPF---NEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
Y + VG+G S RAL + ++ A+K + + +S + + +EA + + HP
Sbjct: 2 YNVLRVVGEG---SFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHP 58
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N++ SF +D +L++VM + GG + +K F E I ++ G+ ++H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
+HRD+KS NI + G +KLGDFG + L G T+VGTP ++ PE+ E +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA---YACTYVGTPYYVPPEIWENM 175
Query: 190 HGYDFKADIWSFGITALELAHGHAPFS----KYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
Y+ K+DIWS G EL PF K +KV + + P YE +
Sbjct: 176 -PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHS 272
FK ++P RPSA +L
Sbjct: 235 MFK--------RNPRSRPSATTILSRG 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 79/260 (30%), Positives = 123/260 (47%), Gaps = 13/260 (5%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSF 78
+G+G V+ A + +A+K + ERD+ + + E + H N+++ S
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIP-ERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 79 VSDHNLWVVMPFMSGGSCLHILKAAY-PDGFEEVVIATILREVLKGLDYLHHHGHIHRDV 137
+ + M + GGS +L++ + P E I +++L+GL YLH + +HRD+
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134
Query: 138 KSGNILIDV-RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ-LHGYDFK 195
K N+L++ G +K+ DFG S L TF GT +MAPEV+++ GY
Sbjct: 135 KGDNVLVNTYSGVVKISDFGTSKRL---AGINPCTETFTGTLQYMAPEVIDKGPRGYGAP 191
Query: 196 ADIWSFGITALELAHGHAPFSKY--PPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253
ADIWS G T +E+A G PF + P + + + P E S K I
Sbjct: 192 ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP----EIPESLSAEAKNFILR 247
Query: 254 CLVKDPSKRPSAKKLLKHSF 273
C DP KR SA LL+ F
Sbjct: 248 CFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 73/251 (29%), Positives = 118/251 (47%), Gaps = 25/251 (9%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMS 92
+E+ AVK+L D + D+ E + + L HP + + H F + L+ VM +++
Sbjct: 20 DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79
Query: 93 GGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG + HI ++ F+E E++ GL +LH G I+RD+K N+L+D G IK
Sbjct: 80 GGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIK 136
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
+ DFG+ C TF GTP ++APE++ Y D W+ G+ E+ G
Sbjct: 137 IADFGM--CKEGILGGVTTS-TFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAG 192
Query: 212 HAPFSKYPPMKVLLMTLQNAP--PGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PS 264
+PF ++ L++ P R SK K ++ S L K+P KR
Sbjct: 193 QSPFEGDDEDELFQSILEDEVRYP-------RWLSKEAKSILKSFLTKNPEKRLGCLPTG 245
Query: 265 AKKLLKHSFFK 275
+ + H FF+
Sbjct: 246 EQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 85/273 (31%), Positives = 130/273 (47%), Gaps = 37/273 (13%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSN----ISREAQTMILVDHPNVLKS 74
+GQG V+ +AVK + F+ ++ + S + E Q + + H +++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 75 HCSFVSD---HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
+ + D L + M M GGS LK+ E V R++L+G+ YLH +
Sbjct: 70 Y-GCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM 126
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVSA-----CLFDSGDRQRMRNTFVGTPCWMAPEVM 186
+HRD+K NIL D G +KLGDFG S CL +G + + GTP WM+PEV+
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK-----SVTGTPYWMSPEVI 181
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL-MTLQNAPPGL-----DYERD 240
GY KADIWS G T +E+ P++++ M + + Q P L D+ RD
Sbjct: 182 SG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
F K + + RPSA +LL+H+F
Sbjct: 241 --FLKR--------IFVEAKLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 71/248 (28%), Positives = 126/248 (50%), Gaps = 23/248 (9%)
Query: 36 NEIVAVKILD----FERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPF 90
NE A+K L E D+ + + + R + + L +HP + C+F + +L+ VM +
Sbjct: 20 NEFFAIKALKKDVVLEDDDVECTMVER--RVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77
Query: 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAI 150
++GG + ++++ F+E E++ GL +LH G I+RD+K N+L+D G I
Sbjct: 78 LNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHI 135
Query: 151 KLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH 210
K+ DFG+ ++ + + +TF GTP ++APE+++ Y+ D WSFG+ E+
Sbjct: 136 KIADFGMCK---ENMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLI 191
Query: 211 GHAPFSKYPPMKVLLMTLQNAP--PGLDYERDRKFSKSFKQMIASCLVKDPSKR-PSAKK 267
G +PF ++ L + P P R SK K ++ +DP+KR
Sbjct: 192 GQSPFHGEDEDELFDSILNDRPHFP-------RWISKEAKDCLSKLFERDPTKRLGVDGD 244
Query: 268 LLKHSFFK 275
+ +H FF+
Sbjct: 245 IRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 73/267 (27%), Positives = 124/267 (46%), Gaps = 18/267 (6%)
Query: 13 YTLYEEVGQG----VSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILVD 67
Y VG+G VS HR + +K L+ + + +EAQ + +
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQY----VIKKLNLRNASRRERKAAEQEAQLLSQLK 57
Query: 68 HPNVLKSHCSFV-SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDY 126
HPN++ S+ D L++VM F GG H LK E + ++ L Y
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM 186
LH +HRD+K+ N+ + IK+GD G++ L + D M +T +GTP +M+PE+
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD---MASTLIGTPYYMSPELF 174
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246
Y++K+D+W+ G E+A F+ ++ ++ P + + +S
Sbjct: 175 SN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM----PKDYSPE 229
Query: 247 FKQMIASCLVKDPSKRPSAKKLLKHSF 273
++IA+ L K P KRPS K +L+ +
Sbjct: 230 LGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 47/281 (16%)
Query: 36 NEIVAVKILD----FERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFM 91
I A+K L E++ ++++ E + D+P V+K + SF ++ L+++M ++
Sbjct: 26 GHIYAMKKLRKSEMLEKEQ--VAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83
Query: 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG + +L D F E + E + +D +H G+IHRD+K N+L+D +G IK
Sbjct: 84 PGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIK 141
Query: 152 LGDFGVSACL---------------------------FDSGDR----QRMRNTF----VG 176
L DFG+ L S + +R R VG
Sbjct: 142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVG 201
Query: 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 236
TP ++APEV Q GY+ + D WS G+ E+ G+ PF P + + N L
Sbjct: 202 TPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKII-NWKETLQ 259
Query: 237 YERDRKFSKSFKQMIAS--CLVKDPSKRPSAKKLLKHSFFK 275
+ + S K +I C + ++ H FFK
Sbjct: 260 FPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 67/228 (29%), Positives = 114/228 (50%), Gaps = 19/228 (8%)
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYL 127
P ++ H +F +D L +++ +++GG H+ + + F E + + E++ LD+L
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALDHL 121
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187
H G I+RD+K NIL+D G + L DFG+S F + + +R +F GT +MAPEV+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSK-EFLAEEEERA-YSFCGTIEYMAPEVIR 179
Query: 188 Q-LHGYDFKADIWSFGITALELAHGHAPFS----KYPPMKVLLMTLQNAPPGLDYERDRK 242
G+D D WS G+ EL G +PF+ + ++ L++ PP +
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP-----FPKT 234
Query: 243 FSKSFKQMIASCLVKDPSKR---PSAKKLLKHSFFKQARSNEYIARTL 287
S + I L KDP KR A ++ H FF+ ++ A+ +
Sbjct: 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRI 282
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 89/306 (29%), Positives = 148/306 (48%), Gaps = 20/306 (6%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-FER-DNSDLSNISREAQ 61
+K + AE Y + + +G+G V ++ A+K+L FE SD + E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKA-AYPDGFEEVVIATILREV 120
M + P V++ C+F D L++VM +M GG ++++ P+ + + A EV
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA----EV 151
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
+ LD +H G IHRDVK N+L+D G +KL DFG + ++G +T VGTP +
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG--MVRCDTAVGTPDY 209
Query: 181 MAPEVMEQLHG---YDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGL 235
++PEV++ G Y + D WS G+ E+ G PF + +M +N+ L
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS---L 266
Query: 236 DYERDRKFSKSFKQMIASCLVKDPSK--RPSAKKLLKHSFFKQARSN-EYIARTLLEGLP 292
++ D + SK K +I + L + R +++ +H FFK + N + I T +P
Sbjct: 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVP 326
Query: 293 ALGDRI 298
L I
Sbjct: 327 ELSSDI 332
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 80/276 (28%), Positives = 133/276 (48%), Gaps = 27/276 (9%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSN----ISREAQTMILV 66
++ L + +G+G V+ +AVK + F+ D+ + S + E Q + +
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 67 DHPNVLKSHCSFVSDH---NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
H +++ + + D L + + +M GGS LKA E V R++L+G
Sbjct: 62 RHDRIVQYY-GCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQG 118
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA-----CLFDSGDRQRMRNTFVGTP 178
+ YLH + +HRD+K NIL D G +KLGDFG S C+ +G + + GTP
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK-----SVTGTP 173
Query: 179 CWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL-MTLQNAPPGLDY 237
WM+PEV+ GY KAD+WS T +E+ P+++Y M + + Q P L
Sbjct: 174 YWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML-- 230
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
S + + + V++ +RP+A+ LL+H F
Sbjct: 231 --PDGVSDACRDFLKQIFVEE-KRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 71/236 (30%), Positives = 110/236 (46%), Gaps = 29/236 (12%)
Query: 58 REAQTMILVDHPNVLKSHCSFV--------SDHNLWVVMPFMSGGSC-LHILKAAYPDGF 108
R+ + M L + + K F+ + +L +VM M+GG HI P GF
Sbjct: 34 RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP-GF 92
Query: 109 EEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168
E +++ GL++LH ++RD+K N+L+D G +++ D G+ A G +
Sbjct: 93 PEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL-AVELKGGKKI 151
Query: 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK----VL 224
+ R GTP +MAPEV+ Q YDF D ++ G T E+ G +PF + +
Sbjct: 152 KGR---AGTPGYMAPEVL-QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK 207
Query: 225 LMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFFK 275
TL+ A E KFS K + + L KDP KR SA ++ +H FK
Sbjct: 208 RRTLEMA-----VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 78/309 (25%), Positives = 129/309 (41%), Gaps = 70/309 (22%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVK---ILDFE--RDNSDLSNISREAQTMILVD 67
Y +++G+G A V++A IVA+K + + + +D + + + RE + + +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQELK 60
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG---FEEVVIATILREVLKGL 124
HPN++ F N+ +V FM L+ D I + + L+GL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETD-----LEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
+YLH + +HRD+K N+LI G +KL DFG+ A F S +R +M + V T + APE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGL-ARSFGSPNR-KMTHQVV-TRWYRAPE 172
Query: 185 VMEQLHG---YDFKADIWSFGITALELAHGHAPF----------------------SKYP 219
+ L G Y D+WS G EL PF +P
Sbjct: 173 L---LFGARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLGKIFEALGTPTEENWP 228
Query: 220 PMKVLL--MTLQNAPPGLDYERDRKFSKSFKQM-----------IASCLVKDPSKRPSAK 266
+ L + + PP KQ+ + L +P+KR +A+
Sbjct: 229 GVTSLPDYVEFKPFPP-----------TPLKQIFPAASDDALDLLQRLLTLNPNKRITAR 277
Query: 267 KLLKHSFFK 275
+ L+H +F
Sbjct: 278 QALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 74/266 (27%), Positives = 123/266 (46%), Gaps = 14/266 (5%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISR-EAQTMILVDHPNV 71
Y + +++G+G ++ A +E +K +D + S+ E + + HPN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
+ SF + L++VM + GG + + F E I + ++ GL ++H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 132 HIHRDVKSGNILIDVRGAI-KLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
+HRD+KS NI + G + KLGDFG++ L DS + T VGTP +++PE+ +
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY---TCVGTPYYLSPEICQN-R 177
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN--APPGLDYERDRKFSKSFK 248
Y+ K DIWS G EL PF +++L Q AP ++ RD +
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD------LR 231
Query: 249 QMIASCLVKDPSKRPSAKKLLKHSFF 274
+I+ P RPS +LK F
Sbjct: 232 SLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-24
Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 23/260 (8%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMS 92
E AVK L D + D+ E + + L ++P + +C+F + +L+ VM F++
Sbjct: 20 GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79
Query: 93 GGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG + HI D + A E++ GL +LH G I+RD+K N+++D G IK
Sbjct: 80 GGDLMFHIQDKGRFDLYRATFYAA---EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIK 136
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
+ DFG+ C + R +TF GTP ++APE+++ L Y F D WSFG+ E+ G
Sbjct: 137 IADFGM--CKENVFGDNRA-STFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIG 192
Query: 212 HAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK- 270
+PF ++ + P R +K K ++ +DP++R ++
Sbjct: 193 QSPFHGDDEDELFESIRVDTP-----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRG 247
Query: 271 HSFFKQARSNEYIARTLLEG 290
H FFK I T LE
Sbjct: 248 HPFFKT------INWTALEK 261
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 79/292 (27%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNIS-REAQTMILVDHP 69
E Y VG+G V + +IVA+K D+ + I+ RE + + + H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N++ F L++V F+ + L L+ YP+G +E + L ++L+G+++ H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
H IHRD+K NIL+ G +KL DFG + L G+ + +V T + APE++
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLVGD 175
Query: 190 HGYDFKADIWSFGITALELAHGHA--P-------------------------FSKYPPMK 222
Y DIW+ G E+ G P F K P
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235
Query: 223 VLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274
+ + L+ +R K S + CL DP RPS+ +LL H FF
Sbjct: 236 GMRLPEVKEIEPLE-KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 76/278 (27%), Positives = 119/278 (42%), Gaps = 32/278 (11%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD----FERDNSDLSNISREAQTMILVD 67
+ + +VGQG V A EIVA+K + F+ + ++ ++ E +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLN--EVRHVLTERDILTTTK 59
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGG------SCLHILKAAYPDGFEEVVIATILREVL 121
++K +F D L++ M ++ GG + L +L + + + E+
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFY--------MAEMF 111
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
+ +D LH G+IHRD+K N LID G IKL DFG+S + N+ VG+P +M
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------YANSVVGSPDYM 165
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY---- 237
APEV+ GYDF D WS G E G PFS P + L+ L
Sbjct: 166 APEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKYWKETLQRPVYD 223
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275
+ S +I + + S + + H FFK
Sbjct: 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 35/285 (12%)
Query: 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVL 72
+ E +G G V A E A+K L + ++++E ++ + HP ++
Sbjct: 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCL-HILKAA-YPDGFEEVVIATILREVLKGLDYLHHH 130
CSF ++ ++ ++ F+ GG H+ KA +P+ + A E++ +YLH
Sbjct: 82 NMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA----ELVLAFEYLHSK 137
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN-TFVGTPCWMAPEVMEQL 189
I+RD+K N+L+D +G +K+ DFG + + R T GTP ++APEV+ Q
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFA-------KKVPDRTFTLCGTPEYLAPEVI-QS 189
Query: 190 HGYDFKADIWSFGITALELAHGHAPFSKYPPM----KVLLMTLQNAPPGLDYERDRKFSK 245
G+ D W+ G+ E G+ PF P K+L L+ P D R R K
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK-FPNWFD-GRARDLVK 247
Query: 246 SFKQMIASCLVKDPSKRPSAKK-----LLKHSFFKQARSNEYIAR 285
L D +KR K + H +F A ++ AR
Sbjct: 248 GL-------LQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYAR 285
|
Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 71/216 (32%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 64 ILVD--HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
IL + HP ++K H +F ++ L++++ F+ GG L F E + L E+
Sbjct: 51 ILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELA 108
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
LD+LH G I+RD+K NIL+D G IKL DFG+S +S D ++ +F GT +M
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYM 165
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAPPGLDYE 238
APEV+ + G+ AD WSFG+ E+ G PF + M ++L P L E
Sbjct: 166 APEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPE 224
Query: 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274
FK+ A+ L P +++ +H FF
Sbjct: 225 AQSLLRALFKRNPANRLGAGPD---GVEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 91/318 (28%), Positives = 146/318 (45%), Gaps = 20/318 (6%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-FER-DNSDLSNISREAQTMILVD 67
AE Y + + +G+G V ++ A+K+L FE SD + E M +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKA-AYPDGFEEVVIATILREVLKGLDY 126
P V++ +F D L++VM +M GG ++++ P+ + A EV+ LD
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA----EVVLALDA 157
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM 186
+H G IHRDVK N+L+D G +KL DFG C+ + + +T VGTP +++PEV+
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 187 EQLHG---YDFKADIWSFGITALELAHGHAPFSKYPPMKV-LLMTLQNAPPGLDYERDRK 242
+ G Y + D WS G+ E+ G PF Y V + N L + D
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMNHKNSLTFPDDND 273
Query: 243 FSKSFKQMIASCLVKDPSK--RPSAKKLLKHSFFKQAR-SNEYIARTLLEGLPALGDRIK 299
SK K +I + L + R +++ +H FFK + + E + T+ +P L I
Sbjct: 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDID 333
Query: 300 A--LKKKEEDMLAQKKMP 315
EED ++ P
Sbjct: 334 TSNFDDIEEDKGEEETFP 351
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 5e-23
Identities = 65/237 (27%), Positives = 114/237 (48%), Gaps = 13/237 (5%)
Query: 37 EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96
EI K+ ER+ S +E + + HPN+++ SF + NL++VM + GG
Sbjct: 32 EINISKMSPKEREES-----RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL 86
Query: 97 LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFG 156
+ A F E I ++ L ++H +HRD+KS NI + G IKLGDFG
Sbjct: 87 YKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFG 146
Query: 157 VSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS 216
++ L + + R T +GTP +++PE+ E Y+ K+DIW+ G E+ F
Sbjct: 147 IARVLNSTVELAR---TCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFE 202
Query: 217 KYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
++L ++ + P + +S + +++ ++P RPS +L+ +F
Sbjct: 203 AGNMKNLVLKIIRGSYPPVSS----HYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 6e-23
Identities = 76/303 (25%), Positives = 122/303 (40%), Gaps = 37/303 (12%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHPN 70
Y L + +G G V A+ VA+K I + D D I RE + + + H N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 71 VLKSHCSFVSD-----HNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGL 124
++ +++++V M + LH ++K+ P + I L ++L+GL
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKS--PQPLTDDHIQYFLYQILRGL 116
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
YLH IHRD+K NIL++ +K+ DFG++ + D + +V T + APE
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPP--GLDYERD 240
++ Y DIWS G EL F Y L++ + P L +
Sbjct: 177 LLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236
Query: 241 ---------------RKFSKSFKQ-------MIASCLVKDPSKRPSAKKLLKHSFFKQAR 278
+ SK F ++ LV DP KR +A + L H + Q
Sbjct: 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296
Query: 279 SNE 281
E
Sbjct: 297 DPE 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 8e-23
Identities = 70/249 (28%), Positives = 116/249 (46%), Gaps = 21/249 (8%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILVDHPNVLKS-HCSFVSDHNLWVVMPFMS 92
+E+ A+KIL D + D+ E + + L P L H F + L+ VM +++
Sbjct: 25 DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84
Query: 93 GGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG + HI + F+E E+ GL +LH G I+RD+K N+++D G IK
Sbjct: 85 GGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIK 141
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
+ DFG+ G R TF GTP ++APE++ Y D W+FG+ E+ G
Sbjct: 142 IADFGMCKENIFGGKTTR---TFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAG 197
Query: 212 HAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR----PSAKK 267
PF ++ +++ + SK + L K P+KR P+ ++
Sbjct: 198 QPPFDGEDEDELFQSIMEHNV-----SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGER 252
Query: 268 LLK-HSFFK 275
++ H+FF+
Sbjct: 253 DIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 85/277 (30%), Positives = 127/277 (45%), Gaps = 27/277 (9%)
Query: 11 EH-YTLYEEVGQGVSASVHRAL--CIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
EH Y L VG+ + + A P ++VA ++ D + E + D
Sbjct: 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVM--LNDERQAAYARSELHCLAACD 123
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGG----SCLHILKAAYPDGFEEVVIATILREVLKG 123
H ++K F SD L ++M + SGG LK P F+E + + +++
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP--FQEYEVGLLFYQIVLA 181
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
LD +H +HRD+KS NI + G IKLGDFG S DS + ++F GTP ++AP
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAP 240
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK-----VLLMTLQNAPPGLDYE 238
E+ E+ Y KAD+WS G+ EL H PF K P + VL P +
Sbjct: 241 ELWERKR-YSKKADMWSLGVILYELLTLHRPF-KGPSQREIMQQVLYGKYDPFPCPV--- 295
Query: 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275
S K ++ L K+P+ RP+ ++LL F K
Sbjct: 296 -----SSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-22
Identities = 71/264 (26%), Positives = 128/264 (48%), Gaps = 19/264 (7%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKIL--DFERDNSDLSNISREAQTMILV-DHPNVLKSH 75
+G+G V A N+ A+K L D + D+ E + + L +HP + +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 76 CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHR 135
C+F + NL+ VM +++GG + +++ + F+ E++ GL +LH G ++R
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 136 DVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFK 195
D+K NIL+D G IK+ DFG+ ++ TF GTP ++APE++ Y+
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTS 176
Query: 196 ADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP--PGLDYERDRKFSKSFKQMIAS 253
D WSFG+ E+ G +PF + ++ + P P R ++ K ++
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP-------RWLTREAKDILVK 229
Query: 254 CLVKDPSKRPSAK-KLLKHSFFKQ 276
V++P +R K + +H FF++
Sbjct: 230 LFVREPERRLGVKGDIRQHPFFRE 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 71/263 (26%), Positives = 118/263 (44%), Gaps = 24/263 (9%)
Query: 36 NEIVAVKILD----FERDNSD-LSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90
E+ A+K L RD + L R +T HP ++ F ++ ++ VM +
Sbjct: 24 GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83
Query: 91 MSGG-SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA 149
+GG +HI D F E V+ GL YLH + ++RD+K N+L+D G
Sbjct: 84 AAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF 139
Query: 150 IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELA 209
+K+ DFG+ C G R +TF GTP ++APEV+ + Y D W G+ E+
Sbjct: 140 VKIADFGL--CKEGMGFGDRT-STFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEML 195
Query: 210 HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PS 264
G +PF +V + + Y R S+ ++ L ++P +R
Sbjct: 196 VGESPFPGDDEEEVFDSIVNDEVR---YP--RFLSREAISIMRRLLRRNPERRLGSGEKD 250
Query: 265 AKKLLKHSFFKQARSNEYIARTL 287
A+ + K FF+ ++ +AR +
Sbjct: 251 AEDVKKQPFFRDINWDDLLARKI 273
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 59/183 (32%), Positives = 93/183 (50%), Gaps = 9/183 (4%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMS 92
+E+ A+K+L D + D+ E + + L HP + HC F + L+ VM +++
Sbjct: 20 DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79
Query: 93 GGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152
GG + ++ + F+E EV L +LH HG I+RD+K NIL+D G KL
Sbjct: 80 GGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKL 137
Query: 153 GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGH 212
DFG+ +G TF GTP ++APE++++L Y D W+ G+ E+ G
Sbjct: 138 ADFGMCKEGILNG---VTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQ 193
Query: 213 APF 215
PF
Sbjct: 194 PPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 83/300 (27%), Positives = 137/300 (45%), Gaps = 59/300 (19%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKI--LDFERDNSDLSNISREAQTMILVDHPNVLKSHC 76
+G+G V+RA EIVA+K +D ERD +S++ RE ++ + HPN+++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPNIVELKE 73
Query: 77 SFVSDH--NLWVVMPFMSGGSCLHILKA---AYPDGFEEVVIATILREVLKGLDYLHHHG 131
V H ++++VM + C L + P F E + ++ ++L+GL YLH +
Sbjct: 74 VVVGKHLDSIFLVMEY-----CEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC----WM-APEVM 186
IHRD+K N+L+ +G +K+ DFG+ A + + TP W APE++
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGL-ARTYGLPAKPM-------TPKVVTLWYRAPELL 180
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV------LLMTLQNAP-----PGL 235
Y D+W+ G EL H P P K L++ L P PG
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELL-AHKPLL---PGKSEIEQLDLIIQLLGTPNESIWPGF 236
Query: 236 D--------------YER-DRKF---SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277
Y KF S++ +++ L+ DP KR +A++ L+ S+FK+
Sbjct: 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 4e-22
Identities = 81/286 (28%), Positives = 133/286 (46%), Gaps = 21/286 (7%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-FER-DNSDLSNISR 58
K + AE + + + +G+G V ++ A+K+L FE SD +
Sbjct: 33 EKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAY--PDGFEEVVIATI 116
E M + +++ H +F D L++VM +M GG ++++ + Y P+ + A
Sbjct: 93 ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTA-- 149
Query: 117 LREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176
EV+ LD +H G IHRDVK N+L+D G +KL DFG C+ + +T VG
Sbjct: 150 --EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMDANGMVRCDTAVG 205
Query: 177 TPCWMAPEVMEQLHG---YDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNA 231
TP +++PEV++ G Y + D WS G+ E+ G PF +M +N+
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS 265
Query: 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSK--RPSAKKLLKHSFFK 275
L + D + SK K +I + L + R ++ H FFK
Sbjct: 266 ---LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 4e-22
Identities = 74/243 (30%), Positives = 118/243 (48%), Gaps = 20/243 (8%)
Query: 40 AVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL 97
A+KIL E ++++ E++ + HP + SF + L VM +++GG
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELF 83
Query: 98 -HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFG 156
H+ + F E E++ LDYLH ++RD+K N+++D G IK+ DFG
Sbjct: 84 FHLSRERV---FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFG 140
Query: 157 VSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS 216
+ C D M+ TF GTP ++APEV+E + Y D W G+ E+ G PF
Sbjct: 141 L--CKEGITDAATMK-TFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196
Query: 217 KYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKH 271
K+ + L D + R S K +++ L+KDP+KR AK++++H
Sbjct: 197 NQDHEKLFELILME-----DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251
Query: 272 SFF 274
SFF
Sbjct: 252 SFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 6e-22
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDY 126
HP + SF + L VM + +GG H+ + F E E++ L Y
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALGY 110
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM 186
LH ++RD+K N+++D G IK+ DFG+ C D M+ TF GTP ++APEV+
Sbjct: 111 LHSCDVVYRDLKLENLMLDKDGHIKITDFGL--CKEGISDGATMK-TFCGTPEYLAPEVL 167
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246
E + Y D W G+ E+ G PF K+ + L + R S
Sbjct: 168 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----EIRFPRTLSPE 221
Query: 247 FKQMIASCLVKDPSKR-----PSAKKLLKHSFF 274
K ++A L KDP +R AK++++H FF
Sbjct: 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 9e-22
Identities = 49/145 (33%), Positives = 81/145 (55%), Gaps = 7/145 (4%)
Query: 75 HCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIH 134
H +F ++NL++VM + GG L +L + + D E + L E++ +D +H G++H
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH 125
Query: 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG--- 191
RD+K N+L+D G I+L DFG +CL D N VGTP +++PE+++ +
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 192 -YDFKADIWSFGITALELAHGHAPF 215
Y + D WS G+ E+ +G PF
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-21
Identities = 79/312 (25%), Positives = 122/312 (39%), Gaps = 56/312 (17%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKIL---DFERDNSDLSNISREAQTMILVDH 68
+ + +G G V + N + A+K L D N +++ E + D+
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQ-AAHVKAERDILAEADN 60
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHIL--KAAYPDGFEEVVIATILREVLKGLDY 126
V+K + SF NL+ VM ++ GG + +L + + IA E+ ++
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA----ELTCAIES 116
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFG------------------------------ 156
+H G IHRD+K NILID G IKL DFG
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 157 ---VSACLFDSGDRQRMR-------NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITAL 206
+ C +R+R R ++ VGTP ++APEV+ + GY D WS G+
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILY 235
Query: 207 ELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR---P 263
E+ G PF P + + + N L K S+ +I L R
Sbjct: 236 EMLVGQPPFLADTPAET-QLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKN 293
Query: 264 SAKKLLKHSFFK 275
A ++ H FFK
Sbjct: 294 GADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-21
Identities = 88/333 (26%), Positives = 151/333 (45%), Gaps = 44/333 (13%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKIL--DFERDNSDLSNISREAQTMILV-DHPNVLKSH 75
+G+G V A + AVK+L D + D+ E + + L +HP + + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 76 CSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIH 134
C F + L+ VM F++GG + HI K+ F+E E+ L +LH G I+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEITSALMFLHDKGIIY 119
Query: 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM-EQLHGYD 193
RD+K N+L+D G KL DFG+ +G + +TF GTP ++APE++ E L+G
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 194 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA---PPGLDYERDRKFSKSFKQM 250
D W+ G+ E+ GHAPF + L + P L + +
Sbjct: 177 --VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAV--------DI 226
Query: 251 IASCLVKDPSKRPSA------KKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKK- 303
+ + + K+P+ R + + +L+H FFK+ + R + P RIK+ +
Sbjct: 227 LKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQI---EPPFRPRIKSREDV 283
Query: 304 --------KEEDMLAQKKMPDGQKEEISQNEYK 328
KE+ +L + + I+Q+E++
Sbjct: 284 SNFDPDFIKEDPVLT--PIEESLLPMINQDEFR 314
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 81/293 (27%), Positives = 135/293 (46%), Gaps = 41/293 (13%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDL-SNISREAQTMILVDHPNV 71
Y E++G+G V++A EIVA+K + E ++ + S RE + ++HPN+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILK----AAYPDGFEEVVIATILREVLKGLDYL 127
++ S++ L++V F+ LK ++ G + +I + L ++L+G+ Y
Sbjct: 61 VRLLDVVHSENKLYLVFEFLD-----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187
H H +HRD+K N+LID GA+KL DFG+ A F G R V T + APE++
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGL-ARAF--GVPVRTYTHEVVTLWYRAPEILL 172
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSK-------YPPMKVLLMTLQNAPPGLDYERD 240
Y DIWS G E+ + F + + L ++ PG+ D
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232
Query: 241 RKFSKSFKQ-------------------MIASCLVKDPSKRPSAKKLLKHSFF 274
+ +F + +++ LV DP+KR SAK L+H +F
Sbjct: 233 --YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 91/345 (26%), Positives = 151/345 (43%), Gaps = 37/345 (10%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDH 68
A+ Y + +G G + +V A + E AVK++D E + +D + E ++ D
Sbjct: 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDF 90
Query: 69 PNVLKSHCSFV-SDHN-------LWVVMPFMSGGSCLHILK--AAYPDGFEEVVIATILR 118
+++K H F D + +V+ + + G +K A F E +
Sbjct: 91 FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD--SGDRQRMRNTFVG 176
+VL + ++H IHRD+KS NIL+ G +KLGDFG S S D R TF G
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR---TFCG 207
Query: 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA----P 232
TP ++APE+ + Y KAD++S G+ EL PF +V+ TL P
Sbjct: 208 TPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266
Query: 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
P + S ++++ + L DP +RPS+ KLL K S +++ P
Sbjct: 267 PSI--------SPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS---GLLEIVQTQP 315
Query: 293 A----LGDRI-KALKKKEEDMLAQKKMPDGQKEEISQNEYKRGIS 332
L D I + +++ ++ + +++ Q EE I
Sbjct: 316 GFSGPLRDTISRQIQQTKQLLQVERRRIVRQMEESLSTAASTTIL 360
|
Length = 496 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 68/238 (28%), Positives = 110/238 (46%), Gaps = 19/238 (7%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH 98
VAVK L + + +EA M +HPN++K + + +++M M GG L
Sbjct: 29 VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS 88
Query: 99 ILKAA-----YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG----- 148
L+ A P + I +V KG YL IHRD+ + N L+ +G
Sbjct: 89 YLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADR 148
Query: 149 AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG-YDFKADIWSFGITALE 207
+K+GDFG++ ++ S D R + WMAPE + L G + ++D+WSFG+ E
Sbjct: 149 VVKIGDFGLARDIYKS-DYYRKEGEGLLPVRWMAPESL--LDGKFTTQSDVWSFGVLMWE 205
Query: 208 -LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
L G P+ +V LQ+ G ++ Q++ +C +DPS+RP+
Sbjct: 206 ILTLGQQPYPALNNQEV----LQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 45/283 (15%)
Query: 27 VHRALCIPFNEIVAVKILDFERDNSDLSNIS-REAQTMILVDHPNVLKSHCSFVSDH--N 83
V+RA EIVA+K L E++ S RE ++ + HPN++ V +
Sbjct: 21 VYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80
Query: 84 LWVVMPFMSGGSCLHILKAA---YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSG 140
+++VM ++ H LK+ F + + ++ ++L G+ +LH + +HRD+K+
Sbjct: 81 IYMVMEYVE-----HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTS 135
Query: 141 NILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWS 200
N+L++ RG +K+ DFG+ A + S + + V T + APE++ Y D+WS
Sbjct: 136 NLLLNNRGILKICDFGL-AREYGSPLKPYTQL--VVTLWYRAPELLLGAKEYSTAIDMWS 192
Query: 201 FG------ITALELAHGHAP---------------------FSKYPPMKVLLMTLQNAPP 233
G +T L G + FS+ P K T P
Sbjct: 193 VGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK--KKTFTKYPY 250
Query: 234 GLDYERDRKFSKSFK--QMIASCLVKDPSKRPSAKKLLKHSFF 274
++ S S ++ L DP+KR SA+ LKH +F
Sbjct: 251 NQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 67/239 (28%), Positives = 106/239 (44%), Gaps = 34/239 (14%)
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG-------FEEV 111
E + ++P V+ CSF + +L +VM ++ GG C +LK F E
Sbjct: 51 ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAET 110
Query: 112 VIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC----------- 160
V+A L+YLH++G +HRD+K N+LI G IKL DFG+S
Sbjct: 111 VLA---------LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161
Query: 161 -LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP 219
+ R+ + GTP ++APEV+ + GY D W+ GI E G PF
Sbjct: 162 GHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220
Query: 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR---PSAKKLLKHSFFK 275
P ++ + + E D + +I+ L ++P +R A ++ +H FF
Sbjct: 221 PEELFGQVISDDIEWP--EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 4e-21
Identities = 71/233 (30%), Positives = 114/233 (48%), Gaps = 22/233 (9%)
Query: 51 SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG-FE 109
S++++ E + V+ P ++ SF S L++V+ F++GG H L+ +G F+
Sbjct: 35 SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR---EGRFD 91
Query: 110 EVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169
E+L L+ LH I+RD+K NIL+D +G I L DFG+ C + D +
Sbjct: 92 LSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGL--CKLNMKDDDK 149
Query: 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ 229
NTF GTP ++APE++ HGY D W+ G+ E+ G PF ++ LQ
Sbjct: 150 T-NTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
Query: 230 NA---PPGLDYERDRKFSKSFKQMIASCLVKDPSKR---PSAKKLLKHSFFKQ 276
P G D + K ++ L +DP++R A+++ H FF Q
Sbjct: 208 EPLRFPDGFDRDA--------KDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 5e-21
Identities = 59/211 (27%), Positives = 110/211 (52%), Gaps = 9/211 (4%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-FER-DNSDLSNISREAQTMILVDH 68
E + + + +G+G V +++ A+KIL+ +E ++ + E ++ D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
+ H +F ++NL++VM + GG L +L + + D E + L E++ +D +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
++HRD+K NIL+D+ G I+L DFG L + G Q + VGTP +++PE+++
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ--SSVAVGTPDYISPEILQA 177
Query: 189 LHG----YDFKADIWSFGITALELAHGHAPF 215
+ Y + D WS G+ E+ +G PF
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 73/259 (28%), Positives = 124/259 (47%), Gaps = 17/259 (6%)
Query: 36 NEIVAVKILD---FERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMS 92
+I A+K+L R+ D ++ E + V HP ++ +F + L++++ ++S
Sbjct: 24 GKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLS 83
Query: 93 GGSC-LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG +H+ + F E L E+ L++LH G I+RD+K NIL+D +G +K
Sbjct: 84 GGELFMHLEREGI---FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVK 140
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
L DFG+ +S + +TF GT +MAPE++ + G+ D WS G ++ G
Sbjct: 141 LTDFGLCK---ESIHEGTVTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTG 196
Query: 212 HAPFSKYPPMKVLLMTLQ---NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
PF+ K + L+ N PP L E K K+ +S L P A ++
Sbjct: 197 APPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPG---DAAEV 253
Query: 269 LKHSFFKQARSNEYIARTL 287
H FF+ ++ +AR +
Sbjct: 254 QSHPFFRHVNWDDLLARKV 272
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 83/284 (29%), Positives = 132/284 (46%), Gaps = 31/284 (10%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVKI--LDFERDNSDLSNISREAQTMILVDHPNVLKS 74
E++G+G V++A E+VA+K LD E + + I RE + ++HPN++K
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKL 64
Query: 75 HCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIH 134
+++ L++V F+ + A+ G +I + L ++L+GL + H H +H
Sbjct: 65 LDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123
Query: 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDF 194
RD+K N+LI+ GAIKL DFG++ G R V T + APE++ Y
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 195 KADIWSFGITALELAHGHAPF---SKYPPMKVLLMTL----QNAPPGLDYERDRKFS--- 244
DIWS G E+ A F S+ + + TL + PG+ D K S
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240
Query: 245 ---KSFKQ-----------MIASCLVKDPSKRPSAKKLLKHSFF 274
+ F + +++ L DP+KR SAK L H FF
Sbjct: 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 8e-21
Identities = 57/214 (26%), Positives = 106/214 (49%), Gaps = 11/214 (5%)
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR 118
EA+ M+ + HP +++ + L++V FM G L+ L+ + ++ ++ +
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQ 107
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+V +G++YL + IHRD+ + N L+ G +K+ DFG++ + D + ++ P
Sbjct: 108 DVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD---EYTSSSGAKFP 164
Query: 179 C-WMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLD 236
W PEV Y K+D+WSFG+ E+ G PF K +V+ M + G
Sbjct: 165 VKWSPPEVF-NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR----GFR 219
Query: 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
R + S + +++ SC + P RP+ +LL+
Sbjct: 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 54/213 (25%), Positives = 105/213 (49%), Gaps = 11/213 (5%)
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR 118
EA+ M+ + H +++ + +++V +MS G L+ L+ F+ + + +
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCK 107
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+V +G+ YL IHRD+ + N L+D +G +K+ DFG+S + D + + F P
Sbjct: 108 DVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF---P 164
Query: 179 C-WMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLD 236
W PEV+ + K+D+W+FG+ E+ + G P+ ++ + + Q GL
Sbjct: 165 VRWSPPEVL-LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ----GLR 219
Query: 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLL 269
R S+ ++ SC + +RP+ ++LL
Sbjct: 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 71/289 (24%), Positives = 116/289 (40%), Gaps = 34/289 (11%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM-ILVDHPNV 71
Y + ++G+G + V +A + A+K + + + N RE Q + L HPN+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 72 LKSH-CSFVSDHN-LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
L+ F L +V M I P E + + + ++LK LD++H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP--LPEKRVKSYMYQLLKSLDHMHR 118
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
+G HRD+K NILI +KL DFG S S + ++ T + APE +
Sbjct: 119 NGIFHRDIKPENILIK-DDILKLADFG-SCRGIYS---KPPYTEYISTRWYRAPECLLTD 173
Query: 190 HGYDFKADIWSFGITALELAHGHAPF---------SKY------PPMKVLLMTLQNAPPG 234
Y K DIW+ G E+ F +K P +VL ++
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233
Query: 235 LDY--ERDRKFSKSFKQMIASC-------LVKDPSKRPSAKKLLKHSFF 274
++ ++ K A L DP +R +AK+ L+H +F
Sbjct: 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 75/295 (25%), Positives = 121/295 (41%), Gaps = 41/295 (13%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDF--ERDNSDLSNISREAQTMILVD--- 67
Y E+G+G +V++A + VA+K + + LS + RE + ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL-REIALLKQLESFE 59
Query: 68 HPNVLK--SHCSFVSDHN---LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
HPN+++ C L +V + ++ K P G I ++R++L+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKP-GLPPETIKDLMRQLLR 118
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM- 181
G+D+LH H +HRD+K NIL+ G +K+ DFG+ A ++ M T V W
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL-ARIYSF----EMALTSVVVTLWYR 173
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ--NAPPGLDYER 239
APEV+ Q Y D+WS G EL F L P ++ R
Sbjct: 174 APEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232
Query: 240 D---------RKFSKSFKQMIAS-----------CLVKDPSKRPSAKKLLKHSFF 274
+ +SFK + L +P KR SA + L+H +F
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 64/252 (25%), Positives = 119/252 (47%), Gaps = 25/252 (9%)
Query: 37 EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGG 94
E VAVK L E + ++++ +E + + + H N++K C+ + + ++M F+ G
Sbjct: 34 EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93
Query: 95 SCLHILKAAYPDGFEEVVIATILR---EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
S LK P ++ + L+ ++ KG+DYL ++HRD+ + N+L++ +K
Sbjct: 94 S----LKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK 149
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
+GDFG++ + + +++ W APE + Q Y +D+WSFG+T EL
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTY 208
Query: 212 HAPFSKYPPMKVLL---------MTLQNAPPGLDYE----RDRKFSKSFKQMIASCLVKD 258
S+ PM + L MT+ L+ R + Q++ C
Sbjct: 209 CD--SESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQ 266
Query: 259 PSKRPSAKKLLK 270
PSKR + + L++
Sbjct: 267 PSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 83 NLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGN 141
+++VVM M S LH I+ + P E I L ++L+GL Y+H IHRD+K N
Sbjct: 82 DVYVVMDLM--ESDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSN 137
Query: 142 ILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT-FVGTPCWMAPEVMEQLHGYDFKADIWS 200
+L++ +++GDFG++ L S + T +V T + APE++ L Y D+WS
Sbjct: 138 LLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWS 197
Query: 201 FG-ITALELAHGHA-PFSKYPPMKVLLMTLQNAPPG-----LDYERDRKFSKSFKQ---- 249
G I A L P Y L++++ +P + +R RK+ ++ +
Sbjct: 198 VGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPV 257
Query: 250 ---------------MIASCLVKDPSKRPSAKKLLKHSFFKQARSNEY 282
+++ L DP +R + ++ L+H F Q +
Sbjct: 258 PWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 37 EIVAVKILDFERDNSDLSNISREAQTMILVDHPNV--LKSHCSFVSDHNLWVVMPFMSGG 94
E VAVK L+ + S+ RE + + +DH N+ K C +L ++M ++ G
Sbjct: 34 EQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSG 93
Query: 95 SCLHILKAAYPDGFEEVVIATILR---EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
S L +++ + +L ++ KG+DYL +IHRD+ + NIL++ +K
Sbjct: 94 SLRDYL----QRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVK 149
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALEL-AH 210
+ DFG++ L + D ++ W APE + + +D+WSFG+T EL +
Sbjct: 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTY 208
Query: 211 GHAPFSKYPPMKVLLM 226
G S+ PP + L M
Sbjct: 209 GDP--SQSPPAEFLRM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 69/234 (29%), Positives = 106/234 (45%), Gaps = 21/234 (8%)
Query: 58 REAQTMIL--------VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC-LHILKAAYPDGF 108
R+ + M L V+ V+ ++ + L +V+ M+GG HI P GF
Sbjct: 41 RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GF 99
Query: 109 EEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168
+E E+ GL+ LH ++RD+K NIL+D G I++ D G+ A G+
Sbjct: 100 DEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL-AVEIPEGETI 158
Query: 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL 228
R R VGT +MAPEV++ Y F D W G E+ G +PF + KV +
Sbjct: 159 RGR---VGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-KVKREEV 213
Query: 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFFKQA 277
+ E KFS++ + + L KDP R A+++ H FF+ A
Sbjct: 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 17/221 (7%)
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDG-FEEVVIATILR 118
+L + P ++ SF +D +L++V +MSGG H+ K +G F E +
Sbjct: 48 VRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIA 103
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
E++ L++LH + ++RD+K NIL+D G I L DFG+S NTF GT
Sbjct: 104 ELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---TTNTFCGTT 160
Query: 179 CWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238
++APEV+ GY D WS G+ E+ G +PF Y M A + +
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF--YAE-DTQQMYRNIAFGKVRFP 217
Query: 239 RDRKFSKSFKQMIASCLVKDPSKR----PSAKKLLKHSFFK 275
++ S +Q + L ++P R A +L +H FF
Sbjct: 218 KN-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 71/273 (26%), Positives = 115/273 (42%), Gaps = 23/273 (8%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDH 68
+ + VG G VH A+K++ ++ E + + V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
P +++ + L+++M ++ GG L+ + F E++ L+YLH
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLH 118
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN-TFVGTPCWMAPEVME 187
++RD+K NIL+D G IKL DFG + L D R T GTP ++APEV+
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-------RTWTLCGTPEYLAPEVI- 170
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247
Q G++ D W+ GI E+ G+ PF P + L L++ R
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK---LEFP--RHLDLYA 225
Query: 248 KQMIASCLVKDPSKR-----PSAKKLLKHSFFK 275
K +I LV D ++R A + H +FK
Sbjct: 226 KDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 17 EEVGQGVSASVHRALCI-PFNEI--VAVKILDFERDNSDLSNISREAQTMILVDHPNVLK 73
+++G G V R ++ VAVK L ++ + + + +EA M +DH N+++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 74 SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR---EVLKGLDYLHHH 130
+ V H L +V GS L L+ D +I+T+ ++ G+ YL
Sbjct: 61 LY-GVVLTHPLMMVTELAPLGSLLDRLRK---DALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
IHRD+ + NIL+ +K+GDFG+ L + D M W APE +
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 191 GYDFKADIWSFGITALEL-AHGHAPF 215
+ +D+W FG+T E+ +G P+
Sbjct: 177 -FSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 70/295 (23%), Positives = 124/295 (42%), Gaps = 45/295 (15%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
+ E++G+G A+V++ EIVA+K + + + S RE M + H N++
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH 132
+ H +++ L +V +M ++ + + + ++LKG+ + H +
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 133 IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR------NTF---VGTPCWMAP 183
+HRD+K N+LI+ RG +KL DFG++ R NTF V T + AP
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLA------------RAFGIPVNTFSNEVVTLWYRAP 169
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAP-----PGL- 235
+V+ Y DIWS G E+ G F + + + + P PG+
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229
Query: 236 ---DYERD--RKFSKSFKQMIASC-----------LVKDPSKRPSAKKLLKHSFF 274
+Y+ R + +Q+ L +P R SA L+H +F
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 78/304 (25%), Positives = 123/304 (40%), Gaps = 58/304 (19%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNIS-REAQTMILVDHP 69
E Y ++G+G V + +IVA+K D+ + I+ RE + + + HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N++ F L +V + + L+ L+ P G E +I I+ + L+ +++ H
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
H IHRDVK NILI +G IKL DFG + L GD +V T + APE++
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---DYTDYVATRWYRAPELLVGD 175
Query: 190 HGYDFKADIWSFGITALELAHGHA--P-------------------------FS--KY-- 218
Y D+W+ G EL G P FS ++
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235
Query: 219 -------PPMKVLLMTLQNA-PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
+ L N P L + + CL DP++R S ++LL+
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSF-------------LKGCLQMDPTERLSCEELLE 282
Query: 271 HSFF 274
H +F
Sbjct: 283 HPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 76 CSFVSDHNLWVVMPFMSGGSC-LHILKAAYPD-GFEEVVIATILREVLKGLDYLHHHGHI 133
+F + +L +VM M+GG HI + GF E +++ GL++LH I
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 134 HRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYD 193
+RD+K N+L+D G +++ D G++ L D + + + GTP +MAPE++ Q YD
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK---GYAGTPGFMAPELL-QGEEYD 175
Query: 194 FKADIWSFGITALELAHGHAPF----SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249
F D ++ G+T E+ PF K ++ L ++ + Y KFS + K
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS---VTYP--DKFSPASKS 230
Query: 250 MIASCLVKDPSKR-----PSAKKLLKHSFFKQ 276
+ L KDP KR + L H F+
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYL 127
P ++ H +F ++ L +++ ++SGG H+ + D F E + E++ L++L
Sbjct: 65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHL 121
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187
H G ++RD+K NIL+D G + L DFG+S F S +++R +F GT +MAPE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSK-EFLSEEKERTY-SFCGTIEYMAPEIIR 179
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFS----KYPPMKVLLMTLQNAPPGLDYERDRKF 243
G+ D WS GI EL G +PF+ + +V L+ PP
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP-----FPSFI 234
Query: 244 SKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFFK 275
+ ++ L KDP KR A ++ +H FFK
Sbjct: 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-19
Identities = 81/316 (25%), Positives = 124/316 (39%), Gaps = 58/316 (18%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD----FERDNSDLSNISREAQTMILV 66
E + + +G+G V +I A+K L F++D L+++ E +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQ--LAHVKAERDVLAES 58
Query: 67 DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDY 126
D P V+ + SF L+++M F+ GG + +L Y D F E V + E + ++
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-IKY-DTFSEDVTRFYMAECVLAIEA 116
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD-------------------- 166
+H G IHRD+K NILID G IKL DFG+S D
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 167 ------------------------RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFG 202
R+ M + VGTP ++APE+ Q GY + D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG 235
Query: 203 ITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSK- 261
E G PF + + N L + D S + +I L+ +
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKII-NWRETLYFPDDIHLSVEAEDLIRR-LITNAENR 293
Query: 262 --RPSAKKLLKHSFFK 275
R A ++ H FF+
Sbjct: 294 LGRGGAHEIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 20/198 (10%)
Query: 35 FNEIVAVKILDFERDNS----DLSNISREAQTMILVDHPNVLKS---------HCSFVSD 81
F E+ VK+ ER + + + + A+T + NVL + H +F +
Sbjct: 14 FGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE 73
Query: 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGN 141
+ L++VM + GG L +L + + D E + + E++ + +H ++HRD+K N
Sbjct: 74 NYLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDN 132
Query: 142 ILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG----YDFKAD 197
+L+D+ G I+L DFG +CL + D + VGTP +++PE+++ + Y + D
Sbjct: 133 VLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 190
Query: 198 IWSFGITALELAHGHAPF 215
WS G+ E+ +G PF
Sbjct: 191 WWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 75/276 (27%), Positives = 114/276 (41%), Gaps = 31/276 (11%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCI-PFNEI--VAVKILDFERDNSDLSNISREAQT 62
Y I E TL +G+G V++ + + P NE VAVK S +EA
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
M DHP+++K ++++ +W+VM G L+ + + ++
Sbjct: 61 MRQFDHPHIVKL-IGVITENPVWIVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLST 118
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WM 181
L YL +HRD+ + N+L+ +KLGDFG+S L D + + P WM
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE---SYYKASKGKLPIKWM 175
Query: 182 APEVMEQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVL--------LMTLQNAP 232
APE + + +D+W FG+ E L G PF V+ L N P
Sbjct: 176 APESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCP 234
Query: 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
P L Y ++ C DPSKRP +L
Sbjct: 235 PTL-Y-----------SLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 73/252 (28%), Positives = 121/252 (48%), Gaps = 27/252 (10%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILVDHPNVLKS-HCSFVSDHNLWVVMPFMS 92
+E+ A+KIL D + D+ E + + L P L H F + L+ VM +++
Sbjct: 25 DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84
Query: 93 GGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152
GG ++ ++ F+E E+ GL +LH G I+RD+K N+++D G IK+
Sbjct: 85 GGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKI 142
Query: 153 GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGH 212
DFG+ C + D + TF GTP ++APE++ Y D W+FG+ E+ G
Sbjct: 143 ADFGM--CKENMWDGVTTK-TFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQ 198
Query: 213 APFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF-KQMIASC---LVKDPSKR----PS 264
APF ++ + E + + KS K+ +A C + K P KR P
Sbjct: 199 APFEGEDEDELFQSIM---------EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPE 249
Query: 265 AKKLLK-HSFFK 275
++ +K H+FF+
Sbjct: 250 GERDIKEHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 36/272 (13%)
Query: 13 YTLYEEVGQGVSASVH--RALCIPFNEIVAVKILDF----------ERDNSDLSNISREA 60
Y + E +G G V+ R N ++A+K ++ ERD S +S
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQN-LLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILR 118
+ HPN+++ + +F+ + L++VM + G + F E I I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 119 EVLKGLDYLHHHGHI-HRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF--- 174
+++ L YLH I HRD+ NI++ + + DFG++ +Q+ +
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA--------KQKQPESKLTS 172
Query: 175 -VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233
VGT + PE+++ Y KAD+W+FG ++ PF M L + A
Sbjct: 173 VVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEA-- 228
Query: 234 GLDYE--RDRKFSKSFKQMIASCLVKDPSKRP 263
YE + +S+ +I SCL D RP
Sbjct: 229 --VYEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 18/261 (6%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNEI-VAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
T +E+G G VH +I VA+K++ + D + EA+ M+ + HPN++
Sbjct: 7 TFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAMSED--DFIEEAKVMMKLSHPNLV 62
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH 132
+ + +++V +M+ G L+ L+ + + +V + ++YL +G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 133 IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLHG 191
IHRD+ + N L+ +K+ DFG++ + D Q + P W PEV +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDD---QYTSSQGTKFPVKWAPPEVF--DYS 176
Query: 192 -YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249
+ K+D+WSFG+ E+ + G P+ ++ +V+ G R +
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA----GYRLYRPKLAPTEVYT 232
Query: 250 MIASCLVKDPSKRPSAKKLLK 270
++ SC + P RP+ KKLL
Sbjct: 233 IMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 75/294 (25%), Positives = 133/294 (45%), Gaps = 43/294 (14%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDL-SNISREAQTMILVDHPNV 71
Y E++G+G +V +A +EIVA+K + + D+ + S+ RE + + H N+
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG----FEEVVIATILREVLKGLDYL 127
++ + SD L +V + C LK Y D + ++ + + ++LKGL +
Sbjct: 62 VRLYDVLHSDKKLTLVFEY-----CDQDLKK-YFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187
H H +HRD+K N+LI+ G +KL DFG++ G R + V T + P+V+
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVRCYSAEVVTLWYRPPDVLF 172
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSKYPP----------MKVLLMTLQNAPPGLDY 237
Y D+WS G ELA+ P +P ++L + + PG+
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230
Query: 238 ERDRKFSKSF-----------------KQMIASCLVKDPSKRPSAKKLLKHSFF 274
D K + + ++ + LV +P +R SA++ L+H +F
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 8e-19
Identities = 71/266 (26%), Positives = 117/266 (43%), Gaps = 16/266 (6%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+ I E L ++GQG V +N V I + +EAQ M
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKK 57
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
+ H +++ + + VS+ +++V +MS GS L LK + + ++ G+
Sbjct: 58 LRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPE 184
Y+ ++HRD+++ NIL+ K+ DFG++ + D+ R F P W APE
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIKWTAPE 173
Query: 185 VMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242
L+G + K+D+WSFGI EL G P YP M V L G +
Sbjct: 174 A--ALYGRFTIKSDVWSFGILLTELTTKGRVP---YPGM-VNREVLDQVERGYRMPCPPE 227
Query: 243 FSKSFKQMIASCLVKDPSKRPSAKKL 268
+S ++ C K+P +RP+ + L
Sbjct: 228 CPESLHDLMCQCWRKEPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 69/246 (28%), Positives = 112/246 (45%), Gaps = 26/246 (10%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH 98
VAVK L + +EAQ M + H +++ + + +++V +MS GS L
Sbjct: 33 VAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD 90
Query: 99 ILKAAYPDG----FEEVV-IATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLG 153
LK+ +G ++V +A ++ +G+ YL +IHRD+ + NIL+ K+
Sbjct: 91 FLKS--GEGKKLRLPQLVDMAA---QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIA 145
Query: 154 DFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLHG-YDFKADIWSFGITALEL-AH 210
DFG++ + D R F P W APE +G + K+D+WSFGI E+ +
Sbjct: 146 DFGLARLIEDDEYTAREGAKF---PIKWTAPEAA--NYGRFTIKSDVWSFGILLTEIVTY 200
Query: 211 GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
G P YP M L+ G R + ++ C KDP +RP+ + L
Sbjct: 201 GRVP---YPGM-TNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYL-- 254
Query: 271 HSFFKQ 276
SF +
Sbjct: 255 QSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 73/254 (28%), Positives = 121/254 (47%), Gaps = 29/254 (11%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILVDHPNVLKS-HCSFVSDHNLWVVMPFMS 92
+E+ A+KIL D + D+ E + + L D P L H F + L+ VM +++
Sbjct: 25 DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84
Query: 93 GGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG + HI + F+E E+ GL +LH G I+RD+K N+++D G IK
Sbjct: 85 GGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIK 141
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
+ DFG+ G R TF GTP ++APE++ Y D W++G+ E+ G
Sbjct: 142 IADFGMCKEHMVDGVTTR---TFCGTPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAG 197
Query: 212 HAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF-KQMIASC---LVKDPSKR----P 263
PF ++ + E + + KS K+ ++ C + K PSKR P
Sbjct: 198 QPPFDGEDEDELFQSIM---------EHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGP 248
Query: 264 SAKKLLK-HSFFKQ 276
++ ++ H+FF++
Sbjct: 249 EGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 28/287 (9%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDL-SNISREAQTMILVDHPNV 71
YT E++G+G V++ +IVA+K + E + + S RE + + HPN+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
+ + + L+++ F+S ++ + ++ + L ++L+G+ + H
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG 191
+HRD+K N+LID +G IKL DFG++ G R+ V T + APEV+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF---GIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 192 YDFKADIWSFGITALELA------HGHAPFSKYPPMKVLLMTLQNAP-PGLDYERDRK-- 242
Y DIWS G E+A HG + + + +L T PG+ D K
Sbjct: 179 YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238
Query: 243 --------FSKSFKQM-------IASCLVKDPSKRPSAKKLLKHSFF 274
+ K + + L+ DP+KR SAKK L H +F
Sbjct: 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 69/232 (29%), Positives = 101/232 (43%), Gaps = 21/232 (9%)
Query: 58 REAQTMILVDHPNVLKSHCSFV--------SDHNLWVVMPFMSGGSC-LHILKAAYPDGF 108
R+ + M L + + K + FV + L +V+ M+GG HI P GF
Sbjct: 41 RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GF 99
Query: 109 EEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168
+E E+ GL+ L ++RD+K NIL+D RG I++ D G+ A G+
Sbjct: 100 DEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGL-AVQIPEGETV 158
Query: 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL 228
R R VGT +MAPEV+ Y F D W G E+ G +PF K +V +
Sbjct: 159 RGR---VGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE-RVKREEV 213
Query: 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFFK 275
E KFS+ K + L K+P +R A + +H FK
Sbjct: 214 DRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 66/238 (27%), Positives = 103/238 (43%), Gaps = 37/238 (15%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHC 76
+G+G V I A+KIL + +++I E ++ D V+K
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 77 SFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRD 136
SF NL+++M F+ GG + +L D E + E + +D +H G IHRD
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRD 126
Query: 137 VKSGNILIDVRGAIKLGDFGVSACL---------------------FDSGDRQRMRNTF- 174
+K N+L+D +G +KL DFG+ L F + + +R T+
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186
Query: 175 ----------VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 222
VGTP ++APEV Q GY+ D WS G+ E+ G+ PF P +
Sbjct: 187 KNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 70/227 (30%), Positives = 119/227 (52%), Gaps = 19/227 (8%)
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
P ++ H +F +D L +++ +++GG L + + F+E + E++ L++LH
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYINGGELFTHL--SQRERFKEQEVQIYSGEIVLALEHLH 122
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
G I+RD+K NIL+D G + L DFG+S F + +R + F GT +MAP+++
Sbjct: 123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYS-FCGTIEYMAPDIVRG 180
Query: 189 LH-GYDFKADIWSFGITALELAHGHAPFS----KYPPMKVLLMTLQNAPPGLDYERDRKF 243
G+D D WS G+ EL G +PF+ K ++ L++ PP Y ++
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP---YPQE--M 235
Query: 244 SKSFKQMIASCLVKDPSKR----PS-AKKLLKHSFFKQARSNEYIAR 285
S K +I L+KDP KR PS A ++ KH FF++ ++ A+
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAK 282
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 65/262 (24%), Positives = 112/262 (42%), Gaps = 17/262 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E +TL ++G G V L VA+KIL + D + +E Q + + H +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD-DLLKQQDFQKEVQALKRLRHKH 63
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR---EVLKGLDYL 127
++ ++++ M GS L L++ P+G + + +A+++ +V +G+ YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEG-QVLPVASLIDMACQVAEGMAYL 120
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187
IHRD+ + NIL+ K+ DFG++ + + + W APE
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK---WTAPEAAS 177
Query: 188 QLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246
+ K+D+WSFGI E+ +G P YP M G K +
Sbjct: 178 HGT-FSTKSDVWSFGILLYEMFTYGQVP---YPGMNN-HEVYDQITAGYRMPCPAKCPQE 232
Query: 247 FKQMIASCLVKDPSKRPSAKKL 268
+++ C +P RPS K L
Sbjct: 233 IYKIMLECWAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 20/236 (8%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH 98
VAVK L + D + EAQ M + HP +++ + + +++V M GS L
Sbjct: 33 VAVKTL--KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE 90
Query: 99 ILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158
L+ + + + +V G+ YL +IHRD+ + N+L+ K+ DFG++
Sbjct: 91 YLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLA 150
Query: 159 ACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFS 216
+ + R F P W APE + + K+D+WSFGI E+ +G P+
Sbjct: 151 RVIKEDIYEAREGAKF---PIKWTAPEAA-LYNRFSIKSDVWSFGILLTEIVTYGRMPYP 206
Query: 217 KYPPMKVLLMTLQN----APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
+VL Q PPG K ++ C +DP RP+ + L
Sbjct: 207 GMTNAEVLQQVDQGYRMPCPPGC--------PKELYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 73/311 (23%), Positives = 125/311 (40%), Gaps = 54/311 (17%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNISREAQTMILVDH 68
Y + ++G+G V++A I +VA+K ++ E+D ++ + RE + + + H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKH 66
Query: 69 PNVLKSHCSFVSDHN--------LWVVMPFMSGGSC--LHILKAAYPD-GFEEVVIATIL 117
PNV+ V + +++V P+M L P E I +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-----NPSVKLTESQIKCYM 121
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG- 176
++L+G++YLH + +HRD+K+ NILID +G +K+ DFG+ A +D G
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL-ARPYDGPPPNPKGGGGGGT 180
Query: 177 ---TPC----WM-APEVMEQLHGYDFKADIWSFGIT-------------ALELAHGHAPF 215
T W PE++ Y DIW G ++ H F
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240
Query: 216 SKYPPMKVLLMTLQNAPPG-------LDYER--DRKFSKSFKQMI---ASCLVKDPSKRP 263
+ PG +Y R + +F K + + + L DP KR
Sbjct: 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300
Query: 264 SAKKLLKHSFF 274
+A L+H +F
Sbjct: 301 TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 60/250 (24%), Positives = 113/250 (45%), Gaps = 25/250 (10%)
Query: 37 EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGG 94
E+VAVK L E + S +E + + H N++K CS L ++M ++ G
Sbjct: 34 EMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLG 93
Query: 95 SCLHILKAAYPDGFEEVVIATIL---REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
S L ++ +A +L +++ +G+ YLH +IHRD+ + N+L+D +K
Sbjct: 94 SLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVK 147
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
+GDFG++ + + + R+R W A E +++ + + + +D+WSFG+T EL
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELL-T 205
Query: 212 HAPFSKYPPMKVLLM-----TLQNAPP-------GLDYERDRKFSKSFKQMIASCLVKDP 259
H + PP K M G+ + + ++ +C +
Sbjct: 206 HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEA 265
Query: 260 SKRPSAKKLL 269
RP+ + L+
Sbjct: 266 KFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 80/306 (26%), Positives = 137/306 (44%), Gaps = 56/306 (18%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMIL---VDH 68
Y + +++G+G V +A+ E+VA+K I D R+ +D RE M L DH
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE--IMFLQELGDH 66
Query: 69 PN------VLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVL 121
PN V+K+ +D ++++V +M + LH +++A + E+V I+ ++L
Sbjct: 67 PNIVKLLNVIKA----ENDKDIYLVFEYME--TDLHAVIRA---NILEDVHKRYIMYQLL 117
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL--FDSGDRQRMRNTFVGTPC 179
K L Y+H IHRD+K NIL++ +KL DFG++ L + + +V T
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 180 WMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDY 237
+ APE++ Y D+WS G E+ G F + L ++ + P D
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237
Query: 238 E----------------RDRKFSKSFKQM-----------IASCLVKDPSKRPSAKKLLK 270
E R R K ++ + LV +P+KR +A++ L+
Sbjct: 238 ESIKSPFAATMLDSLPSRPR---KPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294
Query: 271 HSFFKQ 276
H + Q
Sbjct: 295 HPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 65/279 (23%), Positives = 124/279 (44%), Gaps = 35/279 (12%)
Query: 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCS 77
E G+ V A+ R VAVK+L +S+L ++ E + V+HP+V+K + +
Sbjct: 12 EFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGA 71
Query: 78 FVSDHNLWVVMPFMSGGSCLHILKAA-------------------YPDGFEEVVIATILR 118
D L +++ + GS L+ + + + ++
Sbjct: 72 CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLIS 131
Query: 119 ---EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175
++ +G+ YL +HRD+ + N+L+ +K+ DFG+S +++ + ++ +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE--EDSYVKRSKG 189
Query: 176 GTPC-WMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKV--LLMTLQNA 231
P WMA E + H Y ++D+WSFG+ E+ G P+ P ++ LL T
Sbjct: 190 RIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT---- 244
Query: 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
G ER S+ ++ +C ++P KRP+ + K
Sbjct: 245 --GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 68/223 (30%), Positives = 101/223 (45%), Gaps = 13/223 (5%)
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC-LHILKAAYPDGFEEVVIATIL 117
E Q + V+ V+ ++ + L +V+ M+GG HI P GFEE
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYA 108
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177
E+L GL+ LH ++RD+K NIL+D G I++ D G+ A G+ R R VGT
Sbjct: 109 AEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL-AVKIPEGESIRGR---VGT 164
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237
+MAPEV+ Y D W G E+ G +PF + KV + +
Sbjct: 165 VGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPF-RGRKEKVKREEVDRRVLETEE 222
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFFK 275
KFS+ K + L KDP +R A ++ +H FF+
Sbjct: 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 74/260 (28%), Positives = 119/260 (45%), Gaps = 26/260 (10%)
Query: 40 AVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL 97
A+KIL E ++++ E++ + HP + +F + L VM + +GG
Sbjct: 24 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 83
Query: 98 HILKAAYPDGFEEVVIATILR----EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLG 153
L E V R E++ L+YLH ++RD+K N+++D G IK+
Sbjct: 84 FHLSR------ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKIT 137
Query: 154 DFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHA 213
DFG+ C D M+ TF GTP ++APEV+E + Y D W G+ E+ G
Sbjct: 138 DFGL--CKEGISDGATMK-TFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRL 193
Query: 214 PFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR----PS-AKKL 268
PF ++ + L + R S K ++A L KDP +R PS AK++
Sbjct: 194 PFYNQDHERLFELILME-----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 248
Query: 269 LKHSFFKQARSNEYIARTLL 288
++H FF + + + LL
Sbjct: 249 MEHRFFLSINWQDVVQKKLL 268
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 20/217 (9%)
Query: 67 DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDY 126
D P ++ +F + L ++ M+GG LH + + F E + E++ GL++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGD-LHYHLSQH-GVFSEKEMRFYATEIILGLEH 112
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM 186
+H+ ++RD+K NIL+D G +++ D G+ AC F ++ + VGT +MAPEV+
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGL-ACDFS----KKKPHASVGTHGYMAPEVL 167
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---KVLLMTLQNAPPGLDYERDRKF 243
++ YD AD +S G +L GH+PF ++ ++ MTL ++ E F
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----VNVELPDSF 222
Query: 244 SKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFFK 275
S K ++ L +D SKR A+++ +H FFK
Sbjct: 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 30/272 (11%)
Query: 17 EEVGQGVSASVHRALCIPFN--EI-VAVKILDFERDNSDLSNISREAQTMILVDHPNVLK 73
+E+G G SV + + + + E+ VAVK L E + REA M +DHP +++
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 74 SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHI 133
+ L +VM G L LK + + + +V G+ YL +
Sbjct: 61 LIGVCKGE-PLMLVMELAPLGPLLKYLKK-RRE-IPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 134 HRDVKSGNILIDVRGAIKLGDFGVSACL--------FDSGDRQRMRNTFVGTPCWMAPEV 185
HRD+ + N+L+ R K+ DFG+S L + R ++ W APE
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK--------WYAPEC 169
Query: 186 MEQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244
+ + K+D+WS+G+T E ++G P+ + +V+ M G R +
Sbjct: 170 I-NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES----GERLPRPEECP 224
Query: 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
+ ++ SC P RP+ +L S F++
Sbjct: 225 QEIYSIMLSCWKYRPEDRPTFSEL--ESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-18
Identities = 66/246 (26%), Positives = 105/246 (42%), Gaps = 37/246 (15%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDH 68
E + + +G+G V + A+KIL + + +I E ++ D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
V+K SF NL+++M F+ GG + +L D E + E + +D +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIH 118
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL---------------------FDSGDR 167
G IHRD+K N+L+D +G +KL DFG+ L F + +
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 168 QRMRNTF-----------VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS 216
+R T+ VGTP ++APEV Q GY+ D WS G+ E+ G+ PF
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 217 KYPPMK 222
P +
Sbjct: 238 SETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 63/242 (26%), Positives = 114/242 (47%), Gaps = 28/242 (11%)
Query: 36 NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGS 95
+ VAVK L + D++ EA M + HPN+++ + + L++V +M+ GS
Sbjct: 29 GQKVAVKCL--KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86
Query: 96 CLHILKAAYPDGFEEVVIATIL---REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152
+ L++ G + +A L +V +G++YL +HRD+ + N+L+ K+
Sbjct: 87 LVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKV 143
Query: 153 GDFGVS--ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALEL-A 209
DFG++ A + ++ W APE + + K+D+WSFGI E+ +
Sbjct: 144 SDFGLAKEASQGQDSGKLPVK--------WTAPEALR-EKKFSTKSDVWSFGILLWEIYS 194
Query: 210 HGHAPFSKYP--PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKK 267
G P YP P+K ++ ++ G E +++ C DP+KRP+ K+
Sbjct: 195 FGRVP---YPRIPLKDVVPHVEK---GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQ 248
Query: 268 LL 269
L
Sbjct: 249 LR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-18
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFE--RDNSDLSNISREAQTMILV-DHPNVLKSH 75
+G+G A V I A+K++ E D+ D+ + E +HP ++ H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 76 CSFVSDHNLWVVMPFMSGGSCL-HILKA-AYPDGFEEVVIATILREVLKGLDYLHHHGHI 133
F ++ L+ V+ +++GG + H+ + P+ A E+ L+YLH G I
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA----EISLALNYLHERGII 118
Query: 134 HRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYD 193
+RD+K N+L+D G IKL D+G+ GD +TF GTP ++APE++ Y
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRG-EDYG 174
Query: 194 FKADIWSFGITALELAHGHAPF 215
F D W+ G+ E+ G +PF
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 58 REAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATIL 117
+EAQ M + H ++ + + VS+ +++V FM GS L LK + + +
Sbjct: 50 QEAQIMKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA 108
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177
++ G+ Y+ +IHRD+++ NIL+ K+ DFG++ + D+ R F
Sbjct: 109 AQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF--- 165
Query: 178 PC-WMAPEVMEQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPG 234
P W APE L+G + K+D+WSFGI EL G P YP M V L+ G
Sbjct: 166 PIKWTAPEA--ALYGRFTIKSDVWSFGILLTELVTKGRVP---YPGM-VNREVLEQVERG 219
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
+ +S +++ C KDP +RP+
Sbjct: 220 YRMPCPQGCPESLHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 79/312 (25%), Positives = 132/312 (42%), Gaps = 64/312 (20%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDL-SNISREAQTMILVDHP 69
+ Y E++G+G V++A NE +A+K + E+++ + S RE + + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKA--AYPDGFEEV-VIATILREVLKGLDY 126
N+++ S+ L++V ++ L + K + PD + +I T L ++L+G+ Y
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 127 LHHHGHIHRDVKSGNILIDVR-GAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
H H +HRD+K N+LID R A+KL DFG++ G R V T + APE+
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTFTHEVVTLWYRAPEI 174
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAP------------------------------- 214
+ Y DIWS G E+ + P
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233
Query: 215 -------FSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKK 267
F K+PP + + P G+D +++ L DPSKR +A+
Sbjct: 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVD-------------LLSKMLRLDPSKRITARA 280
Query: 268 LLKHSFFKQARS 279
L+H +FK
Sbjct: 281 ALEHEYFKDLGD 292
|
Length = 294 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFE--RDNSDLSNISREAQTM-ILVDHPNVLKSH 75
+G+G A V I A+K++ E D+ D+ + E +HP ++ H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 76 CSFVSDHNLWVVMPFMSGGSCL-HILKA-AYPDGFEEVVIATILREVLKGLDYLHHHGHI 133
F ++ L+ V+ F+SGG + H+ + P+ A E+ L++LH G I
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA----EISLALNFLHERGII 118
Query: 134 HRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYD 193
+RD+K N+L+D G IKL D+G+ GD +TF GTP ++APE++ Y
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEILRG-EDYG 174
Query: 194 FKADIWSFGITALELAHGHAPF 215
F D W+ G+ E+ G +PF
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 18/266 (6%)
Query: 20 GQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSH 75
G G +V++ + IP E VA+K+L E I EA M VDHP+V++
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 76 C-SFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIH 134
S L + M G L ++ + D + ++ KG+ YL +H
Sbjct: 76 GICLSSQVQL--ITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVH 132
Query: 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLHGYD 193
RD+ + N+L+ +K+ DFG+ A L D +++ P WMA E + Y
Sbjct: 133 RDLAARNVLVKTPQHVKITDFGL-AKLLDVDEKE-YHAEGGKVPIKWMALESI-LHRIYT 189
Query: 194 FKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIA 252
K+D+WS+G+T EL G P+ P +++ + L+ G + + ++
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL-LEK---GERLPQPPICTIDVYMVLV 245
Query: 253 SCLVKDPSKRPSAKKLLKHSFFKQAR 278
C + D RP+ K+L+ F K AR
Sbjct: 246 KCWMIDAESRPTFKELIN-EFSKMAR 270
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 71/249 (28%), Positives = 111/249 (44%), Gaps = 28/249 (11%)
Query: 38 IVAVKILDFE--RDNSDLSNISREAQTMIL-VDHPNVLKSHCSFVSDHNLWVVMPFMSGG 94
AVK+L + + +I E ++ V HP ++ H SF + L+ V+ +++GG
Sbjct: 22 FYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81
Query: 95 SCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLG 153
H+ + F E E+ L YLH I+RD+K NIL+D +G + L
Sbjct: 82 ELFFHLQRERS---FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLT 138
Query: 154 DFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHA 213
DFG+ + + + +TF GTP ++APEV+ + YD D W G E+ +G
Sbjct: 139 DFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLP 194
Query: 214 PF--SKYPPM--KVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLL 269
PF M +L L+ P + S S + ++ L KD +KR AK
Sbjct: 195 PFYSRDTAEMYDNILNKPLR-LKPNI--------SVSARHLLEGLLQKDRTKRLGAKDDF 245
Query: 270 K----HSFF 274
H FF
Sbjct: 246 LEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 63/225 (28%), Positives = 109/225 (48%), Gaps = 31/225 (13%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKI--LDFERDNSDLSNISREAQTMILVDH 68
+ + + ++G+G V++A E+VA+K LD E++ ++ I RE + + ++H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI-REIKILRQLNH 65
Query: 69 PNVLKSHCSFVSDH-----------NLWVVMPFMSGGSCLHILKAAYPDG---FEEVVIA 114
N++ V+D ++V +M H L G F E I
Sbjct: 66 RNIVNLK-EIVTDKQDALDFKKDKGAFYLVFEYMD-----HDLMGLLESGLVHFSEDHIK 119
Query: 115 TILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF 174
+ ++++L+GL+Y H +HRD+K NIL++ +G IKL DFG+ A L++S + + N
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL-ARLYNSEESRPYTNK- 177
Query: 175 VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP 219
V T + PE++ Y D+WS G EL F+K P
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGEL------FTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDY 126
HP + SF + L VM + +GG H+ + F E E++ LDY
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDY 110
Query: 127 LHHHGHI-HRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
LH ++ +RD+K N+++D G IK+ DFG+ C D M+ TF GTP ++APEV
Sbjct: 111 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGL--CKEGIKDGATMK-TFCGTPEYLAPEV 167
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
+E + Y D W G+ E+ G PF K+ + L + R S
Sbjct: 168 LED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----EIRFPRTLSP 221
Query: 246 SFKQMIASCLVKDPSKR-----PSAKKLLKHSFF 274
K +++ L KDP +R AK++++H FF
Sbjct: 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 20/207 (9%)
Query: 77 SFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRD 136
+F + L ++ M+GG LH + + F E + E++ GL+++H+ ++RD
Sbjct: 65 AFHTPDKLSFILDLMNGGD-LHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRD 122
Query: 137 VKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKA 196
+K NIL+D G +++ D G+ AC F ++ + VGT +MAPEV+++ YD A
Sbjct: 123 LKPANILLDEHGHVRISDLGL-ACDFS----KKKPHASVGTHGYMAPEVLQKGVAYDSSA 177
Query: 197 DIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253
D +S G +L GH+PF ++ ++ MTL A E FS + ++
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-----ELPDSFSPELRSLLEG 232
Query: 254 CLVKDPSKR-----PSAKKLLKHSFFK 275
L +D ++R A+++ +H FF+
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 72/274 (26%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFE--RDNSDLSNISREAQTMILVD-HPNVLKSH 75
+G+G A V ++I A+K++ E D+ D+ + E +P ++ H
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 76 CSFVSDHNLWVVMPFMSGGSCL-HILKA-AYPDGFEEVVIATILREVLKGLDYLHHHGHI 133
F + L++V+ +++GG + H+ + P+ A E+ L++LH G I
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA----EICIALNFLHERGII 118
Query: 134 HRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYD 193
+RD+K N+L+D G IKL D+G+ GD +TF GTP ++APE++ Y
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIAPEILRG-EEYG 174
Query: 194 FKADIWSFGITALELAHGHAPF---SKYPPMKV---LLMTLQNAPPGLDYERDRKFSKSF 247
F D W+ G+ E+ G +PF + P M L + P + R S
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI----PRFLSVKA 230
Query: 248 KQMIASCLVKDPSKRPSAK------KLLKHSFFK 275
++ L KDP +R + + H+FF+
Sbjct: 231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFR 264
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 16/266 (6%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+ I E L +++G G V +N V + + + EAQ M
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGT---WNGNTKVAVKTLKPGTMSPESFLEEAQIMKK 57
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
+ H +++ + + VS+ +++V +MS GS L LK + + + +V G+
Sbjct: 58 LRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPE 184
Y+ +IHRD++S NIL+ K+ DFG++ + D+ R F P W APE
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF---PIKWTAPE 173
Query: 185 VMEQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242
L+G + K+D+WSFGI EL G P YP M L+ G +
Sbjct: 174 A--ALYGRFTIKSDVWSFGILLTELVTKGRVP---YPGMNN-REVLEQVERGYRMPCPQD 227
Query: 243 FSKSFKQMIASCLVKDPSKRPSAKKL 268
S +++ C KDP +RP+ + L
Sbjct: 228 CPISLHELMLQCWKKDPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 6/181 (3%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH 98
VA+K+L E + S + REA+ M +D+P +++ L +VM M+ G L+
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM-IGVCEAEALMLVME-MASGGPLN 82
Query: 99 ILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158
+ D + ++ +V G+ YL +HRD+ + N+L+ + K+ DFG+S
Sbjct: 83 KFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLS 142
Query: 159 ACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLHGYDFKADIWSFGITALE-LAHGHAPFS 216
L + D + P W APE + + ++D+WS+GIT E ++G P+
Sbjct: 143 KAL-GADDSYYKARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200
Query: 217 K 217
K
Sbjct: 201 K 201
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-17
Identities = 50/174 (28%), Positives = 70/174 (40%), Gaps = 22/174 (12%)
Query: 113 IATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172
I + + L L LH KSGNIL+ G +KL G A R
Sbjct: 19 IWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRP---- 66
Query: 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP 232
P +MAPEV++ Y KADI+S GIT E P+++ + +L L N
Sbjct: 67 ----DPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM 121
Query: 233 PGLDYER---DRKFS--KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
P D S +SF+ + C + P +R +A L H A + E
Sbjct: 122 PADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLE 175
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 50/299 (16%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHP 69
Y + VG G V A + VA+K I+ RE + + + H
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 70 NVLKSHCSFVSD-HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
N++ F+S +++ V + G+ LH L + P E+ I L ++L+GL Y+H
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVH 125
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT-FVGTPCWMAPEVME 187
G +HRD+K NILI+ +K+ DFG++ Q + T +V T + APE+M
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGLARI-------QDPQMTGYVSTRYYRAPEIML 178
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSKY---------------PPMKVL-------- 224
YD + DIWS G E+ G F PP V+
Sbjct: 179 TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238
Query: 225 LMTLQNAPPGLDYERDRK-FSKSFKQ-------MIASCLVKDPSKRPSAKKLLKHSFFK 275
L +Q+ P +R+ FS+ FK ++ LV DP KR SA + L H +
Sbjct: 239 LRFVQSLP-----KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-17
Identities = 75/276 (27%), Positives = 112/276 (40%), Gaps = 58/276 (21%)
Query: 49 DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHIL--KAAYPD 106
+ + ++++ E + D+ V+K + SF NL+ VM ++ GG + +L +P+
Sbjct: 41 NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPE 100
Query: 107 GFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFG---------- 156
IA E+ ++ +H G IHRD+K NILID+ G IKL DFG
Sbjct: 101 VLARFYIA----ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156
Query: 157 -----------------------VSACLFDSGDR-----QRMR--------NTFVGTPCW 180
VS C GDR QR ++ VGTP +
Sbjct: 157 SKYYQKGSHIRQDSMEPSDLWDDVSNC--RCGDRLKTLEQRATKQHQRCLAHSLVGTPNY 214
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
+APEV+ + GY D WS G+ E+ G PF P + L + N L
Sbjct: 215 IAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI-NWENTLHIPPQ 272
Query: 241 RKFSKSFKQMIAS--CLVKDPSKRPSAKKLLKHSFF 274
K S +I C ++ R A + H FF
Sbjct: 273 VKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 9e-17
Identities = 69/264 (26%), Positives = 122/264 (46%), Gaps = 28/264 (10%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ TL E +G+G +V + + VAVK + + + E M + H N
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKNI---KCDVTAQAFLEETAVMTKLHHKN 60
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR---EVLKGLDYL 127
+++ + + L++VM MS G+ ++ L+ G V + +L+ +V +G++YL
Sbjct: 61 LVRL-LGVILHNGLYIVMELMSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYL 116
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVM 186
+HRD+ + NIL+ G K+ DFG++ D ++ P W APE +
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-------PVKWTAPEAL 169
Query: 187 EQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244
+ H + K+D+WS+G+ E+ ++G AP YP M + + + G E
Sbjct: 170 K--HKKFSSKSDVWSYGVLLWEVFSYGRAP---YPKMSLKEVK-ECVEKGYRMEPPEGCP 223
Query: 245 KSFKQMIASCLVKDPSKRPSAKKL 268
++ SC +P KRPS KL
Sbjct: 224 ADVYVLMTSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 65/250 (26%), Positives = 118/250 (47%), Gaps = 26/250 (10%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL 97
VAVK+L + DLS++ E + M ++ H N++ + D L+V++ + S G+
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 98 HILKAAYPDGFEEVV--------------IATILREVLKGLDYLHHHGHIHRDVKSGNIL 143
L+A P G E + + +V +G++YL IHRD+ + N+L
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172
Query: 144 IDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGI 203
+ +K+ DFG++ + ++ N + WMAPE + Y ++D+WSFG+
Sbjct: 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFD-RIYTHQSDVWSFGV 230
Query: 204 TALEL-AHGHAPFSKYP--PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPS 260
E+ G +P YP P++ L L+ G ++ + M+ C PS
Sbjct: 231 LLWEIFTLGGSP---YPGVPVEELFKLLKE---GHRMDKPSNCTNELYMMMRDCWHAVPS 284
Query: 261 KRPSAKKLLK 270
+RP+ K+L++
Sbjct: 285 QRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 23/230 (10%)
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
V HP ++ H SF + L+ V+ +++GG + L+ F E E+ L
Sbjct: 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALG 110
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
YLH ++RD+K NIL+D +G I L DFG+ ++ + +TF GTP ++APEV
Sbjct: 111 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEV 167
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK----VLLMTLQNAPPGLDYERDR 241
+ + YD D W G E+ +G PF + +L LQ P
Sbjct: 168 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP--------- 217
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAK----KLLKHSFFKQARSNEYIARTL 287
+ S + ++ L KD +KR AK ++ H FF ++ I + +
Sbjct: 218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKI 267
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 13/224 (5%)
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC-LHILKAAYPDGFEEVVIATIL 117
E Q + V+ V+ ++ + L +V+ M+GG HI GFEE
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYA 108
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177
E+ GL+ LH ++RD+K NIL+D G I++ D G+ A G + R VGT
Sbjct: 109 AEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTIKGR---VGT 164
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237
+MAPEV++ Y F D W+ G E+ G +PF + K+ ++ +
Sbjct: 165 VGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKK-KIKREEVERLVKEVQE 222
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFFKQ 276
E KFS + + L KDP +R A+++ +H FKQ
Sbjct: 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 65/282 (23%), Positives = 118/282 (41%), Gaps = 26/282 (9%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALC---IPFNE--IVAVKILDFERDNSDLSNISREAQT 62
+ + L E+G+G V C P N+ +VAVK L N + REA+
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG------------FEE 110
+ H N++K + +V +M G L++ PD
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 111 VVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170
+ I ++ G+ YL +HRD+ + N L+ +K+GDFG+S ++ + D R+
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-TTDYYRV 180
Query: 171 RNTFVGTPCWMAPEVMEQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTL 228
+ WM PE + ++ + ++D+WSFG+ E+ +G P+ +V+
Sbjct: 181 GGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238
Query: 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
Q G +R R ++ C +DP +R + K + +
Sbjct: 239 Q----GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 78/305 (25%), Positives = 120/305 (39%), Gaps = 55/305 (18%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD--FERDNSDLSNISREAQTMILVDH 68
+ Y VG G V A VA+K L F+ RE + + +DH
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDH 73
Query: 69 PNVLKSHCSFVSDHNL------WVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVL 121
NV+ F +L ++V M G+ L+ I+K + I ++ ++L
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKC---QKLSDDHIQFLVYQIL 128
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT----FVGT 177
+GL Y+H G IHRD+K NI ++ +K+ DFG++ R + +V T
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA----------RHTDDEMTGYVAT 178
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPP-- 233
+ APE+M Y+ DIWS G EL G F S + +M L P
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238
Query: 234 ---GLDYERDRKFSKSFKQM-------------------IASCLVKDPSKRPSAKKLLKH 271
+ E R + +S QM + LV DP KR +A + L H
Sbjct: 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298
Query: 272 SFFKQ 276
+ +
Sbjct: 299 PYLAE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 63/257 (24%), Positives = 117/257 (45%), Gaps = 12/257 (4%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLK 73
T+ ++G G V+ + ++ VAVK L + D ++ +EA M + HPN+++
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 74 SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHI 133
+ +++ FM+ G+ L L+ VV+ + ++ ++YL I
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 134 HRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLHGY 192
HRD+ + N L+ +K+ DFG+S + F P W APE + + +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIKWTAPESL-AYNKF 182
Query: 193 DFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251
K+D+W+FG+ E+A +G +P YP + L + G ER +++
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSP---YPGID-LSQVYELLEKGYRMERPEGCPPKVYELM 238
Query: 252 ASCLVKDPSKRPSAKKL 268
+C +PS RPS ++
Sbjct: 239 RACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 77/307 (25%), Positives = 122/307 (39%), Gaps = 54/307 (17%)
Query: 19 VGQGVSASVHRALCIPFNEIVA---VKILDFERD-NSDLSNIS---------REAQTMIL 65
+G+G V +A +IVA VKI++ D D + RE + M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVLKG 123
+ H N++ +V + +VM M+ LK E + IL ++L G
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASD-----LKKVVDRKIRLTESQVKCILLQILNG 131
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC---------LFDSGDRQRMRN-- 172
L+ LH +HRD+ NI I+ +G K+ DFG++ L QR
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQN 230
+ V T + APE++ Y F D+WS G EL G F + L + L
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 231 APPGLDYERDRK------FSKSFKQ---------------MIASCLVKDPSKRPSAKKLL 269
P ++ + +K F+ + ++ S L +P +R SAK+ L
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 270 KHSFFKQ 276
KH +FK
Sbjct: 312 KHEYFKS 318
|
Length = 335 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 77/310 (24%), Positives = 120/310 (38%), Gaps = 61/310 (19%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNIS-REAQTMILVDHPNV 71
Y ++GQG V +A +IVA+K + E + + RE + + L+ H NV
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV 73
Query: 72 --LKSHC-SFVSDHN-----LWVVMPFMSGGSCLH----ILKAAYPDGFEEVVIATILRE 119
L C + + +N ++V F C H +L F I +++
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEF-----CEHDLAGLLSNKNVK-FTLSEIKKVMKM 127
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA--CLFDSGDRQRMRNTFVGT 177
+L GL Y+H + +HRD+K+ NILI G +KL DFG++ L + R N V T
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---------------- 221
+ PE++ Y D+W G E+ +++ P M
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEM------WTRSPIMQGNTEQHQLTLISQLC 240
Query: 222 ---------KVLLMTLQNA---PPGL-DYERDRKFSKSFKQ----MIASCLVKDPSKRPS 264
V + L P G ++R +I LV DP+KR
Sbjct: 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID 300
Query: 265 AKKLLKHSFF 274
A L H FF
Sbjct: 301 ADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 67/252 (26%), Positives = 121/252 (48%), Gaps = 30/252 (11%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL 97
VAVK+L + DLS++ E + M ++ H N++ + D L+V++ + S G+
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 98 HILKAAYPDG----------------FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGN 141
L+A P G F+++V T +V +G++YL IHRD+ + N
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTY--QVARGMEYLASQKCIHRDLAARN 167
Query: 142 ILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSF 201
+L+ +K+ DFG++ + + ++ N + WMAPE + Y ++D+WSF
Sbjct: 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK-WMAPEALFD-RVYTHQSDVWSF 225
Query: 202 GITALEL-AHGHAPFSKYP--PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKD 258
G+ E+ G +P YP P++ L L+ G ++ + M+ C
Sbjct: 226 GVLMWEIFTLGGSP---YPGIPVEELFKLLKE---GHRMDKPANCTNELYMMMRDCWHAI 279
Query: 259 PSKRPSAKKLLK 270
PS RP+ K+L++
Sbjct: 280 PSHRPTFKQLVE 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 31/278 (11%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRA-LCIPFNE--IVAVKILDFERDNSDLSNISREAQTMI 64
I + T+ + +G G V R L +P + VA+K L + + EA M
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMG 60
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG-FEEVVIATILREVLKG 123
DHPN+++ + ++ +M GS L+ DG F + +LR + G
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASG 118
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS-------GDRQRMRNTFVG 176
+ YL ++HRD+ + NIL++ K+ DFG+S L DS G + +R
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR----- 173
Query: 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVL--LMTLQNAPP 233
W APE + + +D+WSFGI E +++G P+ V+ + PP
Sbjct: 174 ---WTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP 229
Query: 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+D + Q++ C KD ++RP+ +++
Sbjct: 230 PMD------CPSALYQLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 70/285 (24%), Positives = 130/285 (45%), Gaps = 33/285 (11%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNE-------IVAVKILDFERDNSDLSNISREAQTM 63
+ L + +G+G V RA ++ VAVK+L + DL+++ E + M
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 64 ILVD-HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILRE--- 119
L+ H N++ + L+V++ + + G+ L+A P G + T + E
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 120 -----------VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168
V +G++YL IHRD+ + N+L+ +K+ DFG++ + D +
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYP--PMKVLL 225
+ N + WMAPE + Y ++D+WSFGI E+ G +P YP P++ L
Sbjct: 192 KTSNGRLPVK-WMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSP---YPGIPVEELF 246
Query: 226 MTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
L+ G ++ + ++ C P++RP+ K+L++
Sbjct: 247 KLLRE---GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKA-AYPDGFEEVVIATILREVLKG 123
V HP ++ H SF + L+ V+ F++GG H+ + ++P+ A E+
Sbjct: 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA----EIASA 108
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
L YLH ++RD+K NIL+D +G + L DFG+ D TF GTP ++AP
Sbjct: 109 LGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---TTTTFCGTPEYLAP 165
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPF 215
EV+ + YD D W G E+ +G PF
Sbjct: 166 EVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 69/276 (25%), Positives = 124/276 (44%), Gaps = 27/276 (9%)
Query: 15 LYEEVGQGVSASVHRALCI---PFNE--IVAVKILDFERDNSDLSNISREAQTMILVDHP 69
L E+G+G V A C P + +VAVK L + + + REA+ + + H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHE 67
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGF-----------EEVVIATILR 118
+++K + L +V +M G L+A PD E+ ++ +L
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 119 ---EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175
++ G+ YL +HRD+ + N L+ +K+GDFG+S ++ S D R+ +
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY-STDYYRVGGHTM 186
Query: 176 GTPCWMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPG 234
WM PE + + ++D+WSFG+ E+ +G P+ + +V+ Q G
Sbjct: 187 LPIRWMPPESI-MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ----G 241
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
ER R K ++ C ++P +R + K++ K
Sbjct: 242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-16
Identities = 74/274 (27%), Positives = 113/274 (41%), Gaps = 56/274 (20%)
Query: 51 SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHIL--KAAYPDGF 108
+ ++++ E + D+ V++ + SF NL+ VM ++ GG + +L +P+
Sbjct: 43 NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL 102
Query: 109 EEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL------- 161
IA E+ ++ +H G IHRD+K NILID G IKL DFG+
Sbjct: 103 ARFYIA----ELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 162 -FDSGD---------------------------------RQRMR---NTFVGTPCWMAPE 184
+ SGD RQ R ++ VGTP ++APE
Sbjct: 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE 218
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244
V+ + GY D WS G+ E+ G PF P++ M + N L K S
Sbjct: 219 VLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLET-QMKVINWQTSLHIPPQAKLS 276
Query: 245 KSFKQMIASCLVKDPSKR---PSAKKLLKHSFFK 275
+I L + P R A ++ H FFK
Sbjct: 277 PEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 76/296 (25%), Positives = 130/296 (43%), Gaps = 39/296 (13%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
A+ Y E++G+G A+V++ ++VA+K++ + + REA + + H
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N++ H + L +V ++ C ++ K +P G + L ++L+GL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
+HRD+K N+LI G +KL DFG++ S N V T + P+V+
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVV-TLWYRPPDVLLGS 178
Query: 190 HGYDFKADIWSFGITALELAHGHAPFSKYPPMK-----------VLLMTLQNAPPG---L 235
Y D+W G +E+ G A F P MK VL ++ PG L
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAF---PGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235
Query: 236 DYERDRKF----SKSFKQM------------IASCLVK-DPSKRPSAKKLLKHSFF 274
+ + +F K+ +Q +AS L++ P R SA+ L H +F
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 35/282 (12%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNISREAQTMILV-D 67
TL + +G+G V +A + + VAVK+L + DLS++ E + M ++
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILRE-------- 119
H N++ + L+VV+ + + G+ L+A P G E
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 120 ------VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173
V +G+++L IHRD+ + N+L+ +K+ DFG++ D R T
Sbjct: 135 VSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR---DIHHIDYYRKT 191
Query: 174 FVG-TPC-WMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYP--PMKVLLMTL 228
G P WMAPE + Y ++D+WSFG+ E+ G +P YP P++ L L
Sbjct: 192 TNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSP---YPGIPVEELFKLL 247
Query: 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
+ G E+ + ++ ++ C + PS+RP+ K+L++
Sbjct: 248 KE---GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC-LHILKAAYPDGFEEVVIATILREVLKGL 124
+ HP ++ H SF + L+ V+ +++GG H+ + F E EV +
Sbjct: 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC---FLEPRARFYAAEVASAI 109
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
YLH I+RD+K NIL+D +G + L DFG+ + + + +TF GTP ++APE
Sbjct: 110 GYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPE 166
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPF 215
V+ + YD D W G E+ +G PF
Sbjct: 167 VLRK-EPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 17/231 (7%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH 98
VA+K L + EA M DHPN++ + +V +M GS
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94
Query: 99 ILKAAYPDG-FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157
L+ DG F + + +LR + G+ YL G++HRD+ + NIL++ K+ DFG+
Sbjct: 95 FLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGL 152
Query: 158 SACLFDSGDRQRMRNTFVGT-PC-WMAPEVMEQLHGYDFKADIWSFGITALE-LAHGHAP 214
S L D D + T G P W APE + + +D+WS+GI E +++G P
Sbjct: 153 SRVLED--DPEAAYTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERP 209
Query: 215 FSKYPPMKVLLMTLQN--APPGLDYERDRKFSKSFKQMIASCLVKDPSKRP 263
+ + V+ + P +D + Q++ C KD ++RP
Sbjct: 210 YWEMSNQDVIKAIEEGYRLPAPMD------CPAALHQLMLDCWQKDRNERP 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 80/307 (26%), Positives = 128/307 (41%), Gaps = 49/307 (15%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDL--SNISREAQTMILVDH 68
+ Y ++VG G +V AL VA+K L + S+L RE + + + H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKH 73
Query: 69 PNVLKSHCSFVSD------HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
NV+ F D H+ ++VMPFM G ++K + E I ++ ++LK
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLK 129
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT--FVGTPCW 180
GL Y+H G IHRD+K GN+ ++ +K+ DFG++ RQ +V T +
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA--------RQTDSEMTGYVVTRWY 181
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPG---- 234
APEV+ Y DIWS G E+ G F + + L +M + P
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241
Query: 235 -LDYERDRKFSKSFKQ-------------------MIASCLVKDPSKRPSAKKLLKHSFF 274
L E + + K + ++ LV D R +A + L H +F
Sbjct: 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
Query: 275 KQARSNE 281
++ E
Sbjct: 302 EEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 44/304 (14%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNIS-REAQTMILVDHP 69
E YT ++VG G SV A+ E VA+K L + + + RE + + H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 70 NVLK------SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
NV+ S S + ++VMP+M L+ E + ++ ++L G
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
L Y+H G IHRD+K GN+ ++ +K+ DFG L D + +V T + AP
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFG----LARHADAEM--TGYVVTRWYRAP 183
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ-NAPPGLDY--ERD 240
EV+ Y+ DIWS G E+ G F + L L+ PG ++ + +
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243
Query: 241 RKFSKSFKQ-----------------------MIASCLVKDPSKRPSAKKLLKHSFFKQA 277
K +KS+ + ++ L D KR +A + L+H +F
Sbjct: 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303
Query: 278 RSNE 281
R +
Sbjct: 304 RDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 70/265 (26%), Positives = 118/265 (44%), Gaps = 14/265 (5%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
I TL +E+G G V + + VA+K + E S+ + EAQ M+ +
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIR-EGAMSE-EDFIEEAQVMMKLS 57
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYL 127
HP +++ + + +V FM G L+A +E ++ L +V +G+ YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL-DVCEGMAYL 116
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVM 186
IHRD+ + N L+ +K+ DFG++ + D Q +T P W +PEV
Sbjct: 117 ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD---QYTSSTGTKFPVKWSSPEVF 173
Query: 187 EQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
Y K+D+WSFG+ E+ + G P+ +V ++ G + R S+
Sbjct: 174 -SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV----VETINAGFRLYKPRLASQ 228
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLK 270
S +++ C + P RPS LL
Sbjct: 229 SVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 73/291 (25%), Positives = 137/291 (47%), Gaps = 33/291 (11%)
Query: 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNE-------IVAVKILDFERDNSDLSNIS 57
K+ + TL + +G+G V A I ++ VAVK+L + + DLS++
Sbjct: 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65
Query: 58 REAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGF-------- 108
E + M ++ H N++ + D L+V++ + S G+ L+A P G
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 109 --EEVV----IATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162
EE + + + +V +G++YL IHRD+ + N+L+ +K+ DFG++ +
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYP-- 219
+ ++ N + WMAPE + Y ++D+WSFG+ E+ G +P YP
Sbjct: 186 NIDYYKKTTNGRLPVK-WMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSP---YPGI 240
Query: 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
P++ L L+ G ++ + ++ C PS+RP+ K+L++
Sbjct: 241 PVEELFKLLKE---GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 5/206 (2%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
A Y E++G+G A+V++ + ++VA+K++ + + REA + + H
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N++ H + L V +M + L +P G + + ++L+GL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMH--TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG 121
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
+HRD+K N+LI G +KL DFG++ S Q + V T + P+V+
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSEVV-TLWYRPPDVLLGA 178
Query: 190 HGYDFKADIWSFGITALELAHGHAPF 215
Y DIW G +E+ G F
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 69/276 (25%), Positives = 121/276 (43%), Gaps = 24/276 (8%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALC---IPFNE--IVAVKILDFERDNSDLSNISREAQT 62
I + L E+G+G V A C P + +VAVK L DN+ + REA+
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR-KDFHREAEL 60
Query: 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG-----------FEEV 111
+ + H +++K + V L +V +M G L+A PD +
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 112 VIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171
+ I +++ G+ YL +HRD+ + N L+ +K+GDFG+S ++ S D R+
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY-STDYYRVG 179
Query: 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQN 230
+ WM PE + + ++D+WS G+ E+ +G P+ + +V+ Q
Sbjct: 180 GHTMLPIRWMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ- 237
Query: 231 APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAK 266
G +R R K ++ C ++P R + K
Sbjct: 238 ---GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIK 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 69/287 (24%), Positives = 113/287 (39%), Gaps = 38/287 (13%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQT 62
+ + TL +G G V+ L VAVK L D S+ EA
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62
Query: 63 MILVDHPNVLKSHCSFVSDHNL--WVVMPFMSGGSCLHILKAAYPDGFEEVVIAT----- 115
M +H N++ VS L ++++ M+GG L+ P +
Sbjct: 63 MSKFNHQNIV--RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA---IKLGDFGVSACLFDS-----GDR 167
R+V KG YL + IHRD+ + N L+ +G K+ DFG++ ++ + G R
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 168 QRMRNTFVGTPC-WMAPEVMEQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVL 224
+ P WM PE L G + K D+WSFG+ E+ + G+ P+ +V+
Sbjct: 181 AML-------PIKWMPPEAF--LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
Query: 225 LMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
LD + +++ C P RP+ +L+
Sbjct: 232 EFVTGGGR--LDPPKG--CPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 75/294 (25%), Positives = 126/294 (42%), Gaps = 38/294 (12%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E Y E++G+G A+V + +VA+K + E + RE + + H N
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVV----IATILREVLKGLDY 126
++ H +D +L +V ++ LK Y D ++ + L ++L+GL Y
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDKD-----LKQ-YMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM 186
H +HRD+K N+LI+ RG +KL DFG++ S + N V T + P+V+
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVV-TLWYRPPDVL 176
Query: 187 EQLHGYDFKADIWSFGITALELAHGHA--PFSKYPPMKVLLMTLQNAP-----PGL---D 236
Y + D+W G E+A G P S L+ L P PG+ D
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236
Query: 237 YERDRKFSKSFKQ---------------MIASCLVKDPSKRPSAKKLLKHSFFK 275
++ F K Q ++ L + KR SA++ +KH++F+
Sbjct: 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 38/297 (12%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHPNV 71
Y + E +G+G V A+ E VA+K I D SD + I RE + + L+ HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 72 LK-SHCSFVSDHN----LWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGLD 125
++ H ++VV M S LH ++KA D L ++L+ L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALK 117
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
Y+H HRD+K NIL + +K+ DFG++ F+ +V T + APE+
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 186 MEQLHG-YDFKADIWSFGITALELAHGHAPFSKYPPMKVL-LMT-LQNAPP-----GLDY 237
Y DIWS G E+ G F + L L+T L P +
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237
Query: 238 ERDRK------------FSKSFK-------QMIASCLVKDPSKRPSAKKLLKHSFFK 275
E+ R+ FS+ F +++ L DP RP+A++ L +FK
Sbjct: 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 15 LYEEVGQGVSASVHRALC----------IPFNE------IVAVKILDFERDNSDLSNISR 58
L E++G+G VH LC E +VAVK+L + + ++ +
Sbjct: 9 LKEKLGEGQFGEVH--LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK 66
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHIL-------KAAYPDGFEEV 111
E + M + +PN+++ VSD L ++ +M G L + + V
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 112 VIATILR---EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168
IA +L ++ G+ YL +HRD+ + N L+ IK+ DFG+S L+ SGD
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY-SGDYY 185
Query: 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALEL 208
R++ V WMA E + L + +D+W+FG+T E+
Sbjct: 186 RIQGRAVLPIRWMAWESI-LLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 8/162 (4%)
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR 118
EA + V+HP+V++ + VS +V+P S ++ K + P ++ +I I +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALI--IEK 164
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
++L+GL YLH IHRDVK+ NI I+ + +GD G + + + GT
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTV 220
Query: 179 CWMAPEVMEQLHGYDFKADIWSFGITALE-LAHGHAPFSKYP 219
APEV+ + Y+ KADIWS GI E LA+ F P
Sbjct: 221 ETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPP 261
|
Length = 357 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 12/256 (4%)
Query: 19 VGQGVSASVHRALCIPFNEI---VAVKILDFERDNSDLSNISREAQTMILVDHPNVLK-S 74
+G+G V+ I + AVK L+ D ++ +E M HPNVL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 75 HCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIH 134
S+ + VV+P+M G + +++ + + +I L +V KG++YL +H
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-QVAKGMEYLASKKFVH 121
Query: 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLHGYD 193
RD+ + N ++D +K+ DFG++ ++D +T P WMA E + Q +
Sbjct: 122 RDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL-QTQKFT 180
Query: 194 FKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIA 252
K+D+WSFG+ EL G P+ + + LQ G + +++
Sbjct: 181 TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ----GRRLLQPEYCPDPLYEVML 236
Query: 253 SCLVKDPSKRPSAKKL 268
SC P RP+ +L
Sbjct: 237 SCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 80/296 (27%), Positives = 121/296 (40%), Gaps = 43/296 (14%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL-----VD 67
Y E+G G +V++A VA+K + + + L +S + +L D
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP-LSTVREVALLKRLEAFD 60
Query: 68 HPNVLKSH---CSFVSDHNLWVVMPFMSGGSCLHI-LKAAYPDGFEEVVIATILREVLKG 123
HPN+++ + +D V + F L L P G I ++R+ L+G
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS---ACLFDSGDRQRMRNTFVGTPCW 180
LD+LH + +HRD+K NIL+ G +KL DFG++ +C Q V T +
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC-------QMALTPVVVTLWY 173
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYE 238
APEV+ Q Y D+WS G E+ F L + L PP D+
Sbjct: 174 RAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232
Query: 239 RD-----RKFSKSFKQMIASC---------------LVKDPSKRPSAKKLLKHSFF 274
RD FS + + S L +P KR SA + L+H FF
Sbjct: 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 68/297 (22%), Positives = 120/297 (40%), Gaps = 36/297 (12%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDL-SNISREAQTMILVDH- 68
+ Y E++G+G V++A ++VA+K E D + RE + ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 69 PNVLKSHCSFVSDHN-----LWVVMPFMSGG--SCLHILKAAYPDGFEEVVIATILREVL 121
+++ + L++V ++ + I + + ++L
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 122 KGLDYLHHHGHIHRDVKSGNILID-VRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
KG+ + H HG +HRD+K N+L+D +G +K+ D G+ S + + V T +
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF--SIPVKSYTHEIV-TLWY 177
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL--MTLQNAP-----P 233
APEV+ Y DIWS G E++ F ++ LL L P P
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 234 GLDYERD---------RKFSKSFKQM-------IASCLVKDPSKRPSAKKLLKHSFF 274
G+ RD + S++ + + L DP+KR SAK L H +F
Sbjct: 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 63/263 (23%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+ I E L +++G G V A +N+ V + + + + EA M
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMA---TYNKHTKVAVKTMKPGSMSVEAFLAEANVMKT 57
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
+ H ++K H + V+ ++++ FM+ GS L LK+ + ++ +G+
Sbjct: 58 LQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPE 184
++ +IHRD+++ NIL+ K+ DFG++ + D+ R F P W APE
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF---PIKWTAPE 173
Query: 185 VMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKV--LLMTLQNAPPGLDYERDR 241
+ + K+D+WSFGI +E+ +G P YP M ++ L+ G R
Sbjct: 174 AI-NFGSFTIKSDVWSFGILLMEIVTYGRIP---YPGMSNPEVIRALER---GYRMPRPE 226
Query: 242 KFSKSFKQMIASCLVKDPSKRPS 264
+ ++ C P +RP+
Sbjct: 227 NCPEELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 15/231 (6%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH 98
VA+K L + EA M DHPN++ + ++ FM G+
Sbjct: 35 VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDS 94
Query: 99 ILKAAYPDG-FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157
L+ DG F + + +LR + G+ YL ++HRD+ + NIL++ K+ DFG+
Sbjct: 95 FLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL 152
Query: 158 SACLFDSGDRQRMRNTFVGT-PC-WMAPEVMEQLHGYDFKADIWSFGITALE-LAHGHAP 214
S L D ++ G P W APE + + +D+WS+GI E +++G P
Sbjct: 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERP 211
Query: 215 FSKYPPMKVLLMTLQN--APPGLDYERDRKFSKSFKQMIASCLVKDPSKRP 263
+ V+ Q+ PP +D + Q++ C KD + RP
Sbjct: 212 YWDMSNQDVINAIEQDYRLPPPMD------CPTALHQLMLDCWQKDRNARP 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 17/225 (7%)
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR 118
E + + V+ P ++ +F S +L +VM M+GG + + G E +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
++ G+ +LH ++RD+K N+L+D +G +L D G++ L D G R GT
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD-GKTITQR---AGTN 158
Query: 179 CWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM----KVLLMTLQNAPPG 234
+MAPE++++ Y + D ++ G + E+ G PF + ++ TL++
Sbjct: 159 GYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE--- 214
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL----LKHSFFK 275
+ +E F++ K + L K P R +++ KH FFK
Sbjct: 215 VKFEHQ-NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 59/234 (25%), Positives = 112/234 (47%), Gaps = 19/234 (8%)
Query: 36 NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGS 95
+ VA+K L ++ + EA M + HP +++ + + V+ ++++ +M GS
Sbjct: 30 HTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGS 86
Query: 96 CLHILKAAYPDGFEEVVIATIL---REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152
+ LK P+G ++ I ++ ++ +G+ ++ +IHRD+++ NIL+ K+
Sbjct: 87 LVDFLKT--PEG-IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKI 143
Query: 153 GDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLHGYDFKADIWSFGITALEL-AH 210
DFG++ + D+ R F P W APE + + K+D+WSFGI E+ +
Sbjct: 144 ADFGLARLIEDNEYTAREGAKF---PIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTY 199
Query: 211 GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
G P YP M +QN G R + +++ C + P +RP+
Sbjct: 200 GRIP---YPGMTN-PEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 68/270 (25%), Positives = 120/270 (44%), Gaps = 26/270 (9%)
Query: 18 EVGQGVSASVHRALC---IPFNE--IVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
E+G+G V A C +P + +VAVK L E S + REA+ + ++ H +++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIV 70
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPD-----GFEEVVIA--------TILRE 119
+ + L +V +M G L++ PD G E+V I +
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
+ G+ YL +HRD+ + N L+ +K+GDFG+S ++ S D R+ +
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDYYRVGGRTMLPIR 189
Query: 180 WMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238
WM PE + + ++DIWSFG+ E+ +G P+ + + + Q G + E
Sbjct: 190 WMPPESI-LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ----GRELE 244
Query: 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
R R ++ C ++P +R K +
Sbjct: 245 RPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 65/276 (23%), Positives = 113/276 (40%), Gaps = 51/276 (18%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHC 76
E++G+G V++ + + N VAVK +EA+ + DHPN++K
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 77 SFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRD 136
V +++VM + GGS L L+ + + + + G++YL IHRD
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 137 VKSGNILIDVRGAIKLGDFGVS------ACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQL 189
+ + N L+ +K+ DFG+S G +Q P W APE +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ--------IPIKWTAPEALN-- 168
Query: 190 HG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS- 246
+G Y ++D+WS+GI E + G P+ PG+ ++ R+ +S
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPY-----------------PGMSNQQTRERIESG 211
Query: 247 ------------FKQMIASCLVKDPSKRPSAKKLLK 270
+++ C DP RPS ++
Sbjct: 212 YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 71/306 (23%), Positives = 120/306 (39%), Gaps = 51/306 (16%)
Query: 10 AEHYTLYEEVGQG----VSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMI 64
Y +G+G V ++ H+ P VA+K I FE + RE + +
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHK----PTGVKVAIKKISPFEHQTFCQRTL-REIKILR 58
Query: 65 LVDHPNVLK--------SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATI 116
H N++ S SF +++++V M + L+ K I
Sbjct: 59 RFKHENIIGILDIIRPPSFESF---NDVYIVQELME--TDLY--KLIKTQHLSNDHIQYF 111
Query: 117 LREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176
L ++L+GL Y+H +HRD+K N+L++ +K+ DFG++ D +V
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPPG 234
T + APE+M GY DIWS G E+ F Y L++ + P
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231
Query: 235 LDY-----ERDRKFSKS--------FKQMIASC-----------LVKDPSKRPSAKKLLK 270
D R R + KS + ++ + L +P KR + ++ L
Sbjct: 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291
Query: 271 HSFFKQ 276
H + +Q
Sbjct: 292 HPYLEQ 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-13
Identities = 72/258 (27%), Positives = 112/258 (43%), Gaps = 40/258 (15%)
Query: 47 ERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN--LWVVMPFMSGGSCLHILKAAY 104
ER+ S L E M + H N+++ F++ N L+++M F G ++ Y
Sbjct: 53 EREKSQLV---IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCY 109
Query: 105 P--DGFEEVVIATILREVLKGLDYLHH-----HGH--IHRDVKSGNILIDV--------- 146
EE I I R++L L Y H+ +G +HRD+K NI +
Sbjct: 110 KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169
Query: 147 --------RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM-EQLHGYDFKAD 197
R K+GDFG+S + + M ++ VGTP + +PE++ + YD K+D
Sbjct: 170 AQANNLNGRPIAKIGDFGLSKNI----GIESMAHSCVGTPYYWSPELLLHETKSYDDKSD 225
Query: 198 IWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVK 257
+W+ G EL G PF K L+ L+ P D K SK +I + L
Sbjct: 226 MWALGCIIYELCSGKTPFHKANNFSQLISELKRGP---DLPIKGK-SKELNILIKNLLNL 281
Query: 258 DPSKRPSAKKLLKHSFFK 275
+RPSA + L + K
Sbjct: 282 SAKERPSALQCLGYQIIK 299
|
Length = 1021 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 65/274 (23%), Positives = 125/274 (45%), Gaps = 32/274 (11%)
Query: 19 VGQGVSASVHRALCIPFNEI----VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKS 74
+G GV +VH+ + IP + VA+K + I+ M +DH +++
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 75 HCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIH 134
+L +V GS L ++ + D + + ++ KG+ YL H +H
Sbjct: 75 -LGICPGASLQLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVH 132
Query: 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLH--G 191
R++ + NIL+ +++ DFGV+ L+ D++ + TP WMA +E +
Sbjct: 133 RNLAARNILLKSDSIVQIADFGVADLLYPD-DKKYFYSE-HKTPIKWMA---LESILFGR 187
Query: 192 YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK----- 245
Y ++D+WS+G+T E+ ++G P++ P +V P L E+ + ++
Sbjct: 188 YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---------PDL-LEKGERLAQPQICT 237
Query: 246 -SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278
++ C + D + RP+ K+ L + F + AR
Sbjct: 238 IDVYMVMVKCWMIDENVRPTFKE-LANEFTRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 67/255 (26%), Positives = 114/255 (44%), Gaps = 35/255 (13%)
Query: 37 EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGG 94
E+VAVK L L + RE + + + H N++K C NL +VM ++ G
Sbjct: 34 EVVAVKKLQHSTAEH-LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 95 SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGD 154
S L+ + + + + ++ KG++YL ++HRD+ + NIL++ +K+GD
Sbjct: 93 SLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGD 151
Query: 155 FGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAP 214
FG++ L + ++R W APE + + + +D+WSFG+ EL ++
Sbjct: 152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYEL-FTYSD 209
Query: 215 FSKYPPMKVLLMT----------------LQN-----APPGLDYERDRKFSKSFKQMIAS 253
S PP + + M L+N APPG E ++
Sbjct: 210 KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAE--------IYAIMKE 261
Query: 254 CLVKDPSKRPSAKKL 268
C DPS+RPS +L
Sbjct: 262 CWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 37/275 (13%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFN---EIVAVKILDFE-RDNSDLSNISREAQTMILVDH 68
+TL +G+G SV A + + VAVK+L + +SD+ REA M DH
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 69 PNVLKSHCSFVSDHNL--------WVVMPFMSGGSCLHILKAAYPDGFE--EVVIATILR 118
PNV+K VS + V++PFM G LH G E + + T++R
Sbjct: 61 PNVIK--LIGVSLRSRAKGRLPIPMVILPFMKHGD-LHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 119 ---EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175
++ G++YL IHRD+ + N +++ + + DFG+S ++ SGD R
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY-SGDYYRQGCASK 176
Query: 176 GTPCWMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKV--LLMT---LQ 229
W+A E + + Y +D+W+FG+T E+ G P++ ++ L+ L+
Sbjct: 177 LPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235
Query: 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
P L+ +++ C +P RPS
Sbjct: 236 QPPDCLE---------DVYELMCQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 57/190 (30%), Positives = 93/190 (48%), Gaps = 16/190 (8%)
Query: 39 VAVKILDFE-RDNSDLSNISREAQTMILVDHPNVLK--SHCSFVSDHNLW----VVMPFM 91
VAVK + + S++ EA M DHPNV+K C S V++PFM
Sbjct: 30 VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM 89
Query: 92 SGGSCLH--ILKAAYPDGFEEVVIATILR---EVLKGLDYLHHHGHIHRDVKSGNILIDV 146
G LH +L + E++ + T+L+ ++ G++YL + IHRD+ + N ++
Sbjct: 90 KHGD-LHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE 148
Query: 147 RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITAL 206
+ + DFG+S ++ SGD R W+A E + Y K+D+W+FG+T
Sbjct: 149 DMTVCVADFGLSKKIY-SGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMW 206
Query: 207 ELA-HGHAPF 215
E+A G P+
Sbjct: 207 EIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 55/234 (23%), Positives = 96/234 (41%), Gaps = 18/234 (7%)
Query: 37 EIVAVKILDFERDNSDLSN-ISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGS 95
+ VAVKIL + ++ L + + REA M +D+P +++ + +VM G
Sbjct: 23 KTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM-IGICEAESWMLVMELAELGP 81
Query: 96 CLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDF 155
L+ E I ++ +V G+ YL +HRD+ + N+L+ + K+ DF
Sbjct: 82 LNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDF 139
Query: 156 GVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALE-LAHGHAP 214
G+S L + + + W APE M + + K+D+WSFG+ E ++G P
Sbjct: 140 GLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
Query: 215 FSKYPPMKVLLMTLQ----NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
+ +V M P E ++ C +RP
Sbjct: 199 YKGMKGNEVTQMIESGERMECPQRCPPE--------MYDLMKLCWTYGVDERPG 244
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 58/200 (29%), Positives = 81/200 (40%), Gaps = 34/200 (17%)
Query: 113 IATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172
TI R +L+ L YLH G IHRDVK+ NI +D LGDFG +AC D+
Sbjct: 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG-AACKLDAHPDTPQCY 245
Query: 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAP-FSKYPP-----MKVLLM 226
+ GT +PE++ L Y K DIWS G+ E++ + F K ++ ++
Sbjct: 246 GWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
Query: 227 TLQNAPPGLDYERDRKFSKSFKQ--------------------------MIASCLVKDPS 260
+Q P K FKQ +IA L D
Sbjct: 305 CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQE 364
Query: 261 KRPSAKKLLKHSFFKQARSN 280
RPSA+ +L F + N
Sbjct: 365 FRPSAQDILSLPLFTKEPIN 384
|
Length = 392 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 14 TLYEEVGQGVSASVHRAL---CIPFNEI--VAVKILDFERDNS-DLSNISREAQTMILVD 67
TL E+GQG V+ L + VA+K + E + + EA M +
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-NENASMRERIEFLNEASVMKEFN 67
Query: 68 HPNVLKSHCSFVSDHN-LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR-------- 118
+V++ VS VVM M+ G L++ P+ +
Sbjct: 68 CHHVVRLL-GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG----DRQRMRNTF 174
E+ G+ YL +HRD+ + N ++ +K+GDFG++ ++++ + +
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL---- 182
Query: 175 VGTPC-WMAPEVMEQLHG-YDFKADIWSFGITALELA 209
P WMAPE ++ G + K+D+WSFG+ E+A
Sbjct: 183 --LPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 61/243 (25%), Positives = 108/243 (44%), Gaps = 23/243 (9%)
Query: 41 VKILDFER----DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96
V I FE+ + ++ E + + ++HP + + SF + L++V+ F+ GG
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 97 LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFG 156
L+ F V +++ +YL ++RD+K N+L+D G IK+ DFG
Sbjct: 119 FTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG 176
Query: 157 VSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS 216
+ + T GTP ++APE++ + G+ AD W+ GI E+ G PF
Sbjct: 177 FAKVV------DTRTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFY 229
Query: 217 KYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKH 271
P L+ Q G+ Y + + K ++ L D +KR A+ + +H
Sbjct: 230 ANEP----LLIYQKILEGIIY-FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284
Query: 272 SFF 274
+F
Sbjct: 285 PWF 287
|
Length = 340 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 70/258 (27%), Positives = 102/258 (39%), Gaps = 63/258 (24%)
Query: 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT---------------- 115
LK C F D+ L S L IL+ + D FEE+ + T
Sbjct: 50 LKMLCFFKHDNVL----------SALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQP 99
Query: 116 --------ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167
L ++L+GL YLH G +HRD+K GN+L++ +K+ DFG+ A + + +
Sbjct: 100 LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGL-ARVEEPDES 158
Query: 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--- 224
+ M V T + APE++ Y DIWS G EL F P++ L
Sbjct: 159 KHMTQEVV-TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
Query: 225 ---LMT-----------------LQNA--PPGLD--YERDRKFSKSFKQMIASCLVKDPS 260
L T L+ PP L Y + + ++ LV DP
Sbjct: 218 TDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD 277
Query: 261 KRPSAKKLLKHSFFKQAR 278
KR SA L H + + R
Sbjct: 278 KRISAADALAHPYLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 76/296 (25%), Positives = 122/296 (41%), Gaps = 38/296 (12%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFN-EIVAVKIL--DFERDNSDLSNISREA--QTMIL 65
+ Y E+G+G V +A + VA+K + + LS I A + +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 66 VDHPNVLK--SHCSFVS---DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
+HPNV++ C+ + L +V + ++ K P G I ++ ++
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-GVPTETIKDMMFQL 119
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
L+GLD+LH H +HRD+K NIL+ G IKL DFG++ Q + V T +
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTLWY 175
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYE 238
APEV+ Q Y D+WS G E+ F + L ++ + P D+
Sbjct: 176 RAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 239 RDRKFSKSF--------------------KQMIASCLVKDPSKRPSAKKLLKHSFF 274
RD + K ++ CL +P+KR SA L H +F
Sbjct: 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 32/290 (11%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E Y +++G+G A+V + +VA+K + E + RE + + H N
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN 64
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ H ++ L +V ++ ++ V I + ++L+GL Y H
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI--FMFQLLRGLSYCHKR 122
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
+HRD+K N+LI+ +G +KL DFG++ S + N V T + P+V+
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVV-TLWYRPPDVLLGST 179
Query: 191 GYDFKADIWSFGITALELAHGHA--PFSKYPPMKVLLMTLQNAP-----PGLDYERDRKF 243
Y D+W G E+A G P S L+ L P PG+ + +
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR- 238
Query: 244 SKSFKQ-------------------MIASCLVKDPSKRPSAKKLLKHSFF 274
S F Q +++S L+ + R SA+ L+HS+F
Sbjct: 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 30/273 (10%)
Query: 19 VGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTMILVDHPNV--L 72
+G G +V++ L IP E VA+K L I EA M VD+P+V L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH 132
C + + +MPF CL + D + ++ KG++YL
Sbjct: 75 LGICLTSTVQLITQLMPF----GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 133 IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLHG 191
+HRD+ + N+L+ +K+ DFG++ L D + P WMA E +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLL--GADEKEYHAEGGKVPIKWMALESILH-RI 187
Query: 192 YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNA-----PPGLDYERDRKFSK 245
Y ++D+WS+G+T EL G P+ P ++ + L+ PP +
Sbjct: 188 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LEKGERLPQPPICTID------- 239
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278
++ C + D RP ++L+ F K AR
Sbjct: 240 -VYMIMVKCWMIDADSRPKFRELIIE-FSKMAR 270
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 50/187 (26%), Positives = 80/187 (42%), Gaps = 32/187 (17%)
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175
++ ++L+GL Y+H IHRD+K N+ ++ +K+ DFG++ D +V
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MTGYV 178
Query: 176 GTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHA--PFSKYPPMKVLLMTLQNAPP 233
T + APE+M Y+ DIWS G EL G P + + L++ L P
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238
Query: 234 G-----LDYERDRKFSKSFKQM-------------------IASCLVKDPSKRPSAKKLL 269
+ E R + +S QM + LV D KR +A + L
Sbjct: 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298
Query: 270 KHSFFKQ 276
H++F Q
Sbjct: 299 AHAYFAQ 305
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATIL- 117
EA M + H +++ + + ++++ +M+ GS L LK+ D +V++ ++
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKS---DEGGKVLLPKLID 107
Query: 118 --REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175
++ +G+ Y+ +IHRD+++ N+L+ K+ DFG++ + D+ R F
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF- 166
Query: 176 GTPC-WMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKV--LLMTLQNA 231
P W APE + + K+D+WSFGI E+ +G P YP M ++ LQ
Sbjct: 167 --PIKWTAPEAI-NFGSFTIKSDVWSFGILLYEIVTYGKIP---YPGMSNSDVMSALQR- 219
Query: 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
G R ++ +C + +RP+
Sbjct: 220 --GYRMPRMENCPDELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 65/257 (25%), Positives = 105/257 (40%), Gaps = 51/257 (19%)
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMP-FMSGGSCLHILKAAYPDGFEEVVIATIL 117
EA + ++HP++++ +F + +++P + + C Y + I IL
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYC-------YLAAKRNIAICDIL 185
Query: 118 ---REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF 174
R VL+ + YLH + IHRD+K+ NI I+ G + LGDFG +AC F +
Sbjct: 186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AAC-FPVDINANKYYGW 243
Query: 175 VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM--------KVLLM 226
GT APE++ + Y DIWS GI E+A H + + ++ L+
Sbjct: 244 AGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI 302
Query: 227 TLQ----------NAPPGLDYERDRKFSKSFKQ-------------------MIASCLVK 257
+ +A LD KS ++ +I L
Sbjct: 303 IRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAF 362
Query: 258 DPSKRPSAKKLLKHSFF 274
D RPSA+ LL + F
Sbjct: 363 DAHHRPSAEALLDFAAF 379
|
Length = 391 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 65/282 (23%), Positives = 130/282 (46%), Gaps = 46/282 (16%)
Query: 17 EEVGQGVSASVHRA-LCIP---FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
EE+G+ +++ L +P ++VA+K L + +EA M + HPN++
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCLH---ILKAAYPD----GFEEVVIATILR------- 118
+ + ++ +++ G LH I+++ + D E+ + + L
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGD-LHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 119 --EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176
++ G++YL H +H+D+ + NILI + +K+ D G+S ++ S D R++ +
Sbjct: 130 AIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY-SADYYRVQPKSLL 188
Query: 177 TPCWMAPEVMEQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTL------ 228
WM PE + ++G + +DIWSFG+ E+ + G P+ + +V+ M
Sbjct: 189 PIRWMPPEAI--MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLP 246
Query: 229 --QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
++ PP R +S ++ C + PS+RP K +
Sbjct: 247 CSEDCPP-------RMYS-----LMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 64/263 (24%), Positives = 111/263 (42%), Gaps = 36/263 (13%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--SDL-SNISREAQTMILVDHPNVLK 73
E +G+G V N VAVK R+ DL + +EA+ + HPN+++
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSC---RETLPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 74 SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR---EVLKGLDYLHHH 130
+++VM + GG L L+ P + + +++ G++YL
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP----RLKVKELIQMVENAAAGMEYLESK 113
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT------PC-WMAP 183
IHRD+ + N L+ + +K+ DFG+S R+ + T P W AP
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMS--------REEEDGVYASTGGMKQIPVKWTAP 165
Query: 184 EVMEQLHG-YDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
E + +G Y ++D+WSFGI E + G P++ + T + G+
Sbjct: 166 EALN--YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----TREAIEQGVRLPCPE 219
Query: 242 KFSKSFKQMIASCLVKDPSKRPS 264
+ +++ C DP +RPS
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 30/274 (10%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNEI--VAVKILDFER-DNSDLSNISREAQTMILVDHPN 70
L + +G+G SV + I VAVK + S++ + EA M DHPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 71 VLK--SHCSFVSDHNLW----VVMPFMSGGSC----LHILKAAYPDGFEEVVIATILREV 120
V++ C + + V++PFM G L+ P ++ + ++
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
G++YL IHRD+ + N +++ + + DFG+S +++ GD R W
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN-GDYYRQGRIAKMPVKW 180
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLM-----TLQNAPPG 234
+A E + Y K+D+WSFG+T E+A G P+ ++ L+ P
Sbjct: 181 IAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
LD +++SC + +P RPS + L
Sbjct: 240 LD---------GLYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 75/311 (24%), Positives = 126/311 (40%), Gaps = 62/311 (19%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL---VD 67
+ Y + +G G V A VAVK L R + ++ R + ++L V+
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVN 78
Query: 68 HPNVLKSHCSFVSD------HNLWVVMPFMSGGSC--LHILKAAYPDGFEEVVIATILRE 119
H N++ F ++++VM M C +H+ + ++ +L +
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM-------ELDHERMSYLLYQ 131
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
+L G+ +LH G IHRD+K NI++ +K+ DFG++ + M +V T
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TACTNFMMTPYVVTRY 187
Query: 180 WMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS------------------KYPPM 221
+ APEV+ + GY DIWS G EL G F M
Sbjct: 188 YRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246
Query: 222 KVLLMTLQN------APPGL-------------DYERDRKFSKSFKQMIASCLVKDPSKR 262
L T++N PG+ + ERD+ + + +++ LV DP KR
Sbjct: 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306
Query: 263 PSAKKLLKHSF 273
S + L+H +
Sbjct: 307 ISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-12
Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 17/186 (9%)
Query: 39 VAVKIL--DFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS-DHNLWVVMPFMSGGS 95
VA+K+L D + + RE + HPN++ S + L+ V ++ G +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 96 CLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA---IKL 152
+L A E ++ +VL L H+ G +HRD+K NI++ G K+
Sbjct: 66 LREVLAADGALPAGETG--RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKV 123
Query: 153 GDFGVSACLFDSGDRQRMRNT----FVGTPCWMAPEVMEQLHGYDF--KADIWSFGITAL 206
DFG+ L D T +GTP + AP EQL G +D++++G+ L
Sbjct: 124 LDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP---EQLRGEPVTPNSDLYAWGLIFL 180
Query: 207 ELAHGH 212
E G
Sbjct: 181 ECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 76/326 (23%), Positives = 125/326 (38%), Gaps = 75/326 (23%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA--QTMIL--VDH 68
Y + +G+G V++A + I F+ D + IS+ A + +L + H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 69 PNVLKSHCSFVSDHNLWVVMPF-MSGGSCLHILK-------AAYPDGFEEVVIATILREV 120
NV+ F+ + V + F + I+K + P ++ ++L ++
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPS----MVKSLLWQI 117
Query: 121 LKGLDYLHHHGHIHRDVKSGNILI----DVRGAIKLGDFGVSACLFD-------SGDRQR 169
L G+ YLH + +HRD+K NIL+ RG +K+GD G+ A LF+ D
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL-ARLFNAPLKPLADLDP-- 174
Query: 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFG------ITALELAHG-HAPFSKYPP-- 220
V T + APE++ Y DIW+ G +T + G A K P
Sbjct: 175 ----VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230
Query: 221 -------MKVLLM-TLQNAPPGLDYERDRKFSKSFKQMIASC--LVK------------- 257
+VL T ++ P K FK L K
Sbjct: 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 258 ---------DPSKRPSAKKLLKHSFF 274
DP+KR +A++ L+H +F
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 57/244 (23%), Positives = 105/244 (43%), Gaps = 20/244 (8%)
Query: 38 IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLK--SHCSFVSDHNLWVVMPFMSGGS 95
+V VK L +D + S RE + H NV++ C H ++++ + G
Sbjct: 37 LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH--YMILEYTDLGD 94
Query: 96 CLHILKAA-------YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG 148
L+A P + ++ G+D+L + +HRD+ + N L+ +
Sbjct: 95 LKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR 154
Query: 149 AIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLHGYDFKADIWSFGITALE 207
+K+ +S +++S + ++RN + P W+APE + Q + K+D+WSFG+ E
Sbjct: 155 EVKVSLLSLSKDVYNS-EYYKLRNALI--PLRWLAPEAV-QEDDFSTKSDVWSFGVLMWE 210
Query: 208 L-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAK 266
+ G PF +V L LQ L+ +++ C +P RPS
Sbjct: 211 VFTQGELPFYGLSDEEV-LNRLQAGK--LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFS 267
Query: 267 KLLK 270
+L+
Sbjct: 268 ELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 77/301 (25%), Positives = 120/301 (39%), Gaps = 47/301 (15%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP- 69
E Y VG G SV A + VAVK L R L + R + + L+ H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKL--SRPFQSLIHARRTYRELRLLKHMK 72
Query: 70 --------NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
+V S + + +++V M G +I+K + + ++ ++L
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLL 128
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
+GL Y+H G IHRD+K N+ ++ +++ DFG++ D +V T +
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE------MTGYVATRWYR 182
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHA--PFSKYPPMKVLLMTLQNAPPG----- 234
APE+M Y+ DIWS G EL G A P + Y +M + P
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242
Query: 235 LDYERDRKFSKSFKQM-------------------IASCLVKDPSKRPSAKKLLKHSFFK 275
+ E RK+ +S M + LV D KR SA + L H +F
Sbjct: 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302
Query: 276 Q 276
Q
Sbjct: 303 Q 303
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 39/85 (45%), Positives = 51/85 (60%), Gaps = 8/85 (9%)
Query: 77 SFVSDHNLWVVMPFMSGG---SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHI 133
S S +N+++VM ++ GG S LHI Y F+E + + EV LDYLH HG I
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIY--GY---FDEEMAVKYISEVALALDYLHRHGII 126
Query: 134 HRDVKSGNILIDVRGAIKLGDFGVS 158
HRD+K N+LI G IKL DFG+S
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 38/239 (15%)
Query: 58 REAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGG-------SC-LHILKAAYPDGFE 109
+E Q ++HPNVL+ + +V+ F G S + + A D
Sbjct: 44 QEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD--- 100
Query: 110 EVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169
V+ + EV GL +LH IH D+ N + ++K+GD+G++ Q
Sbjct: 101 --VLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALE-------QY 151
Query: 170 MRNTFVGTPC------WMAPEVMEQLHGYDFKAD------IWSFGITALELAH-GHAPFS 216
+ ++ C W+APE++E D IWS G+T EL P+
Sbjct: 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211
Query: 217 KYPPMKVLLMTLQNAPPGLDYER-DRKFSKSFKQMIASCLVKDPSKRPSAK---KLLKH 271
+VL ++ L + D K+S + +++ C + DP RP+A+ +LL +
Sbjct: 212 DLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 55/240 (22%), Positives = 106/240 (44%), Gaps = 32/240 (13%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH-NLWVVMPFMSGGSCL 97
VAVK + ++++ EA M + H N+++ V + L++V +M+ GS +
Sbjct: 32 VAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88
Query: 98 HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157
L++ + +V + ++YL + +HRD+ + N+L+ K+ DFG+
Sbjct: 89 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL 148
Query: 158 SACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPF 215
+ + D ++ P W APE + + + K+D+WSFGI E+ + G P+
Sbjct: 149 TKEASSTQDTGKL-------PVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY 200
Query: 216 SKYPPMKVL-------LMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
+ P V+ M + P + Y+ ++ C D + RPS +L
Sbjct: 201 PRIPLKDVVPRVEKGYKMDAPDGCPPVVYD-----------VMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 59/259 (22%), Positives = 109/259 (42%), Gaps = 32/259 (12%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH 98
VAVK+L + ++ + +E + + + PN+ + D L ++M +M G
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 99 ILKAAYP-DGFEEVVIATILREVLK--------GLDYLHHHGHIHRDVKSGNILIDVRGA 149
L+ ++ L G+ YL +HRD+ + N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT 168
Query: 150 IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG-YDFKADIWSFGITALEL 208
IK+ DFG+S L+ S D R++ WMA E + L G + K+D+W+FG+T E+
Sbjct: 169 IKIADFGMSRNLY-SSDYYRVQGRAPLPIRWMAWESV--LLGKFTTKSDVWAFGVTLWEI 225
Query: 209 AHGHAPFSKYPPMKVLL--MTLQNAPPGLDYERDRKF---------SKSFKQMIASCLVK 257
+ P + L ++NA G + D + K +++ C +
Sbjct: 226 ----LTLCREQPYEHLTDQQVIENA--GHFFRDDGRQIYLPRPPNCPKDIYELMLECWRR 279
Query: 258 DPSKRPSAKKLLKHSFFKQ 276
D RP+ +++ H F ++
Sbjct: 280 DEEDRPTFREI--HLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 57/238 (23%), Positives = 107/238 (44%), Gaps = 38/238 (15%)
Query: 17 EEVGQGVSASVHRA-LCIPFNE----IVAVKILDFERDNSDLSN-ISREAQTMILVDHPN 70
EE+G+G V++ L P VA+K L E + +EA+ M + HPN
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHPN 69
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLH--------------------ILKAAYPDGFEE 110
++ + ++ +++ G LH + + F
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGD-LHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 111 VVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170
+ I ++ G++YL H +HRD+ + N L+ +K+ DFG+S ++ S D R+
Sbjct: 129 IAI-----QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY-SADYYRV 182
Query: 171 RNTFVGTPCWMAPEVMEQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLM 226
++ + WM PE + L+G + ++DIWSFG+ E+ ++G P+ + +V+ M
Sbjct: 183 QSKSLLPVRWMPPEAI--LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 43/155 (27%), Positives = 80/155 (51%), Gaps = 8/155 (5%)
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+V KG+++L IHRD+ + NIL+ +K+ DFG++ ++ D R + +
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 179 CWMAPE-VMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLD 236
WMAPE + +++ Y ++D+WSFG+ E+ + G +P YP +K+ + G
Sbjct: 247 -WMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEEFCRRLKEGTR 300
Query: 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ Q + C +PS+RP+ +L++H
Sbjct: 301 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 20/268 (7%)
Query: 19 VGQGVSASVHRALCIPFNEIV----AVKILDFERDNSDLSNISREAQTMILVDHPNVLKS 74
+G G +V++ + +P E V A+KIL+ EA M +DHP++++
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 75 HCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIH 134
+S + +V M G CL + D ++ ++ KG+ YL +H
Sbjct: 75 LGVCLSP-TIQLVTQLMPHG-CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132
Query: 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQLHGYD 193
RD+ + N+L+ +K+ DFG++ L GD + P WMA E + +
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLL--EGDEKEYNADGGKMPIKWMALECI-HYRKFT 189
Query: 194 FKADIWSFGITALEL-AHGHAPFSKYPPMKV--LLMTLQNAPPGLDYERDRKFSKSFKQM 250
++D+WS+G+T EL G P+ P ++ LL + P + + +
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP------QPPICTIDVYMV 243
Query: 251 IASCLVKDPSKRPSAKKLLKHSFFKQAR 278
+ C + D RP K+L F + AR
Sbjct: 244 MVKCWMIDADSRPKFKELAAE-FSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 57/252 (22%), Positives = 114/252 (45%), Gaps = 30/252 (11%)
Query: 38 IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGS-- 95
+VAVK+L + + + ++ +E + M + PN+++ ++ L ++ +M G
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 96 ---CLHILKAAYPDGFEEVVIATILR----EVLKGLDYLHHHGHIHRDVKSGNILIDVRG 148
H + A + + L ++ G+ YL +HRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167
Query: 149 AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALEL 208
IK+ DFG+S L+ SGD R++ V WM+ E + L + +D+W+FG+T E+
Sbjct: 168 TIKIADFGMSRNLY-SGDYYRIQGRAVLPIRWMSWESI-LLGKFTTASDVWAFGVTLWEI 225
Query: 209 AH--GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS----------KSFKQMIASCLV 256
P+S+ +V+ T + + RD+ S +++ SC
Sbjct: 226 LTLCKEQPYSQLSDEQVIENTGE-------FFRDQGRQVYLPKPALCPDSLYKLMLSCWR 278
Query: 257 KDPSKRPSAKKL 268
++ +RPS +++
Sbjct: 279 RNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 13/209 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E Y +++G+G A+V++ + +VA+K + E + RE + + H N
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVV----IATILREVLKGLDY 126
++ H ++ +L +V ++ LK Y D + + L ++L+GL+Y
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDKD-----LKQ-YLDDCGNSINMHNVKLFLFQLLRGLNY 119
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM 186
H +HRD+K N+LI+ RG +KL DFG++ S + N V T + P+++
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVV-TLWYRPPDIL 176
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPF 215
Y + D+W G E++ G F
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
E Y +++G+G A+V++ ++VA+K + E + REA + + H
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N++ H + L +V ++ ++ G + L ++L+GL Y H
Sbjct: 64 NIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDD--CGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR----NTF---VGTPCWMA 182
+HRD+K N+LI RG +KL DFG++ R + T+ V T +
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLA----------RAKSVPSKTYSNEVVTLWYRP 171
Query: 183 PEVMEQLHGYDFKADIWSFGITALELAHGHAPF 215
P+V+ Y D+W G E+A G F
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 31/230 (13%)
Query: 54 SNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVV 112
S SRE T+I PN++ H VS+ ++++V+ GG HI K E
Sbjct: 30 SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN---IPEEC 86
Query: 113 IATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172
+ E++ LD LH G + RD+ NIL+D RG I+L F + + DS D + + N
Sbjct: 87 VKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN 146
Query: 173 TFVGTPCWMAPEV---MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ 229
+ APEV E+ D+ WS G EL G + P + T
Sbjct: 147 MYC------APEVGGISEETEACDW----WSLGAILFELLTGKT-LVECHPSGINTHTTL 195
Query: 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSA-----KKLLKHSFF 274
N P + S+ + ++ L +P++R A + + H FF
Sbjct: 196 NIPEWV--------SEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 68/272 (25%), Positives = 113/272 (41%), Gaps = 34/272 (12%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRA-LCIPFNE--IVAVKILDFERDNSDLSNISREAQTMI 64
I H T + +G G V R L +P + VA+K L + EA M
Sbjct: 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMG 61
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG-FEEVVIATILREVLKG 123
H N+++ ++ +M G+ L+ DG F + +LR + G
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAG 119
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD--------SGDRQRMRNTFV 175
+ YL ++HRD+ + NIL++ K+ DFG+S L D SG + +R
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR---- 175
Query: 176 GTPCWMAPEVMEQLHGYDFKADIWSFGITALE-LAHGHAPF---SKYPPMKVLLMTLQNA 231
W APE + + +D+WSFGI E ++ G P+ S + MK + +
Sbjct: 176 ----WTAPEAI-AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR-L 229
Query: 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRP 263
P +D + Q++ C +D ++RP
Sbjct: 230 PAPMD------CPSAVYQLMLQCWQQDRARRP 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 64/279 (22%), Positives = 116/279 (41%), Gaps = 42/279 (15%)
Query: 18 EVGQGVSASVHRALC---IPFNE--IVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
++GQG V +A +P+ +VAVK+L E ++ REA M DHPN++
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT----------------- 115
K + ++ +M+ G L+ P + +T
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 116 ---ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172
I ++V G+ YL +HRD+ + N L+ +K+ DFG+S ++ + + N
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191
Query: 173 TFVGTPC-WMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLM---- 226
+ P WM PE + + Y ++D+W++G+ E+ ++G P+ +V+
Sbjct: 192 DAI--PIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG 248
Query: 227 TLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSA 265
+ + P E ++ C K PS RPS
Sbjct: 249 NVLSCPDNCPLE--------LYNLMRLCWSKLPSDRPSF 279
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-11
Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 31/250 (12%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILVDHPNVLK--SHCSFVSDHNLWVVMPFMSGGSC 96
V VK L + EAQ + H N+L+ C+ V+ + L VM F G
Sbjct: 25 VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLL--VMEFCPLGDL 82
Query: 97 ---LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLG 153
L + A + + + E+ GL +LH + IH D+ N L+ +K+G
Sbjct: 83 KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIG 142
Query: 154 DFGVSACLFDSGDRQRMRNTFVGTP-------CWMAPEVMEQLHGYDFKAD------IWS 200
D+G+S + + + TP W+APE+++++HG D +WS
Sbjct: 143 DYGLSHN--------KYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS 194
Query: 201 FGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDR-KFSKSFKQMIASCLVKD 258
G+T EL G P+ +VL T++ L R + S + +++ C ++
Sbjct: 195 LGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQ- 253
Query: 259 PSKRPSAKKL 268
P +RPSA+++
Sbjct: 254 PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+V KG+ +L IHRD+ + N+L+ +K+ DFG++ + + + N +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 179 CWMAPEVMEQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLD 236
WMAPE + + Y F++D+WS+GI E+ + G P YP M V + G
Sbjct: 209 -WMAPESI--FNCVYTFESDVWSYGILLWEIFSLGSNP---YPGMPVDSKFYKLIKEGYR 262
Query: 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
+ ++ +C DP KRP+ K++
Sbjct: 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 52/243 (21%), Positives = 92/243 (37%), Gaps = 41/243 (16%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH 98
VA+ L + EA T+ DH N+++ + + +V +MS G+
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL-- 93
Query: 99 ILKAAYPDGF----EEVVIATILREVLKGL----DYLHHHGHIHRDVKSGNILIDVRGAI 150
D F E ++A L +L GL YL G++H+ + + +L++
Sbjct: 94 -------DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVC 146
Query: 151 KLGDFGVSACLFDSGDRQRMRNTFV-----GTPCWMAPEVMEQLHGYDFKADIWSFGITA 205
K+ F + + W APE + Q H + +D+WSFGI
Sbjct: 147 KISGFR-------RLQEDKSEAIYTTMSGKSPVLWAAPEAI-QYHHFSSASDVWSFGIVM 198
Query: 206 LE-LAHGHAPF---SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSK 261
E +++G P+ S +K + + P R Q++ C K+ +
Sbjct: 199 WEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP-------RNCPNLLHQLMLDCWQKERGE 251
Query: 262 RPS 264
RP
Sbjct: 252 RPR 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 72/314 (22%), Positives = 133/314 (42%), Gaps = 62/314 (19%)
Query: 11 EHYTLYEEVGQGVSASVHRALC------------IPFNE------IVAVKILDFERDNSD 52
H E++G+G VH LC PFN +VAVKIL + + +
Sbjct: 5 GHLLFKEKLGEGQFGEVH--LCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNA 62
Query: 53 LSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEE-- 110
++ +E + + + PN+++ V + L ++ +M G L + + D EE
Sbjct: 63 RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 111 ---------------VVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDF 155
+ + ++ G+ YL +HRD+ + N L+ IK+ DF
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADF 182
Query: 156 GVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG-YDFKADIWSFGITALELAH--GH 212
G+S L+ +GD R++ V WMA E + L G + +D+W+FG+T E+
Sbjct: 183 GMSRNLY-AGDYYRIQGRAVLPIRWMAWECI--LMGKFTTASDVWAFGVTLWEILMLCKE 239
Query: 213 APFSKYPPMKVLLMTLQNAPPGLDYERDRKFS----------KSFKQMIASCLVKDPSKR 262
P+ + +V ++NA ++ RD+ + +++ C +D +R
Sbjct: 240 QPYGELTDEQV----IENAG---EFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRER 292
Query: 263 PSAKKLLKHSFFKQ 276
PS + H+F +
Sbjct: 293 PSFSDI--HAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 61/245 (24%), Positives = 96/245 (39%), Gaps = 34/245 (13%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC-- 96
V +K+L L+ A M + H +++K + V D N+ +V ++ G
Sbjct: 33 VVLKVLG-SDHRDSLAFF-ETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDV 89
Query: 97 -LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI---DVRGA--- 149
LH K ++ V +++ L YL +H +V NIL+ +
Sbjct: 90 FLHREKNNVSLHWKLDV----AKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVP 145
Query: 150 -IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGY-DFKADIWSFGITALE 207
IKL D G+ + +R P W+APE + AD WSFG T LE
Sbjct: 146 FIKLSDPGIPITVLSREERVER------IP-WIAPECIRNGQASLTIAADKWSFGTTLLE 198
Query: 208 L-AHGHAPFSKYPPM-KVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSA 265
+ ++G P S K Q+ P D +I C DP+KRPS
Sbjct: 199 ICSNGEEPLSTLSSSEKERFYQDQHRLPMPD-------CAELANLINQCWTYDPTKRPSF 251
Query: 266 KKLLK 270
+ +L+
Sbjct: 252 RAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 55/173 (31%), Positives = 75/173 (43%), Gaps = 29/173 (16%)
Query: 57 SREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILK---------AAYPDG 107
EA+ + + HP VL L V + G +CL + K A
Sbjct: 208 VHEARLLRRLSHPAVLA----------LLDVRV-VGGLTCLVLPKYRSDLYTYLGARLRP 256
Query: 108 FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167
+ + R++L +DY+H G IHRD+K+ N+L++ I LGDFG +AC F G
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG-AAC-FARGSW 314
Query: 168 QR-MRNTFVGTPCWMAPEVMEQLHG--YDFKADIWSFGITALELA-HGHAPFS 216
GT APEV L G Y DIWS G+ E A H + FS
Sbjct: 315 STPFHYGIAGTVDTNAPEV---LAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364
|
Length = 461 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/266 (21%), Positives = 106/266 (39%), Gaps = 33/266 (12%)
Query: 19 VGQGVSASVHRALC----IPFNEIVAVKILDFERDNSDLSNISREAQTMI-LVDHPNVLK 73
+G+G V +A + + A+K + D + + E + + L HPN++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMD--AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 74 SHCSFVSDHNLWVVMPFMSGGSCLHILKAAY-----PDGFEEVVIATIL--REVLK---- 122
+ L++ + + G+ L L+ + P A+ L +++L
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 123 ---GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
G+DYL IHRD+ + NIL+ K+ DFG+S G ++ T P
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMGRLPV 175
Query: 180 -WMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY 237
WMA E + Y +D+WS+G+ E+ G P+ ++ + P G
Sbjct: 176 RWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----YEKLPQGYRL 230
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRP 263
E+ ++ C + P +RP
Sbjct: 231 EKPLNCDDEVYDLMRQCWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 60/245 (24%), Positives = 101/245 (41%), Gaps = 43/245 (17%)
Query: 49 DNSDLSNISR---EAQTMILVDHPNVLKSHCSFVSDHNL-WVVMPFMSGGSC-LHILKAA 103
D++ ++ E+ + + H N+L + D +V+ P+M+ G+ L + +
Sbjct: 45 DHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCR 104
Query: 104 YPDGFEEVVIATI-----LREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158
+ ++T ++ G+ YLH G IH+D+ + N +ID +K+ D +S
Sbjct: 105 LGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164
Query: 159 ACLFDS-----GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GH 212
LF GD + N V WMA E + Y +D+WSFG+ EL G
Sbjct: 165 RDLFPMDYHCLGDNE---NRPVK---WMALESLVNKE-YSSASDVWSFGVLLWELMTLGQ 217
Query: 213 APFSKYPPMKVLLMTLQ--------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
P+ + P ++ N P L F M A C DP +RPS
Sbjct: 218 TPYVEIDPFEMAAYLKDGYRLAQPINCPDEL-----------FAVM-ACCWALDPEERPS 265
Query: 265 AKKLL 269
+L+
Sbjct: 266 FSQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 3e-10
Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 64 ILVDHPNVLKSHCSFVS-DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
++ D+PN +K + S + ++ + M ++ G +LK E + I+R++++
Sbjct: 64 LMKDNPNFIKLYYSVTTLKGHVLI-MDYIKDGDLFDLLK--KEGKLSEAEVKKIIRQLVE 120
Query: 123 GLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSACLFDSGDRQRMRNT---FVGTP 178
L+ LH H IH D+K N+L D + I L D+G+ ++ T + GT
Sbjct: 121 ALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC----------KIIGTPSCYDGTL 170
Query: 179 CWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP----PMKVLLMTLQNAPPG 234
+ +PE ++ H YD D W+ G+ EL G PF + ++ LL Q P
Sbjct: 171 DYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF 229
Query: 235 LDYERDRKFSKSFKQMIASCLVK-DPSKR-PSAKKLLKHSFFK 275
+ + K + F Q ++K + + R + +++KH F K
Sbjct: 230 I--KNVSKNANDFVQ----SMLKYNINYRLTNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 71/305 (23%), Positives = 129/305 (42%), Gaps = 31/305 (10%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIP--FNEIVAVKILDFERDNSDLSNISREAQTMI-LVD 67
E + +G+G V RA+ A+K+L +D + + E + + L
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAY-----PDGFEEVVIATIL--REV 120
HPN++ + + L++ + + G+ L L+ + P +E A+ L +++
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 121 LK-------GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173
L+ G+ YL IHRD+ + N+L+ A K+ DFG+S G+ ++ T
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS-----RGEEVYVKKT 176
Query: 174 FVGTPC-WMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 231
P WMA E + Y K+D+WSFG+ E+ G P+ ++ +
Sbjct: 177 MGRLPVRWMAIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL----YEKL 231
Query: 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL-LKHSFFKQARSNEYIARTLLEG 290
P G E+ R +++ C P +RP ++ ++ S +AR Y+ L E
Sbjct: 232 PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR-KAYVNMALFEN 290
Query: 291 LPALG 295
G
Sbjct: 291 FTYAG 295
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 32/172 (18%)
Query: 58 REAQTMILVDHPNVLKSHCSFVSDHNL------WVVMPFMSGGSCLHILKAAYPDGFEEV 111
RE M LV+H N++ F +L ++VM M C +V
Sbjct: 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLC-------------QV 110
Query: 112 V--------IATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163
+ ++ +L ++L G+ +LH G IHRD+K NI++ +K+ DFG++
Sbjct: 111 IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170
Query: 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF 215
S M +V T + APEV+ + GY DIWS G E+ G F
Sbjct: 171 S----FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 29/189 (15%)
Query: 113 IATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS-ACLFDSGDRQRMR 171
+ + ++L GL Y+H +HRD+K GN+L++ +K+ DFG++ + G+
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSK---YPPMKVLLMTL 228
+V T + APE+M Y D+WS G EL G P K Y ++ +
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPVFKGKDYVDQLNQILQV 225
Query: 229 QNAPP-----------GLDYERD------RKFSKSFK-------QMIASCLVKDPSKRPS 264
P +Y R + F F ++ L DP+KR S
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285
Query: 265 AKKLLKHSF 273
++ L+H +
Sbjct: 286 VEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 29/184 (15%)
Query: 117 LREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176
L ++L+GL Y+H +HRD+K N+L++ +K+ DFG++ S M +V
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFM-TEYVV 170
Query: 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPPG 234
T + APE++ Y D+WS G EL F Y L+ L +P
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230
Query: 235 -----LDYERDRKFSKS--------FKQM-----------IASCLVKDPSKRPSAKKLLK 270
+ E+ R++ +S F ++ + LV DPSKR + ++ L
Sbjct: 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290
Query: 271 HSFF 274
H +
Sbjct: 291 HPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 11/168 (6%)
Query: 106 DGFEEVVIATILR---EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162
DG E + +L +V +G+++L +HRD+ + N+L+ +K+ DFG++ +
Sbjct: 229 DGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM 288
Query: 163 DSGDRQRMRNTFVGTPCWMAPE-VMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPP 220
+ +TF+ WMAPE + + L Y +D+WS+GI E+ + G P YP
Sbjct: 289 HDSNYVSKGSTFLPVK-WMAPESIFDNL--YTTLSDVWSYGILLWEIFSLGGTP---YPG 342
Query: 221 MKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
M V G + ++ ++ C +P KRPS L
Sbjct: 343 MIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 38/169 (22%)
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+V KG+ +L IHRD+ + NIL+ K+ DFG++ + + + N +
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 179 CWMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237
WMAPE + Y F++D+WS+GI E+ + G +P YP M V
Sbjct: 282 -WMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSP---YPGMPV-------------- 322
Query: 238 ERDRKFSKSFK----------------QMIASCLVKDPSKRPSAKKLLK 270
D KF K K ++ SC DP KRP+ K++++
Sbjct: 323 --DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 75/307 (24%), Positives = 122/307 (39%), Gaps = 54/307 (17%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHP 69
+ Y + +G G V A + VA+K L N + RE M V+H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 70 NVLKSHCSFVSDHNL------WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
N++ F +L ++VM M C I + ++ +L ++L G
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQMLCG 131
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
+ +LH G IHRD+K NI++ +K+ DFG++ + M +V T + AP
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRYYRAP 187
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPF-----------------SKYPP-MKVLL 225
EV+ + GY DIWS G E+ F + P MK L
Sbjct: 188 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 226 MTLQNA----------------PPGL---DYERDRKFSKSFKQMIASCLVKDPSKRPSAK 266
T++N P L D E ++ + + +++ LV DP+KR S
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 267 KLLKHSF 273
+ L+H +
Sbjct: 307 EALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 40/154 (25%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+V +G+++L IHRD+ + NIL+ +K+ DFG++ ++ D R + +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 179 CWMAPE-VMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLD 236
WMAPE + +++ Y ++D+WSFG+ E+ + G +P YP +++ Q G
Sbjct: 242 -WMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASP---YPGVQINEEFCQRLKDGTR 295
Query: 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
+ +++ +C DP +RP+ L++
Sbjct: 296 MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 39/156 (25%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+V +G+++L IHRD+ + NIL+ +K+ DFG++ ++ D +R P
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDARLP 238
Query: 179 C-WMAPE-VMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGL 235
WMAPE + +++ Y ++D+WSFG+ E+ + G +P YP +++ + G
Sbjct: 239 LKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASP---YPGVQIDEEFCRRLKEGT 293
Query: 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ ++ C +P RP+ +L++
Sbjct: 294 RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 28/174 (16%)
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR 118
EA+ + DHPN++K +++VM + GG L L+ +E+ +++
Sbjct: 42 EARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK----DELKTKQLVK 97
Query: 119 ---EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS-----ACLFDSGDRQRM 170
+ G+ YL IHRD+ + N L+ +K+ DFG+S SG +Q
Sbjct: 98 FALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-- 155
Query: 171 RNTFVGTPC-WMAPEVMEQLHG-YDFKADIWSFGITALE-LAHGHAPFSKYPPM 221
P W APE + +G Y ++D+WS+GI E + G P YP M
Sbjct: 156 ------IPIKWTAPEALN--YGRYSSESDVWSYGILLWETFSLGVCP---YPGM 198
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 48/198 (24%), Positives = 93/198 (46%), Gaps = 6/198 (3%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNIS-REAQTMILVDHPNVLKSHCS 77
VG+G V + EIVA+K +N ++ + RE + + + N+++ +
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDV 137
F L++V ++ + L +L+ P+G + + + +++K + + H + +HRD+
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDI 126
Query: 138 KSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKAD 197
K N+LI +KL DFG + L + + +V T + +PE++ Y D
Sbjct: 127 KPENLLISHNDVLKLCDFGFARNLSEGSNANYTE--YVATRWYRSPELLLGA-PYGKAVD 183
Query: 198 IWSFGITALELAHGHAPF 215
+WS G EL+ G F
Sbjct: 184 MWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 47/169 (27%), Positives = 71/169 (42%), Gaps = 31/169 (18%)
Query: 115 TILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA-------IKLGDFGVSACLFDSGDR 167
T+ +++ L YL +H +V + NIL+ G IKL D GVS +R
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER 180
Query: 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPF-SKYPPMKVLL 225
V W+APE + + AD WSFG T LE+ G P + P K
Sbjct: 181 -------VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233
Query: 226 MTLQNAPPGLDYERDRKFS----KSFKQMIASCLVKDPSKRPSAKKLLK 270
YE+ + K +I+ CL +P++RPS + +L+
Sbjct: 234 -----------YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 45/173 (26%), Positives = 73/173 (42%), Gaps = 12/173 (6%)
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+V +G+DYL IHRD+ + NIL+ K+ DFG+S G ++ T P
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMGRLP 186
Query: 179 C-WMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLD 236
WMA E + Y +D+WS+G+ E+ G P+ ++ + P G
Sbjct: 187 VRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----YEKLPQGYR 241
Query: 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLE 289
E+ ++ C + P +RPS ++L Y+ TL E
Sbjct: 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 294
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 30/273 (10%)
Query: 19 VGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLS---NISREAQTMILVDHPNV 71
+G G +V++ + IP E VA+K+L R+N+ I EA M V P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVL---RENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 72 --LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
L C + + +MP+ CL D + ++ KG+ YL
Sbjct: 72 CRLLGICLTSTVQLVTQLMPY----GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
+HRD+ + N+L+ +K+ DFG+ A L D + + + WMA E + L
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGL-ARLLDIDETEYHADGGKVPIKWMALESI--L 184
Query: 190 H-GYDFKADIWSFGITALEL-AHGHAPFSKYPPMKV--LLMTLQNAPPGLDYERDRKFSK 245
H + ++D+WS+G+T EL G P+ P ++ LL + P + +
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP------QPPICTI 238
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278
++ C + D RP ++L+ F + AR
Sbjct: 239 DVYMIMVKCWMIDSECRPRFRELV-DEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 17/212 (8%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHP 69
+ Y + +G G V A VA+K L N + RE M V+H
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 70 N------VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
N V S ++++VM M C I + ++ +L ++L G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----LDHERMSYLLYQMLCG 138
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
+ +LH G IHRD+K NI++ +K+ DFG++ + M +V T + AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRYYRAP 194
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPF 215
EV+ + GY DIWS G E+ G F
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMIKGGVLF 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 16/165 (9%)
Query: 58 REAQTMILVDHPNVLKSHCSFVS--DHNLWVVMPFMSGGSCLHILK-------AAYPDGF 108
RE + + HPNV+ F+S D +W++ + + HI+K P
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQL 105
Query: 109 EEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI----DVRGAIKLGDFGVSACLFDS 164
++ ++L ++L G+ YLH + +HRD+K NIL+ RG +K+ D G A LF+S
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNS 164
Query: 165 GDRQRMR-NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALEL 208
+ + V T + APE++ Y DIW+ G EL
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 16/165 (9%)
Query: 58 REAQTMILVDHPNVLKSHCSFVS--DHNLWVVMPFMSGGSCLHILK-------AAYPDGF 108
RE + + HPNV+ F+S D +W++ + + HI+K P
Sbjct: 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQL 105
Query: 109 EEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI----DVRGAIKLGDFGVSACLFDS 164
++ ++L ++L G+ YLH + +HRD+K NIL+ RG +K+ D G A LF+S
Sbjct: 106 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNS 164
Query: 165 GDRQRMR-NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALEL 208
+ + V T + APE++ Y DIW+ G EL
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 23/229 (10%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
Y L +G G V+ A+CI +E VA+K + D +RE M ++H N++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIK-----KVLQDPQYKNRELLIMKNLNHINII 122
Query: 73 ------KSHCSFVSDHNLW--VVMPFMSGGSCLHILKAAYPDGFEEV---VIATILREVL 121
+ C ++ N++ VVM F+ +H Y + ++ ++
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRG-AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
+ L Y+H HRD+K N+LID +KL DFG + L +G R +++ + +
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL-AGQRSV---SYICSRFY 236
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ 229
APE+M Y D+WS G E+ G+ FS + L+ +Q
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
|
Length = 440 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 44/207 (21%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 37 EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96
+ VA+K L + + EA + HPN++ + L ++ + S
Sbjct: 36 QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD- 94
Query: 97 LH---ILKAAYPD------------GFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGN 141
LH ++++ + D E I+ ++ G+++L H +H+D+ + N
Sbjct: 95 LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154
Query: 142 ILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG-YDFKADIWS 200
+L+ + +K+ D G+ ++ + + M N+ + WM+PE + ++G + +DIWS
Sbjct: 155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR-WMSPEAI--MYGKFSIDSDIWS 211
Query: 201 FGITALEL-AHGHAPFSKYPPMKVLLM 226
+G+ E+ ++G P+ Y V+ M
Sbjct: 212 YGVVLWEVFSYGLQPYCGYSNQDVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 59/273 (21%), Positives = 117/273 (42%), Gaps = 20/273 (7%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALC--IPFNEI---VAVKILDFERDNSDLSNISREA 60
+ + E T+ E+GQG V+ + + +E VA+K ++ + EA
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIA------ 114
M + +V++ V+M M+ G L++ P+ V A
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 115 --TILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172
+ E+ G+ YL+ + +HRD+ + N ++ +K+GDFG++ ++++ D R
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-DYYRKGG 179
Query: 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 231
+ WM+PE ++ + +D+WSFG+ E+A P+ +VL ++
Sbjct: 180 KGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG- 237
Query: 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
GL ++ +++ C +P RPS
Sbjct: 238 --GL-LDKPDNCPDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 3/93 (3%)
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175
I++++L ++Y+H IHRD+K NI ++ G I LGDFG +A F+ +R+ +V
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEK-EREAFDYGWV 329
Query: 176 GTPCWMAPEVMEQLHGYDFKADIWSFGITALEL 208
GT +PE++ GY DIWS G+ L++
Sbjct: 330 GTVATNSPEILAG-DGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 40/168 (23%)
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+V +G+D+L IHRDV + N+L+ K+ DFG++ + + + N +
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 179 CWMAPE-VMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLD 236
WMAPE + + + Y ++D+WS+GI E+ + G +P YP + V
Sbjct: 280 -WMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGKSP---YPGILV------------- 320
Query: 237 YERDRKFSKSFK---QM-------------IASCLVKDPSKRPSAKKL 268
+ KF K K QM + C +P++RP+ ++
Sbjct: 321 ---NSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 9e-07
Identities = 42/190 (22%), Positives = 84/190 (44%), Gaps = 19/190 (10%)
Query: 86 VVMPFMSGGSCLHILKAAYPDG----------FEEVVIATILREVLKGLDYLHHHGHIHR 135
VVM M+ G L++ P+ +E++ + E+ G+ YL+ +HR
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADGMAYLNAKKFVHR 143
Query: 136 DVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFK 195
D+ + N ++ +K+GDFG++ ++++ D R + WMAPE ++ +
Sbjct: 144 DLAARNCMVAHDFTVKIGDFGMTRDIYET-DYYRKGGKGLLPVRWMAPESLKD-GVFTTS 201
Query: 196 ADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASC 254
+D+WSFG+ E+ P+ +VL + G ++ + ++ C
Sbjct: 202 SDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----GGYLDQPDNCPERVTDLMRMC 257
Query: 255 LVKDPSKRPS 264
+P RP+
Sbjct: 258 WQFNPKMRPT 267
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 54/271 (19%), Positives = 112/271 (41%), Gaps = 33/271 (12%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+ +G+ + L +G G + V A+ ++ VAVK + D + + RE + +
Sbjct: 1 FDLGSRYMDLRP-LGCGSNGLVFSAVDSDCDKRVAVKKI-VLTDPQSVKHALREIKIIRR 58
Query: 66 VDHPNVLK--------------SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEV 111
+DH N++K S +++++V +M + + + +
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL 118
Query: 112 VIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-AIKLGDFGVSACLFDSGDRQRM 170
+ +LR GL Y+H +HRD+K N+ I+ +K+GDFG++ + +
Sbjct: 119 FMYQLLR----GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN 230
+ + T + +P ++ + Y D+W+ G E+ G F+ ++ + + L++
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234
Query: 231 APPGLDYERDRKFSKSFKQMIASCLVKDPSK 261
P + E DR L PS
Sbjct: 235 VP--VVREEDRN----------ELLNVIPSF 253
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 22/47 (46%), Positives = 32/47 (68%)
Query: 112 VIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158
VI ++R+VL GL LH G +HRD+K N+L+ V G +K+ DFG +
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 44/171 (25%), Positives = 67/171 (39%), Gaps = 38/171 (22%)
Query: 119 EVLKGLDYLHHH----GHIHRDVKSGNILIDVRGA--------IKLGDFGVSACLFDSGD 166
EV K L + H G H +V + N+L+ IKL D G+S +
Sbjct: 104 EVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP--- 160
Query: 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLL 225
+ + W+ PE +E AD WSFG T E+ + G P S K L
Sbjct: 161 ----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216
Query: 226 MTLQNAPPGLDYERDR------KFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
YE DR K+++ +I C+ +P RPS + +++
Sbjct: 217 F----------YE-DRHQLPAPKWTE-LANLINQCMDYEPDFRPSFRAIIR 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 5/103 (4%)
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+V G+++L +HRD+ + N+LI +K+ DFG++ + + +TF+
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 179 CWMAPE-VMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYP 219
WMAPE + L Y +D+WSFGI E+ G P+ + P
Sbjct: 307 -WMAPESIFNNL--YTTLSDVWSFGILLWEIFTLGGTPYPELP 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 67/291 (23%), Positives = 125/291 (42%), Gaps = 39/291 (13%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSN-ISREAQTMILVDH 68
+ Y + +G+G V+ A + VA+K I + +N L REA+ + H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 69 PNVLKSHCSFVSDHNL-WVVMPFMSGGSCLHILKAAY------PDGFEEVVIATILR--- 118
P ++ + S SD + + MP++ G + +LK+ + + E+ + L
Sbjct: 62 PGIVPVY-SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ-------RMR 171
++ ++Y+H G +HRD+K NIL+ + G + + D+G A +F + + R
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG--AAIFKKLEEEDLLDIDVDER 178
Query: 172 NTF----------VGTPCWMAPEVMEQLHGYD--FKADIWSFGITALELAHGHAPFSKYP 219
N VGTP +MAP E+L G DI++ G+ ++ P+ +
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAP---ERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
Query: 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
K + ++ R+ Q+ L DP++R S+ + LK
Sbjct: 236 GRK--ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284
|
Length = 932 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 36/158 (22%), Positives = 75/158 (47%), Gaps = 10/158 (6%)
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
E+ G+ ++H H +H D+ N + +K+GD+G+ + D +
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPL 165
Query: 179 CWMAPEVMEQLHGYDFKAD------IWSFGITALELAHGHA-PFSKYPPMKVLLMTLQNA 231
W+APE++ + HG A+ +W+ G+T EL A P+S +VL +++
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ 225
Query: 232 PPGL-DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
L + + +S+ + +++ C + P KR +A+++
Sbjct: 226 QVKLFKPQLELPYSERWYEVLQFCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 24/54 (44%), Positives = 33/54 (61%), Gaps = 1/54 (1%)
Query: 109 EEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID-VRGAIKLGDFGVSACL 161
E +I TI+R++L LD LH G +HRDVK NI+ G+ K+ D G +A L
Sbjct: 253 ENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADL 306
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 175 VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 234
+GTP ++APE++ + D W+ G+ E G PF+ P +V L P
Sbjct: 541 LGTPDYLAPELLLG-KPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPW 599
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274
E + K S + + I L DP+KR K+L +H F
Sbjct: 600 P--EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 16/48 (33%), Positives = 31/48 (64%)
Query: 112 VIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159
+I I++++L L+Y+H HG H D+K NI++D + D+G+++
Sbjct: 127 LIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 51/204 (25%), Positives = 71/204 (34%), Gaps = 60/204 (29%)
Query: 24 SAS---VHRALCIPFNEIVAVKILDF---ERDNSDLSNI--------------------- 56
SAS VHRA+ + E VAVK+ ER +DL +
Sbjct: 135 SASIAQVHRAV-LKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVE 193
Query: 57 ---------------SREAQTMI-----LVDHPNVL--KSHCSFVSDHNLWVVMPFMSGG 94
REA D P+V K + + + L M ++ G
Sbjct: 194 VVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVL--TMEWIDGI 251
Query: 95 SCLHI--LKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152
I LK+A G + +A +L L L G H D GNIL+ G I L
Sbjct: 252 KISDIAALKSA---GIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVL 306
Query: 153 GDFGVSACLFDSGDRQRMRNTFVG 176
DFG+ L D R+ + +
Sbjct: 307 LDFGIVGRL-DPKFRRYLAELLLA 329
|
Length = 517 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 45/251 (17%)
Query: 39 VAVKILDFERDNSDLSNISREAQTMI-LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL 97
V +K+LD + D+S E +M+ V H +++ + V D +V F+ G L
Sbjct: 35 VILKVLD--PSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP-L 91
Query: 98 HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA-------I 150
+ D + +++ L YL +H +V + NIL+ G I
Sbjct: 92 DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151
Query: 151 KLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH 210
KL D G+ + R V W+APE +E AD WSFG T E+ +
Sbjct: 152 KLSDPGIPITVLS-------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY 204
Query: 211 -GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS----------KSFKQMIASCLVKDP 259
G P K L E++R + K ++ C+ DP
Sbjct: 205 NGEIPLKD----KTLA------------EKERFYEGQCMLVTPSCKELADLMTHCMNYDP 248
Query: 260 SKRPSAKKLLK 270
++RP + +++
Sbjct: 249 NQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 636 | |||
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.01 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.69 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.66 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.23 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.22 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.13 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.08 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.0 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.88 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.83 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.8 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.64 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.64 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.48 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.43 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.39 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.3 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.28 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.27 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.22 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.07 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.01 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.65 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.44 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.33 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.3 | |
| PLN02236 | 344 | choline kinase | 96.17 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.17 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.09 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.89 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.83 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.72 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.47 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.2 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.94 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 94.9 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.38 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.11 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.02 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.79 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.41 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.76 |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-69 Score=567.73 Aligned_cols=337 Identities=66% Similarity=1.125 Sum_probs=312.2
Q ss_pred CCcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 2 ~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
.+..|+++.++|++.++||.|..++||+|++++++++||||++++++++.+++.+++|+..|+.++||||+++|++|..+
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
+.+|+||.||.+|+++++++..++.+|+|..|+.|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||++.++
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCccccc-ccccCCCCCCChhh-hhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC-----C
Q 006664 162 FDSGDRQRMR-NTFVGTPCWMAPEV-MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP-----G 234 (636)
Q Consensus 162 ~~~~~~~~~~-~~~~GT~~YmAPEv-l~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~-----~ 234 (636)
++.+.+.+.+ ++++|||+|||||+ ++...+|+.|+|||||||++.||++|+.||..+++++++.+.+++.++ .
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 9999888777 99999999999999 667789999999999999999999999999999999999999999998 6
Q ss_pred CCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccChHHHHHHHhccCcchHHHHHHHHHHHHHHHHhcCC
Q 006664 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKEEDMLAQKKM 314 (636)
Q Consensus 235 ~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~~i~~~ll~~l~~l~~~i~~l~~~~~~~~~~~~~ 314 (636)
+++...+.+++.|+++|..||++||.+|||+.++|+|+||++++..++..+.++..++.+..++...+.+++.......
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~~l~~l~~l~~r~~~~q~~~~~~~~~~~- 335 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKKLLQSLPPLGTRFKKSQSKEESQISGLS- 335 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchhhhccCCcHHHHHHHHHhhhcccccccc-
Confidence 7778888999999999999999999999999999999999999999999999999999999998877655433211110
Q ss_pred CCcccchhhhhhhhcCccCCCCChhhHHhhhhc
Q 006664 315 PDGQKEEISQNEYKRGISGWNFNLEDVKAQASL 347 (636)
Q Consensus 315 ~~~~~~~~s~~e~~~~~~~~~f~~~~~~~~~~l 347 (636)
.. .+.++.++ +|+|+.+++..++++
T Consensus 336 -----~~-~~~e~~~~--~W~f~~~~~~~~~~~ 360 (516)
T KOG0582|consen 336 -----GN-PLSEYQKG--EWNFDYEDLDEEASL 360 (516)
T ss_pred -----CC-chhhhcCC--Cccccccchhccccc
Confidence 01 15566666 899999998888776
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-58 Score=477.89 Aligned_cols=264 Identities=27% Similarity=0.430 Sum_probs=229.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc------hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN------SDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~------~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
..+.|.+.+.||.|+||.|.+|..+.||+.||||++++.... .....+.+|++||++|+|||||+++++|....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 357899999999999999999999999999999999765422 23456889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC---CcEEEeccCccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR---GAIKLGDFGVSA 159 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~---g~vKL~DFGla~ 159 (636)
..|+||||++||+|++.+..+ +.+.|...+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|||+|+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999999886 678899999999999999999999999999999999999765 689999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhc--cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQL--HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~--~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
... ......|+||||.|.|||++.+. ..|..++||||+||+||.+++|.+||++......+.+.+..+.-.+..
T Consensus 328 ~~g----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 328 VSG----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred ccc----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 653 23456799999999999999752 224558999999999999999999998766555344444444444455
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
..|..+|.++.+||.+||..||++|||++|+|+||||+.+.
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 67889999999999999999999999999999999999764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-56 Score=464.82 Aligned_cols=262 Identities=36% Similarity=0.616 Sum_probs=238.9
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe-E
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN-L 84 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~-l 84 (636)
..+...+.+.+..||+|+.|+||+++++.|++.+|+|+|.....+....++.+|+++++.++|||||.+|++|..++. +
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 445567899999999999999999999999999999999877788888999999999999999999999999999995 9
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+||||+||+|.++++.. +.++|.....++.++++||.|||. ++||||||||+|||++..|.|||||||+++.+.+
T Consensus 154 sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999999987 789999999999999999999996 8999999999999999999999999999998754
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCC-----ChHHHHHHHHhcCCCCCCcc
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKY-----PPMKVLLMTLQNAPPGLDYE 238 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~-----~~~~~l~~~~~~~~~~~~~~ 238 (636)
. ..++++||..|||||.+.+ ..|+.++||||||++++||+.|+.||... ...+.+..++.+.++.+.-
T Consensus 232 S-----~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~- 304 (364)
T KOG0581|consen 232 S-----IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE- 304 (364)
T ss_pred h-----hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc-
Confidence 4 5689999999999999987 68999999999999999999999999764 5566666777666665542
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
..+|++|++||..||.+||.+||++.|+++|||+++..
T Consensus 305 --~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 305 --GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred --ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 25999999999999999999999999999999998654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-56 Score=462.11 Aligned_cols=269 Identities=30% Similarity=0.517 Sum_probs=241.7
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
.+..++|++++.||+|+||+||+++.+.|++.||+|++++... ..+...+..|..||..++||+||+++..|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 4668999999999999999999999999999999999987653 34688899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+|+||+.||+|+.+|++. +.|+|..++.|+.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+|+.....
T Consensus 101 ylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999999987 78999999999999999999999999999999999999999999999999999865444
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
+. ...++|||+.|||||++.+ .+|+.++|+|||||++|||++|.+||.+.+.......+.+...+ ..+..++
T Consensus 179 ~~---~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~----~~p~~ls 250 (357)
T KOG0598|consen 179 GD---ATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP----LPPGYLS 250 (357)
T ss_pred CC---ccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC----CCCccCC
Confidence 33 3457999999999999987 69999999999999999999999999998887777777665422 2235589
Q ss_pred HHHHHHHHhhcccCCCCCC----CHHHHHhCcccccccChHHHHH
Q 006664 245 KSFKQMIASCLVKDPSKRP----SAKKLLKHSFFKQARSNEYIAR 285 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRp----sa~elL~Hpffk~~~~~~~i~~ 285 (636)
.++++||+++|.+||++|. ++.+|..||||+.+.|.....+
T Consensus 251 ~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k 295 (357)
T KOG0598|consen 251 EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAK 295 (357)
T ss_pred HHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhc
Confidence 9999999999999999995 6899999999999887655443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-56 Score=480.39 Aligned_cols=273 Identities=30% Similarity=0.511 Sum_probs=241.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
.+|...+.||+|+|++||++.+..+|+.||+|++++.. .....+.+.+||+|.+.|+|||||++|++|++..++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999998654 3446778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
|+|..|+|..++++. +.++|.++++|++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|+.+...+++
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er- 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER- 174 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc-
Confidence 999999999999976 78999999999999999999999999999999999999999999999999999988655544
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
..|.||||.|.|||++.. .++++.+||||+|||||.||.|++||....-.+.+..+..+ +|..+..+|.+++
T Consensus 175 --k~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-----~Y~~P~~ls~~A~ 246 (592)
T KOG0575|consen 175 --KKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-----EYSMPSHLSAEAK 246 (592)
T ss_pred --cceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-----CcccccccCHHHH
Confidence 358999999999999985 88999999999999999999999999987666666555543 5666779999999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCcccccccChHHHHHHHhccCcch
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPAL 294 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~~i~~~ll~~l~~l 294 (636)
+||.++|..||.+|||++++|.|+||+.......+....+...|..
T Consensus 247 dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~~l~~~p~~ 292 (592)
T KOG0575|consen 247 DLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSSCLTMVPRF 292 (592)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCccccccCCcC
Confidence 9999999999999999999999999965444433333444444444
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-54 Score=462.40 Aligned_cols=275 Identities=29% Similarity=0.489 Sum_probs=243.7
Q ss_pred CCcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 2 ~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
++++--+..++|+++..||+|+||.||+|+.+.||++||+|++++... ...+..++.|-.||...++|+||++|++|.
T Consensus 132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred HhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 455667889999999999999999999999999999999999987653 346788999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
+..++|+||||++|||+..+|.+. +.|+|..++.|+.+++.|++.||+.|+|||||||+|+|||..|++||+|||+|+
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999999999987 789999999999999999999999999999999999999999999999999985
Q ss_pred ccccC---------------------CCcc-----------------------cccccccCCCCCCChhhhhhccCCCcc
Q 006664 160 CLFDS---------------------GDRQ-----------------------RMRNTFVGTPCWMAPEVMEQLHGYDFK 195 (636)
Q Consensus 160 ~~~~~---------------------~~~~-----------------------~~~~~~~GT~~YmAPEvl~~~~~ys~k 195 (636)
-+... .+.. ......+|||.|||||++.+ ++|+..
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~ 368 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKE 368 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCcc
Confidence 43210 0000 01235699999999999998 789999
Q ss_pred cchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCC---HHHHHhCc
Q 006664 196 ADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS---AKKLLKHS 272 (636)
Q Consensus 196 sDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRps---a~elL~Hp 272 (636)
+|+||||||+||||.|.+||.+..+.+....++.. ...+.++....++++++|||.+||. ||++|.. ++||.+||
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw-r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP 446 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNW-RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHP 446 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence 99999999999999999999999999888777654 3345667777889999999999999 9999975 99999999
Q ss_pred ccccccChH
Q 006664 273 FFKQARSNE 281 (636)
Q Consensus 273 ffk~~~~~~ 281 (636)
||+.+.|..
T Consensus 447 fF~~v~W~~ 455 (550)
T KOG0605|consen 447 FFKGVDWDH 455 (550)
T ss_pred ccccCCcch
Confidence 999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=428.29 Aligned_cols=266 Identities=26% Similarity=0.460 Sum_probs=241.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
...++|++++.||.|+||.|.+++.+.+|..||+|++++... -...+.+.+|..+|+.+.||+++++++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 455889999999999999999999999999999999986652 235678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.||.|+.++++. ++|+|..++.|+.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+...+.
T Consensus 121 mvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999999999987 78999999999999999999999999999999999999999999999999999876221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
..+.||||.|+|||+++. ++|+.++|+|||||++|||+.|.+||.+..++.....++.. .+..+..++.
T Consensus 198 -----T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-----~v~fP~~fs~ 266 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-----KVKFPSYFSS 266 (355)
T ss_pred -----EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-----cccCCcccCH
Confidence 468899999999999987 89999999999999999999999999999998888888765 3345688999
Q ss_pred HHHHHHHhhcccCCCCC-----CCHHHHHhCcccccccChHHHHHHH
Q 006664 246 SFKQMIASCLVKDPSKR-----PSAKKLLKHSFFKQARSNEYIARTL 287 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kR-----psa~elL~Hpffk~~~~~~~i~~~l 287 (636)
++++||.++|+.|-++| ....+|..||||+.+.|.....+.+
T Consensus 267 ~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~i 313 (355)
T KOG0616|consen 267 DAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKI 313 (355)
T ss_pred HHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccc
Confidence 99999999999999999 3678999999999988776655443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=454.94 Aligned_cols=265 Identities=28% Similarity=0.507 Sum_probs=239.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~ 85 (636)
...||.+++.||.|+|++|++|.++.+++.||||++++.- .....+.+.+|-.+|..| +||.|+++|..|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4689999999999999999999999999999999997653 223456788999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+|+||+.+|+|.++|++. +.|+|.-++.|+.||+.||+|||++|||||||||+|||||.+|++||+|||.|+.+....
T Consensus 151 FvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 999999999999999997 889999999999999999999999999999999999999999999999999998774322
Q ss_pred Cc----------ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 006664 166 DR----------QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 235 (636)
Q Consensus 166 ~~----------~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~ 235 (636)
.. ...+.+|+||-.|++||+|.. ...++.+|||+||||+|.|+.|.+||.+.++...+..++. +
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~-----l 302 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA-----L 302 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH-----h
Confidence 11 111357999999999999986 6788999999999999999999999999999988888875 3
Q ss_pred CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccChH
Q 006664 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 236 ~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~ 281 (636)
+|..+..+++.+++||+++|+.||.+|+|+.+|..||||..+.|..
T Consensus 303 ~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 303 DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 6677788999999999999999999999999999999999988764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=456.23 Aligned_cols=266 Identities=46% Similarity=0.789 Sum_probs=245.7
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
......|..++.||+|+||.||+|.+..+++.||||+++++....+++.++.|+.++..+++|||.++|+.|..+..+|+
T Consensus 9 ~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 9 IDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred CCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 34557799999999999999999999999999999999999988899999999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
+||||.||++.++|+.. ..+.|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++..+....
T Consensus 89 iMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred HHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 99999999999999875 445899999999999999999999999999999999999999999999999998764332
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
..+.+|+|||+|||||++.+ .+|+.++|||||||++|||++|.+||.+..++.++..+.++.+|.++ ..+|+.
T Consensus 166 --~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~----~~~S~~ 238 (467)
T KOG0201|consen 166 --KRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD----GDFSPP 238 (467)
T ss_pred --hccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc----cccCHH
Confidence 23489999999999999985 78999999999999999999999999999999999888888888765 489999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCcccccccChHH
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEY 282 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~~ 282 (636)
+++||..||++||+.||+|.+||+|+|++.+.+...
T Consensus 239 ~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~ 274 (467)
T KOG0201|consen 239 FKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSE 274 (467)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchH
Confidence 999999999999999999999999999998665544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-52 Score=432.04 Aligned_cols=259 Identities=26% Similarity=0.457 Sum_probs=229.4
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
...+|.+.+.||+|+||+||+|.++.++..||||.+.+.+ .....+.+..|+.||+.++|||||.+++++.+++.+|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3578999999999999999999999999999999998776 556678889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC------CcEEEeccCccccc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR------GAIKLGDFGVSACL 161 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~------g~vKL~DFGla~~~ 161 (636)
||||+||||.++|.++ +.++|.+++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999987 689999999999999999999999999999999999999764 46899999999977
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
.. ..+..+.||+|.|||||++.. ..|+.|+|+||+|+|+|+|++|++||......+.+..+-+.... -...+.
T Consensus 166 ~~----~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~--~~~~~~ 238 (429)
T KOG0595|consen 166 QP----GSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI--VPVLPA 238 (429)
T ss_pred Cc----hhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc--cCchhh
Confidence 43 234568999999999999975 67999999999999999999999999988888777644433221 112335
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
.++....+|+...|..+|..|.+..+-+.|++...
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 56777889999999999999999999999999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=442.87 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=228.1
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc----hhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN----SDLSNISREAQTMILVD-HPNVLKSHCSFVSDH 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~----~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~ 82 (636)
.....|.+++.||+|+||+|++|.+..+|+.||||+++..... .....+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567999999999999999999999999999999988765221 34567889999999999 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC-CcEEEeccCccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR-GAIKLGDFGVSACL 161 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~-g~vKL~DFGla~~~ 161 (636)
.+|+|||||.||+|++++... +.+.|..++.+|+||+.|++|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999984 789999999999999999999999999999999999999999 99999999999865
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCC-CcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGY-DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~y-s~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
. .......++||||.|+|||++.+...| +.++|||||||+||.|++|+.||.+.........+... .+..+
T Consensus 172 ~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-----~~~~p 243 (370)
T KOG0583|consen 172 P---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-----EFKIP 243 (370)
T ss_pred C---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-----CccCC
Confidence 3 122345789999999999999985426 58899999999999999999999997766665554332 23334
Q ss_pred hhh-hHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 241 RKF-SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 241 ~~~-S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
..+ |.++++||.+||..||.+|+++.+|+.||||+.
T Consensus 244 ~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 555 999999999999999999999999999999985
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-52 Score=448.15 Aligned_cols=265 Identities=38% Similarity=0.672 Sum_probs=241.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
...|...++||+|+.|.||.|....+++.||||.+++.... ..+-+.+|+.+|+..+|||||++++.|..+..+|+|||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 46799999999999999999999999999999999877654 34668999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|++||+|.+++... .++|.+++.|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|+.+... ..
T Consensus 351 ym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~---~~ 424 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE---QS 424 (550)
T ss_pred ecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc---cC
Confidence 99999999999874 5999999999999999999999999999999999999999999999999999877443 33
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
.+.+.+|||+|||||++.. ..|++++|||||||+++||+-|++||-..++...+..+-.+..+.+. .+..+|+.|++
T Consensus 425 KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk--~~~klS~~~kd 501 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLK--NPEKLSPELKD 501 (550)
T ss_pred ccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcC--CccccCHHHHH
Confidence 5779999999999999987 78999999999999999999999999988888888888877776654 56789999999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCcccccccChHHHH
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIA 284 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~~i~ 284 (636)
|+.+||+.|+.+|+++.+||+||||+.+.....+.
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~ 536 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLKMAKPESSLN 536 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHhH
Confidence 99999999999999999999999998776655543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-52 Score=419.28 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=226.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchh-HHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD-LSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~-~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
+.|+.+.++|+|+||+||+++++.||+.||||.+--..++.. .+-..|||++|+.|+|||+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 679999999999999999999999999999999864444333 4456899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||+. ++.+-|... +.+.++..+..|+.|++.|+.|||++++|||||||+||||..+|.+||||||+|+.+...++.
T Consensus 82 ~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~-- 157 (396)
T KOG0593|consen 82 YCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN-- 157 (396)
T ss_pred ecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch--
Confidence 9987 667777664 578999999999999999999999999999999999999999999999999999987654432
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC----------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP---------------- 233 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~---------------- 233 (636)
.+.++-|+||+|||.+.+...|+..+||||+||++.||++|.+.|++..+.+++..+......
T Consensus 158 -YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 158 -YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred -hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 457899999999999999889999999999999999999999999999998888666532111
Q ss_pred CCCcc----------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 234 GLDYE----------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 234 ~~~~~----------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
++..+ ....++.-+.+|+++||..||++|++.+++|.|+||..
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 11111 12356778899999999999999999999999999953
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=450.91 Aligned_cols=270 Identities=29% Similarity=0.509 Sum_probs=240.5
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCC
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDH 82 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~ 82 (636)
..++.++|.++++||+|+||+|+++..+.+++.||||++++.. ...+++..+.|.+|+...+ ||+++.+|++|++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4577899999999999999999999999999999999998765 4567889999999998775 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
++|+||||+.|||+..+... +.|+|..++.|+..|+.||.|||++||||||||.+|||||..|++||+|||+++...
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999995554443 679999999999999999999999999999999999999999999999999998655
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
..+. ...|+||||.|||||++.+ ..|+.++|+|||||+|||||.|..||.+.+..++...++.. +...+..
T Consensus 520 ~~g~---~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-----~~~yP~~ 590 (694)
T KOG0694|consen 520 GQGD---RTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-----EVRYPRF 590 (694)
T ss_pred CCCC---ccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----CCCCCCc
Confidence 4443 4679999999999999987 78999999999999999999999999999988887777654 3345678
Q ss_pred hhHHHHHHHHhhcccCCCCCCC-----HHHHHhCcccccccChHHHHHHH
Q 006664 243 FSKSFKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSNEYIARTL 287 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~~~i~~~l 287 (636)
+|.++.++++++|.++|++|.. +++|..||||+.+.|.....+.+
T Consensus 591 ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i 640 (694)
T KOG0694|consen 591 LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRI 640 (694)
T ss_pred ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccC
Confidence 9999999999999999999985 58999999999988765554443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=445.72 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=230.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
.-|++++.||.|+.|.|.+|++..||+.+|||+|.+.. .......|.+||-||+.|.||||+++|++|++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 56999999999999999999999999999999997663 2334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||++||.|+++|..+ ++++|.+++.+|+||+.|+.|||..+|+||||||+|+|||..++|||+|||+|..-. ..
T Consensus 92 Eyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~----~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV----PG 165 (786)
T ss_pred EecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc----CC
Confidence 999999999999887 889999999999999999999999999999999999999999999999999987432 12
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
....+.||+|.|.|||++.|..+.+.++||||||||||.||+|+.||++.+-...+..+.++ .|..+..+|.++.
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G-----~f~MPs~Is~eaQ 240 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG-----VFEMPSNISSEAQ 240 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-----cccCCCcCCHHHH
Confidence 35668899999999999999777788999999999999999999999977666555554443 3456688999999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+||.+||..||.+|+|.+||++|||+.+..
T Consensus 241 dLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 241 DLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999999999999999999998643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-52 Score=438.51 Aligned_cols=265 Identities=28% Similarity=0.423 Sum_probs=230.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCC-eEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDH-NLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~-~l~ 85 (636)
+..++|.++++||.|+||.||+|+.+.+|+.||||.++......+...=.||++.|++|+ |||||++++++.+.. .+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 456899999999999999999999999999999999875544333333468999999999 999999999999987 999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+|||||+. +|+++|+.+ ...|+|..++.|+.||+.||+|+|.+|++||||||+|||+..+..|||+|||+|+....
T Consensus 87 fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S-- 162 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS-- 162 (538)
T ss_pred eeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc--
Confidence 99999986 899999987 68899999999999999999999999999999999999999899999999999987632
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CC----------
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PP---------- 233 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~--~~---------- 233 (636)
....+.++.|+||+|||+|.....|+.++||||+|||++|+++-++.|+|..+.+++..++.-. +.
T Consensus 163 --kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 --KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred --CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 2335678999999999999988889999999999999999999999999999999988776421 11
Q ss_pred ----CCCccc---------chhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 234 ----GLDYER---------DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 234 ----~~~~~~---------~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++.++. -...+.++.+||.+||.+||.+||||.++|+||||+...
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 111111 124788999999999999999999999999999998643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=437.57 Aligned_cols=256 Identities=30% Similarity=0.550 Sum_probs=231.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
.++|.+.+.||+|+||+||+|+.+.|.+.||||++++.. ...++..+++|++|++.|+|||||.++++|+...++|+|+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 368999999999999999999999999999999998765 4567899999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
|||.| +|+.+|... +.++|+.++.+..+++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+.+.. ..
T Consensus 81 e~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---~t 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---NT 154 (808)
T ss_pred hhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc---Cc
Confidence 99988 999999876 7899999999999999999999999999999999999999999999999999997743 33
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
.+.....|||.|||||++.+ ..|+..+|+||+|||+|||+.|++||....-...+..+..... ..+...|..|+
T Consensus 155 ~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v-----~~p~~~S~~f~ 228 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV-----KPPSTASSSFV 228 (808)
T ss_pred eeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC-----CCcccccHHHH
Confidence 45567789999999999986 7899999999999999999999999987666665555554422 22358899999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+|+..+|.+||.+|.++.+++.|||++..
T Consensus 229 nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 229 NFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 99999999999999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=410.42 Aligned_cols=247 Identities=27% Similarity=0.532 Sum_probs=213.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeee-EEEeCCe-EEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHC-SFVSDHN-LWV 86 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~-~~~~~~~-l~i 86 (636)
..+|+++++||+|+||+||++.+..+|..||.|.+.....+ .....+..|+.+|+.|+|||||++|+ .|..+.. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 45699999999999999999999999999999999866543 34567889999999999999999998 6666665 999
Q ss_pred EEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH--CC--CcccccCcccEEEccCCcEEEeccCcccc
Q 006664 87 VMPFMSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLHH--HG--HIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH~--~g--IvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
|||||++|||..+++... ...++|.++|.++.|++.||..||. .. |+||||||.||+++.+|.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999887543 3459999999999999999999999 44 99999999999999999999999999986
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcc-c
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE-R 239 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~-~ 239 (636)
+.. ......+++|||+||+||++.+ .+|++++||||+||++|||+..++||.+..-......+.+. +++ .
T Consensus 178 l~s---~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-----d~~~~ 248 (375)
T KOG0591|consen 178 LSS---KTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-----DYPPL 248 (375)
T ss_pred hcc---hhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-----CCCCC
Confidence 632 2334668899999999999987 78999999999999999999999999988554444444333 222 2
Q ss_pred c-hhhhHHHHHHHHhhcccCCCCCCCH
Q 006664 240 D-RKFSKSFKQMIASCLVKDPSKRPSA 265 (636)
Q Consensus 240 ~-~~~S~~l~dLI~~cL~~DP~kRpsa 265 (636)
+ ..+|.++..||..|+..||+.||+.
T Consensus 249 p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 249 PDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred cHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 3 6899999999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=427.07 Aligned_cols=268 Identities=28% Similarity=0.440 Sum_probs=231.7
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSD-- 81 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-- 81 (636)
+++-..+.|+.+++||+|+||.||+|++..||+.||+|.+.++... ....-+.|||.||++|+||||+++.+...+.
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 3455678899999999999999999999999999999999988743 3455678999999999999999999999887
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+|+|+|||+. ||.-++... .-.|++.+++.||+||+.||+|||.+||+|||||..|||||.+|.+||+|||+|+.+
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 789999999986 888888652 357999999999999999999999999999999999999999999999999999865
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-CCCCc-c-
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-PGLDY-E- 238 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~-~~~~~-~- 238 (636)
..... ...+..+-|+||+|||+|.|...|+.++|+||+||||.||+.|++.|.+....+++..+.+-+- +..++ +
T Consensus 269 ~~~~~--~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 269 TPSGS--APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred cCCCC--cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 43332 2245678899999999999999999999999999999999999999999999999888765321 11111 0
Q ss_pred ---------------------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 239 ---------------------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 239 ---------------------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
....++..+.+|+..||..||.+|.||.++|+|+||..
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 12346788899999999999999999999999999954
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=418.96 Aligned_cols=263 Identities=31% Similarity=0.520 Sum_probs=223.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC--eEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH--NLWVV 87 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~--~l~iV 87 (636)
..+|..++.||+|+||+||++.++.+|+.+|||.+....... .+.+.+|+.+|+.++|||||++++...... .++++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 456899999999999999999999999999999998764333 677999999999999999999999855544 69999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-CCcEEEeccCcccccccCCC
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-~g~vKL~DFGla~~~~~~~~ 166 (636)
|||+.||+|.+++++... .++|..++.+.+||+.||+|||++|||||||||+|||++. ++.+||+|||++........
T Consensus 95 mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999999998743 7999999999999999999999999999999999999999 79999999999886643222
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCC-CChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSK-YPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~-~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
.......+.|||.|||||++.......+++|||||||++.||++|.+||.. ......+..+..... ....+..+|.
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~---~P~ip~~ls~ 250 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS---LPEIPDSLSD 250 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC---CCCCCcccCH
Confidence 333345689999999999998522334599999999999999999999998 455554555544431 1144567999
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
++++||.+||.+||.+||||.++|+|||.+..
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 99999999999999999999999999999754
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=398.09 Aligned_cols=260 Identities=27% Similarity=0.451 Sum_probs=229.7
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
-.+.|++.++||+|.|+.||++.+..||+.+|+|+++...- ....+.+.+|+.|.+.|.||||+++++.+.+.+..|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 45789999999999999999999999999999999986542 23678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc---CCcEEEeccCcccccccC
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---RGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---~g~vKL~DFGla~~~~~~ 164 (636)
+|+|+||+|..-+... -.++|..+..+++||+.||.|||.+||||||+||+|+|+-+ ..-+||+|||+|..+. .
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~ 165 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D 165 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence 9999999997655444 35899999999999999999999999999999999999953 4479999999998764 2
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
+ ..-..++|||.|||||+++. ..|+..+|||++|+|||-|+.|++||.+.+.......+++.. -.++.+.+..++
T Consensus 166 g---~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~-yd~~~~~w~~is 240 (355)
T KOG0033|consen 166 G---EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA-YDYPSPEWDTVT 240 (355)
T ss_pred c---cccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc-cCCCCcccCcCC
Confidence 2 23457899999999999986 789999999999999999999999999988877777776553 334456678999
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
+++++||++||..||.+|+|+.|.|+|||+++
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 99999999999999999999999999999975
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=390.36 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=228.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|...+.||+|.||.||+|++..||+.||||.|+...... .--...|||+.|+.++||||+.+.++|.....+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 68999999999999999999999999999999998765433 23357899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|++. ||...++.. ...++...++.|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 82 fm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--- 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--- 156 (318)
T ss_pred eccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc---
Confidence 9975 899988875 36799999999999999999999999999999999999999999999999999987754432
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CCCCCcc---------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLDYE--------- 238 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~--~~~~~~~--------- 238 (636)
.....+-|.+|+|||++.|.+.|+..+||||.|||+.||+-|.+.|.+..+.+++..+.+.. |..-.|+
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 22334889999999999999999999999999999999999999999999999887766522 1111111
Q ss_pred ------------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 239 ------------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 239 ------------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.....+.++.+|+.+||..||.+|+++.|+|+|+||+...
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 1124567889999999999999999999999999999754
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=411.69 Aligned_cols=272 Identities=30% Similarity=0.433 Sum_probs=242.2
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
.-.++..+|++++.||+|.-|+||+|..+.++..+|+|+++++.. ...+.++..|-.||+.++||.++.+|..|+.++
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 345677899999999999999999999999999999999987653 345778899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
..|+|||||.||+|..++++.....|++..++.|+.+++.||+|||..|||+|||||+||||..+|+|.|+||.++....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999875431
Q ss_pred c------C--------------------------CCc---------------------ccccccccCCCCCCChhhhhhc
Q 006664 163 D------S--------------------------GDR---------------------QRMRNTFVGTPCWMAPEVMEQL 189 (636)
Q Consensus 163 ~------~--------------------------~~~---------------------~~~~~~~~GT~~YmAPEvl~~~ 189 (636)
. . ..+ ....+.|+||-.|+|||++.|
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 1 0 000 011356899999999999998
Q ss_pred cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCC----H
Q 006664 190 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS----A 265 (636)
Q Consensus 190 ~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRps----a 265 (636)
.+.+.++|||+|||.+|||++|..||.+.+..+.+..++.... .++....++..++|||+++|++||.+|.. +
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l---~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL---KFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC---cCCCCCcchhHHHHHHHHHhccChhhhhccccch
Confidence 7899999999999999999999999999999888888876543 34445588999999999999999999998 9
Q ss_pred HHHHhCcccccccCh
Q 006664 266 KKLLKHSFFKQARSN 280 (636)
Q Consensus 266 ~elL~Hpffk~~~~~ 280 (636)
.||.+||||+++.|.
T Consensus 387 ~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 387 AEIKRHPFFEGVNWA 401 (459)
T ss_pred HHhhcCccccCCChh
Confidence 999999999999886
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=408.52 Aligned_cols=258 Identities=25% Similarity=0.455 Sum_probs=224.7
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
..++|++.+.||+|+||.||+|.++.+|+.||||++.... .......+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 4589999999999999999999999999999999997542 12345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 96 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 99999999999999875 67899999999999999999999999999999999999999999999999998754221
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
..+.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.... ...+..++..
T Consensus 172 ----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-----~~~p~~~~~~ 241 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-----LKFPNWFDGR 241 (329)
T ss_pred ----cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-----cCCCCCCCHH
Confidence 235689999999999976 678999999999999999999999998877766555444332 1223457889
Q ss_pred HHHHHHhhcccCCCCCCC-----HHHHHhCcccccccCh
Q 006664 247 FKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSN 280 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~ 280 (636)
+++||.+||..||.+||+ +++++.||||+...+.
T Consensus 242 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 242 ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 999999999999999997 7999999999876543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-48 Score=400.02 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=223.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 479999999999999999999999999999999975432 224556889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 999999999999875 57999999999999999999999999999999999999999999999999998755321
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..... ..+..++..++
T Consensus 155 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~ 226 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-----EFPRHLDLYAK 226 (291)
T ss_pred --cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-----CCCccCCHHHH
Confidence 234679999999999976 6789999999999999999999999998777666555554321 22345688999
Q ss_pred HHHHhhcccCCCCCCC-----HHHHHhCcccccccC
Q 006664 249 QMIASCLVKDPSKRPS-----AKKLLKHSFFKQARS 279 (636)
Q Consensus 249 dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~ 279 (636)
+||.+||..||.+||+ +++++.||||....+
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 9999999999999995 999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=396.51 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=226.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHH-HHHHHHHHHHhCCCCCcceeeeEEEeC--CeEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLS-NISREAQTMILVDHPNVLKSHCSFVSD--HNLWVV 87 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~-~i~rEi~iL~~L~HPNIVkl~~~~~~~--~~l~iV 87 (636)
++|+.+..|++|+||.||+|+++.|++.||+|.++.+....... .-.|||.+|.+++|||||.+.++.... +.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 68999999999999999999999999999999998876443222 246899999999999999999998765 579999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
||||+. ||..+|.... .+|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+...
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--- 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--- 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC---
Confidence 999986 8999998863 68999999999999999999999999999999999999999999999999999876433
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-------CCCCCccc-
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA-------PPGLDYER- 239 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~-------~~~~~~~~- 239 (636)
....+..+-|.||+|||++.+...|+.++||||+|||+.||+.+++.|.+....+++..+.+.. ++++....
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 2334567889999999999999999999999999999999999999999999999988776521 22211100
Q ss_pred -------------------chhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 240 -------------------DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 240 -------------------~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
...++....+|+..+|..||.+|.||.|.|+|.||....
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 011558889999999999999999999999999998743
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=397.70 Aligned_cols=264 Identities=23% Similarity=0.366 Sum_probs=216.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++.+.||.|+||.||+|.+..+++.||||++...........+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 57899999999999999999999999999999999765444444567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---H 158 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---c
Confidence 996 5788888664 3568999999999999999999999999999999999999999999999999986432211 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHH-HHHHhc--CCCC------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL-LMTLQN--APPG------------ 234 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l-~~~~~~--~~~~------------ 234 (636)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....... ..+... .+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 2234678999999999876567899999999999999999999999876543222 221110 0000
Q ss_pred ----CCcc---------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 235 ----LDYE---------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 235 ----~~~~---------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+... ....++.++++||.+||++||.+|||+.++++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0000 0012457899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=404.69 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=218.1
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GG 94 (636)
+.||+|+||.||+|.+..+|+.||||+++... .......+.+|+.+++.++||||++++++|..+..+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997543 2234566788999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccc
Q 006664 95 SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF 174 (636)
Q Consensus 95 sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 174 (636)
+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......+ ......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTF 155 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---Ccccce
Confidence 999999765 679999999999999999999999999999999999999999999999999987532222 123457
Q ss_pred cCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhh
Q 006664 175 VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASC 254 (636)
Q Consensus 175 ~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~c 254 (636)
+||+.|+|||++.+ ..|+.++|||||||++|||++|..||...........+... . ...+..++.++++||.+|
T Consensus 156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-~----~~~p~~~~~~~~~li~~~ 229 (323)
T cd05571 156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-E----IRFPRTLSPEAKSLLAGL 229 (323)
T ss_pred ecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-C----CCCCCCCCHHHHHHHHHH
Confidence 89999999999976 67899999999999999999999999877665544444332 1 123456899999999999
Q ss_pred cccCCCCCC-----CHHHHHhCcccccccCh
Q 006664 255 LVKDPSKRP-----SAKKLLKHSFFKQARSN 280 (636)
Q Consensus 255 L~~DP~kRp-----sa~elL~Hpffk~~~~~ 280 (636)
|.+||.+|| ++.++++||||....+.
T Consensus 230 L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 230 LKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred ccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999999 89999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=402.73 Aligned_cols=260 Identities=40% Similarity=0.731 Sum_probs=239.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEecc
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~ 91 (636)
-|.++++||+|+||.||+|+++.+|+.+|||.+..+ .++..+..|+.||+.++.|+||++|+.|-....+|||||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 477889999999999999999999999999998754 46888999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
..|+..++++.+. ..++|.++..+++..+.||+|||-..-||||||..|||++.+|+.||+|||+|..+.+ ....+
T Consensus 111 GAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD---TMAKR 186 (502)
T KOG0574|consen 111 GAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD---TMAKR 186 (502)
T ss_pred CCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh---hHHhh
Confidence 9999999998763 6799999999999999999999999999999999999999999999999999987744 34457
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHH
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI 251 (636)
++..|||.|||||++.. -+|+.++||||||++..||+.|++||.+..++..+.++-.+.++.+ ..+..+|.+|.+||
T Consensus 187 NTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF--~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTF--KKPEEWSSEFNDFI 263 (502)
T ss_pred CccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCC--CChHhhhhHHHHHH
Confidence 89999999999999987 7899999999999999999999999999999998888887777655 45678999999999
Q ss_pred HhhcccCCCCCCCHHHHHhCcccccccChH
Q 006664 252 ASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 252 ~~cL~~DP~kRpsa~elL~Hpffk~~~~~~ 281 (636)
++||.+.|++|-|+.++++|||++.+..-+
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 999999999999999999999999876443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=393.51 Aligned_cols=260 Identities=22% Similarity=0.369 Sum_probs=218.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++.+.||.|+||.||+|.+..++..||+|+++..........+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 47899999999999999999999999999999999765444445567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.| +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 84 ~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~---~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT---K 158 (288)
T ss_pred CCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC---c
Confidence 9985 899988764 2458899999999999999999999999999999999999999999999999986542211 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC--------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-------------- 235 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~-------------- 235 (636)
......||+.|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 123457899999999987656789999999999999999999999988776665544433211000
Q ss_pred --Cc---------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 236 --DY---------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 236 --~~---------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.+ .....++.++++||.+||.+||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 0112467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=411.00 Aligned_cols=260 Identities=30% Similarity=0.466 Sum_probs=234.1
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch--hHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS--DLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~--~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~ 85 (636)
..+.|++.+.||+|.||.||+++++.||+.+|+|++++..... ....+.+|+.||+.+. |||||.++++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4568999999999999999999999999999999998765432 4578999999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC----CcEEEeccCccccc
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR----GAIKLGDFGVSACL 161 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~----g~vKL~DFGla~~~ 161 (636)
+|||+|.||+|++.+... .++|..+..+++|++.++.|||+.||+||||||+|+|+... +.+|++|||++...
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 999999999999999876 39999999999999999999999999999999999999633 57999999999865
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
.. .....+.+|||.|+|||++.+ ..|+..+||||+|+++|.|++|.+||.+.........+..... .+..+.+.
T Consensus 190 ~~----~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-~f~~~~w~ 263 (382)
T KOG0032|consen 190 KP----GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-DFTSEPWD 263 (382)
T ss_pred cC----CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-CCCCCCcc
Confidence 33 234568899999999999986 6899999999999999999999999999888877776665443 55667788
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.+|..+++||.+||..||.+|+++.++|+|||++..
T Consensus 264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 264 DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 899999999999999999999999999999999865
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=393.14 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=219.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.|++++.||+|+||.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999875432 1233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||.||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence 9999999988876544579999999999999999999999999999999999999999999999999987542211
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
.....+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||................. .........++.++.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ 234 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK-EDQEEYSEKFSEDAKS 234 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-cccccCCccCCHHHHH
Confidence 1234579999999999976 6789999999999999999999999987544222111111111 1112234568999999
Q ss_pred HHHhhcccCCCCCCC-----HHHHHhCcccccccChH
Q 006664 250 MIASCLVKDPSKRPS-----AKKLLKHSFFKQARSNE 281 (636)
Q Consensus 250 LI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~~ 281 (636)
||.+||+.||.+||+ ++++++||||....+..
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05631 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR 271 (285)
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence 999999999999997 89999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=401.76 Aligned_cols=249 Identities=29% Similarity=0.493 Sum_probs=215.9
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCH
Q 006664 19 VGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96 (636)
Q Consensus 19 IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL 96 (636)
||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++..+..+|+|||||.||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999997542 233456788999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccC
Q 006664 97 LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176 (636)
Q Consensus 97 ~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~G 176 (636)
.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~g 155 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---DKTNTFCG 155 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC---CccccccC
Confidence 9999875 679999999999999999999999999999999999999999999999999987533222 12345689
Q ss_pred CCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcc
Q 006664 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLV 256 (636)
Q Consensus 177 T~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~ 256 (636)
|+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+... + ...+..+++++++||.+||.
T Consensus 156 t~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~li~~~L~ 229 (312)
T cd05585 156 TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-P----LRFPDGFDRDAKDLLIGLLS 229 (312)
T ss_pred CcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-C----CCCCCcCCHHHHHHHHHHcC
Confidence 999999999976 67999999999999999999999999887766655554433 2 12335688999999999999
Q ss_pred cCCCCCC---CHHHHHhCccccccc
Q 006664 257 KDPSKRP---SAKKLLKHSFFKQAR 278 (636)
Q Consensus 257 ~DP~kRp---sa~elL~Hpffk~~~ 278 (636)
.||.+|| ++.+++.||||....
T Consensus 230 ~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 230 RDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred CCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 9999997 589999999998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=403.95 Aligned_cols=254 Identities=25% Similarity=0.445 Sum_probs=228.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
.-+|++.+.||+|+||.|.+|.....|+.||||.|.++. ...++-.|+|||.||..|+||||+.+|++|++...+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 357999999999999999999999999999999998775 445677899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||..||+|++++... +.++|.+++.+|+||++|+.|||.++++|||||.+|||+|.++++||+|||++..+.+
T Consensus 132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---- 205 (668)
T ss_pred EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc----
Confidence 9999999999999987 7899999999999999999999999999999999999999999999999999976533
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.....+|||+|.|.+||++.+..+-++.+|-|||||+||.|..|.+||++.+....+.++...... .+.-+.++
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr------EP~~PSdA 279 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR------EPETPSDA 279 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc------CCCCCchH
Confidence 245679999999999999999666688999999999999999999999998776666555544321 23346688
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
.-||++||..+|++|.|+++|-.|=|+.
T Consensus 280 ~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 280 SGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHHHhcCcccchhHHHHhhhheee
Confidence 9999999999999999999999998886
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=405.20 Aligned_cols=264 Identities=24% Similarity=0.396 Sum_probs=227.6
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCC-cEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFN-EIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg-~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
++.+.+..++|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred ccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 3456777899999999999999999999877655 789999986543 2234567889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
++..+|+|||||.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 999999999999999999999875 579999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
.+.. ...+.+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.........+..... ..
T Consensus 180 ~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-----~~ 247 (340)
T PTZ00426 180 VVDT------RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-----YF 247 (340)
T ss_pred ecCC------CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-----CC
Confidence 5421 1235689999999999976 6789999999999999999999999998776655554443321 22
Q ss_pred chhhhHHHHHHHHhhcccCCCCCC-----CHHHHHhCcccccccCh
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRP-----SAKKLLKHSFFKQARSN 280 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~ 280 (636)
+..++..++++|++||..||.+|+ +++++++||||....+.
T Consensus 248 p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 356788999999999999999995 89999999999876654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=406.55 Aligned_cols=265 Identities=26% Similarity=0.453 Sum_probs=222.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||+||+|.++.+++.||||++.... .......+.+|+.++..++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999997532 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc-
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR- 167 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~- 167 (636)
|||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999999875 67999999999999999999999999999999999999999999999999998754211100
Q ss_pred -------------------------------ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCC
Q 006664 168 -------------------------------QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS 216 (636)
Q Consensus 168 -------------------------------~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~ 216 (636)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 001235689999999999976 679999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCC---CCCCHHHHHhCcccccccCh
Q 006664 217 KYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPS---KRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 217 ~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~---kRpsa~elL~Hpffk~~~~~ 280 (636)
+.........+... ...+.++....++.++++||.+|+. +|. .||++++|++||||+...+.
T Consensus 238 ~~~~~~~~~~i~~~-~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 238 SETPQETYKKVMNW-KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred CCCHHHHHHHHHcC-cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence 87776666555432 2222333344688999999999775 454 45899999999999977543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-48 Score=396.86 Aligned_cols=265 Identities=24% Similarity=0.347 Sum_probs=226.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecC-CCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe-----CCe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFE-RDNSDLSNISREAQTMILVDHPNVLKSHCSFVS-----DHN 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~-~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~-----~~~ 83 (636)
..+|..++.||+|+||.|+.|.++.+|+.||||.+... ......++..||+++|+.++|+||+.+++++.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 45677789999999999999999999999999998622 244567889999999999999999999999976 357
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|+|+| +.||..+++.. ..+++..+..+++||+.||+|+|+.||+||||||.|+|++.+..+||||||+|+....
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999999 55899999875 4599999999999999999999999999999999999999999999999999987644
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC--------
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-------- 235 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~-------- 235 (636)
. ......+.++-|.||.|||++.....|+.++||||+|||++||++|++.|.+.+...++..++......-
T Consensus 178 ~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 178 F-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred c-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 3 3344456789999999999999888999999999999999999999999999887777665543221110
Q ss_pred -----------------Cc-ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 236 -----------------DY-ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 236 -----------------~~-~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.+ ...+..++.+.+|+.+||..||.+|+|++|+|.||||....
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 00 11235678999999999999999999999999999998754
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=408.49 Aligned_cols=266 Identities=27% Similarity=0.456 Sum_probs=221.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
..|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999997543 2234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC--
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD-- 166 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~-- 166 (636)
|||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999999875 5799999999999999999999999999999999999999999999999999753210000
Q ss_pred ------------------------------------------cccccccccCCCCCCChhhhhhccCCCcccchhhHHHH
Q 006664 167 ------------------------------------------RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGIT 204 (636)
Q Consensus 167 ------------------------------------------~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGii 204 (636)
......+.+||+.|||||++.+ ..|+.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhH
Confidence 0001235689999999999976 679999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcc--cCCCCCCCHHHHHhCcccccccCh
Q 006664 205 ALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLV--KDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 205 LyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~--~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
+|||++|..||...........++.. ......+....+++++++||.+||. .+|..|+++.+++.||||....+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINW-ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHcc-ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 99999999999887766555444432 1222334445689999999999654 455569999999999999876544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=405.90 Aligned_cols=264 Identities=27% Similarity=0.478 Sum_probs=224.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||++++++|.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 58999999999999999999999999999999997542 2234566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc-
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR- 167 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~- 167 (636)
|||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999999875 57999999999999999999999999999999999999999999999999998754221100
Q ss_pred ----------------------------------ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCC
Q 006664 168 ----------------------------------QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHA 213 (636)
Q Consensus 168 ----------------------------------~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~ 213 (636)
.....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCC
Confidence 001124579999999999976 679999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCC---HHHHHhCcccccccC
Q 006664 214 PFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS---AKKLLKHSFFKQARS 279 (636)
Q Consensus 214 PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRps---a~elL~Hpffk~~~~ 279 (636)
||.+.........+... ...+..+....+++++++||.+||. +|.+|++ +.+++.||||+...+
T Consensus 238 Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 238 PFCSDNPQETYRKIINW-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCCCCHHHHHHHHHcC-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 99988776665555432 2223334445689999999999996 9999998 999999999987653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=399.66 Aligned_cols=259 Identities=29% Similarity=0.426 Sum_probs=223.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999975432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
|||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999999865 5789999999999999999999999999999999999999999999999999875422
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCccc----chhhh
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER----DRKFS 244 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~----~~~~S 244 (636)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.... ..+..+. ...++
T Consensus 154 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~s 230 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-ETLQRPVYDDPRFNLS 230 (333)
T ss_pred -ccCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-ccccCCCCCccccccC
Confidence 2346689999999999987 579999999999999999999999999877766554443221 1111111 13578
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
.++.+||.+||..+|.+||++.++++||||....+
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 99999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=418.91 Aligned_cols=269 Identities=36% Similarity=0.667 Sum_probs=241.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.+.|+++..||-|+||.||+|.++.++-..|-|+|... ....++.+.-||.||..++||+||++++.|..++.+||+.|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 46688999999999999999999999999999999744 44568888999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||.||-...+|-.. ...+.|.++..+++|++.||.|||+++|||||||..|||+.-+|.|+|+|||+++... ....
T Consensus 110 FC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~---~t~q 185 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK---STRQ 185 (1187)
T ss_pred ecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch---hHHh
Confidence 99999988887765 4789999999999999999999999999999999999999999999999999987542 2223
Q ss_pred ccccccCCCCCCChhhhh----hccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 170 MRNTFVGTPCWMAPEVME----QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~----~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
.+.+|+|||+|||||++. ...+|++++|||||||+|.||+.+.+|.....++.+++.+-+..||.+- .+..|+.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl--qPS~Ws~ 263 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL--QPSHWSR 263 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc--Ccchhhh
Confidence 467899999999999974 2357999999999999999999999999999999999999988888764 4578999
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCcccccccChHHHHH
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIAR 285 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~~i~~ 285 (636)
.|.||+.+||.+||..||++.+||+||||..+.++..+..
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ire 303 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRE 303 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHHH
Confidence 9999999999999999999999999999999887755533
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=407.12 Aligned_cols=265 Identities=27% Similarity=0.452 Sum_probs=222.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
.+|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+++.++||||++++++|.++..+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999997532 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC--
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD-- 166 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~-- 166 (636)
|||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999999775 5789999999999999999999999999999999999999999999999999753210000
Q ss_pred ------------------------------------------cccccccccCCCCCCChhhhhhccCCCcccchhhHHHH
Q 006664 167 ------------------------------------------RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGIT 204 (636)
Q Consensus 167 ------------------------------------------~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGii 204 (636)
......+.+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHH
Confidence 0001234689999999999976 679999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCC---HHHHHhCcccccccCh
Q 006664 205 ALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS---AKKLLKHSFFKQARSN 280 (636)
Q Consensus 205 LyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRps---a~elL~Hpffk~~~~~ 280 (636)
+|||++|++||.+..+......+... ......+....++++++++|.+|+ .||.+|++ +++++.||||+...+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINW-QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcc-CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 99999999999987776655554432 222333444578999999999986 59999997 9999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=407.13 Aligned_cols=263 Identities=29% Similarity=0.462 Sum_probs=220.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|.+++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+++.++||||++++++|.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 58999999999999999999999999999999986542 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc-
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR- 167 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~- 167 (636)
|||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999999865 67999999999999999999999999999999999999999999999999998643211000
Q ss_pred -------------------------------------------ccccccccCCCCCCChhhhhhccCCCcccchhhHHHH
Q 006664 168 -------------------------------------------QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGIT 204 (636)
Q Consensus 168 -------------------------------------------~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGii 204 (636)
.......+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchh
Confidence 000113579999999999976 679999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCC---CCHHHHHhCccccccc
Q 006664 205 ALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR---PSAKKLLKHSFFKQAR 278 (636)
Q Consensus 205 LyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kR---psa~elL~Hpffk~~~ 278 (636)
+|||++|.+||.+....+....+... ...+.++....++.++++||.+||. +|.+| +++.+++.||||+...
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINW-RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHcc-CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 99999999999887776655544432 2223334445688999999999997 77765 5999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=404.92 Aligned_cols=262 Identities=27% Similarity=0.444 Sum_probs=219.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-------------chhHHHHHHHHHHHHhCCCCCcceeee
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-------------NSDLSNISREAQTMILVDHPNVLKSHC 76 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-------------~~~~~~i~rEi~iL~~L~HPNIVkl~~ 76 (636)
.++|++++.||+|.||.|.+|.+..+++.||||++++... ....+.+++||.||++|+|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 4789999999999999999999999999999999975421 123578999999999999999999999
Q ss_pred EEEeC--CeEEEEEeccCCCCHHHHHHHhCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEe
Q 006664 77 SFVSD--HNLWVVMPFMSGGSCLHILKAAYPDG-FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLG 153 (636)
Q Consensus 77 ~~~~~--~~l~iVmEy~~GGsL~~lL~~~~~~~-lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~ 153 (636)
+..+. ..+|+|+|||..|.+...= .... +++.+++.|+++++.||+|||.+|||||||||.|+||+.+|+|||+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 99775 6899999999998754321 2234 8999999999999999999999999999999999999999999999
Q ss_pred ccCcccccccCC--CcccccccccCCCCCCChhhhhhcc---CCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 006664 154 DFGVSACLFDSG--DRQRMRNTFVGTPCWMAPEVMEQLH---GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL 228 (636)
Q Consensus 154 DFGla~~~~~~~--~~~~~~~~~~GT~~YmAPEvl~~~~---~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~ 228 (636)
|||++....... +........+|||.|||||.+.+.. ..+.+.||||+||+||-|+.|+.||.+....+....++
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 999986542111 1111123368999999999997622 34678999999999999999999999988887776665
Q ss_pred hcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 229 ~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.. .+.++..+.+...+++||.+||.+||++|+++.+|..|||....
T Consensus 333 n~---pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 333 ND---PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cC---cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 43 23445556788999999999999999999999999999999753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=387.11 Aligned_cols=259 Identities=22% Similarity=0.372 Sum_probs=214.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++.+.||+|+||+||+|.++.+++.||+|++..... ......+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 479999999999999999999999999999999975432 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+.... ..
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 156 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS--NA 156 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc--cc
Confidence 9998766554433 3579999999999999999999999999999999999999999999999999987653221 11
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC----------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP---------------- 233 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~---------------- 233 (636)
......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+.+..+.....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2235679999999999976 56899999999999999999999999887655544332211000
Q ss_pred CCCc-----------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 234 GLDY-----------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 234 ~~~~-----------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.... .....+|.++++||.+||.+||++|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 0012368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=394.34 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=214.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC-----CeEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD-----HNLW 85 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-----~~l~ 85 (636)
+|++.+.||+|+||.||+|.+..+|..||||++.... .......+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999986432 223455788999999999999999999988643 3589
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+|||||. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 9999995 6899988765 569999999999999999999999999999999999999999999999999987543322
Q ss_pred CcccccccccCCCCCCChhhhhhc-cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHh---------------
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ--------------- 229 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~--------------- 229 (636)
.........+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+......+..+..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 222223456899999999998652 4689999999999999999999999987654433221111
Q ss_pred -----------cCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 230 -----------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 230 -----------~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
...+.........+++.+.+||.+||..||++||++.++++||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00000000112346778999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=405.57 Aligned_cols=263 Identities=28% Similarity=0.443 Sum_probs=221.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
.+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++.|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986432 1224566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC--
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD-- 166 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~-- 166 (636)
|||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.....
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999999875 5789999999999999999999999999999999999999999999999999753210000
Q ss_pred --------------------------------------cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHH
Q 006664 167 --------------------------------------RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALEL 208 (636)
Q Consensus 167 --------------------------------------~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeL 208 (636)
........+||+.|||||++.+ ..++.++|||||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeeh
Confidence 0001124689999999999976 6789999999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCC---CHHHHHhCccccccc
Q 006664 209 AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRP---SAKKLLKHSFFKQAR 278 (636)
Q Consensus 209 ltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRp---sa~elL~Hpffk~~~ 278 (636)
++|+.||.+....+....+.. .......+....++.++.+||.+|+ .+|.+|+ ++.++++||||+...
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVIN-WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhc-cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 999999998777665544432 2222333344568999999999977 5999999 999999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=402.63 Aligned_cols=268 Identities=28% Similarity=0.444 Sum_probs=227.8
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
.+.+..++|++.+.||+|+||.||+|.+..+++.||+|+++... .......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 35567789999999999999999999999999999999997532 2223455788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||.||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999999999876 358999999999999999999999999999999999999999999999999987543
Q ss_pred cCCCcccccccccCCCCCCChhhhhhc---cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQL---HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~---~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
..+ .......+||+.|||||++.+. ..++.++|||||||++|||++|..||.+.........+... ...+.++.
T Consensus 194 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 270 (370)
T cd05596 194 ANG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH-KNSLTFPD 270 (370)
T ss_pred CCC--cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCcCCCCC
Confidence 221 1123456899999999998652 24789999999999999999999999987776655555433 22334444
Q ss_pred chhhhHHHHHHHHhhcccCCCC--CCCHHHHHhCccccccc
Q 006664 240 DRKFSKSFKQMIASCLVKDPSK--RPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~k--Rpsa~elL~Hpffk~~~ 278 (636)
...+|.++++||.+||..+|.+ |++++++++||||+...
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 5568999999999999999998 99999999999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=397.86 Aligned_cols=264 Identities=29% Similarity=0.484 Sum_probs=225.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|.+++.||+|+||+||+|.+..+|+.||||+++... .......+.+|+.++..++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 57999999999999999999999999999999997543 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC--
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD-- 166 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~-- 166 (636)
||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999999876 6799999999999999999999999999999999999999999999999999876543220
Q ss_pred ------------------------cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHH
Q 006664 167 ------------------------RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 222 (636)
Q Consensus 167 ------------------------~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~ 222 (636)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 0112345679999999999987 579999999999999999999999999877666
Q ss_pred HHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCC-HHHHHhCcccccccC
Q 006664 223 VLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS-AKKLLKHSFFKQARS 279 (636)
Q Consensus 223 ~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRps-a~elL~Hpffk~~~~ 279 (636)
....+... ...+..+....+++++.+||.+||. ||.+||+ +.++++||||+...+
T Consensus 238 ~~~~i~~~-~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 238 TYNKIINW-KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred HHHHHhcc-CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 55444431 1222333334579999999999997 9999999 999999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=396.18 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=217.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GG 94 (636)
+.||+|+||.||+|.+..+|..||+|++.... .......+.+|+.+++.++||||++++++|..+..+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997543 2234566788999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccc
Q 006664 95 SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF 174 (636)
Q Consensus 95 sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 174 (636)
+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~ 155 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTF 155 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---ccccc
Confidence 999988765 5799999999999999999999999999999999999999999999999999865322211 12356
Q ss_pred cCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhh
Q 006664 175 VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASC 254 (636)
Q Consensus 175 ~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~c 254 (636)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ...+..+++++++||.+|
T Consensus 156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-----~~~p~~~~~~~~~li~~~ 229 (323)
T cd05595 156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-----IRFPRTLSPEAKSLLAGL 229 (323)
T ss_pred cCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCCHHHHHHHHHH
Confidence 89999999999976 578999999999999999999999998776655544443321 123356899999999999
Q ss_pred cccCCCCCC-----CHHHHHhCcccccccCh
Q 006664 255 LVKDPSKRP-----SAKKLLKHSFFKQARSN 280 (636)
Q Consensus 255 L~~DP~kRp-----sa~elL~Hpffk~~~~~ 280 (636)
|.+||.+|+ ++.++++|+||....+.
T Consensus 230 L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 230 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred ccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999998 89999999999876544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=391.65 Aligned_cols=262 Identities=32% Similarity=0.547 Sum_probs=221.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
+..++|++++.||+|+||.||++.+..+|..||+|++...........+.+|+++|+.++||||+++++++..++.+|+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 56789999999999999999999999999999999998665545567799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
|||++||+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred eecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999999999875 5689999999999999999999986 6999999999999999999999999998755322
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC-------------
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP------------- 233 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~------------- 233 (636)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.. ..+.....
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhcccccccccCCccccCcc
Confidence 2345679999999999976 56899999999999999999999999765543321 11110000
Q ss_pred -------------------------------CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 234 -------------------------------GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 234 -------------------------------~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.........++.++++||.+||.+||++|||+.+|++||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 000001124788999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=395.54 Aligned_cols=253 Identities=29% Similarity=0.466 Sum_probs=217.0
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GG 94 (636)
+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++..+..+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997543 2234567889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccc
Q 006664 95 SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF 174 (636)
Q Consensus 95 sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 174 (636)
+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~---~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA---ATMKTF 155 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc---cccccc
Confidence 999988765 579999999999999999999999999999999999999999999999999987532211 123456
Q ss_pred cCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhh
Q 006664 175 VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASC 254 (636)
Q Consensus 175 ~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~c 254 (636)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+... ....+..++.++.+||.+|
T Consensus 156 ~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----~~~~p~~~~~~~~~li~~~ 229 (328)
T cd05593 156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----DIKFPRTLSADAKSLLSGL 229 (328)
T ss_pred cCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----CccCCCCCCHHHHHHHHHH
Confidence 89999999999976 57899999999999999999999999877665544433322 1223456899999999999
Q ss_pred cccCCCCCC-----CHHHHHhCcccccccCh
Q 006664 255 LVKDPSKRP-----SAKKLLKHSFFKQARSN 280 (636)
Q Consensus 255 L~~DP~kRp-----sa~elL~Hpffk~~~~~ 280 (636)
|.+||.+|+ ++.++++||||....+.
T Consensus 230 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 230 LIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred cCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999999997 89999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=389.40 Aligned_cols=272 Identities=28% Similarity=0.461 Sum_probs=240.5
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+-.+..++|++++.||+|.||.|.+++.+.+|+.||||+++++- ...++.....|-++|+..+||.+..+...|+...
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34466799999999999999999999999999999999998764 3345667788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+||||+.||+|+.+|.+. ..|+|..++.+-.+|+.||.|||+++||+||||.+|+|+|.+|++||+|||+|+.-.
T Consensus 242 rlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred eEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999999999999875 789999999999999999999999999999999999999999999999999998655
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
..+. ...++||||.|+|||++.. ..|+.++|+|.+|+++|||++|+.||...+..+.+..++.. +...+..
T Consensus 320 ~~g~---t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----d~kFPr~ 390 (516)
T KOG0690|consen 320 KYGD---TTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----DLKFPRT 390 (516)
T ss_pred cccc---eeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----hccCCcc
Confidence 4443 3568999999999999986 78999999999999999999999999987776666555543 3345678
Q ss_pred hhHHHHHHHHhhcccCCCCCC-----CHHHHHhCcccccccChHHHHHHH
Q 006664 243 FSKSFKQMIASCLVKDPSKRP-----SAKKLLKHSFFKQARSNEYIARTL 287 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~~~i~~~l 287 (636)
++++++.|+..+|.+||.+|. .+.+|+.|+||..+.|.....+.+
T Consensus 391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki 440 (516)
T KOG0690|consen 391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKI 440 (516)
T ss_pred CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhcc
Confidence 999999999999999999996 489999999999988776554433
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=373.67 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=230.1
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
..++|++++.||+|.||.||+|+.++++-.||+|++.++.- .....+++||+.|-..|+||||+++|++|.+...+|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34899999999999999999999999999999999976542 2345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
++||..+|+++..|.......|+|..++.|++|++.||.|||.++||||||||+|+|++..|.+||+|||-+..- .
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~-p--- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-P--- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec-C---
Confidence 999999999999999766678999999999999999999999999999999999999999999999999998642 1
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
...+.+.|||..|.+||+..+ ..++..+|+|++|++.||++.|.+||......+....+.+. ++..+..++.+
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-----~~~~p~~is~~ 248 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-----DLKFPSTISGG 248 (281)
T ss_pred -CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-----cccCCcccChh
Confidence 234679999999999999987 78999999999999999999999999887765555555432 34455889999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
++|+|.+||.++|.+|.+..|++.|||+..
T Consensus 249 a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 249 AADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999999999864
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=394.83 Aligned_cols=264 Identities=28% Similarity=0.437 Sum_probs=225.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|.+.+.||+|+||+||+|.+..+|+.||||+++.... ......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 579999999999999999999999999999999975432 234566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-- 157 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--
Confidence 999999999999875 35799999999999999999999999999999999999999999999999999876533221
Q ss_pred cccccccCCCCCCChhhhhh-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 169 RMRNTFVGTPCWMAPEVMEQ-----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~-----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
......+||+.|+|||++.. ...++.++|||||||++|+|++|..||...........+... .....++....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 236 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF-QRFLKFPEDPKV 236 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC-CCccCCCCCCCC
Confidence 12234579999999999863 345789999999999999999999999887776655554432 223344445578
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
+.++++||.+||. ||.+||++.+++.||||....+
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 9999999999997 9999999999999999987653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=399.27 Aligned_cols=266 Identities=27% Similarity=0.482 Sum_probs=224.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||+||+|.++.+++.||||+++... .......+.+|+.++..++||||++++++|.++..+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999997432 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC--
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD-- 166 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~-- 166 (636)
|||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999999875 6799999999999999999999999999999999999999999999999999865421110
Q ss_pred ------------------------------cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCC
Q 006664 167 ------------------------------RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS 216 (636)
Q Consensus 167 ------------------------------~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~ 216 (636)
......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCC
Confidence 0011234689999999999976 679999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCC---CHHHHHhCcccccccChH
Q 006664 217 KYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRP---SAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 217 ~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRp---sa~elL~Hpffk~~~~~~ 281 (636)
+..+......+... ...+.++....++.++++||.+|+ .||.+|+ ++.+++.||||+...+..
T Consensus 238 ~~~~~~~~~~i~~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 238 SETPQETYRKVMNW-KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred CCCHHHHHHHHHcC-CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence 88776665554432 222233333457899999999987 5999998 489999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=400.06 Aligned_cols=268 Identities=29% Similarity=0.482 Sum_probs=225.8
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
...+..++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||++++++|.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 35566789999999999999999999999999999999996432 2223456789999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||.||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999999753 58999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhcc---CCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLH---GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~---~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
... .....+.+||+.|||||++.+.. .++.++|||||||++|+|++|..||...........+.... ..+.++.
T Consensus 194 ~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~p~ 270 (370)
T cd05621 194 ETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK-NSLNFPE 270 (370)
T ss_pred cCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cccCCCC
Confidence 221 11224678999999999997532 37889999999999999999999998877766655554432 2334444
Q ss_pred chhhhHHHHHHHHhhcccCCCC--CCCHHHHHhCccccccc
Q 006664 240 DRKFSKSFKQMIASCLVKDPSK--RPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~k--Rpsa~elL~Hpffk~~~ 278 (636)
...++..++++|.+||..++.+ |+++.++++||||+...
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 4568999999999999865544 89999999999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=391.22 Aligned_cols=257 Identities=26% Similarity=0.466 Sum_probs=220.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCC-CcceeeeEEEeCCeEEEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHP-NVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HP-NIVkl~~~~~~~~~l~iVm 88 (636)
+|++++.||+|+||.||+|.+..+++.||||++.... .......+..|+.++..++|+ +|++++++|.....+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 6999999999999999999999999999999997543 233566788899999999765 5888999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--- 155 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC---
Confidence 999999999999775 578999999999999999999999999999999999999999999999999986432211
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.... ...+..++.+++
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~ 229 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----VSYPKSLSKEAV 229 (324)
T ss_pred CceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----CCCCCCCCHHHH
Confidence 12335689999999999976 668999999999999999999999999887766665554332 122356889999
Q ss_pred HHHHhhcccCCCCCCCH-----HHHHhCcccccccC
Q 006664 249 QMIASCLVKDPSKRPSA-----KKLLKHSFFKQARS 279 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa-----~elL~Hpffk~~~~ 279 (636)
+||.+||.+||.+|+++ .++++||||....+
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 230 SICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999999976 89999999987654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=391.59 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=218.0
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHH---HhCCCCCcceeeeEEEeCCeEEEE
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTM---ILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL---~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
|++++.||+|+||.||+|.+..+|+.||||+++... .......+.+|+.++ +.++||||+++++++..+..+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999997543 223455677777766 466899999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+.||+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-- 155 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--
Confidence 999999999988864 469999999999999999999999999999999999999999999999999986432221
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
......+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.........+..... ..+..++..+
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-----~~p~~~~~~~ 228 (324)
T cd05589 156 -DRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-----RYPRFLSREA 228 (324)
T ss_pred -CcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCCCCCHHH
Confidence 12346789999999999976 6789999999999999999999999998777666555544322 2235678999
Q ss_pred HHHHHhhcccCCCCCC-----CHHHHHhCcccccccC
Q 006664 248 KQMIASCLVKDPSKRP-----SAKKLLKHSFFKQARS 279 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~ 279 (636)
.+||.+||.+||.+|| ++.++++||||+...+
T Consensus 229 ~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 229 ISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred HHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 9999999999999999 7999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=380.09 Aligned_cols=260 Identities=30% Similarity=0.487 Sum_probs=228.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-------hhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCC
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-------SDLSNISREAQTMILV-DHPNVLKSHCSFVSDH 82 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-------~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~ 82 (636)
..|.-.+.||+|..++|.++.++.+|..+|+|+++..... ...+...+|+.||+++ .||||+.+.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4577788999999999999999999999999999754321 1245567899999877 6999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+++|+|.|..|.|+|+|... -.++|...+.|++|++.|++|||.++||||||||+|||+|.+.++||+|||+|+.+.
T Consensus 97 F~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999999999886 579999999999999999999999999999999999999999999999999998763
Q ss_pred cCCCcccccccccCCCCCCChhhhh-----hccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVME-----QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~-----~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
. |.+ ....||||.|+|||.+. +..+|+..+|+|++|+|||.|+.|.+||.....+-.+.+++.+. -.+..
T Consensus 175 ~-Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk-yqF~s 249 (411)
T KOG0599|consen 175 P-GEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK-YQFRS 249 (411)
T ss_pred C-chh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc-cccCC
Confidence 3 332 34679999999999985 34679999999999999999999999999877777666666543 34566
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+.|..+|...++||.+||+.||++|+|++|+|.||||.++
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 7788999999999999999999999999999999999643
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=399.45 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=234.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
+.-|.+.+.||+|.|+.|.+|++.-||+.||||+|++.+.+. ....+..|++.|+.+.|||||++|++......+|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 456999999999999999999999999999999999877543 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc-cCCcEEEeccCcccccccCCCc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID-VRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld-~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|+-+||+|++||.++ ..++.|..+++||.||+.|+.|||+..+|||||||+||++. .-|-|||+|||++..+.. +
T Consensus 97 ELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-G-- 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-G-- 172 (864)
T ss_pred EecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-c--
Confidence 999999999999876 46899999999999999999999999999999999999775 568999999999976532 2
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
...+++||+..|.|||++.+..+..+++||||||||||.|.+|++||...++.+.+.+++.. .|..+..+|+++
T Consensus 173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC-----KYtvPshvS~eC 246 (864)
T KOG4717|consen 173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC-----KYTVPSHVSKEC 246 (864)
T ss_pred -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-----cccCchhhhHHH
Confidence 23578999999999999999666678899999999999999999999999988888888765 345678899999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++||..||+.||.+|.+.++|..|+|++..+
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 9999999999999999999999999999764
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=391.89 Aligned_cols=252 Identities=28% Similarity=0.480 Sum_probs=216.6
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||+||+|.++.+++.||||++.... .......+.+|+.++..+ +||||+++++++.....+|+|||||.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997543 223456677888888766 799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......+ .....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KTTST 155 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC---Ccccc
Confidence 9999998775 579999999999999999999999999999999999999999999999999987532221 12345
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..... ..+..++.++++||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~ 229 (320)
T cd05590 156 FCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-----VYPTWLSQDAVDILKA 229 (320)
T ss_pred cccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-----CCCCCCCHHHHHHHHH
Confidence 689999999999976 6789999999999999999999999998877666555543321 2234578999999999
Q ss_pred hcccCCCCCCCH------HHHHhCcccccccC
Q 006664 254 CLVKDPSKRPSA------KKLLKHSFFKQARS 279 (636)
Q Consensus 254 cL~~DP~kRpsa------~elL~Hpffk~~~~ 279 (636)
||.+||.+||++ +++++||||+...+
T Consensus 230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred HcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999998 99999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=389.78 Aligned_cols=259 Identities=26% Similarity=0.419 Sum_probs=216.0
Q ss_pred CeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeecCC---CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeE
Q 006664 12 HYTLYEEVGQGVSASVHRALCI---PFNEIVAVKILDFER---DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~---~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l 84 (636)
+|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||++++++|..+..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998764 578999999996432 223456678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999999765 57999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC---hHHHHHHHHhcCCCCCCcccch
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP---PMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~---~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
.. ......+||+.|||||++.+...++.++|||||||++|+|++|..||.... ....+...+.... ...+.
T Consensus 159 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 232 (332)
T cd05614 159 EK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD----PPFPS 232 (332)
T ss_pred CC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC----CCCCC
Confidence 21 122356899999999999865568899999999999999999999996432 2222222222222 22335
Q ss_pred hhhHHHHHHHHhhcccCCCCCC-----CHHHHHhCccccccc
Q 006664 242 KFSKSFKQMIASCLVKDPSKRP-----SAKKLLKHSFFKQAR 278 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~ 278 (636)
.++..+++||.+||..||.+|| +++++++||||+...
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 6889999999999999999999 889999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=389.39 Aligned_cols=252 Identities=29% Similarity=0.480 Sum_probs=216.6
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||.||+|.+..+++.||||++.... .......+..|..++..+ +||||++++++|.++..+|+|||||+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999997543 223455677899998865 799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTT 155 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC---ccccc
Confidence 9999998765 579999999999999999999999999999999999999999999999999987543222 12345
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||...........+..... ..+..++.++.+||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~~~~~~~ll~~ 229 (321)
T cd05591 156 FCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-----LYPVWLSKEAVSILKA 229 (321)
T ss_pred cccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----CCCCCCCHHHHHHHHH
Confidence 689999999999976 6789999999999999999999999998887766655544321 2234578999999999
Q ss_pred hcccCCCCCC-------CHHHHHhCcccccccC
Q 006664 254 CLVKDPSKRP-------SAKKLLKHSFFKQARS 279 (636)
Q Consensus 254 cL~~DP~kRp-------sa~elL~Hpffk~~~~ 279 (636)
||.+||.+|| ++.++++||||....+
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 9999999999 9999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=395.58 Aligned_cols=259 Identities=30% Similarity=0.482 Sum_probs=221.5
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcE-EEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEI-VAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~-vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
..|.+..++..+.+.||.|+||+||+|.+. |.. ||||++.... .......+.+|+.+|.+++|||||++++++.+.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 457888899999999999999999999986 555 9999997543 222367899999999999999999999999998
Q ss_pred C-eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccccCcccEEEccCC-cEEEeccCcc
Q 006664 82 H-NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG-HIHRDVKSGNILIDVRG-AIKLGDFGVS 158 (636)
Q Consensus 82 ~-~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g-IvHRDLKP~NILld~~g-~vKL~DFGla 158 (636)
. .+++||||+.+|+|.+++.......++...+..++.||+.|++|||+++ ||||||||+|||++.++ ++||||||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 7 7999999999999999998754578999999999999999999999999 99999999999999998 9999999999
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhh-ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ-LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~-~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
+...... .......||+.|||||++.+ ...|+.|+|||||||++|||++|+.||.+............+.. +.
T Consensus 192 r~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~---Rp 265 (362)
T KOG0192|consen 192 REKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL---RP 265 (362)
T ss_pred eeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC---CC
Confidence 8654321 12233689999999999985 25799999999999999999999999999888555555543332 22
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+..+++.+..||.+||..||.+||++.+|+.
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 233458899999999999999999999999874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=383.70 Aligned_cols=266 Identities=27% Similarity=0.435 Sum_probs=226.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCC-cceeeeEEEeCC-----
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPN-VLKSHCSFVSDH----- 82 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPN-IVkl~~~~~~~~----- 82 (636)
...|+.+++||+|+||+||+|+.+.+|+.||+|++..+... ..-....||+.+|+.|+|+| ||.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688899999999999999999999999999999887653 34456789999999999999 999999999887
Q ss_pred -eEEEEEeccCCCCHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 83 -NLWVVMPFMSGGSCLHILKAAYP--DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 83 -~l~iVmEy~~GGsL~~lL~~~~~--~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.+++||||++- +|..++..... .+++...++.+++||+.||+|||++||+||||||.||||+++|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 89999999975 89999988643 368888999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CCCCCc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLDY 237 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~--~~~~~~ 237 (636)
...-. .+....-++|.+|+|||++.+...|+..+||||+|||++||+++++.|.+..+.+++..+.+.. +....|
T Consensus 169 a~~ip---~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 169 AFSIP---MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HhcCC---cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 54322 2234566899999999999998889999999999999999999999999999988887765421 111111
Q ss_pred -------------cc---ch-------hhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 238 -------------ER---DR-------KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 238 -------------~~---~~-------~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
.. +. ..+.+..+++.+||..+|.+|.|+..+|.||||.....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 01 11 22347899999999999999999999999999987643
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=390.15 Aligned_cols=253 Identities=28% Similarity=0.489 Sum_probs=212.9
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||.||+|.+..+++.||+|+++... .......+.+|+.++..+ +||||++++++|.++..+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997543 233456688999999888 799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......+. ...+
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTST 155 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---cccc
Confidence 9999988765 6799999999999999999999999999999999999999999999999999864322221 2345
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC--------hHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP--------PMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~--------~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+.....+..... ..+..++.
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~p~~~~~ 230 (329)
T cd05588 156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----RIPRSLSV 230 (329)
T ss_pred ccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----CCCCCCCH
Confidence 789999999999986 678999999999999999999999996321 11222233332221 23456889
Q ss_pred HHHHHHHhhcccCCCCCCC------HHHHHhCcccccccC
Q 006664 246 SFKQMIASCLVKDPSKRPS------AKKLLKHSFFKQARS 279 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRps------a~elL~Hpffk~~~~ 279 (636)
.+++||.+||++||.+|++ +.++++||||....+
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 9999999999999999987 799999999987653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=377.87 Aligned_cols=258 Identities=27% Similarity=0.385 Sum_probs=211.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcC-CCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhC---CCCCcceeeeEEEe-----
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIP-FNEIVAVKILDFERDN-SDLSNISREAQTMILV---DHPNVLKSHCSFVS----- 80 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~-tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L---~HPNIVkl~~~~~~----- 80 (636)
++|++++.||+|+||.||+|.+.. +|..||+|++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 4788999998755432 2334566788887765 69999999998852
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
...+++||||+. ++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456999999997 5899999876556699999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--CCCcc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--GLDYE 238 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~--~~~~~ 238 (636)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+..+...... ..+++
T Consensus 160 ~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 160 YSFQ----MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred ccCC----cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 4222 22345679999999999976 57899999999999999999999999988777666555432210 00000
Q ss_pred --------------------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 239 --------------------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 239 --------------------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
....++..+++||.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=391.90 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=215.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GG 94 (636)
+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+++++.++||||++++++|..+..+|+||||+.||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997543 2234556788999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 95 SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 95 sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
+|..++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++........ ....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~ 155 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKT 155 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---cccc
Confidence 999988765 579999999999999999999997 7999999999999999999999999999864322211 2235
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.........+... . ...+..+++++.+||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~----~~~p~~~~~~~~~li~~ 229 (325)
T cd05594 156 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-E----IRFPRTLSPEAKSLLSG 229 (325)
T ss_pred ccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-C----CCCCCCCCHHHHHHHHH
Confidence 679999999999976 67899999999999999999999999877665544443322 1 12235688999999999
Q ss_pred hcccCCCCCC-----CHHHHHhCcccccccCh
Q 006664 254 CLVKDPSKRP-----SAKKLLKHSFFKQARSN 280 (636)
Q Consensus 254 cL~~DP~kRp-----sa~elL~Hpffk~~~~~ 280 (636)
||.+||.+|+ ++.++++||||....+.
T Consensus 230 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 230 LLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred HhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9999999997 89999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=387.94 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=221.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVm 88 (636)
+|.+++.||+|+||.||+|.+..+++.||||++..... ......+..|..++..+ +||+|+++++++.+...+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 68999999999999999999999999999999975432 23345567788888777 5899999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......+
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--- 155 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC---
Confidence 999999999999775 579999999999999999999999999999999999999999999999999986432211
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+..... ..+..++.++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s~~~~ 229 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----AYPKSMSKEAV 229 (323)
T ss_pred CccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCCcCCHHHH
Confidence 12345689999999999986 6799999999999999999999999998877766655554321 22356889999
Q ss_pred HHHHhhcccCCCCCCC-----HHHHHhCcccccccCh
Q 006664 249 QMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSN 280 (636)
Q Consensus 249 dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~ 280 (636)
+||.+||.+||.+|++ ..++++||||+...+.
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred HHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9999999999999997 4899999999876544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=407.50 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=212.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC-------
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD------- 81 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~------- 81 (636)
...+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++||||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 4568999999999999999999999999999999885432 2345799999999999999999887542
Q ss_pred -CeEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-cEEEeccCc
Q 006664 82 -HNLWVVMPFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-AIKLGDFGV 157 (636)
Q Consensus 82 -~~l~iVmEy~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-~vKL~DFGl 157 (636)
..+++||||+.+ +|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 257899999975 677776542 235699999999999999999999999999999999999998654 799999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC---
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG--- 234 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~--- 234 (636)
|+.+.... .....+||+.|||||++.+...|+.++|||||||++|+|++|.+||.+....+.+..+++.....
T Consensus 218 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 218 AKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred chhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 97653221 12356899999999998775679999999999999999999999999887766665554321100
Q ss_pred -----------CCc----------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 235 -----------LDY----------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 235 -----------~~~----------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
+.+ ..+...+.++++||.+||.+||.+|||+.+++.||||.....
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 000 112246789999999999999999999999999999986543
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=387.76 Aligned_cols=253 Identities=26% Similarity=0.454 Sum_probs=216.3
Q ss_pred EeEEcccCceEEEEEEEc---CCCcEEEEEEeecCC---CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 16 YEEVGQGVSASVHRALCI---PFNEIVAVKILDFER---DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~---~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+|+.++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 578999999997532 22334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... .
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~ 155 (323)
T cd05584 81 YLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---T 155 (323)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC---C
Confidence 99999999999875 578999999999999999999999999999999999999999999999999986543222 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ...+..+++.+.+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 229 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-----LNLPPYLTPEARD 229 (323)
T ss_pred cccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----CCCCCCCCHHHHH
Confidence 2345689999999999976 568899999999999999999999999877766555554432 1234567899999
Q ss_pred HHHhhcccCCCCCC-----CHHHHHhCcccccccC
Q 006664 250 MIASCLVKDPSKRP-----SAKKLLKHSFFKQARS 279 (636)
Q Consensus 250 LI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~ 279 (636)
||.+||.+||.+|| ++.+++.||||+...+
T Consensus 230 li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 230 LLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred HHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=394.54 Aligned_cols=268 Identities=28% Similarity=0.453 Sum_probs=225.5
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
...+..++|++.+.||+|+||.||+|.++.+++.||+|++.... .......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 35667799999999999999999999999999999999996432 2223456788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||.||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 999999999999999999763 58999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhcc---CCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLH---GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~---~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
..+. ....+.+||+.|||||++.+.. .++.++|||||||++|+|++|..||...+.......+... ...+.++.
T Consensus 194 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 270 (371)
T cd05622 194 KEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH-KNSLTFPD 270 (371)
T ss_pred cCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCcccCCC
Confidence 2221 1234678999999999997532 3789999999999999999999999987776655555433 22334445
Q ss_pred chhhhHHHHHHHHhhcccCCCC--CCCHHHHHhCccccccc
Q 006664 240 DRKFSKSFKQMIASCLVKDPSK--RPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~k--Rpsa~elL~Hpffk~~~ 278 (636)
...++..+++||.+||..++.+ |++++++++|+||++..
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 5678999999999999844443 78999999999998643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=381.00 Aligned_cols=264 Identities=23% Similarity=0.375 Sum_probs=219.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|.+++.||+|+||.||+|.+..+++.||+|.++..........+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 57899999999999999999999999999999999766544444567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.+ +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 85 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~ 159 (309)
T cd07872 85 YLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT---K 159 (309)
T ss_pred CCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc---c
Confidence 9975 888888664 2458999999999999999999999999999999999999999999999999986532211 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG--------------- 234 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~--------------- 234 (636)
......||+.|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+.......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 12345789999999999765678999999999999999999999998776655544333211100
Q ss_pred -CC---------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 235 -LD---------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 235 -~~---------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.. ......++.++++||.+||..||.+|||+.|+++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00 011134688999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=383.92 Aligned_cols=259 Identities=27% Similarity=0.409 Sum_probs=219.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC-----eEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH-----NLWV 86 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~-----~l~i 86 (636)
.|.-.+.+|.|+||.||+|+...+++.||||.+..++... .+|+.||+.++|||||++..+|.... ++.+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 5888999999999999999999999999999986554432 37999999999999999988886532 4678
Q ss_pred EEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC-CcEEEeccCccccccc
Q 006664 87 VMPFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR-GAIKLGDFGVSACLFD 163 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~-g~vKL~DFGla~~~~~ 163 (636)
|||||+. +|..+++.. ....++...++-|..||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+..
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999975 899888742 23568899999999999999999999999999999999999965 9999999999988754
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC----------
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP---------- 233 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~---------- 233 (636)
... ..++..|++|+|||.+.+...|+.+.||||.||++.||+.|++.|.+.+..+++..+++-...
T Consensus 179 ~ep----niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 179 GEP----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred CCC----ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 432 246788999999999999999999999999999999999999999999998888777642110
Q ss_pred -C--------CCc-----ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 234 -G--------LDY-----ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 234 -~--------~~~-----~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
. +.. ......++++.+|+.++|..+|.+|.++.+++.||||...+..
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0 000 0124568899999999999999999999999999999876543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=399.54 Aligned_cols=258 Identities=27% Similarity=0.454 Sum_probs=234.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe-EEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILVDHPNVLKSHCSFVSDHN-LWVV 87 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~-l~iV 87 (636)
.++|..++.||+|+||.+++++++..+..||+|.|...+... .......|+.+++++.|||||.+++.|+.++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 578999999999999999999999999999999999887443 34478899999999999999999999999988 9999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|+||+||++.+.++......|+|..+..||.||+.|+.|||+++|+|||||+.|||+..++.|||+|||+|+.+....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-- 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-- 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence 999999999999998866779999999999999999999999999999999999999999999999999999874432
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
....+.+|||.||.||++.+ ..|+.|+|||||||++|||++-+++|...+.......+.+... .+.+..++.++
T Consensus 161 -~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~----~Plp~~ys~el 234 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY----SPLPSMYSSEL 234 (426)
T ss_pred -hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC----CCCCccccHHH
Confidence 24567899999999999987 7899999999999999999999999998888777777776542 34567899999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
+.+|+.||.++|..||++.+||.+|...
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 9999999999999999999999997765
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=385.75 Aligned_cols=252 Identities=29% Similarity=0.515 Sum_probs=213.5
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHh-CCCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMIL-VDHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~-L~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||.||+|.+..+++.||||+++... .......+..|..++.. ++||||+++++++..+..+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997543 22344556677777764 4899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKAST 155 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Ccccc
Confidence 9999999875 579999999999999999999999999999999999999999999999999987542221 22346
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+... .+ ..+..++.++.+||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~----~~~~~~~~~~~~ll~~ 229 (316)
T cd05592 156 FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RP----HFPRWISKEAKDCLSK 229 (316)
T ss_pred ccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CC----CCCCCCCHHHHHHHHH
Confidence 789999999999976 56899999999999999999999999987776655444332 22 2235678999999999
Q ss_pred hcccCCCCCCCH-HHHHhCcccccccC
Q 006664 254 CLVKDPSKRPSA-KKLLKHSFFKQARS 279 (636)
Q Consensus 254 cL~~DP~kRpsa-~elL~Hpffk~~~~ 279 (636)
||..||.+||++ .+++.||||+...+
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 230 LFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred HccCCHHHcCCChHHHHcCcccCCCCH
Confidence 999999999986 58899999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=384.65 Aligned_cols=265 Identities=24% Similarity=0.440 Sum_probs=219.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||+||++.+..+++.||+|+++... .......+.+|+.+++.++||||++++++|.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999997432 2234556889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-- 157 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC--
Confidence 999999999999764 35699999999999999999999999999999999999999999999999999875533221
Q ss_pred cccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc-ccchhh
Q 006664 169 RMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY-ERDRKF 243 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~-~~~~~~ 243 (636)
......+||+.|||||++.. ...++.++|||||||++|+|++|+.||.+....+....+..... .... .....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~ 236 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-HFQFPPDVTDV 236 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-cccCCCccCCC
Confidence 11223579999999999973 23578899999999999999999999988776655544443221 1111 122357
Q ss_pred hHHHHHHHHhhcccCCCC--CCCHHHHHhCcccccccC
Q 006664 244 SKSFKQMIASCLVKDPSK--RPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~k--Rpsa~elL~Hpffk~~~~ 279 (636)
+..+++||.+||..++++ |+++.++++||||....+
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 899999999999765554 789999999999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=384.95 Aligned_cols=252 Identities=28% Similarity=0.468 Sum_probs=213.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHh-CCCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMIL-VDHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~-L~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||.||+|.++.+|+.||+|+++... .......+..|..++.. ++||||++++++|.+++.+|+|||||.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999999999999999997543 12345567778888875 5899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG---DNRAST 155 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC---CCceec
Confidence 9999998775 57899999999999999999999999999999999999999999999999998643211 112346
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+.......+... .+. .+..++.++++||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~li~~ 229 (316)
T cd05620 156 FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPH----YPRWITKESKDILEK 229 (316)
T ss_pred cCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCC----CCCCCCHHHHHHHHH
Confidence 789999999999986 67899999999999999999999999887765554443322 221 234578999999999
Q ss_pred hcccCCCCCCCH-HHHHhCcccccccC
Q 006664 254 CLVKDPSKRPSA-KKLLKHSFFKQARS 279 (636)
Q Consensus 254 cL~~DP~kRpsa-~elL~Hpffk~~~~ 279 (636)
||..||.+||++ +++++||||+...+
T Consensus 230 ~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 230 LFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred HccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 999999999997 58999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=385.92 Aligned_cols=260 Identities=34% Similarity=0.586 Sum_probs=219.3
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
++..++|++.+.||+|+||.||+|.+..++..+|+|++...........+.+|+++++.++||||++++++|.+++.+|+
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 35678999999999999999999999999999999999766554556678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
||||+.||+|.+++... ..+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999999999875 5689999999999999999999975 7999999999999999999999999998754222
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHH------------------
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT------------------ 227 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~------------------ 227 (636)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 158 ----MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred ----ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 2235679999999999976 56899999999999999999999999754432221110
Q ss_pred --------------------------HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 228 --------------------------LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 228 --------------------------~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.....+. .....++.++++||.+||.+||.+||++.+++.||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPK---LPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCcc---CCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000000 0012367889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=366.07 Aligned_cols=264 Identities=60% Similarity=1.076 Sum_probs=231.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
++|++++.||.|+||+||+|.+..++..+|+|++...........+.+|+.+++.++||||+++++.+..+...|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 58999999999999999999999999999999997665555677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc-
Q 006664 91 MSGGSCLHILKAAYP-DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ- 168 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~- 168 (636)
+.|++|.+++..... ..+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++..+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 999999999987644 568999999999999999999999999999999999999999999999999987765443221
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCccc-chhhhHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER-DRKFSKSF 247 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~-~~~~S~~l 247 (636)
......+|++.|+|||++.....++.++|+|||||++|+|++|+.||...+..+.+.......++.+.... ...++..+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence 23355689999999999977557899999999999999999999999988777766666665444433322 24688999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.+||.+||.+||.+||++.+|++||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=376.39 Aligned_cols=263 Identities=25% Similarity=0.365 Sum_probs=218.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.|++.+.||+|+||+||++.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999965332 1223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.||+|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence 9999999998876544569999999999999999999999999999999999999999999999999987542211
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
.....+|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+............... ......+..++..+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK-EDQEEYSEKFSEAARS 234 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh-hcccccCcccCHHHHH
Confidence 1234589999999999976 5689999999999999999999999987654332222211111 1111223568899999
Q ss_pred HHHhhcccCCCCCC-----CHHHHHhCcccccccCh
Q 006664 250 MIASCLVKDPSKRP-----SAKKLLKHSFFKQARSN 280 (636)
Q Consensus 250 LI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~ 280 (636)
||.+||..||.+|| +++++++||||....+.
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred HHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 99999999999999 99999999999875543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=385.29 Aligned_cols=252 Identities=29% Similarity=0.443 Sum_probs=212.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHH-HHHhCCCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQ-TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~-iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||+||+|.+..+|+.||||++..... ......+.+|.. +++.++||||+++++++.++..+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 479999999999999999999999999975421 223344555655 45789999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---KTTST 155 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC---Ccccc
Confidence 9999999875 579999999999999999999999999999999999999999999999999986532221 12345
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+... .. .....++..+.++|.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~----~~~~~~~~~~~~li~~ 229 (323)
T cd05575 156 FCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-PL----RLKPNISVSARHLLEG 229 (323)
T ss_pred ccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CC----CCCCCCCHHHHHHHHH
Confidence 689999999999976 67999999999999999999999999887765555444432 22 2234578999999999
Q ss_pred hcccCCCCCCCH----HHHHhCcccccccC
Q 006664 254 CLVKDPSKRPSA----KKLLKHSFFKQARS 279 (636)
Q Consensus 254 cL~~DP~kRpsa----~elL~Hpffk~~~~ 279 (636)
||.+||.+||++ .++++||||....+
T Consensus 230 ~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 230 LLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred HhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999987 69999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=400.99 Aligned_cols=260 Identities=37% Similarity=0.658 Sum_probs=233.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.|.-++.||.|+||.||.|.+..+.++||||.+.... ....+.+|..|+..|+.++|||++.+.+||..++..|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4666789999999999999999999999999997654 33457789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||-| +-.|++.-. ..++-|..|+.|+.+.+.||.|||+++.||||||..|||+...|.|||+|||.|..+ .
T Consensus 107 YClG-SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~-------~ 177 (948)
T KOG0577|consen 107 YCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM-------A 177 (948)
T ss_pred HHhc-cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc-------C
Confidence 9965 777777654 367999999999999999999999999999999999999999999999999998754 2
Q ss_pred ccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
..++|+|||+|||||++.. ...|+-++|||||||+..||+..++|+...+.+..+..+-++..|.+. ...||..|
T Consensus 178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq---s~eWS~~F 254 (948)
T KOG0577|consen 178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ---SNEWSDYF 254 (948)
T ss_pred chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC---CchhHHHH
Confidence 3468999999999999864 235999999999999999999999999999999999999999988876 46789999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCcccccccChHHH
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYI 283 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~~i 283 (636)
++||..||.+-|.+|||++++|+|+|+...+....+
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi 290 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVI 290 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHH
Confidence 999999999999999999999999999876665443
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=383.44 Aligned_cols=258 Identities=26% Similarity=0.464 Sum_probs=220.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~iVm 88 (636)
+|++.+.||+|+||+||+|.++.+|+.||||++.... .......+..|+.++..+. ||+|+++++++.++..+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999997543 2234566788999998885 577889999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......+.
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-- 156 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--
Confidence 999999999999775 5799999999999999999999999999999999999999999999999999875322211
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..... ..+..++.++.
T Consensus 157 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-----~~p~~~~~~~~ 229 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-----SYPKSLSKEAV 229 (323)
T ss_pred -cccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCccCCHHHH
Confidence 2235679999999999976 6789999999999999999999999998877666655554321 23356789999
Q ss_pred HHHHhhcccCCCCCCC-----HHHHHhCcccccccCh
Q 006664 249 QMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSN 280 (636)
Q Consensus 249 dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~ 280 (636)
+++.+||.+||.+|++ ..++++||||....+.
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred HHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 9999999999999997 5899999999976544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=384.76 Aligned_cols=253 Identities=28% Similarity=0.490 Sum_probs=211.4
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++..+ +||||+++++++..+..+|+|||||.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997653 233456688899998766 899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......+. ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTST 155 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---cccc
Confidence 9999988765 5799999999999999999999999999999999999999999999999999875322221 2345
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCC--------ChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKY--------PPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~--------~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... .....+...+.... ...+..++.
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----~~~p~~~~~ 230 (329)
T cd05618 156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----IRIPRSLSV 230 (329)
T ss_pred ccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----CCCCCCCCH
Confidence 789999999999986 67899999999999999999999999521 11122222222221 123456789
Q ss_pred HHHHHHHhhcccCCCCCCC------HHHHHhCcccccccC
Q 006664 246 SFKQMIASCLVKDPSKRPS------AKKLLKHSFFKQARS 279 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRps------a~elL~Hpffk~~~~ 279 (636)
.+++||.+||+.||.+||+ +.++++||||+...+
T Consensus 231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 9999999999999999998 589999999987643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=374.62 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=211.2
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCH
Q 006664 19 VGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96 (636)
Q Consensus 19 IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL 96 (636)
||+|+||+||++.+..+|+.||+|++..... ......+..|+.+++.++||||++++++|..+..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999999999999999999865432 22345678899999999999999999999999999999999999999
Q ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccc
Q 006664 97 LHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF 174 (636)
Q Consensus 97 ~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 174 (636)
.+++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+.... ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---cccccc
Confidence 9887542 22468999999999999999999999999999999999999999999999999987543221 123356
Q ss_pred cCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhh
Q 006664 175 VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASC 254 (636)
Q Consensus 175 ~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~c 254 (636)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................. .....+..++..+.+|+.+|
T Consensus 158 ~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 158 AGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-DSVTYPDKFSPASKSFCEAL 235 (280)
T ss_pred CCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc-cCCCCcccCCHHHHHHHHHH
Confidence 89999999999986 57899999999999999999999999764432111111111111 11123356889999999999
Q ss_pred cccCCCCCC-----CHHHHHhCcccccccCh
Q 006664 255 LVKDPSKRP-----SAKKLLKHSFFKQARSN 280 (636)
Q Consensus 255 L~~DP~kRp-----sa~elL~Hpffk~~~~~ 280 (636)
|..||.+|| +++++++||||+...+.
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 999999999 88999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=383.12 Aligned_cols=252 Identities=29% Similarity=0.499 Sum_probs=215.9
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+++.+ +||||+++++++.+...+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997543 223456678899999877 799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTST 155 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC---Ccccc
Confidence 9999998775 579999999999999999999999999999999999999999999999999986432221 12235
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+... .. ..+..++..+++||.+
T Consensus 156 ~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-~~----~~~~~~~~~~~~li~~ 229 (318)
T cd05570 156 FCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-EV----RYPRWLSKEAKSILKS 229 (318)
T ss_pred eecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CC----CCCCcCCHHHHHHHHH
Confidence 689999999999976 67899999999999999999999999887766555444332 21 2235678999999999
Q ss_pred hcccCCCCCCCH-----HHHHhCcccccccC
Q 006664 254 CLVKDPSKRPSA-----KKLLKHSFFKQARS 279 (636)
Q Consensus 254 cL~~DP~kRpsa-----~elL~Hpffk~~~~ 279 (636)
||.+||.+||++ .+++.||||+...+
T Consensus 230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 230 FLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred HccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999999 99999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=371.96 Aligned_cols=257 Identities=27% Similarity=0.384 Sum_probs=210.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhC---CCCCcceeeeEEEe-----CC
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILV---DHPNVLKSHCSFVS-----DH 82 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L---~HPNIVkl~~~~~~-----~~ 82 (636)
+|++++.||+|+||+||+|.++.+|+.||+|.++..... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 599999999999999999999999999999999754322 2233456788877665 79999999998865 34
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+++||||+.+ +|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 68999999985 89999887655569999999999999999999999999999999999999999999999999987542
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC--CCCCc---
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP--PGLDY--- 237 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~--~~~~~--- 237 (636)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+..+..... ....+
T Consensus 160 ~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 160 CQ----MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred Cc----ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 21 12234578999999999976 5789999999999999999999999988776655544432110 00000
Q ss_pred -----------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 238 -----------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 238 -----------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.....++..+++||.+||.+||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=383.10 Aligned_cols=265 Identities=24% Similarity=0.435 Sum_probs=220.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||+||++.++.+++.||+|++.... .......+.+|+.++..++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999986432 1223445788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...+.
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-- 157 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-- 157 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc--
Confidence 999999999999764 25689999999999999999999999999999999999999999999999999875433221
Q ss_pred cccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcc-cchhh
Q 006664 169 RMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE-RDRKF 243 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~-~~~~~ 243 (636)
......+||+.|||||++.+ ...|+.++|||||||++|||++|+.||......+....+..... ...++ ....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~ 236 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-RFQFPAQVTDV 236 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-cccCCCccccC
Confidence 12234689999999999863 24588999999999999999999999998777666655543321 11221 12457
Q ss_pred hHHHHHHHHhhcccCCCC--CCCHHHHHhCcccccccC
Q 006664 244 SKSFKQMIASCLVKDPSK--RPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~k--Rpsa~elL~Hpffk~~~~ 279 (636)
++++++||.+||..++.+ |++++++++||||..+.+
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 999999999999765554 689999999999987654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=390.97 Aligned_cols=258 Identities=31% Similarity=0.500 Sum_probs=212.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
...++|++++.||+|+||.||+|.+..+|+.||||++...........+.+|+.+++.++||||++++++|..++.+|+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 44578999999999999999999999999999999997555444566789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
||||+||+|... ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 151 ~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 222 (353)
T PLN00034 151 LEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-- 222 (353)
T ss_pred EecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--
Confidence 999999998642 235678889999999999999999999999999999999999999999999987653221
Q ss_pred ccccccccCCCCCCChhhhhhc----cCCCcccchhhHHHHHHHHHcCCCCCCCCCh--HHHHHHHHhcCCCCCCcccch
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQL----HGYDFKADIWSFGITALELAHGHAPFSKYPP--MKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~----~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~--~~~l~~~~~~~~~~~~~~~~~ 241 (636)
......+||+.|+|||++... ..++.++|||||||++|+|++|+.||..... ...+...+.. ........
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~ 298 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM---SQPPEAPA 298 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc---cCCCCCCC
Confidence 112356899999999987431 2345689999999999999999999974322 1111111111 11122345
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.++.++++||.+||..||.+||++.|+++||||...
T Consensus 299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 299 TASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 678999999999999999999999999999999864
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=385.35 Aligned_cols=254 Identities=26% Similarity=0.469 Sum_probs=213.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.++..+ +||||+++++++.+...+|+|||||.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976532 23456788999999887 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......+ ....+
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DTTST 155 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC---Cceec
Confidence 9999988765 579999999999999999999999999999999999999999999999999987432222 12346
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCC------ChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKY------PPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~------~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||... .........+...+. ..+..++..+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~p~~~~~~~ 230 (327)
T cd05617 156 FCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----RIPRFLSVKA 230 (327)
T ss_pred ccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----CCCCCCCHHH
Confidence 789999999999976 67899999999999999999999999532 222333333333222 2345678999
Q ss_pred HHHHHhhcccCCCCCCC------HHHHHhCcccccccCh
Q 006664 248 KQMIASCLVKDPSKRPS------AKKLLKHSFFKQARSN 280 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRps------a~elL~Hpffk~~~~~ 280 (636)
.++|.+||.+||.+|++ +.+++.||||+...+.
T Consensus 231 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 99999999999999997 5799999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=392.96 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=209.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
+...+|.+++.||+|+||.||+|.+..+++.||||... ...+.+|+.+++.++||||++++++|..+...++|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 45578999999999999999999999999999999753 23467899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+. ++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 162 ~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-- 236 (391)
T PHA03212 162 LPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-- 236 (391)
T ss_pred EecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc--
Confidence 99995 6899888765 568999999999999999999999999999999999999999999999999986532221
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC-------hHHHHHHHHhcC---CCCC--
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP-------PMKVLLMTLQNA---PPGL-- 235 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~-------~~~~l~~~~~~~---~~~~-- 235 (636)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.... ....+..++... +..+
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred ccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 112345689999999999976 679999999999999999999998875321 111111111100 0000
Q ss_pred -------------------------CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 236 -------------------------DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 236 -------------------------~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.+.....++.++.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 000112356789999999999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=383.78 Aligned_cols=261 Identities=22% Similarity=0.373 Sum_probs=213.4
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEE-----cCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALC-----IPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSF 78 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~-----~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~ 78 (636)
.|++..++|++++.||+|+||.||+|.+ ..++..||+|++...........+.+|+.+++.+ +||||+++++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 4889999999999999999999999975 2456789999997544444566789999999999 899999999988
Q ss_pred EeC-CeEEEEEeccCCCCHHHHHHHhC-----------------------------------------------------
Q 006664 79 VSD-HNLWVVMPFMSGGSCLHILKAAY----------------------------------------------------- 104 (636)
Q Consensus 79 ~~~-~~l~iVmEy~~GGsL~~lL~~~~----------------------------------------------------- 104 (636)
... ..+|+|||||+||+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 46899999999999999987531
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccCC
Q 006664 105 -------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177 (636)
Q Consensus 105 -------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT 177 (636)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..... ........++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~ 239 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLP 239 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCC
Confidence 12477888999999999999999999999999999999999999999999999876532211 1112334567
Q ss_pred CCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcc
Q 006664 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLV 256 (636)
Q Consensus 178 ~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~ 256 (636)
+.|||||++.+ ..|+.++|||||||++|||++ |..||.+..........+.... ....+..+++.+.+||.+||.
T Consensus 240 ~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 240 LKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT---RMRAPENATPEIYRIMLACWQ 315 (338)
T ss_pred ccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC---CCCCCCCCCHHHHHHHHHHcc
Confidence 88999999976 678999999999999999997 9999987654444434433322 122345678899999999999
Q ss_pred cCCCCCCCHHHHHh
Q 006664 257 KDPSKRPSAKKLLK 270 (636)
Q Consensus 257 ~DP~kRpsa~elL~ 270 (636)
.||.+||++.++++
T Consensus 316 ~dp~~RPs~~el~~ 329 (338)
T cd05102 316 GDPKERPTFSALVE 329 (338)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=384.47 Aligned_cols=252 Identities=29% Similarity=0.464 Sum_probs=215.6
Q ss_pred EeEEcccCceEEEEEEEc---CCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEecc
Q 006664 16 YEEVGQGVSASVHRALCI---PFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~ 91 (636)
++.||+|+||.||++.+. .+|+.||+|++..... ......+.+|+.+++.++||||+++++++.++..+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999998763 5789999999975432 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
.||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~ 155 (318)
T cd05582 81 RGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---KKA 155 (318)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC---Cce
Confidence 999999999765 569999999999999999999999999999999999999999999999999987543221 123
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHH
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI 251 (636)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..... ..+..+++++++||
T Consensus 156 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-----~~p~~~~~~~~~li 229 (318)
T cd05582 156 YSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-----GMPQFLSPEAQSLL 229 (318)
T ss_pred ecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-----CCCCCCCHHHHHHH
Confidence 45689999999999976 6789999999999999999999999998777666655543321 22356789999999
Q ss_pred HhhcccCCCCCCC-----HHHHHhCccccccc
Q 006664 252 ASCLVKDPSKRPS-----AKKLLKHSFFKQAR 278 (636)
Q Consensus 252 ~~cL~~DP~kRps-----a~elL~Hpffk~~~ 278 (636)
.+||.+||.+||+ +.+++.||||....
T Consensus 230 ~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 230 RALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 9999999999999 78899999998764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=383.25 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=212.5
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHH-HHHhCCCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQ-TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~-iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||+||+|.+..+++.||+|++..... ......+.+|.. +++.++||||+++++++..+..+|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999999999999999975421 122334444544 46789999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---~~~~~ 155 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---GTTST 155 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC---CCccc
Confidence 9999999875 578999999999999999999999999999999999999999999999999987543222 12346
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+....+....+... +. .....++..++++|.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~----~~~~~~~~~~~~li~~ 229 (325)
T cd05602 156 FCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PL----QLKPNITNSARHLLEG 229 (325)
T ss_pred ccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-Cc----CCCCCCCHHHHHHHHH
Confidence 789999999999976 67899999999999999999999999987776655544432 21 2235688999999999
Q ss_pred hcccCCCCCCCHH----HHHhCcccccccCh
Q 006664 254 CLVKDPSKRPSAK----KLLKHSFFKQARSN 280 (636)
Q Consensus 254 cL~~DP~kRpsa~----elL~Hpffk~~~~~ 280 (636)
||++||.+|+++. ++++|+||....+.
T Consensus 230 ~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~ 260 (325)
T cd05602 230 LLQKDRTKRLGAKDDFMEIKNHIFFSPINWD 260 (325)
T ss_pred HcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence 9999999999865 89999999876544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=380.45 Aligned_cols=252 Identities=27% Similarity=0.493 Sum_probs=213.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHh-CCCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMIL-VDHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~-L~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||+||+|.+..+++.||||++.... ..........|..++.. ++||||+++++++.++..+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997543 12334556778888875 5999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCT 155 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC---Cceee
Confidence 9999999875 568999999999999999999999999999999999999999999999999986432211 12345
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+... .+. .+..++.++++||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~~~----~~~~~~~~~~~li~~ 229 (316)
T cd05619 156 FCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-NPC----YPRWLTREAKDILVK 229 (316)
T ss_pred ecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCC----CCccCCHHHHHHHHH
Confidence 689999999999976 67899999999999999999999999887765554443322 222 234578999999999
Q ss_pred hcccCCCCCCCHH-HHHhCcccccccC
Q 006664 254 CLVKDPSKRPSAK-KLLKHSFFKQARS 279 (636)
Q Consensus 254 cL~~DP~kRpsa~-elL~Hpffk~~~~ 279 (636)
||..||.+||++. +++.||||+...+
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCCCCH
Confidence 9999999999996 9999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=372.48 Aligned_cols=264 Identities=22% Similarity=0.373 Sum_probs=220.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++++.||.|+||.||+|.+..+++.||+|.+...........+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 57899999999999999999999999999999999766544445567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+. ++|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 85 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT---K 159 (301)
T ss_pred ccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC---C
Confidence 997 5898888764 3568999999999999999999999999999999999999999999999999986542211 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG--------------- 234 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~--------------- 234 (636)
......+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+....+.......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 12345679999999998775668899999999999999999999998876655543332211100
Q ss_pred -CCcc---------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 235 -LDYE---------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 235 -~~~~---------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
..++ ....+++.+++||.+||..||.+|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0000 1134688999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=424.84 Aligned_cols=267 Identities=26% Similarity=0.436 Sum_probs=235.1
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
-+.+++|++++.||+|+||.|.+++++.|+++||+|++++-.. ..+...+..|-.+|.-.+.+-|+.++..|.++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 4678999999999999999999999999999999999975321 23455688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||+.||||..+|.+. ..++|..+++|+..|+.||.-||+.|+|||||||+|||||..|+|||+|||.|..+...
T Consensus 151 YlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999999987 48999999999999999999999999999999999999999999999999998877544
Q ss_pred CCcccccccccCCCCCCChhhhhhc----cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQL----HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~----~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
|.- .....+|||-|.+||+|... ..|+..+|+||+||++|||++|..||....-.+.+-.|+.. ...+.++..
T Consensus 229 G~V--~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-k~~l~FP~~ 305 (1317)
T KOG0612|consen 229 GTV--RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-KESLSFPDE 305 (1317)
T ss_pred CcE--EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-hhhcCCCcc
Confidence 432 24567999999999999742 34899999999999999999999999887777766666654 344566656
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCC---HHHHHhCcccccccC
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPS---AKKLLKHSFFKQARS 279 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRps---a~elL~Hpffk~~~~ 279 (636)
..+|+++++||.++| .+|..|.. ++++..||||.+..|
T Consensus 306 ~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 306 TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred cccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCCh
Confidence 779999999999988 58999998 999999999999988
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=385.13 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=210.2
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhC---CCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 19 VGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILV---DHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 19 IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L---~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
||+|+||+||+|.+..+|+.||||++..... ........+|..++..+ +||||++++++|..+..+|+||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999964321 12334455677777655 799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---~~~~~ 155 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---KTTNT 155 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC---CCccC
Confidence 9999998765 679999999999999999999999999999999999999999999999999987543222 22346
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+||+.|||||++.+...++.++|||||||++|+|++|..||...........+.... .. ++ ...+++++++||.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~--~~-~~~~~~~~~~li~~ 231 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK-VR--FP-KNVLSDEGRQFVKG 231 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC-CC--CC-CccCCHHHHHHHHH
Confidence 7899999999999765668999999999999999999999998876655444433221 11 11 23478999999999
Q ss_pred hcccCCCCCC----CHHHHHhCccccccc
Q 006664 254 CLVKDPSKRP----SAKKLLKHSFFKQAR 278 (636)
Q Consensus 254 cL~~DP~kRp----sa~elL~Hpffk~~~ 278 (636)
||.+||.+|| ++.++++||||+...
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 9999999998 799999999998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=382.25 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=211.9
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHH-HHHhCCCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQ-TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~-iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||+||+|.+..+|+.||+|++.... .......+.+|.. +++.++||||+++++++..+..+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999996542 1223345556655 46779999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---~~~~~ 155 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---DTTTT 155 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC---CCccc
Confidence 9999988765 679999999999999999999999999999999999999999999999999986432221 12345
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+||+.|||||++.+ ..++.++|||||||++|+|++|..||...+..+....+... .. ......+..+.++|.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~ll~~ 229 (325)
T cd05604 156 FCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-PL----VLRPGASLTAWSILEE 229 (325)
T ss_pred ccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-Cc----cCCCCCCHHHHHHHHH
Confidence 689999999999976 67899999999999999999999999887766655554432 21 2234578899999999
Q ss_pred hcccCCCCCCCH----HHHHhCcccccccC
Q 006664 254 CLVKDPSKRPSA----KKLLKHSFFKQARS 279 (636)
Q Consensus 254 cL~~DP~kRpsa----~elL~Hpffk~~~~ 279 (636)
||.+||.+||++ .++++||||....+
T Consensus 230 ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 230 LLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred HhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999976 69999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=379.50 Aligned_cols=265 Identities=22% Similarity=0.414 Sum_probs=219.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||+||++.+..+++.||+|++.... .......+.+|+.++..++||||+++++++.++..+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999996432 2223455788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-- 157 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc--
Confidence 999999999999864 25789999999999999999999999999999999999999999999999999875532221
Q ss_pred cccccccCCCCCCChhhhhhc----cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcc-cchhh
Q 006664 169 RMRNTFVGTPCWMAPEVMEQL----HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE-RDRKF 243 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~----~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~-~~~~~ 243 (636)
......+||+.|||||++.+. ..++.++|||||||++|+|++|+.||......+....+..... .+.++ ....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~ 236 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE-RFQFPSHITDV 236 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC-cccCCCccccC
Confidence 112346799999999998642 3578899999999999999999999988776665554443221 11111 12357
Q ss_pred hHHHHHHHHhhcccCCCC--CCCHHHHHhCcccccccC
Q 006664 244 SKSFKQMIASCLVKDPSK--RPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~k--Rpsa~elL~Hpffk~~~~ 279 (636)
+.++++||.+||..++.+ |++++++++|+||....+
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 899999999999876655 568999999999987653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=382.05 Aligned_cols=259 Identities=26% Similarity=0.400 Sum_probs=210.5
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC-----
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH----- 82 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~----- 82 (636)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3589999999999999999999999999999999996543 2234567789999999999999999999987543
Q ss_pred -eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 83 -NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 83 -~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999976 5666654 34889999999999999999999999999999999999999999999999998753
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC---------
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP--------- 232 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~--------- 232 (636)
... .......||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+....+........
T Consensus 174 ~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 174 CTN----FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccC----ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 221 12345689999999999976 6789999999999999999999999987665443322221110
Q ss_pred ------------CCC---C-------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 233 ------------PGL---D-------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 233 ------------~~~---~-------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+.. . .......++.+++||.+||..||.+|||+.|+|.||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 000 0 00112346789999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=363.90 Aligned_cols=257 Identities=37% Similarity=0.559 Sum_probs=213.7
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchh-HHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEecc
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD-LSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~-~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~ 91 (636)
|++++.||+|+||+||+|.+..+++.||+|+++....... .....+|+.+++.++||||+++++++.+...+++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999986653322 223456999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+..+. ......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~---~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS---ENNENF 155 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST---STTSEB
T ss_pred cccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccc
Confidence 999999999855 679999999999999999999999999999999999999999999999999987541 122234
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc--ccchhhhHHHHH
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY--ERDRKFSKSFKQ 249 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~--~~~~~~S~~l~d 249 (636)
....||+.|+|||++.....++.++||||||+++|+|++|..||...................... ......+..+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 467899999999999733678999999999999999999999999873333322222111111110 111122489999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCccc
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+|.+||..||++||++.++++||||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=386.47 Aligned_cols=262 Identities=25% Similarity=0.361 Sum_probs=216.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC-----eEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH-----NLW 85 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~-----~l~ 85 (636)
+|++++.||+|+||.||+|.+..+|+.||||.+.... .......+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999999999999999986432 2234567889999999999999999999998876 899
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9999997 5788887654 579999999999999999999999999999999999999999999999999987542221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--------------
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA-------------- 231 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~-------------- 231 (636)
.......+||+.|+|||++.+...|+.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 158 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 158 --SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred --cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 1122345789999999999875668999999999999999999999998877666554433210
Q ss_pred --------CCCCC-----cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 232 --------PPGLD-----YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 232 --------~~~~~-----~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+.... +......+.++.+||.+||..||.+|||+.+++.||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00000 011234578999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=361.03 Aligned_cols=258 Identities=30% Similarity=0.517 Sum_probs=219.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc----hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN----SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~----~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
+.|.+.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..+..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 6799999999999999999999999999999998754322 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
||||+.|++|.+++... ..+++..+..++.|++.||.|||..||+||||+|+||+++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999999875 5689999999999999999999999999999999999999999999999999875432211
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
.........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||................ .....+..++..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 235 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP---TNPQLPSHVSPD 235 (263)
T ss_pred ccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC---CCCCCCccCCHH
Confidence 1111134678999999999987 568999999999999999999999998766655444333221 122334568899
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+.++|.+||.+||.+||++.++++|+||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=370.07 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=208.6
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCH
Q 006664 19 VGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96 (636)
Q Consensus 19 IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL 96 (636)
||+|+||.||++.++.+|+.||+|++..... ......+..|+.+++.++||||+++++++.++..+|+||||+.||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999999999999999964332 12234456799999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccC
Q 006664 97 LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176 (636)
Q Consensus 97 ~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~G 176 (636)
.+++.......+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ......|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~ 156 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAG 156 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----eeeccCC
Confidence 998876655568999999999999999999999999999999999999999999999999987543221 1234579
Q ss_pred CCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-CCCCcccchhhhHHHHHHHHhhc
Q 006664 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-PGLDYERDRKFSKSFKQMIASCL 255 (636)
Q Consensus 177 T~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~-~~~~~~~~~~~S~~l~dLI~~cL 255 (636)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||................. .... .....++.++++||.+||
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L 234 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKDICRLFL 234 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHHHHHHHh
Confidence 999999999976 4599999999999999999999999976433211111111111 1111 112467899999999999
Q ss_pred ccCCCCCCCH----HHHHhCcccccccC
Q 006664 256 VKDPSKRPSA----KKLLKHSFFKQARS 279 (636)
Q Consensus 256 ~~DP~kRpsa----~elL~Hpffk~~~~ 279 (636)
++||.+||++ .++++|+||+...+
T Consensus 235 ~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 235 AKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred ccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 9999999999 77889999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=378.11 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=210.5
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHH-HHHhCCCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQ-TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~-iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|.. +++.++||||+++++++.+.+.+|+|||||.|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999975432 123344555554 57889999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---ETTST 155 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC---Ccccc
Confidence 9999988764 578999999999999999999999999999999999999999999999999986432221 12345
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.. .+. ..+...+..+.++|.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-~~~----~~~~~~~~~~~~li~~ 229 (321)
T cd05603 156 FCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-KPL----QLPGGKTVAACDLLVG 229 (321)
T ss_pred ccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc-CCC----CCCCCCCHHHHHHHHH
Confidence 689999999999976 6789999999999999999999999988766554444433 222 2234578899999999
Q ss_pred hcccCCCCCCCH----HHHHhCcccccccC
Q 006664 254 CLVKDPSKRPSA----KKLLKHSFFKQARS 279 (636)
Q Consensus 254 cL~~DP~kRpsa----~elL~Hpffk~~~~ 279 (636)
||.+||.+||++ .++++|+||..+.+
T Consensus 230 ~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 230 LLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred HccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 999999999875 59999999986653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=365.12 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=214.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|++++.||.|+||.||+|.+..++..||||.+...... .....+.+|+.+++.++||||+++++++.++..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 689999999999999999999999999999998754432 2346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 91 MSGGSCLHILKAAYP-DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
+. ++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++...... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---VR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC---cc
Confidence 97 588888876433 46899999999999999999999999999999999999999999999999998654221 12
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC----------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP---------------- 233 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~---------------- 233 (636)
......|++.|+|||++.+...++.++|||||||++|+|++|++||.+................
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234568999999999876566889999999999999999999999876655444333221100
Q ss_pred --------CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 234 --------GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 234 --------~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.........++.++++||.+||..||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00001123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=377.33 Aligned_cols=265 Identities=39% Similarity=0.678 Sum_probs=215.6
Q ss_pred EEEeEEccc--CceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 14 TLYEEVGQG--VSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 14 ~l~~~IG~G--~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+++++||+| +||+||++.++.+|+.||||.++..... .....+.+|+.+++.++||||++++++|..+..+|+||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 357889999 7899999999999999999999766433 3456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc-
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR- 169 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~- 169 (636)
+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+......+....
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999999876556799999999999999999999999999999999999999999999999987654432221111
Q ss_pred ---ccccccCCCCCCChhhhhhc-cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 006664 170 ---MRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL---------- 235 (636)
Q Consensus 170 ---~~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~---------- 235 (636)
......++..|+|||++.+. ..|+.++|||||||++|+|++|..||.................+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 11234678889999999753 4589999999999999999999999987655443333322111100
Q ss_pred -------------------------------CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 236 -------------------------------DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 236 -------------------------------~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
..+....+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0011234678899999999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=379.36 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=211.5
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC------
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSD------ 81 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~------ 81 (636)
..++|++++.||+|+||.||+|.+..+++.||||.+..... ......+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 35899999999999999999999999999999999865432 23456778999999999999999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999976 56666653 4889999999999999999999999999999999999999999999999998754
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--------
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP-------- 233 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~-------- 233 (636)
... .......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+....+.....+.....
T Consensus 170 ~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 170 GTS----FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred CCc----cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 221 12345689999999999976 67999999999999999999999999877655443332221100
Q ss_pred -------------C---C-------------CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 234 -------------G---L-------------DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 234 -------------~---~-------------~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
. . +.......+.++++||.+||..||.+|||+.|+++||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 0 001112345788999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=367.19 Aligned_cols=266 Identities=25% Similarity=0.412 Sum_probs=223.7
Q ss_pred CCCcccccCCCCeEE-EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEE
Q 006664 1 MDKKKYPIGAEHYTL-YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSF 78 (636)
Q Consensus 1 ~~k~~~~i~~~~Y~l-~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~ 78 (636)
|+.++|.| .++|.+ -++||-|-.|.|..+.++.||+.+|+|++. +....+||++..-.. .|||||.++++|
T Consensus 52 m~~k~~~i-tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~------Ds~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 52 MDFKEYSI-TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL------DSPKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred cchhcccc-hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh------cCHHHHhHhhhhhhhcCCCceEEeehhh
Confidence 34455555 356666 468999999999999999999999999984 345678999886544 699999999998
Q ss_pred EeC----CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc---CCcEE
Q 006664 79 VSD----HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---RGAIK 151 (636)
Q Consensus 79 ~~~----~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---~g~vK 151 (636)
++. ..+.+|||.|+||+|+..+..+....|+|.++..|++||..|+.|||+.+|.||||||+|+|... +..+|
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceE
Confidence 753 57899999999999999999987777999999999999999999999999999999999999964 45799
Q ss_pred EeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHH---HHHHHH
Q 006664 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK---VLLMTL 228 (636)
Q Consensus 152 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~---~l~~~~ 228 (636)
|+|||+|+.-.. .....+.|.||+|.|||++.. ..|+..+|+||+||++|.|++|.+||....... -....+
T Consensus 205 LtDfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI 279 (400)
T KOG0604|consen 205 LTDFGFAKETQE----PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI 279 (400)
T ss_pred ecccccccccCC----CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh
Confidence 999999986432 234567899999999999965 679999999999999999999999996533211 123344
Q ss_pred hcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 229 ~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
..+.-.+..+.|..+|+.++++|+.+|..+|++|.|+.+++.|||+.+..
T Consensus 280 ~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 280 RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 55555566677889999999999999999999999999999999998653
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=379.05 Aligned_cols=258 Identities=25% Similarity=0.378 Sum_probs=212.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC------C
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSD------H 82 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~------~ 82 (636)
.++|.+++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 5899999999999999999999999999999999975432 33456778999999999999999999988643 3
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+||||+.+ +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 58999999976 67777753 47899999999999999999999999999999999999999999999999987542
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC-------
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL------- 235 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~------- 235 (636)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++.......
T Consensus 178 ~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 178 TS----FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred CC----CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 21 12345689999999999976 6789999999999999999999999988776665544433211000
Q ss_pred ------------------------------CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 236 ------------------------------DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 236 ------------------------------~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+.......+..+++||.+||..||.+|||+.++|+||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000111235678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=395.95 Aligned_cols=265 Identities=28% Similarity=0.417 Sum_probs=224.5
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC---
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH--- 82 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~--- 82 (636)
....++|.+.+.||+|+||+||+|.+..+|+.||||+++.... ......+.+|+.++..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3456899999999999999999999999999999999976543 344567889999999999999999988876432
Q ss_pred -----eEEEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEecc
Q 006664 83 -----NLWVVMPFMSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDF 155 (636)
Q Consensus 83 -----~l~iVmEy~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DF 155 (636)
.+++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 4789999999999999987532 346899999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 006664 156 GVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 235 (636)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~ 235 (636)
|+++.+.... ......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+......+..+......
T Consensus 188 Gls~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-- 263 (496)
T PTZ00283 188 GFSKMYAATV-SDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-- 263 (496)
T ss_pred ccCeeccccc-cccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC--
Confidence 9987653221 1122346789999999999976 66999999999999999999999999987776665555543322
Q ss_pred CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 236 ~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+.+..+++++.+||.+||..||.+||++.+++.|||++..
T Consensus 264 --~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 264 --PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred --CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 2345688999999999999999999999999999999753
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=393.18 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=221.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCC-CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPF-NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~t-g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
..|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+++|+.+++.++|||||+++++|..++.+|+|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 4499999999999999999998877 7889999875432 2344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 90 FMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 90 y~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|+.||+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... .
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~-~ 224 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV-S 224 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc-c
Confidence 99999999988653 22458999999999999999999999999999999999999999999999999997653321 1
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+...... +.+..++.++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----~~~~~~s~~~ 299 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----PFPCPVSSGM 299 (478)
T ss_pred cccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----CCCccCCHHH
Confidence 223446789999999999976 67999999999999999999999999887776666555543322 2234678999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
++||.+||.+||.+||++.+++.|+|++.
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999974
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=394.17 Aligned_cols=259 Identities=23% Similarity=0.313 Sum_probs=205.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCC------CCcceeeeEEEeC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDH------PNVLKSHCSFVSD 81 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~H------PNIVkl~~~~~~~ 81 (636)
+...+|++++.||+|+||+||+|.+..+++.||||+++... ........|+.++..+.| ++|++++++|..+
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 44678999999999999999999999999999999996322 223445678888877654 4588899988765
Q ss_pred -CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCC-----------
Q 006664 82 -HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRG----------- 148 (636)
Q Consensus 82 -~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g----------- 148 (636)
..+|+|||++ |++|.+++... +.+++..++.|+.||+.||.|||. .|||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 5789999998 77899988765 679999999999999999999998 5999999999999998665
Q ss_pred -----cEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHH
Q 006664 149 -----AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV 223 (636)
Q Consensus 149 -----~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~ 223 (636)
.+||+|||.+... .......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+....+.
T Consensus 281 ~~~~~~vkl~DfG~~~~~------~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDE------RHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred CCCCceEEECCCCccccC------ccccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 4999999987532 112346789999999999987 6799999999999999999999999988776554
Q ss_pred HHHHHhcCCC--------------------------CCCc-----------ccchhhhHHHHHHHHhhcccCCCCCCCHH
Q 006664 224 LLMTLQNAPP--------------------------GLDY-----------ERDRKFSKSFKQMIASCLVKDPSKRPSAK 266 (636)
Q Consensus 224 l~~~~~~~~~--------------------------~~~~-----------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~ 266 (636)
+..+...... .... ......+..+.+||.+||++||.+|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 4332221000 0000 00001245678999999999999999999
Q ss_pred HHHhCccccccc
Q 006664 267 KLLKHSFFKQAR 278 (636)
Q Consensus 267 elL~Hpffk~~~ 278 (636)
|+|+||||....
T Consensus 434 e~L~Hp~~~~~~ 445 (467)
T PTZ00284 434 QMTTHPYVLKYY 445 (467)
T ss_pred HHhcCccccccC
Confidence 999999998643
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=354.21 Aligned_cols=255 Identities=27% Similarity=0.492 Sum_probs=218.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEe-CCeEEEEEe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVS-DHNLWVVMP 89 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~-~~~l~iVmE 89 (636)
+|++++.||+|+||.||++.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+.. +..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 59999999999999999999999999999999975443 3345678899999999999999999998864 457899999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.|++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..+.... .
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~---~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---D 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---C
Confidence 9999999999987655568999999999999999999999999999999999999999999999999987653221 2
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.............+ ..+..+++.+.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 232 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP----PMPKDYSPELGE 232 (257)
T ss_pred ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC----CCccccCHHHHH
Confidence 2345679999999999876 56889999999999999999999999877665554444433222 123568899999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCccc
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
||.+||..||.+||++.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=378.97 Aligned_cols=259 Identities=27% Similarity=0.387 Sum_probs=212.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeC------C
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSD------H 82 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~------~ 82 (636)
.++|++++.||+|+||+||+|.+..+++.||||++...... .....+.+|+.+++.++||||++++++|... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 58999999999999999999999999999999998654322 2345677899999999999999999988643 3
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|++|+++ |++|.++++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 579999998 7799888764 469999999999999999999999999999999999999999999999999987542
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC--------
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-------- 234 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~-------- 234 (636)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+.......
T Consensus 170 ~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 170 D------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred C------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 2 12356899999999999775678999999999999999999999998766554443332211000
Q ss_pred --------------CCc----ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 235 --------------LDY----ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 235 --------------~~~----~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
... ......++.+.+||.+||..||.+|||+.+++.||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000 00123456789999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=366.60 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=215.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++|+||+.+++.+.++..+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 478899999999999999999999999999998654322 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.||+|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 9999999999876544569999999999999999999999999999999999999999999999999986542211
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH---HHHHHHHhcCCCCCCcccchhhhHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---KVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~---~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ............ .....++.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 231 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE----EYSEKFSPD 231 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh----hcCccCCHH
Confidence 1224579999999999976 56899999999999999999999999864321 112222221111 123457889
Q ss_pred HHHHHHhhcccCCCCCCC-----HHHHHhCccccccc
Q 006664 247 FKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQAR 278 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~ 278 (636)
+++||.+||+.||.+||| ++++++||||+...
T Consensus 232 ~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred HHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 999999999999999999 99999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=391.11 Aligned_cols=258 Identities=28% Similarity=0.420 Sum_probs=219.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-C-----CCcceeeeEEEeCCe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-H-----PNVLKSHCSFVSDHN 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-H-----PNIVkl~~~~~~~~~ 83 (636)
+.+|++++.||+|+||.|.+|.+..|++.||||+++... .-..+...|+.||..|+ | -|||+++++|...++
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 348999999999999999999999999999999996433 34566788999999997 4 479999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC--CcEEEeccCccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR--GAIKLGDFGVSACL 161 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~--g~vKL~DFGla~~~ 161 (636)
+|||+|.++. +|+++|+.+...+|+...++.++.||+.||.+||+.||||+||||+||||... ..|||+|||.|+..
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999964 89999999988999999999999999999999999999999999999999643 47999999998743
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--CCCC-----
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN--APPG----- 234 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~--~~~~----- 234 (636)
.+. ..+++-+++|+|||++.| ..|+.+.||||||||++||++|.+.|.+.+..+++..++.- .++.
T Consensus 342 -----~q~-vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 342 -----SQR-VYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred -----CCc-ceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 122 238889999999999998 67999999999999999999999999999998887666531 1110
Q ss_pred -------CCc-----------c----------------------cc-----------hhhhHHHHHHHHhhcccCCCCCC
Q 006664 235 -------LDY-----------E----------------------RD-----------RKFSKSFKQMIASCLVKDPSKRP 263 (636)
Q Consensus 235 -------~~~-----------~----------------------~~-----------~~~S~~l~dLI~~cL~~DP~kRp 263 (636)
++. . .+ ..-...|.+||++||.+||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 000 0 00 01235678999999999999999
Q ss_pred CHHHHHhCcccccc
Q 006664 264 SAKKLLKHSFFKQA 277 (636)
Q Consensus 264 sa~elL~Hpffk~~ 277 (636)
|+.++|+||||...
T Consensus 495 tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 495 TPAQALNHPFLTGT 508 (586)
T ss_pred CHHHHhcCcccccc
Confidence 99999999999853
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=370.80 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=197.5
Q ss_pred EeEEcccCceEEEEEEEc--CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe--CCeEEEEEecc
Q 006664 16 YEEVGQGVSASVHRALCI--PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS--DHNLWVVMPFM 91 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~--~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~--~~~l~iVmEy~ 91 (636)
.++||+|+||+||+|.++ .+++.||+|.+.... ....+.+|+.+|+.++||||++++++|.. +..+|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999965 477899999986432 23456789999999999999999999864 46789999999
Q ss_pred CCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE----ccCCcEEEeccCcccc
Q 006664 92 SGGSCLHILKAAY-------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI----DVRGAIKLGDFGVSAC 160 (636)
Q Consensus 92 ~GGsL~~lL~~~~-------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl----d~~g~vKL~DFGla~~ 160 (636)
.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 65 8888876431 2358999999999999999999999999999999999999 4567899999999976
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh---------HHHHHHHHhcC
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---------MKVLLMTLQNA 231 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~---------~~~l~~~~~~~ 231 (636)
..............+||+.|+|||++.+...|+.++||||+||++|+|++|.+||..... ...+..+....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 533222222234568999999999998756789999999999999999999999964321 11111111100
Q ss_pred --CCCCCc-------------------------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 232 --PPGLDY-------------------------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 232 --~~~~~~-------------------------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+....+ ......+..+.+||.+||.+||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000000 0001234578999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=362.27 Aligned_cols=265 Identities=39% Similarity=0.691 Sum_probs=225.2
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
..++|++++.||.|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 457899999999999999999999989999999999754 3334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.||+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--- 157 (280)
T cd06611 82 EFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--- 157 (280)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc---
Confidence 999999999998764 2469999999999999999999999999999999999999999999999999876542221
Q ss_pred cccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 169 RMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
.......|++.|+|||++.. ...++.++|||||||++|+|++|..||.................+.+ ..+..++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 235 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL--DQPSKWS 235 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc--CCcccCC
Confidence 12235679999999999853 23467899999999999999999999988777665555544333322 2345688
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
.++.+||.+||..||.+||++.++++||||......
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN 271 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhcccchh
Confidence 999999999999999999999999999999876433
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=363.36 Aligned_cols=262 Identities=26% Similarity=0.369 Sum_probs=219.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.|+..+.||.|+||+||+|.+..+++.||+|++..... ......+.+|+.+|+.++|+||+.+++++..+..+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999865432 2234457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.||+|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----E 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC----C
Confidence 999999998887654457999999999999999999999999999999999999999999999999998654221 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.................. ........++..+.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE-TEEVYSAKFSEEAKS 234 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc-cccccCccCCHHHHH
Confidence 1234579999999999976 57899999999999999999999999876554333222221111 112233567889999
Q ss_pred HHHhhcccCCCCCCC-----HHHHHhCcccccccC
Q 006664 250 MIASCLVKDPSKRPS-----AKKLLKHSFFKQARS 279 (636)
Q Consensus 250 LI~~cL~~DP~kRps-----a~elL~Hpffk~~~~ 279 (636)
|+.+||..||.+||+ +.+++.|+||+....
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 999999999999999 899999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=351.98 Aligned_cols=255 Identities=27% Similarity=0.503 Sum_probs=221.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++..+...|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5899999999999999999999999999999997543 334566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+.|++|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++..+.... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---NF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc---ch
Confidence 999999999987655679999999999999999999999999999999999999999999999999987653322 12
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....+.. ...++..+.++
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 232 (256)
T cd08529 158 ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV----SQMYSQQLAQL 232 (256)
T ss_pred hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccccCHHHHHH
Confidence 235679999999999976 5688999999999999999999999988776665555554433222 23678899999
Q ss_pred HHhhcccCCCCCCCHHHHHhCccc
Q 006664 251 IASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~Hpff 274 (636)
|.+||+.+|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=360.91 Aligned_cols=258 Identities=37% Similarity=0.651 Sum_probs=216.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 4689999999999999999999999999999999875532 334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.+++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..+.... .
T Consensus 87 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~---~ 161 (267)
T cd06645 87 FCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI---A 161 (267)
T ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc---c
Confidence 99999999999765 579999999999999999999999999999999999999999999999999986543221 1
Q ss_pred ccccccCCCCCCChhhhh--hccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 170 MRNTFVGTPCWMAPEVME--QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~--~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
......|++.|+|||++. ....++.++|||||||++|+|++|..||....+...+..................++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 223567999999999974 224588899999999999999999999976655444333222211111111223578899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCcc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSF 273 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpf 273 (636)
.+||.+||..||++||+++++++|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=359.07 Aligned_cols=260 Identities=49% Similarity=0.857 Sum_probs=225.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
++|++.+.||.|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.++..+|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999999999999999998665455567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+.+++|.+++... .+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..+.... ..
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---~~ 154 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM---SK 154 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---cc
Confidence 9999999999763 78999999999999999999999999999999999999999999999999987653321 12
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
.....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||....+......+.....+... ...++..+.++
T Consensus 155 ~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE---GNKFSKPFKDF 230 (274)
T ss_pred cccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc---ccccCHHHHHH
Confidence 335678999999999986 45899999999999999999999999877666555444443332221 12278899999
Q ss_pred HHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 251 IASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
|.+||..||.+||+++++++||||......
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 999999999999999999999999877654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=366.01 Aligned_cols=266 Identities=29% Similarity=0.416 Sum_probs=225.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.+++.++||||+++++.+..+...|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 5799999999999999999999999999999999765433 25567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc-
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR- 167 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~- 167 (636)
||+.|++|.+++.......+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 9999999999998765567999999999999999999999999999999999999999999999999998654211100
Q ss_pred -------------------------ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHH
Q 006664 168 -------------------------QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 222 (636)
Q Consensus 168 -------------------------~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~ 222 (636)
....+.++||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 011234579999999999976 568999999999999999999999998877666
Q ss_pred HHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCC----HHHHHhCcccccccCh
Q 006664 223 VLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS----AKKLLKHSFFKQARSN 280 (636)
Q Consensus 223 ~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRps----a~elL~Hpffk~~~~~ 280 (636)
.+..+..... .+.....++..++++|.+||..||.+||+ +++++.||||+...+.
T Consensus 240 ~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~ 298 (316)
T cd05574 240 TFSNILKKEV---TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWA 298 (316)
T ss_pred HHHHHhcCCc---cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChh
Confidence 5555443222 22223347899999999999999999999 9999999999986543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=358.70 Aligned_cols=259 Identities=37% Similarity=0.636 Sum_probs=214.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
..++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35689999999999999999999999999999999965432 34556889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+....
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--- 160 (267)
T cd06646 86 EYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--- 160 (267)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc---
Confidence 999999999998765 578999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
.......|++.|+|||.+.. ...++.++|||||||++|+|++|..||....+......................++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 11234679999999999852 2447889999999999999999999997655443322211111111111222457899
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCcc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSF 273 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpf 273 (636)
+.+||.+||..||++||++++|++|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=366.42 Aligned_cols=259 Identities=34% Similarity=0.561 Sum_probs=217.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
++|++.+.||+|+||.||++.+..++..||+|.+...........+.+|+++++.++||||++++++|..+..+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999999999999999987654444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
++|++|.+++... ..+++..+..++.||+.||.|||+ +|++||||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-----
Confidence 9999999999875 678999999999999999999997 69999999999999999999999999998654322
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC-------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD------------- 236 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~------------- 236 (636)
.....+|++.|+|||.+.+ ..++.++|||||||++|+|++|..||......... ...........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCC
Confidence 2245689999999999876 56899999999999999999999999754432221 11111100000
Q ss_pred ---------------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 237 ---------------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 237 ---------------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
......++.++++||.+||..||++||++.++++||||....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 000123678899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=358.04 Aligned_cols=257 Identities=39% Similarity=0.675 Sum_probs=216.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeC------C
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSD------H 82 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~------~ 82 (636)
...|++.+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+.+++.+ +||||+++++++... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 467899999999999999999999999999999997543 2345788999999988 799999999998753 4
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+||||+.+|+|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 68999999999999999987545578999999999999999999999999999999999999999999999999987542
Q ss_pred cCCCcccccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~ 238 (636)
... .......|++.|+|||++.+ ...|+.++|||||||++|+|++|..||................. ...
T Consensus 163 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~ 236 (272)
T cd06637 163 RTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA---PRL 236 (272)
T ss_pred ccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCC---CCC
Confidence 211 12345689999999999863 23588899999999999999999999987666554444333221 112
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
....++..+.+||.+||..||.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 234678899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=351.99 Aligned_cols=259 Identities=41% Similarity=0.714 Sum_probs=221.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++.+.||.|+||.||+|.+..+++.+|+|++...... ....+.+|+.+++.++||||+++++++.++..+|++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 47899999999999999999999999999999999755433 56788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.|++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---~ 156 (262)
T cd06613 81 YCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI---A 156 (262)
T ss_pred CCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh---h
Confidence 99999999998764 2569999999999999999999999999999999999999999999999999987653221 1
Q ss_pred ccccccCCCCCCChhhhhhc--cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQL--HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~--~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
......|+..|+|||++.+. ..++.++|||||||++|+|++|..||...........................++.++
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 12356789999999998652 2678899999999999999999999988776665554443322211222345678899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCcc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSF 273 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpf 273 (636)
.+||.+||..||..||++.+++.|+|
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=361.47 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=223.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+++++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 479999999999999999999999999999999865432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||+|.|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999999876 67999999999999999999999999999999999999999999999999998765322
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
....+|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+... . ...+..++..++
T Consensus 155 --~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~----~~~~~~~~~~l~ 226 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-K----VRFPSFFSPDAK 226 (290)
T ss_pred --CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-C----ccCCccCCHHHH
Confidence 235579999999999876 56889999999999999999999999877755444444422 1 122345689999
Q ss_pred HHHHhhcccCCCCCC-----CHHHHHhCcccccccChHH
Q 006664 249 QMIASCLVKDPSKRP-----SAKKLLKHSFFKQARSNEY 282 (636)
Q Consensus 249 dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~~~ 282 (636)
++|.+||..||.+|+ +++++++||||....+...
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 265 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHH
Confidence 999999999999999 9999999999987765433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=357.64 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=215.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+|+.+++.++||||+++++++..+..+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 5799999999999999999999999999999998654322 233557899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|++++.|..++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--- 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--- 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc---
Confidence 99998887776543 5699999999999999999999999999999999999999999999999999876533221
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG--------------- 234 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~--------------- 234 (636)
......|+..|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+.......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 12345688999999998765568899999999999999999999998877655543332211000
Q ss_pred -CCc----------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 235 -LDY----------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 235 -~~~----------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
... .....++..+.+||.+||..||++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=360.59 Aligned_cols=269 Identities=36% Similarity=0.625 Sum_probs=225.3
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
+-...+.|++++.||.|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++++..+..+|
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 344557899999999999999999999999999999998643 3335667889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.|++|..++... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 86 IMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred EEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 999999999998887654 256899999999999999999999999999999999999999999999999998653221
Q ss_pred CcccccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
........|++.|+|||++.+ ...++.++|||||||++|+|++|..||.................+. ...+.
T Consensus 164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 239 (292)
T cd06644 164 --LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT--LSQPS 239 (292)
T ss_pred --ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc--CCCCc
Confidence 111235678999999999852 2347889999999999999999999998777655554444332222 22345
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccChH
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~ 281 (636)
.++.++.+||.+||..||.+||++.++++||||..+....
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 6788999999999999999999999999999998766543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=359.68 Aligned_cols=253 Identities=32% Similarity=0.556 Sum_probs=212.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
++|++++.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 57899999999999999999999999999999997654444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+++|+|..+ ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... .
T Consensus 81 ~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-----~ 149 (279)
T cd06619 81 MDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-----I 149 (279)
T ss_pred CCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-----c
Confidence 999998643 34789999999999999999999999999999999999999999999999998754322 1
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH-------HHHHHHHhcCCCCCCcccchhh
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-------KVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~-------~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..........++. .....+
T Consensus 150 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 225 (279)
T cd06619 150 AKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV---LPVGQF 225 (279)
T ss_pred ccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC---CCCCcC
Confidence 235689999999999976 56899999999999999999999999653221 1111111111111 112447
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+.++++||.+||..||.+||++++++.||||....
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 88999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=375.66 Aligned_cols=265 Identities=27% Similarity=0.459 Sum_probs=235.3
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCe
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~ 83 (636)
.|...+|.++.+||+|+||.|.+|..+.+.+.||||+++++- ...+.+--..|.++|... +-|.++.++.+|+.-..
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 577889999999999999999999999999999999998664 334556667788888876 47899999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+||||+.||+|...|+.. +.|.|+.+..|+.+|+-||-|||++|||+||||.+||++|..|++||+|||+++.-..
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999999999987 8899999999999999999999999999999999999999999999999999975433
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.+. ...++||||.|+|||++.. ..|+.++|+||+|++||||+.|++||++.+..+....+.... ...++.+
T Consensus 503 ~~~---TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-----vsyPKsl 573 (683)
T KOG0696|consen 503 DGV---TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-----VSYPKSL 573 (683)
T ss_pred CCc---ceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-----CcCcccc
Confidence 332 2458999999999999976 789999999999999999999999999999988887776552 2346889
Q ss_pred hHHHHHHHHhhcccCCCCCCC-----HHHHHhCcccccccChHH
Q 006664 244 SKSFKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSNEY 282 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~~~ 282 (636)
|+++.++++..|.+.|.+|.. -.+|-.||||+.+.|...
T Consensus 574 SkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~ 617 (683)
T KOG0696|consen 574 SKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL 617 (683)
T ss_pred cHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence 999999999999999999975 378999999998877644
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=361.10 Aligned_cols=258 Identities=25% Similarity=0.374 Sum_probs=209.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|++.+.||+|+||.||+|.+..+|+.||+|.++..... .....+.+|+.+++.++||||+++++++.+...+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 589999999999999999999999999999999754322 2235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+... ...
T Consensus 81 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~---~~~ 155 (284)
T cd07839 81 CDQ-DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP---VRC 155 (284)
T ss_pred CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC---CCC
Confidence 975 788887654 356999999999999999999999999999999999999999999999999998754221 112
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCC-CCCChHHHHHHHHhcCC--------------C--
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTLQNAP--------------P-- 233 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF-~~~~~~~~l~~~~~~~~--------------~-- 233 (636)
.....+++.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+..... .
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 234568999999999977566899999999999999999988885 44333333222211100 0
Q ss_pred ---CCC-----cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 234 ---GLD-----YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 234 ---~~~-----~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
... ......++.++++||.+||..||.+|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000 00113478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=362.87 Aligned_cols=316 Identities=25% Similarity=0.438 Sum_probs=263.5
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHh-CCCCCcceeeeEEE
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMIL-VDHPNVLKSHCSFV 79 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~-L~HPNIVkl~~~~~ 79 (636)
+..|.++..+|.++++||+|+|+.|.++..++|.+.||+|+++++- ...+++-++.|..+... -+||.+|-++.+|.
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 5678899999999999999999999999999999999999998764 44566778888888864 58999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.+..+++|.||++||+|.-++++. ..++|+.++.|-.+|+.||.|||+.|||+||||.+|+|+|..|++||+|+|+++
T Consensus 322 tesrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred ccceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh
Confidence 999999999999999999888876 789999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCC-------CCChHHHHHHHHhcCC
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS-------KYPPMKVLLMTLQNAP 232 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~-------~~~~~~~l~~~~~~~~ 232 (636)
.-...++. ..++||||.|.|||++++ ..|++.+|+|+||++++||+.|+.||+ +.+..+.+.+++-...
T Consensus 400 e~l~~gd~---tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq 475 (593)
T KOG0695|consen 400 EGLGPGDT---TSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ 475 (593)
T ss_pred cCCCCCcc---cccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence 76555543 568999999999999998 789999999999999999999999995 2334445555544332
Q ss_pred CCCCcccchhhhHHHHHHHHhhcccCCCCCC------CHHHHHhCcccccccChHHHHHHHhccCcchHHHHHHHHHHHH
Q 006664 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRP------SAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKEE 306 (636)
Q Consensus 233 ~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRp------sa~elL~Hpffk~~~~~~~i~~~ll~~l~~l~~~i~~l~~~~~ 306 (636)
...++.+|..+..+++..|++||++|. .+.++..|+||+.+.|.
T Consensus 476 ----iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd-------------------------- 525 (593)
T KOG0695|consen 476 ----IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD-------------------------- 525 (593)
T ss_pred ----ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH--------------------------
Confidence 234567888899999999999999995 47899999999876543
Q ss_pred HHHHhcCCCCcccchhhhhhhhcCccCCCCChhhHHhhhhcccCcccccccCCC
Q 006664 307 DMLAQKKMPDGQKEEISQNEYKRGISGWNFNLEDVKAQASLIQDEDMISESNHG 360 (636)
Q Consensus 307 ~~~~~~~~~~~~~~~~s~~e~~~~~~~~~f~~~~~~~~~~l~~~~~~~~~~~~~ 360 (636)
++.++.+-+..+..++.+ ...-+||...+.....+++|++++..-...
T Consensus 526 -~leqk~v~ppf~p~i~~d-----~~l~~fd~qft~e~~qltpdd~d~i~ridq 573 (593)
T KOG0695|consen 526 -LLEQKQVLPPFQPQITDD-----YGLDNFDTQFTSEPVQLTPDDEDAIKRIDQ 573 (593)
T ss_pred -HHhhcccCCCCCCccccc-----cCccccccccccCCcccCCCCHHHHHhcch
Confidence 344555555555444431 223467777777888999998877755443
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=387.91 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=230.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
.....|.+...||+|.|+.|.+|.+..|+..||||+|++...+ .....+.+|+++|+.|+|||||++|.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 4456799999999999999999999999999999999887644 344568999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
||||+.||++++++.++ +...+..++.+|.|+++|++|||+++|||||||++||||+.+.++||+|||++..+. .
T Consensus 133 V~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~-- 207 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-Y-- 207 (596)
T ss_pred EEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-c--
Confidence 99999999999999987 778889999999999999999999999999999999999999999999999998663 2
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
..+..++||+|.|.|||++.+....++.+|+||+|+++|.|++|.+||++..-.......+.. .+..+..++.+
T Consensus 208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g-----k~rIp~~ms~d 281 (596)
T KOG0586|consen 208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG-----KYRIPFYMSCD 281 (596)
T ss_pred -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee-----eecccceeech
Confidence 234678999999999999999777789999999999999999999999975543332222222 34455678999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
++++|.++|..+|.+|++.+++++|.|......
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 999999999999999999999999999975443
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=360.06 Aligned_cols=261 Identities=36% Similarity=0.647 Sum_probs=222.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
....+|++.+.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++.|..+...|+|
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 3457999999999999999999999999999999999765433 346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+.|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-- 170 (296)
T cd06654 96 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (296)
T ss_pred ecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--
Confidence 999999999999865 358899999999999999999999999999999999999999999999999987542211
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||....+............+. ...+..++..+
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 246 (296)
T cd06654 171 -SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE--LQNPEKLSAIF 246 (296)
T ss_pred -cccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCC--CCCccccCHHH
Confidence 12234579999999999876 568899999999999999999999998776655444333322221 12345678899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.+||.+||..||.+||++.+++.||||...+
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=357.16 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=218.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|++.+.||.|+||.||+|.+..+|..||+|++..... ......+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 69999999999999999999999999999999976543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+ |++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--RL 156 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--Cc
Confidence 9 999999987643 5699999999999999999999999999999999999999999999999999876533221 22
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC----------------
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG---------------- 234 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~---------------- 234 (636)
.....|+..|+|||++.+...++.++|||||||++|+|++|.+||.+......+..........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 3355799999999998765667899999999999999999999998776655554443321100
Q ss_pred CCc---------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 235 LDY---------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 235 ~~~---------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
..+ ......+..+.+||.+||..||.+||++++++.||||.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 000 00124568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.10 Aligned_cols=252 Identities=28% Similarity=0.488 Sum_probs=218.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEecc
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~ 91 (636)
+|++.+.||.|+||.||++.+..+++.||+|.++........+.+.+|+.+++.++||||+++++++.++..+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 68999999999999999999999999999999976655556778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
++|+|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+...+ ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~ 157 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYA 157 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc---ccc
Confidence 99999999876555568999999999999999999999999999999999999999999999999987653322 122
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHH
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI 251 (636)
....|++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.............. ..+..++..+++||
T Consensus 158 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li 232 (255)
T cd08219 158 CTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----PLPSHYSYELRSLI 232 (255)
T ss_pred ccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC----CCCcccCHHHHHHH
Confidence 35679999999999876 56899999999999999999999999887665555444433222 12345788999999
Q ss_pred HhhcccCCCCCCCHHHHHhC
Q 006664 252 ASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 252 ~~cL~~DP~kRpsa~elL~H 271 (636)
.+||..||.+||++.+++.-
T Consensus 233 ~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 233 KQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHhCCcccCCCHHHHhhc
Confidence 99999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=355.72 Aligned_cols=267 Identities=32% Similarity=0.560 Sum_probs=234.9
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCC
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDH 82 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~ 82 (636)
.+|....++.+++..||.|+.|+|+++..+.+|...|||.+....+..+.++|...+.++.+.+ +|+||+.|++|..+.
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 4567777888899999999999999999999999999999988777778889999999987775 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
.++|.||.|. .+.+-|.+...++++|..+-.+...++.||.||..+ ||+|||+||+|||+|..|++||||||++.++
T Consensus 165 dV~IcMelMs--~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 165 DVFICMELMS--TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred hHHHHHHHHH--HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 9999999985 567766666668899999999999999999999864 8999999999999999999999999999988
Q ss_pred ccCCCcccccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCC-ChHHHHHHHHhcCCCCCCcc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGLDYE 238 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~-~~~~~l~~~~~~~~~~~~~~ 238 (636)
.++... ....|.+.|||||.+.. ...|+.++|||||||+++||++|..||.+. .+.+++..++.+.++.++..
T Consensus 243 vdSkAh----trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~ 318 (391)
T KOG0983|consen 243 VDSKAH----TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH 318 (391)
T ss_pred eccccc----ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc
Confidence 776433 34579999999999864 245899999999999999999999999874 46677777777777666543
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.++|++|.+|+..||.+|+.+||...+||+|||++...
T Consensus 319 --~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 319 --MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred --cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 45999999999999999999999999999999998654
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=351.94 Aligned_cols=261 Identities=39% Similarity=0.676 Sum_probs=219.8
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCC---
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDH--- 82 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~--- 82 (636)
+...++|++.+.||.|+||.||+|.++.+++.||+|++..... ....+.+|+.+++.+ +||||+++++++....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 3456899999999999999999999999999999999865433 346789999999998 7999999999997644
Q ss_pred ---eEEEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCc
Q 006664 83 ---NLWVVMPFMSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 83 ---~l~iVmEy~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
.+|+||||+.+++|.+++.... ...+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 5899999999999999987643 46799999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~ 233 (636)
+....... .......|++.|+|||++.. ...++.++|||||||++|+|++|..||...........+.....+
T Consensus 160 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 160 SAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred ceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 87543221 22345679999999999854 234788999999999999999999999877666655555544332
Q ss_pred CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 234 ~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
. ......++..+++||.+||..||.+|||+.++++|||+
T Consensus 237 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 T--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred C--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2 22234578899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=347.85 Aligned_cols=255 Identities=28% Similarity=0.493 Sum_probs=221.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|++++.||.|+||.||.+.+..+++.+++|.++... .......+.+|+.+++.++||||+++++++.+...++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 6999999999999999999999999999999987654 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
|.||+|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---M 157 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---c
Confidence 9999999999876556689999999999999999999999999999999999999999999999999875533221 2
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+....... ....++.++.++
T Consensus 158 ~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 232 (256)
T cd08221 158 AETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP----VVSVYSSELISL 232 (256)
T ss_pred ccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC----CccccCHHHHHH
Confidence 345679999999999876 458889999999999999999999998877666555554432221 225678899999
Q ss_pred HHhhcccCCCCCCCHHHHHhCccc
Q 006664 251 IASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~Hpff 274 (636)
|.+||.+||.+||++.++++|+|+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=351.54 Aligned_cols=256 Identities=33% Similarity=0.570 Sum_probs=217.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--------hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--------SDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--------~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+|.+...||.|+||.||+|.+..++..||+|.+...... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999999999999999998654322 123568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
.++||||+.|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999999875 5689999999999999999999999999999999999999999999999999876542
Q ss_pred CCC---cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 164 SGD---RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 164 ~~~---~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
... .........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.................+ ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~ 233 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP----EIP 233 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCC----cCC
Confidence 111 1111234578999999999976 56888999999999999999999999887665554443332222 223
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
..++..+.++|.+||..||.+||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 5678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=356.24 Aligned_cols=259 Identities=46% Similarity=0.817 Sum_probs=222.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
..|+.++.||.|+||.||+|.+..++..||||+++..........+.+|+.+++.++||||+++++++.++...|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 56888999999999999999999999999999998665555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+.||+|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 157 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IK 157 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc---cc
Confidence 999999999865 468999999999999999999999999999999999999999999999999987553221 11
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
.....|+..|+|||++.+ ..++.++|+|||||++|+|++|..||....+......+....++ .....++..+.+|
T Consensus 158 ~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l 232 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP----TLTGEFSKPFKEF 232 (277)
T ss_pred cccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC----CCchhhhHHHHHH
Confidence 234578999999999876 56899999999999999999999999877665554433222222 2234678899999
Q ss_pred HHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 251 IASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
|.+||..+|.+||++.++++|+||......
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred HHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 999999999999999999999999866543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=358.72 Aligned_cols=260 Identities=37% Similarity=0.661 Sum_probs=223.2
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
..++|++++.||.|+||.||+|.+..+|+.||+|.+...... ....+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 456899999999999999999999999999999999754332 3567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.|++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 96 EYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred EecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 99999999998875 358999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
.......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.................+. ...+..++..+.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 246 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE--LQNPEKLSPIFR 246 (296)
T ss_pred ccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc--cCCcccCCHHHH
Confidence 12234579999999999876 568899999999999999999999998877765554443332222 223456788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+||.+||..||.+||++.++++||||+...
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=356.54 Aligned_cols=261 Identities=35% Similarity=0.639 Sum_probs=221.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+.|++.+.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++||||+++++++..+...|+||||
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 34688999999999999999999999999999986432 33466788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+.+|+|..++... ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....... ..
T Consensus 84 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---~~ 159 (282)
T cd06643 84 CAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---QR 159 (282)
T ss_pred cCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc---cc
Confidence 9999999887653 2568999999999999999999999999999999999999999999999999987543221 12
Q ss_pred cccccCCCCCCChhhhh----hccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 171 RNTFVGTPCWMAPEVME----QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~----~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
.....||+.|+|||++. ....++.++|||||||++|+|++|.+||.................+.. ..+..++.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 237 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL--AQPSRWSSE 237 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC--CCccccCHH
Confidence 33567999999999984 224578899999999999999999999988777666555554433222 234567899
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+++||.+||..||.+||++.++++||||+...
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 99999999999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=352.05 Aligned_cols=261 Identities=28% Similarity=0.533 Sum_probs=215.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-----hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-----SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-----~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
+|+..+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+++++.++||||+++++++.+...+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488899999999999999999999999999999754421 135678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-cEEEeccCcccccccCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-AIKLGDFGVSACLFDSG 165 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-~vKL~DFGla~~~~~~~ 165 (636)
||||+.|++|.+++... +.+++..+..++.||+.||.|||++|++||||+|+||+++.++ .+||+|||++..+....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999999875 5789999999999999999999999999999999999998776 69999999987654321
Q ss_pred Cc-ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DR-QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~-~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
.. ........|+..|+|||++.+ ..++.++||||+||++|+|++|..||...........+............+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred ccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 112234578999999999876 6789999999999999999999999975443222222211111111223345688
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
+++.+++.+||..||.+||++.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=356.34 Aligned_cols=258 Identities=40% Similarity=0.684 Sum_probs=216.7
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEe------C
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVS------D 81 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~------~ 81 (636)
....|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||++++++|.. .
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 3478999999999999999999999999999999986542 2345678899999888 79999999999853 4
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+|++|||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 67999999999999999998765556899999999999999999999999999999999999999999999999998654
Q ss_pred ccCCCcccccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
.... .......|++.|+|||++.. ...++.++|||||||++|+|++|..||....+...............
T Consensus 172 ~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 246 (282)
T cd06636 172 DRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL-- 246 (282)
T ss_pred hccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC--
Confidence 2211 12345679999999999852 24578899999999999999999999987766555544433322221
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
....++.++.+||.+||..||.+||++.+|++||||
T Consensus 247 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 -KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 234678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=352.77 Aligned_cols=260 Identities=32% Similarity=0.563 Sum_probs=213.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHH-HHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT-MILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~i-L~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++.+.||+|+||.||+|.+..+|+.||||+++..........+..|+.+ ++.++||||+++++++..+..+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4799999999999999999999999999999999765443344456667665 567799999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 90 FMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 90 y~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
|++ |+|.+++... ....+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 997 5788887653 224689999999999999999999997 99999999999999999999999999987653221
Q ss_pred cccccccccCCCCCCChhhhhhc---cCCCcccchhhHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCCCCCcccchh
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQL---HGYDFKADIWSFGITALELAHGHAPFSKYP-PMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~---~~ys~ksDIWSLGiiLyeLltG~~PF~~~~-~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
......|+..|+|||++.+. ..++.++|||||||++|+|++|..||.... ..+.+........+.+. ...
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 232 (283)
T cd06617 159 ---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP---AEK 232 (283)
T ss_pred ---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC---ccc
Confidence 12335789999999998642 347889999999999999999999997533 33334444433222221 235
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++.++.+||.+||..||.+||++.+++.||||....
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 789999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=360.42 Aligned_cols=260 Identities=37% Similarity=0.661 Sum_probs=220.7
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
...+|++++.||.|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++..+...|+||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 348999999999999999999999999999999999754433 3466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred cccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 99999999999875 358899999999999999999999999999999999999999999999999987542221
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
.......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||....+............+. ...+..++..++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 246 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE--LQNPERLSAVFR 246 (297)
T ss_pred cCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCC--CCCccccCHHHH
Confidence 12234579999999999976 668899999999999999999999998765544333222222221 122356788899
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+||.+||..||++||++.++++||||+..+
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 999999999999999999999999998664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=355.40 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=210.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++.+.||.|+||.||+|.++.+++.||||.+...........+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 47899999999999999999999999999999999765433334456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 84 ~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---~ 158 (291)
T cd07844 84 YLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS---K 158 (291)
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC---c
Confidence 9985 8999887643 478999999999999999999999999999999999999999999999999986432111 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCC--C------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP-PMKVLLMTLQNAPP--G------------ 234 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~-~~~~l~~~~~~~~~--~------------ 234 (636)
......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.. ..+.+..+...... .
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 12234578999999998765668999999999999999999999997655 22222222110000 0
Q ss_pred ----CCc-------ccchhhh--HHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 235 ----LDY-------ERDRKFS--KSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 235 ----~~~-------~~~~~~S--~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
... .....++ .++.++|.+||..||.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=358.06 Aligned_cols=259 Identities=30% Similarity=0.536 Sum_probs=217.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
++|++++.||+|+||.||+|.+..+|..||+|.+...........+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 57999999999999999999999999999999997654444567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 91 MSGGSCLHILKAAY-PDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 91 ~~GGsL~~lL~~~~-~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
+.|++|..++.... ...+++..+..++.||+.||.|||. .||+||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----
Confidence 99999999887631 2368999999999999999999997 59999999999999999999999999998754222
Q ss_pred cccccccCCCCCCChhhhhhcc-----CCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHH---HHhcCCCCCCcccc
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLH-----GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLM---TLQNAPPGLDYERD 240 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~-----~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~---~~~~~~~~~~~~~~ 240 (636)
......|++.|+|||.+.+.. .++.++|||||||++|+|++|..||........... +....++ ..+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~ 231 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP----TLP 231 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC----CCC
Confidence 223457899999999986422 358899999999999999999999976544332221 2222211 223
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
..++.++.+||.+||..+|.+||++.+++.||||....
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 45899999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=347.45 Aligned_cols=255 Identities=24% Similarity=0.462 Sum_probs=220.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|++.+.||+|+||.||++.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6999999999999999999999999999999997543 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+.|++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV---EL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch---hh
Confidence 999999999987544568999999999999999999999999999999999999999999999999987543221 11
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||......+....++....+. ....++.++.++
T Consensus 158 ~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l 232 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP----VSSHYSYDLRNL 232 (256)
T ss_pred hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC----CcccCCHHHHHH
Confidence 234568999999999876 568889999999999999999999998777766665555443322 235678899999
Q ss_pred HHhhcccCCCCCCCHHHHHhCccc
Q 006664 251 IASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~Hpff 274 (636)
|.+||..+|.+||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=358.25 Aligned_cols=260 Identities=21% Similarity=0.365 Sum_probs=209.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcC----------------CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCc
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIP----------------FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNV 71 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~----------------tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNI 71 (636)
+...+|.+.+.||+|+||.||+|.+.. ++..||+|++...........+.+|+.++..++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 456899999999999999999997532 3457999998765444456678899999999999999
Q ss_pred ceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 006664 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYP-----------------DGFEEVVIATILREVLKGLDYLHHHGHIH 134 (636)
Q Consensus 72 Vkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~-----------------~~lse~~i~~i~~QIl~aL~yLH~~gIvH 134 (636)
+++++++.+....|+||||+.+|+|.+++..... ..+++..+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 9999999999999999999999999999865321 23677889999999999999999999999
Q ss_pred cccCcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc--CC
Q 006664 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH--GH 212 (636)
Q Consensus 135 RDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt--G~ 212 (636)
|||||+|||++.++.+||+|||++..+.... .........+++.|||||++.+ ..++.++|||||||++|+|++ |.
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGD-YYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCc-eeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999987553322 2222334567889999999876 568999999999999999986 67
Q ss_pred CCCCCCChHHHHHHHHh---cCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 006664 213 APFSKYPPMKVLLMTLQ---NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLL 269 (636)
Q Consensus 213 ~PF~~~~~~~~l~~~~~---~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL 269 (636)
.||......+....... ..........+..++..+.+||.+||..||.+|||+.+|.
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 88887665554433221 1111111122345788999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=356.10 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=215.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|++++.||.|+||.||+|.+..+|+.||||.+...... .....+.+|+++++.++||||+++++++.++...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 489999999999999999999999999999998754432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+. ++|..++.......+++..+..++.|++.||+|||.+|++||||+|+||+++.++.+||+|||++..+.... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc---cc
Confidence 96 589998877655678999999999999999999999999999999999999999999999999986542211 11
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC--------------
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD-------------- 236 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~-------------- 236 (636)
.....+++.|+|||++.+...++.++|||||||++|+|++|..||.....................
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 234467899999999876555788999999999999999999999877665555444332111100
Q ss_pred -c---------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 237 -Y---------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 237 -~---------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+ .....++.+++++|.+||..||.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 0012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=353.46 Aligned_cols=258 Identities=40% Similarity=0.719 Sum_probs=220.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC---CCCcceeeeEEEeCCeEEEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD---HPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~---HPNIVkl~~~~~~~~~l~iVm 88 (636)
.|++.+.||.|+||.||+|.+..+++.||+|+++..........+.+|+.+++.++ ||||+++++++..+...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58889999999999999999999999999999976655556678899999999986 999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06917 82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--- 155 (277)
T ss_pred ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---
Confidence 99999999999865 368999999999999999999999999999999999999999999999999987654332
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
.......|+..|+|||.+.+...++.++|||||||++|+|++|..||................++.+. ...++.++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE---DNGYSKLLR 232 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCC---cccCCHHHH
Confidence 12234579999999999876566789999999999999999999999876655443322222222211 123788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++|.+||..||.+||++.+++.|+||+...
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999999999999999999999999998654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=348.08 Aligned_cols=259 Identities=30% Similarity=0.487 Sum_probs=215.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC----chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--Ce
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD----NSDLSNISREAQTMILVDHPNVLKSHCSFVSD--HN 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~----~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~--~~ 83 (636)
+.+|++.+.||+|+||.||+|.+..+|..||||.+..... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 3689999999999999999999999999999999864432 12356788999999999999999999998764 57
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+++||||+.||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..+..
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 89999999999999999865 4688999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
............|+..|+|||++.+ ..++.++|||||||++|+|++|+.||............... + .....+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~ 234 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-P--TNPVLPPHV 234 (265)
T ss_pred ccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC-C--CCCCCchhh
Confidence 1111111234579999999999876 56889999999999999999999999876655544433322 1 112234567
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
+..+.++|.+||. +|.+||+++++++|||+.
T Consensus 235 ~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 235 SDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 8899999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=374.44 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=210.1
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEc--CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCI--PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~--~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
+...+|.+++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||++++++|.....+|
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 34567999999999999999999754 45688999987532 23468999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 163 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9999996 5888888544 679999999999999999999999999999999999999999999999999987553322
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh---HHHHHHHHhc---CCCCCC---
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQN---APPGLD--- 236 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~---~~~l~~~~~~---~~~~~~--- 236 (636)
.......++||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+... ...+..++.. .+..+.
T Consensus 240 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 240 -DTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred -ccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 1222335689999999999976 6789999999999999999999999976432 1222222111 000000
Q ss_pred ------------------c-----ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 237 ------------------Y-----ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 237 ------------------~-----~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
+ .....++.++.+||.+||..||.+||++.++|.||||+....
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 0 011245678899999999999999999999999999986543
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=357.51 Aligned_cols=266 Identities=27% Similarity=0.446 Sum_probs=221.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++.+.||+|+||.||++.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 479999999999999999999999999999999875432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC---
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG--- 165 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~--- 165 (636)
||++||+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999999775 568999999999999999999999999999999999999999999999999986321100
Q ss_pred ---------CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 006664 166 ---------DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 236 (636)
Q Consensus 166 ---------~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~ 236 (636)
..........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+....+............ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~ 236 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW-P 236 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC-C
Confidence 00011123568899999999876 678999999999999999999999998876665554444332111 1
Q ss_pred cccchhhhHHHHHHHHhhcccCCCCCCC---HHHHHhCcccccccChH
Q 006664 237 YERDRKFSKSFKQMIASCLVKDPSKRPS---AKKLLKHSFFKQARSNE 281 (636)
Q Consensus 237 ~~~~~~~S~~l~dLI~~cL~~DP~kRps---a~elL~Hpffk~~~~~~ 281 (636)
.....++.++.++|.+||.+||.+||+ +.+++.||||...+...
T Consensus 237 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 237 -EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred -CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 112357899999999999999999998 79999999998766544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=349.86 Aligned_cols=258 Identities=29% Similarity=0.519 Sum_probs=214.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC----chhHHHHHHHHHHHHhCCCCCcceeeeEEEe--CCeE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD----NSDLSNISREAQTMILVDHPNVLKSHCSFVS--DHNL 84 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~----~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~--~~~l 84 (636)
.+|+..+.||+|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++.. +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999865432 1234578899999999999999999999876 3678
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
+++|||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999999775 46899999999999999999999999999999999999999999999999998754221
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
...........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||................. ....+..++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~ 235 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT---NPQLPSHIS 235 (266)
T ss_pred cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC---CCCCchhcC
Confidence 111111223568999999999976 5688999999999999999999999987766554443332211 122235678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
+.+++|| +||..+|++||+++++++||||+
T Consensus 236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 8899999 68889999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=348.06 Aligned_cols=255 Identities=43% Similarity=0.771 Sum_probs=219.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+|+.+++.++||||+++++++..+..+|+++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 4789999999999999999999998899999999864422 6788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.+++|.+++... ...+++..+..++.|++.||.|||..|++||||+|.||+++.++.++|+|||++....... .
T Consensus 79 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~---~ 154 (256)
T cd06612 79 YCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM---A 154 (256)
T ss_pred cCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---c
Confidence 99999999999753 3568999999999999999999999999999999999999999999999999987653321 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
......|+..|+|||++.+ ..++.++|||||||++|+|++|..||....+............. ....+..++.++.+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 231 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP--TLSDPEKWSPEFND 231 (256)
T ss_pred ccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC--CCCchhhcCHHHHH
Confidence 2234568999999999976 57899999999999999999999999877665544433322222 22234567889999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCccc
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
||.+||..||.+||++.+++.||||
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=354.55 Aligned_cols=267 Identities=21% Similarity=0.359 Sum_probs=219.3
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIP-----FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~-----tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
|++..++|++.+.||+|+||.||+|.++. .+..||+|.++..........+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 78999999999999999999999997652 3558999998755444445567889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEE
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYP--------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~--------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL 152 (636)
....|+||||+.+|+|.+++..... ..++...+..++.||+.||.|||++||+||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999999976421 22456788899999999999999999999999999999999999999
Q ss_pred eccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 006664 153 GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 231 (636)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~ 231 (636)
+|||+++....... ........++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+....
T Consensus 161 ~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 161 GDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred CcCCcccccccccc-ccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999875533221 111223456778999999876 568999999999999999998 899998877666554443322
Q ss_pred CCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh------Cccccccc
Q 006664 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK------HSFFKQAR 278 (636)
Q Consensus 232 ~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~------Hpffk~~~ 278 (636)
.. ..+..+++.++++|.+||+.||.+||++.++++ ||||..+.
T Consensus 239 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 239 YL----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred CC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 21 223456789999999999999999999999987 99998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=365.85 Aligned_cols=265 Identities=22% Similarity=0.342 Sum_probs=213.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC-----CeE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD-----HNL 84 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-----~~l 84 (636)
.++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.+++.++||||+++++++... ..+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999999999999999986433334456678899999999999999999887654 358
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||+.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 999999975 88887754 46999999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-------------
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA------------- 231 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~------------- 231 (636)
..........+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+............
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 2222222346799999999998665678999999999999999999999997755433322211100
Q ss_pred ----------CCCC--Cc-ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 232 ----------PPGL--DY-ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 232 ----------~~~~--~~-~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+... .. .....++.++.+||.+||..||.+||++.+++.||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000 00 00124578899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=352.24 Aligned_cols=257 Identities=39% Similarity=0.651 Sum_probs=218.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
++|++.+.||.|+||.||+|.++.+++.||+|.+...........+.+|+.+++.++||||+++++.+..+..+|+||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47889999999999999999999999999999997665555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
+.|++|.+++.... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---- 155 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---- 155 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----
Confidence 99999999998753 578999999999999999999999 999999999999999999999999999986543221
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC-----hHHHHHHHHhcCCCCCCcccchhhh
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP-----PMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~-----~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.... .............+... ...++
T Consensus 156 -~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 230 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP---SGKFS 230 (265)
T ss_pred -hhcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC---hhhcC
Confidence 122679999999999976 578999999999999999999999997542 22222233332222221 11288
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.++++||.+||..||.+||++.+++.||||+..
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=344.55 Aligned_cols=254 Identities=29% Similarity=0.485 Sum_probs=218.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|++.+.||+|+||.||+|.+..+++.+|+|.++... .......+.+|+.+++.++||||+++++.+..+..+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5999999999999999999999999999999997654 233466788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC-CcEEEeccCcccccccCCCccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR-GAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~-g~vKL~DFGla~~~~~~~~~~~ 169 (636)
+.|++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc----
Confidence 999999999987654568999999999999999999999999999999999999854 468999999987653221
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+...... .....++.++++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~ 231 (256)
T cd08220 157 KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA----PISDRYSPDLRQ 231 (256)
T ss_pred cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC----CCCCCcCHHHHH
Confidence 1234578999999999976 56889999999999999999999999887766555555443222 123457889999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCccc
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+|.+||..||.+|||+.+++.||||
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=354.53 Aligned_cols=258 Identities=22% Similarity=0.375 Sum_probs=216.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCC-----cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFN-----EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg-----~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+..++|++++.||+|+||.||+|.+...+ ..||+|.+...........+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 34578999999999999999999876555 7899999875544445667899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYP--------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG 148 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~--------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g 148 (636)
..|++|||+.+|+|.+++..... ..+++..+..++.||+.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999999986532 4578899999999999999999999999999999999999999
Q ss_pred cEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 006664 149 AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMT 227 (636)
Q Consensus 149 ~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~ 227 (636)
.+||+|||++....... .........+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+
T Consensus 162 ~~~L~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSAD-YYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred cEEECCCcceeeccccc-cccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999987553322 1222344567899999999876 568999999999999999998 99999887776654444
Q ss_pred HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 228 ~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.....+ ..+..++.++.+|+.+||+.||.+||++.+|+++
T Consensus 240 ~~~~~~----~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLL----PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcC----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 332222 2245688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=352.44 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=215.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEecc
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~ 91 (636)
+|++++.||.|++|.||+|.+..+|..||||++...........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999999986654445567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 92 SGGSCLHILKAAY-PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 92 ~GGsL~~lL~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
.| +|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~---~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---cc
Confidence 85 8888887643 2458999999999999999999999999999999999999999999999999986542211 12
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-------------C--
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-------------L-- 235 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~-------------~-- 235 (636)
.....+++.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+....... +
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 2345689999999998765668899999999999999999999998776655544433211000 0
Q ss_pred Ccc---------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 236 DYE---------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 236 ~~~---------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.++ ....++..++++|.+||+.||.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000 012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=376.97 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=222.7
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+..|++..+.+.+++.||+|.||.||+|.+.. ...||+|.++.... ..+.+.+|+++|++|+|+|||++|+++..++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 56789999999999999999999999999853 34799999975432 3456779999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|||||||..|+|.++|+......+.-.....++.||++|++||+++++|||||.+.||||+++..+||+|||+|+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999998656779999999999999999999999999999999999999999999999999999433
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
+.... .....--...|.|||.+.. ..++.++|||||||+||||++ |+.||.+.+..+++..+- .+.+.+++.
T Consensus 355 d~~Y~--~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le----~GyRlp~P~ 427 (468)
T KOG0197|consen 355 DDEYT--ASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE----RGYRLPRPE 427 (468)
T ss_pred CCcee--ecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh----ccCcCCCCC
Confidence 32221 2222334567999999986 569999999999999999998 999999988877665554 355677889
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLL 269 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL 269 (636)
.+++++.+++..||..+|++|||++.+.
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999999999999999665
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=359.25 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=196.5
Q ss_pred EeEEcccCceEEEEEEEcC--CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe--CCeEEEEEecc
Q 006664 16 YEEVGQGVSASVHRALCIP--FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS--DHNLWVVMPFM 91 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~--tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~--~~~l~iVmEy~ 91 (636)
..+||+|+||+||+|.++. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +..+|+||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 3589999999999998653 66899999986432 23457789999999999999999999854 56789999998
Q ss_pred CCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE----ccCCcEEEeccCcccc
Q 006664 92 SGGSCLHILKAAY-------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI----DVRGAIKLGDFGVSAC 160 (636)
Q Consensus 92 ~GGsL~~lL~~~~-------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl----d~~g~vKL~DFGla~~ 160 (636)
.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 75 7888775321 2348899999999999999999999999999999999999 4567999999999976
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH---------HHHHHHHhcC
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---------KVLLMTLQNA 231 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~---------~~l~~~~~~~ 231 (636)
..............+||+.|+|||++.+...++.++|||||||++|||++|.+||...... ..+..+....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 5332222222345689999999999977566899999999999999999999999643211 1111111000
Q ss_pred --CCCCCc-------------------------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 232 --PPGLDY-------------------------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 232 --~~~~~~-------------------------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+....+ ......+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000000 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=350.51 Aligned_cols=255 Identities=18% Similarity=0.299 Sum_probs=212.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCI---PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
+..++|++.+.||+|+||.||+|.++ ..+..||+|+++..........+.+|+.+++.++||||+++++++..+..+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 56789999999999999999999765 456799999997654444556788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||+.+|+|.+++... ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+|++|||.+......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999999764 356899999999999999999999999999999999999999999999999986543111
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.........++..|+|||++.+ ..++.++|||||||++|||++ |..||........+..+.... ..+.+..+
T Consensus 161 --~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 233 (266)
T cd05064 161 --AIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF----RLPAPRNC 233 (266)
T ss_pred --chhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC----CCCCCCCC
Confidence 1111123345678999999976 678999999999999999775 999998877665544443222 22334567
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+..+.+++.+||..+|.+||++++|++
T Consensus 234 ~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 234 PNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=373.62 Aligned_cols=268 Identities=28% Similarity=0.409 Sum_probs=230.6
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+++..+.|...+.||+|+||.||-++.+.||+.||+|.+++.+. ........+|..||.+++.|+||.+-..|++...
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 67888999999999999999999999999999999999976542 2234567899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+||..|+||||..+|.+....+|+|..+..|+.+|+.||++||+.+||+|||||+|||+|..|++.|+|.|+|..+.+
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999999999888667899999999999999999999999999999999999999999999999999986633
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHH----HHHHHhcCCCCCCccc
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV----LLMTLQNAPPGLDYER 239 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~----l~~~~~~~~~~~~~~~ 239 (636)
.. . ....+||..|||||++.. ..|+...|+|||||++|||+.|+.||........ -.+++ .. ....
T Consensus 340 g~---~-~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~-~~----~~ey 409 (591)
T KOG0986|consen 340 GK---P-IRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL-ED----PEEY 409 (591)
T ss_pred CC---c-cccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh-cc----hhhc
Confidence 21 1 234599999999999987 4599999999999999999999999976443222 22222 22 2233
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCC-----HHHHHhCcccccccChHHH
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSNEYI 283 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~~~i 283 (636)
+.++|+++++|...+|.+||.+|.. +.++.+||||+.+.+....
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rle 458 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLE 458 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHh
Confidence 4789999999999999999999974 6799999999988765443
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=351.63 Aligned_cols=263 Identities=40% Similarity=0.650 Sum_probs=215.8
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEE----
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFV---- 79 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~---- 79 (636)
.+....++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 44557799999999999999999999999999999999875322 2235678899999998 7999999999874
Q ss_pred -eCCeEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccC
Q 006664 80 -SDHNLWVVMPFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFG 156 (636)
Q Consensus 80 -~~~~l~iVmEy~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFG 156 (636)
.+..+|+||||++||+|.+++... ....+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 446799999999999999988643 22468899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 006664 157 VSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP 232 (636)
Q Consensus 157 la~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~ 232 (636)
++..+.... .......|++.|+|||++.. ...++.++|||||||++|+|++|..||........+........
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (286)
T cd06638 170 VSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP 246 (286)
T ss_pred ceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence 987553221 12234579999999999853 23478899999999999999999999987766554433322222
Q ss_pred CCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 233 ~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+. ...+..++..+.+||.+||..||.+||++.++++|+||
T Consensus 247 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 PT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred Cc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 21 12234567899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=353.31 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=213.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCe-----
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVD-HPNVLKSHCSFVSDHN----- 83 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~----- 83 (636)
++|++.+.||+|+||.||+|.+..+|+.||||.+...... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998755332 23456788999999995 6999999999987665
Q ss_pred EEEEEeccCCCCHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-CCcEEEeccCccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYP---DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSA 159 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~---~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-~g~vKL~DFGla~ 159 (636)
.|+||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 78888865432 35899999999999999999999999999999999999998 8899999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC--CCCCc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP--PGLDY 237 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~--~~~~~ 237 (636)
.+..... ......+++.|+|||++.+...++.++||||||+++|+|++|..||.+......+..+..... ....+
T Consensus 160 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 160 AFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred ecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 5422211 112346789999999987656689999999999999999999999988777666554433211 00000
Q ss_pred ---------------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 238 ---------------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 238 ---------------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
.....++..+.+||.+||..||.+||++.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00134788899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=373.88 Aligned_cols=262 Identities=19% Similarity=0.344 Sum_probs=214.5
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCC-----cEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeE
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFN-----EIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCS 77 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg-----~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~ 77 (636)
..|.+..++|++++.||+|+||.||+|.+..+| ..||||+++..........+.+|+.+++.+ +||||++++++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 356677789999999999999999999875544 579999997655555567788999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHHhC-----------------------------------------------------
Q 006664 78 FVSDHNLWVVMPFMSGGSCLHILKAAY----------------------------------------------------- 104 (636)
Q Consensus 78 ~~~~~~l~iVmEy~~GGsL~~lL~~~~----------------------------------------------------- 104 (636)
+.....+|+|||||.+|+|.+++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999986531
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 105 ---------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 105 ---------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YV 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-ee
Confidence 12478888999999999999999999999999999999999999999999999876533211 11
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
......+++.|||||++.+ ..|+.++|||||||++|+|++ |..||................. ....+..++++++
T Consensus 270 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~ 345 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY---QMSRPDFAPPEIY 345 (374)
T ss_pred eccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc---CccCCCCCCHHHH
Confidence 2223345678999999976 679999999999999999997 9999987655444434433321 2223345689999
Q ss_pred HHHHhhcccCCCCCCCHHHHHh
Q 006664 249 QMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++|.+||..||.+||++.++++
T Consensus 346 ~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 346 SIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=353.90 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=209.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|.+++.||+|+||.||+|.+..+|..||+|++...........+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 47899999999999999999999999999999999765443334467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+. ++|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS---Q 158 (291)
T ss_pred ccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC---C
Confidence 996 6777776553 2567888999999999999999999999999999999999999999999999987542221 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcC--CC-----------CC
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQNA--PP-----------GL 235 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~-~~l~~~~~~~--~~-----------~~ 235 (636)
......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.... +.+..+.... +. ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 1234568999999999876556888999999999999999999999765542 2222221100 00 00
Q ss_pred -C-c------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 236 -D-Y------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 236 -~-~------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
. + ......+..+.+++.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0 0001235788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=358.13 Aligned_cols=257 Identities=46% Similarity=0.829 Sum_probs=219.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+.|+.++.||.|+||.||+|.+..++..||+|+++..........+.+|+.+++.++||||+++++++..+...|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45777889999999999999999999999999997665555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+.|++|.+++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+.... ..
T Consensus 84 ~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---~~ 157 (277)
T cd06642 84 LGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IK 157 (277)
T ss_pred cCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc---hh
Confidence 999999998864 468999999999999999999999999999999999999999999999999987653221 12
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||....+............+. ....++.++.++
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l 232 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT----LEGQYSKPFKEF 232 (277)
T ss_pred hhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC----CCcccCHHHHHH
Confidence 234578999999999976 568899999999999999999999998766555443333222221 224577899999
Q ss_pred HHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 251 IASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
|.+||..+|.+||++.++++||||....
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 9999999999999999999999997654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=348.09 Aligned_cols=257 Identities=31% Similarity=0.559 Sum_probs=215.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-----hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-----SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-----~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
+|++.+.||.|+||.||+|.+ .+|+.+|+|.+...... .....+.+|+.+++.++||||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 57899999998754321 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC-
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG- 165 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~- 165 (636)
||||+.|++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999999775 568999999999999999999999999999999999999999999999999987542211
Q ss_pred --CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 166 --DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 166 --~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
..........|++.|+|||++.+ ..++.++|||||||++|+|++|..||................. .....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 234 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG--LMPRLPDSF 234 (265)
T ss_pred cccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC--CCCCCCCCC
Confidence 11122335679999999999976 5688999999999999999999999987665544433322211 111234568
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+.++.+||.+||.++|.+||++.+++.||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=400.01 Aligned_cols=264 Identities=27% Similarity=0.442 Sum_probs=220.1
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--C
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSD--H 82 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~--~ 82 (636)
.+....+|++++.||+|+||+||+|.+..++..||+|++..... ......+.+|+.+|+.|+|||||+++++|... .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 34566899999999999999999999999999999999975542 33456788999999999999999999998654 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCcccccCcccEEEcc-------
Q 006664 83 NLWVVMPFMSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLHHH-------GHIHRDVKSGNILIDV------- 146 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~-------gIvHRDLKP~NILld~------- 146 (636)
.+|||||||.+|+|.++|.... ...+++..++.|+.||+.||.|||.. +||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 7999999999999999997642 24699999999999999999999985 4999999999999964
Q ss_pred ----------CCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhc-cCCCcccchhhHHHHHHHHHcCCCCC
Q 006664 147 ----------RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPF 215 (636)
Q Consensus 147 ----------~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLltG~~PF 215 (636)
.+.+||+|||++..+... ......+||+.|+|||++.+. ..++.++||||||||||+|++|..||
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~----s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIE----SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccc----ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 235899999998754221 123456899999999998642 45889999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 216 SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 216 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
........+...+...+. + ....++.++.+||..||..+|.+||++.++|.|+||+..
T Consensus 244 ~~~~~~~qli~~lk~~p~-l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPD-L---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CcCCcHHHHHHHHhcCCC-C---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 877766666555544321 1 123468899999999999999999999999999999743
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.54 Aligned_cols=264 Identities=24% Similarity=0.384 Sum_probs=217.3
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhCCCCCcceeeeEEEeC--CeEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILVDHPNVLKSHCSFVSD--HNLW 85 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~--~~l~ 85 (636)
..++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.+++.++||||+++++++... ..+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 4688999999999999999999999999999999997554322 233466899999999999999999999765 5689
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.+ +|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999975 888888764 2568999999999999999999999999999999999999999999999999987653221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG----------- 234 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~----------- 234 (636)
.......+++.|+|||++.+...++.++|||||||++|+|++|.+||....+...+..+.......
T Consensus 163 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 163 ---KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ---CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 112233568899999999765678999999999999999999999999887776665544321100
Q ss_pred -----CCcc---------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 235 -----LDYE---------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 235 -----~~~~---------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+... ....+++.+.+||.+||..||.+|||+.+++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0000 012358899999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=354.06 Aligned_cols=259 Identities=28% Similarity=0.440 Sum_probs=214.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 57999999999999999999999999999999986543322 34567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+++++|..+.... ..+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++..+.... .
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~---~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---E 155 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---c
Confidence 99999888776543 458999999999999999999999999999999999999999999999999987543322 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC----------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP---------------- 233 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~---------------- 233 (636)
......|+..|+|||++.+...++.++|||||||++|+|++|.+||......+....+......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2234578999999999876556788999999999999999999999876654433332211000
Q ss_pred -----CCC-----cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 234 -----GLD-----YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 234 -----~~~-----~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
... ......++..+.+|+.+||..||.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 01123568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=369.78 Aligned_cols=254 Identities=27% Similarity=0.346 Sum_probs=202.9
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
...+|.+++.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++||||+++++++..+...|+||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 345799999999999999999999999999999985322 2356999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---- 210 (357)
T ss_pred EccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC----
Confidence 9996 5888888664 356999999999999999999999999999999999999999999999999998643211
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCC-CCCCCCChH---------HHHHHHHhc---CCCCC
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGH-APFSKYPPM---------KVLLMTLQN---APPGL 235 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~-~PF~~~~~~---------~~l~~~~~~---~~~~~ 235 (636)
.......||+.|+|||++.+ ..|+.++|||||||++|||+++. .+|...+.. ..+...+.. .+..+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred cccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 11235679999999999976 57899999999999999999854 444432211 111111110 00000
Q ss_pred C--------------------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 236 D--------------------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 236 ~--------------------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
. ......++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0 0011245677888999999999999999999999999975
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=372.08 Aligned_cols=261 Identities=21% Similarity=0.356 Sum_probs=214.3
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEE-----cCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALC-----IPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSF 78 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~-----~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~ 78 (636)
.|.+..++|++.+.||+|+||.||+|.+ ..++..||+|+++..........+.+|+.+++.+ +||||+++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 5667778999999999999999999974 3467789999997554444566788999999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHHhCC-----------------------------------------------------
Q 006664 79 VSDHNLWVVMPFMSGGSCLHILKAAYP----------------------------------------------------- 105 (636)
Q Consensus 79 ~~~~~l~iVmEy~~GGsL~~lL~~~~~----------------------------------------------------- 105 (636)
..+...|+|||||+||+|.+++.....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999999999999875321
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 106 --------------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 106 --------------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 146788899999999999999999999999999999999999999999999987653322
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
. ........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||............+..... ...+...+
T Consensus 269 ~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 343 (375)
T cd05104 269 N-YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR---MLSPECAP 343 (375)
T ss_pred c-ccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc---CCCCCCCC
Confidence 1 111223445678999999976 678999999999999999997 99999876655444444443221 12234567
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.++++||.+||..||++||++.++++
T Consensus 344 ~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 344 SEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHH
Confidence 89999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=356.55 Aligned_cols=265 Identities=34% Similarity=0.551 Sum_probs=215.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~iV 87 (636)
..++|+..+.||+|+||.||++.+..+++.||+|.+...........+.+|+.++.++. ||||+++++++..+...|++
T Consensus 2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 45678889999999999999999999999999999976554455667889999999986 99999999999999999999
Q ss_pred EeccCCCCHHHHH---HHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 88 MPFMSGGSCLHIL---KAAYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 88 mEy~~GGsL~~lL---~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
|||+.+ ++.++. .......+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++..+..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999875 554433 222235699999999999999999999975 999999999999999999999999999876533
Q ss_pred CCCcccccccccCCCCCCChhhhhhc--cCCCcccchhhHHHHHHHHHcCCCCCCCCCh-HHHHHHHHhcCCCCCCcccc
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQL--HGYDFKADIWSFGITALELAHGHAPFSKYPP-MKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~--~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~-~~~l~~~~~~~~~~~~~~~~ 240 (636)
.. ......|++.|+|||++.+. ..++.++|||||||++|+|++|+.||..... ...+.......++.+.....
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 161 SI----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred CC----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 22 12344689999999999764 3689999999999999999999999976542 22222222222233332333
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
..++.++.+||.+||.+||.+||++++++.||||+...
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 45889999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=346.91 Aligned_cols=256 Identities=22% Similarity=0.410 Sum_probs=217.3
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|.+...+|.+.+.||+|+||.||+|.+..++..||+|++..+ ......+.+|+.+++.++||||+++++++..+..++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 778899999999999999999999999999999999998633 334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.+|+|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999987655668999999999999999999999999999999999999999999999999987543211
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+......... ....+..++
T Consensus 159 --~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~ 231 (263)
T cd05052 159 --YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY----RMERPEGCP 231 (263)
T ss_pred --eeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC----CCCCCCCCC
Confidence 111122334678999999876 678899999999999999998 999998876655443333221 223346688
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.++.++|.+||..||++||++.++++
T Consensus 232 ~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 232 PKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=349.27 Aligned_cols=262 Identities=33% Similarity=0.544 Sum_probs=215.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--CeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD--HNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~--~~l~iVm 88 (636)
++|+..+.||.|++|.||+|.+..+++.||+|.+...........+.+|+++++.++||||++++++|... ..+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47999999999999999999999999999999997655444567789999999999999999999998654 4799999
Q ss_pred eccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 89 PFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
||++|++|.+++... ....+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 999999999887642 23558999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC-----hHHHHHHHHhcCCCCCCc--cc
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP-----PMKVLLMTLQNAPPGLDY--ER 239 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~-----~~~~l~~~~~~~~~~~~~--~~ 239 (636)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..+..........+.+.. ..
T Consensus 160 ----~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 160 ----AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ----cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 124568899999999876 578999999999999999999999997652 222222222211111111 11
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
...+++.+.+||.+||..||.+|||+.|+++||||+...
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 235678999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=343.35 Aligned_cols=260 Identities=32% Similarity=0.551 Sum_probs=217.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|++.+.||+|+||.||+|.+..++..||+|+++..... .....+.+|+.+++.++||||+++++++.....+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 699999999999999999999999999999999765443 4577899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++............
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999999999864 45889999999999999999999999999999999999999999999999998765332221111
Q ss_pred -cccccCCCCCCChhhhhhcc--CCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 171 -RNTFVGTPCWMAPEVMEQLH--GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 171 -~~~~~GT~~YmAPEvl~~~~--~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.....|++.|+|||++.+.. .++.++||||||+++|+|++|..||............+... .....+....++..+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-HKPPIPDSLQLSPEG 237 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcC-CCCCCCcccccCHHH
Confidence 22457899999999997632 27889999999999999999999997654332222222221 111223334568899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.+||.+||+.||.+||++.+++.|||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=354.54 Aligned_cols=251 Identities=16% Similarity=0.242 Sum_probs=209.8
Q ss_pred ccCCCCeEEE--eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--hhHHHHHHHHHHHHhCCCCCcceeeeEEEe--
Q 006664 7 PIGAEHYTLY--EEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--SDLSNISREAQTMILVDHPNVLKSHCSFVS-- 80 (636)
Q Consensus 7 ~i~~~~Y~l~--~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~-- 80 (636)
.+..++++.. ..||+|++|.||+|.. +|+.||||.+...... ...+.+.+|+.+|++++||||+++++++.+
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 3455666666 6899999999999987 6999999999754322 224678899999999999999999999977
Q ss_pred --CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCc
Q 006664 81 --DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 81 --~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
...+++|||||.||+|.+++... ..+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccch
Confidence 35789999999999999999875 5688999999999999999999984 999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhc-cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 236 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~ 236 (636)
+..+... ....+||+.|+|||++.+. ..|+.++|||||||++|||++|..||.+....+....+......
T Consensus 170 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~--- 240 (283)
T PHA02988 170 EKILSSP------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS--- 240 (283)
T ss_pred Hhhhccc------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC---
Confidence 8754221 1245789999999999752 46899999999999999999999999988766655554433221
Q ss_pred cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 237 ~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
...+..++..+++||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 2223457889999999999999999999999985
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=349.37 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=208.5
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeC--CeEEEEEe
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSD--HNLWVVMP 89 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~--~~l~iVmE 89 (636)
|++++.||+|+||.||+|.+..++..||+|++.............+|+.++.++. ||||+++++++.++ +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999999875433333334457899998885 99999999999988 89999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.| +|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++. +.+||+|||++..+....
T Consensus 81 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~---- 153 (282)
T cd07831 81 LMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP---- 153 (282)
T ss_pred cCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC----
Confidence 9975 8888887642 46899999999999999999999999999999999999998 999999999987653221
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC---------------CC
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP---------------PG 234 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~---------------~~ 234 (636)
......+++.|+|||++.....++.++|||||||++|+|++|..||.+.+..+.+........ ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 122456899999999876545678999999999999999999999988766554433321110 01
Q ss_pred CCcc---------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 235 LDYE---------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 235 ~~~~---------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+.++ ....++..+++||.+||.+||.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 012468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.12 Aligned_cols=258 Identities=46% Similarity=0.810 Sum_probs=220.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+-|++++.||.|+||.||+|.+..+++.||||++...........+.+|+.+++.++||||+++++++..+...|+||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34788999999999999999999999999999987655445567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+.||+|..++.. ..+++..+..++.|++.|+.|||++|++|+||+|.||+++.++.++|+|||++..+.... ..
T Consensus 84 ~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~---~~ 157 (277)
T cd06641 84 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---IK 157 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch---hh
Confidence 999999999865 468999999999999999999999999999999999999999999999999986543221 11
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
.....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.....+. ....++.++.++
T Consensus 158 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 232 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKPLKEF 232 (277)
T ss_pred hccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC----CCcccCHHHHHH
Confidence 234578999999999875 567889999999999999999999998776655444433222221 234578899999
Q ss_pred HHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 251 IASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
|.+||..||.+||++.++++||||.....
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 233 VEACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 99999999999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.37 Aligned_cols=264 Identities=25% Similarity=0.358 Sum_probs=216.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++.+.||+|+||+||+|.+..+|+.||+|.+...... .....+.+|+++++.++||||+++++++.++...|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6899999999999999999999999999999998654332 234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-CCcEEEeccCcccccccCCCcc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-~g~vKL~DFGla~~~~~~~~~~ 168 (636)
|+. ++|..++.......+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++...... .
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~---~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP---V 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC---c
Confidence 996 58888887654445789999999999999999999999999999999999985 567999999998654221 1
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC-------------
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL------------- 235 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~------------- 235 (636)
.......|++.|+|||.+.+...++.++|||||||++|+|++|.+||......+.+...........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 1123456889999999987655688999999999999999999999987766655544432111000
Q ss_pred -------C----cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 236 -------D----YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 236 -------~----~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
. ......++..+.++|.+||..||.+||++.+++.||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 0 001235688899999999999999999999999999998653
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=353.46 Aligned_cols=259 Identities=34% Similarity=0.587 Sum_probs=218.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
+..++|++++.||+|+||+||+|.+..+|..||+|++...........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 45678999999999999999999999999999999987655455567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
|||+++|+|.+++... +.+++..+..++.+++.||.|||+ +|++||||||+||+++.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred EecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 9999999999998764 568999999999999999999997 69999999999999999999999999998654222
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH-----------HHHHHHHhcCCCCC
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-----------KVLLMTLQNAPPGL 235 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~-----------~~l~~~~~~~~~~~ 235 (636)
.....+|+..|+|||++.+ ..++.++|||||||++|+|++|..||...... +..........+.+
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233 (284)
T ss_pred ---ccCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC
Confidence 1234679999999999876 57889999999999999999999999864432 11222222222111
Q ss_pred CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 236 ~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
. ...++..+.+||.+||.+||.+||++.++++|+||.+.
T Consensus 234 ~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 234 P---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred C---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 1 12377899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=385.98 Aligned_cols=266 Identities=40% Similarity=0.700 Sum_probs=237.9
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEe----
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVS---- 80 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~---- 80 (636)
.+...+-|++.++||.|.+|.||+++++++|+..|+|+.+..... -+.+..|++|++.+ +|||++.+|++|.-
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 455678899999999999999999999999999999998765443 34677899999876 79999999999964
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 81 -DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 81 -~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
++.+|+|||||.||+.-|+++......+.|..+++|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||+++
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 4689999999999999999999877789999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhc----cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQL----HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 235 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~----~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~ 235 (636)
.+.. ....+++++|||+|||||++.-. ..|+..+|+|||||+..||.-|.+|+.+..++..++.+.++.++.+
T Consensus 172 Qlds---T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL 248 (953)
T KOG0587|consen 172 QLDS---TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 248 (953)
T ss_pred eeec---ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc
Confidence 7632 23346899999999999999643 3478899999999999999999999999999999998888877765
Q ss_pred CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 236 ~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
..+.+++++|.+||..||.+|..+||+..++|+|||.+...
T Consensus 249 --krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 249 --KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred --cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 46789999999999999999999999999999999998543
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.49 Aligned_cols=262 Identities=25% Similarity=0.327 Sum_probs=217.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc----hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN----SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~----~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
+|++.+.||.|+||.||+|.+..+|+.||||.+...... .....+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999755432 1234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+ +|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-- 156 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--
Confidence 9999 899999997652 369999999999999999999999999999999999999999999999999987553321
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC--C---------C
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG--L---------D 236 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~--~---------~ 236 (636)
.......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+....+.+..+....... . .
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 -RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred -ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 112334678899999998765678899999999999999999999998777655544433211000 0 0
Q ss_pred ------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 237 ------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 237 ------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.......+..+.+||.+||.+||++||++.+++.|+||.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 001134578899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=348.96 Aligned_cols=260 Identities=20% Similarity=0.364 Sum_probs=214.2
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
|.+..++|++.+.||+|+||.||+|.+. .++..||||++...........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 7888999999999999999999999864 24578999998644333345568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEE
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYP--------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~--------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL 152 (636)
+...++||||+.+|+|.+++..... ..++...+..++.|++.||.|||++|++||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999999976421 23567888999999999999999999999999999999999999999
Q ss_pred eccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 006664 153 GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 231 (636)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~ 231 (636)
+|||++........ ........+++.|||||++.+ ..++.++|||||||++|+|++ |..||.+.........+....
T Consensus 161 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 161 GDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred CCCCCccccCCcce-eecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999875432211 111123356788999999976 568999999999999999998 799998877766555444433
Q ss_pred CCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 232 ~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.. .....++..+.++|.+||..||.+||++.+++++
T Consensus 239 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22 1234577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=346.89 Aligned_cols=260 Identities=29% Similarity=0.511 Sum_probs=215.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc---------hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN---------SDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~---------~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588999999999999999999999999999998643211 12356788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+++||||+.||+|.+++... +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999999876 578999999999999999999999999999999999999999999999999987542
Q ss_pred cCCCcccccccccCCCCCCChhhhhhcc-CCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-CCCCCcccc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLH-GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA-PPGLDYERD 240 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~-~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~-~~~~~~~~~ 240 (636)
... .........|+..|+|||.+.... .++.++|+||||+++|+|++|..||................ ...+.....
T Consensus 160 ~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 160 DIY-DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred ccc-cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 211 111233457899999999987533 47899999999999999999999997665554443322211 112222223
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
..++..++++|.+||..||.+||++++++.||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 4578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=378.09 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=206.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+++|+.++|||||++++++..++..|+|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457999999999999999999999999999999643 2235689999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+. ++|..++... ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.... ...
T Consensus 241 ~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-~~~ 317 (461)
T PHA03211 241 KYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-STP 317 (461)
T ss_pred ccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc-ccc
Confidence 995 6888888764 2469999999999999999999999999999999999999999999999999987543221 112
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC-------hHHHHHHHHhcCCC---CC----
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP-------PMKVLLMTLQNAPP---GL---- 235 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~-------~~~~l~~~~~~~~~---~~---- 235 (636)
.....+||+.|||||++.+ ..++.++|||||||++|||++|..|+.... ....+..+++.... .+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2335679999999999976 578999999999999999999876553211 11222233222110 00
Q ss_pred -----------------------CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 236 -----------------------DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 236 -----------------------~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
.+.....++.++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 01111245668999999999999999999999999999963
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=348.27 Aligned_cols=261 Identities=39% Similarity=0.630 Sum_probs=216.1
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeC-----
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSD----- 81 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~----- 81 (636)
...++|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 34688999999999999999999999999999999986432 2345678899999988 899999999998753
Q ss_pred CeEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
...|+||||+.||+|.++++.. ....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 4689999999999999988642 23468999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhcc----CCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH----GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 235 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~----~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~ 235 (636)
....... ......|+..|+|||++.... .++.++|||||||++|+|++|+.||........+..+.....+..
T Consensus 177 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 177 QLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred hcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 6532211 123457899999999986422 368899999999999999999999987766555544443333222
Q ss_pred CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 236 ~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
.....++..+++||.+||.+||++||++.+|+.||||+
T Consensus 254 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 --LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 22345678899999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=346.86 Aligned_cols=259 Identities=22% Similarity=0.374 Sum_probs=216.8
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCC-----cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFN-----EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg-----~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
|++..++|++.+.||+|+||.||+|.++..+ ..||+|.+...........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 7889999999999999999999999886544 88999998654444445678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEE
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYP--------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~--------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL 152 (636)
+...|+||||+.+|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 9999999999999999999976421 23678899999999999999999999999999999999999999999
Q ss_pred eccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 006664 153 GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 231 (636)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~ 231 (636)
+|||+++.+..... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+..............
T Consensus 161 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 161 GDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred CCcccchhhccCcc-cccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 99999876543321 112234567889999999876 568999999999999999998 999998877666554444222
Q ss_pred CCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 232 ~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
. ...+..++..+.++|.+||..+|.+|||+.+++.
T Consensus 239 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 H----LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2 2233456899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.46 Aligned_cols=255 Identities=22% Similarity=0.373 Sum_probs=215.8
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|+|..++|+++++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++......|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 7899999999999999999999999864 56789999875432 23567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.||+|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....+..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999999987655678999999999999999999999999999999999999999999999999987653221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
. .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.... ..+....++
T Consensus 158 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~ 230 (261)
T cd05072 158 Y--TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY----RMPRMENCP 230 (261)
T ss_pred e--eccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC----CCCCCCCCC
Confidence 1 11223456778999999876 568899999999999999998 999998776665544443221 223345678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.++.++|.+||..||++||+++++++
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 231 DELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=346.59 Aligned_cols=252 Identities=28% Similarity=0.488 Sum_probs=217.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
+|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999975432 2356788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.|++|.+++... ..+++..+..++.||+.||.|||.+|++|+||+|.||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc----
Confidence 99999999999875 579999999999999999999999999999999999999999999999999987553321
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh--HHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP--MKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~--~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
......|+..|+|||++.+ ..++.++|+||||+++|+|++|..||..... ...+....... ....+..++..+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 229 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA----DVLYPATWSTEA 229 (258)
T ss_pred cccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc----cccCcccCcHHH
Confidence 1234578999999999976 5689999999999999999999999987653 23222222211 122335678999
Q ss_pred HHHHHhhcccCCCCCCCH--HHHHhCccc
Q 006664 248 KQMIASCLVKDPSKRPSA--KKLLKHSFF 274 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa--~elL~Hpff 274 (636)
.++|.+||..||.+||++ .+++.||||
T Consensus 230 ~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 230 IDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=341.67 Aligned_cols=257 Identities=38% Similarity=0.636 Sum_probs=220.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
++|++.+.||.|+||.||+|.+..+++.||||++...........+.+|+.++..++||||+++++++..+..+++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47999999999999999999999999999999997665444567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
+.|++|.+++... ..+++..+..++.||+.||.|||+ +|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--- 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--- 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC---
Confidence 9999999999875 679999999999999999999999 9999999999999999999999999999876532221
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC---hHHHHHHHHhcCCCCCCcccchh-hhH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP---PMKVLLMTLQNAPPGLDYERDRK-FSK 245 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~---~~~~l~~~~~~~~~~~~~~~~~~-~S~ 245 (636)
......|+..|+|||.+.. ..++.++||||||+++|+|++|..||.... .......+.....+. .... ++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 230 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS----LPAEEFSP 230 (264)
T ss_pred cccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC----CCcccCCH
Confidence 1235578999999999876 578899999999999999999999997764 333333333222222 2233 789
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.+.++|.+||..+|++||++.+++.||||+.+
T Consensus 231 ~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 231 EFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=341.75 Aligned_cols=255 Identities=28% Similarity=0.480 Sum_probs=218.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|++.+.||+|+||.||+|.+..+|..||+|.+..... ......+.+|+.+++.++||||+++++.+..+...|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58999999999999999999999999999999976432 23456778999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-cEEEeccCcccccccCCCccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-AIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-~vKL~DFGla~~~~~~~~~~~ 169 (636)
+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||.||+++.++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--- 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--- 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc---
Confidence 9999999999876545689999999999999999999999999999999999998775 569999999876533221
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||......+........... .....++.++.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 232 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA----PISPNFSRDLRS 232 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC----CCCCCCCHHHHH
Confidence 2234568999999999875 56889999999999999999999999877666655544433222 123457889999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCccc
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+|.+||..+|++||++.++++||||
T Consensus 233 ~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 233 LISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHhccChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.89 Aligned_cols=256 Identities=41% Similarity=0.707 Sum_probs=209.7
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecC-CCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCHHHHHH
Q 006664 23 VSASVHRALCIPFNEIVAVKILDFE-RDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILK 101 (636)
Q Consensus 23 ~fG~Vyka~~~~tg~~vAIK~i~~~-~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~ 101 (636)
++|.||.+++..+++.||||++... ........+.+|+.+++.++||||++++++|..+...|++|||+.+|+|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4456677777779999999999765 234467789999999999999999999999999999999999999999999998
Q ss_pred HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc----cccccccCC
Q 006664 102 AAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ----RMRNTFVGT 177 (636)
Q Consensus 102 ~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~----~~~~~~~GT 177 (636)
......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.+..+...+... .......++
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence 8766779999999999999999999999999999999999999999999999999987654332211 112345688
Q ss_pred CCCCChhhhhhc-cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC----------------------
Q 006664 178 PCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG---------------------- 234 (636)
Q Consensus 178 ~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~---------------------- 234 (636)
..|+|||++... ..|+.++|||||||++|+|++|..||...+.............+.
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
T cd08216 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE 251 (314)
T ss_pred ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccccc
Confidence 899999998653 358899999999999999999999998766555443333211100
Q ss_pred -------CCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 235 -------LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 235 -------~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
........++.++.+||.+||..||++|||+.++++||||+..+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 01111235678899999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=340.60 Aligned_cols=254 Identities=34% Similarity=0.608 Sum_probs=216.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC----chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD----NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~----~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
+|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 57888999999999999999998999999999865432 22456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||++|++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999999999875 468999999999999999999999999999999999999999999999999987543221
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
......|++.|+|||.+.....++.++|+|||||++|+|++|..||.................. ...+..+++.+
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---PPIPDHLSDEA 231 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---CCcCCCcCHHH
Confidence 1235679999999999876333889999999999999999999999877655544443331111 12234578999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
++||.+||..+|.+||++.+++.|||+
T Consensus 232 ~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 232 KDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=348.59 Aligned_cols=260 Identities=25% Similarity=0.433 Sum_probs=214.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... ......+.+|+++++.++||||+++++++..+...|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 479999999999999999999999999999999875432 2345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.++.+..++... ..+++..+..++.||+.||.|||.+|++||||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~--~ 156 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA--S 156 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--c
Confidence 99987666555443 5689999999999999999999999999999999999999999999999999876533321 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC---C-------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP---P------------- 233 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~---~------------- 233 (636)
......|++.|+|||++.+...++.++||||||+++|+|++|.+||.+....+.+........ +
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 223567899999999998744789999999999999999999999987665544433221100 0
Q ss_pred CCCc-----------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 234 GLDY-----------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 234 ~~~~-----------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
...+ ..+..++.++++||.+||..||++||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 0112348899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.36 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=215.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhCCCCCcceeeeEEEeC--CeEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILVDHPNVLKSHCSFVSD--HNLWV 86 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~--~~l~i 86 (636)
.++|++.+.||.|+||.||+|.+..+++.||+|.++...... ....+.+|+.+++.++||||+++++++..+ ..+|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 368999999999999999999999999999999997554322 234567899999999999999999999887 89999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..+....
T Consensus 84 v~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 9999975 8999887643 468999999999999999999999999999999999999999999999999987653321
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC------------
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG------------ 234 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~------------ 234 (636)
.......+++.|+|||.+.+...++.++||||||+++|+|++|.+||...........+.......
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 122345688999999998765567899999999999999999999998877665554433221100
Q ss_pred --------------CCcccchh-hhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 235 --------------LDYERDRK-FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 235 --------------~~~~~~~~-~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+....+.. +++.+++||.+||+.||++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00001111 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.94 Aligned_cols=262 Identities=37% Similarity=0.651 Sum_probs=211.6
Q ss_pred eEEccc--CceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQG--VSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G--~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
..||+| +||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||++++++|..+..+|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 999999999999999999999976543 33457789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc---
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM--- 170 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~--- 170 (636)
|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+......+.....
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 99999998876567999999999999999999999999999999999999999999999999865443322211111
Q ss_pred -cccccCCCCCCChhhhhhc-cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC---------------
Q 006664 171 -RNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--------------- 233 (636)
Q Consensus 171 -~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~--------------- 233 (636)
.....++..|||||++.+. ..++.++|||||||++|+|++|..||............+...+.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 1122456779999999753 34789999999999999999999999876554443333221110
Q ss_pred ---------------------------CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 234 ---------------------------GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 234 ---------------------------~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.........++..+++||.+||..||.+|||+.++++||||+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 001112234678899999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=379.26 Aligned_cols=253 Identities=30% Similarity=0.507 Sum_probs=217.5
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCHH
Q 006664 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL 97 (636)
Q Consensus 18 ~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL~ 97 (636)
+||+|+||+||-|++..|....|||-|. ++......-+..||.+.+.|+|.|||++.+++..++.+-|.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIp-ekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIP-EKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecc-cccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 7999999999999999999999999996 344445667899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc-cCCcEEEeccCcccccccCCCcccccccc
Q 006664 98 HILKAAYPDGF--EEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID-VRGAIKLGDFGVSACLFDSGDRQRMRNTF 174 (636)
Q Consensus 98 ~lL~~~~~~~l--se~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 174 (636)
.+|+... +++ .|.++..|-+||++||.|||.+.|||||||-+||||+ ..|.+||+|||.++++..- .....+|
T Consensus 661 sLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi---nP~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI---NPCTETF 736 (1226)
T ss_pred HHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC---Ccccccc
Confidence 9998764 666 8999999999999999999999999999999999997 5799999999999887433 3345689
Q ss_pred cCCCCCCChhhhh-hccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 175 VGTPCWMAPEVME-QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 175 ~GT~~YmAPEvl~-~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.||..|||||++. |..+|+.++|||||||++.||++|++||-.......- ..+-+.-....+.+..+|.+++.||.+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 9999999999996 4567999999999999999999999999654322211 111111122335567899999999999
Q ss_pred hcccCCCCCCCHHHHHhCcccccc
Q 006664 254 CLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 254 cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
|+..||..||++.++|.+||++..
T Consensus 815 cFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999854
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=348.23 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=215.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIP-----FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~-----tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+...+|.+.+.||+|+||.||+|.+.. ++..||||++...........+.+|+++++.++||||+++++++..+.
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 456789999999999999999998753 468899999976555445678899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcE
Q 006664 83 NLWVVMPFMSGGSCLHILKAAY------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAI 150 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~v 150 (636)
..|+||||+.||+|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997642 1347889999999999999999999999999999999999999999
Q ss_pred EEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 006664 151 KLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQ 229 (636)
Q Consensus 151 KL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~ 229 (636)
||+|||++........ ........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 162 kl~d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 162 KIGDFGMSRDVYTTDY-YRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EECCcccceecccCcc-eecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 9999999875432221 112234456789999999976 668999999999999999998 9999988776665554443
Q ss_pred cCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 230 ~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.... ..+..++..+++||.+||..||.+||++.++++
T Consensus 240 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLL----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3221 223467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=349.58 Aligned_cols=251 Identities=26% Similarity=0.373 Sum_probs=203.6
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--hhHHHHHHHHHHH---HhCCCCCcceeeeEEEeCCeEEEEEeccC
Q 006664 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERDN--SDLSNISREAQTM---ILVDHPNVLKSHCSFVSDHNLWVVMPFMS 92 (636)
Q Consensus 18 ~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--~~~~~i~rEi~iL---~~L~HPNIVkl~~~~~~~~~l~iVmEy~~ 92 (636)
.||+|+||.||++.+..+++.||+|++...... .......+|..++ ...+||||+.+++++..++..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999999999999999999754322 1122334444433 34579999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccc
Q 006664 93 GGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172 (636)
Q Consensus 93 GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 172 (636)
||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ...
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-----~~~ 153 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPH 153 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-----Ccc
Confidence 99999988765 56999999999999999999999999999999999999999999999999998644221 122
Q ss_pred cccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH--HHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM--KVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 173 ~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~--~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
...||+.|+|||.+.....++.++|||||||++|+|++|..||...... ..+..... ......+..++.+++++
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l 229 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----TVNVELPDSFSPELKSL 229 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh----cCCcCCccccCHHHHHH
Confidence 4579999999999865456899999999999999999999999754321 11111111 12223345688999999
Q ss_pred HHhhcccCCCCCC-----CHHHHHhCcccccccC
Q 006664 251 IASCLVKDPSKRP-----SAKKLLKHSFFKQARS 279 (636)
Q Consensus 251 I~~cL~~DP~kRp-----sa~elL~Hpffk~~~~ 279 (636)
|.+||..||.+|| ++.++++||||+...+
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 230 LEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 9999999999999 6999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=339.27 Aligned_cols=255 Identities=28% Similarity=0.493 Sum_probs=215.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEe--CCeEEEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVS--DHNLWVVM 88 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~--~~~l~iVm 88 (636)
+|++++.||.|+||.||+|.+..+|..||+|+++.... ......+.+|+.+++.++||||+++++++.. +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999975432 3345678899999999999999999998764 45789999
Q ss_pred eccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 89 PFMSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLH-----HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH-----~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
||+.+++|.+++.... ...+++..++.++.||+.||.||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999997642 356899999999999999999999 899999999999999999999999999998765
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
.... .......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...........+.....+ ..+.
T Consensus 161 ~~~~---~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~ 232 (265)
T cd08217 161 GHDS---SFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR----RIPY 232 (265)
T ss_pred cCCc---ccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC----CCcc
Confidence 3222 11234679999999999976 55889999999999999999999999887644433333222211 2335
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.++..+.+++.+||..+|.+||++.+|++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 678999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=343.02 Aligned_cols=251 Identities=29% Similarity=0.467 Sum_probs=213.5
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCH
Q 006664 19 VGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96 (636)
Q Consensus 19 IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL 96 (636)
||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++.+.++..+|+||||+.|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999999999999999975442 23456789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccC
Q 006664 97 LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176 (636)
Q Consensus 97 ~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~G 176 (636)
.+++... ..+++..+..++.||+.||.|||++|++|+||+|.||+++.++.++|+|||++....... ......|
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~~~~ 154 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCG 154 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----ccccccC
Confidence 9999875 468999999999999999999999999999999999999999999999999987653321 2234578
Q ss_pred CCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC--hHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhh
Q 006664 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP--PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASC 254 (636)
Q Consensus 177 T~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~--~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~c 254 (636)
++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.... .......+... ... ...+...+.++.++|.+|
T Consensus 155 ~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~i~~~ 230 (262)
T cd05572 155 TPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG-NGK--LEFPNYIDKAAKDLIKQL 230 (262)
T ss_pred CcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc-CCC--CCCCcccCHHHHHHHHHH
Confidence 999999999875 568999999999999999999999998766 44444443321 111 122334488999999999
Q ss_pred cccCCCCCCC-----HHHHHhCcccccccC
Q 006664 255 LVKDPSKRPS-----AKKLLKHSFFKQARS 279 (636)
Q Consensus 255 L~~DP~kRps-----a~elL~Hpffk~~~~ 279 (636)
|..||.+||+ +.|+++||||+...+
T Consensus 231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 9999999999 999999999987644
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=362.46 Aligned_cols=262 Identities=21% Similarity=0.363 Sum_probs=214.1
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSF 78 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~ 78 (636)
+|++..++|++++.||+|+||.||+|.+. .+++.||+|+++..........+.+|+.++..+ +||||+++++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 58999999999999999999999999754 345889999987554444556788999999999 899999999987
Q ss_pred Ee-CCeEEEEEeccCCCCHHHHHHHhCC----------------------------------------------------
Q 006664 79 VS-DHNLWVVMPFMSGGSCLHILKAAYP---------------------------------------------------- 105 (636)
Q Consensus 79 ~~-~~~l~iVmEy~~GGsL~~lL~~~~~---------------------------------------------------- 105 (636)
.. +..++++|||+.||+|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 65 4678999999999999999865321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccCCC
Q 006664 106 -------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178 (636)
Q Consensus 106 -------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~ 178 (636)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ........++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCc
Confidence 2578899999999999999999999999999999999999999999999999976533221 11223445678
Q ss_pred CCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhccc
Q 006664 179 CWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVK 257 (636)
Q Consensus 179 ~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~ 257 (636)
.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+...+..... ...+..++.++.+++.+||+.
T Consensus 240 ~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 240 KWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR---MRAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred cccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC---CCCCccCCHHHHHHHHHHccC
Confidence 8999999976 679999999999999999997 99999875544444334333221 122345788999999999999
Q ss_pred CCCCCCCHHHHHhC
Q 006664 258 DPSKRPSAKKLLKH 271 (636)
Q Consensus 258 DP~kRpsa~elL~H 271 (636)
+|.+||++.++++|
T Consensus 316 ~p~~RPs~~ell~~ 329 (337)
T cd05054 316 NPEDRPTFSELVEI 329 (337)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=347.57 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=211.2
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCH
Q 006664 19 VGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96 (636)
Q Consensus 19 IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL 96 (636)
||+|+||+||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||++++++|...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999999999999999999975432 22345567899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccC
Q 006664 97 LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176 (636)
Q Consensus 97 ~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~G 176 (636)
.+++.......+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... .......|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG----KKIKGRAG 156 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC----CccccccC
Confidence 99998765457999999999999999999999999999999999999999999999999998654221 11234578
Q ss_pred CCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcc
Q 006664 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLV 256 (636)
Q Consensus 177 T~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~ 256 (636)
+..|+|||++.+ ..++.++|||||||++|+|++|+.||.............. .........+..+++.+.++|.+||.
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~ 234 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR-RTLEMAVEYPDKFSPEAKDLCEALLQ 234 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh-ccccccccCCccCCHHHHHHHHHHcc
Confidence 899999999876 4588999999999999999999999976543111111111 11112223345678999999999999
Q ss_pred cCCCCCC-----CHHHHHhCcccccccC
Q 006664 257 KDPSKRP-----SAKKLLKHSFFKQARS 279 (636)
Q Consensus 257 ~DP~kRp-----sa~elL~Hpffk~~~~ 279 (636)
.||.+|| ++.+++.||||+...+
T Consensus 235 ~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 235 KDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred CChhHccCCCcccHHHHHhChhhhcCCh
Confidence 9999999 8999999999986653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.83 Aligned_cols=260 Identities=35% Similarity=0.594 Sum_probs=219.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+..+...|+||||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 56677788999999999999999999999999986433 23456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 101 ~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~---~~ 174 (292)
T cd06658 101 LEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV---PK 174 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc---cc
Confidence 999999998854 468999999999999999999999999999999999999999999999999986542211 12
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
.....|++.|+|||.+.+ ..++.++||||||+++|||++|..||........+.......+.. ......++..+.+|
T Consensus 175 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 251 (292)
T cd06658 175 RKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR--VKDSHKVSSVLRGF 251 (292)
T ss_pred CceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc--cccccccCHHHHHH
Confidence 235679999999999875 568999999999999999999999998777665544433322221 12234578899999
Q ss_pred HHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 251 IASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
|.+||..||.+|||++++++||||+.....
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 999999999999999999999999865544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=336.17 Aligned_cols=255 Identities=29% Similarity=0.516 Sum_probs=221.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|.+.+.||.|+||.||++.+..++..||+|++...... .....+.+|+++++.++|||++++++.+..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 689999999999999999999999999999999765432 4566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 91 MSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 91 ~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
++|++|.+++.... ...+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--- 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc---
Confidence 99999999998753 3679999999999999999999999999999999999999999999999999987543322
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
.......|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||................... .+..++..+.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 232 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP----IPSQYSSELR 232 (258)
T ss_pred ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC----CCCCCCHHHH
Confidence 22345689999999999876 568899999999999999999999998777665555554433222 2346789999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
++|.+||..+|.+||++.++++||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=347.77 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=214.2
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEecc
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~ 91 (636)
|++.+.||.|++|.||+|.+..+|..||+|++...... .....+.+|+.+++.++||||+++++++.++...|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 77899999999999999999999999999999765432 23356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
. ++|.+++.......+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..+.... ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV---RTY 156 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc---ccc
Confidence 5 689999987643468999999999999999999999999999999999999999999999999986542211 112
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-----------------
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG----------------- 234 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~----------------- 234 (636)
....+++.|+|||++.+...++.++||||||+++|+|++|.+||........+..+.+.....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 234678999999988765567899999999999999999999998877655544433211000
Q ss_pred -------CCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 235 -------LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 235 -------~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
........++..+.++|.+||+.||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0001124567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=348.09 Aligned_cols=264 Identities=25% Similarity=0.349 Sum_probs=210.3
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhCCCCCcceeeeEEEeCC-----
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILVDHPNVLKSHCSFVSDH----- 82 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~----- 82 (636)
..++|++.+.||+|+||.||+|.+..+++.||||.+....... ....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3578999999999999999999999999999999986543222 2345678999999999999999999887653
Q ss_pred ---eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 83 ---NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 83 ---~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
..|+||||+.+ +|.+++... ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 46999999975 888887654 2468999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCc-ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC---CCCC
Q 006664 160 CLFDSGDR-QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA---PPGL 235 (636)
Q Consensus 160 ~~~~~~~~-~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~---~~~~ 235 (636)
.+...... ........++..|+|||++.+...++.++||||||+++|+|++|..||...........+..-. ++..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 65332211 1122345688999999998765567889999999999999999999998776654433222210 0000
Q ss_pred -------------Ccc-----------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 236 -------------DYE-----------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 236 -------------~~~-----------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
..+ .....+..+++||.+||..||.+||+++++++||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000 011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=351.38 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=209.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcC--CCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--CeEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIP--FNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD--HNLW 85 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~--tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~--~~l~ 85 (636)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 89999999997643 122345678899999999999999999999988 8899
Q ss_pred EEEeccCCCCHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc----CCcEEEeccCcc
Q 006664 86 VVMPFMSGGSCLHILKAAYP---DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV----RGAIKLGDFGVS 158 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~---~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~----~g~vKL~DFGla 158 (636)
+||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 67777754321 36899999999999999999999999999999999999998 899999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHH---------HHHHHHh
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK---------VLLMTLQ 229 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~---------~l~~~~~ 229 (636)
..+..............||+.|+|||++.+...++.++|||||||++|+|++|++||.+..... .+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 7653332212223456789999999998775678999999999999999999999997543221 1111100
Q ss_pred cC-------------------------CCCCC-------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 230 NA-------------------------PPGLD-------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 230 ~~-------------------------~~~~~-------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.. ..... .......+..+.++|.+||..||.+|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00 00000 00011566789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=349.79 Aligned_cols=263 Identities=29% Similarity=0.450 Sum_probs=222.1
Q ss_pred eEE-EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEEec
Q 006664 13 YTL-YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 13 Y~l-~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
|++ .+.||+|+||.|--+....+|..||||+|++. ..-...++.||++++..+ .|+||+.++++|+++..+|+|||-
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 444 45899999999999999999999999999866 334577899999999988 599999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC---cEEEeccCcccccccCCC-
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGD- 166 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g---~vKL~DFGla~~~~~~~~- 166 (636)
|.||+|..+|.++ ..|+|.++.++.++|+.||.|||.+||.||||||+|||..... -||||||.+..-+...++
T Consensus 158 m~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 158 MRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999999999887 6799999999999999999999999999999999999996443 589999998654322211
Q ss_pred ---cccccccccCCCCCCChhhhh----hccCCCcccchhhHHHHHHHHHcCCCCCCCCCh--------------HHHHH
Q 006664 167 ---RQRMRNTFVGTPCWMAPEVME----QLHGYDFKADIWSFGITALELAHGHAPFSKYPP--------------MKVLL 225 (636)
Q Consensus 167 ---~~~~~~~~~GT~~YmAPEvl~----~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~--------------~~~l~ 225 (636)
......+.+|+-.|||||+.. ....|+.++|.||||+|+|.|++|++||.+.-. ...+.
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 112234678999999999974 235699999999999999999999999965311 23355
Q ss_pred HHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 226 MTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.-++...-.+.-..|..+|.+++++|..+|..|+..|.++.++++|||+....
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 56666655555566789999999999999999999999999999999998654
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=347.25 Aligned_cols=262 Identities=23% Similarity=0.447 Sum_probs=217.6
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCC-----CcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeE
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPF-----NEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCS 77 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t-----g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~ 77 (636)
-.|.+..++|++.+.||+|+||.||++.+... ...+|+|.+...........+.+|+.+++.+ +||||++++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 46788899999999999999999999987644 3789999987655445566788999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEE
Q 006664 78 FVSDHNLWVVMPFMSGGSCLHILKAA--------------YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNIL 143 (636)
Q Consensus 78 ~~~~~~l~iVmEy~~GGsL~~lL~~~--------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NIL 143 (636)
+..+..+|+||||+.+|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 99999999999999999999999753 2345889999999999999999999999999999999999
Q ss_pred EccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHH
Q 006664 144 IDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMK 222 (636)
Q Consensus 144 ld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~ 222 (636)
++.++.+||+|||++..+..... ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EcCCCeEEeCccccccccccccc-eeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99999999999999876533211 111122345678999999865 678999999999999999997 999998877655
Q ss_pred HHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 223 VLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 223 ~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.......... ...+..++..+.+|+.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGYR----MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCCc----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5444333221 12334678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=368.00 Aligned_cols=267 Identities=24% Similarity=0.409 Sum_probs=214.0
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCe
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~ 83 (636)
.+.+....|++++.||+|+.+.||++.....+.+++.|+.....++..+..+.+|+..|.+| .|.+||++|+|-..++.
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 35677899999999999999999999875544444444545556777889999999999999 49999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+||||-+ .||..+|++.. ...+...++.|.+||+.|++++|.+||||.||||.|+|+ -.|.+||+|||+|..+..
T Consensus 435 lYmvmE~Gd-~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 435 LYMVMECGD-IDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEEeeccc-ccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence 999999864 48999998763 445545889999999999999999999999999999998 489999999999986543
Q ss_pred CCCcccccccccCCCCCCChhhhhhccC----------CCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHG----------YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~----------ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~ 233 (636)
......+.+.+||+.||+||.+..... .+.++||||||||||+|+.|++||..+...-.-...+....-
T Consensus 512 -DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~ 590 (677)
T KOG0596|consen 512 -DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH 590 (677)
T ss_pred -cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence 334455678899999999999964221 457899999999999999999999876533332333333222
Q ss_pred CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 234 ~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
.+.|+.-.. ..++.++++.||..||++||++.++|+|||+..
T Consensus 591 ~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 591 EIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 233332221 123999999999999999999999999999975
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=351.26 Aligned_cols=260 Identities=37% Similarity=0.664 Sum_probs=220.5
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
...+|.+.+.||.|+||.||++.+..++..||+|.++..... ..+.+.+|+.+++.++||||+++++++..+...|+|+
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 357899999999999999999999989999999998654332 3466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||++|++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--- 169 (293)
T cd06647 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (293)
T ss_pred ecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc---
Confidence 999999999998763 58899999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
.......|++.|+|||.+.. ..++.++|||||||++|+|++|..||........+........+. ...+..++..++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~ 246 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE--LQNPEKLSAIFR 246 (293)
T ss_pred cccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCC--CCCccccCHHHH
Confidence 12334579999999999876 568899999999999999999999998766544433332222222 223345788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+||.+||..+|.+||++++++.|+||+..+
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=358.56 Aligned_cols=265 Identities=25% Similarity=0.387 Sum_probs=215.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEe----CCeEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVS----DHNLW 85 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~----~~~l~ 85 (636)
.+|++.+.||.|+||.||+|.+..+|+.||+|++..... ......+.+|+.+|+.++||||++++++|.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 789999999999999999999999999999999875432 2345677889999999999999999998863 35789
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+. |+|.+++... ..+++..++.++.||+.||.|||.+||+||||||+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 9999996 5898888754 569999999999999999999999999999999999999999999999999987653322
Q ss_pred Cc-ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--------------
Q 006664 166 DR-QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN-------------- 230 (636)
Q Consensus 166 ~~-~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~-------------- 230 (636)
.. .......+|+..|+|||++.+...++.++|||||||++|+|++|+.||.+......+..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 11 112235689999999999876556899999999999999999999999876554433222211
Q ss_pred ---------CCC--CCCc-ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 231 ---------APP--GLDY-ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 231 ---------~~~--~~~~-~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.+. ...+ ......+.+++++|.+||+.||.+||++.+++.||||.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 000 0000 01134688999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=375.48 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=218.4
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
..|+|..++..+++.||+|+||+||+|.+. -.||||+++.+. .+..++.+++|+..+++-+|.||+-|.|++..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 579999999999999999999999999985 459999998775 3456888999999999999999999999999888
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
. .||+-+|+|.+|+.+|.-.. ..|.....+.|++||+.|+.|||.++|||||||..|||+.+++.|||+|||++..-.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred e-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 7 99999999999999987643 579999999999999999999999999999999999999999999999999987532
Q ss_pred cCCCcccccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
... .........|..+|||||+++. ...|++.+|||||||++|||++|..||.......++.++-++....-.....
T Consensus 540 ~w~-g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 540 RWS-GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eec-cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 221 1122344568899999999863 3469999999999999999999999999555554444443332111112233
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+++++++|+..||.+++++||.+.+||.
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 567889999999999999999999999985
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=345.64 Aligned_cols=258 Identities=20% Similarity=0.375 Sum_probs=213.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEc----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCI----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+..++|++.+.||+|+||.||+|.+. .++..||+|.+...........+.+|+.+++.++||||+++++++..+..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 34578999999999999999999853 45688999998754444455678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC
Q 006664 84 LWVVMPFMSGGSCLHILKAAY---------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG 148 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~---------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g 148 (636)
.|+||||+.+|+|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 999999999999999986432 12478889999999999999999999999999999999999999
Q ss_pred cEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 006664 149 AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMT 227 (636)
Q Consensus 149 ~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~ 227 (636)
.+||+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+..........
T Consensus 162 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcc-eecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999876533221 122334567788999999976 568999999999999999998 99999877665544433
Q ss_pred HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 228 ~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
...... ..+..++..++++|.+||+.||.+||++.+|+++
T Consensus 240 ~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLL----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 332221 2335678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=372.41 Aligned_cols=269 Identities=27% Similarity=0.420 Sum_probs=228.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
....-|..++.||-|+||.|.++....|...||+|.+.+.. ....+..++.|-.||..-+.+-||++|..|.++.++|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34467889999999999999999999999999999986542 2345667889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc--
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD-- 163 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~-- 163 (636)
+||||+.|||+..+|.+. +-|+|..++.|+.++.+|+++.|..|+|||||||+|||||.+|+|||+|||+|+-+-.
T Consensus 706 FVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999999887 7899999999999999999999999999999999999999999999999999864311
Q ss_pred ------CCCcc-------------------------------cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHH
Q 006664 164 ------SGDRQ-------------------------------RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITAL 206 (636)
Q Consensus 164 ------~~~~~-------------------------------~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLy 206 (636)
.++.. ......+||+.|+|||++.. .+|+..||+||.|||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILY 862 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHH
Confidence 11100 00124589999999999986 78999999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCC---HHHHHhCcccccccChH
Q 006664 207 ELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS---AKKLLKHSFFKQARSNE 281 (636)
Q Consensus 207 eLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRps---a~elL~Hpffk~~~~~~ 281 (636)
||+.|++||-...+.+....+ .+....+++.....+|+++.+||.++. .+++.|.. ++++..||||+.++...
T Consensus 863 em~~g~~pf~~~tp~~tq~kv-~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKV-INWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred HHhhCCCCccCCCCCcceeee-eehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHh
Confidence 999999999776665543333 344455677777899999999998865 58889974 78899999999887543
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=344.98 Aligned_cols=258 Identities=23% Similarity=0.389 Sum_probs=213.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIP-----FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~-----tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+..+.|.+.+.||+|+||.||+|.+.. ++..||+|.+...........+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 456889999999999999999999987 788999999875544444567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC---cEEEec
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYP-----DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGD 154 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~-----~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g---~vKL~D 154 (636)
..|+||||+.||+|.+++..... ..+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999999987532 2489999999999999999999999999999999999998654 699999
Q ss_pred cCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCC
Q 006664 155 FGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPP 233 (636)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~ 233 (636)
||++..+..... ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 163 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 163 FGMARDIYRASY-YRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred CccccccCCccc-eecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 999876532211 111122344568999999976 569999999999999999996 99999887766655444333221
Q ss_pred CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 234 ~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
..+..++..+.+++.+||..||++||++.++++|
T Consensus 241 ----~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 ----DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2245678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=357.79 Aligned_cols=263 Identities=20% Similarity=0.330 Sum_probs=213.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--------
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD-------- 81 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-------- 81 (636)
..+|.+.+.||.|+||.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 4799999999999999999999999999999999975543 3456788999999999999999999877654
Q ss_pred ------CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-CCcEEEec
Q 006664 82 ------HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGD 154 (636)
Q Consensus 82 ------~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-~g~vKL~D 154 (636)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35899999997 588888864 46899999999999999999999999999999999999974 56789999
Q ss_pred cCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 006664 155 FGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 234 (636)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~ 234 (636)
||++..+..............|+..|+|||++.+...++.++|||||||++|+|++|+.||.+..+.......+...+..
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99987542221111112234689999999988665678899999999999999999999998777666555444322111
Q ss_pred CC-------------------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 235 LD-------------------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 235 ~~-------------------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.. ......++.++++||.+||+.||.+||++.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 00112467889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=385.29 Aligned_cols=262 Identities=23% Similarity=0.368 Sum_probs=218.9
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeE-EEeC
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCS-FVSD 81 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~-~~~~ 81 (636)
..+.|+.-++++.+.|.+|+|+.||+|.+...|..||+|.+-.. +...+..+++||.+|++|. |||||.|++. ....
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 35678889999999999999999999999988899999998654 6667889999999999996 9999999993 3221
Q ss_pred ------CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCcccEEEccCCcEEEe
Q 006664 82 ------HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG--HIHRDVKSGNILIDVRGAIKLG 153 (636)
Q Consensus 82 ------~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHRDLKP~NILld~~g~vKL~ 153 (636)
..++|.||||.||.|.++|..+...+|+|.++.+||+++++||.+||... |||||||-|||||+.+|+.|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 35789999999999999999877788999999999999999999999997 9999999999999999999999
Q ss_pred ccCcccccccCCCcccc------cccccCCCCCCChhhhh--hccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHH
Q 006664 154 DFGVSACLFDSGDRQRM------RNTFVGTPCWMAPEVME--QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL 225 (636)
Q Consensus 154 DFGla~~~~~~~~~~~~------~~~~~GT~~YmAPEvl~--~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~ 225 (636)
|||.|+-.......... --....|+.|+|||++. .....+.|+|||+|||+||-|++...||.+.....++
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl- 267 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL- 267 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE-
Confidence 99998643322111000 01235799999999974 3356899999999999999999999999876543322
Q ss_pred HHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcc
Q 006664 226 MTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273 (636)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpf 273 (636)
...+.++....++..+++||+.||+.||.+||++.+++.+-+
T Consensus 268 ------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 268 ------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 123445555789999999999999999999999999987544
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=339.04 Aligned_cols=258 Identities=28% Similarity=0.471 Sum_probs=216.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC----CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--Ce
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER----DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD--HN 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~----~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~--~~ 83 (636)
+.+|.+.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 368999999999999999999999999999999986432 223456788999999999999999999998764 56
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+++||||+.|++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999999765 4589999999999999999999999999999999999999999999999999875422
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
............|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||................ .....+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~p~~~ 234 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP---TKPMLPDGV 234 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC---CCCCCCccc
Confidence 1111111234578999999999976 568899999999999999999999998876666554433221 122335678
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
++.+.++|.+||+ +|.+||++.+++.|||.
T Consensus 235 ~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 235 SDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 8999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.23 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=214.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPF---NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~t---g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
+..++|++.+.||+|+||.||+|.+..+ ...||||.++..........+.+|+.+++.++||||+++++++..+...
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 4568899999999999999999988644 4689999987655555566788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||+.+|+|.+++.... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999997642 47899999999999999999999999999999999999999999999999999866421
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
... .......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+..... .+....+
T Consensus 160 ~~~-~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~ 233 (266)
T cd05033 160 EAT-YTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR----LPPPMDC 233 (266)
T ss_pred ccc-eeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC----CCCCCCC
Confidence 111 11112345678999999876 568999999999999999997 9999987766554444433211 1223467
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
+..+.+|+.+||..||++||++.+++++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=358.03 Aligned_cols=260 Identities=25% Similarity=0.377 Sum_probs=211.5
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC------
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD------ 81 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~------ 81 (636)
..++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3578999999999999999999999999999999986443 223455677899999999999999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
...|+||||+.+ +|.+.+... +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 357999999965 888877642 889999999999999999999999999999999999999999999999998754
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-------
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG------- 234 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~------- 234 (636)
... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......++......
T Consensus 169 ~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 169 GTS----FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred CCC----CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 221 11335678999999999976 679999999999999999999999998766544433332111000
Q ss_pred --------------C---C---------c-----ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 235 --------------L---D---------Y-----ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 235 --------------~---~---------~-----~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
. . + ......++.+++||.+||..||.+||++.++|.||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 0 0 0 00123466789999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=339.58 Aligned_cols=254 Identities=30% Similarity=0.510 Sum_probs=214.4
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCH
Q 006664 19 VGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96 (636)
Q Consensus 19 IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL 96 (636)
||.|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++.+..+...|+||||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999999965432 23466789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc-----cccc
Q 006664 97 LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR-----QRMR 171 (636)
Q Consensus 97 ~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~-----~~~~ 171 (636)
.+++... +.+++..+..++.||+.||.|||.+|++||||+|+||+++.++.++|+|||++......... ....
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 9999875 47899999999999999999999999999999999999999999999999998754322110 1122
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHH
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI 251 (636)
....+++.|+|||.+.. ..++.++||||||+++|+|++|..||................ ..++....++..+.+||
T Consensus 159 ~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 159 KRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK---IEWPEDVEVSDEAIDLI 234 (265)
T ss_pred cCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---cCCCccccCCHHHHHHH
Confidence 34578999999999876 458899999999999999999999998877666554443321 12222223589999999
Q ss_pred HhhcccCCCCCCCH---HHHHhCccccccc
Q 006664 252 ASCLVKDPSKRPSA---KKLLKHSFFKQAR 278 (636)
Q Consensus 252 ~~cL~~DP~kRpsa---~elL~Hpffk~~~ 278 (636)
.+||+.+|.+||++ .++++||||+.+.
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 99999999999999 9999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=340.40 Aligned_cols=252 Identities=32% Similarity=0.483 Sum_probs=208.1
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--hhHHHHHHHHHHH-HhCCCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--SDLSNISREAQTM-ILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--~~~~~i~rEi~iL-~~L~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||.|+||.||+|.+..+|+.||+|++...... .....+..|..++ ..++||||+++++++..+..+|+||||+.|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998654321 1223344555544 455899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
++|.+++... ..+++..+..++.||+.||.|||++|++||||+|.||+++.++.++|+|||++..... ...
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------~~~ 152 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------NKK 152 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------ccc
Confidence 9999999875 5689999999999999999999999999999999999999999999999999864321 234
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
..|++.|+|||.+.+ ..++.++||||||+++|+|++|..||................ ..........+++++.++|.+
T Consensus 153 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 230 (260)
T cd05611 153 FVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-INWPEEVKEFCSPEAVDLINR 230 (260)
T ss_pred CCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-cCCCCcccccCCHHHHHHHHH
Confidence 578999999999987 458999999999999999999999998777665544433322 111212233578999999999
Q ss_pred hcccCCCCCC---CHHHHHhCcccccccC
Q 006664 254 CLVKDPSKRP---SAKKLLKHSFFKQARS 279 (636)
Q Consensus 254 cL~~DP~kRp---sa~elL~Hpffk~~~~ 279 (636)
||..||++|| ++.|++.||||+..++
T Consensus 231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 231 LLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 9999999999 4589999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.19 Aligned_cols=252 Identities=26% Similarity=0.446 Sum_probs=210.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
++.++|++.+.||+|+||.||+|.++ .+..+|+|.+.... .....+.+|+.+++.++||||+++++++..+..+|+|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 35678999999999999999999875 45689999875332 2345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+.||+|.+++.... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999999999987642 46899999999999999999999999999999999999999999999999998754322111
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||......+.+..+...... ..+...+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----~~~~~~~~~ 229 (256)
T cd05114 157 --SSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL----YRPKLASMT 229 (256)
T ss_pred --ccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----CCCCCCCHH
Confidence 1122345678999999875 578999999999999999999 99999887776665555443221 223456788
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHh
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+.+++.+||..||++||++.++++
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=371.68 Aligned_cols=250 Identities=29% Similarity=0.480 Sum_probs=219.8
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
...|+|..+...-++-||.|+.|.||+|+.. ++.||||.++. .-..+|+-|++|+||||+.|.+++....
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e--------lkETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE--------LKETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhh--------hhhhhHHHHHhccCcceeeEeeeecCCc
Confidence 4578899899999999999999999999874 89999998741 2245888899999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|||||||..|-|..+|+.. ..+.......|.++|+.|+.|||.+.|||||||.-||||..+..|||+|||.++.+.
T Consensus 186 cyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 999999999999999999986 678888999999999999999999999999999999999999999999999987653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
+. .....|+||..|||||+++. ...+.|+|||||||+|||||+|..||.+.+...++.-. ....+..+.+..
T Consensus 264 ~~----STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV---GsNsL~LpvPst 335 (904)
T KOG4721|consen 264 DK----STKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV---GSNSLHLPVPST 335 (904)
T ss_pred hh----hhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEec---cCCcccccCccc
Confidence 32 22357999999999999986 78999999999999999999999999887766543322 223455667788
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHhCc
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHS 272 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~Hp 272 (636)
+++.|+=||+.||+-.|..||++.+|+.|-
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 999999999999999999999999999883
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=345.63 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=205.7
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--hhHHHHHHH---HHHHHhCCCCCcceeeeEEEeCCeEEEEEeccC
Q 006664 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERDN--SDLSNISRE---AQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMS 92 (636)
Q Consensus 18 ~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--~~~~~i~rE---i~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~ 92 (636)
.||+|+||.||+|.+..+++.||||++...... ........| +..++..+||||++++++|..+..+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999999754322 111122333 344555689999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccc
Q 006664 93 GGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172 (636)
Q Consensus 93 GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 172 (636)
||+|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+... ...
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~ 153 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPH 153 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-----CCc
Confidence 99999988764 57999999999999999999999999999999999999999999999999998654221 123
Q ss_pred cccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHH--HHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV--LLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 173 ~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~--l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
..+|++.|+|||++.+...++.++||||+||++|+|++|..||........ ....... .....+..++..+.++
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~s~~~~~l 229 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----MAVELPDSFSPELRSL 229 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc----cCCCCCCcCCHHHHHH
Confidence 568999999999997645689999999999999999999999986532211 1111111 1222334578999999
Q ss_pred HHhhcccCCCCCC-----CHHHHHhCcccccccChH
Q 006664 251 IASCLVKDPSKRP-----SAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 251 I~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~~ 281 (636)
|.+||..||.+|| ++.++++||||+...+..
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred HHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 9999999999999 999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=366.35 Aligned_cols=262 Identities=19% Similarity=0.357 Sum_probs=215.9
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCC-----CcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeE
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPF-----NEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCS 77 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t-----g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~ 77 (636)
.+|++..++|.+++.||+|+||.||+|.+... +..||||++.........+.+.+|+.+|+.++ ||||++++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 48999999999999999999999999987533 35799999975544445667899999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHHhC-----------------------------------------------------
Q 006664 78 FVSDHNLWVVMPFMSGGSCLHILKAAY----------------------------------------------------- 104 (636)
Q Consensus 78 ~~~~~~l~iVmEy~~GGsL~~lL~~~~----------------------------------------------------- 104 (636)
+.....+|+|||||.||+|.+++....
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999999999999886531
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEE
Q 006664 105 -----------------------------------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNIL 143 (636)
Q Consensus 105 -----------------------------------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NIL 143 (636)
...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 124778888999999999999999999999999999999
Q ss_pred EccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHH
Q 006664 144 IDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMK 222 (636)
Q Consensus 144 ld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~ 222 (636)
++.++.+||+|||++........ ........|++.|+|||++.+ ..++.++|||||||++|+|++ |..||.......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EeCCCEEEEEeCCcceecccccc-ccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 99999999999999875532211 112234567889999999976 568999999999999999996 999998755444
Q ss_pred HHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 223 VLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 223 ~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.....+.... ....+..++..+.++|.+||..||++||++.++.+
T Consensus 348 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSGY---RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcCC---CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 4433333321 22334567889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=330.77 Aligned_cols=253 Identities=46% Similarity=0.801 Sum_probs=218.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEecc
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~ 91 (636)
+|++.+.||.|++|.||++.+..+++.|++|++..... .....+.+|+.+++.++||||+++++++..+...++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 58999999999999999999999999999999975543 35677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
.|++|.+++.... ..+++..+..++.|++.||.|||.+|++||||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~ 154 (253)
T cd05122 80 SGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----R 154 (253)
T ss_pred CCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----c
Confidence 9999999987753 5789999999999999999999999999999999999999999999999999875532211 3
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHH
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI 251 (636)
....|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.................+.. .....++..+.++|
T Consensus 155 ~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i 231 (253)
T cd05122 155 NTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL--RNPEKWSDEFKDFL 231 (253)
T ss_pred cceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc--CcccccCHHHHHHH
Confidence 45679999999999976 4588999999999999999999999988766555544443322222 22233588999999
Q ss_pred HhhcccCCCCCCCHHHHHhCcc
Q 006664 252 ASCLVKDPSKRPSAKKLLKHSF 273 (636)
Q Consensus 252 ~~cL~~DP~kRpsa~elL~Hpf 273 (636)
.+||..||.+|||+.++++|||
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHccCChhhCCCHHHHhcCCC
Confidence 9999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=351.74 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=210.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcE----EEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEI----VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~----vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+...+|++.+.||+|+||.||+|.+..+++. ||||+++..........+.+|+.+++.++||||+++++++..+ .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 4568899999999999999999998776664 8999987544444566788999999999999999999988764 5
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
.++|+||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 78999999999999999874 24688999999999999999999999999999999999999999999999999976532
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
... ........++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....... .++... ...+.+..
T Consensus 162 ~~~-~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~---~~~~~~~~ 235 (316)
T cd05108 162 DEK-EYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKG---ERLPQPPI 235 (316)
T ss_pred CCc-ceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCC---CCCCCCCC
Confidence 211 111122345678999999976 678999999999999999997 99999887665433 333222 12223345
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
++.++.+++.+||..||.+||++.+++.+
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.51 Aligned_cols=262 Identities=24% Similarity=0.446 Sum_probs=214.7
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcC-------CCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCccee
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIP-------FNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKS 74 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~-------tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl 74 (636)
.++|++..++|.+.+.||+|+||.||+|.+.. ++..||+|.++..........+.+|+.+++.+ +||||+++
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 45788999999999999999999999998643 33579999997654444566788999999999 79999999
Q ss_pred eeEEEeCCeEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcc
Q 006664 75 HCSFVSDHNLWVVMPFMSGGSCLHILKAAYP--------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSG 140 (636)
Q Consensus 75 ~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~--------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~ 140 (636)
++++..+...|+||||+.+|+|.+++....+ ..+++..+..++.||+.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 9999999999999999999999999976432 24788899999999999999999999999999999
Q ss_pred cEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCC
Q 006664 141 NILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYP 219 (636)
Q Consensus 141 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~ 219 (636)
||+++.++.+||+|||++....... .........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred heEEcCCCcEEECCCcccccccccc-hhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999999999999999986543211 1111112234578999999976 568999999999999999998 999998766
Q ss_pred hHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 220 ~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+.... +.... ....+..++.++++||.+||..+|.+||++.++++
T Consensus 248 ~~~~~~~-~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 248 VEELFKL-LKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHH-HHcCC---CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 5444333 33221 12234567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.09 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=213.5
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|++..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ....+.+|+.+++.++||||+++++++...+.+|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 6788999999999999999999999875 457899999864432 3456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.|++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999987644568999999999999999999999999999999999999999999999999987654221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
.. ......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+.........+..... ......++
T Consensus 158 ~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~ 230 (261)
T cd05068 158 YE--AREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR----MPCPPGCP 230 (261)
T ss_pred cc--ccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----CCCCCcCC
Confidence 11 1111223457999999876 678999999999999999998 9999988776655544433322 12234578
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+.+++.+||..||.+||++.++++
T Consensus 231 ~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 231 KELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 89999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=346.97 Aligned_cols=260 Identities=38% Similarity=0.653 Sum_probs=218.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
...+.|.+.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.++...|
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 345779999999999999999999999999999999864432 234467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||+|.||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 92 LVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 9999997 4777777543 24689999999999999999999999999999999999999999999999999864321
Q ss_pred CcccccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.....|++.|+|||++.+ ...++.++||||||+++|+|++|..||...........+.....+.. ....+
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 239 (307)
T cd06607 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL---SSNDW 239 (307)
T ss_pred -----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC---Cchhh
Confidence 234578999999998752 24588899999999999999999999988776665544443333222 12457
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
+..++++|.+||..||.+||++.+++.||||.....
T Consensus 240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 275 (307)
T cd06607 240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP 275 (307)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence 889999999999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.57 Aligned_cols=259 Identities=35% Similarity=0.605 Sum_probs=219.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
.+|...+.||+|++|.||++.+..+++.||+|.++.... .....+.+|+.+++.++||||+++++++..+...|+|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 367778899999999999999999999999999864432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... ..
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~---~~ 171 (285)
T cd06648 98 LEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---PR 171 (285)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC---cc
Confidence 999999999876 468999999999999999999999999999999999999999999999999876542221 12
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
.....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||....+...........++.. .....++..+.+|
T Consensus 172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 248 (285)
T cd06648 172 RKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL--KNLHKVSPRLRSF 248 (285)
T ss_pred cccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC--cccccCCHHHHHH
Confidence 234679999999999876 5689999999999999999999999987766555544433322221 2233478899999
Q ss_pred HHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 251 IASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
|.+||..||.+||++.+++.||||+....
T Consensus 249 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 249 LDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHcccChhhCcCHHHHccCcccccCCC
Confidence 99999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=341.97 Aligned_cols=255 Identities=23% Similarity=0.377 Sum_probs=217.5
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|+....+|++++.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++......|
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 56677899999999999999999999987 89999999864432 24567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999999999987655678999999999999999999999999999999999999999999999999987553221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
.......++..|+|||++.. ..++.++||||||+++|+|++ |+.||........+..+... ...+.+..++
T Consensus 159 ---~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~ 230 (261)
T cd05148 159 ---YLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG----YRMPCPAKCP 230 (261)
T ss_pred ---ccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC----CcCCCCCCCC
Confidence 11223456778999999876 578899999999999999998 89999887766655554432 2223346778
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+.++|.+||..||.+|||+.+|++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=343.48 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=202.1
Q ss_pred CCeEEEeEE--cccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHh-CCCCCcceeeeEEEeCCeEEEE
Q 006664 11 EHYTLYEEV--GQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL-VDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 11 ~~Y~l~~~I--G~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~-L~HPNIVkl~~~~~~~~~l~iV 87 (636)
++|++.+.+ |.|+||.||++.++.++..+|+|++....... .|+..... .+||||++++++|..+..+|+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 567777766 99999999999999999999999986432211 12222222 2799999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-cEEEeccCcccccccCCC
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-AIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-~vKL~DFGla~~~~~~~~ 166 (636)
|||++||+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--- 162 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT--- 162 (267)
T ss_pred EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC---
Confidence 9999999999999875 4799999999999999999999999999999999999999888 999999999875421
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||............+.... .........++..
T Consensus 163 ----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (267)
T PHA03390 163 ----PSCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKN 236 (267)
T ss_pred ----CccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHH
Confidence 124578999999999976 6689999999999999999999999975543322111111111 1112233478999
Q ss_pred HHHHHHhhcccCCCCCCC-HHHHHhCcccc
Q 006664 247 FKQMIASCLVKDPSKRPS-AKKLLKHSFFK 275 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRps-a~elL~Hpffk 275 (636)
+++||.+||+.||.+||+ ++++++||||+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999999996 69999999996
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=365.99 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=223.3
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCC
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GG 94 (636)
.+.||.|.||+||-|+++++|+.||||+|++.+-+ ...+.+++|+.||+.++||.||.+-..|+..+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 46899999999999999999999999999887643 4567899999999999999999999999999999999999976
Q ss_pred CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC---CcEEEeccCcccccccCCCccccc
Q 006664 95 SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR---GAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 95 sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~---g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
|..+.|-....++++|.....++.||+.||.|||-++|+|+||||+|||+... -.+||||||+|+++.+. ..+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk----sFR 723 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK----SFR 723 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh----hhh
Confidence 55555544456889999999999999999999999999999999999999643 37999999999987432 356
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHH
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI 251 (636)
.+.+|||.|+|||+++. ++|+..-|+||.|+|+|.-+.|..||....+ +...+++....+....|+.++.++.+||
T Consensus 724 rsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---IndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---INDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred hhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccc---hhHHhhccccccCCCchhhcCHHHHHHH
Confidence 68899999999999987 8999999999999999999999999975432 4456667666666677899999999999
Q ss_pred HhhcccCCCCCCCHHHHHhCcccccc
Q 006664 252 ASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 252 ~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
..+|+..-.+|.+.++.|.|||+++.
T Consensus 800 n~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999999864
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=338.96 Aligned_cols=262 Identities=28% Similarity=0.446 Sum_probs=212.1
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
+++..+.......||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++..+...+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3445555666679999999999999999999999999986443 234567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-CCcEEEeccCcccccc
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGF--EEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSACLF 162 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~l--se~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-~g~vKL~DFGla~~~~ 162 (636)
+||||+.|++|.+++.... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999999997642 334 78889999999999999999999999999999999976 6799999999987543
Q ss_pred cCCCcccccccccCCCCCCChhhhhhc-cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
... .......|++.|+|||++.+. ..++.++||||||+++|+|++|..||............... .......+.
T Consensus 161 ~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (268)
T cd06624 161 GIN---PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--FKIHPEIPE 235 (268)
T ss_pred cCC---CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh--hccCCCCCc
Confidence 211 112345689999999998653 34789999999999999999999999764432222111110 011112235
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.++.++++|+.+||..+|.+||++.+++.||||
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 678899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=342.55 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=219.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~iV 87 (636)
++|.+.+.||.|+||.||+|.+..+|+.||+|+++.... ......+.+|+.+++.+. ||||+++++++..+...++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 579999999999999999999999999999999975432 233467889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+.+++|.+++.+. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999999875 57999999999999999999999999999999999999999999999999998755322210
Q ss_pred -----------------ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhc
Q 006664 168 -----------------QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN 230 (636)
Q Consensus 168 -----------------~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~ 230 (636)
......+.|+..|+|||++.. ..++.++||||||+++|+|++|..||........+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 122345678999999999876 56888999999999999999999999877655544444321
Q ss_pred CCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCH----HHHHhCccc
Q 006664 231 APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSA----KKLLKHSFF 274 (636)
Q Consensus 231 ~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa----~elL~Hpff 274 (636)
.+..+..+++.+.+||.+||..||.+||++ .++++||||
T Consensus 238 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 -----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred -----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 223345678999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=349.62 Aligned_cols=258 Identities=33% Similarity=0.586 Sum_probs=217.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
..|.....||+|+||.||+|.+..++..||||+++.... .....+.+|+.+++.++||||+++++++..+...|+||||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 456667789999999999999999999999999975433 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+++++|..++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+.... ..
T Consensus 100 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~---~~ 173 (297)
T cd06659 100 LQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---PK 173 (297)
T ss_pred CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc---cc
Confidence 999999998765 468999999999999999999999999999999999999999999999999986442221 11
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.................. .......++..+.++
T Consensus 174 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~ 250 (297)
T cd06659 174 RKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP--KLKNAHKISPVLRDF 250 (297)
T ss_pred ccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC--CccccCCCCHHHHHH
Confidence 235679999999999976 56899999999999999999999999876665544433222111 122334678899999
Q ss_pred HHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 251 IASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
|.+||..||.+||++.+++.||||.+..
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 9999999999999999999999998664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.65 Aligned_cols=262 Identities=21% Similarity=0.367 Sum_probs=217.9
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeE
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCS 77 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~ 77 (636)
.+|++..++|.+.+.||+|+||.||+|.+. .++..||+|+++..........+.+|+.+++++ +||||++++++
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 467888899999999999999999999753 356689999987554444566789999999999 79999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCc
Q 006664 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 78 ~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
+.....+|+||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999999999865444589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCC
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLD 236 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~ 236 (636)
+..+..... ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+............... .
T Consensus 188 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~---~ 262 (302)
T cd05055 188 ARDIMNDSN-YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY---R 262 (302)
T ss_pred cccccCCCc-eeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC---c
Confidence 875533221 111223456788999999876 568999999999999999998 9999987766554444443321 1
Q ss_pred cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 237 ~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
...+...+..+.+|+.+||.++|++||++.++++
T Consensus 263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1223456889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=342.52 Aligned_cols=264 Identities=41% Similarity=0.706 Sum_probs=225.5
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
..+.|+..+.||.|+||.||+|.+..++..||+|+++.... ....+.+|+.+++.++||||+++++++..+...|+|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35679999999999999999999998999999999975443 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||++|++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--- 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--- 170 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch---
Confidence 9999999999998763 379999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|..||....+......+.....+. ......++..++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~ 247 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP--LKNPEKWSPEFK 247 (286)
T ss_pred hhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CcchhhCCHHHH
Confidence 12234568999999999876 568999999999999999999999998877765554444333222 122334788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCcccccccChH
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~ 281 (636)
+||.+||..+|.+||++.+++.|+||+.+.+..
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKACPKE 280 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhChHhhccCchH
Confidence 999999999999999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=334.15 Aligned_cols=249 Identities=24% Similarity=0.431 Sum_probs=212.8
Q ss_pred eEEcccCceEEEEEEEcCC---CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPF---NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~t---g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||.||+|.+... +..||+|++...........+.+|+.+++.++||||+++++++..+..+++||||+.|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999866 8999999997665544577889999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 94 GSCLHILKAAY-------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 94 GsL~~lL~~~~-------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
|+|.+++.... ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 99999998742 35689999999999999999999999999999999999999999999999999976543321
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||................ ....+..++.
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 234 (262)
T cd00192 161 -YRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY----RLPKPEYCPD 234 (262)
T ss_pred -cccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----CCCCCccCCh
Confidence 122345578899999999876 478999999999999999998 699999887665554444321 2233456789
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
++.+++.+||..||.+||++.+++++
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.50 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=212.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE---IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~---~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
+...+|++.+.||+|+||.||+|.++.++. .+|+|.++..........+.+|+.+++.++||||+++++++..++..
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 356789999999999999999999875543 79999987554444567789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||++||+|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999999765 356899999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
...........++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+....+....+... ...+....+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~ 234 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG----YRLPAPMDC 234 (267)
T ss_pred cceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC----CcCCCCCCC
Confidence 211111122234568999999976 568999999999999999886 99999877665544443322 122334567
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+..+.+++.+||+++|.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.26 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=212.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC-----Ce
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD-----HN 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-----~~ 83 (636)
..+|.+.+.||+|+||+||+|.+..+|+.||||.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357999999999999999999999999999999986532 223355678899999999999999999988654 35
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+||||+. ++|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 899999996 6899888764 5799999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhc-------------
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN------------- 230 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~------------- 230 (636)
.. .......|+..|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+...
T Consensus 161 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 161 KG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred Cc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 21 22345678999999999875456899999999999999999999999765443322211110
Q ss_pred ----------CCCCCC---cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 231 ----------APPGLD---YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 231 ----------~~~~~~---~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.+.... ......++.++++||.+||+.||.+|||+.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000 01123578899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=354.10 Aligned_cols=264 Identities=25% Similarity=0.349 Sum_probs=218.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC-----eEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH-----NLW 85 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~-----~l~ 85 (636)
+|++.+.||.|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999875432 344567899999999999999999999998875 799
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.+ +|..++... ..+++..+..++.||+.||.|||++||+||||||.|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMET-DLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhh-hHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 99999984 888888764 479999999999999999999999999999999999999999999999999987654332
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC-C--------
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-D-------- 236 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~-~-------- 236 (636)
..........|++.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+........ .
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 1112234557899999999998754789999999999999999999999988776655444433211000 0
Q ss_pred -----------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 237 -----------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 237 -----------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
......++.++.+||.+||.+||.+||++.+++.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 001123678899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=331.27 Aligned_cols=253 Identities=36% Similarity=0.650 Sum_probs=219.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|++.+.||.|++|.||+|.+..+++.||+|.+...... .....+.+|+++++.++||||+++++++.++...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 589999999999999999999999999999999755432 3567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK---D 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc---c
Confidence 9999999999876 6799999999999999999999999999999999999999999999999999876533221 1
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
.....|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.................+ ..+..++..+.++
T Consensus 156 ~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 230 (254)
T cd06627 156 DASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP----PLPEGISPELKDF 230 (254)
T ss_pred ccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC----CCCCCCCHHHHHH
Confidence 235678999999999876 45889999999999999999999999877765555444433222 2235678999999
Q ss_pred HHhhcccCCCCCCCHHHHHhCccc
Q 006664 251 IASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~Hpff 274 (636)
|.+||..+|++||++.+++.||||
T Consensus 231 i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHhCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=336.44 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=203.4
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCH
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL 96 (636)
+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.+++.++||||+++++++......|+||||+.|++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999999999999999986444444556789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccC
Q 006664 97 LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176 (636)
Q Consensus 97 ~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~G 176 (636)
.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....+.. .........+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV-YASTGGMKQI 158 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccc-ccccCCCCCC
Confidence 9999764 2458999999999999999999999999999999999999999999999999987542211 0000111123
Q ss_pred CCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhc
Q 006664 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCL 255 (636)
Q Consensus 177 T~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL 255 (636)
+..|+|||.+.+ ..++.++|||||||++|+|++ |..||................. ...+..++..+.+|+.+||
T Consensus 159 ~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 159 PVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR----LPCPELCPDAVYRLMERCW 233 (252)
T ss_pred ceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----CCCcccCCHHHHHHHHHHc
Confidence 456999999876 568999999999999999997 9999987665544333333222 1234567889999999999
Q ss_pred ccCCCCCCCHHHHHh
Q 006664 256 VKDPSKRPSAKKLLK 270 (636)
Q Consensus 256 ~~DP~kRpsa~elL~ 270 (636)
..||++||++.++++
T Consensus 234 ~~~p~~Rps~~~~~~ 248 (252)
T cd05084 234 EYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=346.17 Aligned_cols=263 Identities=24% Similarity=0.436 Sum_probs=217.7
Q ss_pred CCcccccCCCCeEEEeEEcccCceEEEEEEEc-------CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcce
Q 006664 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCI-------PFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLK 73 (636)
Q Consensus 2 ~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-------~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVk 73 (636)
+..+|.+..++|.+.+.||+|+||.||+|.+. ..+..||+|.+...........+.+|+.+++.+ +||||++
T Consensus 6 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 6 EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred cCCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchh
Confidence 45679999999999999999999999999753 245689999987554445567889999999999 8999999
Q ss_pred eeeEEEeCCeEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCc
Q 006664 74 SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYP--------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKS 139 (636)
Q Consensus 74 l~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~--------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP 139 (636)
+++++......|+||||+.+|+|.+++..... ..++...+..++.||+.||.|||++||+||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 99999999999999999999999999976422 2477888999999999999999999999999999
Q ss_pred ccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCC
Q 006664 140 GNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKY 218 (636)
Q Consensus 140 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~ 218 (636)
+||+++.++.+||+|||++..+..... ........+++.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDY-YKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccc-cccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999876532221 111223456788999999976 568999999999999999998 89999887
Q ss_pred ChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 219 PPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 219 ~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+..+.......... ...+..++..+++||.+||..+|.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 244 PVEELFKLLKEGHR----MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred CHHHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 76655444332221 1223567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.08 Aligned_cols=254 Identities=26% Similarity=0.381 Sum_probs=211.2
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|.+..++|++++.||+|+||.||+|.+. .+..||+|.+..... ....+.+|+.+++.++||||+++++++. ....|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 6788899999999999999999999765 567799999865433 3456889999999999999999999875 45689
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
++|||+.+++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999999987555568999999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
. .......++..|+|||++.+ ..++.++||||||+++|+|++ |.+||.+....+....+.... ..+.+...+
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~ 229 (260)
T cd05070 157 Y--TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY----RMPCPQDCP 229 (260)
T ss_pred c--ccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----CCCCCCcCC
Confidence 1 11123345667999999875 568899999999999999999 999998877665554443322 223345678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+.+|+.+||.+||.+|||+.++..
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 89999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=336.24 Aligned_cols=254 Identities=25% Similarity=0.484 Sum_probs=209.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++.+.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999886432 2234456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 89 PFMSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
||+.+|+|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 9999999999886432 2448899999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh-HHHHHHHHhcCCCCCCcccchhhhH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP-MKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~-~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
.......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... .......+.... ........++.
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08228 161 --TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE 235 (267)
T ss_pred --HHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence 11234579999999999976 5688999999999999999999999965432 122222222211 11111245778
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+.++|.+||..+|.+||++.++++
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHH
Confidence 9999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.06 Aligned_cols=265 Identities=23% Similarity=0.361 Sum_probs=215.7
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC--
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH-- 82 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~-- 82 (636)
++...++|++.+.||.|+||.||+|.++.+|+.||||+++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 45667899999999999999999999999999999999976532 223456778999999999999999999987655
Q ss_pred --------eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEec
Q 006664 83 --------NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGD 154 (636)
Q Consensus 83 --------~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~D 154 (636)
.+|+||||+.+ ++..++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 79999999986 777777654 34689999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--CC
Q 006664 155 FGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN--AP 232 (636)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~--~~ 232 (636)
||++..+..... .......++..|+|||.+.+...++.++|||||||++|+|++|++||......+.+..+... .+
T Consensus 160 fg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999876533321 11123356889999999876556789999999999999999999999876665544333321 11
Q ss_pred CCCCc-----------------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 233 PGLDY-----------------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 233 ~~~~~-----------------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
....+ .....++..+.++|.+||..||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 10000 0112468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=342.96 Aligned_cols=256 Identities=24% Similarity=0.413 Sum_probs=212.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
|...+|.+.+.||+|+||.||++.+. .++..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 56788999999999999999999863 345679999886432 334567899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEE
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYP-----------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~-----------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vK 151 (636)
.+|+||||+.+|+|.+++..... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 99999999999999999976421 2489999999999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc
Q 006664 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQN 230 (636)
Q Consensus 152 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~ 230 (636)
|+|||++....... .........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+...
T Consensus 161 l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 161 IGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred eccCCccccccCCc-eeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999987553221 1122234456788999999976 678999999999999999998 99999887766655544433
Q ss_pred CCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 231 APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 231 ~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
... .....++.++.+|+.+||..||.+||++.+++.
T Consensus 239 ~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 RVL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 221 223457889999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=344.60 Aligned_cols=257 Identities=19% Similarity=0.335 Sum_probs=213.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCC-----CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPF-----NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~t-----g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+...+|.+.+.||+|+||.||+|.+..+ +..||||+++..........+.+|+.++..++||||+++++++....
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 4567899999999999999999987643 57899999975544444567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC
Q 006664 83 NLWVVMPFMSGGSCLHILKAAY--------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG 148 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~--------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g 148 (636)
..++++||+.+++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 9999999999999999986421 13478888999999999999999999999999999999999999
Q ss_pred cEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 006664 149 AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMT 227 (636)
Q Consensus 149 ~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~ 227 (636)
.+||+|||+++.+..... ........+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 162 NVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred ceEecccccccccccchh-eeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999876533321 122234457889999999876 568999999999999999998 99999887776655544
Q ss_pred HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 228 ~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
...... ..+..++..+.+|+.+||+.||.+||++.+|+.
T Consensus 240 ~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 240 RNRQVL----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HcCCcC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 433221 223568889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=337.54 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=209.9
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|.+..++|++.++||+|+||.||+|.+..+ ..||+|++..... ....+.+|+.+++.++||||+++++.+. ....|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 678889999999999999999999988655 4699999864332 3456889999999999999999998875 45689
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.+|+|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999987544568999999999999999999999999999999999999999999999999987553222
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
. .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..... ......++
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~ 229 (262)
T cd05071 157 Y--TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----MPCPPECP 229 (262)
T ss_pred c--ccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC----CCCccccC
Confidence 1 11223456778999999865 568999999999999999999 8999987766554444332221 22235678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+.++|.+||.+||.+||++.+++.
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHH
Confidence 89999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=370.79 Aligned_cols=270 Identities=27% Similarity=0.429 Sum_probs=240.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
+..++.+++..||-|+||.|-++........+|+|++++.. .....+.+..|-+||..++.|+||++|..|.++.++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34577888999999999999999877666679999997553 3445778999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
++||-|-||+|+.+|... +.|++.+++.|+.-+++|++|||++|||+|||||+|.++|.+|-+||.|||+|+.+...
T Consensus 497 mLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred hhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 999999999999999987 88999999999999999999999999999999999999999999999999999877433
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
....+|||||.|.|||++.. ++.+.++|.|||||++|||++|.+||++.+++.....+++... . +..++.+++
T Consensus 574 ---~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-~--i~~Pr~I~k 646 (732)
T KOG0614|consen 574 ---RKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-K--IEFPRRITK 646 (732)
T ss_pred ---CceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-h--hhcccccch
Confidence 34569999999999999987 7899999999999999999999999999999999888887543 2 234578999
Q ss_pred HHHHHHHhhcccCCCCCCC-----HHHHHhCcccccccChHHHHHHH
Q 006664 246 SFKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSNEYIARTL 287 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~~~i~~~l 287 (636)
.+.+||+++...+|.+|.. +.+|.+|.||....|.....+.+
T Consensus 647 ~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L 693 (732)
T KOG0614|consen 647 TATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTL 693 (732)
T ss_pred hHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccC
Confidence 9999999999999999976 89999999999988776554443
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=334.70 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=215.0
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|++..++|.+.+.||+|+||.||+|.+. .+..||||.+.... .....+.+|+.+++.++||||+++++++..+...|
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 7899999999999999999999999875 56789999986433 23567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+++++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..+....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999987654578999999999999999999999999999999999999999999999999987553211
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+......+..+.... ....+...+
T Consensus 158 --~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~ 230 (261)
T cd05034 158 --YTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY----RMPRPPNCP 230 (261)
T ss_pred --hhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCCCCC
Confidence 111122345678999999976 568999999999999999998 999998877666555544332 222234568
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.++.+++.+||..+|.+||++.+++.
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 231 EELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHH
Confidence 89999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.09 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=211.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhCCCCCcceeeeEEEeC-------
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILVDHPNVLKSHCSFVSD------- 81 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~------- 81 (636)
.++|++.+.||.|+||.||+|.+..+++.||||++....... ....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 589999999999999999999999999999999986543222 234567899999999999999999887543
Q ss_pred -CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 82 -HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 82 -~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
..+|+||||+.+ +|...+... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999975 677766543 34699999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCc--------ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 006664 161 LFDSGDR--------QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP 232 (636)
Q Consensus 161 ~~~~~~~--------~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~ 232 (636)
....... ........|++.|+|||++.+...++.++|||||||++|+|++|.+||.+.........+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 5322211 11123446889999999987656689999999999999999999999988777665544332111
Q ss_pred CC--CCc-----------------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 233 PG--LDY-----------------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 233 ~~--~~~-----------------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.. ..+ .....++..+.+||.+||..||.+|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 000 0012345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=336.99 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=213.9
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNE---IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~---~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+|...+|+..+.||+|+||.||+|.+..++. .+|+|.++..........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CCChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 3667899999999999999999999876654 7999998765444456678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
.|+||||+.+++|.+++... .+.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999999764 35689999999999999999999999999999999999999999999999999876533
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.............++.|+|||++.. ..++.++|||||||++|+|++ |..||......+....+.... ..+....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~----~~~~~~~ 234 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF----RLPAPMD 234 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC----CCCCCCC
Confidence 2211111112223457999999876 568999999999999999997 999998776655554443321 2223345
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++..+.+++.+||..||.+||++.++++
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=335.58 Aligned_cols=254 Identities=21% Similarity=0.371 Sum_probs=212.2
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|+|..++|++++.||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++.++||||+++++++. ....|
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 7889999999999999999999999864 678899999864332 3467889999999999999999998874 45789
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
++|||+.+|+|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999999987655678999999999999999999999999999999999999999999999999987543211
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
. .......++..|+|||++.. ..++.++||||||+++|+|++ |++||.+....+.......... .+.+..++
T Consensus 157 ~--~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~ 229 (260)
T cd05067 157 Y--TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR----MPRPDNCP 229 (260)
T ss_pred c--ccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC----CCCCCCCC
Confidence 1 11223456778999999876 568899999999999999998 9999987766555444332221 22335578
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.++.++|.+||..+|++||++++++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 89999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=346.45 Aligned_cols=262 Identities=24% Similarity=0.438 Sum_probs=215.9
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcC-------CCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCccee
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIP-------FNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKS 74 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~-------tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl 74 (636)
+..|.+..++|.+.+.||+|+||.||+|.+.. ....||+|++...........+.+|+.+++.+ +||||+++
T Consensus 4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 56789999999999999999999999998642 34579999987554555567788999999999 69999999
Q ss_pred eeEEEeCCeEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcc
Q 006664 75 HCSFVSDHNLWVVMPFMSGGSCLHILKAAYP--------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSG 140 (636)
Q Consensus 75 ~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~--------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~ 140 (636)
++++..++.+|+||||+.+|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 9999999999999999999999999976421 34788899999999999999999999999999999
Q ss_pred cEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCC
Q 006664 141 NILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYP 219 (636)
Q Consensus 141 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~ 219 (636)
|||++.++.+||+|||+++........ .......+++.|||||++.+ ..++.++|||||||++|+|++ |..||...+
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccc-cccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999998755322111 11112234568999999976 678999999999999999998 999998877
Q ss_pred hHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 220 ~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+.......... ...+..++.+++++|.+||..||.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLREGHR----MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 6555544433221 1223567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=336.35 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=210.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
+..++|++++.||+|+||+||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 456889999999999999999997753 4569999986432 2345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+.+|+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999999997642 46899999999999999999999999999999999999999999999999998765332211
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+...... ......+..
T Consensus 157 --~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 229 (256)
T cd05113 157 --SSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----YRPHLASEK 229 (256)
T ss_pred --ecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----CCCCCCCHH
Confidence 1112345678999999976 568999999999999999998 99999887766555555443221 223456889
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
+++++.+||..||.+||++.+|+.+
T Consensus 230 ~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 230 VYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.69 Aligned_cols=255 Identities=21% Similarity=0.342 Sum_probs=207.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcE--EEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEI--VAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~--vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l 84 (636)
+..++|++.+.||+|+||.||+|.+..++.. +|+|.+...........+.+|+.++..+ +||||+++++++..++.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 4568999999999999999999999887765 4777665333334456788999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcE
Q 006664 85 WVVMPFMSGGSCLHILKAAY--------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAI 150 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~--------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~v 150 (636)
|+||||+.||+|.+++.... ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 99999999999999997542 1247899999999999999999999999999999999999999999
Q ss_pred EEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 006664 151 KLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQ 229 (636)
Q Consensus 151 KL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~ 229 (636)
||+|||++..... ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+.......
T Consensus 164 kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 164 KIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred EeCccccCcccch----hhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 9999999853211 011112234677999999876 568999999999999999998 9999987666554433322
Q ss_pred cCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 230 ~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
......+..++.++.+||.+||..+|.+||++.+++.+
T Consensus 239 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 ----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11222334578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.30 Aligned_cols=261 Identities=21% Similarity=0.362 Sum_probs=214.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCC----------------cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCc
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFN----------------EIVAVKILDFERDNSDLSNISREAQTMILVDHPNV 71 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg----------------~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNI 71 (636)
+...+|++++.||+|+||.||+|.+..++ ..||+|.+...........+.+|+++++.++||||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 45679999999999999999999876544 56899998766555567788999999999999999
Q ss_pred ceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccE
Q 006664 72 LKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAY---------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNI 142 (636)
Q Consensus 72 Vkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~---------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NI 142 (636)
+++++++..+...++||||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997753 12589999999999999999999999999999999999
Q ss_pred EEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc--CCCCCCCCCh
Q 006664 143 LIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH--GHAPFSKYPP 220 (636)
Q Consensus 143 Lld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt--G~~PF~~~~~ 220 (636)
+++.++.++|+|||++..+.... .........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eecCCCceEEccccceeecccCc-ceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999987653322 1222334567889999999876 568999999999999999997 7889987666
Q ss_pred HHHHHHHHhcC---CCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 221 MKVLLMTLQNA---PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 221 ~~~l~~~~~~~---~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
...+....... ........+..++.++.+||.+||..||.+||++.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 55544333220 111111223456789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=328.72 Aligned_cols=257 Identities=36% Similarity=0.598 Sum_probs=217.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--CeEEEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSD--HNLWVVM 88 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~--~~l~iVm 88 (636)
+|.+.+.||+|++|.||+|.+..++..|++|++..... ....+.+.+|+.++++++||||+++++.+... ..+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58899999999999999999999999999999975543 23567889999999999999999999999998 8999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 157 (260)
T cd06606 81 EYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG- 157 (260)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc-
Confidence 999999999999876 37999999999999999999999999999999999999999999999999998765333211
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............+.. .......+..++..+.
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--SGEPPEIPEHLSEEAK 234 (260)
T ss_pred ccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--cCCCcCCCcccCHHHH
Confidence 01234678999999999876 45889999999999999999999999876622222222221 1111223455689999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+||.+||..||.+||++.+++.||||
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.53 Aligned_cols=266 Identities=26% Similarity=0.389 Sum_probs=218.7
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
+..|++ .++|++.+.||.|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++..+
T Consensus 8 ~~~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 8 KTVWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred cceecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 444444 5689999999999999999999999999999999865422 22345678899999999999999999888766
Q ss_pred Ce------EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEecc
Q 006664 82 HN------LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDF 155 (636)
Q Consensus 82 ~~------l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DF 155 (636)
.. +|+|+||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccc
Confidence 54 89999999 6699998875 46999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 006664 156 GVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 235 (636)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~ 235 (636)
|++...... .....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+......+..+........
T Consensus 163 g~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 236 (343)
T cd07851 163 GLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236 (343)
T ss_pred ccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Confidence 998754221 23457899999999987645688999999999999999999999987776655544433211000
Q ss_pred -------------------------Cc-ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 236 -------------------------DY-ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 236 -------------------------~~-~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
++ .....++..+.+||.+||..||.+|||+.+|+.||||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 00 001235889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=320.60 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=222.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
..|...++||+|.||+||+|+++.+++.||+|.+..+.+.+ .-....||+.+++.++|.|||+++++...+..+-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46788899999999999999999999999999998876543 45668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||+. +|..+.... .+.++...++.++.|++.||.|||++++.||||||.|+||+.+|.+||+|||+++.+.-. .+
T Consensus 82 ~cdq-dlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip---vr 156 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP---VR 156 (292)
T ss_pred HhhH-HHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc---eE
Confidence 9975 788887765 467999999999999999999999999999999999999999999999999999865321 22
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC-------CCCC----Cc
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA-------PPGL----DY 237 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~-------~~~~----~~ 237 (636)
-...-+-|.+|.+|.++.+.+-|+...|+||.|||+.|+.. |++.|++.+-.+++..+.... .+.+ +|
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 23345789999999999998889999999999999999997 999999988888877765421 1111 11
Q ss_pred cc-------------chhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 238 ER-------------DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 238 ~~-------------~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.. -+++...-++++.++|..+|..|++++..++||||...
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 10 01233456899999999999999999999999999754
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=351.00 Aligned_cols=264 Identities=26% Similarity=0.352 Sum_probs=214.0
Q ss_pred CCeE-EEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-------------hHHHHHHHHHHHHhCCCCCcceeee
Q 006664 11 EHYT-LYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-------------DLSNISREAQTMILVDHPNVLKSHC 76 (636)
Q Consensus 11 ~~Y~-l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-------------~~~~i~rEi~iL~~L~HPNIVkl~~ 76 (636)
++|. +.+.||.|+||+||+|.+..+++.||||++....... ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 5678999999999999999999999999986543221 0124678999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccC
Q 006664 77 SFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFG 156 (636)
Q Consensus 77 ~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFG 156 (636)
++..+...|+||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999997 5899998764 568999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-----------CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHH
Q 006664 157 VSACLFDSG-----------DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL 225 (636)
Q Consensus 157 la~~~~~~~-----------~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~ 225 (636)
++....... ..........+++.|+|||.+.+...++.++|||||||++|+|++|.+||......+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 987553111 001112234678999999999765568999999999999999999999999887766554
Q ss_pred HHHhcC--CCCCCc---------------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 226 MTLQNA--PPGLDY---------------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 226 ~~~~~~--~~~~~~---------------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.+.... +....+ ......+..+.+||.+||..||.+||++++++.||||+..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 443311 110000 0012457889999999999999999999999999999854
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=338.63 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=213.7
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--CeEEEEEe
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD--HNLWVVMP 89 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~--~~l~iVmE 89 (636)
|++++.||.|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++... ...|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 789999999999999999999999999999998654 223345678899999999999999999999988 89999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.+ +|.+++.... ..+++..+..++.||+.||+|||.+|++|+||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~--~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--A 156 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--c
Confidence 9975 8888886542 4799999999999999999999999999999999999999999999999999876543321 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--CCCcc---------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--GLDYE--------- 238 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~--~~~~~--------- 238 (636)
......++..|+|||.+.+...++.++||||||+++|+|++|..||........+..+...... ...+.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 1223467889999998876556899999999999999999999999887766655444332110 00000
Q ss_pred --------------cchh-hhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 239 --------------RDRK-FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 239 --------------~~~~-~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.... ++..+.++|.+||..||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0011 37889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=342.23 Aligned_cols=269 Identities=33% Similarity=0.582 Sum_probs=219.3
Q ss_pred CCcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEe
Q 006664 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVS 80 (636)
Q Consensus 2 ~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~ 80 (636)
....|.+..++|++.+.||.|+||.||+|.+..+++.||||.++..........+.+|+.++..+ +||||+++++++.+
T Consensus 6 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 6 DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred cceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 35678889999999999999999999999999999999999997654444455667788777666 59999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
+..+|+||||+. ++|.+++... ...+++..+..++.||+.||.|||+ +||+||||+|+||+++.++.+||+|||++.
T Consensus 86 ~~~~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 86 DSDVFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred CCeEEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 999999999985 4777777664 3578999999999999999999997 699999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhc---cCCCcccchhhHHHHHHHHHcCCCCCCCCCh-HHHHHHHHhcCCCCC
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQL---HGYDFKADIWSFGITALELAHGHAPFSKYPP-MKVLLMTLQNAPPGL 235 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~---~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~-~~~l~~~~~~~~~~~ 235 (636)
.+..... .....|++.|+|||.+.+. ..++.++||||||+++|+|++|+.||..... .+.+........+..
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06618 164 RLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239 (296)
T ss_pred hccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC
Confidence 5432211 1234688999999998753 2378899999999999999999999976433 233333333322222
Q ss_pred CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 236 ~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+....++.++.+||.+||..||.+||++++++.|+||....
T Consensus 240 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 240 --PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 22235788999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.40 Aligned_cols=262 Identities=23% Similarity=0.370 Sum_probs=211.6
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEE-----cCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALC-----IPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSF 78 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~-----~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~ 78 (636)
+|.+..++|++++.||+|+||.||+|.+ ..+++.||||+++..........+.+|+.++..+ +||||+++++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 5889999999999999999999999984 3567899999997655444566788999999999 689999999987
Q ss_pred Ee-CCeEEEEEeccCCCCHHHHHHHhC-----------------------------------------------------
Q 006664 79 VS-DHNLWVVMPFMSGGSCLHILKAAY----------------------------------------------------- 104 (636)
Q Consensus 79 ~~-~~~l~iVmEy~~GGsL~~lL~~~~----------------------------------------------------- 104 (636)
.. +..+++|||||.+|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 65 457899999999999999986531
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccc
Q 006664 105 ------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172 (636)
Q Consensus 105 ------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 172 (636)
...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcC
Confidence 123677788899999999999999999999999999999999999999999998765322211 1122
Q ss_pred cccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHH
Q 006664 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251 (636)
Q Consensus 173 ~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI 251 (636)
...+++.|+|||++.+ ..++.++|||||||++|+|++ |..||............+.... ....+...++++.+++
T Consensus 240 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 315 (343)
T cd05103 240 DARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---RMRAPDYTTPEMYQTM 315 (343)
T ss_pred CCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC---CCCCCCCCCHHHHHHH
Confidence 3346678999999876 678999999999999999996 9999987554433333333222 1122344678999999
Q ss_pred HhhcccCCCCCCCHHHHHhC
Q 006664 252 ASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 252 ~~cL~~DP~kRpsa~elL~H 271 (636)
.+||..||.+||++.+|++|
T Consensus 316 ~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=335.52 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=207.8
Q ss_pred eEEEeEEcccCceEEEEEEEcC---CCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe-----
Q 006664 13 YTLYEEVGQGVSASVHRALCIP---FNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN----- 83 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~---tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~----- 83 (636)
|++++.||+|+||.||+|.+.. ++..||||.+..... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6789999999999999998765 348899999876543 2345678999999999999999999998866544
Q ss_pred -EEEEEeccCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcc
Q 006664 84 -LWVVMPFMSGGSCLHILKAAY----PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158 (636)
Q Consensus 84 -l~iVmEy~~GGsL~~lL~~~~----~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla 158 (636)
.++||||+.+|+|..++.... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 799999999999999886532 235899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
+.+..... ........++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+...........
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---- 234 (273)
T cd05035 161 KKIYSGDY-YRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL---- 234 (273)
T ss_pred eecccccc-ccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 76543321 111223345778999999865 678999999999999999999 99999887766655444433222
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
..+..++..+.++|.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.07 Aligned_cols=257 Identities=27% Similarity=0.419 Sum_probs=212.8
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEEEEecc
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~iVmEy~ 91 (636)
|++.+.||.|+||+||+|.+..+++.||||.+.............+|+..++.++ ||||+++++++.++...|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999998999999999865443333334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
+|+|.+++.......+++..+..++.|++.+|.|||++|++|+||+|.||+++.++.++|+|||++....... ..
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~----~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----PY 155 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC----Cc
Confidence 7899999987644578999999999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC--------------C-
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL--------------D- 236 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~--------------~- 236 (636)
....|+..|+|||++.+...++.++||||||+++|+|++|++||......+....+........ .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 3457899999999986656689999999999999999999999987766555443332111000 0
Q ss_pred ----------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 237 ----------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 237 ----------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.......+..+++||.+||..||.+||++.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00011235789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=337.23 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=209.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCc----EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~----~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+..++|++++.||+|+||+||+|.+..+|+ .||+|++...........+.+|+.+++.++||||+++++++.. ..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 456899999999999999999999887776 4899998755444456678899999999999999999998875 45
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
.+++|||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 78999999999999999764 35689999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
... ........+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.......... .+.... ..+.+..
T Consensus 162 ~~~-~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~---~~~~~~~ 235 (279)
T cd05109 162 DET-EYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGE---RLPQPPI 235 (279)
T ss_pred ccc-eeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCC---cCCCCcc
Confidence 211 111122345678999999976 568999999999999999998 999998766544333 332221 1122356
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++.++.++|.+||..||.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=332.35 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=212.9
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|.+..++|++.+.||.|+||.||+|... |+.||+|.++.... ....+.+|+.+++.++||||+++++++.+....|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 5678899999999999999999999864 89999999965433 4677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.+++|.+++.......+++..+..++.|++.||.|||.+|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999999999987654579999999999999999999999999999999999999999999999999987552111
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
....++..|+|||.+.. ..++.++||||||+++|+|++ |..||...+............. ...+..++
T Consensus 157 ------~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~ 225 (256)
T cd05039 157 ------DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR----MEAPEGCP 225 (256)
T ss_pred ------ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC----CCCccCCC
Confidence 12345667999999875 568889999999999999997 9999988766554433332211 12234578
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+.+.++|.+||..+|.+||++.+++.
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=334.44 Aligned_cols=253 Identities=24% Similarity=0.424 Sum_probs=209.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
|...+|++.+.||+|+||.||+|.+. ++..+|+|++.... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 1 IDPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred CChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 35678999999999999999999875 56789999985332 2345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...+...
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~- 155 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY- 155 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence 99999999999997642 4689999999999999999999999999999999999999999999999999875532211
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
.......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+........ .....+..++..
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 229 (256)
T cd05059 156 -TSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG----YRLYRPKLAPTE 229 (256)
T ss_pred -cccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC----CcCCCCCCCCHH
Confidence 11112234457999999976 578999999999999999998 89999877665554433322 122334568899
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
+.+++.+||..+|++||++.++++.
T Consensus 230 ~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 230 VYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=332.00 Aligned_cols=253 Identities=26% Similarity=0.502 Sum_probs=209.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++.+.||+|+||.||+|.+..+|+.||+|.++... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999986432 2233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 89 PFMSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
||+.||+|..++.... ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 9999999999987532 2458999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh--HHHHHHHHhcCCCCCCcccchhhh
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP--MKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~--~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
.......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... ............+. .....++
T Consensus 161 --~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 234 (267)
T cd08224 161 --TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP---LPADHYS 234 (267)
T ss_pred --cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC---CChhhcC
Confidence 11234578999999999876 6689999999999999999999999965432 12222222111111 1123678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+.++|.+||..+|.+||++.+|++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 89999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=341.57 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=207.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCc--EEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNE--IVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~--~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~i 86 (636)
.++|++.+.||+|+||.||+|.+..++. .+|+|.++..........+.+|+.++.++ +||||+++++++.....+|+
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 3789999999999999999999887765 46888876434444556788999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEE
Q 006664 87 VMPFMSGGSCLHILKAAY--------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~--------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL 152 (636)
||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 999999999999997642 134888999999999999999999999999999999999999999999
Q ss_pred eccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 006664 153 GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 231 (636)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~ 231 (636)
+|||++...... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+..............
T Consensus 161 ~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 161 ADFGLSRGEEVY----VKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred CCcCCCccccce----eccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999997532110 00111223457999999876 568999999999999999997 999998877665554443322
Q ss_pred CCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 232 ~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
....+..++..+.+||.+||..||.+||+++++++
T Consensus 236 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 236 ----RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=339.93 Aligned_cols=256 Identities=22% Similarity=0.374 Sum_probs=202.3
Q ss_pred CCe-EEEeEEcccCceEEEEEE----EcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--Ce
Q 006664 11 EHY-TLYEEVGQGVSASVHRAL----CIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD--HN 83 (636)
Q Consensus 11 ~~Y-~l~~~IG~G~fG~Vyka~----~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~--~~ 83 (636)
++| ++++.||+|+||+||++. ...++..||+|+++..........+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 999999999999998865 34578899999997654434456788999999999999999999987653 46
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+||||+.+|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 89999999999999999763 599999999999999999999999999999999999999999999999999876533
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHH-HH----------HHHhcCC
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV-LL----------MTLQNAP 232 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~-l~----------~~~~~~~ 232 (636)
............++..|+|||.+.+ ..++.++|||||||++|+|++|..||......-. .. .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 2221122223456778999999876 5689999999999999999999999865332100 00 0000000
Q ss_pred CCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 233 ~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.....+.+..++..+.+++.+||..||.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 01112224567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=340.23 Aligned_cols=263 Identities=26% Similarity=0.415 Sum_probs=213.7
Q ss_pred CeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeecCCC---chhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeE
Q 006664 12 HYTLYEEVGQGVSASVHRALCI---PFNEIVAVKILDFERD---NSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~~---~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l 84 (636)
.|++.+.||.|+||.||+|.+. .+|..||+|++..... ....+.+.+|+.+++.+ +||||++++++|..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 4789999999975332 22346678999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||+.|++|.+++... ..+++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999999875 56899999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCCCCCCChhhhhhc-cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
. ........|+..|+|||.+.+. ..++.++||||||+++|+|++|..||.................. ...+.+..+
T Consensus 159 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (290)
T cd05613 159 E--VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEM 235 (290)
T ss_pred c--ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccC
Confidence 1 1122356799999999998642 34788999999999999999999999643221111111111100 011223457
Q ss_pred hHHHHHHHHhhcccCCCCCC-----CHHHHHhCcccccccC
Q 006664 244 SKSFKQMIASCLVKDPSKRP-----SAKKLLKHSFFKQARS 279 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~ 279 (636)
+..+.+|+.+||..||.+|| ++++++.||||....+
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 88999999999999999997 8999999999987764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=338.69 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=213.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+...+|.+.++||+|+||.||+|.+. .++..+|+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 45688999999999999999999753 35678999987633 3344567899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYP-------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA 149 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~-------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~ 149 (636)
..|+||||+.+|+|.+++....+ ..+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 99999999999999999976532 34789999999999999999999999999999999999999999
Q ss_pred EEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 006664 150 IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTL 228 (636)
Q Consensus 150 vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~ 228 (636)
+||+|||++..+.... .........+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.............
T Consensus 161 ~kL~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred EEECCCCceeEcCCCc-eeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 9999999987543221 1122234456789999999876 568999999999999999998 999998776666554444
Q ss_pred hcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 229 ~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..... ..+..+++.+.+||.+||..||.+||++.+++.
T Consensus 239 ~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 33222 233567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.61 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=209.7
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|++..++|.+.+.||+|+||.||+|.+..+ ..+|+|.+.... .....+.+|+++++.++||||+++++++. ....|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 678889999999999999999999987654 469999875432 23456789999999999999999998875 45689
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.+|+|.+++.......+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999987644568999999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
. .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+............... ...+..++
T Consensus 157 ~--~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~ 229 (260)
T cd05069 157 Y--TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR----MPCPQGCP 229 (260)
T ss_pred c--cccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----CCCCcccC
Confidence 1 11223346778999999875 568899999999999999999 9999988776655544433221 12335678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+.++|.+||.+||.+||+++++++
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 89999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=360.15 Aligned_cols=263 Identities=19% Similarity=0.337 Sum_probs=217.7
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeee
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHC 76 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~ 76 (636)
...|++..++|.+++.||+|+||.||+|.+. .++..||+|+++..........+.+|+.+|..+. ||||+++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 4569999999999999999999999999853 4567899999976544444567889999999997 999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHHHhCC---------------------------------------------------
Q 006664 77 SFVSDHNLWVVMPFMSGGSCLHILKAAYP--------------------------------------------------- 105 (636)
Q Consensus 77 ~~~~~~~l~iVmEy~~GGsL~~lL~~~~~--------------------------------------------------- 105 (636)
++.....+|+|||||.||+|.+++.....
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 99999999999999999999999975321
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcc
Q 006664 106 ---------------------------------------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSG 140 (636)
Q Consensus 106 ---------------------------------------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~ 140 (636)
..+++..+..++.||+.||.|||++||+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 13567778899999999999999999999999999
Q ss_pred cEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCC
Q 006664 141 NILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYP 219 (636)
Q Consensus 141 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~ 219 (636)
|||++.++.+||+|||++......... ......+|++.|||||.+.+ ..++.++|||||||++|||++ |..||...+
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999998754322111 11234567889999999976 568999999999999999998 899998766
Q ss_pred hHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 220 ~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+.....+.... ....+..++.++.+||.+||..||.+||++.+|++
T Consensus 347 ~~~~~~~~~~~~~---~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 347 MNEQFYNAIKRGY---RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred chHHHHHHHHcCC---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6555444443321 22234567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.57 Aligned_cols=266 Identities=25% Similarity=0.389 Sum_probs=213.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCc----EEEEEEeecCCCch-hHHHHHHHHHHHHhCCCCCcceeeeEEEe-CCeE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNS-DLSNISREAQTMILVDHPNVLKSHCSFVS-DHNL 84 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~----~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~HPNIVkl~~~~~~-~~~l 84 (636)
..|+.+..||+|+||.||+|..+.++. .+|||.++-+++.. ......||+.+++.|+||||+.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 579999999999999999997665543 78999997665433 33457899999999999999999999988 8899
Q ss_pred EEEEeccCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC----CcEEEeccCc
Q 006664 85 WVVMPFMSGGSCLHILKAAY---PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR----GAIKLGDFGV 157 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~---~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~----g~vKL~DFGl 157 (636)
|+++||++. ||+++|+.+. ...++...++.|+.||+.|+.|||++-|+||||||.||||..+ |.|||+|||+
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999999986 8999987542 2358899999999999999999999999999999999999766 8999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC---------hHHHHHHHH
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP---------PMKVLLMTL 228 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~---------~~~~l~~~~ 228 (636)
++.+.+.-.........+-|.+|+|||++.|.+.|++++|||+.|||+.||++..+.|.+.. ..+++..+.
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 98764433222234567889999999999999999999999999999999999999885421 122233332
Q ss_pred h--cCCCCCCccc------------------------------chhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 229 Q--NAPPGLDYER------------------------------DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 229 ~--~~~~~~~~~~------------------------------~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
. ..+..-+|+. .+.-++...+|+.+||..||.+|+|++++|+|+||..
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 2 1111111111 1112455789999999999999999999999999985
Q ss_pred c
Q 006664 277 A 277 (636)
Q Consensus 277 ~ 277 (636)
.
T Consensus 343 d 343 (438)
T KOG0666|consen 343 D 343 (438)
T ss_pred C
Confidence 4
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=368.10 Aligned_cols=250 Identities=28% Similarity=0.468 Sum_probs=214.6
Q ss_pred EEEeEEcccCceEEEEEEEcCCCcEEEEEEee---cCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe--EEEEE
Q 006664 14 TLYEEVGQGVSASVHRALCIPFNEIVAVKILD---FERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN--LWVVM 88 (636)
Q Consensus 14 ~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~---~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~--l~iVm 88 (636)
.+.++||+|+|-+||+|.|..+|..||+-.+. +.+.+..++++..|+.+|+.|+|||||++|++|.+..+ +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999999999999875553 44566778999999999999999999999999998755 89999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccccCcccEEEcc-CCcEEEeccCcccccccCC
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH--GHIHRDVKSGNILIDV-RGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~--gIvHRDLKP~NILld~-~g~vKL~DFGla~~~~~~~ 165 (636)
|.+..|+|+.|++++ +..+...++.|++||+.||.|||++ -|||||||.+||||+. .|.|||+|+|+|+.+-..
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999999998 7788999999999999999999998 5999999999999974 589999999999876332
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHH-HHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL-MTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~-~~~~~~~~~~~~~~~~~~S 244 (636)
.....+|||-|||||++. ..|+..+||||||++++||+|+..||.......++. .+..+..|.- + .+--.
T Consensus 200 ----~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s-l--~kV~d 270 (632)
T KOG0584|consen 200 ----HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA-L--SKVKD 270 (632)
T ss_pred ----ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH-h--hccCC
Confidence 233578999999999997 589999999999999999999999998866555544 4444443321 1 12236
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
+++++||.+||.. ...|+|+.|||+||||..
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 7999999999999 999999999999999975
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=337.82 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=214.9
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEecc
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~ 91 (636)
|++.+.||.|++|.||+|.+..+|+.+|+|.++..... .....+.+|+.+++.++||||+++++++.++..+|+||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999999999999998754432 34567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
.+ +|.+++.... ..+++..+..++.||+.||.|||.+||+||||||+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~---~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV---RPY 155 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---ccc
Confidence 75 8888887643 578999999999999999999999999999999999999999999999999987653322 122
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC---------------
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD--------------- 236 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~--------------- 236 (636)
....++..|+|||.+.+...++.++||||||+++|+|++|+.||......+.+..+.........
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 33568899999999987547899999999999999999999999887766655444322111000
Q ss_pred ----------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 237 ----------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 237 ----------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
......++.++++||.+||.+||.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=349.83 Aligned_cols=260 Identities=27% Similarity=0.375 Sum_probs=214.4
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC-----
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH----- 82 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~----- 82 (636)
..++|++++.||+|+||.||+|.+..+|..||||++..... ......+.+|+.+|+.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 36789999999999999999999999999999999865432 223456889999999999999999999997654
Q ss_pred -eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 83 -NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 83 -~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
.+++||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 469999999 7799888864 46999999999999999999999999999999999999999999999999998754
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-------
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG------- 234 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~------- 234 (636)
... .....+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.........+.......
T Consensus 169 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 169 DSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 211 2245789999999998764568899999999999999999999998776554444333211110
Q ss_pred ---------------CC----cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 235 ---------------LD----YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 235 ---------------~~----~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.. ......++..+.++|.+||..||.+|||+.+++.||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00 011235678899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=334.29 Aligned_cols=256 Identities=23% Similarity=0.390 Sum_probs=212.0
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNE---IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~---~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
...+|++.+.||+|+||.||+|.++.++. .||||+++..........+.+|+.+++.++||||+++++++..+..++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 45789999999999999999999887665 699999876544555677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.+|+|.+++... .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 82 IITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999998764 3568999999999999999999999999999999999999999999999999987553322
Q ss_pred Cccccccccc--CCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 166 DRQRMRNTFV--GTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 166 ~~~~~~~~~~--GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.......... ++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+... ...+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~----~~~~~~~~ 235 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD----YRLPPPMD 235 (269)
T ss_pred cccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC----CcCCCccc
Confidence 1111111111 2457999999976 568999999999999999886 99999887766554444322 12233356
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++..+.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.14 Aligned_cols=251 Identities=29% Similarity=0.460 Sum_probs=206.3
Q ss_pred EEEeEEcccCceEEEEEEEc----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 14 TLYEEVGQGVSASVHRALCI----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 14 ~l~~~IG~G~fG~Vyka~~~----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.+.+.||.|+||.||+|... ..+..|+||++.........+.+.+|++++++++||||+++++++.....+++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 57889999999999999987 45688999999655455557889999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||.+|+|.++|.......+++..+..++.||+.||.|||+++++||||++.|||++.++.+||+|||++...... ....
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~-~~~~ 160 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK-SKYK 160 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS-SSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccc
Confidence 999999999999875567999999999999999999999999999999999999999999999999998765222 1112
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
......+...|+|||.+.. ..++.++||||||+++|||++ |..||.+....+.......... ...+..++..+.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 235 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR----LPIPDNCPKDIY 235 (259)
T ss_dssp ESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE----TTSBTTSBHHHH
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccc----ceeccchhHHHH
Confidence 2334457788999999987 458999999999999999999 7899998877665555533322 223456889999
Q ss_pred HHHHhhcccCCCCCCCHHHHHh
Q 006664 249 QMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++|.+||..||.+||++.+|++
T Consensus 236 ~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=331.86 Aligned_cols=249 Identities=22% Similarity=0.384 Sum_probs=208.2
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE-eCCeE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV-SDHNL 84 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~-~~~~l 84 (636)
|-+..++|++.+.||+|+||.||++... |..||+|.+... .....+.+|+.+++.++||||+++++++. .+...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 6678899999999999999999999764 888999998533 23456889999999999999999998754 55679
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||+.+|+|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999998764445899999999999999999999999999999999999999999999999998754221
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...........+..... ......+
T Consensus 156 ------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~ 224 (256)
T cd05082 156 ------QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----MDAPDGC 224 (256)
T ss_pred ------CCCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----CCCCCCC
Confidence 123345678999999876 678999999999999999997 9999987665544433332222 1223567
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++.+.++|.+||..||.+|||+.++++
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=333.01 Aligned_cols=245 Identities=23% Similarity=0.366 Sum_probs=201.2
Q ss_pred EEcccCceEEEEEEE--cCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCC
Q 006664 18 EVGQGVSASVHRALC--IPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 18 ~IG~G~fG~Vyka~~--~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GG 94 (636)
+||+|+||.||+|.+ ..++..||+|+++..... .....+.+|+.+++.++||||+++++++. +...++||||+.+|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 467899999998755432 34567889999999999999999999875 45679999999999
Q ss_pred CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccc
Q 006664 95 SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF 174 (636)
Q Consensus 95 sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 174 (636)
+|.+++... ..+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++..+.............
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 999999765 568999999999999999999999999999999999999999999999999987653322111111223
Q ss_pred cCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 175 VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 175 ~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.+++.|+|||.+.. ..++.++|||||||++|||++ |..||...........+..... ...+..++.++.+||.+
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~----~~~~~~~~~~l~~li~~ 233 (257)
T cd05116 159 KWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER----MECPQRCPPEMYDLMKL 233 (257)
T ss_pred CCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC----CCCCCCCCHHHHHHHHH
Confidence 45678999999865 568889999999999999997 9999988776655444433221 22345688999999999
Q ss_pred hcccCCCCCCCHHHHHh
Q 006664 254 CLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 254 cL~~DP~kRpsa~elL~ 270 (636)
||+.||.+||++.+|.+
T Consensus 234 ~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 234 CWTYGVDERPGFAVVEL 250 (257)
T ss_pred HhccCchhCcCHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=331.03 Aligned_cols=249 Identities=24% Similarity=0.418 Sum_probs=207.6
Q ss_pred eEEcccCceEEEEEEEcC-CCc--EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIP-FNE--IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~-tg~--~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||.||+|.+.. .+. .||||.+...........+.+|+.+++.++||||+++++.+.. ..+++||||+.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 333 6999999765544556788999999999999999999999988 899999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+............
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 99999998764356899999999999999999999999999999999999999999999999998766433222222223
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHH
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIA 252 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~ 252 (636)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+..... ....+..++..+.+++.
T Consensus 160 ~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 160 LKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE---RLERPEACPQDIYNVML 235 (257)
T ss_pred CCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---cCCCCccCCHHHHHHHH
Confidence 567889999999876 568999999999999999998 9999987777665544443211 12233457889999999
Q ss_pred hhcccCCCCCCCHHHHHh
Q 006664 253 SCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 253 ~cL~~DP~kRpsa~elL~ 270 (636)
+||..+|++||++.+++.
T Consensus 236 ~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 236 QCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHCCCCcccCCCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.06 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=210.6
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhC---CCCCcceeeeEEEeCCe-----
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILV---DHPNVLKSHCSFVSDHN----- 83 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L---~HPNIVkl~~~~~~~~~----- 83 (636)
|++.+.||+|+||.||+|.++.+++.||+|++....... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 789999999999999999999899999999997544322 234566788877665 69999999999998776
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
++++|||+.+ +|.+++.......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999999975 899988876445699999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC--CC-----
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG--LD----- 236 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~--~~----- 236 (636)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+..+....... ..
T Consensus 160 ~~----~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 160 EM----ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred Cc----ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 1224468999999999976 568899999999999999999999999877766655554321100 00
Q ss_pred ---------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 237 ---------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 237 ---------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
......++..+.++|.+||..||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00012456788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.84 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=217.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+|++.+.||.|+||.||++.+..+++.+|+|.+.... .......+.+|+.+++.++||||+++++++..+...|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999999999999997644 233456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 91 MSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 91 ~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
++|++|..++.... ...+++..++.++.|++.||.|||++|++||||+|.||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----
Confidence 99999999887632 246899999999999999999999999999999999999999999999999998765322
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
......|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.................+. ....++.+++
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 230 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP----IPPIYSQDLQ 230 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----CchhhCHHHH
Confidence 2234568999999999976 668889999999999999999999998877655444444332222 2246788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
++|.+||..+|.+||++.++++||++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.21 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=202.7
Q ss_pred eEEcccCceEEEEEEEcCCC---cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFN---EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg---~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
++||+|+||.||+|.+..++ ..||+|.+...........+.+|+.+++.++||||+++++++. ....++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876555 7899999976554445667899999999999999999999876 4568999999999
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|.+++... ..+++..+..++.|++.||.|||.+|++||||||+|||++.++.+||+|||++..+............
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 9999999875 46899999999999999999999999999999999999999999999999998765332211111112
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHH
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIA 252 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~ 252 (636)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+..... ...+..++..++++|.
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~ 232 (257)
T cd05060 158 GRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER----LPRPEECPQEIYSIML 232 (257)
T ss_pred ccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc----CCCCCCCCHHHHHHHH
Confidence 224567999999876 568999999999999999997 9999988776555444433221 2334567899999999
Q ss_pred hhcccCCCCCCCHHHHHh
Q 006664 253 SCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 253 ~cL~~DP~kRpsa~elL~ 270 (636)
+||..||.+||++.++++
T Consensus 233 ~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 233 SCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.13 Aligned_cols=260 Identities=26% Similarity=0.372 Sum_probs=211.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC------
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSD------ 81 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~------ 81 (636)
..++|++++.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 45889999999999999999999999999999999865432 22345678899999999999999999988653
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
...|++++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3478888887 7799888764 36899999999999999999999999999999999999999999999999998653
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--------
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP-------- 233 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~-------- 233 (636)
.. ......|++.|+|||++.+...++.++|||||||++|+|++|+.||........+..+......
T Consensus 171 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 171 DD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cc------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 21 1234578999999999876556889999999999999999999999876655443332221100
Q ss_pred -----------------CCCc-ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 234 -----------------GLDY-ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 234 -----------------~~~~-~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
...+ ......++++++||.+||..||.+||++.+++.||||++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0000 00123578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=346.84 Aligned_cols=263 Identities=24% Similarity=0.441 Sum_probs=216.1
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCC-------CcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCccee
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPF-------NEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKS 74 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t-------g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl 74 (636)
-.+|++...+|++++.||+|+||.||+|.+... +..||+|+++..........+.+|+.+++++ +||||+++
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 368999999999999999999999999986432 2378999987554455567889999999999 79999999
Q ss_pred eeEEEeCCeEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcc
Q 006664 75 HCSFVSDHNLWVVMPFMSGGSCLHILKAAYP--------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSG 140 (636)
Q Consensus 75 ~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~--------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~ 140 (636)
++++..+..+|+||||+.+|+|.+++....+ ..++...+..++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 9999999999999999999999999976421 23677888999999999999999999999999999
Q ss_pred cEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCC
Q 006664 141 NILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYP 219 (636)
Q Consensus 141 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~ 219 (636)
|||++.++.+||+|||+++....... ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccc-cccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999875432211 111122334567999999976 678999999999999999998 899998877
Q ss_pred hHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 220 ~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
..+....+..... ...+..++..+.+||.+||..+|.+||++.+++.+
T Consensus 242 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHR----MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 6665544433222 12234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.69 Aligned_cols=246 Identities=24% Similarity=0.390 Sum_probs=201.4
Q ss_pred EEcccCceEEEEEEEc--CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCC
Q 006664 18 EVGQGVSASVHRALCI--PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGS 95 (636)
Q Consensus 18 ~IG~G~fG~Vyka~~~--~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGs 95 (636)
.||+|+||.||+|.+. ..+..||+|++.........+.+.+|+.+++.++||||+++++++. ....|+||||+.||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999775 4566799999976544445567899999999999999999999875 457899999999999
Q ss_pred HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccccc
Q 006664 96 CLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175 (636)
Q Consensus 96 L~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 175 (636)
|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+..............
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 99998753 35689999999999999999999999999999999999999999999999999875432221111112223
Q ss_pred CCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhh
Q 006664 176 GTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASC 254 (636)
Q Consensus 176 GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~c 254 (636)
+++.|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+....+...... ..+...+.++.++|.+|
T Consensus 160 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~c 234 (257)
T cd05115 160 WPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL----DCPAECPPEMYALMKDC 234 (257)
T ss_pred CCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC----CCCCCCCHHHHHHHHHH
Confidence 4678999999875 568999999999999999996 99999887776655444433222 23356789999999999
Q ss_pred cccCCCCCCCHHHHHh
Q 006664 255 LVKDPSKRPSAKKLLK 270 (636)
Q Consensus 255 L~~DP~kRpsa~elL~ 270 (636)
|..||++||++.++.+
T Consensus 235 ~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 235 WIYKWEDRPNFAKVEE 250 (257)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.63 Aligned_cols=255 Identities=22% Similarity=0.404 Sum_probs=206.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcE----EEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEI----VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~----vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+..++|++++.||+|+||+||+|.+..+|.. ||+|.+...........+..|+.+++.++||||+++++++. +..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 4567999999999999999999999877764 77777754333334567788888999999999999999875 456
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
.++++||+.+|+|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 78999999999999999764 25689999999999999999999999999999999999999999999999999876533
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.. .........|+..|+|||.+.+ ..|+.++|||||||++|||++ |..||.+....... ..+..... ...+..
T Consensus 162 ~~-~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~---~~~~~~ 235 (279)
T cd05111 162 DD-KKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGER---LAQPQI 235 (279)
T ss_pred CC-cccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCc---CCCCCC
Confidence 22 1122234557788999999976 568999999999999999998 99999877654432 23332221 122334
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++.++.+++.+||..||.+||++.++++
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 6778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.11 Aligned_cols=253 Identities=24% Similarity=0.416 Sum_probs=209.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIP-----FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~-----tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
+|++.+.||+|+||.||+|.+.. ....+|+|.+...........+.+|+.+++.++||||+++++.+..++..|+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 3367999998755554556778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE
Q 006664 87 VMPFMSGGSCLHILKAAY----------------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI 144 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~----------------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl 144 (636)
||||+.+|+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 999999999999987531 1347888999999999999999999999999999999999
Q ss_pred ccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHH
Q 006664 145 DVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKV 223 (636)
Q Consensus 145 d~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~ 223 (636)
+.++.+||+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+..+...
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred cCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999998765333221 11223456778999999865 668999999999999999998 9999988776654
Q ss_pred HHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 224 LLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 224 l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
....... .....+..++.++.+||.+||..||.+||++.++++
T Consensus 239 ~~~~~~~----~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 239 FNLLKTG----YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHhCC----CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 4333222 222334567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=369.42 Aligned_cols=265 Identities=22% Similarity=0.312 Sum_probs=199.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCC-CcEEEEEEeec----------------CCCchhHHHHHHHHHHHHhCCCCCcc
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPF-NEIVAVKILDF----------------ERDNSDLSNISREAQTMILVDHPNVL 72 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~t-g~~vAIK~i~~----------------~~~~~~~~~i~rEi~iL~~L~HPNIV 72 (636)
.++|++++.||+|+||+||+|..+.. +..+++|.++. .........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 36899999999999999999876533 33333331110 01112345678999999999999999
Q ss_pred eeeeEEEeCCeEEEEEeccCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc
Q 006664 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAY---PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA 149 (636)
Q Consensus 73 kl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~---~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~ 149 (636)
++++++......|+||+++. ++|..++.... ........++.++.||+.||.|||++|||||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999995 47777765431 122446678899999999999999999999999999999999999
Q ss_pred EEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCC-CCCC--ChHHHHHH
Q 006664 150 IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAP-FSKY--PPMKVLLM 226 (636)
Q Consensus 150 vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~P-F~~~--~~~~~l~~ 226 (636)
+||+|||++..+.... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|..+ |... .+...+..
T Consensus 306 vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 306 IVLGDFGTAMPFEKER--EAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred EEEEeCCCceecCccc--ccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 9999999997653221 122335789999999999986 6799999999999999999998754 4322 23333333
Q ss_pred HHhcCCC-CCC--------------------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 227 TLQNAPP-GLD--------------------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 227 ~~~~~~~-~~~--------------------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++..... ... ......++.++.++|.+||.+||.+|||+.|+|.||||....
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 3321110 000 001123566788999999999999999999999999998653
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=341.29 Aligned_cols=257 Identities=36% Similarity=0.608 Sum_probs=215.9
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccC
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMS 92 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~ 92 (636)
|+....||+|+||.||++.+..+|+.||||.+.... ......+.+|+.+++.++||||+++++++..+...|+||||+.
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 444567999999999999999999999999986432 2345668899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccc
Q 006664 93 GGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172 (636)
Q Consensus 93 GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 172 (636)
+++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 101 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---~~~~ 174 (292)
T cd06657 101 GGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PRRK 174 (292)
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc---cccc
Confidence 9999998754 468999999999999999999999999999999999999999999999999876543211 1123
Q ss_pred cccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHH
Q 006664 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIA 252 (636)
Q Consensus 173 ~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~ 252 (636)
...|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||................+..+ .....++..+.++|.
T Consensus 175 ~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~ 251 (292)
T cd06657 175 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL--KNLHKVSPSLKGFLD 251 (292)
T ss_pred ccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc--CCcccCCHHHHHHHH
Confidence 4678999999999865 5678999999999999999999999987766655444433333222 123456889999999
Q ss_pred hhcccCCCCCCCHHHHHhCcccccccC
Q 006664 253 SCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 253 ~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
+||..||.+||++.+++.||||.....
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHHhccCC
Confidence 999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=333.52 Aligned_cols=254 Identities=26% Similarity=0.485 Sum_probs=208.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++.+.||+|+||.||+|.+..++..||||.+.... .......+.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999999999999886432 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 89 PFMSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
||+.|++|.+++.... ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 9999999999887432 2458999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCCCCCcccchhhhH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~-~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
.......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.... ......+.... ........++.
T Consensus 161 --~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08229 161 --TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSE 235 (267)
T ss_pred --cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccH
Confidence 11234579999999999976 56889999999999999999999999754321 11111111111 11112245788
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.++++|.+||..||.+|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.86 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=211.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+...+|.+.+.||+|+||.||+|.+. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 34578999999999999999999854 345679999875332 223456889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYP--------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG 148 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~--------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g 148 (636)
..++||||+.+++|.+++....+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999999976421 3488999999999999999999999999999999999999999
Q ss_pred cEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 006664 149 AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMT 227 (636)
Q Consensus 149 ~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~ 227 (636)
.++|+|||++....... .........|++.|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+
T Consensus 161 ~~~l~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 161 LVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred cEEECCCCcccccCCCc-eeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999987543321 1122334567889999999876 678999999999999999998 99999887766654443
Q ss_pred HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 228 ~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
...... .....++..+.+++.+||..||.+||++.++++
T Consensus 239 ~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVL----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCC----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 332221 223457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.51 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=200.9
Q ss_pred eEEcccCceEEEEEEEcC--CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCC
Q 006664 17 EEVGQGVSASVHRALCIP--FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~--tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GG 94 (636)
++||+|+||.||+|.... ....+|+|.+...........+.+|+.+++.++||||+++++++.....+|+||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999996543 446788888765444444566789999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 95 SCLHILKAAYP---DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 95 sL~~lL~~~~~---~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......+. ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~ 159 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-YITK 159 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh-eecc
Confidence 99999977532 2356788899999999999999999999999999999999999999999999864322211 1112
Q ss_pred ccccCCCCCCChhhhhh------ccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCc-ccchhh
Q 006664 172 NTFVGTPCWMAPEVMEQ------LHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY-ERDRKF 243 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~------~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~-~~~~~~ 243 (636)
....+++.|+|||++.. ...++.++|||||||++|+|++ |..||......+.+...+......+.. .....+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence 23456778999999853 2346889999999999999998 889998877766665555544322221 223468
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+..+.+++..|| .||.+||+++++++
T Consensus 240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 240 SDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 889999999999 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.56 Aligned_cols=257 Identities=37% Similarity=0.657 Sum_probs=216.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
+.|...+.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.++...|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 347778899999999999999999999999999975432 234457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+. |++.+++... ...+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++....
T Consensus 101 e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------ 172 (313)
T cd06633 101 EYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------ 172 (313)
T ss_pred ecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence 9996 5788877654 3568999999999999999999999999999999999999999999999999875321
Q ss_pred cccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
......|+..|+|||++.. ...++.++|||||||++|+|++|..||.................+.. ....++..
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 248 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL---QSNEWTDS 248 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CccccCHH
Confidence 1235679999999999852 24578899999999999999999999988777666655554433222 23456788
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
+++||.+||+.+|.+||++.+++.||||.....
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 999999999999999999999999999986553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.95 Aligned_cols=253 Identities=24% Similarity=0.410 Sum_probs=203.8
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCc--EEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC------Ce
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNE--IVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD------HN 83 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~--~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~------~~ 83 (636)
|.+++.||+|+||.||+|.+..++. .||+|.++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999887775 69999987653 234467788999999999999999999876432 25
Q ss_pred EEEEEeccCCCCHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 84 LWVVMPFMSGGSCLHILKAA----YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~----~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.++||||+.+|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 78999999999999887532 12348899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYE 238 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~ 238 (636)
.+..... ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+..... ..
T Consensus 161 ~~~~~~~-~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----~~ 234 (272)
T cd05075 161 KIYNGDY-YRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR----LK 234 (272)
T ss_pred ccCcccc-eecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC----CC
Confidence 6533221 111223356778999999976 678999999999999999999 8999987766554443332211 12
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
....++..++++|.+||..||.+|||+.+|+++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=349.11 Aligned_cols=263 Identities=28% Similarity=0.381 Sum_probs=212.8
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSD-- 81 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-- 81 (636)
-|++ ..+|.+.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 10 VWEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 4555 4689999999999999999999999999999999865432 22345678999999999999999999998754
Q ss_pred ----CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCc
Q 006664 82 ----HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 82 ----~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
..+|+||||+.+ +|..++. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 89 GDEFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred CCCCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 356999999964 6666542 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC---
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG--- 234 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~--- 234 (636)
+..... ......|++.|+|||++.+...++.++|||||||++|+|++|+.||.+......+..++......
T Consensus 164 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 164 ARHADA------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CcCCCC------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 864311 12345789999999998764568899999999999999999999998876655544333211100
Q ss_pred -------------------C---C-cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 235 -------------------L---D-YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 235 -------------------~---~-~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
. + .......+..+.+||.+||+.||.+||++.+++.||||...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0 0 0001246778999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=396.63 Aligned_cols=263 Identities=30% Similarity=0.510 Sum_probs=223.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
.-+|+..-.||.|.||.||-|.+..+|+..|+|-|...- .......+.+|.+++..|+|||+|++|++-.....++|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 346788889999999999999999999999999987543 2345677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC-Cc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG-DR 167 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~-~~ 167 (636)
|||+||+|.+++... +..+|...+.|..|++.|+.|||++|||||||||+|||++.+|.+|++|||.|..+.... +-
T Consensus 1314 EyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999999999999864 568889999999999999999999999999999999999999999999999998765442 11
Q ss_pred ccccccccCCCCCCChhhhhhcc--CCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLH--GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~--~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
....+..+|||.|||||++.+.. +..-++|||||||+..||++|+.||...+..-.+...+.. +-....+..+|.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~---gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA---GHKPQIPERLSS 1468 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc---cCCCCCchhhhH
Confidence 22245679999999999998743 4667899999999999999999999876554333222221 112233455999
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+.++||.+||..||++|.++.||+.|.|-+..
T Consensus 1469 ~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred hHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 99999999999999999999999999998754
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.62 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=211.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIP-----FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~-----tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++...........+.+|+.+++.++||||+++++++.++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 466899999999999999999998753 678999999875544445567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCC--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccE
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYP--------------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNI 142 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~--------------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NI 142 (636)
.+|+||||+.+|+|.+++..... ..+++..+..++.||+.||.|||.+|++||||||.||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 99999999999999999975421 2477888999999999999999999999999999999
Q ss_pred EEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChH
Q 006664 143 LIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPM 221 (636)
Q Consensus 143 Lld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~ 221 (636)
+++.++.++|+|||++..+...... .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred EecCCCceEECccccceecccCccc-cccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999998754322111 11122345677999999876 568999999999999999997 88999877665
Q ss_pred HHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 222 KVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 222 ~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+....+..... ...+..++.++.+||.+||+.||.+||++.|+++
T Consensus 240 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNV----LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCC----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 55443332211 1223457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=340.01 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=209.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCC--------------cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcce
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFN--------------EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLK 73 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg--------------~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVk 73 (636)
+...+|++.+.||+|+||.||+|.+..++ ..||+|.+...........+.+|+++++.++||||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 44579999999999999999999875432 3589999875544445567899999999999999999
Q ss_pred eeeEEEeCCeEEEEEeccCCCCHHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEE
Q 006664 74 SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYP----------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNIL 143 (636)
Q Consensus 74 l~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~----------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NIL 143 (636)
+++++..+...|+||||+.|++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 99999999999999999999999999865321 13678889999999999999999999999999999999
Q ss_pred EccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc--CCCCCCCCChH
Q 006664 144 IDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH--GHAPFSKYPPM 221 (636)
Q Consensus 144 ld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt--G~~PF~~~~~~ 221 (636)
++.++.+||+|||++..+.... .........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EcCCCcEEecccccccccccCc-ceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999987653322 1122233456788999999876 568999999999999999987 77899876665
Q ss_pred HHHHHHHh---cCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 222 KVLLMTLQ---NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 222 ~~l~~~~~---~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+....... ..........+..++..+++||.+||..||.+||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 54433322 11111111223457889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.66 Aligned_cols=260 Identities=22% Similarity=0.374 Sum_probs=208.9
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcC----------------CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcc
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIP----------------FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~----------------tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIV 72 (636)
..++|++.+.||+|+||.||++.+.. ++..||+|++...........+.+|+.+++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 45789999999999999999986432 34579999987554444566789999999999999999
Q ss_pred eeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEE
Q 006664 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYP---------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNIL 143 (636)
Q Consensus 73 kl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~---------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NIL 143 (636)
++++++..+...|+||||+.+|+|.+++..... ..+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999999999999999999999999999976421 23677889999999999999999999999999999999
Q ss_pred EccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc--CCCCCCCCChH
Q 006664 144 IDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH--GHAPFSKYPPM 221 (636)
Q Consensus 144 ld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt--G~~PF~~~~~~ 221 (636)
++.++.++|+|||++..+..... ........+++.|+|||...+ ..++.++|||||||++|||++ |..||......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999876533221 122233455778999998876 568999999999999999998 78999876655
Q ss_pred HHHHHHHh---cCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 222 KVLLMTLQ---NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 222 ~~l~~~~~---~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+....... ........+.+..+++.+.+||.+||..||.+||++.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54332211 11111112334557789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=376.34 Aligned_cols=148 Identities=30% Similarity=0.481 Sum_probs=136.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
.++|.+++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999975432 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
|||+.|++|.+++... +.+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999765 568999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=349.10 Aligned_cols=266 Identities=26% Similarity=0.398 Sum_probs=215.2
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeC--CeE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSD--HNL 84 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~--~~l 84 (636)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.+ +||||+++++++... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3578999999999999999999999999999999885432 223345677899999999 999999999998654 468
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||+.+ +|..++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+...
T Consensus 85 ~lv~e~~~~-~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEeccccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 999999974 899888763 6889999999999999999999999999999999999999999999999998765433
Q ss_pred CCc--ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC---------
Q 006664 165 GDR--QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--------- 233 (636)
Q Consensus 165 ~~~--~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~--------- 233 (636)
... ......+.||+.|+|||++.+...++.++|||||||++|+|++|+.||.+................
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 211 122345679999999999876566889999999999999999999999876655443332221110
Q ss_pred -------------CCC----cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 234 -------------GLD----YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 234 -------------~~~----~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
... ......++.++.+||.+||+.||.+||++.+++.||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 000 011123688999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.49 Aligned_cols=254 Identities=30% Similarity=0.514 Sum_probs=212.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC----CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER----DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~----~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
+|.+.+.||+|+||.||++.+..++..+++|+++... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6999999999999999999998888878777765322 222344577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 88 MPFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
|||+.+++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++ ++.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-~~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-cCCEeecccCceeecCCCc
Confidence 9999999999988652 234689999999999999999999999999999999999997 4679999999987653322
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
. ......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.................+. .+..++.
T Consensus 160 ~---~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 231 (260)
T cd08222 160 D---LATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS----LPETYSR 231 (260)
T ss_pred c---cccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC----CcchhcH
Confidence 1 2335678999999999865 668889999999999999999999998766655544444332222 2356788
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
++.++|.+||..||.+||++.++++||||
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.35 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=211.3
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPF---NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t---g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
|.+..++|.+.+.||+|+||.||+|.+... ...||||.+.........+.+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred CeechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 567788999999999999999999987644 356899998755544556678999999999999999999998875 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
..|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 578999999999999999764 2468999999999999999999999999999999999999999999999999987543
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
... ........+++.|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+....+...... ..+.
T Consensus 159 ~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~ 231 (270)
T cd05056 159 DES--YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL----PMPP 231 (270)
T ss_pred ccc--ceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC----CCCC
Confidence 221 111122335568999999865 678999999999999999986 99999887766555443332221 2345
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.++..+.++|.+||..+|.+||++.+++.
T Consensus 232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 232 NCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=337.82 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=206.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEE----cCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--Ce
Q 006664 10 AEHYTLYEEVGQGVSASVHRALC----IPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD--HN 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~----~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~--~~ 83 (636)
..-|++++.||+|+||.||+|.. ..++..||+|.++..........+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 34578999999999999999974 4678999999987555455567789999999999999999999998875 67
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
.|+||||++|++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..+..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 899999999999999997642 4589999999999999999999999999999999999999999999999999876543
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC--------------hHHHHHHHHh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP--------------PMKVLLMTLQ 229 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~--------------~~~~l~~~~~ 229 (636)
............|+..|+|||++.+ ..++.++|||||||++|+|+++..|+.... ........+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 3222222335567888999999876 568999999999999999999877653210 0111111111
Q ss_pred cCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 230 ~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.. ...+.+..++..+.+||.+||+.||.+||++.++++
T Consensus 241 ~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 241 EG---KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred cC---ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11 112234567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=378.80 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=208.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||.||+|.+..+|+.||||++..... .....++.+|+.+++.++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 689999999999999999999999999999999975432 223567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 89 PFMSGGSCLHILKAAY---------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~---------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
||++||+|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999999987531 1235566788999999999999999999999999999999999999999999997
Q ss_pred ccccCCC---------------cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHH
Q 006664 160 CLFDSGD---------------RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL 224 (636)
Q Consensus 160 ~~~~~~~---------------~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l 224 (636)
....... ........+||+.|||||++.+ ..++.++|||||||++|||++|..||......+..
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 6521110 0111234679999999999976 67899999999999999999999999875554433
Q ss_pred HHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 225 LMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.......+ ........+++.+.+++.+||..||++|++..+.+.+
T Consensus 241 ~~~~i~~P--~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 241 YRDVILSP--IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhccCh--hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22211111 1112234678899999999999999999876665543
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=327.79 Aligned_cols=254 Identities=23% Similarity=0.398 Sum_probs=210.9
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|++..++|++.+.||+|+||.||+|.+. .+..+|+|.+... ....+.+.+|+.+++.++||||+++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 7899999999999999999999999854 4667999987533 2235678899999999999999999999887 7889
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
++|||+.+|+|.+++.......+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999999987555568888999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
........++..|+|||++.. ..++.++|||||||++|+|++ |..||.+.........+.... ..+....++
T Consensus 157 --~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~ 229 (260)
T cd05073 157 --YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY----RMPRPENCP 229 (260)
T ss_pred --cccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC----CCCCcccCC
Confidence 111223345677999999976 568999999999999999998 999998766655443333221 222335678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.++.+++.+||.+||.+||++.+++.
T Consensus 230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 230 EELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 89999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=325.86 Aligned_cols=251 Identities=27% Similarity=0.469 Sum_probs=211.4
Q ss_pred eEEEeEEcccCceEEEEEEEcCCC----cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFN----EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg----~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
+++.+.||.|+||.||++.+...+ ..||+|++...........+..|+.+++.++||||+++++++.+....|++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 357889999999999999998766 9999999976554446778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.|++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY- 159 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc-
Confidence 9999999999998753333999999999999999999999999999999999999999999999999998765332111
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.................. .....++.++
T Consensus 160 -~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 233 (258)
T smart00219 160 -KKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL----PKPENCPPEI 233 (258)
T ss_pred -ccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC----CCCCcCCHHH
Confidence 1112237889999999855 678999999999999999998 89999877666555544433222 2234478999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHh
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+++.+||..||.+|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 234 YKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=342.34 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=210.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCC--CcEEEEEEeecCCCc-hhHHHHHHHHHHHHhC-CCCCcceeeeEEEeC----Ce
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPF--NEIVAVKILDFERDN-SDLSNISREAQTMILV-DHPNVLKSHCSFVSD----HN 83 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~t--g~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~----~~ 83 (636)
+|++.+.||+|+||.||+|.+..+ +..||||.+...... .....+.+|+.+++.+ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999888 999999998643222 2355678899999998 599999999875432 46
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|++|+|+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 889999986 5899888754 5799999999999999999999999999999999999999999999999999876532
Q ss_pred CCC-cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC----------
Q 006664 164 SGD-RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP---------- 232 (636)
Q Consensus 164 ~~~-~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~---------- 232 (636)
... ........+||+.|+|||++.+...++.++|||||||++|+|++|.+||........+..++....
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 211 111223468999999999987656789999999999999999999999987654443332222100
Q ss_pred ---------------CCCCc-ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 233 ---------------PGLDY-ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 233 ---------------~~~~~-~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+...+ ......+..+.+||.+||..||.+|||+.+++.||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 00000 11123578899999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.29 Aligned_cols=257 Identities=28% Similarity=0.396 Sum_probs=213.1
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEecc
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~ 91 (636)
|++.+.||+|.||.||+|++..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+...+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 678899999999999999999999999999997654 2233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
.+ +|.+++.... ..+++..+..++.|++.||.|||.+||+||||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~-~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~---~~~ 155 (282)
T cd07829 81 DM-DLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL---RTY 155 (282)
T ss_pred Cc-CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc---ccc
Confidence 84 8999998753 469999999999999999999999999999999999999999999999999987543221 122
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC------------------
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP------------------ 233 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~------------------ 233 (636)
....++..|+|||.+.+...++.++|||||||++|+|++|.+||......+.+..+......
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 34467889999999977557899999999999999999999999877665554433321100
Q ss_pred --CCCc----ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 234 --GLDY----ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 234 --~~~~----~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.... .....++..+.++|.+||..||.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000 0112347789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=331.99 Aligned_cols=258 Identities=22% Similarity=0.374 Sum_probs=212.9
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcC----CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe-C
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIP----FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS-D 81 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~----tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~-~ 81 (636)
.+..++|++.+.||+|+||.||+|.+.. ++..||+|.+...........+.+|+.+++.++||||+++++++.. +
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4678999999999999999999999875 3688999998654444556778999999999999999999998665 5
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEecc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYP------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDF 155 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DF 155 (636)
...+++++|+.+|+|.+++..... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 778999999999999999976432 35899999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC
Q 006664 156 GVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPG 234 (636)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~ 234 (636)
|+++.+..... ........++..|+|||++.+ ..++.++|||||||++|++++ |+.||....+..........
T Consensus 162 g~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---- 235 (280)
T cd05043 162 ALSRDLFPMDY-HCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG---- 235 (280)
T ss_pred CCcccccCCce-EEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC----
Confidence 99876533221 111223356778999999976 568999999999999999998 99999887765543332222
Q ss_pred CCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 235 ~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
........++.++.+++.+||..||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 122223457889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.75 Aligned_cols=262 Identities=27% Similarity=0.444 Sum_probs=213.2
Q ss_pred CeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeecCCC---chhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeE
Q 006664 12 HYTLYEEVGQGVSASVHRALCI---PFNEIVAVKILDFERD---NSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~~---~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l 84 (636)
+|++.+.||+|+||.||++.+. .++..||||++..... ......+.+|+.++..+ +||||+++++++..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 4678999999874432 22345678899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||+.||+|..++... ..+++..+..++.|++.||.|||..|++||||||.||+++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999998764 56899999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccccCCCCCCChhhhhhcc-CCCcccchhhHHHHHHHHHcCCCCCCCCChH----HHHHHHHhcCCCCCCccc
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLH-GYDFKADIWSFGITALELAHGHAPFSKYPPM----KVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~-~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~----~~l~~~~~~~~~~~~~~~ 239 (636)
.. .......|++.|+|||.+.+.. .++.++||||||+++|+|++|..||...... ......... ....
T Consensus 159 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~ 231 (288)
T cd05583 159 EE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-----KPPF 231 (288)
T ss_pred cc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-----CCCC
Confidence 21 1223457899999999986532 3688999999999999999999999643221 111122211 1223
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCC---HHHHHhCcccccccChHH
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPS---AKKLLKHSFFKQARSNEY 282 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRps---a~elL~Hpffk~~~~~~~ 282 (636)
+..++..+.++|.+||+.||.+||| +.++|+||||+.+.+...
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~ 277 (288)
T cd05583 232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL 277 (288)
T ss_pred CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH
Confidence 3557889999999999999999998 578899999998766544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=331.43 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=211.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCc----EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~----~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+...+|++++.||+|+||.||+|.++.+|+ .||+|.+...........+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 456899999999999999999999887765 5899998766555556778899999999999999999999887 78
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
.++||||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..+..
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred eEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999999999764 24589999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
... ........++..|+|||.+.. ..++.++|||||||++|||++ |..||.+....+.......... ...+..
T Consensus 162 ~~~-~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~ 235 (279)
T cd05057 162 DEK-EYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER----LPQPPI 235 (279)
T ss_pred ccc-ceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC----CCCCCC
Confidence 211 111112234678999999865 578999999999999999998 9999988776554443333221 222345
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++..+.+++.+||..||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 7789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=337.92 Aligned_cols=259 Identities=37% Similarity=0.645 Sum_probs=217.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
.+.|+..+.||.|+||.||+|.++.+++.||+|.+.... .......+.+|+.+++.++||||+++++++..+...|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 456888899999999999999999999999999986532 223455678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+. |++.+++... ...+++..+..++.|++.||.|||++|++||||||.||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 99996 5788777653 25689999999999999999999999999999999999999999999999999864321
Q ss_pred ccccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
.....|++.|+|||.+.+ ...++.++|||||||++|+|++|..||.................+. .....++.
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 241 (308)
T cd06634 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA---LQSGHWSE 241 (308)
T ss_pred ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC---cCcccccH
Confidence 234578999999999853 2357889999999999999999999998776655554444433222 12346788
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
.+++||.+||.++|.+||++.++++|||+......
T Consensus 242 ~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 99999999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=330.78 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=199.6
Q ss_pred eEEcccCceEEEEEEEc--CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCC
Q 006664 17 EEVGQGVSASVHRALCI--PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~--~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GG 94 (636)
+.||+|+||.||+|... .++..+|+|.+...........+.+|+.+++.++||||+++++++.+...+|+||||+.+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36999999999999764 4567899999875544444557889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 95 SCLHILKAAYP---DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 95 sL~~lL~~~~~---~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
+|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~ 159 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED-YYVTP 159 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc-eeecC
Confidence 99999975421 245677888999999999999999999999999999999999999999999986432221 11122
Q ss_pred ccccCCCCCCChhhhhhcc------CCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCc-ccchhh
Q 006664 172 NTFVGTPCWMAPEVMEQLH------GYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY-ERDRKF 243 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~------~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~-~~~~~~ 243 (636)
....|++.|+|||++.+.. .++.++|||||||++|+|++ |..||......+............... ......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 3456888999999986421 35789999999999999996 999998776665544433322221111 112346
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++.+.+++.+|| .+|++|||+++|+.
T Consensus 240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 240 SDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.82 Aligned_cols=258 Identities=20% Similarity=0.326 Sum_probs=213.1
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIP-----FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~-----tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+..++|++++.||+|+||.||+|.++. +.+.||+|.+...........+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 456899999999999999999999764 346899999865444445677899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEecc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYP-------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDF 155 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~-------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DF 155 (636)
..|+||||+.+|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999986531 15899999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC
Q 006664 156 GVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPG 234 (636)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~ 234 (636)
|++....... ........++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+......+.... ...
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~-~~~-- 235 (275)
T cd05046 162 SLSKDVYNSE--YYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-AGK-- 235 (275)
T ss_pred ccccccCccc--ccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH-cCC--
Confidence 9986443221 112234467788999999876 567899999999999999998 899998766655444332 211
Q ss_pred CCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 235 ~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
..+.....++..+.++|.+||..||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 1222345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=337.66 Aligned_cols=256 Identities=38% Similarity=0.665 Sum_probs=216.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
+.|...+.||+|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++.++...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 558899999999999999999999999999999875432 234557889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||+.| +|.+++... ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 105 EYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred eCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 99975 788877654 35689999999999999999999999999999999999999999999999998764321
Q ss_pred cccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
.....|++.|+|||++.. ...++.++|||||||++|+|++|..||...........+.....+.. ....++..
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 252 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL---QSNEWSDY 252 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC---CCccccHH
Confidence 234578999999999842 24578899999999999999999999988776665555554433221 23457788
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+++||.+||..+|.+||++.++++|+|+....
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 99999999999999999999999999997544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=328.81 Aligned_cols=265 Identities=24% Similarity=0.346 Sum_probs=213.1
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD-- 81 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-- 81 (636)
...-|+.++|.+.+.||.|+|+-||++++..+++.||+|.+.... ..+.+.+++|+...++++||||++++++...+
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 345688999999999999999999999999999999999997654 45778899999999999999999988776543
Q ss_pred ---CeEEEEEeccCCCCHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCcccEEEccCCcEEEec
Q 006664 82 ---HNLWVVMPFMSGGSCLHILKAAYP--DGFEEVVIATILREVLKGLDYLHHHG--HIHRDVKSGNILIDVRGAIKLGD 154 (636)
Q Consensus 82 ---~~l~iVmEy~~GGsL~~lL~~~~~--~~lse~~i~~i~~QIl~aL~yLH~~g--IvHRDLKP~NILld~~g~vKL~D 154 (636)
+..|++++|...|+|.+.+....- ..++|.++..||.+|++||++||... ++||||||.|||+...+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 459999999999999998876432 35899999999999999999999998 99999999999999999999999
Q ss_pred cCcccccccCCCcccc------cccccCCCCCCChhhhhhc--cCCCcccchhhHHHHHHHHHcCCCCCCCCCh-HHHHH
Q 006664 155 FGVSACLFDSGDRQRM------RNTFVGTPCWMAPEVMEQL--HGYDFKADIWSFGITALELAHGHAPFSKYPP-MKVLL 225 (636)
Q Consensus 155 FGla~~~~~~~~~~~~------~~~~~GT~~YmAPEvl~~~--~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~-~~~l~ 225 (636)
||.++..--.-..... -..-..|..|+|||.+.-. ...+.++|||||||+||.|++|..||...-. ...+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 9998754211111000 0122468899999998532 2367899999999999999999999964211 00010
Q ss_pred HHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 226 MTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
-.+. ...+.++....+|..+.+||+.||+.||.+||++.+++.+
T Consensus 253 LAv~--n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQ--NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred Eeee--ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1111 1234455666799999999999999999999999999863
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=325.33 Aligned_cols=245 Identities=30% Similarity=0.514 Sum_probs=211.1
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCH
Q 006664 19 VGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96 (636)
Q Consensus 19 IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL 96 (636)
||.|+||.||++.+..+++.||+|++..... ......+.+|+.+++.++||||+++++.+..+...|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999998999999999875532 23466789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccC
Q 006664 97 LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176 (636)
Q Consensus 97 ~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~G 176 (636)
.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .......|
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNTFCG 155 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC---CcccCCcC
Confidence 9999875 468999999999999999999999999999999999999999999999999987543221 12345678
Q ss_pred CCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcc
Q 006664 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLV 256 (636)
Q Consensus 177 T~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~ 256 (636)
+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+... ....+...+..+.++|.+||.
T Consensus 156 ~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~i~~~l~ 229 (250)
T cd05123 156 TPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-----PLRFPEFLSPEARDLISGLLQ 229 (250)
T ss_pred CccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-----CCCCCCCCCHHHHHHHHHHhc
Confidence 999999999876 55788999999999999999999999877664444444331 223345568999999999999
Q ss_pred cCCCCCCCH---HHHHhCccc
Q 006664 257 KDPSKRPSA---KKLLKHSFF 274 (636)
Q Consensus 257 ~DP~kRpsa---~elL~Hpff 274 (636)
.||.+||++ +++++||||
T Consensus 230 ~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 230 KDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCHhhCCCcccHHHHHhCCCC
Confidence 999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=332.10 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=202.2
Q ss_pred CCCCeEEEeEEcccCceEEEEEE----EcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe--CC
Q 006664 9 GAEHYTLYEEVGQGVSASVHRAL----CIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS--DH 82 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~----~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~--~~ 82 (636)
..++|++++.||+|+||.||+|. +..++..||+|.+... .......+.+|+++++.++||||+++++++.. ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 45689999999999999999997 4467899999998643 23345678899999999999999999988654 35
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+||||+.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 789999999999999999764 2458999999999999999999999999999999999999999999999999988653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHH---------------HHHHH
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK---------------VLLMT 227 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~---------------~l~~~ 227 (636)
.............++..|+|||++.+ ..++.++|||||||++|||++|..|+....... .+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 32221111122234556999999976 568999999999999999999887764322110 00111
Q ss_pred HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 228 ~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+.. ....+....++.++.+||.+||..+|++|||+.++++
T Consensus 239 ~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 LKN---NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred Hhc---CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111 1122234567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=340.59 Aligned_cols=259 Identities=26% Similarity=0.372 Sum_probs=210.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEe-CCeEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVS-DHNLWV 86 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~-~~~l~i 86 (636)
..++|++++.||.|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||++++++|.. ....|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 45789999999999999999999999999999999865332 2345668899999999999999999999876 567999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||+|.||+++.++.++|+|||++.....
T Consensus 88 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--- 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--- 160 (328)
T ss_pred Eeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---
Confidence 99999 5688888864 4688999999999999999999999999999999999999999999999999864311
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHh-----------------
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ----------------- 229 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~----------------- 229 (636)
......+++.|+|||.+.+...++.++|||||||++|+|++|..||...........+..
T Consensus 161 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 161 ---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred ---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 113457899999999986656789999999999999999999999987654322211111
Q ss_pred ------cCCCCCCc---ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 230 ------NAPPGLDY---ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 230 ------~~~~~~~~---~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
........ .....++..+.++|.+||+.+|.+||++.+++.||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00000000 0113467899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=324.74 Aligned_cols=248 Identities=24% Similarity=0.382 Sum_probs=198.5
Q ss_pred eEEcccCceEEEEEEEcC---CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE-eCCeEEEEEeccC
Q 006664 17 EEVGQGVSASVHRALCIP---FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV-SDHNLWVVMPFMS 92 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~---tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~-~~~~l~iVmEy~~ 92 (636)
+.||+|+||.||+|.+.. .+..||||.+...........+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 346799999864444445677889999999999999999999765 4567899999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc-ccc
Q 006664 93 GGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ-RMR 171 (636)
Q Consensus 93 GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~-~~~ 171 (636)
+|+|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++..+....... ...
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 999999997642 446777888999999999999999999999999999999999999999999987553321111 111
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
....+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||......+.......... ...+..++..+.++
T Consensus 160 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l 234 (262)
T cd05058 160 TGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR----LLQPEYCPDPLYEV 234 (262)
T ss_pred ccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----CCCCCcCCHHHHHH
Confidence 23356778999999876 578999999999999999999 6778877666554444433222 12234568899999
Q ss_pred HHhhcccCCCCCCCHHHHHh
Q 006664 251 IASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~ 270 (636)
+.+||..+|++||++.++++
T Consensus 235 i~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=337.02 Aligned_cols=269 Identities=30% Similarity=0.517 Sum_probs=227.2
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHH-HhCCCCCcceeeeEEEeCC
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM-ILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL-~~L~HPNIVkl~~~~~~~~ 82 (636)
.-|++..++.+-+..||.|+||+|++..++++|+..|||.|.......+..++..|.... +.-++||||++|+..-.++
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 457788888888999999999999999999999999999998777667778888888875 4557999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCcc
Q 006664 83 NLWVVMPFMSGGSCLHILKA---AYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGVS 158 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGla 158 (636)
..||.||+|+- +|..+-+. .....++|..+..|.-..+.||.||-.. .|||||+||+|||+|..|.|||||||++
T Consensus 137 dcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 137 DCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred ceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 99999999964 55443332 2235699999999999999999999875 8999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhhc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCh-HHHHHHHHhcCCCCCC
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPFSKYPP-MKVLLMTLQNAPPGLD 236 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~-~~~l~~~~~~~~~~~~ 236 (636)
..+.++-. .+.-.|...|||||.+... .+|+.++|+|||||+|||+++|..||.+... .+++.++....++.+.
T Consensus 216 GqLv~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 216 GQLVDSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL 291 (361)
T ss_pred HhHHHHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence 87754422 2345799999999999753 3599999999999999999999999987654 5555566666666655
Q ss_pred cccc-hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 237 YERD-RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 237 ~~~~-~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.... ..++..++.||..||.+|-..||...+|+++||++..
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 4443 5689999999999999999999999999999999743
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.14 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=202.0
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCH
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL 96 (636)
+.||+|+||.||+|.. .++..||+|++...........+.+|+.+++.++||||+++++++......|+||||+.||+|
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 4699999999999985 478899999987554444455688999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccC
Q 006664 97 LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176 (636)
Q Consensus 97 ~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~G 176 (636)
.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........+
T Consensus 80 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI--YSSSGLKQI 156 (250)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc--cccCCCCCC
Confidence 99987642 468899999999999999999999999999999999999999999999999986432111 111112344
Q ss_pred CCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhc
Q 006664 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCL 255 (636)
Q Consensus 177 T~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL 255 (636)
++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.... ....+..++..+.+++.+||
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l 231 (250)
T cd05085 157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY----RMSCPQKCPDDVYKVMQRCW 231 (250)
T ss_pred cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----CCCCCCCCCHHHHHHHHHHc
Confidence 677999999976 568899999999999999998 999998776554443333221 11223457899999999999
Q ss_pred ccCCCCCCCHHHHHh
Q 006664 256 VKDPSKRPSAKKLLK 270 (636)
Q Consensus 256 ~~DP~kRpsa~elL~ 270 (636)
..+|++||++.++++
T Consensus 232 ~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 232 DYKPENRPKFSELQK 246 (250)
T ss_pred ccCcccCCCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=328.19 Aligned_cols=245 Identities=21% Similarity=0.347 Sum_probs=200.2
Q ss_pred eEEcccCceEEEEEEEcCCCc--EEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 17 EEVGQGVSASVHRALCIPFNE--IVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~--~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
+.||+|+||.||+|.+..++. .+|+|.+...........+.+|+.+++++ +||||+++++++.....+|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999988776 46888886444444566788999999999 899999999999999999999999999
Q ss_pred CCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 94 GSCLHILKAAY--------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 94 GsL~~lL~~~~--------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
|+|.+++.... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999997642 1247899999999999999999999999999999999999999999999999975
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYE 238 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~ 238 (636)
..... .......++..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+........ ....
T Consensus 161 ~~~~~----~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~----~~~~ 231 (270)
T cd05047 161 GQEVY----VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----YRLE 231 (270)
T ss_pred ccchh----hhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC----CCCC
Confidence 32110 01112234567999999865 678999999999999999996 99999876655544433322 1222
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+..++.++.+|+.+||..||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 33457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.40 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=208.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
+...+|++.+.||.|+||.||+|.+. .+..+|+|.+..... ....+.+|+++++.++||||+++++++......|+|
T Consensus 1 ~~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 1 IHPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred CChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 35679999999999999999999875 477899998864322 345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+.||+|.+++... .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 155 (256)
T cd05112 78 FEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY- 155 (256)
T ss_pred EEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence 9999999999998764 24688999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
.......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||................ ....+...+..
T Consensus 156 -~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 229 (256)
T cd05112 156 -TSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF----RLYKPRLASQS 229 (256)
T ss_pred -cccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC----CCCCCCCCCHH
Confidence 11122345678999999976 568899999999999999998 999998766655444333221 11223446889
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
+.+|+.+||..+|++||++.+++++
T Consensus 230 ~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 230 VYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHh
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.65 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=206.6
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|-+..++|++.+.||+|+||.||++. .+++.||+|.+.... ....+.+|+.+++.++||||+++++++..+ ..|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY 74 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence 45667899999999999999999986 478899999985432 345688999999999999999999998765 479
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||+.||+|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 9999999999999998765456899999999999999999999999999999999999999999999999998643211
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+.... .......++
T Consensus 154 -----~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~ 223 (254)
T cd05083 154 -----VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY----RMEPPEGCP 223 (254)
T ss_pred -----CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC----CCCCCCcCC
Confidence 112344677999999875 568899999999999999997 999998776655443333221 112235678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+.++|.+||..+|++||++.+++.
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=327.16 Aligned_cols=248 Identities=26% Similarity=0.455 Sum_probs=203.5
Q ss_pred eEEcccCceEEEEEEEcCCC------cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 17 EEVGQGVSASVHRALCIPFN------EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg------~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+.||+|+||.||+|.+...+ ..||||.+...........+.+|+.+++.++||||+++++++..+...|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999876544 789999986544344566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-----cEEEeccCcccc
Q 006664 91 MSGGSCLHILKAAY-----PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-----AIKLGDFGVSAC 160 (636)
Q Consensus 91 ~~GGsL~~lL~~~~-----~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-----~vKL~DFGla~~ 160 (636)
+.||+|.+++.... ...+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 99999999997642 23478899999999999999999999999999999999999877 899999999875
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
...... ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+.... ....
T Consensus 161 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----~~~~ 234 (269)
T cd05044 161 IYKSDY-YRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG----RLQK 234 (269)
T ss_pred cccccc-cccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC----ccCC
Confidence 533221 112234456789999999976 568999999999999999998 999998776655443332221 2233
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+..++..+.+||.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4567889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=353.89 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=222.0
Q ss_pred CCcccccCCCCeEEEeEEcccCceEEEEEEEcCCCc---E-EEEEEeecC--CCchhHHHHHHHHHHHHhCCCCCcceee
Q 006664 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNE---I-VAVKILDFE--RDNSDLSNISREAQTMILVDHPNVLKSH 75 (636)
Q Consensus 2 ~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~---~-vAIK~i~~~--~~~~~~~~i~rEi~iL~~L~HPNIVkl~ 75 (636)
.+..|++..++-.+.+.||+|+||.||+|..+..+. . ||||....+ ........+.+|+++|+.++|||||++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 577899999999999999999999999998775432 3 899998752 2345677899999999999999999999
Q ss_pred eEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEecc
Q 006664 76 CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDF 155 (636)
Q Consensus 76 ~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DF 155 (636)
|+......+|+|||+|.||+|.++|++.. ..++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+||
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999999999863 36999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCcccccccc-cCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCC
Q 006664 156 GVSACLFDSGDRQRMRNTF-VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPP 233 (636)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~-~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~ 233 (636)
|+++... ........ --...|+|||.+.. ..|++++|||||||++||+++ |..||.+....+....+..+..
T Consensus 307 GLs~~~~----~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~- 380 (474)
T KOG0194|consen 307 GLSRAGS----QYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGY- 380 (474)
T ss_pred ccccCCc----ceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCc-
Confidence 9987431 11111111 24578999999987 489999999999999999998 8999999998887777755432
Q ss_pred CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 234 ~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+...+...++++..++.+||..||+.||++.++.+
T Consensus 381 --r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 381 --RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 23344577889999999999999999999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=377.47 Aligned_cols=261 Identities=28% Similarity=0.424 Sum_probs=208.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe----------
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS---------- 80 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~---------- 80 (636)
.+|+.++.||+|+||.||+++++-+|..||||.|...........+.+|+..+.+|+|||||+||..|..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 5788889999999999999999999999999999877655667889999999999999999999866510
Q ss_pred --------------------------------------------------------------------C-----------
Q 006664 81 --------------------------------------------------------------------D----------- 81 (636)
Q Consensus 81 --------------------------------------------------------------------~----------- 81 (636)
+
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0
Q ss_pred ------------------------------CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 006664 82 ------------------------------HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131 (636)
Q Consensus 82 ------------------------------~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g 131 (636)
..+||-||||+...|.+++..++... ....+|++|++|++||.|+|++|
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhCc
Confidence 13688999999988888888753211 47789999999999999999999
Q ss_pred CcccccCcccEEEccCCcEEEeccCcccccc------c---------CCCcccccccccCCCCCCChhhhhhcc--CCCc
Q 006664 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACLF------D---------SGDRQRMRNTFVGTPCWMAPEVMEQLH--GYDF 194 (636)
Q Consensus 132 IvHRDLKP~NILld~~g~vKL~DFGla~~~~------~---------~~~~~~~~~~~~GT~~YmAPEvl~~~~--~ys~ 194 (636)
||||||||.|||+|.++.|||+|||+|+... + .+......+..+||-.|+|||++.+.. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998622 0 011111345679999999999998755 5999
Q ss_pred ccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 195 KADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 195 ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
|+||||||||++||+. ||...-........++......+...+..--+.-+.+|.+||+.||.+||||.|+|++.||
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ll 874 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELL 874 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCC
Confidence 9999999999999985 6765444444445554332222211111222455789999999999999999999999999
Q ss_pred c
Q 006664 275 K 275 (636)
Q Consensus 275 k 275 (636)
-
T Consensus 875 p 875 (1351)
T KOG1035|consen 875 P 875 (1351)
T ss_pred C
Confidence 7
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=329.00 Aligned_cols=240 Identities=22% Similarity=0.346 Sum_probs=195.8
Q ss_pred eEEcccCceEEEEEEEcCCCcE-------EEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 17 EEVGQGVSASVHRALCIPFNEI-------VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~-------vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
+.||.|+||.||+|.+..++.. ||+|.++... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 4699999999999998765544 8888875332 2344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc--------EEEeccCccccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA--------IKLGDFGVSACL 161 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~--------vKL~DFGla~~~ 161 (636)
|+.+|+|..++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++...
T Consensus 80 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 80 YVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred cCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999999999997652 36899999999999999999999999999999999999987654 699999987643
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcC-CCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG-~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
.. .....|++.|+|||++.+...++.++|||||||++|+|++| .+||.......... .... .. ..+
T Consensus 159 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~-~~----~~~ 225 (258)
T cd05078 159 LP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED-RH----QLP 225 (258)
T ss_pred CC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc-cc----cCC
Confidence 21 23457899999999998656689999999999999999998 57776655544322 2211 11 122
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
...+.++.+||.+||+.||.+|||+++|++.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 3456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=357.95 Aligned_cols=245 Identities=30% Similarity=0.472 Sum_probs=210.3
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iV 87 (636)
..+.|++...+|.|+|+.|..+.+..+++..++|++..... ...+|+.++... +||||+++++.+.++.+.|+|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 36889999999999999999999999999999999975522 234677666544 799999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE-ccCCcEEEeccCcccccccCCC
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI-DVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl-d~~g~vKL~DFGla~~~~~~~~ 166 (636)
||++.||.|.+.+... ..+. ..+..|+++|+.|+.|||.+|||||||||+|||+ +..|+++|+|||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred ehhccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999988765 2333 7788899999999999999999999999999999 58899999999998754222
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
..+.+-|..|.|||++.. .+|+++|||||||++||+||+|+.||...+....+...+..... ...+|..
T Consensus 470 ----~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~------s~~vS~~ 538 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF------SECVSDE 538 (612)
T ss_pred ----hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc------ccccCHH
Confidence 335577899999999985 88999999999999999999999999877766444444433221 2678999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+++||.+||+.||.+|+++.+++.||||
T Consensus 539 AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 539 AKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHHhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999999999
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.64 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=207.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEc----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe--CC
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCI----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS--DH 82 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~--~~ 82 (636)
..++|++.+.||+|+||.||+|... .++..||||++...........+.+|+.+++.+.||||+++++++.. +.
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 3578999999999999999999864 45889999999755443346778999999999999999999999887 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
..|+||||+.+++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 8999999999999999997652 358999999999999999999999999999999999999999999999999987654
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHH--------------HHHHHH
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK--------------VLLMTL 228 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~--------------~l~~~~ 228 (636)
.............++..|+|||.+.+ ..++.++|||||||++|+|++|..||....... .....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 22221111223345667999999876 568899999999999999999999986532211 111222
Q ss_pred hcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 229 ~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.. ......+..++.++.+|+.+||..+|.+||++.+++.
T Consensus 240 ~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KE---GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred Hc---CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 21 1122333456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=331.48 Aligned_cols=255 Identities=22% Similarity=0.384 Sum_probs=207.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCc----EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~----~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+..++|+..+.||+|+||.||+|.+..+|. .||+|.+...........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 456889999999999999999999988776 46889886554444445688999999999999999999988754 5
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
.++++||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+..
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 67999999999999998764 34689999999999999999999999999999999999999999999999999875532
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.. .........++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....... ..+.... ..+.+..
T Consensus 162 ~~-~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~---~~~~~~~ 235 (303)
T cd05110 162 DE-KEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGE---RLPQPPI 235 (303)
T ss_pred cc-cccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCC---CCCCCCC
Confidence 21 1111223456788999999876 668999999999999999997 99999876654433 2333221 1222345
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++..+.+++.+||..||++||++.++++
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=319.08 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=203.4
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCH
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC 96 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL 96 (636)
+.||+|+||.||+|.+.. ++.||+|.+...........+.+|+++++.++||||+++++++......|+||||+.|++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999877 9999999987654444566789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccC
Q 006664 97 LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176 (636)
Q Consensus 97 ~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~G 176 (636)
.+++... ...+++..+..++.+++.||.|||++|++||||||+|||++.++.+||+|||++....... .........+
T Consensus 80 ~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI-YTVSDGLKQI 157 (251)
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc-ceeccccCcc
Confidence 9999764 2468899999999999999999999999999999999999999999999999986542111 1111112234
Q ss_pred CCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhc
Q 006664 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCL 255 (636)
Q Consensus 177 T~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL 255 (636)
+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.... ....+..++..+.++|.+||
T Consensus 158 ~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l 232 (251)
T cd05041 158 PIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY----RMPAPQLCPEEIYRLMLQCW 232 (251)
T ss_pred eeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC----CCCCCccCCHHHHHHHHHHh
Confidence 567999999876 568999999999999999998 899998776544433332221 12233567889999999999
Q ss_pred ccCCCCCCCHHHHHh
Q 006664 256 VKDPSKRPSAKKLLK 270 (636)
Q Consensus 256 ~~DP~kRpsa~elL~ 270 (636)
..+|.+||++.+++.
T Consensus 233 ~~~p~~Rp~~~ell~ 247 (251)
T cd05041 233 AYDPENRPSFSEIYN 247 (251)
T ss_pred ccChhhCcCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.02 Aligned_cols=252 Identities=18% Similarity=0.341 Sum_probs=199.4
Q ss_pred eEEcccCceEEEEEEEcCC--CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCC
Q 006664 17 EEVGQGVSASVHRALCIPF--NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~t--g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GG 94 (636)
++||+|+||.||+|..... ...+++|.+...........+.+|+.+++.++||||+++++.+......|+||||+.+|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 34567777765544445678899999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccc
Q 006664 95 SCLHILKAAYP--DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172 (636)
Q Consensus 95 sL~~lL~~~~~--~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 172 (636)
+|.+++..... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 159 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETED 159 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch-hhhccc
Confidence 99999976421 346777888999999999999999999999999999999999999999999975432211 111223
Q ss_pred cccCCCCCCChhhhhhc------cCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC-CCcccchhhh
Q 006664 173 TFVGTPCWMAPEVMEQL------HGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPG-LDYERDRKFS 244 (636)
Q Consensus 173 ~~~GT~~YmAPEvl~~~------~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~-~~~~~~~~~S 244 (636)
..+|++.|+|||++... ..++.++|||||||++|||++ |..||......+.....+...... .+......++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS 239 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence 46789999999998531 235788999999999999996 678998777766665555443322 1222234578
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+.+.+++..|| .+|++||++.++++
T Consensus 240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 240 ERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 89999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.33 Aligned_cols=240 Identities=23% Similarity=0.334 Sum_probs=193.4
Q ss_pred eEEcccCceEEEEEEEcC------------CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 17 EEVGQGVSASVHRALCIP------------FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~------------tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
+.||+|+||.||+|.... ....||+|+++... ......+.+|+.+++.++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999997532 23368999876432 23345678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc-------EEEeccCc
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA-------IKLGDFGV 157 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~-------vKL~DFGl 157 (636)
++||||+++|+|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||+
T Consensus 80 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999999998888654 246899999999999999999999999999999999999986664 89999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHH-cCCCCCCCCChHHHHHHHHhcCCCCCC
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLD 236 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLl-tG~~PF~~~~~~~~l~~~~~~~~~~~~ 236 (636)
+..... .....|+..|+|||.+.....++.++|||||||++|+|+ .|..||......+... .....
T Consensus 159 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~----- 225 (262)
T cd05077 159 PITVLS-------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQ----- 225 (262)
T ss_pred CccccC-------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcC-----
Confidence 864421 124568899999999875567899999999999999998 5899987655433221 11111
Q ss_pred cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 237 ~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.......+.++.+||.+||..||.+||++.+|+.+
T Consensus 226 ~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 11122346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=369.92 Aligned_cols=257 Identities=26% Similarity=0.466 Sum_probs=224.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCc-----EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~-----~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+..+.-++.+.||+|+||.||.|....... .||||.+...........+.+|..+|+.++|||||+++++..+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 557888999999999999999998764332 399999987777888899999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAY-----PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~-----~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
..+|++|||+||||..+|++.. +..++......++.+|++|++||+++++|||||...|+||+....|||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999999998762 24588889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCC
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLD 236 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~ 236 (636)
|+.+++.... +......-...|||||.+.. ..++.|+|||||||++||+++ |..||.+....+++....... +
T Consensus 849 ArDiy~~~yy-r~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg----R 922 (1025)
T KOG1095|consen 849 ARDIYDKDYY-RKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG----R 922 (1025)
T ss_pred hHhhhhchhe-eccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC----c
Confidence 9966544322 22222233467999999986 679999999999999999999 999999999988887777665 4
Q ss_pred cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 237 ~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+.+..++..+.++|..||..+|++||++..|++
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 5567889999999999999999999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=322.77 Aligned_cols=229 Identities=25% Similarity=0.304 Sum_probs=192.2
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCHHHHHH
Q 006664 22 GVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILK 101 (636)
Q Consensus 22 G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~ 101 (636)
|.||.||+|.+..+++.||+|.+.... ...+|...+....||||+++++++......|+||||+.||+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999999999999999996542 22345555566779999999999999999999999999999999997
Q ss_pred HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCC
Q 006664 102 AAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181 (636)
Q Consensus 102 ~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~Ym 181 (636)
.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+..+... .....++..|+
T Consensus 78 ~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~y~ 149 (237)
T cd05576 78 KF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVENMYC 149 (237)
T ss_pred Hh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcCcccc
Confidence 75 46899999999999999999999999999999999999999999999999987654221 12345678899
Q ss_pred ChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCC
Q 006664 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSK 261 (636)
Q Consensus 182 APEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~k 261 (636)
|||.+.+ ..++.++||||+||++|+|++|..||...+... . .......+..++..+++||.+||++||.+
T Consensus 150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 219 (237)
T cd05576 150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI------N---THTTLNIPEWVSEEARSLLQQLLQFNPTE 219 (237)
T ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------c---cccccCCcccCCHHHHHHHHHHccCCHHH
Confidence 9999865 568899999999999999999999986543211 0 00111233567899999999999999999
Q ss_pred CCCH-----HHHHhCccc
Q 006664 262 RPSA-----KKLLKHSFF 274 (636)
Q Consensus 262 Rpsa-----~elL~Hpff 274 (636)
||++ +++++||||
T Consensus 220 R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 220 RLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred hcCCCccchHHHHcCCCC
Confidence 9985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=320.17 Aligned_cols=237 Identities=24% Similarity=0.343 Sum_probs=193.8
Q ss_pred eEEcccCceEEEEEEEcCCC----------cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 17 EEVGQGVSASVHRALCIPFN----------EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg----------~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.+++.++||||+++++++.. ...|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46999999999999998777 35888877543322 5678899999999999999999999888 77899
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-------cEEEeccCccc
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-------AIKLGDFGVSA 159 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-------~vKL~DFGla~ 159 (636)
||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 78 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 78 VEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 999999999999998752 3689999999999999999999999999999999999999877 79999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhc-cCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
.... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||............... ..
T Consensus 157 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~--~~--- 224 (259)
T cd05037 157 TVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ--HR--- 224 (259)
T ss_pred cccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC--CC---
Confidence 6432 2244678889999999763 368999999999999999999 68888766433322222111 11
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+......+.++|.+||..+|.+||++.++++
T Consensus 225 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 225 -LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11122378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=327.38 Aligned_cols=258 Identities=18% Similarity=0.260 Sum_probs=195.4
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeecCCCchhHH----------HHHHHHHHHHhCCCCCcce
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPF---NEIVAVKILDFERDNSDLS----------NISREAQTMILVDHPNVLK 73 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t---g~~vAIK~i~~~~~~~~~~----------~i~rEi~iL~~L~HPNIVk 73 (636)
.+..++|++.+.||+|+||+||+|.+..+ +..+|+|+..........+ ....+...+..++|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 46678999999999999999999998877 7788888765443221111 1123334456678999999
Q ss_pred eeeEEEeCC----eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc
Q 006664 74 SHCSFVSDH----NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA 149 (636)
Q Consensus 74 l~~~~~~~~----~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~ 149 (636)
++++..... ..+++|+++.. ++.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 998766543 45788888754 677777654 44788899999999999999999999999999999999999999
Q ss_pred EEEeccCcccccccCCCc----ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHH
Q 006664 150 IKLGDFGVSACLFDSGDR----QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL 225 (636)
Q Consensus 150 vKL~DFGla~~~~~~~~~----~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~ 225 (636)
++|+|||+|+.+...+.. ........||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999866432211 112234579999999999876 678999999999999999999999998763322211
Q ss_pred H-----HHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 226 M-----TLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 226 ~-----~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
. .+...... . ......++.+.+++..||..+|.+||++.+|++
T Consensus 244 ~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEG-K-IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhh-h-hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 11111111 0 112345789999999999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=361.05 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=224.2
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIP-----FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~-----tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
..++...+..+.++||+|+||+||+|.... ....||||.++.........+++||+.+|..|+|||||+++|++.
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 456777888999999999999999997653 346799999986666667788999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYP------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR 147 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~ 147 (636)
.++-+|+|+|||..|||.++|....+ ..++..+...|+.||+.|+.||-++.+|||||...|+||..+
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 99999999999999999999987532 227888999999999999999999999999999999999999
Q ss_pred CcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 006664 148 GAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLM 226 (636)
Q Consensus 148 g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~ 226 (636)
..|||+|||+++..+..+.. +......-..+|||||.+.. ..|+.++|||||||+|||+++ |..||.+....+++..
T Consensus 640 l~VKIsDfGLsRdiYssDYY-k~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYY-KVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred eEEEecccccchhhhhhhhh-cccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 99999999999977655432 22322234678999999987 679999999999999999998 9999999988887766
Q ss_pred HHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 006664 227 TLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLL 269 (636)
Q Consensus 227 ~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL 269 (636)
+-.... ++.+..++.++.+|+..||+..|.+||++.||=
T Consensus 718 i~~g~l----L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 718 IRAGQL----LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHcCCc----ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 554322 567788999999999999999999999999883
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=324.21 Aligned_cols=239 Identities=25% Similarity=0.340 Sum_probs=191.6
Q ss_pred EEcccCceEEEEEEEcCC------------------------CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcce
Q 006664 18 EVGQGVSASVHRALCIPF------------------------NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLK 73 (636)
Q Consensus 18 ~IG~G~fG~Vyka~~~~t------------------------g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVk 73 (636)
.||+|+||.||+|....+ ...||+|+++... ......+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 599999999999975322 2358899886432 223456778999999999999999
Q ss_pred eeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-----
Q 006664 74 SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG----- 148 (636)
Q Consensus 74 l~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g----- 148 (636)
+++++..+...|+||||+++|+|..++... ...+++..+..++.||+.||.|||++||+||||||.|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999888653 35689999999999999999999999999999999999997543
Q ss_pred --cEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHH-cCCCCCCCCChHHHHH
Q 006664 149 --AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLL 225 (636)
Q Consensus 149 --~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLl-tG~~PF~~~~~~~~l~ 225 (636)
.+|++|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||....+.....
T Consensus 160 ~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred cceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 4899999987543211 23467889999999876566899999999999999995 6999998765543322
Q ss_pred HHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 226 MTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
...... ..+...+..+.++|.+||..+|.+||++.+++++
T Consensus 233 -~~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKH-----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhcc-----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 222111 1112345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=356.57 Aligned_cols=264 Identities=37% Similarity=0.651 Sum_probs=237.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
...++|+++..+|.|+||.||+|+++.+++..|+|+++++.. .+...++.|+-+++.++|||||.+++.|.....+||+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 457899999999999999999999999999999999988754 3577889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
||||.||+|.++-.-. +.++|.++.+++++.+.||+|||++|-+|||||-.|||++..|.+|++|||++..+.. .
T Consensus 91 MEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita---t 165 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA---T 165 (829)
T ss_pred EEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh---h
Confidence 9999999999876543 7899999999999999999999999999999999999999999999999999876532 2
Q ss_pred ccccccccCCCCCCChhhhh--hccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 168 QRMRNTFVGTPCWMAPEVME--QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~--~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
-..+..|.|||+|||||+.. ...+|+..+|||++|++..|+..-++|..+..++..+...-+............++++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 33456899999999999853 3457999999999999999999999999888888888777766665556666778999
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.|.+|++.+|.++|++||+++.+|.|||..+.
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 99999999999999999999999999999754
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.33 Aligned_cols=251 Identities=22% Similarity=0.414 Sum_probs=207.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcC-CCcEEEEEEeecCC---------CchhHHHHHHHHHHHHh-CCCCCcceeeeEEEe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIP-FNEIVAVKILDFER---------DNSDLSNISREAQTMIL-VDHPNVLKSHCSFVS 80 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~-tg~~vAIK~i~~~~---------~~~~~~~i~rEi~iL~~-L~HPNIVkl~~~~~~ 80 (636)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .......+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 78999999986432 12234567788888864 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCCcEEEeccCc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
++..|+||||+.|++|.+++... ....+++..++.++.|++.||.|||. .|++||||+|.||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999988542 23468999999999999999999996 7899999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
+....... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...................
T Consensus 161 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 232 (269)
T cd08528 161 AKQKQPES----KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--- 232 (269)
T ss_pred eeeccccc----ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc---
Confidence 87543221 2335678999999999976 568999999999999999999999998766554444433322211
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.....++..+.++|.+||..||++||++.++..
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 112357899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=323.80 Aligned_cols=271 Identities=24% Similarity=0.313 Sum_probs=218.6
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhCCCCCcceeeeEEEe-----
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILVDHPNVLKSHCSFVS----- 80 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~HPNIVkl~~~~~~----- 80 (636)
-+....|+.+.+||+|.||.||+|.++.+|+.||+|++-.+.... .-....+|+++|..|.|+|++.+++.+..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 345678888999999999999999999999999999886544222 22346789999999999999998877643
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCc
Q 006664 81 ---DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 81 ---~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
...+|+||++|+. ||..+|... ...|+..++..++++++.||.|+|++.|+|||+||+|+||+.+|.+||+|||+
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 3459999999986 899988764 35799999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccc-cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhc------
Q 006664 158 SACLFDSGDRQRM-RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN------ 230 (636)
Q Consensus 158 a~~~~~~~~~~~~-~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~------ 230 (636)
++.+......... .+..+-|.+|++||.+.|...|+++.|||..|||+.||.+|.+.|.+.....++..+..-
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9766443322211 234577999999999999999999999999999999999999999988777766544321
Q ss_pred -CCCCCC-cccc-------------h---------hhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 231 -APPGLD-YERD-------------R---------KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 231 -~~~~~~-~~~~-------------~---------~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
.+|..+ ++.. + .-.+++.+|+.++|..||++|+++++++.|.||+.-..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 111111 0000 0 11347789999999999999999999999999986543
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.68 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=202.9
Q ss_pred eEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC------
Q 006664 13 YTLYEEVGQGVSASVHRALCI---PFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH------ 82 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~------ 82 (636)
|.+.+.||+|+||.||+|.+. .++..||||++..... ....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999865 3578999999965432 334667889999999999999999999886542
Q ss_pred eEEEEEeccCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAY----PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~----~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla 158 (636)
..+++++|+.+|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 2478999999999998875432 124788999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
..+.... .........+++.|++||.+.. ..++.++|||||||++|+|++ |.+||.+....+....+......
T Consensus 161 ~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---- 234 (273)
T cd05074 161 KKIYSGD-YYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL---- 234 (273)
T ss_pred ccccCCc-ceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC----
Confidence 7553221 1111223456778999999876 678899999999999999998 99999877665544434332211
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.....++..+.+++.+||..+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.30 Aligned_cols=249 Identities=29% Similarity=0.463 Sum_probs=200.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC------eE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH------NL 84 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~------~l 84 (636)
.-|...+.||+|+||.||+++++.+|+.||||.++........++..+|+++|++++|||||+++++-.+.. .-
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 346677899999999999999999999999999987766667889999999999999999999998866544 46
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc--cCC--cEEEeccCccc
Q 006664 85 WVVMPFMSGGSCLHILKAA-YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID--VRG--AIKLGDFGVSA 159 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld--~~g--~vKL~DFGla~ 159 (636)
.+|||||.||||+.+|..- ...+++|..+..++..+..||.|||++|||||||||+||++- .+| .-||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 8999999999999999752 225799999999999999999999999999999999999984 223 57999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH----HHHHHHHhcCCCCC
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM----KVLLMTLQNAPPGL 235 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~----~~l~~~~~~~~~~~ 235 (636)
.+.+.. ...+++||+.|.+||++.....|+..+|.|||||++|+++||..||-..... +....++...+.+.
T Consensus 173 el~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 173 ELDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cCCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 764432 5678999999999999985578999999999999999999999999543222 22223332222111
Q ss_pred ----------------Ccccchhhh----HHHHHHHHhhcccCCCCCC
Q 006664 236 ----------------DYERDRKFS----KSFKQMIASCLVKDPSKRP 263 (636)
Q Consensus 236 ----------------~~~~~~~~S----~~l~dLI~~cL~~DP~kRp 263 (636)
.++.+...+ ..+...+..+|..+|.+|.
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 112222333 3455788999999999997
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=331.66 Aligned_cols=267 Identities=24% Similarity=0.353 Sum_probs=222.8
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch------hHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS------DLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~------~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
+.-.++|-++..||+|+|+.||+|.+....++||+|+-.+.+... -.+...||..|.+.|+||-||++|++|.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 344578999999999999999999999999999999987665432 34567899999999999999999999975
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccccCcccEEEc---cCCcEEEec
Q 006664 81 -DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH--GHIHRDVKSGNILID---VRGAIKLGD 154 (636)
Q Consensus 81 -~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~--gIvHRDLKP~NILld---~~g~vKL~D 154 (636)
.+.+|-|+|||+|.||.-+|+.+ .-++|.+++.|+.||+.||.||... .|||-||||.|||+- .-|.+||+|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 46789999999999999999987 6799999999999999999999987 599999999999994 347899999
Q ss_pred cCcccccccCCCc----ccccccccCCCCCCChhhhhh---ccCCCcccchhhHHHHHHHHHcCCCCCCCCChH-HHHHH
Q 006664 155 FGVSACLFDSGDR----QRMRNTFVGTPCWMAPEVMEQ---LHGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLM 226 (636)
Q Consensus 155 FGla~~~~~~~~~----~~~~~~~~GT~~YmAPEvl~~---~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~-~~l~~ 226 (636)
||+++++.+.... ......+.||-||++||.+.- ....+.++||||+|||+|.++.|+.||...... +++..
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999988654332 233456789999999998742 234788999999999999999999999764432 23322
Q ss_pred HHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 227 TLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 227 ~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
.-.-......++..+.++.++++||++||..--+.|....+|-.||||.
T Consensus 697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 2112223345667788999999999999999999999999999999996
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.94 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=197.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC-eEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH-NLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~-~l~iVmE 89 (636)
+.|.-...||+|+||.||+|... +|..||||.++...... ...+.+|+.++.+++|||+|+++|++.+.+ ..++|+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 56777789999999999999864 45899999876544322 455999999999999999999999999998 5999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG---HIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g---IvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
||..|+|.++|.......+++.....|+.+++.||+|||... ||||||||.|||||.+++.||+|||+|+.....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-- 230 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-- 230 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--
Confidence 999999999998753227899999999999999999999864 999999999999999999999999999543220
Q ss_pred cccccccc-cCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC---hHHHH---HHHHhcC--CCCCCc
Q 006664 167 RQRMRNTF-VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP---PMKVL---LMTLQNA--PPGLDY 237 (636)
Q Consensus 167 ~~~~~~~~-~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~---~~~~l---~~~~~~~--~~~~~~ 237 (636)
.....+. .||..|+|||++.. ...+.++||||||++|.||++|+.|.+... ..... ...+... ..-++.
T Consensus 231 -~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~ 308 (361)
T KOG1187|consen 231 -DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP 308 (361)
T ss_pred -ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC
Confidence 1111222 89999999999976 568999999999999999999999887532 11111 1112211 011111
Q ss_pred ccc-hh-----hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 238 ERD-RK-----FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 238 ~~~-~~-----~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
... .. .-..+..+..+|+..+|.+||++.++++
T Consensus 309 ~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 309 RLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111 11 2233667889999999999999998743
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=325.06 Aligned_cols=259 Identities=25% Similarity=0.338 Sum_probs=209.7
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCC--CC----cceeeeEEEeCC
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDH--PN----VLKSHCSFVSDH 82 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~H--PN----IVkl~~~~~~~~ 82 (636)
...+|.++..+|+|+||.|-.+.+..++..||||+++.- ..-.+..+-|++++.+|.+ |+ +|.+.++|.-.+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 368999999999999999999999999999999998532 2234456679999999842 33 678889999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc----------------
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---------------- 146 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---------------- 146 (636)
+.|||+|.+ |-+++++|+.+...+|+...++.+.+||+.+++|||..+++|-||||+|||+-.
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999999998 569999999987788999999999999999999999999999999999999821
Q ss_pred ----CCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHH
Q 006664 147 ----RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 222 (636)
Q Consensus 147 ----~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~ 222 (636)
+..|+|+|||.|+.-.. ...+.+.|..|.|||++.+ -+++.++||||+||||+||++|...|...+..+
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e------~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHE------HHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ccCCCcceEEEecCCcceecc------CcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 23589999999875321 1357899999999999998 689999999999999999999999998776555
Q ss_pred HHH---HHHhcCCC---------------CCCcccc-----------------------hhhhHHHHHHHHhhcccCCCC
Q 006664 223 VLL---MTLQNAPP---------------GLDYERD-----------------------RKFSKSFKQMIASCLVKDPSK 261 (636)
Q Consensus 223 ~l~---~~~~~~~~---------------~~~~~~~-----------------------~~~S~~l~dLI~~cL~~DP~k 261 (636)
.+. .++...|. .++|+.. ..--.++.|||++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 332 22211110 1111100 001235789999999999999
Q ss_pred CCCHHHHHhCcccccc
Q 006664 262 RPSAKKLLKHSFFKQA 277 (636)
Q Consensus 262 Rpsa~elL~Hpffk~~ 277 (636)
|+|+.|+|.||||+..
T Consensus 397 RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 397 RITLREALSHPFFARL 412 (415)
T ss_pred cccHHHHhcCHHhhcC
Confidence 9999999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=295.48 Aligned_cols=244 Identities=35% Similarity=0.571 Sum_probs=206.3
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCHHHHHHH
Q 006664 23 VSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKA 102 (636)
Q Consensus 23 ~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~ 102 (636)
+||.||+|.+..+|+.+|+|++...........+.+|+..++.++|+||+++++++..+...+++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999899999999997654433367899999999999999999999999999999999999999999999987
Q ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCC
Q 006664 103 AYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182 (636)
Q Consensus 103 ~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmA 182 (636)
. ..+++..+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||++....... ......|+..|+|
T Consensus 81 ~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~ 154 (244)
T smart00220 81 R--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTPEYMA 154 (244)
T ss_pred c--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCcCCCC
Confidence 5 338999999999999999999999999999999999999999999999999987653321 2345678999999
Q ss_pred hhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCC
Q 006664 183 PEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR 262 (636)
Q Consensus 183 PEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kR 262 (636)
||.+.+ ..++.++||||||+++|+|++|..||............+........ .....++.++.+++.+||..||.+|
T Consensus 155 pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 155 PEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-PPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred HHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-cccccCCHHHHHHHHHHccCCchhc
Confidence 999975 56888999999999999999999999874444444444433222211 1111278899999999999999999
Q ss_pred CCHHHHHhCccc
Q 006664 263 PSAKKLLKHSFF 274 (636)
Q Consensus 263 psa~elL~Hpff 274 (636)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=343.03 Aligned_cols=264 Identities=21% Similarity=0.242 Sum_probs=183.4
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCC----CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEE----
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPF----NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSF---- 78 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t----g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~---- 78 (636)
....++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .+...+| .+....+.++..+...|
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 34568999999999999999999999988 99999998753221 1111111 11222233333322221
Q ss_pred --EeCCeEEEEEeccCCCCHHHHHHHhCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccC
Q 006664 79 --VSDHNLWVVMPFMSGGSCLHILKAAYPD------------------GFEEVVIATILREVLKGLDYLHHHGHIHRDVK 138 (636)
Q Consensus 79 --~~~~~l~iVmEy~~GGsL~~lL~~~~~~------------------~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLK 138 (636)
..+..+|+||||+.+++|.+++...... ...+..+..++.||+.||.|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 3456799999999999999998753210 11234567899999999999999999999999
Q ss_pred cccEEEcc-CCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhc---------------------cCCCccc
Q 006664 139 SGNILIDV-RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL---------------------HGYDFKA 196 (636)
Q Consensus 139 P~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~---------------------~~ys~ks 196 (636)
|+|||++. ++.+||+|||+|+.+... .......++||+.|||||.+... .+++.++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~--~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG--INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc--cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 99999985 589999999999754322 12234567899999999976421 1245567
Q ss_pred chhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-----------CC------cccchhhhHHHHHHHHhhcccCC
Q 006664 197 DIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-----------LD------YERDRKFSKSFKQMIASCLVKDP 259 (636)
Q Consensus 197 DIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~-----------~~------~~~~~~~S~~l~dLI~~cL~~DP 259 (636)
|||||||++|||+++..|+.. ....+...+...... .. +.........+.+||.+||++||
T Consensus 361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999999997766543 222222222111000 00 00001112345689999999999
Q ss_pred CCCCCHHHHHhCcccccccC
Q 006664 260 SKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 260 ~kRpsa~elL~Hpffk~~~~ 279 (636)
.+|||+.++|+||||.....
T Consensus 439 ~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 439 RQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCCHHHHhCCcCcCCCCc
Confidence 99999999999999986543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=337.26 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=225.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcC-CC--cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIP-FN--EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~-tg--~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
|..++..++++||+|+||.|++|.+.. +| -.||||++...........+.+|+.+|.+|+|||++++|++..+ ..+
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 455778889999999999999998874 34 35899999877766678899999999999999999999999988 788
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
.+|||++.+|+|++.|.+.....|-......|+.||+.|+.||..+++|||||...|+|+-....|||||||+.+.+...
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999999999876778999999999999999999999999999999999999999999999999999887554
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.+...+.....-...|+|||.++. ..++.++|||+|||++|||++ |+.||.+.....++..+- .+...++++.+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD----~~erLpRPk~c 340 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID----AGERLPRPKYC 340 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc----ccccCCCCCCC
Confidence 443322222333456999999986 678999999999999999998 999999999887765554 33456788999
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
+.++.+++..||..+|.+||++..|...-+..
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 99999999999999999999999997655544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.91 Aligned_cols=258 Identities=25% Similarity=0.393 Sum_probs=220.8
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcC--C--CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEE
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIP--F--NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSF 78 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~--t--g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~ 78 (636)
-++|++..+...+.+.||.|-||.||+|.... . .--||||..+.+...++.+.+..|..+|+.++|||||+++|++
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 35788999999999999999999999997642 2 3358999998877777889999999999999999999999998
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcc
Q 006664 79 VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158 (636)
Q Consensus 79 ~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla 158 (636)
.+ ...|||||++.-|.|+++|+.+ ...++-.....|+.||+.||.|||+..+|||||...|||+.....|||+|||++
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchh
Confidence 76 4789999999999999999886 367889999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
+.+.+..... .....-..-|||||-+.- ..++.++|||.||+++||++. |..||.+....+++..+ ..+-+.
T Consensus 539 R~~ed~~yYk--aS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i----EnGeRl 611 (974)
T KOG4257|consen 539 RYLEDDAYYK--ASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI----ENGERL 611 (974)
T ss_pred hhccccchhh--ccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe----cCCCCC
Confidence 9876554321 122223456999999865 678999999999999999886 99999987766654332 234456
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLL 269 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL 269 (636)
+.+..+++.+..|+.+||..||.+||.+.+|.
T Consensus 612 P~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred CCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 77889999999999999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=299.45 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=209.7
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeC--CeEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSD--HNLW 85 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~--~~l~ 85 (636)
..++|++++++|+|.|+.||.|.+..+++.++||+++. ...+.+.||++||..|. ||||++++++..+. ....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 46899999999999999999999999999999999853 34567999999999986 99999999999876 4578
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC-CcEEEeccCcccccccC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR-GAIKLGDFGVSACLFDS 164 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~-g~vKL~DFGla~~~~~~ 164 (636)
+|+||++..+...+.. .++...++.++.+|+.||.|||+.||+|||+||.|++||.. -.++|+|+|+|.+....
T Consensus 112 LiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999999987666553 47888999999999999999999999999999999999854 57999999999865332
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCC-CCChHHHHHHHHh------------cC
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS-KYPPMKVLLMTLQ------------NA 231 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~-~~~~~~~l~~~~~------------~~ 231 (636)
. ..+..+.+.+|-.||++-..+.|+..-|+|||||+++.|++.+-||. +.+..+++..+.+ ..
T Consensus 187 ~----eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 187 K----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred c----eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 2 23456788999999999887889999999999999999999888874 4444454433321 00
Q ss_pred CCCCCc--------------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 232 PPGLDY--------------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 232 ~~~~~~--------------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
...++. ....-.++++.+|+.++|..|..+|+|+.|++.||||...
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 000100 0111246899999999999999999999999999999754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=323.64 Aligned_cols=257 Identities=23% Similarity=0.408 Sum_probs=223.7
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
.+|++...+..+..+||-|.||.||.|.+++-.-.||||.++-+.. .++.+..|+.+|+.++|||+|++.+++..+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 5799999999999999999999999999999999999999865444 57789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|||+|||..|+|++||+.......+.....+++.||.+|++||..+++|||||...|+|+.++..||++|||+++.|..
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 99999999999999999988666688888999999999999999999999999999999999999999999999998743
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.... .........-|.|||-|.- ..++.|+|||+|||+|||+++ |-.||.+.+-..+. ..+.+ +++...+..
T Consensus 418 DTYT--AHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-~LLEk---gyRM~~PeG 490 (1157)
T KOG4278|consen 418 DTYT--AHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-GLLEK---GYRMDGPEG 490 (1157)
T ss_pred Ccee--cccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-HHHhc---cccccCCCC
Confidence 3221 1122233567999999875 568899999999999999998 99999987765443 33332 455567789
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHH
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLL 269 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL 269 (636)
+++...+|+..||++.|..||++.||-
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 999999999999999999999999883
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.44 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=219.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
+..+...++++||+|-||.|.++.-. .+..||+|+++-+.+......+.+|+++|.+|+|||||++++++..++.+++|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 44577889999999999999999753 36899999998666665668899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
||||+.|+|..++.++............|+.||++|++||.+.++|||||.+.|+|+|.++++||+|||+++.++.. +.
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg-~y 692 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG-DY 692 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC-Cc
Confidence 99999999999998874333455566679999999999999999999999999999999999999999999877544 34
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc--CCCCCCCCChHHHHHHHH---hcCCCCCCcccchh
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH--GHAPFSKYPPMKVLLMTL---QNAPPGLDYERDRK 242 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt--G~~PF~~~~~~~~l~~~~---~~~~~~~~~~~~~~ 242 (636)
.+....++-..+|||||.+.- ..++.++|+|+||+++||+++ ...||.......++.... .......-..++.-
T Consensus 693 y~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred eeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence 455566778899999999875 579999999999999999865 889998877766654432 22222223355677
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++..+.++|.+||..|-.+||+++++-.
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 8999999999999999999999999843
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=323.47 Aligned_cols=267 Identities=21% Similarity=0.265 Sum_probs=193.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEc----------------CCCcEEEEEEeecCCCch-------------hHHHHHH
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCI----------------PFNEIVAVKILDFERDNS-------------DLSNISR 58 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~----------------~tg~~vAIK~i~~~~~~~-------------~~~~i~r 58 (636)
...++|.+.++||+|+||+||+|.+. ..++.||||.++...... ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45789999999999999999999752 345689999986543211 1112334
Q ss_pred HHHHHHhCCCCCc-----ceeeeEEEe--------CCeEEEEEeccCCCCHHHHHHHhCC--------------------
Q 006664 59 EAQTMILVDHPNV-----LKSHCSFVS--------DHNLWVVMPFMSGGSCLHILKAAYP-------------------- 105 (636)
Q Consensus 59 Ei~iL~~L~HPNI-----Vkl~~~~~~--------~~~l~iVmEy~~GGsL~~lL~~~~~-------------------- 105 (636)
|+.++.+++|.++ ++++++|.. .+..|+||||+.+|+|.+++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766654 566666643 3568999999999999999875311
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCCh
Q 006664 106 --DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183 (636)
Q Consensus 106 --~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAP 183 (636)
..+++..++.++.|++.+|.|||++||+||||||+|||++.++.+||+|||++..+.... ........+|+.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~--~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI--NFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC--ccCccccCCCcceeCh
Confidence 124567788999999999999999999999999999999999999999999986542211 1111223458999999
Q ss_pred hhhhhcc-------------------CC--CcccchhhHHHHHHHHHcCCC-CCCCCChHHHHHHH--------HhcCCC
Q 006664 184 EVMEQLH-------------------GY--DFKADIWSFGITALELAHGHA-PFSKYPPMKVLLMT--------LQNAPP 233 (636)
Q Consensus 184 Evl~~~~-------------------~y--s~ksDIWSLGiiLyeLltG~~-PF~~~~~~~~l~~~--------~~~~~~ 233 (636)
|++.... .| ..+.||||+||++|+|++|.. ||............ ......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9985321 12 234799999999999999875 77543221111110 011112
Q ss_pred CCCcccchhhhHHHHHHHHhhcccCC---CCCCCHHHHHhCccccc
Q 006664 234 GLDYERDRKFSKSFKQMIASCLVKDP---SKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 234 ~~~~~~~~~~S~~l~dLI~~cL~~DP---~kRpsa~elL~Hpffk~ 276 (636)
..++......+..+++|+.+||.++| .+|+|+.|+|+||||..
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 33444556678999999999999876 68999999999999963
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=330.52 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=228.3
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCC---cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFN---EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg---~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
...+|.+....+.+.||.|.||.|++|..+..| ..||||.++..........+..|+.||-+++||||+++-++...
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 345788899999999999999999999988666 57999999877777778889999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
..-+.||+|||+.|+|..+|+.+. +.|+..++.-+++.|+.|++||-..|+|||||...|||++.+-.+|++|||+++.
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999999999874 6799999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
+.+..+.......-.-..+|.|||.+.. ..++.++||||+||+|||.++ |..||.+....+++..+.+ +++.+.
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~----gyRLPp 855 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ----GYRLPP 855 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh----ccCCCC
Confidence 7554422211111122468999999986 679999999999999999876 9999999888777766654 456666
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+-.++..+.+|+..||++|-.+||.+.+|+.
T Consensus 856 PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 856 PMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 7789999999999999999999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=335.22 Aligned_cols=251 Identities=27% Similarity=0.353 Sum_probs=199.0
Q ss_pred EeEEcccCceE-EEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEEeccCC
Q 006664 16 YEEVGQGVSAS-VHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 16 ~~~IG~G~fG~-Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVmEy~~G 93 (636)
-+.+|.|+-|+ ||+|.. .|+.||||.+- ......+.||+..|+.. +|||||++|+.-.++..+||+.|.|..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLL----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHh----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 35689999985 689987 58899999873 33455789999999988 599999999999999999999999976
Q ss_pred CCHHHHHHHh-CCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc---C--CcEEEeccCcccccccCCC
Q 006664 94 GSCLHILKAA-YPD-GFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---R--GAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 94 GsL~~lL~~~-~~~-~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---~--g~vKL~DFGla~~~~~~~~ 166 (636)
+|.++++.. ... .......+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||+|+.+.....
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 899999873 111 1122456789999999999999999999999999999975 3 4789999999998754443
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
..+...+..||-.|+|||++.. ..-+.++|||||||++|+.++ |..||.+.-..+ ..++.+...-........+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~-- 741 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDC-- 741 (903)
T ss_pred hhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchH--
Confidence 3344667789999999999987 345668999999999999998 599998644332 2344333222222222222
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++++||.+||.+||..||+|.++|.||||+...
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE 774 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence 899999999999999999999999999998654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.26 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=211.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC----
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH---- 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~---- 82 (636)
....+|.-+..+|.|+- .|.-|.|..+++.||||..-.... .....+..+|...|..++|+||++++.+|.-..
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 34678999999999999 888899999999999998865543 235678899999999999999999999997543
Q ss_pred --eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 83 --NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 83 --~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
.+|+|||||+. +|...+.. .++-.++.+++.|+++|++|||+.||+||||||+||++..++.+||.|||+|+.
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 58999999976 67776663 377889999999999999999999999999999999999999999999999874
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-CC-----
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-PG----- 234 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~-~~----- 234 (636)
. ......+.++.|++|.|||++.+ .+|...+||||+||++.||+.|...|.+.+..++...++.... +.
T Consensus 168 e----~~~~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 168 E----DTDFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred c----CcccccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 3 11234567899999999999998 5599999999999999999999999988766665544432110 00
Q ss_pred ------------------C---------Cc----ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 235 ------------------L---------DY----ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 235 ------------------~---------~~----~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
+ .+ +..+.-+..+++++.+||..||++|.+++++|.||||+
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 00 00112345688999999999999999999999999998
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=283.02 Aligned_cols=227 Identities=29% Similarity=0.490 Sum_probs=192.9
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHh-CCCCCcceeeeEEEeCC
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL-VDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~-L~HPNIVkl~~~~~~~~ 82 (636)
+.+++.+++..-+..||+|+||.|-+.++..+|...|+|.+...-......++.+|+++... ..+|++|.||+.+....
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 35788888999999999999999999999999999999999877666677788899998765 47999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.+||.||.|+- +|..+-+.. ..+..+|..+-+|+..++.||.|||++ .+||||+||+|||++..|.||+||||.+.
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999975 665554432 235689999999999999999999987 89999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhh---ccCCCcccchhhHHHHHHHHHcCCCCCCC-CChHHHHHHHHhcCCCCC
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQ---LHGYDFKADIWSFGITALELAHGHAPFSK-YPPMKVLLMTLQNAPPGL 235 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~---~~~ys~ksDIWSLGiiLyeLltG~~PF~~-~~~~~~l~~~~~~~~~~~ 235 (636)
.+.++-.. +-..|...|||||.+.. ..+|+.++||||||+++.||++|+.||+. ..+.+++.++....++.+
T Consensus 198 ~L~dSiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~L 273 (282)
T KOG0984|consen 198 YLVDSIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQL 273 (282)
T ss_pred eehhhhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCC
Confidence 87554321 22578999999999863 23699999999999999999999999975 567777777776655544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.69 Aligned_cols=260 Identities=23% Similarity=0.376 Sum_probs=211.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC------CCCcceeeeEEEeC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD------HPNVLKSHCSFVSD 81 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~------HPNIVkl~~~~~~~ 81 (636)
+--.+|.+....|+|-|++|.+|.+..-|..||||+|... ....+.=.+|+.||++|+ --|+++++-.|...
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 4457899999999999999999999999999999999532 122333468999999995 34799999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC-CcEEEeccCccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAY-PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR-GAIKLGDFGVSA 159 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~-g~vKL~DFGla~ 159 (636)
+++|+|+|-+.. +|.++|++.. ..++....++.|+.||+.||..|-.+||+|.||||+||||+++ ..+||||||.|.
T Consensus 507 nHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 507 NHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred ceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 999999999865 8999998863 2358889999999999999999999999999999999999865 578999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHH--hcCCCC---
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL--QNAPPG--- 234 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~--~~~~~~--- 234 (636)
...+.. .+.+.-+.+|.|||++.| ..|+...|+||.||+||||++|+..|++......+...+ ++..+.
T Consensus 586 ~~~ene-----itPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 586 FASENE-----ITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccc-----ccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 553332 345667889999999998 789999999999999999999999999877665553332 221110
Q ss_pred -------------CCc-------------------------------------ccchhhhHHHHHHHHhhcccCCCCCCC
Q 006664 235 -------------LDY-------------------------------------ERDRKFSKSFKQMIASCLVKDPSKRPS 264 (636)
Q Consensus 235 -------------~~~-------------------------------------~~~~~~S~~l~dLI~~cL~~DP~kRps 264 (636)
+.+ .....+-..|++|+.+||..||.+|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 000 001123356889999999999999999
Q ss_pred HHHHHhCccccc
Q 006664 265 AKKLLKHSFFKQ 276 (636)
Q Consensus 265 a~elL~Hpffk~ 276 (636)
..++|+||||..
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999963
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=297.40 Aligned_cols=262 Identities=24% Similarity=0.354 Sum_probs=210.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC-----eE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH-----NL 84 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~-----~l 84 (636)
-+.+-.+.||.|+||.||-+.+..+|+.||+|.+..-. .-...+++.+|+++|..++|.||+...+...-.+ .+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34455678999999999999999999999999875322 2234567889999999999999999888776543 47
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+|+|+|.. ||..++.. +..++...++-+++||+.||+|||+.||.||||||.|+|++.+..+||||||+++.. +.
T Consensus 133 YV~TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve-e~ 208 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW-DQ 208 (449)
T ss_pred HHHHHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc-ch
Confidence 889999864 77777764 367999999999999999999999999999999999999999999999999999753 33
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-------------
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA------------- 231 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~------------- 231 (636)
.+.. ..+.-+-|.+|.|||++.|...|+.++||||.|||+.||+..+..|....+..++..+..-.
T Consensus 209 d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 2222 23345779999999999998999999999999999999999999998887777765554211
Q ss_pred ----------CCCCCccc------chhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 232 ----------PPGLDYER------DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 232 ----------~~~~~~~~------~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
....++.. +..-..+...++.++|..||++|.+.++.+.|++....
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 00001110 11223467789999999999999999999999998754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=341.22 Aligned_cols=241 Identities=20% Similarity=0.288 Sum_probs=188.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
..|.....||+|+||.||+|.+..+|..||||.++..... ...|++++++++|||||++++++.++...|+||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 3456677899999999999999999999999998633221 23568899999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH---HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH---~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|+||+|.++++. +++..+..++.||+.||+||| ..+|+||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 765 IEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 999999999953 788999999999999999999 6699999999999999988887775 665432211
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh----HHHH-HHHHhcC------CCCC-
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP----MKVL-LMTLQNA------PPGL- 235 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~----~~~l-~~~~~~~------~~~~- 235 (636)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... .... ....... .+..
T Consensus 835 ---~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence 123478999999999876 6799999999999999999999999953211 0000 0000000 0000
Q ss_pred -CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 236 -DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 236 -~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..........++.+++.+||..||++||++.++++
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 01112233456789999999999999999999986
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=318.50 Aligned_cols=260 Identities=27% Similarity=0.484 Sum_probs=218.2
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEc---C----CCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeee
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCI---P----FNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHC 76 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~---~----tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~ 76 (636)
.|++..+...+.+.||.|+||.|++|... . ....||||.++......+.+.+..|+++|+.+ .||||+.+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 68999999999999999999999999643 1 14679999997666667788899999999988 5999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHHHhC------C--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccE
Q 006664 77 SFVSDHNLWVVMPFMSGGSCLHILKAAY------P--------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNI 142 (636)
Q Consensus 77 ~~~~~~~l~iVmEy~~GGsL~~lL~~~~------~--------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NI 142 (636)
++..++.+++|+|||..|+|.++++... . ..++......++.||+.|++||++.++|||||...||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999998763 0 1388899999999999999999999999999999999
Q ss_pred EEccCCcEEEeccCcccccccCCCcccccccccCC--CCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCC
Q 006664 143 LIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT--PCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYP 219 (636)
Q Consensus 143 Lld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT--~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~ 219 (636)
|+..+..+||+|||+|+...+..... .....|+ ..|||||.+.. ..|+.++|||||||+|||+++ |..||.+..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~--~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYR--TKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceE--ecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999998554332211 1112232 34999999987 789999999999999999998 999999866
Q ss_pred hHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 220 ~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
....+...++. +.+...+..++.++.+++..||..+|++||++.++.+
T Consensus 527 ~~~~l~~~l~~---G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 527 PTEELLEFLKE---GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred cHHHHHHHHhc---CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 34434444433 4455667788999999999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=295.15 Aligned_cols=248 Identities=26% Similarity=0.333 Sum_probs=192.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHh--CCCCCcceeeeEEEeCC----e
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL--VDHPNVLKSHCSFVSDH----N 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~--L~HPNIVkl~~~~~~~~----~ 83 (636)
....++++.||+|.||.||+|.. +++.||||+++. .+...+.+|.+|++. +.|+||++|+++-.... .
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 45677889999999999999986 469999999863 345678889888874 58999999998876555 7
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---------CCCcccccCcccEEEccCCcEEEec
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH---------HGHIHRDVKSGNILIDVRGAIKLGD 154 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~---------~gIvHRDLKP~NILld~~g~vKL~D 154 (636)
+|+|++|.+.|+|.++|+.+ ..++....+++..|+.||+|||. .+|+|||||..||||.++++..|+|
T Consensus 283 ywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999999985 68999999999999999999996 3599999999999999999999999
Q ss_pred cCcccccccCCCcccccccccCCCCCCChhhhhhccCCC-----cccchhhHHHHHHHHHcCCCCC------------C-
Q 006664 155 FGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYD-----FKADIWSFGITALELAHGHAPF------------S- 216 (636)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys-----~ksDIWSLGiiLyeLltG~~PF------------~- 216 (636)
||+|.++... .........+||.+|||||+|.+..++. .+.||||+|.+||||++...-+ .
T Consensus 360 FGLAl~~~p~-~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 360 FGLALRLEPG-KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred cceeEEecCC-CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 9999877533 2223333479999999999998866555 3589999999999999754333 2
Q ss_pred ---CCChHHHHHHHHhc--CCCCC-CcccchhhhHHHHHHHHhhcccCCCCCCCHHH
Q 006664 217 ---KYPPMKVLLMTLQN--APPGL-DYERDRKFSKSFKQMIASCLVKDPSKRPSAKK 267 (636)
Q Consensus 217 ---~~~~~~~l~~~~~~--~~~~~-~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~e 267 (636)
..+..+.++..+.. ..|.+ +.......-..+++.+.-||..||+-|.|+.=
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 11222222222211 11111 11222234456889999999999999998753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=289.54 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=192.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHH--hCCCCCcceeeeEEEeC----Ce
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI--LVDHPNVLKSHCSFVSD----HN 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~--~L~HPNIVkl~~~~~~~----~~ 83 (636)
+.+..+.+.||+|.||.||+|.++ |+.||||++.- .+...+.||.+|++ .|+|+||+.|++.-..+ .+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 567899999999999999999986 89999999842 23456788988886 57999999999886554 36
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccccCcccEEEccCCcEEEecc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH--------GHIHRDVKSGNILIDVRGAIKLGDF 155 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~--------gIvHRDLKP~NILld~~g~vKL~DF 155 (636)
+|+|++|-+.|+|+|+|... .++.....+++..+++||+|||.. +|.|||||..||||.++|...|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 99999999999999999984 688999999999999999999953 5999999999999999999999999
Q ss_pred CcccccccC-CCcccccccccCCCCCCChhhhhhccC----CC-cccchhhHHHHHHHHHcC----------CCCCCCCC
Q 006664 156 GVSACLFDS-GDRQRMRNTFVGTPCWMAPEVMEQLHG----YD-FKADIWSFGITALELAHG----------HAPFSKYP 219 (636)
Q Consensus 156 Gla~~~~~~-~~~~~~~~~~~GT~~YmAPEvl~~~~~----ys-~ksDIWSLGiiLyeLltG----------~~PF~~~~ 219 (636)
|+|...... +.-....+..+||.+|||||+|...-+ -+ ..+||||||.++||++.. .+||.+.-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999765433 222334567899999999999965222 11 358999999999999852 67886543
Q ss_pred h----HHHHHHHHh--cCCCCCCcccch--hhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 006664 220 P----MKVLLMTLQ--NAPPGLDYERDR--KFSKSFKQMIASCLVKDPSKRPSAKKLL 269 (636)
Q Consensus 220 ~----~~~l~~~~~--~~~~~~~~~~~~--~~S~~l~dLI~~cL~~DP~kRpsa~elL 269 (636)
+ .+.....+- ...|.++ .++. ..-..+..+++-||..+|.-|.|+--|.
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ip-nrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIP-NRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCC-cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 3 333322221 1112211 1111 2224566899999999999998876553
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=289.93 Aligned_cols=134 Identities=25% Similarity=0.381 Sum_probs=117.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-----C---CCcceeeeEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-----H---PNVLKSHCSFV 79 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-----H---PNIVkl~~~~~ 79 (636)
+...+|.+.++||-|-|++||+|.|..+.+.||+|+.+-... -.+....||++|+.++ | .+||++++.|.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh--YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH--YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH--HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 445899999999999999999999999999999999864332 2455678999998873 3 35999999997
Q ss_pred e----CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEE
Q 006664 80 S----DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILI 144 (636)
Q Consensus 80 ~----~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILl 144 (636)
. +.++|+|+|+. |..|+.+|+.....+++...++.|++||+.||.|||+. ||||-||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 5 46899999998 67899999988888999999999999999999999976 99999999999998
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.19 Aligned_cols=200 Identities=29% Similarity=0.443 Sum_probs=177.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-------hhHHHHHHHHHHHHhCC---CCCcceeeeEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-------SDLSNISREAQTMILVD---HPNVLKSHCSFVS 80 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-------~~~~~i~rEi~iL~~L~---HPNIVkl~~~~~~ 80 (636)
.+|..++.+|.|+||.|++|+++.+...|+||.|.+++-- ..+-.+--||+||..++ |+||+++.++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 5699999999999999999999999999999999877621 12223567999999998 9999999999999
Q ss_pred CCeEEEEEecc-CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 81 DHNLWVVMPFM-SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 81 ~~~l~iVmEy~-~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
++++|++||-- +|-||+++|..+ ..++|..+..||+|++.|+++||.+||||||||-+|+.++.+|-+||+|||.|.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 99999999964 557999999886 679999999999999999999999999999999999999999999999999986
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCC
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSK 217 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~ 217 (636)
.. .++ ....|+||..|.|||++.|..+.+..-|||++||+||.++....||..
T Consensus 719 ~~-ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YT-KSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hh-cCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 43 222 356899999999999999877778889999999999999999999853
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=291.19 Aligned_cols=265 Identities=27% Similarity=0.391 Sum_probs=208.4
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcC---CCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeC
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIP---FNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSD 81 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~---tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~ 81 (636)
.+...+.|..+.+||.|+|++||++.+.. ..+.||+|.+..... ..++.+|+.+|..+ .+.||+++.+++..+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 44556889999999999999999999887 789999999975544 45689999999887 599999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-CCcEEEeccCcccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSAC 160 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-~g~vKL~DFGla~~ 160 (636)
+.+.+||||++..+..++... ++-..++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|..
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 999999999999888887754 678899999999999999999999999999999999984 47889999999862
Q ss_pred ccc----------------C-------------------------CCcccccccccCCCCCCChhhhhhccCCCcccchh
Q 006664 161 LFD----------------S-------------------------GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIW 199 (636)
Q Consensus 161 ~~~----------------~-------------------------~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIW 199 (636)
... . ..+........|||.|.|||++......++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 100 0 00011122347999999999999888889999999
Q ss_pred hHHHHHHHHHcCCCCCCCCChH-HHHHHHH--------h-----cCC-------------------CCC--------Cc-
Q 006664 200 SFGITALELAHGHAPFSKYPPM-KVLLMTL--------Q-----NAP-------------------PGL--------DY- 237 (636)
Q Consensus 200 SLGiiLyeLltG~~PF~~~~~~-~~l~~~~--------~-----~~~-------------------~~~--------~~- 237 (636)
|.|+|+..+++++.||-..... +.+.++. + ... ..+ +.
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 9999999999999999432211 1110000 0 000 000 00
Q ss_pred -----ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 238 -----ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 238 -----~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.....++..+.+|+.+||..||.+|+|++++|+||||....
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 00123455789999999999999999999999999998654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-31 Score=253.48 Aligned_cols=214 Identities=41% Similarity=0.632 Sum_probs=188.3
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCHHH
Q 006664 19 VGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH 98 (636)
Q Consensus 19 IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL~~ 98 (636)
||.|.+|.||++.+..+++.+++|++...........+.+|+..++.+.|++|+++++++......+++|||+.|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999755443245778999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-CCcEEEeccCcccccccCCCcccccccccCC
Q 006664 99 ILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177 (636)
Q Consensus 99 lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT 177 (636)
++.... ..++...++.++.+++.+|.|||++|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~ 156 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGT 156 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhcccCC
Confidence 998642 36889999999999999999999999999999999999998 89999999999875533211 12345688
Q ss_pred CCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhccc
Q 006664 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVK 257 (636)
Q Consensus 178 ~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~ 257 (636)
..|++||.+.....++.+.|+|++|+++|+| ..+.+++.+||..
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------HHHHHHHHHHhhC
Confidence 9999999997643788999999999999999 5789999999999
Q ss_pred CCCCCCCHHHHHhCc
Q 006664 258 DPSKRPSAKKLLKHS 272 (636)
Q Consensus 258 DP~kRpsa~elL~Hp 272 (636)
||.+||++.++++|+
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=299.07 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=210.2
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCc----EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~----~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
...+++||.|+||+||+|.+.+.|+ +||||++...........+.+|+-+|.+++|||+++++++..... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 4456799999999999999987775 679998876666656678899999999999999999999987765 88999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
+|+++|.|.++++.+ ...+-......|..||++|+.|||.+.+|||||-..||||.+..++||+|||+++.+. ..+..
T Consensus 777 q~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~-~d~~e 854 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA-PDEKE 854 (1177)
T ss_pred HhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC-ccccc
Confidence 999999999999885 4678888899999999999999999999999999999999999999999999997653 33333
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.......-.+-|||=|.+.. ..|+.++|||||||++||++| |..|+.+.+..++- ..++. +.+...+..++-++
T Consensus 855 y~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-dlle~---geRLsqPpiCtiDV 929 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-DLLEK---GERLSQPPICTIDV 929 (1177)
T ss_pred ccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-HHHhc---cccCCCCCCccHHH
Confidence 33333344667999999876 789999999999999999998 99999998776543 23322 22355667889999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHh
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.-++.+||..|+..||+++++..
T Consensus 930 y~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 930 YMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHhccCcccCccHHHHHH
Confidence 99999999999999999998754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=252.29 Aligned_cols=215 Identities=33% Similarity=0.526 Sum_probs=183.5
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccC
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMS 92 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~ 92 (636)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...........+.+|+..++.++|+||+++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67889999999999999999988999999999755433256788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 93 GGSCLHILKAAYPDG-FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 93 GGsL~~lL~~~~~~~-lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
+++|.+++... .. +++..+..++.+++.++.|||.+|++|+||+|.||+++.++.++|+|||++........ ...
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~--~~~ 156 (225)
T smart00221 81 GGDLFDYLRKK--GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA--ALL 156 (225)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--ccc
Confidence 99999999875 33 88999999999999999999999999999999999999999999999999876543321 123
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCC-CChHHHHHHHHhcC
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSK-YPPMKVLLMTLQNA 231 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~-~~~~~~l~~~~~~~ 231 (636)
....++..|++||.+.....++.++|||+||+++|+|++|+.||.. ......+...+...
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 4567889999999984335678899999999999999999999977 45554444444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=302.61 Aligned_cols=204 Identities=15% Similarity=0.151 Sum_probs=148.7
Q ss_pred hCCC-CCcceeeeEE-------EeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 006664 65 LVDH-PNVLKSHCSF-------VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRD 136 (636)
Q Consensus 65 ~L~H-PNIVkl~~~~-------~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRD 136 (636)
.++| +||++++++| .....++++|||+ +++|+++|... ...+++..+..|++||+.||.|||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 4455 6888888877 3334678889987 56999999753 35699999999999999999999999999999
Q ss_pred cCcccEEEccC-------------------CcEEEeccCcccccccCCCc-------------ccccccccCCCCCCChh
Q 006664 137 VKSGNILIDVR-------------------GAIKLGDFGVSACLFDSGDR-------------QRMRNTFVGTPCWMAPE 184 (636)
Q Consensus 137 LKP~NILld~~-------------------g~vKL~DFGla~~~~~~~~~-------------~~~~~~~~GT~~YmAPE 184 (636)
|||+||||+.. +.+||+|||+++........ .......+||++|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999999543 45566666666432110000 00112357899999999
Q ss_pred hhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCC
Q 006664 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264 (636)
Q Consensus 185 vl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRps 264 (636)
++.+ ..|+.++|||||||+||||++|.+||..... ..........+. ..........+++.+||.+||.+||+
T Consensus 186 ~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 186 EDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPP----QILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred hhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcCh----hhhhcCHHHHHHHHHhCCCChhhCcC
Confidence 9976 5689999999999999999999988764221 111111111110 01112345678999999999999999
Q ss_pred HHHHHhCcccccc
Q 006664 265 AKKLLKHSFFKQA 277 (636)
Q Consensus 265 a~elL~Hpffk~~ 277 (636)
+.++++||||...
T Consensus 259 ~~eil~h~~~~~~ 271 (793)
T PLN00181 259 MSELLQSEFINEP 271 (793)
T ss_pred hHHHhhchhhhhh
Confidence 9999999999764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-27 Score=237.32 Aligned_cols=261 Identities=34% Similarity=0.515 Sum_probs=211.0
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch--hHHHHHHHHHHHHhCCCC-CcceeeeEEEeCCeEEEEEe
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS--DLSNISREAQTMILVDHP-NVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~--~~~~i~rEi~iL~~L~HP-NIVkl~~~~~~~~~l~iVmE 89 (636)
|.+.+.||.|+||.||++.+. ..+|+|.+....... ....+.+|+.++..+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999987 889999997665443 477889999999999988 79999999988888999999
Q ss_pred ccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-cEEEeccCcccccccCCCc
Q 006664 90 FMSGGSCLHILKAAYP-DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-AIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-~vKL~DFGla~~~~~~~~~ 167 (636)
|+.|+++.+++..... ..+.+..+..++.|++.++.|+|..|++|||+||+||+++..+ .++++|||++..+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977766421 2689999999999999999999999999999999999999888 7999999998754333222
Q ss_pred c---cccccccCCCCCCChhhhhhc--cCCCcccchhhHHHHHHHHHcCCCCCCCCCh---HHHHHHHHhcCCCC-CCcc
Q 006664 168 Q---RMRNTFVGTPCWMAPEVMEQL--HGYDFKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPPG-LDYE 238 (636)
Q Consensus 168 ~---~~~~~~~GT~~YmAPEvl~~~--~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~---~~~l~~~~~~~~~~-~~~~ 238 (636)
. ......+||+.|+|||.+.+. ..+....|+||+|+++++++.|..||..... .......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 134678999999999999864 4788899999999999999999999887663 33333333333222 1111
Q ss_pred cchh----hhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 239 RDRK----FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 239 ~~~~----~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
.... ....+.+++.+|+..+|..|.+..+...++|...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 1121 2367899999999999999999999988866543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=250.60 Aligned_cols=241 Identities=21% Similarity=0.320 Sum_probs=189.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeE-EEeCCeEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCS-FVSDHNLWVV 87 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~-~~~~~~l~iV 87 (636)
.+.|.+.+.||+|.||.+.++.++.++..+|+|.+.... .....+.+|...---| .|.||+.-|++ |+..+.++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 478999999999999999999999999999999986443 3567788888765545 59999987654 7777889999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc--CCcEEEeccCcccccccCC
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV--RGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~--~g~vKL~DFGla~~~~~~~ 165 (636)
||||+.|||..-+.. .++-|.....++.|+++||.|+|++++||||||.+||||-. ...|||||||..+.....
T Consensus 101 qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred eccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 999999999877654 57899999999999999999999999999999999999942 348999999997643111
Q ss_pred CcccccccccCCCCCCChhhhhhcc----CCCcccchhhHHHHHHHHHcCCCCCCCC----ChHHHHHHHHhcCCCCCCc
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLH----GYDFKADIWSFGITALELAHGHAPFSKY----PPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~----~ys~ksDIWSLGiiLyeLltG~~PF~~~----~~~~~l~~~~~~~~~~~~~ 237 (636)
-...--+..|.|||++.... ..++..|||.|||++|.+++|.+||... ++........+...+...
T Consensus 177 -----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P- 250 (378)
T KOG1345|consen 177 -----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP- 250 (378)
T ss_pred -----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc-
Confidence 11123466799999886432 2467899999999999999999999742 222223333333333221
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCC
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKR 262 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kR 262 (636)
.....+|+.+..+.++-|..+|++|
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCccccc
Confidence 2235688999999999999999999
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=232.28 Aligned_cols=164 Identities=31% Similarity=0.402 Sum_probs=131.1
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 94 GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 94 GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
|+|.+++... ...+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... .
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~ 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------Q 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------c
Confidence 6899999864 356999999999999999999999999 999999999999999 9998754221 2
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC---cccchhhhH--HHH
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD---YERDRKFSK--SFK 248 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~---~~~~~~~S~--~l~ 248 (636)
..||+.|||||++.+ ..|+.++|||||||++|||++|+.||............+........ ......++. .++
T Consensus 64 ~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 64 SRVDPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred CCCcccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 368999999999986 67899999999999999999999999765443332222222111111 112234555 699
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
++|.+||..||.+||++.++++|+|+.
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=248.05 Aligned_cols=260 Identities=21% Similarity=0.339 Sum_probs=210.4
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCC-----CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPF-----NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t-----g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
...+...++++...+-+|.||.||.|+++.. .+.|-+|.++.....-.+..+..|.-.+..+.|||++.+.++..
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 3456678889999999999999999977632 23456666654444445667788888888889999999888766
Q ss_pred eC-CeEEEEEeccCCCCHHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEE
Q 006664 80 SD-HNLWVVMPFMSGGSCLHILKAA------YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152 (636)
Q Consensus 80 ~~-~~l~iVmEy~~GGsL~~lL~~~------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL 152 (636)
.+ ...++++.++.-|+|..+|... +....+..+...++.|++.|++|||++||||.||...|.+||+.-.|||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 54 5678888999889999999832 2233666777889999999999999999999999999999999999999
Q ss_pred eccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 006664 153 GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 231 (636)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~ 231 (636)
+|=.+++.++..+.. .....-.....||+||.+.. ..|+.++|+||||++||||++ |+.||...++.+.......+
T Consensus 438 tDsaLSRDLFP~DYh-cLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG- 514 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYH-CLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG- 514 (563)
T ss_pred ccchhccccCccccc-ccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-
Confidence 999999987754322 12222234567999999986 679999999999999999998 99999999998876655443
Q ss_pred CCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 232 ~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++...+..+++++..++.-||..+|++||++.|+..
T Consensus 515 ---yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 ---YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ---ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 344556789999999999999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-28 Score=277.40 Aligned_cols=262 Identities=19% Similarity=0.263 Sum_probs=202.4
Q ss_pred EEEeEEcccCceEEEEEEEcCCCcEEEEEEeecC--C---CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 14 TLYEEVGQGVSASVHRALCIPFNEIVAVKILDFE--R---DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 14 ~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~--~---~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
.....+|.|++|.|+.+......+.++.|.+... . .......+..|+.+-..+.||||+.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 5677999999999999988877777777765421 1 1111223667888888999999988777766666666669
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC-c
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD-R 167 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~-~ 167 (636)
|||++ ||+.++... +.+....+..+++||+.||+|||..||.||||||+|+++..+|.+||+|||.+..+-...+ .
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 99999 999999875 5688999999999999999999999999999999999999999999999999876533222 1
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHh-cCCCC---CCcccchhh
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ-NAPPG---LDYERDRKF 243 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~-~~~~~---~~~~~~~~~ 243 (636)
......++|+..|+|||++.+...-...+||||+|++++.|++|+.||......+....... ..... -.......+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 24456789999999999998844444569999999999999999999965433322211111 00000 011223456
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+...+.+|.+||+.||.+|.|+++|++.+||+.+.
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 77889999999999999999999999999998653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=238.62 Aligned_cols=255 Identities=20% Similarity=0.216 Sum_probs=197.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCC-cEEEEEEeecCCCchhHHHHHHHHHHHHhCCC----CCcceeeeEE-EeCCeEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFN-EIVAVKILDFERDNSDLSNISREAQTMILVDH----PNVLKSHCSF-VSDHNLW 85 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg-~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~H----PNIVkl~~~~-~~~~~l~ 85 (636)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+.......... .+..|+.++..+.. +++..+++.. ..+...|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 8999999999999999999988774 68999988755433222 67889999988863 6899999999 5788899
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC-----CcEEEeccCccc-
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR-----GAIKLGDFGVSA- 159 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~-----g~vKL~DFGla~- 159 (636)
+||+.+ |.+|.++.+....+.|+..++..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+++
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 999998 7799998877666789999999999999999999999999999999999999754 369999999998
Q ss_pred -ccccCCCc----ccc-cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 006664 160 -CLFDSGDR----QRM-RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233 (636)
Q Consensus 160 -~~~~~~~~----~~~-~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~ 233 (636)
.+...... .+. ...+.||..|.++....+ ...+.+.|+||++.++.+|+.|..||.+...............
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~- 254 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR- 254 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh-
Confidence 43333211 111 235679999999999887 6789999999999999999999999976553322222211111
Q ss_pred CCCcc-cchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 234 GLDYE-RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 234 ~~~~~-~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..... .....+..+.++...+-..+...+|....+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 11111 12334567777777777778888888776654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=245.34 Aligned_cols=169 Identities=18% Similarity=0.158 Sum_probs=134.6
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcC-CCcEEEEEEeecCC----CchhHHHHHHHHHHHHhCCCCCcce-eeeEEEe
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIP-FNEIVAVKILDFER----DNSDLSNISREAQTMILVDHPNVLK-SHCSFVS 80 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~-tg~~vAIK~i~~~~----~~~~~~~i~rEi~iL~~L~HPNIVk-l~~~~~~ 80 (636)
.....+|.+.+.||+|+||+||+|.+.. +++.||||++.... .......+.+|+.+|+.++|+||+. +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 4456889999999999999999999876 78888999875321 1223566899999999999999985 443
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccc-CcccEEEccCCcEEEeccCccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDV-KSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDL-KP~NILld~~g~vKL~DFGla~ 159 (636)
.+..|+|||||.|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred cCCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 246899999999999963 211 11 1467899999999999999999999 9999999989999999999998
Q ss_pred ccccCCCcccc-----cccccCCCCCCChhhhhh
Q 006664 160 CLFDSGDRQRM-----RNTFVGTPCWMAPEVMEQ 188 (636)
Q Consensus 160 ~~~~~~~~~~~-----~~~~~GT~~YmAPEvl~~ 188 (636)
.+...+..... ..+.+|++.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 76544422221 136689999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-27 Score=261.35 Aligned_cols=251 Identities=29% Similarity=0.437 Sum_probs=210.9
Q ss_pred EEcccCceEEEEEEE---cCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEEEEeccC
Q 006664 18 EVGQGVSASVHRALC---IPFNEIVAVKILDFERDNS-DLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWVVMPFMS 92 (636)
Q Consensus 18 ~IG~G~fG~Vyka~~---~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~iVmEy~~ 92 (636)
.+|.|+||.|+++.. ...|..+|+|+..+..... .......|..++..++ ||.+|+++..|+.+..++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998643 3567889999987654321 1224556888888887 9999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccc
Q 006664 93 GGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172 (636)
Q Consensus 93 GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 172 (636)
||+|+..+... ..|.+...+.+...++.+++++|+.||+|||+|++||+++.+|++++.|||+++...+...
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ 152 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh------
Confidence 99999988876 6789999999999999999999999999999999999999999999999999987654432
Q ss_pred cccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHH
Q 006664 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIA 252 (636)
Q Consensus 173 ~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~ 252 (636)
.|||.-|||||++. ++..++|+||||+++++|++|..||.. +....++... ...+..++..+++++.
T Consensus 153 -~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-----~~~p~~l~~~a~~~~~ 219 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-----LEMPRELSAEARSLFR 219 (612)
T ss_pred -cccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----cCCchhhhHHHHHHHH
Confidence 29999999999997 578899999999999999999999987 4444454432 3445778999999999
Q ss_pred hhcccCCCCCCC-----HHHHHhCcccccccChHHHHHHHhc
Q 006664 253 SCLVKDPSKRPS-----AKKLLKHSFFKQARSNEYIARTLLE 289 (636)
Q Consensus 253 ~cL~~DP~kRps-----a~elL~Hpffk~~~~~~~i~~~ll~ 289 (636)
.++..+|..|.. +.++++|+||..+.+++...+....
T Consensus 220 ~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~ 261 (612)
T KOG0603|consen 220 QLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPP 261 (612)
T ss_pred HHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCC
Confidence 999999999965 5899999999998887655554433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=213.45 Aligned_cols=254 Identities=18% Similarity=0.235 Sum_probs=199.3
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~ 85 (636)
.|....|.++++||.|+||.+|+|+...+|+.||||+-. .......+..|.++...|. .+.|..+..++.+..+-.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es---~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES---SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeec---ccCCCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 366789999999999999999999999999999999853 3334456788999999886 477888888888899999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc---CCcEEEeccCcccccc
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---RGAIKLGDFGVSACLF 162 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---~g~vKL~DFGla~~~~ 162 (636)
+||+.. |.+|.+++.-. ...|+..++.-++.|++.-++|+|.+++|||||||+|+|+.- ...+.|+|||+|+.+.
T Consensus 88 lVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999998 67888887654 467999999999999999999999999999999999999963 3478999999999876
Q ss_pred cCCCcc----cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHH---HHHhcCCCCC
Q 006664 163 DSGDRQ----RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL---MTLQNAPPGL 235 (636)
Q Consensus 163 ~~~~~~----~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~---~~~~~~~~~~ 235 (636)
+..... +......||..|.+-....+ ...+.+.|+-|+|.+|.++.-|..||.+.......+ .+........
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 654332 22335689999988776655 445778999999999999999999999866544332 2222111111
Q ss_pred CcccchhhhHHHHHHHHhhcccCCCCCCCHH
Q 006664 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAK 266 (636)
Q Consensus 236 ~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~ 266 (636)
.-.....++.+|.-.+.-|-..--++-|+..
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 1122357888999999988877766777644
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=217.94 Aligned_cols=253 Identities=19% Similarity=0.243 Sum_probs=198.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~i 86 (636)
+..-.|.++++||.|+||..|.|.+.-+++.||||.-.. ..+..+++.|.+.++.|. .++|...|.+-..+.+-.+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr---kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR---KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccc---cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 556789999999999999999999999999999998543 345667889999999885 7999999988888888999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-----cEEEeccCccccc
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-----AIKLGDFGVSACL 161 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-----~vKL~DFGla~~~ 161 (636)
|||+. |-+|.|++.-. .+.|+..++..++.|++.-++|+|++..|+|||||+|+||...+ .|.|+|||+|+.+
T Consensus 102 VidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 99998 67899888764 47799999999999999999999999999999999999997543 6899999999988
Q ss_pred ccCCCcc----cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHH--HHHHHHhcCCCCC
Q 006664 162 FDSGDRQ----RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK--VLLMTLQNAPPGL 235 (636)
Q Consensus 162 ~~~~~~~----~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~--~l~~~~~~~~~~~ 235 (636)
.+..... +......||-+||+=.-..+ ...+.+.|+-|||-+++++|-|.+||.+..... .-.+.+-......
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred cCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 7665433 33456789999999887776 567888999999999999999999998764432 2222222211111
Q ss_pred C-cccchhhhHHHHHHHHhhcccCCCCCCCHH
Q 006664 236 D-YERDRKFSKSFKQMIASCLVKDPSKRPSAK 266 (636)
Q Consensus 236 ~-~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~ 266 (636)
. ......++.+|..-+.-.-..+-.+-|+.+
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 1 112235666776666655544444444433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-25 Score=251.33 Aligned_cols=231 Identities=26% Similarity=0.418 Sum_probs=181.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
..+|+.++.|..|+||.||.+.++.+.+.+|+| +++.. . +.|- |+..-..|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~--l----ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN--L----ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc--h----hhhc--cccccCCccee-----------------
Confidence 478999999999999999999999999999995 43221 1 1111 44444556555
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC----
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG---- 165 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~---- 165 (636)
||+..+++.. +.++.. ++.+++|||+.||+|||+||+|.+|..=|++|++|||++....-..
T Consensus 136 ----gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ----GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ----chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 7899999875 445443 2889999999999999999999999999999999999976532111
Q ss_pred --------CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 166 --------DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 166 --------~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
.++......||||.|.|||++.. ++|+..+|||++|+|+||++-|..||.+..+.+.+-..+.......
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp-- 278 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP-- 278 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc--
Confidence 11112234599999999999986 7899999999999999999999999999988887766654332111
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCC---CHHHHHhCcccccccChHHH
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRP---SAKKLLKHSFFKQARSNEYI 283 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRp---sa~elL~Hpffk~~~~~~~i 283 (636)
+....+.++++++|.++|..+|..|. .+-++.+|+||+..++...+
T Consensus 279 E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~ll 327 (1205)
T KOG0606|consen 279 EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLL 327 (1205)
T ss_pred ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhh
Confidence 22456789999999999999999994 67899999999998887544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-23 Score=201.29 Aligned_cols=139 Identities=17% Similarity=0.123 Sum_probs=111.3
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-h------------------------HHHHHHHHHHHHhCCCCC
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-D------------------------LSNISREAQTMILVDHPN 70 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~------------------------~~~i~rEi~iL~~L~HPN 70 (636)
...||+|+||.||+|.+. +|+.||||+++...... . .....+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 89999999997543210 0 122345999999998888
Q ss_pred cceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccccCcccEEEccCCc
Q 006664 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYL-HHHGHIHRDVKSGNILIDVRGA 149 (636)
Q Consensus 71 IVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yL-H~~gIvHRDLKP~NILld~~g~ 149 (636)
|...+..... ..++||||++|+++...+... ..+++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7554433322 238999999998776554332 5789999999999999999999 799999999999999998 588
Q ss_pred EEEeccCcccc
Q 006664 150 IKLGDFGVSAC 160 (636)
Q Consensus 150 vKL~DFGla~~ 160 (636)
++|+|||+|..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=200.22 Aligned_cols=173 Identities=13% Similarity=0.165 Sum_probs=133.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--hhHHH------HHHHHHHHHhCCCCCcceeeeEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--SDLSN------ISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--~~~~~------i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
+...+|..++.||.|+||.||++.. ++..+|||++...... ..... +.+|+..+.++.||+|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3468999999999999999999654 4778999999643322 12222 579999999999999999988866
Q ss_pred eC--------CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEE
Q 006664 80 SD--------HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151 (636)
Q Consensus 80 ~~--------~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vK 151 (636)
.. +..++||||++|.+|.++.. +++ ..+.+++.+|..||..|++|||+||+||+++.+| ++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 43 35899999999999987632 333 2466999999999999999999999999999888 99
Q ss_pred EeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHH
Q 006664 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELA 209 (636)
Q Consensus 152 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLl 209 (636)
|+|||........... . .++.. ..|+.++||||||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~-----d----------~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-----D----------RIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH-----H----------HHHHH-hHhcccccccceeEeehHHH
Confidence 9999987644211100 0 02222 45778999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-22 Score=193.34 Aligned_cols=140 Identities=20% Similarity=0.162 Sum_probs=112.9
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--------------------hh-----HHHHHHHHHHHHhCCCCC
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--------------------SD-----LSNISREAQTMILVDHPN 70 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--------------------~~-----~~~i~rEi~iL~~L~HPN 70 (636)
.+.||+|+||.||+|.+. +|+.||||+++..... .. .....+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 8999999999765311 00 123468999999999999
Q ss_pred cceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCCc
Q 006664 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRGA 149 (636)
Q Consensus 71 IVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g~ 149 (636)
|.....+.... .|+||||++|+++....... ..+++..+..++.|++.++.++|. +||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 86555444332 48999999998654432222 467888999999999999999999 9999999999999998 899
Q ss_pred EEEeccCccccc
Q 006664 150 IKLGDFGVSACL 161 (636)
Q Consensus 150 vKL~DFGla~~~ 161 (636)
++|+|||++..+
T Consensus 156 ~~liDFG~a~~~ 167 (190)
T cd05145 156 PYIIDVSQAVEL 167 (190)
T ss_pred EEEEEcccceec
Confidence 999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=203.08 Aligned_cols=235 Identities=23% Similarity=0.350 Sum_probs=152.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--hhHHHHHHHHHHHHhCCC----------CCcceeeeEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--SDLSNISREAQTMILVDH----------PNVLKSHCSFV 79 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--~~~~~i~rEi~iL~~L~H----------PNIVkl~~~~~ 79 (636)
.+...+.||.|+++.||.+.+..||+.+|+|++-..... ...+.+++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 356678999999999999999999999999999765532 356777777755554322 12222223222
Q ss_pred ---------eC---C-----eEEEEEeccCCCCHHHHHHH---hCCCCCCHH-HH-HHHHHHHHHHHHHHHHCCCccccc
Q 006664 80 ---------SD---H-----NLWVVMPFMSGGSCLHILKA---AYPDGFEEV-VI-ATILREVLKGLDYLHHHGHIHRDV 137 (636)
Q Consensus 80 ---------~~---~-----~l~iVmEy~~GGsL~~lL~~---~~~~~lse~-~i-~~i~~QIl~aL~yLH~~gIvHRDL 137 (636)
.. . +.+++|+-+. +||.+++.. ......... .+ ..+..|++..+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 2467888875 478776543 322211222 22 344589999999999999999999
Q ss_pred CcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhc-------cCCCcccchhhHHHHHHHHHc
Q 006664 138 KSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL-------HGYDFKADIWSFGITALELAH 210 (636)
Q Consensus 138 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~-------~~ys~ksDIWSLGiiLyeLlt 210 (636)
+|+|+|++.+|.++|+||+..... +.... ....++.|.+||..... ..++.+.|.|+||+++|.|.+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~---g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRA---GTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEET---TEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeec---Cceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999876543 22211 13456889999987553 247889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCC
Q 006664 211 GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR 262 (636)
Q Consensus 211 G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kR 262 (636)
|..||....+... ...++.....++..++.||..+|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~---------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEAD---------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGST---------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccc---------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999986433211 111233334789999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=232.91 Aligned_cols=250 Identities=24% Similarity=0.251 Sum_probs=183.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchh---HHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD---LSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~---~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
+|...+.||.+.|=+|.+|++. .|. |+||++-+....-. ..+..+|++ ...++|||.+.+..+...+...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 7999999999999999999875 344 89999855443322 333344555 56779999999998888888999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
+|... +|+|.+..+ .-+...+.+.|+.||+.||.-||..||+|||||.+||||..=+=+.|+||..-+-.+-..+..
T Consensus 101 qyvkh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHhh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99975 899999875 346777888999999999999999999999999999999876778999998654433222222
Q ss_pred cc----cccccCCCCCCChhhhhhcc---------C-CCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCC
Q 006664 169 RM----RNTFVGTPCWMAPEVMEQLH---------G-YDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPP 233 (636)
Q Consensus 169 ~~----~~~~~GT~~YmAPEvl~~~~---------~-ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~ 233 (636)
.. ..|...-.||.|||.+.... . .+++-||||+||+++||++ |++||.- .++...-.+..-
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCcc
Confidence 21 22223345799999986421 1 5678999999999999988 8999952 112111111000
Q ss_pred CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 234 ~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
........--+..+++||..|++.||.+|.++++.|+.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00000011123478999999999999999999999974
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-21 Score=189.04 Aligned_cols=189 Identities=14% Similarity=0.088 Sum_probs=142.4
Q ss_pred EEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc---hhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEEEEe
Q 006664 14 TLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN---SDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 14 ~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~---~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.+...|++|+||+||++.. .+..++.+.+...... .....+.+|+++|+.|. |++|++++++ ...|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4578899999999998765 6788887777544321 11225789999999995 5889999875 45799999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccc-CcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDV-KSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDL-KP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
|+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|......+...
T Consensus 79 yI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9999998654321 1 1357889999999999999999999 7999999999999999999997543222100
Q ss_pred cc----------cccccCCCCCCChhhhhhccCCC-cccchhhHHHHHHHHHcCCCCCCC
Q 006664 169 RM----------RNTFVGTPCWMAPEVMEQLHGYD-FKADIWSFGITALELAHGHAPFSK 217 (636)
Q Consensus 169 ~~----------~~~~~GT~~YmAPEvl~~~~~ys-~ksDIWSLGiiLyeLltG~~PF~~ 217 (636)
+. ..-..+++.|++|+...-....+ ...++++.|+.+|.++||..|+..
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00 11123789999999765433333 567999999999999999988754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=203.80 Aligned_cols=248 Identities=27% Similarity=0.366 Sum_probs=174.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCc-----------------------------------EEEEEEee-cCCCch--
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNE-----------------------------------IVAVKILD-FERDNS-- 51 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~-----------------------------------~vAIK~i~-~~~~~~-- 51 (636)
-++|++++.||+|+.+.||.|....+|. +.|||.+- .+....
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 4889999999999999999987654221 24566542 222211
Q ss_pred -hHHHHHHHHH-------H-------HHh--------CCCCCcceeeeEEEe---------------------------C
Q 006664 52 -DLSNISREAQ-------T-------MIL--------VDHPNVLKSHCSFVS---------------------------D 81 (636)
Q Consensus 52 -~~~~i~rEi~-------i-------L~~--------L~HPNIVkl~~~~~~---------------------------~ 81 (636)
.+..+.+|.- . .+. -.|||||+++..|.+ +
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 1222222321 0 111 259999999888743 2
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc--cCC--cEEEeccCc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID--VRG--AIKLGDFGV 157 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld--~~g--~vKL~DFGl 157 (636)
..+|+||..... +|+.++-.. ..+.-..+-++.|+++|+.|||++||.|||+|.+|||+. .++ .+.|+|||.
T Consensus 316 ~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 316 KTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred ceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 358999998765 899998764 467778889999999999999999999999999999993 333 588999997
Q ss_pred ccccccCCCccc-----ccccccCCCCCCChhhhhhccC-----CCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 006664 158 SACLFDSGDRQR-----MRNTFVGTPCWMAPEVMEQLHG-----YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT 227 (636)
Q Consensus 158 a~~~~~~~~~~~-----~~~~~~GT~~YmAPEvl~~~~~-----ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~ 227 (636)
|- .+.....+ .....-|.-.-||||+.....+ .-.++|.|++|.+.||++....||.+...+..-...
T Consensus 392 cL--Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~ 469 (598)
T KOG4158|consen 392 CL--ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT 469 (598)
T ss_pred ee--eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence 63 22221111 1123358888999999875433 124799999999999999999999875554433333
Q ss_pred HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHH
Q 006664 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAK 266 (636)
Q Consensus 228 ~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~ 266 (636)
.+.... ...+..+++.+++++..+|+.||.+|++..
T Consensus 470 Yqe~qL---Palp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 470 YQESQL---PALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hhhhhC---CCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 322211 123467889999999999999999999853
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=188.90 Aligned_cols=135 Identities=19% Similarity=0.188 Sum_probs=108.9
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-----CCCCcceeeeEEEeCC---eEE-
Q 006664 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-----DHPNVLKSHCSFVSDH---NLW- 85 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-----~HPNIVkl~~~~~~~~---~l~- 85 (636)
-.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ +||||+++|+++.++. .++
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 356899999999995 6666666 6999876432 2456789999999999 6799999999999874 434
Q ss_pred EEEec--cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHH-HHHHHCCCcccccCcccEEEcc----CCcEEEeccCcc
Q 006664 86 VVMPF--MSGGSCLHILKAAYPDGFEEVVIATILREVLKGL-DYLHHHGHIHRDVKSGNILIDV----RGAIKLGDFGVS 158 (636)
Q Consensus 86 iVmEy--~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL-~yLH~~gIvHRDLKP~NILld~----~g~vKL~DFGla 158 (636)
+|||| +.+|+|.++++.. .+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+-+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 5579999999763 46666 35688888888 9999999999999999999974 337999995544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7e-23 Score=233.35 Aligned_cols=267 Identities=21% Similarity=0.314 Sum_probs=220.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEc-CCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCI-PFNEIVAVKILDFER-DNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~-~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~i 86 (636)
...|.+.+.||+|+|+.|-.+... .+...+|.|.+.... ......++..|..+-+.+. |+|++.+++...+....++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 467899999999999999998764 345667777776553 3445667778998888887 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccccCcccEEEccCC-cEEEeccCcccccccC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH-HHGHIHRDVKSGNILIDVRG-AIKLGDFGVSACLFDS 164 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH-~~gIvHRDLKP~NILld~~g-~vKL~DFGla~~~~~~ 164 (636)
+++|..||+++..+........+...+..++.|+..++.|+| ..|+.||||||+|.+++..+ .++++|||+|..+...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999999884222226778889999999999999999 99999999999999999999 9999999999877663
Q ss_pred CCcccccccccC-CCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVG-TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~G-T~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
....+.....+| ++.|+|||.+.+.....+..|+||+|+++.-+++|..||........................+..+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 445556667789 9999999999875567888999999999999999999997644433222222222222344566788
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
+....+++.++|..+|..|.+.+++..++|+..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ChhhhhcccccccCCchhccccccccccccccc
Confidence 999999999999999999999999999999986
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=188.77 Aligned_cols=247 Identities=22% Similarity=0.365 Sum_probs=195.1
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
|...+..++.+|.....|..|+|++. |..++.|+++...... ....+..|.-.|+-+.||||+.+++.+....++.+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 45566778889999999999999986 5557778886544332 23456778888888899999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCcccEEEccCCcEEE--eccCcccccc
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG--HIHRDVKSGNILIDVRGAIKL--GDFGVSACLF 162 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHRDLKP~NILld~~g~vKL--~DFGla~~~~ 162 (636)
|..||+.|+|+..+.....-..+..++.+++.+++.|+.|||+.. |.---|....+++|++.+.+| +|--++ +
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs---f 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS---F 341 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee---e
Confidence 999999999999998865445677899999999999999999973 334458888999998876554 443222 1
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccC--CCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHG--YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~--ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
.. ......|.||+||.++.... .-.++|+|||.+++|||.+...||.+.++++.-..+ .-.+++...+
T Consensus 342 qe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---aleglrv~ip 411 (448)
T KOG0195|consen 342 QE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---ALEGLRVHIP 411 (448)
T ss_pred ec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---hhccccccCC
Confidence 11 12345789999999976332 234699999999999999999999999988754333 2345566677
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLL 269 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL 269 (636)
+.++..+..|+.-|++.||.+||.++.++
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 89999999999999999999999987664
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-19 Score=207.92 Aligned_cols=202 Identities=20% Similarity=0.271 Sum_probs=163.5
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC---CCCcceeeeEEE
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD---HPNVLKSHCSFV 79 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~---HPNIVkl~~~~~ 79 (636)
+..+++..+.|.+-+.||+|+||+||+|.... |+.||+|+-.-....+ +.--.+++.+|+ -+.|+.++.++.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHc
Confidence 35678899999999999999999999999876 9999999865443322 112233344444 356677777777
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-------CCcEEE
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-------RGAIKL 152 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-------~g~vKL 152 (636)
-.+.-++|+||.+.|+|.+++.. ...+++..+..+..|++..|++||..||||+||||+|+||.. ...++|
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred cCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence 78888999999999999999984 478999999999999999999999999999999999999942 346999
Q ss_pred eccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCC
Q 006664 153 GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHA 213 (636)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~ 213 (636)
+|||.+--|.--.+. ......++|-.+--+|+..| ..+++.+|.|.|+.++|-||+|+.
T Consensus 843 IDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCC-cEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 999998654322121 22346788999999999987 789999999999999999999854
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=183.94 Aligned_cols=143 Identities=20% Similarity=0.117 Sum_probs=114.0
Q ss_pred CCeEEEeEEcccCceEEEEEE-EcCCCcEEEEEEeecCCCch-----------------------hHHHHHHHHHHHHhC
Q 006664 11 EHYTLYEEVGQGVSASVHRAL-CIPFNEIVAVKILDFERDNS-----------------------DLSNISREAQTMILV 66 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~-~~~tg~~vAIK~i~~~~~~~-----------------------~~~~i~rEi~iL~~L 66 (636)
-.|.+.+.||+|+||.||+|. +..+|+.||||+++...... ....+.+|+.+++.+
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 67899999999997543110 112357899999999
Q ss_pred CCCC--cceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccccCcccEE
Q 006664 67 DHPN--VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG-HIHRDVKSGNIL 143 (636)
Q Consensus 67 ~HPN--IVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g-IvHRDLKP~NIL 143 (636)
.+.+ +.++++. ...|+||||+.|++|...+... ..+.+..+..++.||+.+|.|||.+| |+||||||+||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 7633 3444432 2358999999998887655332 34666778899999999999999999 999999999999
Q ss_pred EccCCcEEEeccCcccc
Q 006664 144 IDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 144 ld~~g~vKL~DFGla~~ 160 (636)
++ ++.++|+|||.+..
T Consensus 182 i~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 182 VH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EE-CCCEEEEEChhhhc
Confidence 98 88999999998764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-19 Score=175.17 Aligned_cols=135 Identities=22% Similarity=0.288 Sum_probs=114.7
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-h------hHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-S------DLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~------~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
+.||+|++|.||+|.+ .|..|++|+....... . ....+.+|+.++..+.|++|.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 6788999986532211 1 12457889999999999999887777778888999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
|++|++|.+++.... . ....++.+++.+|.+||..|++|||++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999986531 2 7788999999999999999999999999999998 88999999998764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=189.64 Aligned_cols=239 Identities=26% Similarity=0.411 Sum_probs=171.3
Q ss_pred HHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-cccccCccc
Q 006664 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH-IHRDVKSGN 141 (636)
Q Consensus 63 L~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gI-vHRDLKP~N 141 (636)
|+.+.|.|+.++++...++..+++|.+||..|+|.+.+... .-.++......++++|+.||.|||.-.| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 45688999999999999999999999999999999999874 3568888889999999999999998866 999999999
Q ss_pred EEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccC------CCcccchhhHHHHHHHHHcCCCCC
Q 006664 142 ILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG------YDFKADIWSFGITALELAHGHAPF 215 (636)
Q Consensus 142 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~------ys~ksDIWSLGiiLyeLltG~~PF 215 (636)
.++|....+||+|||+......... ........-...|.|||.+.+... .+.++||||||+++||+++...||
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~-~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAE-PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred ceeeeeEEEEechhhhccccccccc-ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999876532100 001111123456999999976321 466799999999999999999999
Q ss_pred CCC----ChHHHHHHHHhcCCCCCCccc--chhhhHHHHHHHHhhcccCCCCCCCHHHHHhC--cccccccChHHHHHHH
Q 006664 216 SKY----PPMKVLLMTLQNAPPGLDYER--DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQARSNEYIARTL 287 (636)
Q Consensus 216 ~~~----~~~~~l~~~~~~~~~~~~~~~--~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H--pffk~~~~~~~i~~~l 287 (636)
... .+.+.+..+.......+.... .....+++..+++.||..+|.+||+++++-.. ..++.......+...+
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~~~nl~D~m 238 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSSKGNLMDSL 238 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccccchhHHHH
Confidence 752 233333332221222222111 11455679999999999999999999988541 1122111112444555
Q ss_pred hccCcchHHHHHHHHH
Q 006664 288 LEGLPALGDRIKALKK 303 (636)
Q Consensus 288 l~~l~~l~~~i~~l~~ 303 (636)
...++.+.+..+.+.+
T Consensus 239 ~~~le~Y~~nLe~~v~ 254 (484)
T KOG1023|consen 239 FRMLESYADNLEKLVD 254 (484)
T ss_pred HHHHHHHHhhhHHHHH
Confidence 5555655554444433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.7e-20 Score=197.28 Aligned_cols=250 Identities=19% Similarity=0.244 Sum_probs=162.7
Q ss_pred eEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceee------eEEEe--
Q 006664 13 YTLYEEVGQGVSASVHRALCIPF---NEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSH------CSFVS-- 80 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~t---g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~------~~~~~-- 80 (636)
+.+.+..+.+++|.++...-..+ .+.++-+..+.+... ......+++-.+... .|+..+..- ..+..
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~-~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~ 324 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLC-ACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNK 324 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchh-hhhhhhhhhhheeccccCCcccccCCCCchhhhccccc
Confidence 44455566666666665543322 334444444333311 222334455444443 455443321 11211
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccC
Q 006664 81 ---DHNLWVVMPFMSGGSCLHILKAAY-PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFG 156 (636)
Q Consensus 81 ---~~~l~iVmEy~~GGsL~~lL~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFG 156 (636)
..++||.|++|.-++|.++|.... ....+......++.|+..|++| +|.+|||+||.||++..+..+||+|||
T Consensus 325 v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 325 VGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhh
Confidence 236899999999999999997432 2346677889999999999999 999999999999999988999999999
Q ss_pred cccccccCC---CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCC
Q 006664 157 VSACLFDSG---DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAP 232 (636)
Q Consensus 157 la~~~~~~~---~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~ 232 (636)
+...+.... .........+||++||+||.+.+ ..|+.++||||||+|||||+. =..+|..... ...++...
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t----~~d~r~g~ 476 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFERIAT----LTDIRDGI 476 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHHHHh----hhhhhcCC
Confidence 987654332 11223456789999999999987 789999999999999999996 2223222111 11111111
Q ss_pred CCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 233 ~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
.. +....--++-.+|+.++|.+.|.+||++.+.--|.|.
T Consensus 477 ip---~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 477 IP---PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CC---hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 00 0000111344689999999999999977766666654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-18 Score=169.87 Aligned_cols=131 Identities=19% Similarity=0.230 Sum_probs=108.0
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeecCCC-c------hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERD-N------SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 18 ~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~------~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
.||+|+||.||+|.. +|..|++|+...... . ....++.+|++++..+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999984 678899998643221 1 1235678899999999998876655566677778999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
++|++|.+++.... . .++.+++.+|.+||+.|++|||++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998876531 1 7899999999999999999999999999998 89999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-18 Score=168.62 Aligned_cols=137 Identities=23% Similarity=0.184 Sum_probs=109.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc---------------------hhHHHHHHHHHHHHhCCCCC
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN---------------------SDLSNISREAQTMILVDHPN 70 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~---------------------~~~~~i~rEi~iL~~L~HPN 70 (636)
-|.+.+.||.|+||.||++... +|+.||||+++..... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999874 8999999998654310 01123578999999998874
Q ss_pred --cceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC
Q 006664 71 --VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG 148 (636)
Q Consensus 71 --IVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g 148 (636)
+...++ ....++||||++|++|..+... .....++.+++.++.++|..||+||||||+||+++.++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444443 3456899999999998765421 34567889999999999999999999999999999999
Q ss_pred cEEEeccCccccc
Q 006664 149 AIKLGDFGVSACL 161 (636)
Q Consensus 149 ~vKL~DFGla~~~ 161 (636)
.++|+|||++...
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 9999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=186.90 Aligned_cols=136 Identities=18% Similarity=0.229 Sum_probs=110.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecC--CCc-----hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFE--RDN-----SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~--~~~-----~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
.|...+.||+|+||+||+|.+.. ..+++|+.... ... ....++.+|+.+++.++|++|+..+.++.+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34557899999999999998743 33444443211 111 1235678999999999999999887777777788
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
++||||++|++|.+++. ....++.+++.+|.|||++|++||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999885 235789999999999999999999999999999 588999999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=155.18 Aligned_cols=136 Identities=24% Similarity=0.213 Sum_probs=100.4
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-hHH----------------------HHHHHHHHHHhCCCCC--
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLS----------------------NISREAQTMILVDHPN-- 70 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-~~~----------------------~i~rEi~iL~~L~HPN-- 70 (636)
++.||+|+||+||+|.+. +|+.||||++....... ... ....|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 89999999986543211 111 1145677776665443
Q ss_pred cceeeeEEEeCCeEEEEEeccCCCCHHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCC
Q 006664 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRG 148 (636)
Q Consensus 71 IVkl~~~~~~~~~l~iVmEy~~GGsL~~-lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g 148 (636)
+.+++++ ...++||||+.|+.+.. .+... .. ...++.++.+++.++.++|. +||+||||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh---hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4455443 24699999999965432 22221 01 15678999999999999999 9999999999999999 89
Q ss_pred cEEEeccCccccc
Q 006664 149 AIKLGDFGVSACL 161 (636)
Q Consensus 149 ~vKL~DFGla~~~ 161 (636)
.++|+|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.3e-15 Score=155.50 Aligned_cols=135 Identities=15% Similarity=0.126 Sum_probs=104.5
Q ss_pred eEEc-ccCceEEEEEEEcCCCcEEEEEEeecCC-------C-----chhHHHHHHHHHHHHhCCCCCc--ceeeeEEEeC
Q 006664 17 EEVG-QGVSASVHRALCIPFNEIVAVKILDFER-------D-----NSDLSNISREAQTMILVDHPNV--LKSHCSFVSD 81 (636)
Q Consensus 17 ~~IG-~G~fG~Vyka~~~~tg~~vAIK~i~~~~-------~-----~~~~~~i~rEi~iL~~L~HPNI--Vkl~~~~~~~ 81 (636)
..|| .|+.|+||++.. .+..+|||.+.... . ......+.+|+.++..|.|++| ++.+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3577 788888888865 37889999885321 0 1233568899999999998885 6666654332
Q ss_pred -Ce---EEEEEeccCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccC
Q 006664 82 -HN---LWVVMPFMSG-GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFG 156 (636)
Q Consensus 82 -~~---l~iVmEy~~G-GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFG 156 (636)
.. .++||||++| .+|.+++.. ..+++. .+.+|+.+|.+||.+||+||||||+|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 22 3599999998 699888865 345554 35789999999999999999999999999988999999999
Q ss_pred cccc
Q 006664 157 VSAC 160 (636)
Q Consensus 157 la~~ 160 (636)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.3e-16 Score=141.22 Aligned_cols=131 Identities=21% Similarity=0.190 Sum_probs=111.3
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCC--CCcceeeeEEEeCCeEEEEEeccC
Q 006664 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDH--PNVLKSHCSFVSDHNLWVVMPFMS 92 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~H--PNIVkl~~~~~~~~~l~iVmEy~~ 92 (636)
+++.||.|.++.||++.+. +..+++|....... ...+.+|+.+++.+.| +++++++.++...+..|++|||+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 4678999999999999874 37899999854332 4568899999999976 589999998888889999999999
Q ss_pred CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccccCcccEEEccCCcEEEeccCccc
Q 006664 93 GGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH---GHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 93 GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~---gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
|+.+..+ +......++.+++.+|.+||.. +++|||++|+||+++..+.++++|||.+.
T Consensus 77 g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 77 GETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred CeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 9876543 3455667889999999999985 79999999999999988999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.7e-17 Score=187.21 Aligned_cols=270 Identities=24% Similarity=0.366 Sum_probs=218.9
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
|-...+.+.+.+-+-.|+++.++.+.-..+|...++|+..+... ....+.++++-.++-.-.||.++..+..|.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 77888999999999999999999998888898888887754321 1234455666666655677888888877788889
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc-
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF- 162 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~- 162 (636)
++++|+|..|++|...|... +..+++.++.++..+..+++|||...+.|||++|.|+|...+|+.+++|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred cchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999999999999876 568888889999999999999999999999999999999999999999998432211
Q ss_pred -----cC-C---------------------CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCC
Q 006664 163 -----DS-G---------------------DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF 215 (636)
Q Consensus 163 -----~~-~---------------------~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF 215 (636)
+. + ...+.....+||+.|.+||.+.+ ......+|+|++|++++|.++|.+||
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 00022345689999999999987 56788899999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHH---HHHhCcccccccCh
Q 006664 216 SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAK---KLLKHSFFKQARSN 280 (636)
Q Consensus 216 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~---elL~Hpffk~~~~~ 280 (636)
....+...+..+.....+... -+...+.++.+++.+.|..+|.+|..+. +.-.|+||+...+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~--g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPE--GPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred CCcchhhhhhccccCCCCCCC--CccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence 998888877666654433222 2346788999999999999999998877 99999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.8e-15 Score=165.35 Aligned_cols=258 Identities=21% Similarity=0.232 Sum_probs=197.1
Q ss_pred cCCCCeEEEeEEcc--cCceEEEEEEE--cCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCC-CCCcceeeeEEEeC
Q 006664 8 IGAEHYTLYEEVGQ--GVSASVHRALC--IPFNEIVAVKILDFERD-NSDLSNISREAQTMILVD-HPNVLKSHCSFVSD 81 (636)
Q Consensus 8 i~~~~Y~l~~~IG~--G~fG~Vyka~~--~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~ 81 (636)
.....+.+...+|. |.+|.||.+.+ ..++..+|+|.-+.... ...-.+=.+|+...+.++ |+|.++.+..|...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 44466778889999 99999999998 88999999998433222 122223346777666775 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH----HHHHHHHCCCcccccCcccEEEccC-CcEEEeccC
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK----GLDYLHHHGHIHRDVKSGNILIDVR-GAIKLGDFG 156 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~----aL~yLH~~gIvHRDLKP~NILld~~-g~vKL~DFG 156 (636)
+.+|+-+|+|. .+|..+..... ..+++..++.++.+... ||.++|..+++|-|+||+||++..+ ...+++|||
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred Ccceeeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 99999999996 68888776642 34889999999999999 9999999999999999999999988 889999999
Q ss_pred cccccccCCCcccc--cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCC--ChHHHHHHHHhcCC
Q 006664 157 VSACLFDSGDRQRM--RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKY--PPMKVLLMTLQNAP 232 (636)
Q Consensus 157 la~~~~~~~~~~~~--~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~--~~~~~l~~~~~~~~ 232 (636)
+...+.+.+-.... .....|...|++||.+.+ -++...|||++|.+..+-..|..++... .....+. +.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r----~~- 341 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR----QG- 341 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc----cc-
Confidence 98776544321111 112257888999999975 5889999999999999998877665432 1111111 10
Q ss_pred CCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 233 ~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
.+..+.....+..+...+..|+..||..|+++..++.|+++.
T Consensus 342 -~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 342 -YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred -cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 011122234556667799999999999999999999999986
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=6.4e-15 Score=151.70 Aligned_cols=215 Identities=23% Similarity=0.343 Sum_probs=152.5
Q ss_pred HHHHhCCCCCcceeeeEEEeCC-----eEEEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC--C
Q 006664 61 QTMILVDHPNVLKSHCSFVSDH-----NLWVVMPFMSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLHHH--G 131 (636)
Q Consensus 61 ~iL~~L~HPNIVkl~~~~~~~~-----~l~iVmEy~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~--g 131 (636)
..+..+.|-|||+++.+|.+.. ...+++|||.-|++..+|++.. ...+......+|+.||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3445667999999999997654 4889999999999999998642 23477888899999999999999998 5
Q ss_pred CcccccCcccEEEccCCcEEEeccCcccccccC-CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc
Q 006664 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS-GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH 210 (636)
Q Consensus 132 IvHRDLKP~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt 210 (636)
|+|+++...-|++..+|-+|++--........- ......+....|-+.|.|||.=.. .+.+.++|||+||..+.+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHH
Confidence 999999999999999999998632221111000 001111222346788999997543 446778999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccChHHH
Q 006664 211 GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYI 283 (636)
Q Consensus 211 G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~~i 283 (636)
|..--............+.+...++... .-+++|.+||.-.|..||++.+++.||..-++......
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~len~-------lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslkll 343 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGLENG-------LQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLKLL 343 (458)
T ss_pred heeccCCCcceeehhhhhhhheeeccCc-------cccCcCcccccCCCCCCcchhhhhcCceeeecchHHHH
Confidence 8765332222222223333322222211 22467999999999999999999999998877654433
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.5e-14 Score=159.74 Aligned_cols=143 Identities=22% Similarity=0.250 Sum_probs=96.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc---------------------------------hhHHHH-
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN---------------------------------SDLSNI- 56 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~---------------------------------~~~~~i- 56 (636)
.+|+. +.||.|++|.||+|..+.+|+.||||++...... .....+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 7899999999999999888999999999633100 011223
Q ss_pred -----HHHHHHHHhC----CCCCcceeeeEEEe-CCeEEEEEeccCCCCHHHH--HHHhCC--CCCCHHHHHHHHHHHHH
Q 006664 57 -----SREAQTMILV----DHPNVLKSHCSFVS-DHNLWVVMPFMSGGSCLHI--LKAAYP--DGFEEVVIATILREVLK 122 (636)
Q Consensus 57 -----~rEi~iL~~L----~HPNIVkl~~~~~~-~~~l~iVmEy~~GGsL~~l--L~~~~~--~~lse~~i~~i~~QIl~ 122 (636)
.+|+..+.++ .+.+.+.+-.+|.+ ....++|||||+|+.+.++ +..... ..+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 3344333333 13332332222222 4456799999999999874 332200 0244555556666664
Q ss_pred HHHHHHHCCCcccccCcccEEEccCC----cEEEeccCccccc
Q 006664 123 GLDYLHHHGHIHRDVKSGNILIDVRG----AIKLGDFGVSACL 161 (636)
Q Consensus 123 aL~yLH~~gIvHRDLKP~NILld~~g----~vKL~DFGla~~~ 161 (636)
..|++|+|+||+||+++.+| .++++|||++..+
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 58999999999999999887 9999999998765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.4e-13 Score=150.53 Aligned_cols=140 Identities=24% Similarity=0.323 Sum_probs=97.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch---hH------------------------------------HHHH
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS---DL------------------------------------SNIS 57 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~---~~------------------------------------~~i~ 57 (636)
+.||.|++|.||+|.. .+|+.||||+........ +. -++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 479999999985321000 00 0234
Q ss_pred HHHHHHHhC-----CCCCcceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 006664 58 REAQTMILV-----DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK-GLDYLHHHG 131 (636)
Q Consensus 58 rEi~iL~~L-----~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~-aL~yLH~~g 131 (636)
+|...+..+ ++|+|.-..-++...+..++||||++|++|.++..... .+.. ...++..++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 455555554 24444322222233445799999999999988765421 1222 2345555555 477899999
Q ss_pred CcccccCcccEEEccCCcEEEeccCccccc
Q 006664 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 132 IvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
++|+|++|.||+++.+|.++|+|||++..+
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=7.8e-13 Score=147.56 Aligned_cols=185 Identities=18% Similarity=0.240 Sum_probs=142.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEecc
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~ 91 (636)
-|++ +..+-++.+.+-.|..+.++.+|.|.+++.... .....+.+-++.|+.++||||+++++.++.++.+|+|+|.+
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV 91 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV 91 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc
Confidence 3555 555555555443577788999999999986655 45667889999999999999999999999999999999998
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH-HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH-~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
. .|-.++++. ....+...+.||+.||.||| ..+++|++|.-..|+|+..|..||++|-++......+. .
T Consensus 92 ~--Pl~~~lk~l-----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~ 161 (690)
T KOG1243|consen 92 R--PLETVLKEL-----GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---P 161 (690)
T ss_pred c--cHHHHHHHh-----HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---c
Confidence 6 577778764 37778889999999999998 56899999999999999999999999998754322211 1
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcC
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG 211 (636)
.....---.|..|+.+.. -.-..|.|-|||++++++.|
T Consensus 162 ~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 AKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 111222233666765532 12457999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-13 Score=152.55 Aligned_cols=250 Identities=22% Similarity=0.181 Sum_probs=187.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEc-CCCcEEEEEEeecCCCch-hHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCI-PFNEIVAVKILDFERDNS-DLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~-~tg~~vAIK~i~~~~~~~-~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~i 86 (636)
..+|.++..||.|.|+.|+.+... .++..|++|......... ....-..|+.+...+ -|.+++.++..|......|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 468999999999999999998755 678899999875433221 111123566666555 59999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC-CcEEEeccCcccccccCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR-GAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~-g~vKL~DFGla~~~~~~~ 165 (636)
=-|||+|+++...+... ..+.+...+++..|++.++.++|+..++|+|+||.||++..+ +..+++|||.++.+.-.
T Consensus 344 p~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred chhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-
Confidence 99999999887766332 568889999999999999999999999999999999999875 78899999998643111
Q ss_pred CcccccccccCCCCCC-ChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 166 DRQRMRNTFVGTPCWM-APEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 166 ~~~~~~~~~~GT~~Ym-APEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
...+.+.-+++ .+|++.....+..++|++|||..+++.++|...=... .....+..+ .++.....+
T Consensus 421 -----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~~~-----~~p~~~~~~ 487 (524)
T KOG0601|consen 421 -----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIRSG-----DTPNLPGLK 487 (524)
T ss_pred -----cccccccccccccchhhccccccccccccccccccccccccCcccCccc---ccceeeecc-----cccCCCchH
Confidence 12333444555 3666666577889999999999999999976432211 111111111 123334455
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
.++..+.+.++..|+..|+.+.++..|.-|.
T Consensus 488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 488 LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 7889999999999999999999998887664
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.3e-12 Score=124.50 Aligned_cols=127 Identities=22% Similarity=0.217 Sum_probs=96.9
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcc-eeeeEEEeCCeEEEEEeccCCC
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL-KSHCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIV-kl~~~~~~~~~l~iVmEy~~GG 94 (636)
++.|+.|.++.||++... +..|++|+...... ......+|+.+++.+.+.+++ +++... ....++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 578999999999999864 78899999754322 123467899999988765554 455443 33458999999998
Q ss_pred CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----cccccCcccEEEccCCcEEEeccCccc
Q 006664 95 SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH-----IHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 95 sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gI-----vHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
++... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 77 ~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76543 01123467899999999999985 9999999999998 7789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-11 Score=122.83 Aligned_cols=138 Identities=17% Similarity=0.145 Sum_probs=102.8
Q ss_pred EeEEcccCceEEEEEEEcC------CCcEEEEEEeecCC------------C---------chhHHHH----HHHHHHHH
Q 006664 16 YEEVGQGVSASVHRALCIP------FNEIVAVKILDFER------------D---------NSDLSNI----SREAQTMI 64 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~------tg~~vAIK~i~~~~------------~---------~~~~~~i----~rEi~iL~ 64 (636)
...||.|.-+.||.|.... .+..+|||+..... . ......+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998653 35799999996321 0 0112233 38999999
Q ss_pred hCCC--CCcceeeeEEEeCCeEEEEEeccCCCCHHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccccCcc
Q 006664 65 LVDH--PNVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGLDYL-HHHGHIHRDVKSG 140 (636)
Q Consensus 65 ~L~H--PNIVkl~~~~~~~~~l~iVmEy~~GGsL~~-lL~~~~~~~lse~~i~~i~~QIl~aL~yL-H~~gIvHRDLKP~ 140 (636)
++.. -++.+++++ ..-++||||+.|+.+.. .++. ..+++..+..++.+++.+|.+| |..|+||+||++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 8853 455666654 46789999998764432 3332 2456667778899999999999 8999999999999
Q ss_pred cEEEccCCcEEEeccCccccc
Q 006664 141 NILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 141 NILld~~g~vKL~DFGla~~~ 161 (636)
|||++ ++.+.|+|||.+...
T Consensus 155 NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEE-CCcEEEEECCCceeC
Confidence 99996 678999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.4e-11 Score=116.08 Aligned_cols=140 Identities=15% Similarity=0.109 Sum_probs=104.4
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCC--CCcceeeeEEEeC---CeEEEEEec
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDH--PNVLKSHCSFVSD---HNLWVVMPF 90 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~H--PNIVkl~~~~~~~---~~l~iVmEy 90 (636)
++.||.|.++.||++... +|..+++|+............+.+|+.+++.+.+ .++.+++.+.... +..|+||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 367999999999999864 3688999997544332234568899999999875 3456677666553 367899999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH----------------------------------------- 129 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~----------------------------------------- 129 (636)
++|+++.+.+.. ..+++.....++.+++.+|.+||+
T Consensus 82 i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 82 VDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred eCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 999887664421 245666666777777777777773
Q ss_pred ---------------CCCcccccCcccEEEcc--CCcEEEeccCccc
Q 006664 130 ---------------HGHIHRDVKSGNILIDV--RGAIKLGDFGVSA 159 (636)
Q Consensus 130 ---------------~gIvHRDLKP~NILld~--~g~vKL~DFGla~ 159 (636)
..++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23589999999999987 5678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.1e-10 Score=108.18 Aligned_cols=143 Identities=23% Similarity=0.275 Sum_probs=112.8
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--Cc-----hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DN-----SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~-----~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
.+..|-+|+-+.|+++.+ .|+.+.||.-.... .+ -...+..+|++++.++.--.|.-..-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 678899999999999976 58888888653222 11 1245678899999988766776666677788888999
Q ss_pred EeccCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC---cEEEeccCccc
Q 006664 88 MPFMSG-GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSA 159 (636)
Q Consensus 88 mEy~~G-GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g---~vKL~DFGla~ 159 (636)
|||++| -++.+++...............+++.|=..+.-||.++|||+||..+||++..+| .+.|+|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999988 4677887766444444445578999999999999999999999999999997554 46899999974
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.7e-10 Score=107.30 Aligned_cols=131 Identities=25% Similarity=0.292 Sum_probs=100.1
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC-Cch------hHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNS------DLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~------~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
..|++|+-+.+|.+... |..+++|.-.... ... ...+..+|+.++.++.--.|.-.+-++.+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35889999999999663 4446666532221 111 13456789999998876666665656677788899999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
|++|..|.+.+... ...++..+=.-+.-||..||+|+||.++||++. ++.+.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~-~~~i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS-GGRIYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe-CCcEEEEECCccc
Confidence 99999888888764 145677788888899999999999999999996 4459999999975
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.2e-09 Score=114.99 Aligned_cols=215 Identities=18% Similarity=0.191 Sum_probs=157.1
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe----CCeEEEEEeccCC-CCHH
Q 006664 23 VSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS----DHNLWVVMPFMSG-GSCL 97 (636)
Q Consensus 23 ~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~----~~~l~iVmEy~~G-GsL~ 97 (636)
--.+.|++....+|..|++|.++-.+.... .....-++.++++.|+|||++.++|.. +..+++|++|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 446889999999999999999954432211 112345778999999999999999983 4568999999877 6777
Q ss_pred HHHHHhC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 98 HILKAAY-------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 98 ~lL~~~~-------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
++--... +.+.+|..+|.|+.||..||.++|+.|...+-|.|.+||++.+.+++|...|....+...
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 7543221 124788999999999999999999999999999999999998888999888876543221
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCC-CCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAP-FSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~P-F~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
. . |-+.+ -.+-|.=.||.+++.|.+|..- +............ ....+
T Consensus 447 ~---------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-----------I~~~y 494 (655)
T KOG3741|consen 447 P---------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-----------ITTTY 494 (655)
T ss_pred C---------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-----------hhhhh
Confidence 1 1 11222 1246889999999999998543 2111122111111 12567
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
|.+++++|.-+....+++ -++.+++.|
T Consensus 495 S~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 495 STDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 899999999999999987 688888864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=1e-08 Score=106.57 Aligned_cols=135 Identities=10% Similarity=0.010 Sum_probs=96.0
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCCCch----------hHHHHHHHHHHHHhCCCCCc--ceeeeEEEe-----CCeEE
Q 006664 23 VSASVHRALCIPFNEIVAVKILDFERDNS----------DLSNISREAQTMILVDHPNV--LKSHCSFVS-----DHNLW 85 (636)
Q Consensus 23 ~fG~Vyka~~~~tg~~vAIK~i~~~~~~~----------~~~~i~rEi~iL~~L~HPNI--Vkl~~~~~~-----~~~l~ 85 (636)
....|+++.. .|+.|.||......... ....+.+|...+..|..-+| +.+..+++. ....+
T Consensus 34 ~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 34 EGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred CCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 3334666543 57889999763221110 11137789999887743333 233333332 23578
Q ss_pred EEEeccCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-------CCcEEEeccCc
Q 006664 86 VVMPFMSGG-SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-------RGAIKLGDFGV 157 (636)
Q Consensus 86 iVmEy~~GG-sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-------~g~vKL~DFGl 157 (636)
+|||+++|. +|.+++........++.....++.+++..+.-||.+||+|+|+++.|||++. ++.+.|+||+.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999999986 8999886533345667788899999999999999999999999999999975 46899999997
Q ss_pred cc
Q 006664 158 SA 159 (636)
Q Consensus 158 a~ 159 (636)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 64
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.3e-10 Score=128.50 Aligned_cols=157 Identities=17% Similarity=0.289 Sum_probs=113.9
Q ss_pred HHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCcccccccCCCc------ccccccccCCCCCCChhhhhhccC
Q 006664 119 EVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR------QRMRNTFVGTPCWMAPEVMEQLHG 191 (636)
Q Consensus 119 QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~------~~~~~~~~GT~~YmAPEvl~~~~~ 191 (636)
+++.|+.|+|+. ++||+.|.|++|.++.+|.+||+.|+++.......+. ........-...|.|||++.+ ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 444899999987 8999999999999999999999999998654331110 111112234567999999987 66
Q ss_pred CCcccchhhHHHHHHHHH-cCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 192 YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 192 ys~ksDIWSLGiiLyeLl-tG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+.++|+||+||.+|.+. .|+.-|......... ....+....-.+.....++.++++=+.++|..|+..||++..++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 789999999999999999 466655443221111 111111111112233678899999999999999999999999999
Q ss_pred Ccccccc
Q 006664 271 HSFFKQA 277 (636)
Q Consensus 271 Hpffk~~ 277 (636)
.+||...
T Consensus 265 ~~ff~D~ 271 (700)
T KOG2137|consen 265 IPFFSDP 271 (700)
T ss_pred ccccCCc
Confidence 9999854
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.3e-10 Score=125.92 Aligned_cols=247 Identities=24% Similarity=0.283 Sum_probs=179.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCC-cceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN-VLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPN-IVkl~~~~~~~~~l~iVmE 89 (636)
+.|......++|+++.++|.+...+...+ .+++... ..+.-++++|.+++||| .+..++.+..+...+++|+
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 44666677899999999999887766665 6766432 34566889999999999 7888888888899999999
Q ss_pred ccCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 90 FMSGG-SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 90 y~~GG-sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||.+| +-...+.. ..-.|.+.++..+++.-+.+++|+|+---+||| ||+.. ++..|.+||++...+...
T Consensus 315 i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~---- 384 (829)
T KOG0576|consen 315 ICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRT---- 384 (829)
T ss_pred hhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcc----
Confidence 99988 22221111 012355667778888889999999998889999 88775 588999999998765322
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
...+++.+|+.|+|||+... ..+....|.|++|.-..+|.-|.+|-.. +......+ .+.+..........++..+.
T Consensus 385 ~~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~-g~~p~s~~L~~~~aw~~~~~ 460 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMI-GNGPNSPMLTDKSAWSPVFH 460 (829)
T ss_pred cccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCC--CccccCCC-CCCCCccccchhhhcCcccc
Confidence 24668899999999998876 5688899999999988888888888654 11111111 11110111111122333333
Q ss_pred -HHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 249 -QMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 249 -dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++...|+..-|..|+....++.|.+|....
T Consensus 461 ~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 461 RDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred cCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 488899999999999999999999998653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=6.7e-09 Score=102.35 Aligned_cols=125 Identities=25% Similarity=0.246 Sum_probs=82.5
Q ss_pred EEEEEEEcCCCcEEEEEEeecCC--------------C------c-----hhHHHHHHHHHHHHhCCCC--CcceeeeEE
Q 006664 26 SVHRALCIPFNEIVAVKILDFER--------------D------N-----SDLSNISREAQTMILVDHP--NVLKSHCSF 78 (636)
Q Consensus 26 ~Vyka~~~~tg~~vAIK~i~~~~--------------~------~-----~~~~~i~rEi~iL~~L~HP--NIVkl~~~~ 78 (636)
.||.|.. ..|..+|+|+..... . . .......+|.++|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899986 568899999995321 0 0 0124568899999999765 456666442
Q ss_pred EeCCeEEEEEeccC--CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH-HHHCCCcccccCcccEEEccCCcEEEecc
Q 006664 79 VSDHNLWVVMPFMS--GGSCLHILKAAYPDGFEEVVIATILREVLKGLDY-LHHHGHIHRDVKSGNILIDVRGAIKLGDF 155 (636)
Q Consensus 79 ~~~~~l~iVmEy~~--GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~y-LH~~gIvHRDLKP~NILld~~g~vKL~DF 155 (636)
.-++||||++ |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 3479999998 6554443332 12244566788888886555 579999999999999999865 9999999
Q ss_pred Ccccc
Q 006664 156 GVSAC 160 (636)
Q Consensus 156 Gla~~ 160 (636)
|.+..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.4e-07 Score=94.13 Aligned_cols=106 Identities=17% Similarity=0.183 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHHhCCCCC--cceeeeEEEeC----CeEEEEEeccCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHH
Q 006664 53 LSNISREAQTMILVDHPN--VLKSHCSFVSD----HNLWVVMPFMSG-GSCLHILKAAYPDGFEEVVIATILREVLKGLD 125 (636)
Q Consensus 53 ~~~i~rEi~iL~~L~HPN--IVkl~~~~~~~----~~l~iVmEy~~G-GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~ 125 (636)
.....+|...+..|..-+ +.+.+++.+.. ...++|+|+++| .+|.+++.... .++......++.++...+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 456788999888775333 34455554442 246899999998 48999988742 2667778899999999999
Q ss_pred HHHHCCCcccccCcccEEEccCC---cEEEeccCcccc
Q 006664 126 YLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSAC 160 (636)
Q Consensus 126 yLH~~gIvHRDLKP~NILld~~g---~vKL~DFGla~~ 160 (636)
-||.+||+|+|++|.|||++.++ .+.|+||+-+..
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999998777 899999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.9e-08 Score=98.50 Aligned_cols=135 Identities=21% Similarity=0.221 Sum_probs=102.9
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC---------------------chhHHHHHHHHHHHHhCCCC--
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD---------------------NSDLSNISREAQTMILVDHP-- 69 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~---------------------~~~~~~i~rEi~iL~~L~HP-- 69 (636)
+.++..||-|.-+.||.|.+. .|..+|||.-...+. .......++|..+|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999875 799999998643210 01123468899999998654
Q ss_pred CcceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc
Q 006664 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA 149 (636)
Q Consensus 70 NIVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~ 149 (636)
.|.+.+++ +.-.+||||++|-.|... .++...+..++..|+.-+.-+-..||||+|+.+-||+++.+|.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 67777653 567899999999765532 1234445566777777777777999999999999999999999
Q ss_pred EEEeccCccc
Q 006664 150 IKLGDFGVSA 159 (636)
Q Consensus 150 vKL~DFGla~ 159 (636)
+.++||--+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999997654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.9e-07 Score=96.37 Aligned_cols=252 Identities=17% Similarity=0.203 Sum_probs=158.5
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHh-CCCCCcce--------eee
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL-VDHPNVLK--------SHC 76 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~-L~HPNIVk--------l~~ 76 (636)
|..-.+-....+.||+|+-+.+|-.-.. ...+-|++........ . ..+..|.. =.||-+-. +|+
T Consensus 6 ~~~~ge~i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~-a---qk~a~la~~p~~p~~~~rvaWPqa~L~G 78 (637)
T COG4248 6 YDVYGEPIPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQ-A---QKVAELAATPDAPLLNYRVAWPQATLHG 78 (637)
T ss_pred ccccCcccCCCccccCCccceeeecchh---hchhheeecCCCchHH-H---HHHHHhccCCCCcchhhhhcccHHHhhC
Confidence 3333444556788999999999965322 2235588764432211 1 12222322 25664432 222
Q ss_pred EEEeCCeEEEEEeccCCCC-HHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEE
Q 006664 77 SFVSDHNLWVVMPFMSGGS-CLHILKAA----YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151 (636)
Q Consensus 77 ~~~~~~~l~iVmEy~~GGs-L~~lL~~~----~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vK 151 (636)
--. ...+-+.|..+.|.. ..+++... ....+.+..+.++.+.|+.+.+.||..|.+-+|+.++|+|+..++.|.
T Consensus 79 ~~~-~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~ 157 (637)
T COG4248 79 GRR-GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVV 157 (637)
T ss_pred CCc-cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEE
Confidence 111 123778899888742 23333211 112367888999999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCcccccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcC-CCCCCCCC-------
Q 006664 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHG-HAPFSKYP------- 219 (636)
Q Consensus 152 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG-~~PF~~~~------- 219 (636)
|.|=..-... ...+..-..+|.+.|.+||.-.- ...-+...|.|.||+++++|+.| +.||++..
T Consensus 158 LVdsDsfqi~----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~ 233 (637)
T COG4248 158 LVDSDSFQIN----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN 233 (637)
T ss_pred EEcccceeec----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC
Confidence 9885532211 22233446789999999997541 13356779999999999999985 99997642
Q ss_pred hHHHHHHH------HhcC---CCCCCcccchhhhHHHHHHHHhhccc--CCCCCCCHHHHH
Q 006664 220 PMKVLLMT------LQNA---PPGLDYERDRKFSKSFKQMIASCLVK--DPSKRPSAKKLL 269 (636)
Q Consensus 220 ~~~~l~~~------~~~~---~~~~~~~~~~~~S~~l~dLI~~cL~~--DP~kRpsa~elL 269 (636)
+.+.-+.. .+.. .+........-+++++..|..+|+.. .++-|||++-.+
T Consensus 234 p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 234 PLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred cchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 22211000 0000 01111122345778899999999965 356899987543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.4e-06 Score=85.54 Aligned_cols=139 Identities=15% Similarity=0.090 Sum_probs=101.2
Q ss_pred cccCceEEEEEEEcCCCcEEEEEEeecC--C---CchhHHHHHHHHHHHHhCCCCC--cceee--eEEEeC--CeEEEEE
Q 006664 20 GQGVSASVHRALCIPFNEIVAVKILDFE--R---DNSDLSNISREAQTMILVDHPN--VLKSH--CSFVSD--HNLWVVM 88 (636)
Q Consensus 20 G~G~fG~Vyka~~~~tg~~vAIK~i~~~--~---~~~~~~~i~rEi~iL~~L~HPN--IVkl~--~~~~~~--~~l~iVm 88 (636)
|+|+.+.|++.... |+.+=+|.-..- . .+.-...+.+|+..+..|..-+ +.++. +.-..+ ...+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 66999999987643 446777765310 1 1334567899999998875322 44433 111111 3478999
Q ss_pred eccCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc--EEEeccCcccc
Q 006664 89 PFMSG-GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA--IKLGDFGVSAC 160 (636)
Q Consensus 89 Ey~~G-GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~--vKL~DFGla~~ 160 (636)
|-+.| -+|.+++........++.....++.++..++.-||..|+.|+|+.+.|||++.+|. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97765 68888887654445677888899999999999999999999999999999987777 99999986553
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=6.1e-07 Score=100.98 Aligned_cols=141 Identities=28% Similarity=0.319 Sum_probs=95.5
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC-----------------------C-----c-h----------hHHHHH
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER-----------------------D-----N-S----------DLSNIS 57 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-----------------------~-----~-~----------~~~~i~ 57 (636)
+.|+.++-|.||+|..+ +|+.||||+....- . . . ..-++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 57899999999999875 59999999984210 0 0 0 011245
Q ss_pred HHHHHHHhC-----CCCCcceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 006664 58 REAQTMILV-----DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH 132 (636)
Q Consensus 58 rEi~iL~~L-----~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gI 132 (636)
+|...+..+ +.|+|.-..-++.-.+.-.++|||++|-.+.++..... .+++...+...+.++ -+..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 566666554 34665444445555667789999999988888743322 456644333322222 1233345899
Q ss_pred cccccCcccEEEccCCcEEEeccCccccc
Q 006664 133 IHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 133 vHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
+|.|..|.||+++.+|.+.+.|||+...+
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecC
Confidence 99999999999999999999999998654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.1e-06 Score=83.01 Aligned_cols=139 Identities=17% Similarity=0.189 Sum_probs=89.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchh--H------HHHHHHHHHHHhCC---CCCcceeee
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD--L------SNISREAQTMILVD---HPNVLKSHC 76 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~--~------~~i~rEi~iL~~L~---HPNIVkl~~ 76 (636)
+...+|...+.+-......|.+.. -+|+.+++|.......... + ....+++..+..+. .-....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 345678888888887777777664 3678899998743221100 0 11233444443332 223333333
Q ss_pred EEE-----eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEE
Q 006664 77 SFV-----SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151 (636)
Q Consensus 77 ~~~-----~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vK 151 (636)
+.. -....+++|||++|..|.++.. +++ .+...|..++.-||..|++|+|..|.|+++. ++.++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~-~~~i~ 174 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS-NNGIR 174 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE-CCcEE
Confidence 322 2245678999999987766532 222 2445677889999999999999999999997 45599
Q ss_pred EeccCccc
Q 006664 152 LGDFGVSA 159 (636)
Q Consensus 152 L~DFGla~ 159 (636)
++||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.9e-06 Score=85.17 Aligned_cols=135 Identities=15% Similarity=0.106 Sum_probs=85.0
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCC--cceeeeEEEeCCeEEEEEeccCCC
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN--VLKSHCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPN--IVkl~~~~~~~~~l~iVmEy~~GG 94 (636)
..||.|..+.||+. .|..+++|...... ....+.+|.++++.+..-+ +.+.+.+....+..++|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 67899999999984 25567889875322 3456789999999886443 456777777778889999999996
Q ss_pred C-HH--------------H----HHHHhCC---CCCCHHH-HHHHHHH----------HHH-HHHHHHH----CCCcccc
Q 006664 95 S-CL--------------H----ILKAAYP---DGFEEVV-IATILRE----------VLK-GLDYLHH----HGHIHRD 136 (636)
Q Consensus 95 s-L~--------------~----lL~~~~~---~~lse~~-i~~i~~Q----------Il~-aL~yLH~----~gIvHRD 136 (636)
+ +. . .+.+-+. ....... ...+..+ +.. ...+|.. ..++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 4 11 1 1111111 1111111 0111111 111 1222221 2468999
Q ss_pred cCcccEEEccCCcEEEeccCccc
Q 006664 137 VKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 137 LKP~NILld~~g~vKL~DFGla~ 159 (636)
+.|.||+++.++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999877 9999999864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.23 E-value=7.8e-06 Score=97.11 Aligned_cols=203 Identities=21% Similarity=0.259 Sum_probs=143.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeeEEEeCCe----EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 006664 53 LSNISREAQTMILVDHPNVLKSHCSFVSDHN----LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128 (636)
Q Consensus 53 ~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~----l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH 128 (636)
+.....|+..+.++.|+|++.++.+-..... +.+..+||.+-+|...+... +..+....+.+..++++||.|+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHH
Confidence 3344556777788899999999887655433 33456899999999999876 67888999999999999999999
Q ss_pred HCCCcccccCcc---cEEEccCCcEEEe--ccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcc--cchhhH
Q 006664 129 HHGHIHRDVKSG---NILIDVRGAIKLG--DFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFK--ADIWSF 201 (636)
Q Consensus 129 ~~gIvHRDLKP~---NILld~~g~vKL~--DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~k--sDIWSL 201 (636)
+....|.-+... +.-.+..+.+.++ ||+.+..+.+... .....-+..|.|||.... ..+..+ .|+|.+
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~----~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK----SFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCL 378 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCccc----chhhcCcccccccccccc-ccchhhhhhHHHHH
Confidence 996666655555 3444556667776 9988776543321 123345667888888765 334443 699999
Q ss_pred HHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 202 GITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 202 GiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
|..+..+..|..+-....... ..+ .........+++.+|+.-|+++|+++.+++.|+|.+.
T Consensus 379 gll~~~~~~~~~i~~~~~~~~---~~l-----------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVPV---SLL-----------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred HHHHhhhhhcCcccccccchh---hhh-----------ccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 999999988765522111000 000 0111126778899999999999999999999999873
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.7e-05 Score=78.63 Aligned_cols=139 Identities=22% Similarity=0.257 Sum_probs=83.5
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCC--CcceeeeEEEe---CCeEEEEEec
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP--NVLKSHCSFVS---DHNLWVVMPF 90 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HP--NIVkl~~~~~~---~~~l~iVmEy 90 (636)
++.|+.|..+.||++.... ..+++|+.... .....+.+|..+++.+... .+.+++..... ....+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 5789999999999998754 58999987432 3456788999999887533 34566654322 3457999999
Q ss_pred cCCCCHHH----------------HHHHhC----C-CCCCHHH------HHHH---------------HHHHHH-HHHHH
Q 006664 91 MSGGSCLH----------------ILKAAY----P-DGFEEVV------IATI---------------LREVLK-GLDYL 127 (636)
Q Consensus 91 ~~GGsL~~----------------lL~~~~----~-~~lse~~------i~~i---------------~~QIl~-aL~yL 127 (636)
++|..+.. .+...+ . ..+.... .... ...+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99988777 111110 0 1111100 0000 111222 23333
Q ss_pred HH-------CCCcccccCcccEEEc-cCCcEEEeccCccc
Q 006664 128 HH-------HGHIHRDVKSGNILID-VRGAIKLGDFGVSA 159 (636)
Q Consensus 128 H~-------~gIvHRDLKP~NILld-~~g~vKL~DFGla~ 159 (636)
+. .+++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 32 3599999999999999 66777899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.4e-05 Score=79.78 Aligned_cols=138 Identities=22% Similarity=0.179 Sum_probs=97.6
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc------------------hh-----HHHHHHHHHHHHhCC--CC
Q 006664 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN------------------SD-----LSNISREAQTMILVD--HP 69 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~------------------~~-----~~~i~rEi~iL~~L~--HP 69 (636)
+...|..|.-+.||+|.. .++..+|+|++...... .. ..-..+|+..|+++. +-
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 344788899999999975 56899999999643211 01 112466888888774 44
Q ss_pred CcceeeeEEEeCCeEEEEEeccCCCC-HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccC
Q 006664 70 NVLKSHCSFVSDHNLWVVMPFMSGGS-CLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVR 147 (636)
Q Consensus 70 NIVkl~~~~~~~~~l~iVmEy~~GGs-L~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~ 147 (636)
.+.+.+.++ ...+||||+.... -.-.|+. .++....+..+..+++..+.-|-. .|+||+||..=|||+. +
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C
Confidence 455666554 3579999986531 1112222 123333678888999999988877 8999999999999998 8
Q ss_pred CcEEEeccCccccc
Q 006664 148 GAIKLGDFGVSACL 161 (636)
Q Consensus 148 g~vKL~DFGla~~~ 161 (636)
+.+.|+|||-|...
T Consensus 203 ~~p~iID~~QaV~~ 216 (268)
T COG1718 203 GEPYIIDVSQAVTI 216 (268)
T ss_pred CeEEEEECcccccc
Confidence 99999999988643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.3e-05 Score=92.62 Aligned_cols=146 Identities=17% Similarity=0.254 Sum_probs=92.1
Q ss_pred EEeEEcccCceEEEEEEEcCCC--cEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCc--ceeeeEEEeC---CeEEE
Q 006664 15 LYEEVGQGVSASVHRALCIPFN--EIVAVKILDFERDNSDLSNISREAQTMILVD-HPNV--LKSHCSFVSD---HNLWV 86 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg--~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNI--Vkl~~~~~~~---~~l~i 86 (636)
-++.|+.|.+..+|+......+ ..+++|+............+.+|+.+|+.+. |++| .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4678999999999998764322 4678887653322223456889999999995 7765 6677766554 46789
Q ss_pred EEeccCCCCHHH--------------------HHHHhCCC-----C---------CCHHHHHHHHHH-------------
Q 006664 87 VMPFMSGGSCLH--------------------ILKAAYPD-----G---------FEEVVIATILRE------------- 119 (636)
Q Consensus 87 VmEy~~GGsL~~--------------------lL~~~~~~-----~---------lse~~i~~i~~Q------------- 119 (636)
||||++|..+.+ .|..-+.- + +-...+..+..+
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 999999864211 12111110 0 111223222221
Q ss_pred --HHHHHHHHHH-----------CCCcccccCcccEEEccC-C-cEEEeccCcccc
Q 006664 120 --VLKGLDYLHH-----------HGHIHRDVKSGNILIDVR-G-AIKLGDFGVSAC 160 (636)
Q Consensus 120 --Il~aL~yLH~-----------~gIvHRDLKP~NILld~~-g-~vKL~DFGla~~ 160 (636)
+...+.+|.. ..+||+|+++.|||++.+ + .+-|.||.++..
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2233556632 249999999999999742 3 457999998764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=5.7e-07 Score=108.07 Aligned_cols=255 Identities=11% Similarity=0.064 Sum_probs=164.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEe---ecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEe--CCe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKIL---DFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVS--DHN 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i---~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~--~~~ 83 (636)
.++|++.--||.|.++.--....+..+ +.+|+. +.+... ...+....|..-++...|+++...+.-... ...
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 356666666777766543322222222 344443 222211 122334455556666789998887655543 345
Q ss_pred EEEEEeccCCCCHHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC-----CCcccccCcccEEEccCCcEEEeccC
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPD--GFEEVVIATILREVLKGLDYLHHH-----GHIHRDVKSGNILIDVRGAIKLGDFG 156 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~--~lse~~i~~i~~QIl~aL~yLH~~-----gIvHRDLKP~NILld~~g~vKL~DFG 156 (636)
.|.+++||.+|.+++.|-+.... .+.+..+....++.+.+..-+|+. -.+|++||+-|.+|..+..+|++++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 79999999999999988764322 244445555556657888887764 26899999999999999999999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 006664 157 VSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 236 (636)
Q Consensus 157 la~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~ 236 (636)
+.++.. .........++++.|++|++... -.++.++|+|..|+-+|++..|..+|-. .++..+++....-.
T Consensus 1386 LdKIkn---p~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~fi~-----flq~~Lkgiidn~t 1456 (2724)
T KOG1826|consen 1386 LDKIKN---PVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYFIF-----FLQPALKGIIDNHT 1456 (2724)
T ss_pred cccccC---chHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHHHH-----HHHHHHcCcccccc
Confidence 987331 12234567789999999999876 5578889999999999999999888742 22222222211111
Q ss_pred -cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 237 -YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 237 -~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
...+.-.+.++-.....+|-+.-..||.-...+.-+.|-
T Consensus 1457 f~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1457 FFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred cccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 112223344555555556666667788877777766653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.6e-05 Score=78.25 Aligned_cols=137 Identities=20% Similarity=0.131 Sum_probs=84.4
Q ss_pred eEEcccCc-eEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEEEEeccCCC
Q 006664 17 EEVGQGVS-ASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 17 ~~IG~G~f-G~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~iVmEy~~GG 94 (636)
+.|-.|.+ +.||++... +..+.+|+..... ...+.+|+.+++.+. +--+.+++++...++..++|||+++|.
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 34555555 889999643 4678888874322 345678999998874 444567787777777789999999997
Q ss_pred CHHHHH----------------HHhCCC-----CCCHH---HHHH---HHH----------------HHHHHHHHHH---
Q 006664 95 SCLHIL----------------KAAYPD-----GFEEV---VIAT---ILR----------------EVLKGLDYLH--- 128 (636)
Q Consensus 95 sL~~lL----------------~~~~~~-----~lse~---~i~~---i~~----------------QIl~aL~yLH--- 128 (636)
++.... .+.+.. .+... .... .+. .+...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 765331 111110 11100 0000 000 0111122221
Q ss_pred ----HCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 129 ----HHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 129 ----~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999987778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.3e-05 Score=74.04 Aligned_cols=131 Identities=21% Similarity=0.273 Sum_probs=92.6
Q ss_pred cccCCCCeEEEeEEcccCc-eEEEEEEEcCCCcEEEEEEee---cCCC----------c-------hhHHHHHHHHHHHH
Q 006664 6 YPIGAEHYTLYEEVGQGVS-ASVHRALCIPFNEIVAVKILD---FERD----------N-------SDLSNISREAQTMI 64 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~f-G~Vyka~~~~tg~~vAIK~i~---~~~~----------~-------~~~~~i~rEi~iL~ 64 (636)
|.....++++++.||.|.- |.||++.- .|..||+|++. .... . ...+-+..|.+...
T Consensus 32 F~~h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg 109 (207)
T PF13095_consen 32 FTHHGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG 109 (207)
T ss_pred cCCCCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence 3334589999999999999 99999975 68899999932 1110 0 11234566777665
Q ss_pred hC---CCCCc--ceeeeEEEeC------------------CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHH
Q 006664 65 LV---DHPNV--LKSHCSFVSD------------------HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121 (636)
Q Consensus 65 ~L---~HPNI--Vkl~~~~~~~------------------~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl 121 (636)
+| ++.++ |+.|+++.=. ....||.||+.... .+.. .-+.+|+
T Consensus 110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~ 174 (207)
T PF13095_consen 110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQML 174 (207)
T ss_pred HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHH
Confidence 54 56677 8898887322 12467888877643 1222 3356788
Q ss_pred HHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcc
Q 006664 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158 (636)
Q Consensus 122 ~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla 158 (636)
+-+..+|..||+-+|+++.|.. + =||+|||.+
T Consensus 175 ~dl~~~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 175 RDLKILHKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHHHHHHCCeeeccCcccccc---C--CEEEecccC
Confidence 8889999999999999999986 2 388999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00023 Score=70.99 Aligned_cols=130 Identities=20% Similarity=0.276 Sum_probs=95.1
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCC---------------CchhHHHHHHHHHHHHhCC------CCCcceee
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFER---------------DNSDLSNISREAQTMILVD------HPNVLKSH 75 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~---------------~~~~~~~i~rEi~iL~~L~------HPNIVkl~ 75 (636)
..||+|+.-.||.- +.....+||+..... .........+|+.-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 47999999999853 456667899987554 1122456777888777665 78899999
Q ss_pred eEEEeCCeEEEEEeccCC------CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC--
Q 006664 76 CSFVSDHNLWVVMPFMSG------GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR-- 147 (636)
Q Consensus 76 ~~~~~~~~l~iVmEy~~G------GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~-- 147 (636)
|..+++..+-+|+|.+.. -+|.++++. +.+++ .+...+-.-..||-.++|+.+|++|.||++...
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999999999997543 367888854 35655 333444555678899999999999999999633
Q ss_pred C--cEEEec-cC
Q 006664 148 G--AIKLGD-FG 156 (636)
Q Consensus 148 g--~vKL~D-FG 156 (636)
+ .+.|+| ||
T Consensus 157 ~~~~lvlIDG~G 168 (199)
T PF10707_consen 157 GEFRLVLIDGLG 168 (199)
T ss_pred CceEEEEEeCCC
Confidence 2 466666 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=8.1e-05 Score=84.03 Aligned_cols=136 Identities=24% Similarity=0.269 Sum_probs=87.4
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc------------------------------hhHHH------HHHHH
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDN------------------------------SDLSN------ISREA 60 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~------------------------------~~~~~------i~rEi 60 (636)
+.||.-+.|.||+|..+. |+.||||+-+..-.. +..+. +.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999998765 999999997422100 00112 23344
Q ss_pred HHHHh----CCCCC------cceeeeEEEeCCeEEEEEeccCCCCHHH--HHHHhCCCCCCHHHHHHHHHHHHHHHH-HH
Q 006664 61 QTMIL----VDHPN------VLKSHCSFVSDHNLWVVMPFMSGGSCLH--ILKAAYPDGFEEVVIATILREVLKGLD-YL 127 (636)
Q Consensus 61 ~iL~~----L~HPN------IVkl~~~~~~~~~l~iVmEy~~GGsL~~--lL~~~~~~~lse~~i~~i~~QIl~aL~-yL 127 (636)
+...+ +.|-+ |.++|..+ ...-.++||||+|..+.| .|.+ .+++... ++.-+..+.. -+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~---i~~~l~~~~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK---RGISPHD---ILNKLVEAYLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH---cCCCHHH---HHHHHHHHHHHHH
Confidence 33322 23444 44454333 345789999999986654 4444 3555553 3333333322 23
Q ss_pred HHCCCcccccCcccEEEcc----CCcEEEeccCccccc
Q 006664 128 HHHGHIHRDVKSGNILIDV----RGAIKLGDFGVSACL 161 (636)
Q Consensus 128 H~~gIvHRDLKP~NILld~----~g~vKL~DFGla~~~ 161 (636)
=..|++|+|=.|.||++.. ++.+.+.|||+...+
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 3568999999999999983 678999999997654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00011 Score=71.35 Aligned_cols=128 Identities=18% Similarity=0.196 Sum_probs=90.8
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcce-eeeEEEeCCeEEEEEecc
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLK-SHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVk-l~~~~~~~~~l~iVmEy~ 91 (636)
-...+.||+|.+|.||++.+. |..+|+|+-. .+.....+..|+++|..+..-++.. +|.+-. .++.|||+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr---~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRR---RDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEec---CCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 345678999999999999874 6789999854 3445667889999999998887754 443322 34559999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccC-cc-cEEEccCCcEEEeccCccc
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVK-SG-NILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLK-P~-NILld~~g~vKL~DFGla~ 159 (636)
+|-.|...-... + +.-+..++++---|-..||-|..|. |. ||++ .++.+.|+||.-|+
T Consensus 95 ~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv-~~~~~~iIDFd~At 154 (201)
T COG2112 95 DGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV-NDRDVYIIDFDSAT 154 (201)
T ss_pred cCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe-cCCcEEEEEccchh
Confidence 997766544321 1 2233445556555777899999986 33 5555 46699999999876
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00018 Score=72.95 Aligned_cols=73 Identities=14% Similarity=0.174 Sum_probs=45.7
Q ss_pred EeEEcccCce-EEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCC---CcceeeeEEEeC---CeEEEEE
Q 006664 16 YEEVGQGVSA-SVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP---NVLKSHCSFVSD---HNLWVVM 88 (636)
Q Consensus 16 ~~~IG~G~fG-~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HP---NIVkl~~~~~~~---~~l~iVm 88 (636)
++.|+.|+.. .||+. +..+++|+... ......+.+|..++..+... -+.++++..... ...|++|
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~---~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSA---AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCc---cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 3567877776 59976 23577787542 22345788999999877531 233444333222 2358899
Q ss_pred eccCCCCH
Q 006664 89 PFMSGGSC 96 (636)
Q Consensus 89 Ey~~GGsL 96 (636)
++++|.++
T Consensus 74 ~~i~G~~l 81 (235)
T cd05155 74 RWLEGETA 81 (235)
T ss_pred EeecCCCC
Confidence 99999665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00039 Score=70.11 Aligned_cols=75 Identities=13% Similarity=0.246 Sum_probs=49.6
Q ss_pred EeEEcccCceEEEEEEEcC-CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCc-ceeeeEEEeCCeEEEEEeccCC
Q 006664 16 YEEVGQGVSASVHRALCIP-FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNV-LKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~-tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNI-Vkl~~~~~~~~~l~iVmEy~~G 93 (636)
++.|..|-...||++.... .++.|++|+...... ..-...+|+.+++.+...++ .++++.+. + .+||||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCC
Confidence 5678899999999996532 357889997653221 12234579999988854344 44544332 2 479999999
Q ss_pred CCH
Q 006664 94 GSC 96 (636)
Q Consensus 94 GsL 96 (636)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0012 Score=67.80 Aligned_cols=134 Identities=15% Similarity=0.187 Sum_probs=78.5
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCc-ceeeeEEEeCCeEEEEEeccCCCCH
Q 006664 18 EVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNV-LKSHCSFVSDHNLWVVMPFMSGGSC 96 (636)
Q Consensus 18 ~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNI-Vkl~~~~~~~~~l~iVmEy~~GGsL 96 (636)
.+..|-.+.+|+.. .++..+++|+.......... ...+|..+++.+..-.+ .+++... . -++||||++|..+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGV-DRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccC-cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence 45678889999886 45778889976432211111 35789999988864333 2333332 2 3689999998654
Q ss_pred H--------------HHHHHhCCCC-----CCH-HHHHHHHHHH---------HHHHHHHHH--------CCCcccccCc
Q 006664 97 L--------------HILKAAYPDG-----FEE-VVIATILREV---------LKGLDYLHH--------HGHIHRDVKS 139 (636)
Q Consensus 97 ~--------------~lL~~~~~~~-----lse-~~i~~i~~QI---------l~aL~yLH~--------~gIvHRDLKP 139 (636)
. ..+.+-+... ++. ..+..+..++ ...+..+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 2 2222222111 111 1222222222 111222222 2589999999
Q ss_pred ccEEEccCCcEEEeccCccc
Q 006664 140 GNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 140 ~NILld~~g~vKL~DFGla~ 159 (636)
.||+++.++ +.|+||..|.
T Consensus 156 ~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 156 YNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CcEEEeCCC-CEEEeccccC
Confidence 999998776 7899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00087 Score=70.12 Aligned_cols=140 Identities=12% Similarity=0.064 Sum_probs=85.4
Q ss_pred EEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCC--cceeee------EEEeCCeEE
Q 006664 14 TLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN--VLKSHC------SFVSDHNLW 85 (636)
Q Consensus 14 ~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPN--IVkl~~------~~~~~~~l~ 85 (636)
.-++.|..|....+|++.. .+..+++|+... .....+..|+.++..+.+-+ +.+++. +...++..+
T Consensus 17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred hheecccCccccceEEEEe--CCCcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 3467888898899999864 345788998753 23456778888888774322 444433 123345678
Q ss_pred EEEeccCCCCHHH-----------HHHHhC--CCCCCH--------H--H--HH--------HHHHHHHHHHHHHHH---
Q 006664 86 VVMPFMSGGSCLH-----------ILKAAY--PDGFEE--------V--V--IA--------TILREVLKGLDYLHH--- 129 (636)
Q Consensus 86 iVmEy~~GGsL~~-----------lL~~~~--~~~lse--------~--~--i~--------~i~~QIl~aL~yLH~--- 129 (636)
+|++|++|..+.. .+.+-+ ...+.. . . .. .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999976421 111100 000100 0 0 00 011122334455543
Q ss_pred ----CCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 130 ----HGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 130 ----~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999987777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0024 Score=67.47 Aligned_cols=143 Identities=19% Similarity=0.129 Sum_probs=83.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCC--cceeeeE------EEeCCe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN--VLKSHCS------FVSDHN 83 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPN--IVkl~~~------~~~~~~ 83 (636)
....++.++.|....||++.. . +..+++|+..... ....+..|+.++..|..-+ +.+++.. ...++.
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~---~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV---KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred CceeccccCCccccceEEEEe-C-CCcEEEEEecCCC---CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 345577888888899999864 3 4467789875322 2334566777776663212 3343321 122466
Q ss_pred EEEEEeccCCCCHH-----------HHHHHhC--CCCCCH-------HHHH----------------HHHHHHHHHHHHH
Q 006664 84 LWVVMPFMSGGSCL-----------HILKAAY--PDGFEE-------VVIA----------------TILREVLKGLDYL 127 (636)
Q Consensus 84 l~iVmEy~~GGsL~-----------~lL~~~~--~~~lse-------~~i~----------------~i~~QIl~aL~yL 127 (636)
.+++|+|++|..+. ..+..-+ ...++. ...+ .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 89999999985431 1111100 001100 0000 0111233345555
Q ss_pred HH-------CCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 128 HH-------HGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 128 H~-------~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 42 589999999999999988877899999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0027 Score=67.19 Aligned_cols=80 Identities=9% Similarity=-0.043 Sum_probs=56.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCC---CCcceeeeEEEe---CCeEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDH---PNVLKSHCSFVS---DHNLW 85 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~H---PNIVkl~~~~~~---~~~l~ 85 (636)
.-.-.+.||.|..+.||+.... +..+.+|..+ . ......+.+|...|+.|.- ..|.++++++.. .+..+
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~-~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS--QGNPMPLMAR-S--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred hhheeeecCCccceeEEEEEcC--CCCEEEEEec-c--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 3445678999999999998642 2346777743 2 1123468899999988853 356778876654 36689
Q ss_pred EEEeccCCCCH
Q 006664 86 VVMPFMSGGSC 96 (636)
Q Consensus 86 iVmEy~~GGsL 96 (636)
+|||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999999754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0061 Score=64.56 Aligned_cols=138 Identities=14% Similarity=0.147 Sum_probs=75.9
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-----CCCcceee---eEEEeCCeEEEE
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-----HPNVLKSH---CSFVSDHNLWVV 87 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-----HPNIVkl~---~~~~~~~~l~iV 87 (636)
++.|+.|....+|+.... +..+++|++. .. ....+..|+.++..|. .|.++.-. .+....+..+++
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-RL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI 100 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEec-cC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence 456778888899998743 3468889875 21 2234445666665542 33333210 112335678999
Q ss_pred EeccCCCCHH-----------HHHHHhC--CCCCC----------H--HHHH-----------HHHHHHH-HHHHHHH--
Q 006664 88 MPFMSGGSCL-----------HILKAAY--PDGFE----------E--VVIA-----------TILREVL-KGLDYLH-- 128 (636)
Q Consensus 88 mEy~~GGsL~-----------~lL~~~~--~~~ls----------e--~~i~-----------~i~~QIl-~aL~yLH-- 128 (636)
++|++|..+. ..|.+-+ ...++ . ..+. ..+.+.+ ..+..+.
T Consensus 101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (319)
T PRK05231 101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA 180 (319)
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence 9999997431 1111110 00110 0 0000 1111111 1122232
Q ss_pred -----HCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 129 -----HHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 129 -----~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
..|+||+|+.|.||+++.+...-|+||+.+.
T Consensus 181 ~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 181 AWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2389999999999999866556899999874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0056 Score=67.39 Aligned_cols=79 Identities=22% Similarity=0.066 Sum_probs=56.3
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeecC-C---C--chhHHHHHHHHHHHHhCC---CCCcceeeeEEEeCCeEE
Q 006664 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFE-R---D--NSDLSNISREAQTMILVD---HPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~-~---~--~~~~~~i~rEi~iL~~L~---HPNIVkl~~~~~~~~~l~ 85 (636)
-.+.||-|.+..||++.....++.|+||.-... + . +...++...|...|+.+. ..++.+++.+ +....+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 357899999999999998543368999985311 1 1 234667888999888763 3456777665 446678
Q ss_pred EEEeccCCCC
Q 006664 86 VVMPFMSGGS 95 (636)
Q Consensus 86 iVmEy~~GGs 95 (636)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998744
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00076 Score=66.61 Aligned_cols=97 Identities=23% Similarity=0.137 Sum_probs=78.2
Q ss_pred HHHHHHHHhCCC-CCcceeeeEEEeCCeEEEEEeccCCCCHHHH---HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---
Q 006664 57 SREAQTMILVDH-PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHI---LKAAYPDGFEEVVIATILREVLKGLDYLHH--- 129 (636)
Q Consensus 57 ~rEi~iL~~L~H-PNIVkl~~~~~~~~~l~iVmEy~~GGsL~~l---L~~~~~~~lse~~i~~i~~QIl~aL~yLH~--- 129 (636)
..|.-+|+.+.+ +++.+++|++- -++|.||...+++.+. +... ...++.....|+.+++..+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 458888998976 69999999873 3678899987766532 1111 235788999999999999999998
Q ss_pred CCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 130 ~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
..+.-.|++|+|+-++.+|.+|++|...+.
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 458889999999999999999999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0041 Score=65.34 Aligned_cols=75 Identities=13% Similarity=0.102 Sum_probs=50.0
Q ss_pred EeEEcccCceEEEEEEEcC------CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCc-ceeeeEEEeCCeEEEEE
Q 006664 16 YEEVGQGVSASVHRALCIP------FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNV-LKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~------tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNI-Vkl~~~~~~~~~l~iVm 88 (636)
++.|..|-...||++.... .++.|++|+..... .......+|+.++..+..-++ .++++++.. .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 4667788888999987532 25789999975432 223456789999888754333 345555432 3589
Q ss_pred eccCCCCH
Q 006664 89 PFMSGGSC 96 (636)
Q Consensus 89 Ey~~GGsL 96 (636)
+|++|..+
T Consensus 77 e~i~G~~l 84 (302)
T cd05156 77 EFIPSRTL 84 (302)
T ss_pred heeCCCcC
Confidence 99988765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.00054 Score=72.33 Aligned_cols=134 Identities=19% Similarity=0.156 Sum_probs=97.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-------------------chhHHH--HHHHHHHHHhCC-CC
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-------------------NSDLSN--ISREAQTMILVD-HP 69 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-------------------~~~~~~--i~rEi~iL~~L~-HP 69 (636)
=|.++..||-|.-+-||.+-+. .|...++|+-.+.+. +-.+.+ ..+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4667889999999999999874 688899997643220 111233 467999998884 33
Q ss_pred C-cceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC
Q 006664 70 N-VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG 148 (636)
Q Consensus 70 N-IVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g 148 (636)
. |.+.+++ +.-++|||++.|-.|...-.- ..+..+...++.-+.-|-.+|+||+|..-=||+++.++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 3 4445433 457899999998776543211 12345666777777888999999999999999999999
Q ss_pred cEEEeccCcc
Q 006664 149 AIKLGDFGVS 158 (636)
Q Consensus 149 ~vKL~DFGla 158 (636)
.++++||--+
T Consensus 240 ~i~vIDFPQm 249 (465)
T KOG2268|consen 240 KIVVIDFPQM 249 (465)
T ss_pred CEEEeechHh
Confidence 9999999754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.037 Score=58.14 Aligned_cols=29 Identities=28% Similarity=0.411 Sum_probs=25.3
Q ss_pred CCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 130 ~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999986 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.02 Score=62.14 Aligned_cols=75 Identities=21% Similarity=0.096 Sum_probs=51.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEee----c--CCCchhHHHHHHHHHHHHhCC--CC-CcceeeeEEEeCCeEEEE
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILD----F--ERDNSDLSNISREAQTMILVD--HP-NVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~----~--~~~~~~~~~i~rEi~iL~~L~--HP-NIVkl~~~~~~~~~l~iV 87 (636)
++||-|....||++.+...++.|+||.-. . +.-+...++...|...|+... -| .+.++| +.+.....+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceeh
Confidence 36899999999999975433689999763 1 112345677888999987664 35 445554 3455667799
Q ss_pred EeccCC
Q 006664 88 MPFMSG 93 (636)
Q Consensus 88 mEy~~G 93 (636)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999855
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.013 Score=62.61 Aligned_cols=146 Identities=15% Similarity=0.156 Sum_probs=85.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEee-cCCCchhHHHHHHHHHHHHhCCC--CCcceeeeEEEeCC--eEEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-FERDNSDLSNISREAQTMILVDH--PNVLKSHCSFVSDH--NLWV 86 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~-~~~~~~~~~~i~rEi~iL~~L~H--PNIVkl~~~~~~~~--~l~i 86 (636)
...+++.+-.|..-.+|..... ++.++++ .+ ............+|+.+|+.+.- .-+...++++.++. ..|.
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 3455666655555556666543 8888888 33 22333456677889999987753 22334555555544 6799
Q ss_pred EEeccCCCCHHH------------------HHHHhCC------------CCCCHHHHHHHHHHH--------------HH
Q 006664 87 VMPFMSGGSCLH------------------ILKAAYP------------DGFEEVVIATILREV--------------LK 122 (636)
Q Consensus 87 VmEy~~GGsL~~------------------lL~~~~~------------~~lse~~i~~i~~QI--------------l~ 122 (636)
||+|++|..+.. +|..-+. ..+....+..+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 999999943221 1111100 000111111111111 12
Q ss_pred HHHHHHHC--------CCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 123 GLDYLHHH--------GHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 123 aL~yLH~~--------gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
-..||+.+ .++|+|+.+.||+++.++-+-+.||+++..
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 23344432 379999999999999888899999998763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.021 Score=59.86 Aligned_cols=29 Identities=31% Similarity=0.420 Sum_probs=24.5
Q ss_pred CCcccccCcccEEEccCCc-EEEeccCccc
Q 006664 131 GHIHRDVKSGNILIDVRGA-IKLGDFGVSA 159 (636)
Q Consensus 131 gIvHRDLKP~NILld~~g~-vKL~DFGla~ 159 (636)
.++|+|+.|.|||++.++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4799999999999987455 5699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.0086 Score=66.80 Aligned_cols=167 Identities=22% Similarity=0.238 Sum_probs=106.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeeEEEeC-CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 006664 53 LSNISREAQTMILVDHPNVLKSHCSFVSD-HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131 (636)
Q Consensus 53 ~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g 131 (636)
...+.--..+++.+.|+|.-.+.++-... ....+|||++. .+|.++++... +-.. .+. .+|
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~---l~~~---s~~-----------~~~ 87 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN---LKDE---SLL-----------AHG 87 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc---cchh---hhc-----------ccc
Confidence 34566778889999999999988777654 45888999995 58999888752 1111 111 222
Q ss_pred CcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcC
Q 006664 132 HIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211 (636)
Q Consensus 132 IvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG 211 (636)
+.| .+.++.+| -++ +.. .+ ...+|+||||+|.++.++.-|
T Consensus 88 ~~~------------~~~~~~td-~~~----t~~------~~-----------------~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 88 VLH------------LNIIYITD-HFL----TKY------PS-----------------PIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred cce------------ehhhhccc-ccc----ccC------CC-----------------CCCcchhhhhHHHHHHHHHHh
Confidence 222 12233344 111 110 01 111489999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCc-------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 212 HAPFSKYPPMKVLLMTLQNAPPGLDY-------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 212 ~~PF~~~~~~~~l~~~~~~~~~~~~~-------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
...|......+.+..+..-....... .......+.+.++..+|+-..|..||...++++|+-|..+
T Consensus 128 ~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 128 ISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred hHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 88887655555443333221111000 1112345667889999999999999999999999999754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.06 Score=58.17 Aligned_cols=141 Identities=17% Similarity=0.135 Sum_probs=82.9
Q ss_pred eEEEeEEcccCceEEEEEEEcC----CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcc-eeeeEEEeCCeEEEE
Q 006664 13 YTLYEEVGQGVSASVHRALCIP----FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL-KSHCSFVSDHNLWVV 87 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~----tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIV-kl~~~~~~~~~l~iV 87 (636)
..-+..|-.|-.-.+|++.... .++.|++|+..... ...++ -.+|..+++.+..-++. ++++.+..+ .|
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 3344566668899999986432 34789999875432 22223 36799999888654443 456665432 57
Q ss_pred EeccCCCCHHH--------------HHHHhCCCC------C-CHHHHHHHHHHH-----------------HHHHHHH--
Q 006664 88 MPFMSGGSCLH--------------ILKAAYPDG------F-EEVVIATILREV-----------------LKGLDYL-- 127 (636)
Q Consensus 88 mEy~~GGsL~~--------------lL~~~~~~~------l-se~~i~~i~~QI-----------------l~aL~yL-- 127 (636)
.+|++|.+|.. .|.+.+... + ....+..++.++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 89988766521 122221111 1 122333333222 1112222
Q ss_pred --H----HCCCcccccCcccEEEcc-CCcEEEeccCccc
Q 006664 128 --H----HHGHIHRDVKSGNILIDV-RGAIKLGDFGVSA 159 (636)
Q Consensus 128 --H----~~gIvHRDLKP~NILld~-~g~vKL~DFGla~ 159 (636)
. ...++|+|+++.|||++. ++.+.|+||..|.
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 225899999999999975 4689999998864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.034 Score=60.05 Aligned_cols=139 Identities=17% Similarity=0.181 Sum_probs=95.5
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeecC------C--------------Cc-hh---HH-HHHHHHHHHHhCCCC
Q 006664 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFE------R--------------DN-SD---LS-NISREAQTMILVDHP 69 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~------~--------------~~-~~---~~-~i~rEi~iL~~L~HP 69 (636)
+-.+|..|.-+.||-|.. .+|..+|||+++.. + +. +. +. -...|++.|++|+..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445788999999999975 57888999999522 1 00 01 11 135688888888765
Q ss_pred CcceeeeEEEeCCeEEEEEeccCCCCH-HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccccCcccEEEccC
Q 006664 70 NVLKSHCSFVSDHNLWVVMPFMSGGSC-LHILKAAYPDGFEEVVIATILREVLKGLDYLH-HHGHIHRDVKSGNILIDVR 147 (636)
Q Consensus 70 NIVkl~~~~~~~~~l~iVmEy~~GGsL-~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH-~~gIvHRDLKP~NILld~~ 147 (636)
.|.-.--+.. ..-.+||+|+.+... .-.|+. ..++...+..+-.+++.-+.-|- .++.||.||.--|+|+. +
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence 5543222222 234689999964322 123333 35777778888888887777664 56999999999999994 8
Q ss_pred CcEEEeccCcccc
Q 006664 148 GAIKLGDFGVSAC 160 (636)
Q Consensus 148 g~vKL~DFGla~~ 160 (636)
|.+.|+|.+-+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 9999999987753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.084 Score=55.91 Aligned_cols=29 Identities=14% Similarity=0.129 Sum_probs=26.8
Q ss_pred CCcccccCcccEEEccCCcEEEeccCccc
Q 006664 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 131 gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
++||+|+.+.|||++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999988899999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.071 Score=57.22 Aligned_cols=140 Identities=16% Similarity=0.161 Sum_probs=81.0
Q ss_pred EEEeEEcccCceEEEEEEEcCC---CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCc-ceeeeEEEeCCeEEEEEe
Q 006664 14 TLYEEVGQGVSASVHRALCIPF---NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNV-LKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 14 ~l~~~IG~G~fG~Vyka~~~~t---g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNI-Vkl~~~~~~~~~l~iVmE 89 (636)
.-++.|..|-...+|++..... +..|++|+...... ..-.-.+|..+++.+..-++ .++++++. ++ +|.+
T Consensus 17 i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 17 FSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred eEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 3445566688889999865422 34789998753322 12223678999988865555 34555553 22 4889
Q ss_pred ccCCCCHH--------------HHHHHhCCCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 006664 90 FMSGGSCL--------------HILKAAYPDG------F-EEVVIATILREV----------------------LKGLDY 126 (636)
Q Consensus 90 y~~GGsL~--------------~lL~~~~~~~------l-se~~i~~i~~QI----------------------l~aL~y 126 (636)
|++|..|. ..+++-+... + ....+..++.++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 98876541 1222222211 1 122233333222 111222
Q ss_pred HH----HC----CCcccccCcccEEEcc-CCcEEEeccCccc
Q 006664 127 LH----HH----GHIHRDVKSGNILIDV-RGAIKLGDFGVSA 159 (636)
Q Consensus 127 LH----~~----gIvHRDLKP~NILld~-~g~vKL~DFGla~ 159 (636)
+. .. -++|.|+.+.|||++. ++.++++||..|.
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 21 11 2689999999999974 5789999999874
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.06 Score=59.16 Aligned_cols=76 Identities=24% Similarity=0.151 Sum_probs=54.4
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEee----c-CCCchhHHHHHHHHHHHHhCC--CC-CcceeeeEEEeCCeEEEE
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILD----F-ERDNSDLSNISREAQTMILVD--HP-NVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~----~-~~~~~~~~~i~rEi~iL~~L~--HP-NIVkl~~~~~~~~~l~iV 87 (636)
++.||-|.-.-||++.+...++.|+||.-. . +.-+-..++...|..+|+... .| ++.++|. .+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 788999999999999984445679998752 1 112346788888999998764 35 4555653 455667889
Q ss_pred EeccCC
Q 006664 88 MPFMSG 93 (636)
Q Consensus 88 mEy~~G 93 (636)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.17 Score=53.42 Aligned_cols=76 Identities=20% Similarity=0.103 Sum_probs=48.9
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC---CCCcceeeeEEEeCCeEEEEEe
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD---HPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~---HPNIVkl~~~~~~~~~l~iVmE 89 (636)
-+-.+.|+-|....+|+.. .+++.+.+|+-. ......+..|..-|+.|. .-.+.+.+.+....+.-|+|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 4557789999999999987 678899999875 222345778888888873 3456788888877777799999
Q ss_pred ccCCC
Q 006664 90 FMSGG 94 (636)
Q Consensus 90 y~~GG 94 (636)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.15 Score=56.29 Aligned_cols=75 Identities=15% Similarity=-0.018 Sum_probs=52.8
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeecC-C---C--chhHHHHHHHHHHHHhCC---CCCcceeeeEEEeCCeEE
Q 006664 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFE-R---D--NSDLSNISREAQTMILVD---HPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~-~---~--~~~~~~i~rEi~iL~~L~---HPNIVkl~~~~~~~~~l~ 85 (636)
..+.||-|....||+..+. +..|+||.-..- + . +....+...|...|+.+. ..++.++|.+.. ...+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4788999999999998863 456889976411 1 1 124566677888887664 246777776655 4567
Q ss_pred EEEeccCC
Q 006664 86 VVMPFMSG 93 (636)
Q Consensus 86 iVmEy~~G 93 (636)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999987
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.21 Score=54.93 Aligned_cols=85 Identities=14% Similarity=0.155 Sum_probs=50.5
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCC-CcE-----EEEEEeecCCCchhHHHHHHHHHHHHhCCCCCc-ceeeeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPF-NEI-----VAVKILDFERDNSDLSNISREAQTMILVDHPNV-LKSHCSF 78 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t-g~~-----vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNI-Vkl~~~~ 78 (636)
|+-.......++.|..|-...+|++..... +.. |.+++... .....-.-.+|+.+++.+..-++ .++++.|
T Consensus 45 w~~~~~~~i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~--~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f 122 (383)
T PTZ00384 45 WNNVNPEFIEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST--YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF 122 (383)
T ss_pred cccCCcccEEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC--CCceEeccHHHHHHHHHHHhCCCCCeEEEec
Confidence 443333344456676799999999864322 122 44444321 11111123579999999876555 4567666
Q ss_pred EeCCeEEEEEeccCCCCH
Q 006664 79 VSDHNLWVVMPFMSGGSC 96 (636)
Q Consensus 79 ~~~~~l~iVmEy~~GGsL 96 (636)
.. ++|.||++|..|
T Consensus 123 ~~----g~l~efIeGr~l 136 (383)
T PTZ00384 123 GD----FTIQEWVEGNTM 136 (383)
T ss_pred CC----EEEEEEeccccC
Confidence 43 689999998765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.056 Score=58.37 Aligned_cols=87 Identities=23% Similarity=0.232 Sum_probs=61.4
Q ss_pred CCCCCcceeeeEE-EeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEE
Q 006664 66 VDHPNVLKSHCSF-VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNIL 143 (636)
Q Consensus 66 L~HPNIVkl~~~~-~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NIL 143 (636)
..-++..+.+-+- ....++|++|++- |+-..+++. -..+++..|+.+.+..+.-+..+ .+-|||+...|||
T Consensus 282 ~g~~~~e~~~vv~~de~~y~yl~~kdh--gt~is~ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niL 354 (488)
T COG5072 282 CGSVFLETLKVVSLDETLYLYLHFKDH--GTPISIIKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNIL 354 (488)
T ss_pred ccchhhhcceEEecCCceEEEEEEecC--Cceeeeeec-----ccHHHHHHHHHHHHHHHhhhhhcCCccccccccccee
Confidence 3445555544333 2335677888874 333333332 24567778888888888777766 6889999999999
Q ss_pred EccCCcEEEeccCcccc
Q 006664 144 IDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 144 ld~~g~vKL~DFGla~~ 160 (636)
|+ +|+|.|+||-+++.
T Consensus 355 Id-~GnvtLIDfklsRl 370 (488)
T COG5072 355 ID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ee-cCceEEEEeeeeec
Confidence 99 99999999999874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.0053 Score=68.21 Aligned_cols=72 Identities=18% Similarity=0.237 Sum_probs=64.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
+.+++.+..+|+|+||+|+.+..+.++..+|||.|.+........++.+|..-+.++.||+|++++..|..+
T Consensus 48 a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 48 ANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 578899999999999999999999888899999998877776777889999999999999999998877653
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.14 Score=51.89 Aligned_cols=86 Identities=16% Similarity=0.104 Sum_probs=60.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--C
Q 006664 53 LSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH--H 130 (636)
Q Consensus 53 ~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~--~ 130 (636)
...+.++.+++.+++ .|+++..- +...+-+|.|+|.... -..- .++..=+.+|.-.|+ .
T Consensus 102 ~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------i~~~----N~i~agi~~L~~fH~~~~ 162 (308)
T PF07387_consen 102 DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------INFS----NFITAGIKDLMDFHSENQ 162 (308)
T ss_pred hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------cchh----HHHHHhHHHHHHhhccCC
Confidence 345678888888775 47777633 4567889999995421 0111 112222567778884 3
Q ss_pred CCcccccCcccEEEccCCcEEEeccCc
Q 006664 131 GHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 131 gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 163 ~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 163 HCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CeecCCCChhheeecCCCCEEecChhh
Confidence 799999999999999999999999874
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.67 Score=57.27 Aligned_cols=139 Identities=19% Similarity=0.207 Sum_probs=77.5
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-------CCCCccee-----eeEEEe-CC
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-------DHPNVLKS-----HCSFVS-DH 82 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-------~HPNIVkl-----~~~~~~-~~ 82 (636)
++.|+ |..-.+|++.. .+|..+++|+.+.... ...+..|.+.|..| .-|.+++- +..... ++
T Consensus 30 ~~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G 104 (1013)
T PRK06148 30 ATPLD-GERDLNFRLTT-DDGADYILKIVNPSEP---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDG 104 (1013)
T ss_pred EeecC-CcCCceEEEEe-CCCCeEEEEEcCCccc---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCC
Confidence 35674 45688898864 4677899999864422 22344455555433 23444431 112222 22
Q ss_pred --eEEEEEeccCCCCHHHH-----------------HHHh---CCC-----CCCH-----------------HHHHHHHH
Q 006664 83 --NLWVVMPFMSGGSCLHI-----------------LKAA---YPD-----GFEE-----------------VVIATILR 118 (636)
Q Consensus 83 --~l~iVmEy~~GGsL~~l-----------------L~~~---~~~-----~lse-----------------~~i~~i~~ 118 (636)
..+.+++|++|..+.+. |... ... .+.+ ...+.++.
T Consensus 105 ~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~ 184 (1013)
T PRK06148 105 EPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVE 184 (1013)
T ss_pred ceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHH
Confidence 57789999999776541 1110 000 0101 11122233
Q ss_pred HHHHHHHH-----HH--HCCCcccccCcccEEEccCC--cEE-EeccCccc
Q 006664 119 EVLKGLDY-----LH--HHGHIHRDVKSGNILIDVRG--AIK-LGDFGVSA 159 (636)
Q Consensus 119 QIl~aL~y-----LH--~~gIvHRDLKP~NILld~~g--~vK-L~DFGla~ 159 (636)
+++..+.- +. ..++||+|+.+.|||++.++ .+. |+|||-+.
T Consensus 185 ~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 185 RFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 33333221 11 24799999999999998765 555 99999875
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.14 Score=50.95 Aligned_cols=29 Identities=41% Similarity=0.643 Sum_probs=20.9
Q ss_pred CCcccccCcccEEE-ccCCcEEEeccCccc
Q 006664 131 GHIHRDVKSGNILI-DVRGAIKLGDFGVSA 159 (636)
Q Consensus 131 gIvHRDLKP~NILl-d~~g~vKL~DFGla~ 159 (636)
.++|+|+.|.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 57899999999999 788999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.17 Score=55.52 Aligned_cols=61 Identities=25% Similarity=0.349 Sum_probs=45.5
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH-HHHCCCcccccCcccEEEcc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDY-LHHHGHIHRDVKSGNILIDV 146 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~y-LH~~gIvHRDLKP~NILld~ 146 (636)
...++-+|..|-++..+++.. ..+|...+.+..-.+.|+-- |--.+++|.|+.|.||++-.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 345677789998888888763 45666777777766777554 34568999999999999953
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.41 E-value=2.1 Score=45.85 Aligned_cols=71 Identities=14% Similarity=0.034 Sum_probs=43.3
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCC--Cccee---ee--EEEeCCeEEEEEeccCCC
Q 006664 22 GVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP--NVLKS---HC--SFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 22 G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HP--NIVkl---~~--~~~~~~~l~iVmEy~~GG 94 (636)
+.-..||++.. .+|..+++|+..... .....+..|+..+..|... .|+.. -+ ....++..+.++++++|.
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 34457898864 456789999875332 2355677888888766321 12221 11 123356788899999886
Q ss_pred C
Q 006664 95 S 95 (636)
Q Consensus 95 s 95 (636)
.
T Consensus 113 ~ 113 (325)
T PRK11768 113 A 113 (325)
T ss_pred C
Confidence 4
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.76 E-value=0.91 Score=47.44 Aligned_cols=29 Identities=28% Similarity=0.488 Sum_probs=26.4
Q ss_pred CCcccccCcccEEEccCCcEEEeccCccc
Q 006664 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 131 gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
-++|+|+.|+|+|.+..|.++|+||-.|.
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCC
Confidence 48999999999999988999999998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 636 | ||||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-85 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-84 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-61 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-61 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-60 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-60 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-60 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-60 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-52 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-48 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-46 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-46 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-43 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-43 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-42 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-42 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-42 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-41 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-41 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-41 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-41 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-41 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-41 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-41 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-39 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-37 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-37 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-37 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-37 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-37 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-37 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-35 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-34 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-34 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-34 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-34 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-32 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-32 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-31 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-31 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-31 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-31 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-31 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-31 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-30 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-26 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-25 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-25 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-24 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-24 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-24 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-24 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-24 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-24 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-24 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-23 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-23 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-23 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-23 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-23 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-23 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-23 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-23 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-23 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-23 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-22 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-22 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-22 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-22 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-22 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-22 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-22 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-22 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-22 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-22 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-22 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-21 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-21 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-21 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-21 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-21 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-21 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-21 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-21 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-21 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-21 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-21 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-21 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-21 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-21 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-21 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-21 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-21 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-21 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-20 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-20 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-20 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-20 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-20 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-20 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-20 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-20 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-20 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-20 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-20 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-20 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-20 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-20 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-20 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-20 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-20 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-19 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-19 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-19 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-19 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-19 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-19 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-19 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-19 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-19 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-19 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-19 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-19 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-19 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-19 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-19 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-18 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-18 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-18 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-18 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-18 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-17 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-17 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-17 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-16 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-16 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-15 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-15 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-15 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 |
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 486 bits (1254), Expect = e-170
Identities = 151/295 (51%), Positives = 200/295 (67%), Gaps = 13/295 (4%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQ 61
+ I + Y L E +G G +A V A C P E VA+K ++ E+ + + + +E Q
Sbjct: 6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQ 65
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG------FEEVVIAT 115
M HPN++ + SFV LW+VM +SGGS L I+K G +E IAT
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD--RQRMRNT 173
ILREVL+GL+YLH +G IHRDVK+GNIL+ G++++ DFGVSA L GD R ++R T
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233
FVGTPCWMAPEVMEQ+ GYDFKADIWSFGITA+ELA G AP+ KYPPMKVL++TLQN PP
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245
Query: 234 GL-----DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYI 283
L D E +K+ KSF++MI+ CL KDP KRP+A +LL+H FF++A++ E++
Sbjct: 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFL 300
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 446 bits (1148), Expect = e-153
Identities = 117/380 (30%), Positives = 168/380 (44%), Gaps = 59/380 (15%)
Query: 6 YPIGAEHYTLYEEVGQGVS--ASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQT 62
+ Y L +G+G +V+ A P E V V+ ++ E N ++ + E
Sbjct: 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHV 79
Query: 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
L +HPN++ +F++D+ LWVV FM+ GS ++ + DG E+ IA IL+ VLK
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR----MRNTFVGTP 178
LDY+HH G++HR VK+ +ILI V G + L + + G RQR V
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 179 CWMAPEVMEQ-LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 235
W++PEV++Q L GYD K+DI+S GITA ELA+GH PF P ++LL L P L
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 236 ---------------------------------------DYERDRKFSKSFKQMIASCLV 256
+ R FS F + CL
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 257 KDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKEEDMLAQKKMPD 316
++P RPSA LL HSFFKQ + R E LP L + + E
Sbjct: 320 RNPDARPSASTLLNHSFFKQIK------RRASEALPELLRPVTPITNFEGSQSQDHSGIF 373
Query: 317 GQKEEISQNEYKRGISGWNF 336
G + + E + W F
Sbjct: 374 GLVTNLEELE----VDDWEF 389
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-140
Identities = 127/298 (42%), Positives = 180/298 (60%), Gaps = 20/298 (6%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
E +T E++G+G V + + ++VA+KI+D E ++ +I +E + D P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
V K + S++ D LW++M ++ GGS L +L+ P +E IATILRE+LKGLDYLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHS 137
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
IHRD+K+ N+L+ G +KL DFGV+ L D+ + RNTFVGTP WMAPEV++Q
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAPEVIKQ- 193
Query: 190 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249
YD KADIWS GITA+ELA G P S+ PMKVL + +N PP L + +SK K+
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL----EGNYSKPLKE 249
Query: 250 MIASCLVKDPSKRPSAKKLLKHSFFKQ-ARSNEYIARTLLEGLPALGDRIKALKKKEE 306
+ +CL K+PS RP+AK+LLKH F + A+ Y+ L DR K K ++
Sbjct: 250 FVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE--------LIDRYKRWKAEQS 299
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 349 bits (898), Expect = e-116
Identities = 89/288 (30%), Positives = 137/288 (47%), Gaps = 15/288 (5%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
+ ++Y E+G G V + ++AVK + + + I +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL 74
Query: 61 QT-MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILRE 119
+ D P +++ +F+++ ++++ M M G+C LK E ++ +
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVA 132
Query: 120 VLKGLDYLHH-HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
++K L YL HG IHRDVK NIL+D RG IKL DFG+S L D + ++ G
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD----KAKDRSAGCA 188
Query: 179 CWMAPEVMEQLH----GYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPP 233
+MAPE ++ YD +AD+WS GI+ +ELA G P+ +VL LQ PP
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP 248
Query: 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
L FS F+ + CL KD KRP KLL+HSF K+ + E
Sbjct: 249 LL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 336 bits (863), Expect = e-111
Identities = 96/284 (33%), Positives = 155/284 (54%), Gaps = 11/284 (3%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
E + + E+G G V++A + A K+++ + + +L + E + + DHP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATCDHP 76
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
++K ++ D LW+++ F GG+ I+ G E I + R++L+ L++LH
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM--- 186
IHRD+K+GN+L+ + G I+L DFGVSA + + R++F+GTP WMAPEV+
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPYWMAPEVVMCE 192
Query: 187 -EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
+ YD+KADIWS GIT +E+A P + PM+VLL ++ PP L K+S
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL--LTPSKWSV 250
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLE 289
F+ + L K+P RPSA +LL+H F SN+ + + E
Sbjct: 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAE 294
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 337 bits (865), Expect = e-111
Identities = 109/309 (35%), Positives = 166/309 (53%), Gaps = 23/309 (7%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI-LVDH 68
A + L E VG G V++ + ++ A+K++D D + I +E + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHH 80
Query: 69 PNVLKSHCSFV------SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
N+ + +F+ D LW+VM F GS ++K + +E IA I RE+L+
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
GL +LH H IHRD+K N+L+ +KL DFGVSA L + R RNTF+GTP WMA
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWMA 197
Query: 183 PEVMEQLH----GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238
PEV+ YDFK+D+WS GITA+E+A G P PM+ L + +N P L
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL--- 254
Query: 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRI 298
+ +K+SK F+ I SCLVK+ S+RP+ ++L+KH F + + + L + DR
Sbjct: 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKD----HIDRT 310
Query: 299 KALKKKEED 307
K + ++++
Sbjct: 311 KKKRGEKDE 319
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-110
Identities = 91/287 (31%), Positives = 137/287 (47%), Gaps = 14/287 (4%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT- 62
+ + AE E+G+G SV++ + P +I+AVK + D + + +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAY---PDGFEEVVIATILRE 119
M D P +++ + + + + W+ M M S K Y D E ++ I
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 120 VLKGLDYLHHHGHI-HRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+K L++L + I HRD+K NIL+D G IKL DFG+S L DS + G
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAGCR 189
Query: 179 CWMAPEVMEQ---LHGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQNAPPG 234
+MAPE ++ GYD ++D+WS GIT ELA G P+ K+ + L ++ PP
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
L +R+FS SF + CL KD SKRP K+LLKH F
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 331 bits (850), Expect = e-109
Identities = 112/307 (36%), Positives = 168/307 (54%), Gaps = 21/307 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E + + E++G+G SV++A+ +IVA+K + E SDL I +E M D P+
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPH 85
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
V+K + S+ + +LW+VM + GS I++ E IATIL+ LKGL+YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
IHRD+K+GNIL++ G KL DFGV+ L D+ + RNT +GTP WMAPEV+++
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQE-I 200
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
GY+ ADIWS GITA+E+A G P++ PM+ + M N PP + +S +F
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF--RKPELWSDNFTDF 258
Query: 251 IASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKEEDMLA 310
+ CLVK P +R +A +LL+H F + A+ L D I +
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRSAKGVSI-----------LRDLINEAMDVKLKRQE 307
Query: 311 QKKMPDG 317
++ +G
Sbjct: 308 SQQREEG 314
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 328 bits (843), Expect = e-108
Identities = 96/274 (35%), Positives = 150/274 (54%), Gaps = 10/274 (3%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ YT +E++GQG S +V+ A+ + + VA++ ++ ++ I E M +PN
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPN 78
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ S++ LWVVM +++GGS ++ +E IA + RE L+ L++LH +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
IHRD+KS NIL+ + G++KL DFG A + + R+T VGTP WMAPEV+ +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR-K 191
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
Y K DIWS GI A+E+ G P+ P++ L + N P L + K S F+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIFRDF 249
Query: 251 IASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIA 284
+ CL D KR SAK+LL+H F K A+ +
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-108
Identities = 105/316 (33%), Positives = 157/316 (49%), Gaps = 25/316 (7%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS--DLSNISREAQTMILVD 67
+ ++ E+G G +V+ A + +E+VA+K + + S +I +E + + +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYL 127
HPN ++ ++ +H W+VM + GS +L+ + +EV IA + L+GL YL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYL 170
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV-- 185
H H IHRDVK+GNIL+ G +KLGDFG ++ + N+FVGTP WMAPEV
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANSFVGTPYWMAPEVIL 223
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
YD K D+WS GIT +ELA P M L QN P L + +S+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---QSGHWSE 280
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKE 305
F+ + SCL K P RP+++ LLKH F + R + L R K +E
Sbjct: 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV--------IMDLIQRTKD-AVRE 331
Query: 306 EDMLAQKKMPDGQKEE 321
D L +KM +E
Sbjct: 332 LDNLQYRKMKKILFQE 347
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = e-106
Identities = 89/274 (32%), Positives = 135/274 (49%), Gaps = 10/274 (3%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
Y ++G+G + V A VAVK++D + + E M H N
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHFN 103
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
V++ + S++ LWV+M F+ GG+ I+ E IAT+ VL+ L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQ 160
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
G IHRD+KS +IL+ + G +KL DFG A + + R + VGTP WMAPEV+ +
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISR-S 216
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
Y + DIWS GI +E+ G P+ P++ + + PP L + K S +
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL--KNSHKVSPVLRDF 274
Query: 251 IASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIA 284
+ LV+DP +R +A++LL H F Q E +
Sbjct: 275 LERMLVRDPQERATAQELLDHPFLLQTGLPECLV 308
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 2e-97
Identities = 80/284 (28%), Positives = 130/284 (45%), Gaps = 16/284 (5%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQ-TMI 64
+ A+ E+G+G V + +P +I+AVK + ++ + + + +M
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVLK 122
VD P + + + + ++W+ M M S K G E ++ I ++K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 123 GLDYLHHHGH-IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
L++LH IHRDVK N+LI+ G +K+ DFG+S L D + + G +M
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDAGCKPYM 176
Query: 182 APEV---MEQLHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGLDY 237
APE GY K+DIWS GIT +ELA P+ + P + L ++ P L
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP- 235
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
KFS F + CL K+ +RP+ +L++H FF S
Sbjct: 236 --ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 1e-88
Identities = 92/321 (28%), Positives = 142/321 (44%), Gaps = 54/321 (16%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM 63
K + + + E+G G V + P ++A K++ E + + I RE Q +
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 64 ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
+ P ++ + +F SD + + M M GGS +LK A E ++ + V+KG
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKG 143
Query: 124 LDYLHHHGHI-HRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
L YL I HRDVK NIL++ RG IKL DFGVS L DS M N+FVGT +M+
Sbjct: 144 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMS 198
Query: 183 PEVMEQLHGYDFKADIWSFGITALELAHGHAPF--------------------------- 215
PE ++ Y ++DIWS G++ +E+A G P
Sbjct: 199 PERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 216 -----------SKYPPMKVLLMTLQ----NAPPGLDYERDRKFSKSFKQMIASCLVKDPS 260
P + L PP L FS F+ + CL+K+P+
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPA 314
Query: 261 KRPSAKKLLKHSFFKQARSNE 281
+R K+L+ H+F K++ + E
Sbjct: 315 ERADLKQLMVHAFIKRSDAEE 335
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-88
Identities = 70/284 (24%), Positives = 108/284 (38%), Gaps = 14/284 (4%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
+Y T VG+G VHR AVK + E + E
Sbjct: 48 PVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------EL 101
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
+ P ++ + + + + M + GGS ++K E L +
Sbjct: 102 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQA 159
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGA-IKLGDFGVSACLFDSGDRQRM--RNTFVGT 177
L+GL+YLH +H DVK+ N+L+ G+ L DFG + CL G + + + GT
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237
MAPEV+ D K DIWS L + +G P+++Y + L PP +
Sbjct: 220 ETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI 278
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
+ Q I L K+P R SA +L +
Sbjct: 279 PPS--CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-80
Identities = 64/292 (21%), Positives = 113/292 (38%), Gaps = 37/292 (12%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-DLSNISREAQTM-ILVD 67
+ E++G G SV + + I A+K S D N RE +L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVLKGLD 125
H +V++ ++ D ++ + + +GGS + Y F+E + +L +V +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAI-------------------KLGDFGVSACLFDSGD 166
Y+H +H D+K NI I K+GD G +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----- 184
Query: 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLM 226
G ++A EV+++ + + KADI++ +T + A +
Sbjct: 185 --SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI-- 240
Query: 227 TLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278
Q P + + S+ F +++ + DP +RPSA L+KHS A
Sbjct: 241 -RQGRLPRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-80
Identities = 76/268 (28%), Positives = 121/268 (45%), Gaps = 13/268 (4%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSF 78
+G+G V+ + +A+K + D+ + E + H N+++ SF
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 79 VSDHNLWVVMPFMSGGSCLHILKAAY-PDGFEEVVIATILREVLKGLDYLHHHGHIHRDV 137
+ + + M + GGS +L++ + P E I +++L+GL YLH + +HRD+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 138 KSGNILIDVR-GAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ-LHGYDFK 195
K N+LI+ G +K+ DFG S L TF GT +MAPE++++ GY
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKRLAGINP---CTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 196 ADIWSFGITALELAHGHAPFSKYP-PMKVLLM-TLQNAPPGLDYERDRKFSKSFKQMIAS 253
ADIWS G T +E+A G PF + P + + P + S K I
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI----PESMSAEAKAFILK 261
Query: 254 CLVKDPSKRPSAKKLLKHSFFKQARSNE 281
C DP KR A LL F K + +
Sbjct: 262 CFEPDPDKRACANDLLVDEFLKVSSKKK 289
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 5e-78
Identities = 74/270 (27%), Positives = 128/270 (47%), Gaps = 23/270 (8%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHPNVLKSH 75
E+G+G +V++ L VA + D + S+ EA+ + + HPN+++ +
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 76 CSFV----SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG 131
S+ + +V M+ G+ LK + V+ + R++LKGL +LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRT 149
Query: 132 H--IHRDVKSGNILIDVR-GAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
IHRD+K NI I G++K+GD G++ R +GTP +MAPE+ E+
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVIGTPEFMAPEMYEE 204
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLM--TLQNAPPGLDYERDRKFSKS 246
YD D+++FG+ LE+A P+S+ + T P D +
Sbjct: 205 --KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD----KVAIPE 258
Query: 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
K++I C+ ++ +R S K LL H+FF++
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 3e-77
Identities = 72/302 (23%), Positives = 129/302 (42%), Gaps = 30/302 (9%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
A + +GQG V +A + A+K + LS I E + ++H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 70 NVLKSHCSFVSDHN-------------LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATI 116
V++ + +++ N L++ M + G+ ++ + + +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRL 121
Query: 117 LREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR------- 169
R++L+ L Y+H G IHRD+K NI ID +K+GDFG++ + S D +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 170 ----MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL 225
+ +GT ++A EV++ Y+ K D++S GI E+ + PFS +L
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238
Query: 226 MTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIAR 285
L++ + D K K++I + DP+KRP A+ LL + +E I
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKE 298
Query: 286 TL 287
L
Sbjct: 299 AL 300
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 2e-74
Identities = 65/276 (23%), Positives = 103/276 (37%), Gaps = 16/276 (5%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFE-RDNSDLSNISREAQ 61
+ + + +G G V + + AVK R D + E
Sbjct: 49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108
Query: 62 TMI-LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
+ + HP ++ ++ L++ G S +A + E + LR+
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEA-WGASLPEAQVWGYLRDT 166
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
L L +LH G +H DVK NI + RG KLGDFG+ L G P +
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL----GTAGAGEVQEGDPRY 222
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
MAPE+++ Y AD++S G+T LE+A + L PP
Sbjct: 223 MAPELLQ--GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ--GYLPPEF----T 274
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
S + ++ L DP R +A+ LL +Q
Sbjct: 275 AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-73
Identities = 72/320 (22%), Positives = 134/320 (41%), Gaps = 14/320 (4%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHP 69
E Y +++G+G +K ++ R + + RE + + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N+++ SF + +L++VM + GG + A F+E I ++ L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
+HRD+KS NI + G ++LGDFG++ L + + + +GTP +++PE+ E
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE---LARACIGTPYYLSPEICEN- 199
Query: 190 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249
Y+ K+DIW+ G EL F ++L + + P + +S +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSL----HYSYDLRS 255
Query: 250 MIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKEEDML 309
+++ ++P RPS +L+ F + I + L L A +K K +
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIA-----KRIEKFLSPQLIAEEFCLKTFSKFGSQPI 310
Query: 310 AQKKMPDGQKEEISQNEYKR 329
K+ GQ K
Sbjct: 311 PAKRPASGQNSISVMPAQKI 330
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-72
Identities = 71/281 (25%), Positives = 131/281 (46%), Gaps = 13/281 (4%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDH 68
++ + +++G+G + V+RA C+ VA+K + D ++ +E + ++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVLKGLDY 126
PNV+K + SF+ D+ L +V+ G ++K E + ++ L++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM 186
+H +HRD+K N+ I G +KLGD G+ ++ VGTP +M+PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERI 208
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPPGLDYERDRKFS 244
+ +GY+FK+DIWS G E+A +PF K + Q P L + +S
Sbjct: 209 HE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH---YS 264
Query: 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIAR 285
+ +Q++ C+ DP KRP + + A + +
Sbjct: 265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 4e-72
Identities = 58/289 (20%), Positives = 112/289 (38%), Gaps = 36/289 (12%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
+ E +G G V +A + +K + + + RE + + +DH N++
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK-----AEREVKALAKLDHVNIV 67
Query: 73 KSHCSFV----------------SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATI 116
+ + L++ M F G+ ++ + ++V+ +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 117 LREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176
++ KG+DY+H I+RD+K NI + +K+GDFG+ L R G
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL----KNDGKRTRSKG 183
Query: 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 236
T +M+PE + Y + D+++ G+ EL H + L++
Sbjct: 184 TLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGII--- 236
Query: 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIAR 285
F K K ++ L K P RP+ ++L+ + +S E R
Sbjct: 237 ---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK-KSPEKNER 281
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-66
Identities = 70/333 (21%), Positives = 139/333 (41%), Gaps = 22/333 (6%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILV 66
+ Y++ +++G G S+ V + L +I A+K ++ E DN L + E + +
Sbjct: 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 64
Query: 67 DHPN--VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGL 124
+ +++ + ++D +++VM LK + + + +L+ +
Sbjct: 65 QQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAV 121
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
+H HG +H D+K N LI G +KL DFG++ ++++ VGT +M PE
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 185 VMEQ----------LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 234
++ K+D+WS G + +G PF + L + + P
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--PN 237
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK-QARSNEYIARTLLEGLPA 293
+ E K + ++ CL +DP +R S +LL H + + Q +A+ E +
Sbjct: 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKY 297
Query: 294 LGDRIKALKKKEEDMLAQKKMPDGQKEEISQNE 326
+ ++ L + A K + + S N
Sbjct: 298 VLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-65
Identities = 58/290 (20%), Positives = 113/290 (38%), Gaps = 33/290 (11%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ + +G+G V A + A+K + + RE + + ++HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 71 VLKSHCSFVSDHN------------LWVVMPFMSGGSCLHILKAAYPDGF-EEVVIATIL 117
+++ +++ + L++ M + + E V I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR-------- 169
++ + +++LH G +HRD+K NI + +K+GDFG+ + + Q
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 170 -MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL 228
VGT +M+PE + + Y K DI+S G+ EL + PFS L +
Sbjct: 185 ARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240
Query: 229 QNA--PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
+N PP + M+ L P +RP A +++++ F+
Sbjct: 241 RNLKFPPLFT-----QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 4e-65
Identities = 62/289 (21%), Positives = 125/289 (43%), Gaps = 21/289 (7%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISRE 59
+ + + Y++ +++G G S+ V + L +I A+K ++ E DN L + E
Sbjct: 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNE 76
Query: 60 AQTMILVDHPN--VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATIL 117
+ + + +++ + ++D +++VM LK + +
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYW 133
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177
+ +L+ + +H HG +H D+K N LI G +KL DFG++ ++++ VGT
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN-QMQPDTTSVVKDSQVGT 191
Query: 178 PCWMAPEVMEQL----------HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT 227
+M PE ++ + K+D+WS G + +G PF + L
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251
Query: 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
+ + P + E K + ++ CL +DP +R S +LL H + +
Sbjct: 252 IID--PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-62
Identities = 69/338 (20%), Positives = 139/338 (41%), Gaps = 22/338 (6%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQ 61
+ + Y++ +++G G S+ V + L +I A+K ++ E DN L + E
Sbjct: 48 NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 62 TMILVDHPN--VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILRE 119
+ + + +++ + ++D +++VM LK + + +
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKN 163
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
+L+ + +H HG +H D+K N LI G +KL DFG++ ++++ VG
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN-QMQPDTTSVVKDSQVGAVN 221
Query: 180 WMAPEVMEQ----------LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ 229
+M PE ++ K+D+WS G + +G PF + L +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
Query: 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK-QARSNEYIARTLL 288
+ P + E K + ++ CL +DP +R S +LL H + + Q +A+
Sbjct: 282 D--PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 339
Query: 289 EGLPALGDRIKALKKKEEDMLAQKKMPDGQKEEISQNE 326
E + + ++ L + A K + + S N
Sbjct: 340 EEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 377
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-60
Identities = 61/282 (21%), Positives = 122/282 (43%), Gaps = 18/282 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHP 69
E Y + +G G + +I+ K LD+ ++ + E + + HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 70 NVLKSHCSFV--SDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVLKGLD 125
N+++ + + ++ L++VM + GG ++ + +E + ++ ++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 126 YLHHHGH-----IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
H +HRD+K N+ +D + +KLGDFG++ L TFVGTP +
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---FAKTFVGTPYY 182
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
M+PE M + Y+ K+DIWS G EL PF+ + ++ + +
Sbjct: 183 MSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI----P 237
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEY 282
++S ++I L RPS +++L++ + + +
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 7e-60
Identities = 72/312 (23%), Positives = 125/312 (40%), Gaps = 25/312 (8%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
+G + + +G G ++ + N VAVK + S RE Q + D
Sbjct: 21 VGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRIL----PECFSFADREVQLLRESD 75
Query: 68 -HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDY 126
HPNV++ C+ ++ + + ++ + + + T+L++ GL +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAH 133
Query: 127 LHHHGHIHRDVKSGNILIDVRGA-----IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
LH +HRD+K NILI + A + DFG+ L R+ GT W+
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 182 APEVMEQL--HGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238
APE++ + + DI+S G ++ G PF K + ++ + L E
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRI 298
+ +++I + DP KRPSAK +LKH FF L+ + DRI
Sbjct: 254 KH--EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ-------LQFFQDVSDRI 304
Query: 299 KALKKKEEDMLA 310
+ +
Sbjct: 305 EKESLDGPIVKQ 316
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-57
Identities = 66/290 (22%), Positives = 114/290 (39%), Gaps = 19/290 (6%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM 63
I +HY +++G+G + V + A+K + + D REA
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-HEQQDREEAQREADMH 80
Query: 64 ILVDHPNVLKSHCSFVSD----HNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATIL 117
L +HPN+L+ + + H W+++PF G+ + ++ G E I +L
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN----- 172
+ +GL+ +H G+ HRD+K NIL+ G L D G + R
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 173 -TFVGTPCWMAPEVMEQL--HGYDFKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTL 228
T + APE+ D + D+WS G + G P+ + + + +
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260
Query: 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278
QN L + + S + Q++ S + DP +RP LL Q
Sbjct: 261 QN---QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-56
Identities = 65/276 (23%), Positives = 124/276 (44%), Gaps = 17/276 (6%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREA 60
K+++ + + + +G+G +V+ A I+A+K+L + + RE
Sbjct: 3 KRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
+ + HPN+L+ + F +++++ + G+ L+ F+E AT + E+
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITEL 118
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
L Y H IHRD+K N+L+ G +K+ DFG S S R GT +
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDY 173
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
+ PE++E +D K D+WS G+ E G PF + T + ++
Sbjct: 174 LPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRISRV-EFTFP 227
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
++ + +I+ L +PS+RP +++L+H +
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-55
Identities = 73/288 (25%), Positives = 120/288 (41%), Gaps = 13/288 (4%)
Query: 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMI 64
P Y +G+G A E+ A KI+ +S E
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGL 124
+ H +V+ H F + ++VV+ S L + K E LR+++ G
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 128
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
YLH + IHRD+K GN+ ++ +K+GDFG++ + G+R + GTP ++APE
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIAPE 185
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244
V+ + G+ F+ D+WS G L G PF +K + ++ +Y + +
Sbjct: 186 VLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKN----EYSIPKHIN 239
Query: 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
+I L DP+ RP+ +LL FF + T L P
Sbjct: 240 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPP 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-55
Identities = 85/300 (28%), Positives = 138/300 (46%), Gaps = 38/300 (12%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD-LSNISRE 59
MD I + E++G G +VHRA VAVKIL + +++ ++ RE
Sbjct: 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLRE 84
Query: 60 AQTMILVDHPNVLKSHCSFV----SDHNLWVVMPFMSGGSCLHIL-KAAYPDGFEEVVIA 114
M + HPN++ F+ NL +V ++S GS +L K+ + +E
Sbjct: 85 VAIMKRLRHPNIVL----FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 115 TILREVLKGLDYLHHHGH--IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172
++ +V KG++YLH+ +HR++KS N+L+D + +K+ DFG+S L S
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS-RLKASTFLSSK-- 197
Query: 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN-- 230
+ GTP WMAPEV+ + K+D++SFG+ ELA P+ P +V+
Sbjct: 198 SAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 256
Query: 231 ---APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS-------AKKLLKHSFFKQARSN 280
P L+ +I C +P KRPS + L+K + RS+
Sbjct: 257 RLEIPRNLN--------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 6e-55
Identities = 73/288 (25%), Positives = 120/288 (41%), Gaps = 13/288 (4%)
Query: 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMI 64
P Y +G+G A E+ A KI+ +S E
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGL 124
+ H +V+ H F + ++VV+ S L + K E LR+++ G
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 154
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
YLH + IHRD+K GN+ ++ +K+GDFG++ + G+R + GTP ++APE
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIAPE 211
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244
V+ + G+ F+ D+WS G L G PF +K + ++ +Y + +
Sbjct: 212 VLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKN----EYSIPKHIN 265
Query: 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
+I L DP+ RP+ +LL FF + T L P
Sbjct: 266 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPP 313
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-54
Identities = 70/268 (26%), Positives = 123/268 (45%), Gaps = 12/268 (4%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDH 68
E + + +G+G A V+RA I VA+K++D + + + E + + H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
P++L+ + F + +++V+ G LK F E + +++ G+ YLH
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH 129
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
HG +HRD+ N+L+ IK+ DFG++ L ++ T GTP +++PE+ +
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK---HYTLCGTPNYISPEIATR 186
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
+ ++D+WS G L G PF +K L + A DYE S K
Sbjct: 187 -SAHGLESDVWSLGCMFYTLLIGRPPFDT-DTVKNTLNKVVLA----DYEMPSFLSIEAK 240
Query: 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
+I L ++P+ R S +L H F +
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSR 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-54
Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 29/289 (10%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD-LSNISREAQTMILV 66
I E + E +G+G V+ + VA++++D ERDN D L RE
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 67 DHPNVLKSHCSFV----SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
H NV+ F+ S +L ++ G + +++ A + I +E++K
Sbjct: 87 RHENVVL----FMGACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVK 141
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS--ACLFDSGDRQRMRNTFVGTPCW 180
G+ YLH G +H+D+KS N+ D G + + DFG+ + + +G R+ G C
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 181 MAPEVMEQLHG--------YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP 232
+APE++ QL + +D+++ G EL PF P ++
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260
Query: 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQARS 279
P L K ++ C + +RP+ KL+ K+ R
Sbjct: 261 PNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-54
Identities = 64/314 (20%), Positives = 120/314 (38%), Gaps = 42/314 (13%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
+ L + +GQG +A+V R ++ A+K+ + + RE + + ++
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 68 HPNVLKSHCSF--VSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGL 124
H N++K + + ++M F GS + + + G E +LR+V+ G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 125 DYLHHHGHIHRDVKSGNILI----DVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
++L +G +HR++K GNI+ D + KL DFG + L D + GT +
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEY 181
Query: 181 MAPEVMEQL-------HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233
+ P++ E+ Y D+WS G+T A G PF + + +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 234 G----------------LDYERD--------RKFSKSFKQMIASCLVKDPSKRPSAKKLL 269
G +D+ D R ++A+ L D K +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
Query: 270 KHSFFKQARSNEYI 283
+ R N +
Sbjct: 302 AETSDILHRGNSHH 315
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 7e-54
Identities = 47/263 (17%), Positives = 95/263 (36%), Gaps = 30/263 (11%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSN-ISREAQTMILVDHPNVL 72
++ + S + + + VK+L ++ S + E + + HPNVL
Sbjct: 13 NFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 73 KSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
C + ++ +M GS ++L ++ ++ +G+ +LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 131 GH--IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM-- 186
+ S +++ID ++ V + P W+APE +
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVK--------FSFQSPGRMYAPAWVAPEALQK 182
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN-----APPGLDYERDR 241
+ AD+WSF + EL PF+ M++ + PPG+
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS----- 237
Query: 242 KFSKSFKQMIASCLVKDPSKRPS 264
+++ C+ +DP+KRP
Sbjct: 238 ---PHVSKLMKICMNEDPAKRPK 257
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-53
Identities = 64/296 (21%), Positives = 114/296 (38%), Gaps = 50/296 (16%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNIS----- 57
+ + +++G+G VH+ + +VA+K L + I
Sbjct: 11 SRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 58 -REAQTMILVDHPNVLKSHCSF--VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIA 114
RE M ++HPN++K + + +VM F+ G H L + V
Sbjct: 71 QREVFIMSNLNHPNIVK----LYGLMHNPPRMVMEFVPCGDLYHRLLDK-AHPIKWSVKL 125
Query: 115 TILREVLKGLDYLHHHGH--IHRDVKSGNILIDVRGA-----IKLGDFGVSACLFDSGDR 167
++ ++ G++Y+ + +HRD++S NI + K+ DFG+S
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS------QQS 179
Query: 168 QRMRNTFVGTPCWMAPEVMEQLHG-YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLM 226
+ +G WMAPE + Y KAD +SF + + G PF +Y K+ +
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 227 TL-----------QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ ++ PP L + +I C DP KRP ++K
Sbjct: 240 NMIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-52
Identities = 78/272 (28%), Positives = 121/272 (44%), Gaps = 18/272 (6%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD-LSNISREAQTMILV 66
I T+ + +G G +V++ + VAVK+L+ L E +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 67 DHPNVLKSHCSF---VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
H N+L F + L +V + G S H L A+ FE + I R+ +G
Sbjct: 78 RHVNILL----FMGYSTAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARG 132
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
+DYLH IHRD+KS NI + +K+GDFG+ A G+ WMAP
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL-ATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 184 EV--MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL--QNAPPGLDYER 239
EV M+ + Y F++D+++FGI EL G P+S ++ + + P L R
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
K K+++A CL K +RPS ++L
Sbjct: 252 S-NCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-51
Identities = 71/275 (25%), Positives = 121/275 (44%), Gaps = 29/275 (10%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL 65
+ I + + E VG+G V +A + VA+K + S+ E + +
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQI---ESESERKAFIVELRQLSR 57
Query: 66 VDHPNVLKSHCSF--VSDHNLWVVMPFMSGGSCLHIL-KAAYPDGFEEVVIATILREVLK 122
V+HPN++K + + +VM + GGS ++L A + + + +
Sbjct: 58 VNHPNIVK----LYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 123 GLDYLHHHGH---IHRDVKSGNILIDVRG-AIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
G+ YLH IHRD+K N+L+ G +K+ DFG + D Q G+
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNNKGSA 167
Query: 179 CWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKY--PPMKVLLMTLQNAPPGLD 236
WMAPEV E + Y K D++S+GI E+ PF + P +++ P
Sbjct: 168 AWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP--- 223
Query: 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ K + ++ C KDPS+RPS ++++K
Sbjct: 224 -PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-51
Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 17/278 (6%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISR 58
M K+K+ I + + +G+G +V+ A I+A+K+L + + R
Sbjct: 6 MPKRKFTID--DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR 118
E + + HPN+L+ + F +++++ F G L+ F+E AT +
Sbjct: 64 EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFME 121
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
E+ L Y H IHRD+K N+L+ +G +K+ DFG S R T GT
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTL 176
Query: 179 CWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238
++ PE++E +D K D+W G+ E G PF + T + D +
Sbjct: 177 DYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE----THRRIVNV-DLK 230
Query: 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
S K +I+ L P +R K +++H + K
Sbjct: 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 8e-51
Identities = 67/317 (21%), Positives = 109/317 (34%), Gaps = 52/317 (16%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD--------------- 45
+ +K I Y + + QG + LC N+ A+K +
Sbjct: 23 VKEKDKYIN--DYRIIRTLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNN 78
Query: 46 -FERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGG------SCLH 98
S + E Q + + + L + ++++ +M
Sbjct: 79 DKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF 138
Query: 99 ILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHI-HRDVKSGNILIDVRGAIKLGDFGV 157
+L Y VI I++ VL Y+H+ +I HRDVK NIL+D G +KL DFG
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVME-QLHGYDFKADIWSFGITALELAHGHAPFS 216
S + D GT +M PE + K DIWS GI + + PFS
Sbjct: 199 SEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
Query: 217 -----------------KYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDP 259
+YP + + S + L K+P
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNF--LSNEDIDFLKLFLRKNP 311
Query: 260 SKRPSAKKLLKHSFFKQ 276
++R +++ LKH +
Sbjct: 312 AERITSEDALKHEWLAD 328
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-50
Identities = 69/294 (23%), Positives = 124/294 (42%), Gaps = 38/294 (12%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-------------------------F 46
YTL +E+G+G V A N A+K+L
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 47 ERDNSDLSNISREAQTMILVDHPNVLKSHC--SFVSDHNLWVVMPFMSGGSCLHILKAAY 104
+ + + +E + +DHPNV+K ++ +L++V ++ G + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-- 131
Query: 105 PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164
E ++++KG++YLH+ IHRD+K N+L+ G IK+ DFGVS F
Sbjct: 132 -KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSN-EFKG 189
Query: 165 GDRQRMRNTFVGTPCWMAPEVMEQLH-GYD-FKADIWSFGITALELAHGHAPFSKYPPMK 222
D + + VGTP +MAPE + + + D+W+ G+T G PF +
Sbjct: 190 SD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIM 246
Query: 223 VLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
L +++ L++ ++ K +I L K+P R ++ H + +
Sbjct: 247 CLHSKIKSQA--LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-50
Identities = 61/303 (20%), Positives = 115/303 (37%), Gaps = 42/303 (13%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
+ L + +GQG +A+V R ++ A+K+ + + RE + + ++
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 68 HPNVLKSHCSF--VSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGL 124
H N++K + + ++M F GS + + + G E +LR+V+ G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 125 DYLHHHGHIHRDVKSGNILI----DVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
++L +G +HR++K GNI+ D + KL DFG + L + + GT +
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL----EDDEQFVSLYGTEEY 181
Query: 181 MAPEVMEQL-------HGYDFKADIWSFGITALELAHGHAPFS----------------- 216
+ P++ E+ Y D+WS G+T A G PF
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 217 -KYPPMKVLLMTLQNAPPGLDYE------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLL 269
K + +N P + R ++A+ L D K +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
Query: 270 KHS 272
+
Sbjct: 302 AET 304
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 5e-50
Identities = 47/229 (20%), Positives = 91/229 (39%), Gaps = 21/229 (9%)
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKA-AYPDGFEEVVIATIL 117
+ + M N + L++ M + + + E V I
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM------- 170
++ + +++LH G +HRD+K NI + +K+GDFG+ + + Q +
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 171 --RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL 228
VGT +M+PE + + Y K DI+S G+ EL + FS ++ +
Sbjct: 231 ATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDV 286
Query: 229 QNA--PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275
+N P + M+ L P++RP A +++++ F+
Sbjct: 287 RNLKFPLLFT-----QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 10/82 (12%), Positives = 28/82 (34%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ + +G+G V A + A+K + + RE + + ++HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 71 VLKSHCSFVSDHNLWVVMPFMS 92
+++ +++
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDE 87
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 7e-50
Identities = 43/308 (13%), Positives = 82/308 (26%), Gaps = 43/308 (13%)
Query: 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS--DLSNISREAQTMILV 66
G L E + G + V + E A+K+ +NS +L + +
Sbjct: 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARL 119
Query: 67 DHPNV--------------------------LKSHCSFVSDHNLWVVMPFMSG--GSCLH 98
+ L + N ++MP S
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179
Query: 99 ILKAAYPDG--FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFG 156
L Y + + + ++++ L G +H N+ I G + LGD
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 157 VSACLFDSGDRQRMRNTFVGTPCWMAPEVME-QLHGYDFKADIWSFGITALELAHGHAPF 215
+ G R + E + + + W G++ + PF
Sbjct: 240 ALWKV---GTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293
Query: 216 SKYPPMKVLLMTL----QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
P L + K +I L D +R + ++
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353
Query: 272 SFFKQARS 279
F Q ++
Sbjct: 354 PEFLQLQN 361
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-49
Identities = 76/273 (27%), Positives = 124/273 (45%), Gaps = 15/273 (5%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ + ++G G VH +K ++ +R + I E + + +DHPN
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDG-FEEVVIATILREVLKGLDYLH 128
++K F HN+++VM GG L I+ A E +A ++++++ L Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 129 HHGHIHRDVKSGNILIDVR---GAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
+H+D+K NIL IK+ DFG++ LF S + GT +MAPEV
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHS---TNAAGTALYMAPEV 197
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF-S 244
++ FK DIWS G+ L G PF+ +V +Y + + +
Sbjct: 198 FKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE---PNYAVECRPLT 252
Query: 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277
++ L KDP +RPSA ++L H +FKQA
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-49
Identities = 86/325 (26%), Positives = 150/325 (46%), Gaps = 22/325 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHP 69
E Y +++G G V + A+KI+ S S + E + L+DHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLH 128
N++K + F N ++VM GG I+ F EV A I+++VL G+ YLH
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLH 153
Query: 129 HHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
H +HRD+K N+L++ + IK+ DFG+S +F++ + + +GT ++APEV
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS-AVFENQKKMK---ERLGTAYYIAPEV 209
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
+ + YD K D+WS G+ L G+ PF ++L ++ D + S+
Sbjct: 210 LRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK-VEKGKYTFDSPEWKNVSE 266
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA----- 300
K +I L D +R SA++ L+H + K+ S + L A+ + ++
Sbjct: 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAI-ENMRKFQNSQ 325
Query: 301 -LKKKEEDMLAQKKMPDGQKEEISQ 324
L + +A K + +E++
Sbjct: 326 KLAQAALLYMASKLTSQEETKELTD 350
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-49
Identities = 72/276 (26%), Positives = 115/276 (41%), Gaps = 36/276 (13%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD---LSNISREAQTMILVDHPN 70
TL E +G G V+RA + VAVK + D + N+ +EA+ ++ HPN
Sbjct: 10 TLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 71 VLKSHCSFV----SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDY 126
++ + NL +VM F GG +L ++ ++ +G++Y
Sbjct: 68 IIA----LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP---PDILVNWAVQIARGMNY 120
Query: 127 LHHHGH---IHRDVKSGNILIDVRGA--------IKLGDFGVSACLFDSGDRQRMRNTFV 175
LH IHRD+KS NILI + +K+ DFG++ + + +
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTK----MSAA 175
Query: 176 GTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 235
G WMAPEV+ + +D+WS+G+ EL G PF + V N L
Sbjct: 176 GAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN---KL 231
Query: 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ F +++ C DP RPS +L
Sbjct: 232 ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-48
Identities = 80/326 (24%), Positives = 140/326 (42%), Gaps = 24/326 (7%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS--DLSNISREAQTMILVDH 68
+ Y +G+G V + AVK++ + D ++ RE Q + +DH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYL 127
PN++K + F ++V +GG I+ F EV A I+R+VL G+ Y+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYM 142
Query: 128 HHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
H + +HRD+K N+L++ + I++ DFG+S F++ + + +GT ++APE
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMK---DKIGTAYYIAPE 198
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244
V+ YD K D+WS G+ L G PF+ +L + + +K S
Sbjct: 199 VLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-KGKYTFELPQWKKVS 255
Query: 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA---- 300
+S K +I L PS R SA+ L H + + + L I+
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPS--LDNAILNIRQFQGT 313
Query: 301 --LKKKEEDMLAQKKMPDGQKEEISQ 324
L + + K + +E++
Sbjct: 314 QKLAQAALLYMGSKLTSQDETKELTA 339
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-48
Identities = 84/325 (25%), Positives = 142/325 (43%), Gaps = 22/325 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHP 69
E Y + +G+G V + + AVK+++ N D S I RE + + +DHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGLDYLH 128
N++K + ++V +GG I+K F E A I+++V G+ Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMH 138
Query: 129 HHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
H +HRD+K NIL++ + IK+ DFG+S F + +GT ++APEV
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKM---KDRIGTAYYIAPEV 194
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
+ YD K D+WS G+ L G PF +L ++ D + R S
Sbjct: 195 LRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR-VETGKYAFDLPQWRTISD 251
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKA----- 300
K +I L PS R +A + L+H + ++ S L A+ I+
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAM-TNIRQFQAEK 310
Query: 301 -LKKKEEDMLAQKKMPDGQKEEISQ 324
L + +A K + +++++
Sbjct: 311 KLAQAALLYMASKLTTLDETKQLTE 335
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-47
Identities = 80/344 (23%), Positives = 144/344 (41%), Gaps = 35/344 (10%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD------------FERDN 50
KK+ IG E Y ++G G V + A+K++ +
Sbjct: 29 KKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIE 87
Query: 51 SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFE 109
I E + +DHPN++K F ++V F GG I+ F+
Sbjct: 88 KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---FD 144
Query: 110 EVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGD 166
E A I++++L G+ YLH H +HRD+K NIL++ + IK+ DFG+S F
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS-SFFSKDY 203
Query: 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLM 226
+ +GT ++APEV+++ Y+ K D+WS G+ L G+ PF ++
Sbjct: 204 KL---RDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK 258
Query: 227 TLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIART 286
++ D+ + S K++I L D +KR +A++ L + K+ +N +
Sbjct: 259 -VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQ 317
Query: 287 LLEGLPALGDRIKA------LKKKEEDMLAQKKMPDGQKEEISQ 324
L ++ L + + K +++E++
Sbjct: 318 KT--LCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTD 359
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 79/278 (28%), Positives = 126/278 (45%), Gaps = 19/278 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHP 69
E Y + +G+G V + + AVK+++ N D S I RE + + +DHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGLDYLH 128
N++K + ++V +GG I+K F E A I+++V G+ Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMH 138
Query: 129 HHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
H +HRD+K NIL++ + IK+ DFG+S F +M +GT ++APEV
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQN--TKM-KDRIGTAYYIAPEV 194
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--RKF 243
+ YD K D+WS G+ L G PF +L ++ R
Sbjct: 195 LRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK---YAFDLPQWRTI 249
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
S K +I L PS R +A + L+H + ++ S E
Sbjct: 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 80/305 (26%), Positives = 135/305 (44%), Gaps = 29/305 (9%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD----FERDNSDLSNISREAQTMILV 66
+ Y L E +G+G + V R + + AVKI+D ++ REA ++
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 67 DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH--ILKAAYPDGFEEVVIATILREVLKGL 124
HP++++ ++ SD L++V FM G + +A + E V + +R++L+ L
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 125 DYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
Y H + IHRDVK +L+ + +KLG FGV+ L +SG VGTP +M
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG---GRVGTPHFM 200
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-LDYERD 240
APEV+++ Y D+W G+ L G PF + G
Sbjct: 201 APEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPR 254
Query: 241 --RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRI 298
S+S K ++ L+ DP++R + + L H + K+ R L + +
Sbjct: 255 QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE--------RDRYAYKIHLPETV 306
Query: 299 KALKK 303
+ L+K
Sbjct: 307 EQLRK 311
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 62/327 (18%), Positives = 109/327 (33%), Gaps = 38/327 (11%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM 63
+ +G + + +G A V+ A + A+K L + I +E M
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-NEEEKNRAIIQEVCFM 79
Query: 64 -ILVDHPNVLKSHCSFVSDHN--------LWVVMPFMSGGSCLHILKAAYPDGFEEVVIA 114
L HPN+++ + ++ G + K +
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL 139
Query: 115 TILREVLKGLDYLHHHGH--IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR--- 169
I + + + ++H IHRD+K N+L+ +G IKL DFG + + D
Sbjct: 140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 170 ------MRNTFVGTPCWMAPEVMEQLHG--YDFKADIWSFGITALELAHGHAPFSKYPPM 221
T TP + PE+++ K DIW+ G L PF +
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
Query: 222 KVLLMTLQNA----PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277
+++ N PP F +I + L +P +R S +++ A
Sbjct: 260 RIV-----NGKYSIPPHDTQ------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
Query: 278 RSNEYIARTLLEGLPALGDRIKALKKK 304
N + E L G A +
Sbjct: 309 ARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-47
Identities = 71/275 (25%), Positives = 110/275 (40%), Gaps = 18/275 (6%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
E +G+G + E++ +K L D +E + M ++
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI-RFDEETQRTFLKEVKVMRCLE 65
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG-FEEVVIATILREVLKGLDY 126
HPNVLK D L + ++ GG+ I+K+ D + + +++ G+ Y
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAY 123
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR-----------QRMRNTFV 175
LH IHRD+ S N L+ + + DFG++ + D + ++ R T V
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 176 GTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 235
G P WMAPE++ YD K D++SFGI E+ Y P + L
Sbjct: 184 GNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG--FL 240
Query: 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
D SF + C DP KRPS KL
Sbjct: 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (428), Expect = 5e-47
Identities = 41/311 (13%), Positives = 89/311 (28%), Gaps = 59/311 (18%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS--DLSNISREAQTMIL---V 66
+GQ + A E V + F + + E + L +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 67 DHPNVLKSHCSFVSDH------------------------NLWVVMPFMSG--GSCLHIL 100
+ K H F+ + + + P M + +L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 101 KAAYPDG--FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158
+ + +V++ L LHH+G +H ++ +I++D RG + L F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG----------YDFKADIWSFGITALEL 208
R R + + PE+ + F D W+ G+ +
Sbjct: 254 V-------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 209 AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
P +K + + + + + ++ L R +
Sbjct: 307 WCADLPITKDAALGGS---------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357
Query: 269 LKHSFFKQARS 279
++ ++Q R+
Sbjct: 358 METPEYEQLRT 368
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-47
Identities = 68/299 (22%), Positives = 122/299 (40%), Gaps = 20/299 (6%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD---FERDNSDLSNISREAQTMILVDH 68
Y + + +G+G V L AVKIL R + +N+ +E Q + + H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 69 PNVLKSH--CSFVSDHNLWVVMPFMSGGSCL---HILKAAYPDGFEEVVIATILREVLKG 123
NV++ +++VM + G + + F +++ G
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----RFPVCQAHGYFCQLIDG 121
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
L+YLH G +H+D+K GN+L+ G +K+ GV+ T G+P + P
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE-ALHPFAADDTCRTSQGSPAFQPP 180
Query: 184 EVMEQLHGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242
E+ L + FK DIWS G+T + G PF + L + Y
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKG----SYAIPGD 235
Query: 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKAL 301
++ L +P+KR S +++ +HS+F++ + A + P DR +++
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK-KHPPAEAPVPIPPSPDTKDRWRSM 293
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-47
Identities = 69/328 (21%), Positives = 118/328 (35%), Gaps = 36/328 (10%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNV 71
+ + E +G G V R + E VA+K E + E Q M ++HPNV
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 72 LK------SHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGL 124
+ + + M + GG ++ + G +E I T+L ++ L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 125 DYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
YLH + IHRD+K NI++ K+ D G + D G+ + FVGT ++
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGE---LCTEFVGTLQYL 190
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE--- 238
APE++EQ Y D WSFG A E G PF ++
Sbjct: 191 APELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249
Query: 239 ----------------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEY 282
+ ++ + L+ +R + + F+ +
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL--DSI 307
Query: 283 IARTLLEGLPALGDRIKALKKKEEDMLA 310
++ LL + + R+ E + L
Sbjct: 308 LSLKLLSVMNMVSGRVHTYPVTENENLQ 335
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-47
Identities = 72/297 (24%), Positives = 108/297 (36%), Gaps = 44/297 (14%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
A TL E VG+G V R E VAVKI + S E +++ H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHE 62
Query: 70 NVLK----SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
N+L S S LW++ + GS L+ D + I + GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIV---LSIASGLA 119
Query: 126 YLHHHGH--------IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR--QRMRNTFV 175
+LH HRD+KS NIL+ G + D G+ A + N V
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL-AVMHSQSTNQLDVGNNPRV 178
Query: 176 GTPCWMAPEVME-----QLHGYDFKADIWSFGITALELAHGHA----------PFSKYPP 220
GT +MAPEV++ + DIW+FG+ E+A PF P
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 221 MKVLLMTLQNA-------PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
++ P + S +++ C ++PS R +A ++ K
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 74/317 (23%), Positives = 123/317 (38%), Gaps = 49/317 (15%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD----FERDNSDLSNISREAQTMILV 66
+ Y L +GQG V A+ I A+KI++ + + D+ I E + M +
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 67 DHPNVLKSHCSFVSDHNLWVVMPFMSGG-------------------------------- 94
HPN+ + + + + + +VM GG
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 95 ------SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG 148
+H + + E +I+ I+R++ L YLH+ G HRD+K N L
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 149 --AIKLGDFGVSACL--FDSGDRQRMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGI 203
IKL DFG+S ++G+ M T GTP ++APEV+ Y K D WS G+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGM-TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 204 TALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRP 263
L G PF + L N + S + ++++ L ++ +R
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVL-NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323
Query: 264 SAKKLLKHSFFKQARSN 280
A + L+H + Q
Sbjct: 324 DAMRALQHPWISQFSDK 340
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 68/274 (24%), Positives = 129/274 (47%), Gaps = 18/274 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHP 69
++Y + EE+G+G + V R + A KI++ ++ D + REA+ + HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGLDYLH 128
N+++ H S + ++V ++GG I+ + + E + ++++L+ + Y H
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCH 122
Query: 129 HHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
+G +HR++K N+L+ + A+KL DFG++ + + F GTP +++PEV
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDS--EAWH-GFAGTPGYLSPEV 178
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--RKF 243
+++ Y DIW+ G+ L G+ PF ++ A DY
Sbjct: 179 LKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA---YDYPSPEWDTV 234
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277
+ K +I S L +P KR +A + LK +
Sbjct: 235 TPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 73/274 (26%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
++YTL +G+G V A+ A K + + D+ +E + M +DHPN
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
+++ + +F + ++++VM +GG ++ F E A I+++VL + Y H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHK 124
Query: 130 HGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM 186
HRD+K N L +KL DFG++A F G + M T VGTP +++P+V+
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPG--KMM-RTKVGTPYYVSPQVL 180
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246
E Y + D WS G+ L G+ PFS P +++ ++ + S
Sbjct: 181 EG--LYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSPQ 237
Query: 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280
+ +I L K P +R ++ + L+H +F++ S+
Sbjct: 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 67/271 (24%), Positives = 125/271 (46%), Gaps = 15/271 (5%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E + L + +G+G V A+ E VAVKI+D +R NI +E +++H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
V+K + + ++ + + SGG ++ G E +++ G+ YLH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
G HRD+K N+L+D R +K+ DFG++ +F +R+R+ N GT ++APE++++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR-R 182
Query: 191 GYD-FKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTLQN---APPGLDYERDRKFSK 245
+ D+WS GI + G P+ + + P +K
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------WKKIDS 236
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
+ ++ LV++PS R + + K ++ +
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNK 267
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 4e-46
Identities = 68/293 (23%), Positives = 113/293 (38%), Gaps = 31/293 (10%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI-LVDHP 69
+ +G G S +V VAVK + + E + + DHP
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHP 69
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPD----GFEEVVIATILREVLKGLD 125
NV++ +CS +D L++ + + + D +E ++LR++ G+
Sbjct: 70 NVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 126 YLHHHGHIHRDVKSGNILIDVRGA-------------IKLGDFGVSACLFDSGDRQRMR- 171
+LH IHRD+K NIL+ I + DFG+ L R
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 172 NTFVGTPCWMAPEVMEQLH------GYDFKADIWSFG-ITALELAHGHAPFSKYPPMKVL 224
N GT W APE++E+ + DI+S G + L+ G PF +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 225 LMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277
++ + + DR +I+ + DP KRP+A K+L+H F
Sbjct: 250 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 9e-46
Identities = 64/299 (21%), Positives = 113/299 (37%), Gaps = 44/299 (14%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
A+ + +++G+G V E VAVK+ + S E +L+
Sbjct: 34 TIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMR 89
Query: 68 HPNVLK----SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
H N+L S L+++ + GS LK+ D + ++ + + G
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLD-AKSML--KLAYSSVSG 146
Query: 124 LDYLHHHGH--------IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR--MRNT 173
L +LH HRD+KS NIL+ G + D G+ A F S + NT
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-AVKFISDTNEVDIPPNT 205
Query: 174 FVGTPCWMAPEVMEQLHG-----YDFKADIWSFGITALELAHG----------HAPFSKY 218
VGT +M PEV+++ AD++SFG+ E+A P+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 219 PPMKVLLMTLQNA-------PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
P ++ P + + + +++ C +P+ R +A ++ K
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 68/273 (24%), Positives = 129/273 (47%), Gaps = 18/273 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHP 69
++Y + EE+G+G + V R + A KI++ ++ D + REA+ + HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGLDYLH 128
N+++ H S + ++V ++GG I+ + + E + ++++L+ + Y H
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCH 145
Query: 129 HHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
+G +HR++K N+L+ + A+KL DFG++ + + F GTP +++PEV
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDS--EAWH-GFAGTPGYLSPEV 201
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--RKF 243
+++ Y DIW+ G+ L G+ PF ++ A DY
Sbjct: 202 LKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA---YDYPSPEWDTV 257
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
+ K +I S L +P KR +A + LK +
Sbjct: 258 TPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-45
Identities = 78/323 (24%), Positives = 151/323 (46%), Gaps = 20/323 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-FERDNSDLSNISREAQTMILVDHP 69
E Y L+EE+G+G + V R + + + A I++ + D + REA+ L+ HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGLDYLH 128
N+++ H S + + +++ ++GG I+ Y + E + ++++L+ + + H
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCH 127
Query: 129 HHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
G +HR++K N+L+ + A+KL DFG++ G++Q F GTP +++PEV
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWF-GFAGTPGYLSPEV 184
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--RKF 243
+ + Y D+W+ G+ L G+ PF ++ A D+
Sbjct: 185 LRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA---YDFPSPEWDTV 240
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ--ARSNEYIARTLLEGLPALGDRIKAL 301
+ K +I L +PSKR +A + LKH + ++ + ++ L R K L
Sbjct: 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRK-L 299
Query: 302 KKKEEDMLAQKKMPDGQKEEISQ 324
K ++ + +K+EI +
Sbjct: 300 KGAILTVMLATRNFSVRKQEIIK 322
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-45
Identities = 78/324 (24%), Positives = 135/324 (41%), Gaps = 26/324 (8%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-------FERDNSDLSNISREAQTM 63
+ Y + + +G G V A + VA+KI+ R+ N+ E + +
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 64 ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLK 122
++HP ++K F + ++V+ M GG ++ +E ++L
Sbjct: 70 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLL 125
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
+ YLH +G IHRD+K N+L+ + IK+ DFG S L G+ MR T GTP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMR-TLCGTPT 181
Query: 180 WMAPEVMEQLH--GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237
++APEV+ + GY+ D WS G+ G+ PFS++ L + +
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDR 297
E + S+ ++ LV DP R + ++ L+H + + L E +
Sbjct: 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE-----ENE 296
Query: 298 IKALKKKEEDMLAQKKMPDGQKEE 321
AL + +K P + E
Sbjct: 297 STALPQVLAQPSTSRKRPREGEAE 320
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-45
Identities = 72/292 (24%), Positives = 126/292 (43%), Gaps = 21/292 (7%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-------FERDNSDLSNISREAQTM 63
+ Y + + +G G V A + VA++I+ R+ N+ E + +
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 64 ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLK 122
++HP ++K F + ++V+ M GG ++ +E ++L
Sbjct: 195 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLL 250
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
+ YLH +G IHRD+K N+L+ + IK+ DFG S L G+ MR T GTP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMR-TLCGTPT 306
Query: 180 WMAPEVMEQLH--GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237
++APEV+ + GY+ D WS G+ G+ PFS++ L + +
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLE 289
E + S+ ++ LV DP R + ++ L+H + + L E
Sbjct: 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 418
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-45
Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 29/275 (10%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-------DNSDLSNISREAQTMI 64
Y+ +G G V A+ N+ V VK + E+ ++ L ++ E +
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL--HILKAAYPDGFEEVVIATILREVLK 122
V+H N++K F + +VM G L I + +E + + I R+++
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVS 141
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
+ YL IHRD+K NI+I IKL DFG +A + G + TF GT + A
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA-YLERGK---LFYTFCGTIEYCA 197
Query: 183 PEVMEQLHGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
PEV+ + Y + ++WS G+T L PF + + +
Sbjct: 198 PEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETV---------EAAIHPPY 245
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
SK +++ L P +R + +KL+ + Q
Sbjct: 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 9e-45
Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 27/288 (9%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD--------FERDNSDLSNISREAQT 62
E+Y E +G+GVS+ V R + P + AVKI+D E +E
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 63 MILVD-HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREV 120
+ V HPN+++ ++ ++ ++V M G + + E I+R +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 133
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
L+ + LH +HRD+K NIL+D IKL DFG S C D G +++R GTP +
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPG--EKLR-EVCGTPSY 189
Query: 181 MAPEV-----MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 235
+APE+ + GY + D+WS G+ L G PF M +L M +
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN---Y 246
Query: 236 DYERD--RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
+ +S + K +++ LV P KR +A++ L H FF+Q E
Sbjct: 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 75/327 (22%), Positives = 130/327 (39%), Gaps = 27/327 (8%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKI-----LDFERDNSDLSNISREAQTMIL 65
++Y EE+G G A V + A K R +I RE +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGL 124
+ HPNV+ H + + ++ +++ ++GG + + E L+++L G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 127
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGA----IKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
YLH H D+K NI++ R IK+ DFG++ D G + GTP +
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-HKIDFG--NEFK-NIFGTPEF 183
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
+APE++ +AD+WS G+ L G +PF + L ++E +
Sbjct: 184 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN---YEFEDE 239
Query: 241 --RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIAR----TLLEGLPAL 294
S K I LVKDP KR + + L+H + K + + ++R +E
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKF 299
Query: 295 GDRIKALKKKEEDMLAQKKMPDGQKEE 321
R K+ + + + E
Sbjct: 300 AARKKSNNGSGGGLNDIFEAQKIEWHE 326
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 68/300 (22%), Positives = 131/300 (43%), Gaps = 10/300 (3%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E + L + +G+G V A+ E VAVKI+D +R NI +E +++H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
V+K + + ++ + + SGG ++ G E +++ G+ YLH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
G HRD+K N+L+D R +K+ DFG++ +F +R+R+ N GT ++APE++++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR-R 182
Query: 191 GYD-FKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
+ D+WS GI + G P+ + + +K +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPL 239
Query: 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKEEDM 308
++ LV++PS R + + K ++ + + R + K + ++
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNK-PLKKGAKRPRVTSGGVSESPSGFSKHIQSNL 298
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 69/316 (21%), Positives = 129/316 (40%), Gaps = 35/316 (11%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKI-----LDFERDNSDLSNISREAQTMIL 65
+ Y + EE+G G A V + A K R I RE +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL--HILKAAYPDGFEEVVIATILREVLKG 123
V H NV+ H + + ++ +++ +SGG L + + E + ++++L G
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGE-LFDFLAQKES---LSEEEATSFIKQILDG 127
Query: 124 LDYLHHHGHIHRDVKSGNILIDVR----GAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
++YLH H D+K NI++ + IKL DFG++ + D + GTP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFK-NIFGTPE 183
Query: 180 WMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239
++APE++ +AD+WS G+ L G +PF + L + D++
Sbjct: 184 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS---YDFDE 239
Query: 240 D--RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDR 297
+ S+ K I LVK+ KR + ++ L+H + + + + R
Sbjct: 240 EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVR------RESVVN 293
Query: 298 IKALKKKEEDMLAQKK 313
++ +K +++
Sbjct: 294 LENFRK----QYVRRR 305
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-44
Identities = 65/299 (21%), Positives = 111/299 (37%), Gaps = 44/299 (14%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
A L E +G+G V R E VAVKI + S E +++
Sbjct: 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLR 94
Query: 68 HPNVLK----SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
H N+L + + LW+V + GS L E ++ + G
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-VEGMI--KLALSTASG 151
Query: 124 LDYLHHHGH--------IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG--DRQRMRNT 173
L +LH HRD+KS NIL+ G + D G+ A DS N
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-AVRHDSATDTIDIAPNH 210
Query: 174 FVGTPCWMAPEVMEQLHG-----YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL 228
VGT +MAPEV++ +ADI++ G+ E+A + + ++ L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 229 QNAPPGLD-------YERDR----------KFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
+ P ++ ++ R + + +++ C + + R +A ++ K
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 39/300 (13%), Positives = 86/300 (28%), Gaps = 48/300 (16%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS--DLSNISREAQTMIL---VDHPNV 71
+GQ + A E V + F + + E + L + +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 72 LKSHCSFVSDH------------------------NLWVVMPFMSG--GSCLHILKAAYP 105
K H F+ + + + P M + +L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 106 DG--FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163
+ +V++ L LHH+G +H ++ +I++D RG + L F + D
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH--LVRD 261
Query: 164 SGDRQRMRNTFVGTPCWMAPEVM----EQLHGYDFKADIWSFGITALELAHGHAPFSKYP 219
P A ++ F D W+ G+ + P +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279
+ + + + + ++ L R + ++ ++Q R+
Sbjct: 322 ALGGS---------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 71/275 (25%), Positives = 129/275 (46%), Gaps = 16/275 (5%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPN 70
+Y L + +G+G A V A I VA+KI+D + + + L + RE + M +++HPN
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
++K ++ L+++M + SGG +++ +E + R+++ + Y H
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
+HRD+K+ N+L+D IK+ DFG S F G + F G P + APE+ +
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSN-EFTVGG---KLDAFCGAPPYAAPELFQG- 187
Query: 190 HGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
YD + D+WS G+ L G PF +K L + Y S +
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRG----KYRIPFYMSTDCE 242
Query: 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYI 283
++ LV +P KR + ++++K + + +
Sbjct: 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 277
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 72/282 (25%), Positives = 120/282 (42%), Gaps = 23/282 (8%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKI-----LDFERDNSDLSNISREAQTMIL 65
+HY + EE+G G A V + + A K L R I RE +
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGL 124
+ HPN++ H F + ++ +++ +SGG + + E L+++L G+
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGV 121
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGA----IKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
YLH H D+K NI++ + IKL DFG++ + + GTP +
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFK-NIFGTPEF 177
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
+APE++ +AD+WS G+ L G +PF + L D++ +
Sbjct: 178 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN---YDFDEE 233
Query: 241 --RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280
S+ K I LVKDP +R + + L+HS+ K R
Sbjct: 234 YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 6e-44
Identities = 66/309 (21%), Positives = 128/309 (41%), Gaps = 16/309 (5%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
++Y + EE+G G VHR + + K ++ D + E M + HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-TPYPLDKYTVKNEISIMNQLHHPK 109
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
++ H +F + + +++ F+SGG I Y E + +R+ +GL ++H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHE 167
Query: 130 HGHIHRDVKSGNILIDVRG--AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187
H +H D+K NI+ + + ++K+ DFG++ L + ++ T + APE+++
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVK-VTTATAEFAAPEIVD 223
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--RKFSK 245
+ F D+W+ G+ L G +PF+ ++ L + +++ D S
Sbjct: 224 R-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD---WEFDEDAFSSVSP 279
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKE 305
K I + L K+P KR + L+H + K SN +
Sbjct: 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWP 339
Query: 306 EDMLAQKKM 314
A ++
Sbjct: 340 APQPAIGRI 348
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-44
Identities = 82/298 (27%), Positives = 135/298 (45%), Gaps = 32/298 (10%)
Query: 11 EHYTLYEEV-GQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI-LVDH 68
+ Y L E+V G+G A V + + ++ AVKI++ ++ S + RE + + H
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGH 70
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYL 127
NVL+ F + ++V M GGS L HI K + F E+ + ++++V LD+L
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH---FNELEASVVVQDVASALDFL 127
Query: 128 HHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRN----TFVGTPCW 180
H+ G HRD+K NIL + +K+ DF + + + +GD + T G+ +
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 181 MAPEV----MEQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAPP 233
MAPEV E+ YD + D+WS G+ L G+ PF
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 234 GL-------DYERDRKF----SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280
L YE K S + K +I+ LV+D +R SA ++L+H + +
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-44
Identities = 71/290 (24%), Positives = 127/290 (43%), Gaps = 30/290 (10%)
Query: 4 KKYPIGAEHYTLY---EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
K P +HY L + +G+G + + + N+ AVKI+ +N +E
Sbjct: 2 KDSPF-YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS----KRMEANTQKEI 56
Query: 61 QTMILVD-HPNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILR 118
+ L + HPN++K H F + ++VM ++GG I K + F E + I+R
Sbjct: 57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH---FSETEASYIMR 113
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFV 175
+++ + ++H G +HRD+K N+L IK+ DFG + Q ++ T
Sbjct: 114 KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLK-TPC 170
Query: 176 GTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF------SKYPPMKVLLMTLQ 229
T + APE++ Q +GYD D+WS G+ + G PF ++ ++
Sbjct: 171 FTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK 229
Query: 230 NAPPGLDYERD--RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277
+E + + S+ K +I L DP+KR L + + +
Sbjct: 230 KGD--FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 66/275 (24%), Positives = 113/275 (41%), Gaps = 17/275 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E Y + E++G+G VHR + + K + +D + +E + + H N
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRN 62
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
+L H SF S L ++ F+SG I +A+ E I + + +V + L +LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHS 120
Query: 130 HGHIHRDVKSGNILIDVR--GAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187
H H D++ NI+ R IK+ +FG + GD R P + APEV +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNFR---LLFTAPEYYAPEVHQ 176
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--RKFSK 245
D+WS G L G PF +++ + ++ + ++ S
Sbjct: 177 H-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE---YTFDEEAFKEISI 232
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280
+ LVK+ R +A + L+H + KQ
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 17/278 (6%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREA 60
K + HY L + +G G V VAVKIL+ ++ + I RE
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILRE 119
Q + L HP+++K + + + ++VM ++SGG +I K EE+ + ++
Sbjct: 63 QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQ 119
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
+L +DY H H +HRD+K N+L+D K+ DFG+S + G+ T G+P
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGE---FLRTSCGSPN 175
Query: 180 WMAPEVMEQLHGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238
+ APEV+ Y + DIWS G+ L G PF + L ++ +
Sbjct: 176 YAAPEVISG-RLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGG----VFY 229
Query: 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
++S ++ L DP KR + K + +H +FKQ
Sbjct: 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 70/263 (26%), Positives = 108/263 (41%), Gaps = 14/263 (5%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKIL--DFERDNSDLSNISREAQTMILVDHP 69
Y L VG+G V+ A IVA+K++ D + + REA+T + P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
+V+ H D L+V M ++G +L+ P V I+R++ LD H
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAV--AIVRQIGSALDAAHA 152
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
G HRDVK NIL+ L DFG+++ D Q VGT +MAP E+
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ--LGNTVGTLYYMAP---ERF 207
Query: 190 HGY--DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247
++ADI++ E G P+ + V+ + A P +F
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPS-TVRPGIPVAF 265
Query: 248 KQMIASCLVKDPSKR-PSAKKLL 269
+IA + K+P R + L
Sbjct: 266 DAVIARGMAKNPEDRYVTCGDLS 288
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 74/282 (26%), Positives = 130/282 (46%), Gaps = 26/282 (9%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-------FERDNSDLSNISREAQTM 63
+ Y + +G+GVS+ V R + AVKI++ E+ RE +
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 64 -ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVL 121
+ HP+++ S+ S +++V M G + + E +I+R +L
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA---LSEKETRSIMRSLL 210
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
+ + +LH + +HRD+K NIL+D I+L DFG S C + G +++R GTP ++
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPG--EKLR-ELCGTPGYL 266
Query: 182 APEV-----MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 236
APE+ E GY + D+W+ G+ L G PF + +L M ++
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ---YQ 323
Query: 237 YERD--RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
+ S + K +I+ L DP R +A++ L+H FF++
Sbjct: 324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 70/317 (22%), Positives = 131/317 (41%), Gaps = 35/317 (11%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKI-----LDFERDNSDLSNISREAQTMIL 65
+ Y + EE+G G A V + A K R I RE +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL--HILKAAYPDGFEEVVIATILREVLKG 123
V HPN++ H + + ++ +++ +SGG L + + E + ++++L G
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGE-LFDFLAQKES---LSEEEATSFIKQILDG 127
Query: 124 LDYLHHHGHIHRDVKSGNILIDVR----GAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
++YLH H D+K NI++ + IKL DFG++ + D + GTP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFK-NIFGTPE 183
Query: 180 WMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239
++APE++ +AD+WS G+ L G +PF + L + D++
Sbjct: 184 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS---YDFDE 239
Query: 240 D--RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDR 297
+ + S+ K I LVK+ KR + ++ L+H + + + + R
Sbjct: 240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVR------RESVVN 293
Query: 298 IKALKKKEEDMLAQKKM 314
++ KK +++
Sbjct: 294 LENFKK----QYVRRRW 306
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 72/277 (25%), Positives = 125/277 (45%), Gaps = 24/277 (8%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI-LVDHP 69
+ Y + E++G G + R + N AVKI+D + + + E + ++ HP
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHP 76
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLH 128
N++ + ++VV M GG L IL+ + F E + +L + K ++YLH
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLH 133
Query: 129 HHGHIHRDVKSGNILI----DVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
G +HRD+K NIL +I++ DFG + L + T T ++APE
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN---GLLMTPCYTANFVAPE 190
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM--KVLLMTLQNAPPGLDYERD-- 240
V+E+ GYD DIWS G+ + G+ PF+ P + +L + +
Sbjct: 191 VLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK--FSLSGGYW 247
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277
S + K +++ L DP +R +A +L+H +
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-42
Identities = 73/299 (24%), Positives = 124/299 (41%), Gaps = 16/299 (5%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+HY ++EE+G G VHR A K + SD + +E QTM ++ HP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHPT 215
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
++ H +F D+ + ++ FMSGG + E +R+V KGL ++H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE 273
Query: 130 HGHIHRDVKSGNILIDVRG--AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187
+ ++H D+K NI+ + +KL DFG++ D + GT + APEV E
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVK---VTTGTAEFAAPEVAE 329
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--RKFSK 245
+ D+WS G+ + L G +PF + L + + S+
Sbjct: 330 G-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD---WNMDDSAFSGISE 385
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKK 304
K I L+ DP+ R + + L+H + + ++ + D IK
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDA 444
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 46/330 (13%), Positives = 111/330 (33%), Gaps = 44/330 (13%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFN-----EIVAVKILDFERDNSDLSNIS 57
K ++ +G++ ++ +G+G A V+ A N + +K+ + + +
Sbjct: 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGT 115
Query: 58 REAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHIL---KAAYPDGFEEVVIA 114
+ + + +K + + + + +V S G+ L+ + K + ++
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 115 TILREVLKGLDYLHHHGHIHRDVKSGNILI-----------DVRGAIKLGDFGVSACLFD 163
+ +L ++ +H IH D+K N ++ D+ + L D G S +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV 223
T + E++ ++++ D + T + G K +
Sbjct: 236 FPKGTIFT-AKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293
Query: 224 LLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYI 283
L P LD + + L + LL+ K + +
Sbjct: 294 KPEGLFRRLPHLDM---------WNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH--- 341
Query: 284 ARTLLEGLPALGDRIKALKKKEEDMLAQKK 313
++I+AL+ + +L + K
Sbjct: 342 ----------YTNKIRALRNRLIVLLLECK 361
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 71/299 (23%), Positives = 112/299 (37%), Gaps = 44/299 (14%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
+ L E +G V +A NE VAVKI +D N E ++ +
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFP-IQDKQSWQNE-YEVYSLPGMK 76
Query: 68 HPNVLK----SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
H N+L+ D +LW++ F GS LKA + E+ I + +G
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS-WNELC--HIAETMARG 133
Query: 124 LDYLHHHGH----------IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173
L YLH HRD+KS N+L+ + DFG+ A F++G +
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL-ALKFEAGKSAGDTHG 192
Query: 174 FVGTPCWMAPEVMEQLHGYDF----KADIWSFGITALELAHGHAPFSKYPP--------- 220
VGT +MAPEV+E + + D+++ G+ ELA
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 221 ---------MKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
M+ +++ + P DY + + I C D R SA + +
Sbjct: 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 76/329 (23%), Positives = 126/329 (38%), Gaps = 25/329 (7%)
Query: 2 DKKKYPIGAEHYTLYEEV-GQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
+ KKY + + Y L ++V G GV+ V + A+K+L D +E
Sbjct: 20 EPKKYAV-TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY------DSPKARQEV 72
Query: 61 QTMI-LVDHPNVLKSHCSF----VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT 115
P+++ + L ++M M GG ++ F E A
Sbjct: 73 DHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE 132
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRN 172
I+R++ + +LH H HRDVK N+L + +KL DFG + Q
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQ---- 187
Query: 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP 232
T TP ++APEV+ YD D+WS G+ L G PF + +
Sbjct: 188 TPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 233 PG-LDYERD--RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLE 289
G + + S+ KQ+I L DP++R + + + H + Q+
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTAR 306
Query: 290 GLPALGDRIKALKKKEEDMLAQKKMPDGQ 318
L D +K++ LA ++ Q
Sbjct: 307 VLQEDKDHWDEVKEEMTSALATMRVDYDQ 335
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-42
Identities = 69/288 (23%), Positives = 126/288 (43%), Gaps = 20/288 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ + E +G G + V ++ A+K + + S++ E + + H N
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHEN 67
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
++ + S + ++VM +SGG IL+ + E + ++++VL + YLH
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLHE 124
Query: 130 HGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM 186
+G +HRD+K N+L I + DFG+S + + +T GTP ++APEV+
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPEVL 179
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--RKFS 244
Q Y D WS G+ L G+ PF + K+ + ++E S
Sbjct: 180 AQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY---YEFESPFWDDIS 235
Query: 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ-ARSNEYIARTLLEGL 291
+S K I L KDP++R + +K L H + + I ++ +
Sbjct: 236 ESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQI 283
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 9e-42
Identities = 65/276 (23%), Positives = 123/276 (44%), Gaps = 14/276 (5%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKIL--DFERDNSDLSNISREAQTMILVDHPN 70
Y + +++G G ++V+ A N VA+K + L RE + H N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ D ++VM ++ G + +++ P + + ++L G+ + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI--NFTNQILDGIKHAHDM 130
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
+HRD+K NILID +K+ DFG++ L ++ Q N +GT + +P EQ
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVLGTVQYFSP---EQAK 185
Query: 191 GY--DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
G D DI+S GI E+ G PF+ + + + +Q++ P + + + +S
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245
Query: 249 QMIASCLVKDPSKRP-SAKKLLK--HSFFKQARSNE 281
+I KD + R + +++ S + R+NE
Sbjct: 246 NVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 67/292 (22%), Positives = 122/292 (41%), Gaps = 31/292 (10%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-----DNSDLSNISREAQTMILV 66
Y + +G G SV+ + + N VA+K ++ +R + + + + E + V
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 67 DH--PNVLKSHCSFVSDHNLWVVMPFMSGGSCL--HILKAAYPDGFEEVVIATILREVLK 122
V++ F + +++ L I + +E + + +VL+
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLE 160
Query: 123 GLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
+ + H+ G +HRD+K NILID+ RG +KL DFG A L D+ + F GT +
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYS 215
Query: 182 APEVMEQLHGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
PE + + H Y A +WS GI ++ G PF +++
Sbjct: 216 PPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEII---------RGQVFFR 263
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLP 292
++ S + +I CL PS RP+ +++ H + + + A L L
Sbjct: 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLS 315
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 75/319 (23%), Positives = 143/319 (44%), Gaps = 20/319 (6%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQ 61
D ++ + + E+G+G ++ V+R + A+K+L D + E
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI---VRTEIG 100
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREV 120
++ + HPN++K F + + +V+ ++GG I++ Y + E A ++++
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQI 157
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGT 177
L+ + YLH +G +HRD+K N+L +K+ DFG+S + + M+ T GT
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQ--VLMK-TVCGT 213
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237
P + APE++ Y + D+WS GI L G PF + + + N +
Sbjct: 214 PGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE--YYF 270
Query: 238 ERD--RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALG 295
+ S + K ++ +V DP KR + + L+H + +N T + L
Sbjct: 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFN 330
Query: 296 DRIKALKKKEEDMLAQKKM 314
R K LK + ++A ++
Sbjct: 331 ARRK-LKAAVKAVVASSRL 348
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 74/312 (23%), Positives = 130/312 (41%), Gaps = 24/312 (7%)
Query: 11 EHYTLY-EEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDH 68
Y L +E+G+G A V + + + A K L R + I E + L
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 69 -PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYL 127
P V+ H + + + +++ + +GG + + E + +++++L+G+ YL
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 128 HHHGHIHRDVKSGNILI---DVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
H + +H D+K NIL+ G IK+ DFG+S + G +R +GTP ++APE
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELR-EIMGTPEYLAPE 203
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--RK 242
++ D+W+ GI A L +PF + L Q +DY +
Sbjct: 204 ILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN---VDYSEETFSS 259
Query: 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALK 302
S+ I S LVK+P KRP+A+ L HS+ +Q +
Sbjct: 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHP--------EETSSSSQT 311
Query: 303 KKEEDMLAQKKM 314
+ ++ K
Sbjct: 312 QDHSVRSSEDKT 323
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 63/309 (20%), Positives = 113/309 (36%), Gaps = 53/309 (17%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
+ ++ L E +G+G +V++ VAVK+ F + ++ + + L++
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFIN--EKNIYRVPLME 65
Query: 68 HPNVLK-----SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
H N+ + + +VM + GS L D +A V +
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLA---HSVTR 122
Query: 123 GLDYLH----HHGH-----IHRDVKSGNILIDVRGAIKLGDFGVS-----ACLFDSGDRQ 168
GL YLH H HRD+ S N+L+ G + DFG+S L G+
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 169 RMRNTFVGTPCWMAPEVME------QLHGYDFKADIWSFGITALELAHG---HAPFSKYP 219
+ VGT +MAPEV+E + D+++ G+ E+ P P
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 220 PMKVLLMTLQNAPPGLD------------------YERDRKFSKSFKQMIASCLVKDPSK 261
++ T P + ++ + +S K+ I C +D
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 262 RPSAKKLLK 270
R +A+ +
Sbjct: 303 RLTAQXAEE 311
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 69/278 (24%), Positives = 106/278 (38%), Gaps = 33/278 (11%)
Query: 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-----DNSDLSNISREAQTMILV 66
Y L +G+G +V + VA+K++ R SD E + V
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 67 D----HPNVLKSHCSFVSDHNLWVVMPFMSGGSCL--HILKAAYPDGFEEVVIATILREV 120
HP V++ F + +V+ L +I + E +V
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQV 148
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
+ + + H G +HRD+K NILID+ RG KL DFG A L D F GT
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-----PYTDFDGTRV 203
Query: 180 WMAPEVMEQLHGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238
+ PE + H Y A +WS GI ++ G PF + ++L +
Sbjct: 204 YSPPEWI-SRHQYHALPATVWSLGILLYDMVCGDIPFERD--QEIL---------EAELH 251
Query: 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
S +I CL PS RPS +++L + +
Sbjct: 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-40
Identities = 64/279 (22%), Positives = 122/279 (43%), Gaps = 18/279 (6%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISR 58
M K IG Y + E +G+G V A + VA+K + + + + R
Sbjct: 1 MAISKRHIG--PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER 58
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR 118
E + L+ HP+++K + + ++ +V+ + G +I++ E +
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK---KRMTEDEGRRFFQ 115
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+++ ++Y H H +HRD+K N+L+D +K+ DFG+S + G+ T G+P
Sbjct: 116 QIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGN---FLKTSCGSP 171
Query: 179 CWMAPEVMEQLHGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237
+ APEV+ Y + D+WS GI + G PF + L + + Y
Sbjct: 172 NYAAPEVING-KLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSC----VY 225
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
S + +I +V DP +R + +++ + +F
Sbjct: 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 68/327 (20%), Positives = 127/327 (38%), Gaps = 22/327 (6%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
+ KK I ++ + +G G++ V + E A+K+L D RE
Sbjct: 52 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREV 105
Query: 61 QTMI-LVDHPNVLKSHCSF----VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT 115
+ P++++ + L +VM + GG ++ F E +
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 165
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRN 172
I++ + + + YLH HRDVK N+L + +KL DFG + S +
Sbjct: 166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSH--NSLT- 221
Query: 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQ 229
T TP ++APEV+ YD D+WS G+ L G+ PF + ++
Sbjct: 222 TPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLE 289
+ S+ K +I + L +P++R + + + H + Q+
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 340
Query: 290 GLPALGDRIKALKKKEEDMLAQKKMPD 316
L +R + +K++ LA ++
Sbjct: 341 VLKEDKERWEDVKEEMTSALATMRVDY 367
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-40
Identities = 74/286 (25%), Positives = 133/286 (46%), Gaps = 18/286 (6%)
Query: 11 EHYTL--YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDH 68
YT+ E +G G VH+ +A KI+ R D + E M +DH
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK-TRGMKDKEEVKNEISVMNQLDH 145
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYL 127
N+++ + +F S +++ +VM ++ GG I+ +Y E+ ++++ +G+ ++
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHM 203
Query: 128 HHHGHIHRDVKSGNILIDVRG--AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
H +H D+K NIL R IK+ DFG++ R++++ GTP ++APEV
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLK-VNFGTPEFLAPEV 259
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--RKF 243
+ F D+WS G+ A L G +PF + L L D E + +
Sbjct: 260 VNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR---WDLEDEEFQDI 315
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLE 289
S+ K+ I+ L+K+ S R SA + LKH + + + ++ +
Sbjct: 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKK 361
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 19/268 (7%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKIL--DFERDNSDLSNISREAQTMILVDHPN 70
Y L E +G G + VH A + + VAVK+L D RD S REAQ ++HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 71 VL------KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGL 124
++ ++ ++VM ++ G + I+ P + + ++ + + L
Sbjct: 74 IVAVYDTGEAETPAGPLP--YIVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQAL 129
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
++ H +G IHRDVK NI+I A+K+ DFG++ + DSG+ +GT +++P
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP- 188
Query: 185 VMEQLHGY--DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242
EQ G D ++D++S G E+ G PF+ P+ V ++ P R
Sbjct: 189 --EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-ARHEG 245
Query: 243 FSKSFKQMIASCLVKDPSKRP-SAKKLL 269
S ++ L K+P R +A ++
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAEMR 273
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 75/290 (25%), Positives = 122/290 (42%), Gaps = 24/290 (8%)
Query: 1 MDKKKYPIGA---------EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS 51
MD+ G + Y +++G G E+VAVK ++ R +
Sbjct: 1 MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE--RGAA 58
Query: 52 DLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEV 111
N+ RE + HPN+++ ++ +L ++M + SGG + A F E
Sbjct: 59 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSED 116
Query: 112 VIATILREVLKGLDYLHHHGHIHRDVKSGNILID--VRGAIKLGDFGVSACLFDSGDRQR 169
+++L G+ Y H HRD+K N L+D +K+ DFG S
Sbjct: 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---- 172
Query: 170 MRNTFVGTPCWMAPEVMEQLHGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL 228
+ VGTP ++APEV+ + YD AD+WS G+T + G PF + T+
Sbjct: 173 QPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI 231
Query: 229 QNAPPGLDYE--RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
Q Y D + S +I+ V DP+ R S ++ HS+F +
Sbjct: 232 QRILSV-KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-39
Identities = 77/278 (27%), Positives = 128/278 (46%), Gaps = 17/278 (6%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREA 60
K + HY L + +G G V VAVKIL+ ++ + I RE
Sbjct: 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCL-HILKAAYPDGFEEVVIATILRE 119
Q + L HP+++K + + ++++VM ++SGG +I K +E + ++
Sbjct: 68 QNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN---GRLDEKESRRLFQQ 124
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
+L G+DY H H +HRD+K N+L+D K+ DFG+S + G+ T G+P
Sbjct: 125 ILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGE---FLRTSCGSPN 180
Query: 180 WMAPEVMEQLHGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238
+ APEV+ Y + DIWS G+ L G PF + L + + +
Sbjct: 181 YAAPEVISG-RLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDG----IFY 234
Query: 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
+ + S ++ L DP KR + K + +H +FKQ
Sbjct: 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 70/284 (24%), Positives = 126/284 (44%), Gaps = 25/284 (8%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQ 61
+ E + + +G+G ++V A + + A+KIL+ + + ++RE
Sbjct: 23 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVV----IATIL 117
M +DHP +K + +F D L+ + + G L ++ F+E A
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTA--- 137
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177
E++ L+YLH G IHRD+K NIL++ I++ DFG + L + R N+FVGT
Sbjct: 138 -EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGT 195
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237
+++PE++ + +D+W+ G +L G PF + ++ +Y
Sbjct: 196 AQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-----EY 249
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRP------SAKKLLKHSFFK 275
+ KF + ++ LV D +KR L H FF+
Sbjct: 250 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-37
Identities = 60/263 (22%), Positives = 99/263 (37%), Gaps = 32/263 (12%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNE-IVAVKILDFERDNSDLSNISREAQTMILVDH 68
A Y + + G ++ AL N V +K L D + E Q + V H
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH 138
Query: 69 PNVLK-----SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
P++++ H D ++VM ++ G S P E + L E+L
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLP--VAEAI--AYLLEILPA 194
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
L YLH G ++ D+K NI++ +KL D G + + G GTP + AP
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFG-------YLYGTPGFQAP 246
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243
E++ G DI++ G T L + + L P L
Sbjct: 247 EIVR--TGPTVATDIYTVGRTLAALTLDLPTRN-----GRYVDGLPEDDPVLK------T 293
Query: 244 SKSFKQMIASCLVKDPSKRP-SA 265
S+ +++ + DP +R +A
Sbjct: 294 YDSYGRLLRRAIDPDPRQRFTTA 316
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-37
Identities = 66/284 (23%), Positives = 121/284 (42%), Gaps = 15/284 (5%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKIL--DFERDNSDLSNISREA 60
K+ + + + + + +G+G + V ++ A+KI+ ++S E
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREER 112
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
++ D + + H +F ++ L++VM + GG L +L + + + L E+
Sbjct: 113 DVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK-FGERIPAEMARFYLAEI 171
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
+ +D +H G++HRD+K NIL+D G I+L DFG CL D VGTP +
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS--CLKLRADGTVRSLVAVGTPDY 229
Query: 181 MAPEVMEQLHG------YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 234
++PE+++ + G Y + D W+ G+ A E+ +G PF + +
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKR---PSAKKLLKHSFFK 275
D + + I L+ P R A H FF
Sbjct: 290 SLPLVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFFF 332
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-37
Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 15/280 (5%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQ 61
+ + AE Y + + +G+G V ++ A+K+L SD + E
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
M + P V++ +F D L++VM +M GG ++++ E EV+
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVV 178
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
LD +H G IHRDVK N+L+D G +KL DFG C+ + + +T VGTP ++
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT--CMKMNKEGMVRCDTAVGTPDYI 236
Query: 182 APEVMEQLHG---YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238
+PEV++ G Y + D WS G+ E+ G PF + + N L +
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNHKNSLTFP 295
Query: 239 RDRKFSKSFKQMIASCLVKDPSKR---PSAKKLLKHSFFK 275
D SK K +I + + D R +++ +H FFK
Sbjct: 296 DDNDISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFFK 334
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-37
Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 29/287 (10%)
Query: 4 KKYPIGAEHYTLYEEVGQG----VSASVHRALCIPFNEIVAVKILDFER--DNSDLSNIS 57
++ P+ + Y +G+G V A RA ++ A K L+ +R +
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT----GKMYACKKLEKKRIKKRKGEAMAL 232
Query: 58 REAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATIL 117
E Q + V+ V+ ++ + L +V+ M+GG + GF E
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177
E+ GL+ LH ++RD+K NIL+D G I++ D G+ A G VGT
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTI---KGRVGT 348
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF----SKYPPMKVLLMTLQNAPP 233
+MAPEV++ Y F D W+ G E+ G +PF K +V + +
Sbjct: 349 VGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE- 406
Query: 234 GLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFFK 275
E +FS + + + L KDP++R SA+++ +H FK
Sbjct: 407 ----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-37
Identities = 61/253 (24%), Positives = 117/253 (46%), Gaps = 29/253 (11%)
Query: 36 NEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93
++ A+K ++ ++ + +++ N+ +E Q M ++HP ++ SF + ++++V+ + G
Sbjct: 40 KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG 99
Query: 94 GSCL--HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
G L H+ + + F+E + + E++ LDYL + IHRD+K NIL+D G +
Sbjct: 100 GD-LRYHLQQNVH---FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVH 155
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM--EQLHGYDFKADIWSFGITALELA 209
+ DF + A + + T GT +MAPE+ + GY F D WS G+TA EL
Sbjct: 156 ITDFNI-AAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211
Query: 210 HGHAPF---SKYPPMKVLLMTLQNA---PPGLDYERDRKFSKSFKQMIASCLVKDPSKR- 262
G P+ S +++ P +S+ ++ L +P +R
Sbjct: 212 RGRRPYHIRSSTSSKEIVHTFETTVVTYPSA--------WSQEMVSLLKKLLEPNPDQRF 263
Query: 263 PSAKKLLKHSFFK 275
+ +
Sbjct: 264 SQLSDVQNFPYMN 276
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 69/281 (24%), Positives = 127/281 (45%), Gaps = 13/281 (4%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQ 61
K+ + E + + + +G+G V +++ A+KIL+ ++ + E
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
++ D + H +F D+NL++VM + GG L +L + D E + L E++
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMV 185
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
+D +H ++HRD+K NIL+D+ G I+L DFG CL D + VGTP ++
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS--CLKLMEDGTVQSSVAVGTPDYI 243
Query: 182 APEVMEQLH----GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237
+PE+++ + Y + D WS G+ E+ +G PF ++ + +
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKR---PSAKKLLKHSFFK 275
+ S++ K +I L+ R + KH FF
Sbjct: 304 TQVTDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFFS 343
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 62/324 (19%), Positives = 116/324 (35%), Gaps = 43/324 (13%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
+ KK I ++ + +G G++ V + E A+K+L D RE
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREV 61
Query: 61 QTMI-LVDHPNVLKSHCSF----VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT 115
+ P++++ + L +VM + GG ++ F E +
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 121
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRN 172
I++ + + + YLH HRDVK N+L + +KL DFG
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------- 165
Query: 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQ 229
A E + YD D+WS G+ L G+ PF + ++
Sbjct: 166 --------FAKETTGE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 215
Query: 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLE 289
+ S+ K +I + L +P++R + + + H + Q+
Sbjct: 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 275
Query: 290 GLPALGDRIKALKKKEEDMLAQKK 313
L +R + +K++ LA +
Sbjct: 276 VLKEDKERWEDVKEEMTSALATMR 299
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 72/289 (24%), Positives = 124/289 (42%), Gaps = 30/289 (10%)
Query: 4 KKYPIGAEHYTLYEEVGQG----VSASVHRALCIPFNEIVAVKILDFER--DNSDLSNIS 57
+ P+G + + + +G+G V A +A ++ A K L+ +R
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT----GKLYACKKLNKKRLKKRKGYQGAM 233
Query: 58 REAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSC-LHILKAAYPDG-FEEVVIAT 115
E + + V ++ +F + +L +VM M+GG HI + F+E
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175
+++ GL++LH I+RD+K N+L+D G +++ D G++ L + +
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT---KGYA 350
Query: 176 GTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF----SKYPPMKVLLMTLQNA 231
GTP +MAPE++ YDF D ++ G+T E+ PF K ++ L+ A
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409
Query: 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFFK 275
KFS + K + L KDP KR S L H F+
Sbjct: 410 V-----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 74/308 (24%), Positives = 125/308 (40%), Gaps = 65/308 (21%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-I-LDFERDNSDLSNISREAQTMILVDH 68
+ Y E++G+G +V +A +EIVA+K + LD + + S + RE + + H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKH 60
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKA---AYPDGFEEVVIATILREVLKGLD 125
N+++ H SD L +V F LK + + ++ + L ++LKGL
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
+ H +HRD+K N+LI+ G +KL +FG+ A F G R + V T + P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGL-ARAF--GIPVRCYSAEVVTLWYRPPDV 172
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAP------------------------------- 214
+ Y D+WS G ELA+ P
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 215 ------FSKYPPMKVLLMTLQNAPP-GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKK 267
+ YP L+ + G D ++ + L +P +R SA++
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRD-------------LLQNLLKCNPVQRISAEE 279
Query: 268 LLKHSFFK 275
L+H +F
Sbjct: 280 ALQHPYFS 287
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 21/280 (7%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREA 60
+ + + + +G G V A+KILD ++ + + E
Sbjct: 33 PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
+ + V+ P ++K SF + NL++VM +++GG L+ F E ++
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQI 150
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
+ +YLH I+RD+K N+LID +G I++ DFG F + R T GTP
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG-----FAKRVKGRT-WTLCGTPEA 204
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
+APE++ GY+ D W+ G+ E+A G+ PF P+++ + + +
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---VRFPSH 260
Query: 241 RKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFFK 275
FS K ++ + L D +KR + H +F
Sbjct: 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-34
Identities = 63/289 (21%), Positives = 125/289 (43%), Gaps = 31/289 (10%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT 62
+ + ++++ +G+G V+ ++ A+K LD +R + E
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR----IKMKQGETLA 236
Query: 63 M----ILV-----DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVI 113
+ +L D P ++ +F + L ++ M+GG + L F E +
Sbjct: 237 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADM 294
Query: 114 ATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173
E++ GL+++H+ ++RD+K NIL+D G +++ D G+ S + +
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL--ACDFSKKKP---HA 349
Query: 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT--LQNA 231
VGT +MAPEV+++ YD AD +S G +L GH+PF ++ +
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
Query: 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAKKLLKHSFFK 275
L FS + ++ L +D ++R A+++ + FF+
Sbjct: 410 AVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 37/264 (14%), Positives = 66/264 (25%), Gaps = 41/264 (15%)
Query: 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFE--RDNSDLSNISREAQTMI 64
I Y L G +AL + VA+ +D + + L +
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGL 124
+D P V + + VV ++ GGS L+ V ++ +
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLVVAEWIRGGS----LQEVADTSPSPVGAIRAMQSLAAAA 142
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
D H G + + + G + L M
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-----------------------MPDA 179
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAPPGLDYERDR 241
+ + DI G + L P + P + DR
Sbjct: 180 --------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA-DIDR 230
Query: 242 KFSKSFKQMIASCLVKDPSKRPSA 265
+ A + D R ++
Sbjct: 231 DIPFQISAVAARSVQGDGGIRSAS 254
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 85/354 (24%), Positives = 133/354 (37%), Gaps = 83/354 (23%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNIS--REAQTMIL 65
A+ Y + +G+G A+V++A N+IVA+K L + D N + RE + +
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKA---AYPDGFEEVVIATILREVLK 122
+ HPN++ +F N+ +V FM L+ I + L+
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFME-----TDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC--- 179
GL+YLH H +HRD+K N+L+D G +KL DFG+ A F S +R + T
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL-AKSFGSPNR-----AY--THQVVT 175
Query: 180 -WM-APEVMEQLHGYDFKADIWSFG-ITALELAHGHA----------------------- 213
W APE++ Y D+W+ G I A EL
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILA-ELLLRVPFLPGDSDLDQLTRIFETLGTPTE 234
Query: 214 -------------PFSKYPPMKVLLMTLQNAPP-GLDYERDRKFSKSFKQMIASCLVKDP 259
F +P + L A LD +I + +P
Sbjct: 235 EQWPDMCSLPDYVTFKSFPGIP-LHHIFSAAGDDLLD-------------LIQGLFLFNP 280
Query: 260 SKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKEEDMLAQKK 313
R +A + LK +F T LP ++ LK++ LA K+
Sbjct: 281 CARITATQALKMKYFS-----NRPGPTPGCQLPRPNCPVETLKEQSNPALAIKR 329
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 62/304 (20%), Positives = 112/304 (36%), Gaps = 58/304 (19%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNISREAQTMILVDH 68
E Y +++G+G A+V++ + +VA+K L+ E + + + I RE + + H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAI-REVSLLKDLKH 59
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKA---AYPDGFEEVVIATILREVLKGLD 125
N++ H ++ +L +V ++ LK + + L ++L+GL
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLD-----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
Y H +HRD+K N+LI+ RG +KL DFG+ A + + V T + P++
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGL-ARAK--SIPTKTYDNEVVTLWYRPPDI 171
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPF---------------------------SKY 218
+ Y + D+W G E+A G F
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 219 PPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM-------IASCLVKDPSKRPSAKKLLKH 271
K ++ + L + R SA+ +KH
Sbjct: 232 EEFK--TYNYPKYRA-------EALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282
Query: 272 SFFK 275
FF
Sbjct: 283 PFFL 286
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 82/309 (26%), Positives = 123/309 (39%), Gaps = 68/309 (22%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-I-LDFERDNSDLSNISREAQTMILVDH 68
E Y E+VG+G V++A IVA+K I LD E + + I RE + + H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAI-REISLLKELHH 78
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKA---AYPDGFEEVVIATILREVLKGLD 125
PN++ S+ L +V FM LK G ++ I L ++L+G+
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFME-----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC----WM 181
+ H H +HRD+K N+LI+ GA+KL DFG+ A F R ++ T W
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGL-ARAFGIPVR-----SY--THEVVTLWY 185
Query: 182 -APEVMEQLHGYDFKADIWSFGITALELAHGHAPF------------------------- 215
AP+V+ Y DIWS G E+ G F
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245
Query: 216 --SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM-------IASCLVKDPSKRPSAK 266
+ P K T Q + +S +++ L DP+KR SA+
Sbjct: 246 QVQELPLWK--QRTFQVFEK-------KPWSSIIPGFCQEGIDLLSNMLCFDPNKRISAR 296
Query: 267 KLLKHSFFK 275
+ H +FK
Sbjct: 297 DAMNHPYFK 305
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 73/299 (24%), Positives = 121/299 (40%), Gaps = 47/299 (15%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNISREAQTMILVDH 68
E Y E++G+G V++A E A+K L+ E + + I RE + + H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTI-REISILKELKH 59
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKA---AYPDGFEEVVIATILREVLKGLD 125
N++K + + L +V + LK G E V + L ++L G+
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
Y H +HRD+K N+LI+ G +K+ DFG+ A F G R + T + AP+V
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGL-ARAF--GIPVRKYTHEIVTLWYRAPDV 171
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPF---------------------SKYPPMKVL 224
+ Y DIWS G E+ +G F +P +
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT-- 229
Query: 225 LMTLQNAPPGLDYERDRKFSKSFKQM-------IASCLVKDPSKRPSAKKLLKHSFFKQ 276
L P + K + ++ L DP++R +AK+ L+H++FK+
Sbjct: 230 --ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 66/314 (21%), Positives = 108/314 (34%), Gaps = 74/314 (23%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNISREAQTMILVDH 68
E Y VG+G V + IVA+K + + + RE + + + H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM-REIKLLKQLRH 83
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKA---AYPDGFEEVVIATILREVLKGLD 125
N++ ++V F+ H + +P+G + V+ L +++ G+
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVD-----HTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
+ H H IHRD+K NIL+ G +KL DFG + L + + V T + APE+
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL---AAPGEVYDDEVATRWYRAPEL 195
Query: 186 MEQLHG---YDFKADIWSFG-ITALELAHGHA---------------------------- 213
L G Y D+W+ G + E+ G
Sbjct: 196 ---LVGDVKYGKAVDVWAIGCLVT-EMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251
Query: 214 ----------PFSKYPPMKVLLMTLQNAPP-GLDYERDRKFSKSFKQMIASCLVKDPSKR 262
+ + L +D + CL DP KR
Sbjct: 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVID-------------LAKKCLHIDPDKR 298
Query: 263 PSAKKLLKHSFFKQ 276
P +LL H FF+
Sbjct: 299 PFCAELLHHDFFQM 312
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 68/322 (21%), Positives = 114/322 (35%), Gaps = 75/322 (23%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNISREAQTMILVD 67
Y ++GQG V +A + VA+K +++ E++ ++ + RE + + L+
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-REIKILQLLK 74
Query: 68 HPNVL--------KSHCSFVSDHNLWVVMPFMSGGSCLHILK---AAYPDGFEEVVIATI 116
H NV+ K+ ++++V F H L + F I +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-----HDLAGLLSNVLVKFTLSEIKRV 129
Query: 117 LREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVG 176
++ +L GL Y+H + +HRD+K+ N+LI G +KL DFG+ A F +
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL-ARAFSLAKNSQPNRY--- 185
Query: 177 TPC----WM-APEVMEQLHGYDFKADIWSFG-ITALELAHGHAPF--------------- 215
T W PE++ Y D+W G I A E+
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA-EMWTRSPIMQGNTEQHQLALISQL 244
Query: 216 ------------SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS---------C 254
Y + + L RK K +
Sbjct: 245 CGSITPEVWPNVDNYELYE--KLELVKGQK-------RKVKDRLKAYVRDPYALDLIDKL 295
Query: 255 LVKDPSKRPSAKKLLKHSFFKQ 276
LV DP++R + L H FF
Sbjct: 296 LVLDPAQRIDSDDALNHDFFWS 317
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 5e-32
Identities = 69/320 (21%), Positives = 112/320 (35%), Gaps = 82/320 (25%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNISREAQTMILVDH 68
E Y ++G+G V + +IVA+K + + + RE + + + H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-REIRMLKQLKH 61
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKA---AYPDGFEEVVIATILREVLKGLD 125
PN++ F L +V + H + Y G E ++ +I + L+ ++
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCD-----HTVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF---VGTPCWM- 181
+ H H IHRDVK NILI IKL DFG A L + V T W
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGF-ARLLTGPSD-----YYDDEVAT-RWYR 169
Query: 182 APEVMEQLHG---YDFKADIWSFG------------------------------------ 202
+PE+ L G Y D+W+ G
Sbjct: 170 SPEL---LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226
Query: 203 ---ITALELAHGHAPFSKYPPMKVLLMTLQNAPP-GLDYERDRKFSKSFKQMIASCLVKD 258
+ + G M+ L + N L ++ CL D
Sbjct: 227 QQVFSTNQYFSGV-KIPDPEDMEPLELKFPNISYPALG-------------LLKGCLHMD 272
Query: 259 PSKRPSAKKLLKHSFFKQAR 278
P++R + ++LL H +F+ R
Sbjct: 273 PTERLTCEQLLHHPYFENIR 292
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-32
Identities = 65/292 (22%), Positives = 134/292 (45%), Gaps = 18/292 (6%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQ 61
+ K+ + T+ ++G G V+ + ++ VAVK L + D ++ +EA
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAA 268
Query: 62 TMILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILRE 119
M + HPN+++ C+ + +++ FM+ G+ L L+ VV+ + +
Sbjct: 269 VMKEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 326
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
+ ++YL IHR++ + N L+ +K+ DFG+S + F P
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PI 383
Query: 180 -WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDY 237
W APE + + + K+D+W+FG+ E+A +G +P YP + L +
Sbjct: 384 KWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSP---YPGID-LSQVYELLEKDYRM 438
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQARSNEYIARTL 287
ER + +++ +C +PS RPS ++ + + F+++ ++ + + L
Sbjct: 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 66/248 (26%), Positives = 108/248 (43%), Gaps = 20/248 (8%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93
A+KIL + ++++ E++ + HP + +F + L VM + +G
Sbjct: 30 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 94 GSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152
G H+ + F E E++ L+YLH ++RD+K N+++D G IK+
Sbjct: 90 GELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKI 146
Query: 153 GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGH 212
DFG+ G TF GTP ++APEV+E + Y D W G+ E+ G
Sbjct: 147 TDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGR 202
Query: 213 APFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAKK 267
PF + L + R S K ++A L KDP +R AK+
Sbjct: 203 LPFYN-QDHERLFELILMEEIRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
Query: 268 LLKHSFFK 275
+++H FF
Sbjct: 258 VMEHRFFL 265
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 74/256 (28%), Positives = 120/256 (46%), Gaps = 37/256 (14%)
Query: 36 NEIVAVKILD----FERDNSDLSNISREAQTM----IL--VDHPNVLKSHCSFVSDHNLW 85
++ A+K+L RD +T IL V+HP ++K H +F ++ L+
Sbjct: 52 RQLYAMKVLKKATLKVRD---------RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102
Query: 86 VVMPFMSGGSC-LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI 144
+++ F+ GG + K F E + L E+ LD+LH G I+RD+K NIL+
Sbjct: 103 LILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 145 DVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGIT 204
D G IKL DFG+S D + +F GT +MAPEV+ + G+ AD WSFG+
Sbjct: 160 DEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVL 215
Query: 205 ALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-- 262
E+ G PF K + + A G+ + S + ++ ++P+ R
Sbjct: 216 MFEMLTGTLPFQG-KDRKETMTMILKAKLGM----PQFLSPEAQSLLRMLFKRNPANRLG 270
Query: 263 ---PSAKKLLKHSFFK 275
+++ +HSFF
Sbjct: 271 AGPDGVEEIKRHSFFS 286
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 60/249 (24%), Positives = 113/249 (45%), Gaps = 21/249 (8%)
Query: 36 NEIVAVKIL---DFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMS 92
+I A+K+L R+ D ++ E + V HP ++ +F + L++++ ++S
Sbjct: 45 GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLS 104
Query: 93 GGSC-LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG + + + F E L E+ L +LH G I+RD+K NI+++ +G +K
Sbjct: 105 GGELFMQLEREGI---FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
L DFG+ G +TF GT +MAPE++ + G++ D WS G ++ G
Sbjct: 162 LTDFGLCKESIHDGTVT---HTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTG 217
Query: 212 HAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAK 266
PF+ K + + L ++ + ++ L ++ + R A
Sbjct: 218 APPFTG-ENRKKTIDKILKCKLNLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAG 272
Query: 267 KLLKHSFFK 275
++ H FF+
Sbjct: 273 EVQAHPFFR 281
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 29/268 (10%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHC 76
+G G VH A+K+L E + + + E + +V HP +++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 77 SFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVV----IATILREVLKGLDYLHHHGH 132
+F ++++M ++ GG +L+ + F V A EV L+YLH
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAA----EVCLALEYLHSKDI 127
Query: 133 IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGY 192
I+RD+K NIL+D G IK+ DFG + D T GTP ++APEV+ Y
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK---YVPDVT---YTLCGTPDYIAPEVVST-KPY 180
Query: 193 DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIA 252
+ D WSFGI E+ G+ PF MK L L + F++ K +++
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE---LRFPPF--FNEDVKDLLS 235
Query: 253 SCLVKDPSKR-----PSAKKLLKHSFFK 275
+ +D S+R + + H +FK
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHPWFK 263
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 66/258 (25%), Positives = 117/258 (45%), Gaps = 31/258 (12%)
Query: 36 NEIVAVKILDFERDNSDLSNISREAQTM----ILVD---HPNVLKSHCSFVSDHNLWVVM 88
++ A+K+L + + + T +L P ++ H +F ++ L +++
Sbjct: 82 GKLYAMKVL---KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138
Query: 89 PFMSGGSC-LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR 147
+++GG H+ + F E + + E++ L++LH G I+RD+K NIL+D
Sbjct: 139 DYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195
Query: 148 GAIKLGDFGVS-ACLFDSGDRQRMRNTFVGTPCWMAPEV-MEQLHGYDFKADIWSFGITA 205
G + L DFG+S + D +R F GT +MAP++ G+D D WS G+
Sbjct: 196 GHVVLTDFGLSKEFVADETERA---YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252
Query: 206 LELAHGHAPFSKYPPMKVLLMTLQN---APPGLDYERDRKFSKSFKQMIASCLVKDPSKR 262
EL G +PF+ + + P ++ S K +I L+KDP KR
Sbjct: 253 YELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQEMSALAKDLIQRLLMKDPKKR 308
Query: 263 -----PSAKKLLKHSFFK 275
A ++ +H FF+
Sbjct: 309 LGCGPRDADEIKEHLFFQ 326
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 68/294 (23%), Positives = 117/294 (39%), Gaps = 40/294 (13%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT 62
K K+ + E L E++G+G V N +VAVK + +EA+
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARI 165
Query: 63 MILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
+ HPN+++ C+ +++VM + GG L L+ + ++ +
Sbjct: 166 LKQYSHPNIVRLIGVCT--QKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDA 222
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC- 179
G++YL IHRD+ + N L+ + +K+ DFG+S D V P
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVK 280
Query: 180 WMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMK---VLLMTLQ----- 229
W APE + +G Y ++D+WSFGI E G +P YP + +
Sbjct: 281 WTAPEAL--NYGRYSSESDVWSFGILLWETFSLGASP---YPNLSNQQTREFVEKGGRLP 335
Query: 230 ---NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQAR 278
P + +++ C +P +RPS + + S K+ R
Sbjct: 336 CPELCPDAV------------FRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 64/266 (24%), Positives = 108/266 (40%), Gaps = 45/266 (16%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMS 92
+ I A+K++ + D+ D+ + E +HP ++ H F ++ L+ V+ +++
Sbjct: 34 DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93
Query: 93 GGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG + H+ + E E+ L+YLH G I+RD+K N+L+D G IK
Sbjct: 94 GGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 150
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
L D+G+ GD +TF GTP ++APE++ Y F D W+ G+ E+ G
Sbjct: 151 LTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAG 206
Query: 212 HAPFSKYPPMKVLLMTLQNAPPGLDYERDRK----------------FSKSFKQMIASCL 255
+PF + S ++ S L
Sbjct: 207 RSPFD------------IVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 254
Query: 256 VKDPSKR------PSAKKLLKHSFFK 275
KDP +R + H FF+
Sbjct: 255 NKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 65/299 (21%), Positives = 133/299 (44%), Gaps = 36/299 (12%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM 63
K+ + T+ ++G G V+ + ++ VAVK L + D ++ +EA M
Sbjct: 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVM 63
Query: 64 ILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
+ HPN+++ C+ + +++ FM+ G+ L L+ VV+ + ++
Sbjct: 64 KEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-W 180
++YL IHRD+ + N L+ +K+ DFG+S + F P W
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIKW 178
Query: 181 MAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------N 230
APE + + + K+D+W+FG+ E+A +G +P+ +V + +
Sbjct: 179 TAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 231 APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQARSNEYIARTL 287
P + YE ++ +C +PS RPS ++ + + F+++ ++ + + L
Sbjct: 237 CPEKV-YE-----------LMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 76/321 (23%), Positives = 118/321 (36%), Gaps = 71/321 (22%)
Query: 7 PIG---AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNIS--RE 59
P+G Y E+G G +V++A VA+K + IS RE
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE 61
Query: 60 A---QTMILVDHPNVLKSHCSFVSDHN-----LWVVMPFMSGGSCLH----ILKAAYPDG 107
+ + +HPNV++ + + +V + L A P G
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-----QDLRTYLDKAPPPG 116
Query: 108 FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167
I ++R+ L+GLD+LH + +HRD+K NIL+ G +KL DFG+ A ++ +
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL-ARIY--SYQ 173
Query: 168 QRMRNTFVGTPCWMAPEVMEQLHG--YDFKADIWSFG-ITALELAHGHAPF--------- 215
+ V T + APEV L Y D+WS G I A E+ F
Sbjct: 174 MALTPVVV-TLWYRAPEV---LLQSTYATPVDMWSVGCIFA-EMFRRKPLFCGNSEADQL 228
Query: 216 ------------SKYPPMKVL-LMTLQNAPPGLDYERDRKFSKSFKQM-------IASCL 255
+P L P R +M + L
Sbjct: 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGP-------RPVQSVVPEMEESGAQLLLEML 281
Query: 256 VKDPSKRPSAKKLLKHSFFKQ 276
+P KR SA + L+HS+ +
Sbjct: 282 TFNPHKRISAFRALQHSYLHK 302
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 66/249 (26%), Positives = 106/249 (42%), Gaps = 21/249 (8%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSG 93
A+KIL + ++++ E + + HP + SF + L VM + +G
Sbjct: 173 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 232
Query: 94 GSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLH-HHGHIHRDVKSGNILIDVRGAIK 151
G H+ + F E E++ LDYLH ++RD+K N+++D G IK
Sbjct: 233 GELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK 289
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
+ DFG+ G TF GTP ++APEV+E + Y D W G+ E+ G
Sbjct: 290 ITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCG 345
Query: 212 HAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR----PS-AK 266
PF + L + R K +++ L KDP +R AK
Sbjct: 346 RLPFYN-QDHEKLFELILMEEIRF----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAK 400
Query: 267 KLLKHSFFK 275
++++H FF
Sbjct: 401 EIMQHRFFA 409
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 76/315 (24%), Positives = 126/315 (40%), Gaps = 67/315 (21%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNISREAQTMILVD 67
+ + E++G G A+V++ L VA+K LD E + + + I RE M +
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAI-REISLMKELK 61
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILK--------AAYPDGFEEVVIATILRE 119
H N+++ + +++ L +V FM + LK P G E ++ +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMD-----NDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
+L+GL + H + +HRD+K N+LI+ RG +KLGDFG+ A F G ++ V T
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL-ARAF--GIPVNTFSSEVVTLW 173
Query: 180 WMAPEVMEQLHGYDFKADIWSFGITALELAHG---------------------------- 211
+ AP+V+ Y DIWS G E+ G
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 212 ---------HAPFSKYPPMKVLLMTLQNAPPGLDYE-RDRKFSKSFKQMIASCLVKDPSK 261
+ + PP + + + LD D + L +P
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMD---------FLHGLLQLNPDM 284
Query: 262 RPSAKKLLKHSFFKQ 276
R SAK+ L H +F +
Sbjct: 285 RLSAKQALHHPWFAE 299
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 70/304 (23%), Positives = 117/304 (38%), Gaps = 51/304 (16%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNISREAQTMILVDH 68
+ Y ++G+G V++A+ NE VA+K L+ E + + I RE + + H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI-REVSLLKELQH 92
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPD---GFEEVVIATILREVLKGLD 125
N+++ +H L ++ + + LK Y D VI + L +++ G++
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAE-----NDLKK-YMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 126 YLHHHGHIHRDVKSGNILIDV-----RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
+ H +HRD+K N+L+ V +K+GDFG+ A F G R + T +
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL-ARAF--GIPIRQFTHEIITLWY 203
Query: 181 MAPEVMEQLHGYDFKADIWSFG-ITALELAHGHAPF------------------------ 215
PE++ Y DIWS I A E+ F
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWA-EMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262
Query: 216 ---SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHS 272
+ P K + L ++ + L DP KR SAK L+H
Sbjct: 263 PGVTALPDWKQSF--PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320
Query: 273 FFKQ 276
+F
Sbjct: 321 YFSH 324
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 65/287 (22%), Positives = 115/287 (40%), Gaps = 36/287 (12%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTMILV 66
+ + +G G +V++ L IP E VA+K L I EA M V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 67 DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDY 126
D+P+V + + ++ M G L ++ + D + ++ KG++Y
Sbjct: 75 DNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT--PC-WMAP 183
L +HRD+ + N+L+ +K+ DFG++ L + +++ G P WMA
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-GAEEKEYHAE---GGKVPIKWMAL 188
Query: 184 EVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVL--------LMTLQNAPPG 234
E + Y ++D+WS+G+T EL G P+ P ++ L
Sbjct: 189 ESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
+ Y ++ C + D RP ++ L F K AR +
Sbjct: 248 V-Y-----------MIMRKCWMIDADSRPKFRE-LIIEFSKMARDPQ 281
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 69/245 (28%), Positives = 111/245 (45%), Gaps = 17/245 (6%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMS 92
N+ A+K L D + D+ E + + L +HP + C+F + NL+ VM +++
Sbjct: 42 NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101
Query: 93 GGSC-LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG HI F+ E++ GL +LH G ++RD+K NIL+D G IK
Sbjct: 102 GGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIK 158
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
+ DFG+ + NTF GTP ++APE++ Y+ D WSFG+ E+ G
Sbjct: 159 IADFGMCKENMLGDAKT---NTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIG 214
Query: 212 HAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-PSAKKLLK 270
+PF ++ P R K K ++ V++P KR + +
Sbjct: 215 QSPFHGQDEEELFHSIR-MDNPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269
Query: 271 HSFFK 275
H F+
Sbjct: 270 HPLFR 274
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 68/248 (27%), Positives = 107/248 (43%), Gaps = 20/248 (8%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMIL-VDHPNVLKSHCSFVSDHNLWVVMPFMS 92
AVK+L + +I E ++ V HP ++ H SF + L+ V+ +++
Sbjct: 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122
Query: 93 GGSC-LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG H+ + F E E+ L YLH ++RD+K NIL+D +G I
Sbjct: 123 GGELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
L DFG+ + +TF GTP ++APEV+ + YD D W G E+ +G
Sbjct: 180 LTDFGLCKENIEHNSTT---STFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYG 235
Query: 212 HAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR----PSAKK 267
PF ++ L N P L + S + ++ L KD +KR +
Sbjct: 236 LPPFYSRNTAEMYDNIL-NKPLQL----KPNITNSARHLLEGLLQKDRTKRLGAKDDFME 290
Query: 268 LLKHSFFK 275
+ H FF
Sbjct: 291 IKSHVFFS 298
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 66/286 (23%), Positives = 114/286 (39%), Gaps = 32/286 (11%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNEI---VAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E +G+G V+ + + AVK L+ D ++S E M HPN
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 71 VLKSH-CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
VL S+ + VV+P+M G + ++ + + +V KG+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYLAS 146
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT-PC-WMAPEVME 187
+HRD+ + N ++D + +K+ DFG++ ++D + + N P WMA E ++
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-EYYSVHNKTGAKLPVKWMALESLQ 205
Query: 188 QLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NAPPGLDYE 238
+ K+D+WSFG+ EL G P+ + + LQ P L Y
Sbjct: 206 T-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL-Y- 262
Query: 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQARSNEY 282
+++ C RPS +L+ + F Y
Sbjct: 263 ----------EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 298
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 68/309 (22%), Positives = 112/309 (36%), Gaps = 52/309 (16%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM-ILVDHP 69
+ Y L ++G+G + V A+ I NE V VKIL I RE + + L P
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGP 91
Query: 70 NVLKSHCSFVSDHN---LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDY 126
N++ + V + K Y + I + E+LK LDY
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTD-----FKQLYQT-LTDYDIRFYMYEILKALDY 145
Query: 127 LHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
H G +HRDVK N++ID ++L D+G L + + N V + + PE+
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG----LAEFYHPGQEYNVRVASRYFKGPEL 201
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAPPGLDY----- 237
+ YD+ D+WS G + PF V + + DY
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 238 -ERDRKFSKSFKQM------------------------IASCLVKDPSKRPSAKKLLKHS 272
E D +F+ + + L D R +A++ ++H
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 273 FFKQARSNE 281
+F ++
Sbjct: 322 YFYTVVKDQ 330
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 63/266 (23%), Positives = 108/266 (40%), Gaps = 45/266 (16%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMS 92
+ I A++++ + D+ D+ + E +HP ++ H F ++ L+ V+ +++
Sbjct: 77 DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136
Query: 93 GGSCL-HILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG + H+ + E E+ L+YLH G I+RD+K N+L+D G IK
Sbjct: 137 GGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 193
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
L D+G+ GD +TF GTP ++APE++ Y F D W+ G+ E+ G
Sbjct: 194 LTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAG 249
Query: 212 HAPFSKYPPMKVLLMTLQNAPPGLDYERDRK----------------FSKSFKQMIASCL 255
+PF + S ++ S L
Sbjct: 250 RSPFD------------IVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 297
Query: 256 VKDPSKR------PSAKKLLKHSFFK 275
KDP +R + H FF+
Sbjct: 298 NKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 68/249 (27%), Positives = 109/249 (43%), Gaps = 21/249 (8%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWVVMPFMS 92
+E+ AVKIL D + D+ E + + L P + + H F + L+ VM +++
Sbjct: 45 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104
Query: 93 GGSC-LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG HI + F+E E+ GL +L G I+RD+K N+++D G IK
Sbjct: 105 GGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 161
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
+ DFG+ G TF GTP ++APE++ Y D W+FG+ E+ G
Sbjct: 162 IADFGMCKENIWDGVTT---KTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAG 217
Query: 212 HAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAK 266
APF L ++ + SK + + K P KR +
Sbjct: 218 QAPFEG-EDEDELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGER 272
Query: 267 KLLKHSFFK 275
+ +H+FF+
Sbjct: 273 DIKEHAFFR 281
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 72/307 (23%), Positives = 123/307 (40%), Gaps = 59/307 (19%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHPNV 71
YT + +G G V++A E+VA+K +L +R +RE Q M +DH N+
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNI 109
Query: 72 LKSHCSFVSDHN------LWVVMPFMSGGSCLHILKAAYPDG---FEEVVIATILREVLK 122
++ F S L +V+ ++ ++ + Y + + + ++ +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVR-GAIKLGDFGVSACLFDSGDRQRMRNT-FVGTPCW 180
L Y+H G HRD+K N+L+D +KL DFG SA G+ N ++ + +
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGE----PNVSYICSRYY 222
Query: 181 MAPEVMEQLHGYDFKADIWSFG-ITALELAHGHAPFSKYPP-----------MKVL---- 224
APE++ Y D+WS G + A EL G F P +KVL
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLA-ELLLGQPIF----PGDSGVDQLVEIIKVLGTPT 277
Query: 225 -----LMTLQNAPPGLDYERDRKFSKSFK--------QMIASCLVKDPSKRPSAKKLLKH 271
M + ++K F+ + + L P+ R + + H
Sbjct: 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337
Query: 272 SFFKQAR 278
SFF + R
Sbjct: 338 SFFDELR 344
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 69/298 (23%), Positives = 115/298 (38%), Gaps = 32/298 (10%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEI---VAVKIL--DFERDNSDLSNIS 57
IG + L E++G G V R + VAVK L D + +
Sbjct: 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 58 REAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATIL 117
RE M +DH N+++ + V + +V GS L L+ + F ++
Sbjct: 70 REVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYA 127
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177
+V +G+ YL IHRD+ + N+L+ R +K+GDFG+ L + D M+
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ---EHR 184
Query: 178 --PC-WMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN-- 230
P W APE + + +D W FG+T E+ +G P+ ++L +
Sbjct: 185 KVPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242
Query: 231 ---APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIAR 285
P + ++ C P RP+ L F +A+ + A
Sbjct: 243 RLPRPEDC--------PQDIYNVMVQCWAHKPEDRPTFVAL--RDFLLEAQPTDMRAE 290
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 65/296 (21%), Positives = 111/296 (37%), Gaps = 35/296 (11%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEI---VAVKILDFERDNSDLSNIS 57
M +Y I E L +G+G V+ + VAVK + +
Sbjct: 2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM 61
Query: 58 REAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATIL 117
EA M +DHP+++K + + W++M G H L+ + + +
Sbjct: 62 SEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYS 119
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177
++ K + YL +HRD+ NIL+ +KLGDFG+S + D +
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--- 176
Query: 178 PC-WMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ----- 229
P WM+PE + + +D+W F + E+ G PF V+ + +
Sbjct: 177 PIKWMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP 234
Query: 230 ---NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQARSN 280
PP L Y ++ C DPS RP +L+ ++ +
Sbjct: 235 KPDLCPPVL-Y-----------TLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI 278
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 66/294 (22%), Positives = 116/294 (39%), Gaps = 32/294 (10%)
Query: 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEI---VAVKILDFERDNSDLSNISREAQTM 63
+ E +G+G V+ + + AVK L+ D ++S E M
Sbjct: 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144
Query: 64 ILVDHPNVLKSH-CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
HPNVL S+ + VV+P+M G + ++ + + +V K
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAK 203
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT-PC-W 180
G+ +L +HRD+ + N ++D + +K+ DFG++ ++D + + N P W
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-EFDSVHNKTGAKLPVKW 262
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NA 231
MA E + Q + K+D+WSFG+ EL G P+ + + LQ
Sbjct: 263 MALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 321
Query: 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQARSNEYI 283
P L Y +++ C RPS +L+ + F Y+
Sbjct: 322 PDPL-Y-----------EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 363
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 71/250 (28%), Positives = 114/250 (45%), Gaps = 22/250 (8%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMS 92
++ AVK+L D + D+ E + + L +HP + + C F + L+ VM F++
Sbjct: 48 GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107
Query: 93 GGSC-LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG HI K+ F+E E++ L +LH G I+RD+K N+L+D G K
Sbjct: 108 GGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
L DFG+ +G TF GTP ++APE++++ Y D W+ G+ E+ G
Sbjct: 165 LADFGMCKEGICNGVT---TATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCG 220
Query: 212 HAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR------PSA 265
HAPF L + N + ++ S + K+P+ R
Sbjct: 221 HAPFEA-ENEDDLFEAILNDEVVYP----TWLHEDATGILKSFMTKNPTMRLGSLTQGGE 275
Query: 266 KKLLKHSFFK 275
+L+H FFK
Sbjct: 276 HAILRHPFFK 285
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 60/292 (20%), Positives = 119/292 (40%), Gaps = 42/292 (14%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT 62
+ + + + L + +G+G V VAVK + ++++ EA
Sbjct: 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI---KNDATAQAFLAEASV 67
Query: 63 MILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
M + H N+++ L++V +M+ GS + L++ + +V
Sbjct: 68 MTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP-C 179
+ ++YL + +HRD+ + N+L+ K+ DFG++ + D ++ P
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-------PVK 179
Query: 180 WMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ-------- 229
W APE + + K+D+WSFGI E+ G P+ + P V+ +
Sbjct: 180 WTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 237
Query: 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
PP + YE ++ +C D + RPS +L + +++E
Sbjct: 238 GCPPAV-YE-----------VMKNCWHLDAAMRPSFLQL--REQLEHIKTHE 275
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 57/276 (20%), Positives = 115/276 (41%), Gaps = 30/276 (10%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT 62
+ + + + L + +G+G V VAVK + ++++ EA
Sbjct: 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI---KNDATAQAFLAEASV 239
Query: 63 MILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
M + H N+++ L++V +M+ GS + L++ + +V
Sbjct: 240 MTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC- 179
+ ++YL + +HRD+ + N+L+ K+ DFG++ + D ++ P
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-------PVK 351
Query: 180 WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN----APPG 234
W APE + + + K+D+WSFGI E+ G P+ + P V+ + AP G
Sbjct: 352 WTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 410
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
+ ++ +C D + RP+ +L +
Sbjct: 411 C--------PPAVYDVMKNCWHLDAATRPTFLQLRE 438
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-28
Identities = 67/249 (26%), Positives = 109/249 (43%), Gaps = 21/249 (8%)
Query: 36 NEIVAVKIL--DFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVMPFMS 92
+E+ AVKIL D + D+ E + + L P + + H F + L+ VM +++
Sbjct: 366 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425
Query: 93 GGSC-LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151
GG HI + F+E E+ GL +L G I+RD+K N+++D G IK
Sbjct: 426 GGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482
Query: 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG 211
+ DFG+ G TF GTP ++APE++ Y D W+FG+ E+ G
Sbjct: 483 IADFGMCKENIWDGVTT---KTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAG 538
Query: 212 HAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKR-----PSAK 266
APF ++ + + SK + + K P KR +
Sbjct: 539 QAPFEGEDEDELFQSIM-EHNVAY----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGER 593
Query: 267 KLLKHSFFK 275
+ +H+FF+
Sbjct: 594 DIKEHAFFR 602
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 22/270 (8%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
+ K + I E L ++GQG V VA+K L + +EA
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL--KPGTMSPEAFLQEA 230
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
Q M + H +++ + + VS+ +++V +MS GS L LK + + ++
Sbjct: 231 QVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 289
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC- 179
G+ Y+ ++HRD+++ NIL+ K+ DFG++ + D+ R F P
Sbjct: 290 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIK 346
Query: 180 WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN----APPG 234
W APE + K+D+WSFGI EL G P+ +VL + PP
Sbjct: 347 WTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 405
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
+S ++ C K+P +RP+
Sbjct: 406 --------CPESLHDLMCQCWRKEPEERPT 427
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 69/322 (21%), Positives = 122/322 (37%), Gaps = 38/322 (11%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTMILVDHP 69
+ +G G +V++ L IP E VA+K L I EA M VD+P
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
+V + + ++ M G L ++ + D + ++ KG++YL
Sbjct: 78 HVCRLLG-ICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT--PC-WMAPEVM 186
+HRD+ + N+L+ +K+ DFG++ L + +++ G P WMA E +
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-GAEEKEYHAE---GGKVPIKWMALESI 191
Query: 187 EQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVL--------LMTLQNAPPGLDY 237
Y ++D+WS+G+T EL G P+ P ++ L + Y
Sbjct: 192 -LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV-Y 249
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQARSNEYIARTLLEGLPALG 295
++ C + D RP ++L+ + + I LP+
Sbjct: 250 -----------MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 298
Query: 296 DRIKALK-KKEEDMLAQKKMPD 316
D EEDM +
Sbjct: 299 DSNFYRALMDEEDMDDVVDADE 320
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 66/274 (24%), Positives = 107/274 (39%), Gaps = 36/274 (13%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE---IVAVKILDFERDNSDLSNISREAQTMI 64
I A + + +G G S V + VA+K L + EA M
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMG 105
Query: 65 LVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
DHPN+++ + +V +M GS L+ + F + + +LR V
Sbjct: 106 QFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGA 162
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC--- 179
G+ YL G++HRD+ + N+L+D K+ DFG+S L D D G
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT---GGKIPIR 219
Query: 180 WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------N 230
W APE + + +D+WSFG+ E+ +G P+ V+ +
Sbjct: 220 WTAPEAI-AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMG 278
Query: 231 APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
P L + Q++ C KD ++RP
Sbjct: 279 CPHAL-H-----------QLMLDCWHKDRAQRPR 300
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 70/280 (25%), Positives = 116/280 (41%), Gaps = 33/280 (11%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEI---VAVKILDFERDNSDLSNISRE 59
+ Y I E L +G+G VH+ + + VA+K +S +E
Sbjct: 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 66
Query: 60 AQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILRE 119
A TM DHP+++K ++++ +W++M + G L+ + + +
Sbjct: 67 ALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQ 124
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
+ L YL +HRD+ + N+L+ +KLGDFG+S + DS + + P
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL---PI 181
Query: 180 -WMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVL--------LMTL 228
WMAPE + + +D+W FG+ E+ HG PF V+ L
Sbjct: 182 KWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 239
Query: 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
N PP L Y ++ C DPS+RP +L
Sbjct: 240 PNCPPTL-Y-----------SLMTKCWAYDPSRRPRFTEL 267
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 66/276 (23%), Positives = 114/276 (41%), Gaps = 33/276 (11%)
Query: 4 KKYPIGAEHYTLYE-EVGQGVSASVHRALCIPFNEI--VAVKILDFERDNSDLSNISREA 60
KK + ++ + + E+G G SV + + + VA+K+L + +D + REA
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
Q M +D+P +++ L +VM GG L + +A +L +V
Sbjct: 62 QIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQV 119
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT--P 178
G+ YL +HRD+ + N+L+ R K+ DFG+S L R P
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGKWP 176
Query: 179 C-WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVL--------LMTL 228
W APE + + ++D+WS+G+T E +G P+ K +V+ +
Sbjct: 177 LKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 235
Query: 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
PP L Y +++ C + RP
Sbjct: 236 PECPPEL-Y-----------ALMSDCWIYKWEDRPD 259
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 55/273 (20%), Positives = 115/273 (42%), Gaps = 35/273 (12%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTM 63
+ +G GV +VH+ + IP E V +K+++ + ++ +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 69
Query: 64 ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
+DH ++++ +L +V ++ GS L ++ + ++ ++ KG
Sbjct: 70 GSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKG 127
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT--PC-W 180
+ YL HG +HR++ + N+L+ +++ DFGV+ L D+Q + + P W
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL-PPDDKQLLYS---EAKTPIKW 183
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NA 231
MA E + Y ++D+WS+G+T EL G P++ +V + +
Sbjct: 184 MALESI-HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQIC 242
Query: 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
+ Y ++ C + D + RP+
Sbjct: 243 TIDV-Y-----------MVMVKCWMIDENIRPT 263
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 66/278 (23%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 2 DKKKYPIGAEHYTLYE-EVGQGVSASVHRALCIPFNEI--VAVKILDFERDNSDLSNISR 58
KK + ++ + + E+G G SV + + + VA+K+L + +D + R
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR 118
EAQ M +D+P +++ L +VM GG L + +A +L
Sbjct: 386 EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLH 443
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT- 177
+V G+ YL +HR++ + N+L+ R K+ DFG+S L R
Sbjct: 444 QVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGK 500
Query: 178 -PC-WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ----- 229
P W APE + + ++D+WS+G+T E +G P+ K +V+ Q
Sbjct: 501 WPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 559
Query: 230 ---NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
PP L Y +++ C + RP
Sbjct: 560 CPPECPPEL-Y-----------ALMSDCWIYKWEDRPD 585
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 60/286 (20%), Positives = 113/286 (39%), Gaps = 30/286 (10%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE---IVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+G+G V+ I + A+K L + + RE M ++HPN
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 71 VLKSH-CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
VL + V++P+M G L +++ + + + +V +G++YL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYLAE 142
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPEVMEQ 188
+HRD+ + N ++D +K+ DFG++ + D ++ P W A E ++
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 189 LHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NAPPGLDYER 239
+ + K+D+WSFG+ EL G P+ P + Q P L Y+
Sbjct: 203 -YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL-YQ- 259
Query: 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQARSNEYI 283
++ C DP+ RP+ + L+ + Y+
Sbjct: 260 ----------VMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYV 295
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 70/306 (22%), Positives = 122/306 (39%), Gaps = 53/306 (17%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPF----NEIVAVKILDFERDNSDLSNISREAQTM 63
H +++G+G SV P E+VAVK L L + RE + +
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEIL 65
Query: 64 ILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
+ H N++K C NL ++M ++ GS L+ + + + + + ++
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQIC 124
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT--P- 178
KG++YL +IHRD+ + NIL++ +K+GDFG++ L + +++ P
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE---PGESPI 181
Query: 179 CWMAPEVMEQLHG-YDFKADIWSFGITALEL----------------AHGHAPFSKYPPM 221
W APE + + +D+WSFG+ EL G+ M
Sbjct: 182 FWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK---QGQM 236
Query: 222 KV--LLMTLQN-----APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274
V L+ L+N P G ++ C + ++RPS + L
Sbjct: 237 IVFHLIELLKNNGRLPRPDGC--------PDEIYMIMTECWNNNVNQRPSFRDL--ALRV 286
Query: 275 KQARSN 280
Q R N
Sbjct: 287 DQIRDN 292
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 84/310 (27%), Positives = 129/310 (41%), Gaps = 62/310 (20%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNISREAQTMILVDH 68
YT + +G G V +A + +E VA+K + D N RE Q M +V H
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN-------RELQIMRIVKH 91
Query: 69 PNVLKSHCSFVSDHN------LWVVMPFMSGGSCLHILKAAYP---DGFEEVVIATILRE 119
PNV+ F S+ + L +V+ ++ ++ Y ++I + +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVR-GAIKLGDFGVSACLFDSGDRQRMRNT-FVGT 177
+L+ L Y+H G HRD+K N+L+D G +KL DFG SA + +G+ N ++ +
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG-SAKILIAGE----PNVSYICS 204
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFG-ITALELAHGHAPFSKYPP-----------MKVL- 224
+ APE++ Y DIWS G + A EL G F P +KVL
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMA-ELMQGQPLF----PGESGIDQLVEIIKVLG 259
Query: 225 --------LMTLQNAPPGLDYERDRKFSKSFK--------QMIASCLVKDPSKRPSAKKL 268
M R FSK F+ +I+ L PS R +A +
Sbjct: 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA 319
Query: 269 LKHSFFKQAR 278
L H FF + R
Sbjct: 320 LCHPFFDELR 329
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 62/279 (22%), Positives = 119/279 (42%), Gaps = 31/279 (11%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTM 63
+ ++G+G V P N+ +VAVK L + S +E +
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDIL 87
Query: 64 ILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
+ H +++K C +L +VM ++ GS L + ++ A +++
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA---QQIC 144
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP-CW 180
+G+ YLH +IHRD+ + N+L+D +K+GDFG++ + + + R+R +P W
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR-EDGDSPVFW 203
Query: 181 MAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238
APE + + + +D+WSFG+T EL H + P L + A +
Sbjct: 204 YAPECL--KEYKFYYASDVWSFGVTLYELLTHCDSS---QSPPTKFLELIGIAQGQMTVL 258
Query: 239 RDRKFSKSFKQM-------------IASCLVKDPSKRPS 264
R + + +++ + +C + S RP+
Sbjct: 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPT 297
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 62/307 (20%), Positives = 108/307 (35%), Gaps = 40/307 (13%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTM 63
H ++G+G SV P + +VAVK L + RE Q +
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQIL 78
Query: 64 ILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
+ ++K +L +VM ++ G L+ + + + ++
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQIC 137
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-- 179
KG++YL +HRD+ + NIL++ +K+ DFG++ L D +R P
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR-----EPGQS 192
Query: 180 ---WMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPG 234
W APE + + ++D+WSFG+ EL + P L +
Sbjct: 193 PIFWYAPESL--SDNIFSRQSDVWSFGVVLYELFTYCDKS---CSPSAEFLRMMGCERDV 247
Query: 235 LDYERDRKF-------------SKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQARS 279
R + +++ C P RPS L + +R
Sbjct: 248 PALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307
Query: 280 NEYIART 286
E A T
Sbjct: 308 CETHAFT 314
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 61/300 (20%), Positives = 115/300 (38%), Gaps = 40/300 (13%)
Query: 3 KKKYPIGAEHYTLYEEV-GQGVSASVHRALCIPFNEI--VAVKILDFER-DNSDLSNISR 58
K+ + + TL ++ G G +V + + VAVKIL E D + +
Sbjct: 8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 67
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR 118
EA M +D+P +++ + +VM G L+ ++ I ++
Sbjct: 68 EANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVH 124
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT- 177
+V G+ YL +HRD+ + N+L+ + K+ DFG+S L + + +
Sbjct: 125 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ---THGK 181
Query: 178 -PC-WMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVL--------L 225
P W APE + + + K+D+WSFG+ E +G P+ +V +
Sbjct: 182 WPVKWYAPECI--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 239
Query: 226 MTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL---LKHSFFKQARSNEY 282
P + Y ++ C D RP + L++ ++ +
Sbjct: 240 GCPAGCPREM-Y-----------DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 287
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 38/291 (13%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEI---VAVKILDFER-DNSDLSNISRE 59
+ I L + +G+G SV + VAVK + + ++ E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 60 AQTMILVDHPNVLK-----SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVV-- 112
A M HPNV++ S V++PFM G L + + + +
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 113 --IATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170
+ + ++ G++YL + +HRD+ + N ++ + + DFG+S ++ ++
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 171 RNTFVGTPC-WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTL 228
R + P W+A E + Y K+D+W+FG+T E+A G P+ ++ L
Sbjct: 207 RIAKM--PVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
Query: 229 Q--------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ L YE ++ SC DP RP+ L
Sbjct: 264 HGHRLKQPEDCLDEL-YE-----------IMYSCWRTDPLDRPTFSVLRLQ 302
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 65/288 (22%), Positives = 123/288 (42%), Gaps = 23/288 (7%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQ 61
+K + I E L +++G G V A + VAVK + + + + EA
Sbjct: 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTM--KPGSMSVEAFLAEAN 235
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
M + H ++K H + V+ ++++ FM+ GS L LK+ + ++
Sbjct: 236 VMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-W 180
+G+ ++ +IHRD+++ NIL+ K+ DFG++ + D+ R F P W
Sbjct: 295 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF---PIKW 351
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN----APPGL 235
APE + + K+D+WSFGI +E+ +G P+ +V+ + P
Sbjct: 352 TAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC 410
Query: 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH-SFFKQARSNEY 282
+ ++ C P +RP+ + + F A ++Y
Sbjct: 411 --------PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQY 450
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 22/270 (8%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
+ K + I E L ++GQG V VA+K L + +EA
Sbjct: 257 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTL--KPGTMSPEAFLQEA 313
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
Q M + H +++ + + VS+ +++V +MS GS L LK + + ++
Sbjct: 314 QVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 372
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC- 179
G+ Y+ ++HRD+++ NIL+ K+ DFG++ + D+ R F P
Sbjct: 373 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIK 429
Query: 180 WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN----APPG 234
W APE + K+D+WSFGI EL G P+ +VL + PP
Sbjct: 430 WTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 488
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
+S ++ C K+P +RP+
Sbjct: 489 --------CPESLHDLMCQCWRKEPEERPT 510
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 58/276 (21%), Positives = 110/276 (39%), Gaps = 39/276 (14%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEI----VAVKILDFERDNSDLSNISREAQTM 63
I T + +G G V++ + + VA+K L + EA M
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 100
Query: 64 ILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
H N+++ S + ++ +M G+ L+ F + + +LR +
Sbjct: 101 GQFSHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIA 157
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-- 179
G+ YL + ++HRD+ + NIL++ K+ DFG+S L D + + G
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS---GGKIPI 214
Query: 180 -WMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ------- 229
W APE + + + +D+WSFGI E+ +G P+ + +V+
Sbjct: 215 RWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 272
Query: 230 -NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
+ P + Y Q++ C ++ ++RP
Sbjct: 273 MDCPSAI-Y-----------QLMMQCWQQERARRPK 296
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 64/316 (20%), Positives = 113/316 (35%), Gaps = 62/316 (19%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDH 68
+ + + GQG +V VA+K ++ D + + Q + ++ H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ---DPRFRNRELQIMQDLAVLHH 78
Query: 69 PNVLKSHCSFVSDHN-------LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATI---LR 118
PN+++ F + L VVM ++ LH Y I L
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 119 EVLKGLDYLHHHGH--IHRDVKSGNILIDVR-GAIKLGDFGVSACLFDSGDRQRMRNT-F 174
++++ + LH HRD+K N+L++ G +KL DFG SA + N +
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-SAKKLSPSEP----NVAY 191
Query: 175 VGTPCWMAPEVMEQLHGYDFKADIWSFG-ITALELAHGHAPFSKYPP-----------MK 222
+ + + APE++ Y DIWS G I A E+ G F ++
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFA-EMMLGEPIF----RGDNSAGQLHEIVR 246
Query: 223 VL---------LMTLQNAPPGLDYERDRKFSKSFKQM-----------IASCLVKDPSKR 262
VL + + L + +S F +++ L P +R
Sbjct: 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306
Query: 263 PSAKKLLKHSFFKQAR 278
+ L H +F +
Sbjct: 307 MKPYEALCHPYFDELH 322
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 65/286 (22%), Positives = 122/286 (42%), Gaps = 31/286 (10%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPF----NEIVAVKILDFERDNSDLSNIS 57
D+ H +++G+G SV P E+VAVK L L +
Sbjct: 32 DRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE 90
Query: 58 REAQTMILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT 115
RE + + + H N++K C NL ++M ++ GS L+ + + + + +
Sbjct: 91 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQ 149
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175
++ KG++YL +IHRD+ + NIL++ +K+GDFG++ L + +++
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE--- 206
Query: 176 GT--P-CWMAPEVMEQLHG-YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA 231
P W APE + + +D+WSFG+ EL + SK PP + + M +
Sbjct: 207 PGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELF-TYIEKSKSPPAEFMRMIGNDK 263
Query: 232 PPGLDYERDRKFSKSFKQM-------------IASCLVKDPSKRPS 264
+ + K+ ++ + C + ++RPS
Sbjct: 264 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 63/287 (21%), Positives = 118/287 (41%), Gaps = 43/287 (14%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTMILV 66
++G+G V P + VAVK L E + ++++ +E + + +
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 67 DHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGL 124
H N++K C+ + + ++M F+ GS L + ++ KG+
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGM 139
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT--P-CWM 181
DYL ++HRD+ + N+L++ +K+GDFG++ + + +++ P W
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD---DRDSPVFWY 196
Query: 182 APEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSK-----------YPPMKV--LLM 226
APE + + + +D+WSFG+T EL + + S + M V L+
Sbjct: 197 APECL--MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254
Query: 227 TLQN-----APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
TL+ PP Q++ C PS R S + L
Sbjct: 255 TLKEGKRLPCPPNC--------PDEVYQLMRKCWEFQPSNRTSFQNL 293
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-27
Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 31/279 (11%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEI---VAVKILDFERDNSDLSNISRE 59
+ Y I E L +G+G VH+ + + VA+K +S +E
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441
Query: 60 AQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILRE 119
A TM DHP+++K ++++ +W++M + G L+ + + +
Sbjct: 442 ALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQ 499
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
+ L YL +HRD+ + N+L+ +KLGDFG+S + DS + + P
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL---PI 556
Query: 180 -WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ-------- 229
WMAPE + + +D+W FG+ E+ HG PF V+
Sbjct: 557 KWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 615
Query: 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
N PP L Y ++ C DPS+RP +L
Sbjct: 616 NCPPTL-Y-----------SLMTKCWAYDPSRRPRFTEL 642
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 65/279 (23%), Positives = 111/279 (39%), Gaps = 36/279 (12%)
Query: 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI 64
K+ I T +E+G G VH + ++ VA+K + + EA+ M+
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTI--REGAMSEEDFIEEAEVMM 58
Query: 65 LVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
+ HP +++ + C + +V FM G L+ F + + +V +
Sbjct: 59 KLSHPKLVQLYGVCL--EQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCE 115
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WM 181
G+ YL IHRD+ + N L+ IK+ DFG++ + D F P W
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF---PVKWA 172
Query: 182 APEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NA 231
+PEV Y K+D+WSFG+ E+ G P+ +V+ A
Sbjct: 173 SPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 230
Query: 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
+ Y Q++ C + P RP+ +LL+
Sbjct: 231 STHV-Y-----------QIMNHCWRERPEDRPAFSRLLR 257
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 63/272 (23%), Positives = 108/272 (39%), Gaps = 32/272 (11%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE---IVAVKILDFERDNSDLSNISREAQTMI 64
+ A + ++ + VG G V ++ VA+K L + EA M
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGL 124
DHPN+++ + +V +M GS L+ F + + +LR + G+
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 160
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC---WM 181
YL G++HRD+ + NILI+ K+ DFG+ L D + G W
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR---GGKIPIRWT 217
Query: 182 APEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NAP 232
+PE + + +D+WS+GI E+ +G P+ + V+ + + P
Sbjct: 218 SPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276
Query: 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
L Y Q++ C KD + RP
Sbjct: 277 AAL-Y-----------QLMLDCWQKDRNNRPK 296
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 65/290 (22%), Positives = 122/290 (42%), Gaps = 27/290 (9%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQ 61
+ ++ + E L E +G G V + VAVK L ++ + EA
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSL--KQGSMSPDAFLAEAN 60
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
M + H +++ + + V+ ++++ +M GS + LK + + ++
Sbjct: 61 LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-W 180
+G+ ++ +IHRD+++ NIL+ + K+ DFG++ + D+ R F P W
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF---PIKW 176
Query: 181 MAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN----APPG 234
APE + +G + K+D+WSFGI E+ HG P+ +V+ + P
Sbjct: 177 TAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQARSNEY 282
+ Q++ C + P RP+ L FF A +Y
Sbjct: 235 C--------PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF-TATEGQY 275
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 75/312 (24%), Positives = 119/312 (38%), Gaps = 68/312 (21%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPF-NEIVAVK--ILDFERDNSDLSNISREA---QTMI 64
+ Y E+G+G V +A + VA+K + + LS I RE + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLE 69
Query: 65 LVDHPNVLKSHCSFVS-----DHNLWVVMPFMSGGSCLHILKA---AYPD-GFEEVVIAT 115
+HPNV++ + L +V + L P+ G I
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETIKD 124
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175
++ ++L+GLD+LH H +HRD+K NIL+ G IKL DFG+ A ++ + + + V
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL-ARIY--SFQMALTSVVV 181
Query: 176 GTPCWMAPEVMEQLHG--YDFKADIWSFG-ITALELAHGHAPF----------------- 215
T + APEV L Y D+WS G I A E+ F
Sbjct: 182 -TLWYRAPEV---LLQSSYATPVDLWSVGCIFA-EMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 216 ----SKYPPMKVL-LMTLQNAPPGLDYERDRKFSKSFKQM-------IASCLVKDPSKRP 263
+P L + + K + + CL +P+KR
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSA-------QPIEKFVTDIDELGKDLLLKCLTFNPAKRI 289
Query: 264 SAKKLLKHSFFK 275
SA L H +F+
Sbjct: 290 SAYSALSHPYFQ 301
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 64/292 (21%), Positives = 115/292 (39%), Gaps = 39/292 (13%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNE---IVAVKIL-DFERDNSDLSNISRE 59
+ I + +TL +G+G SV A + VAVK+L +SD+ RE
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 60 AQTMILVDHPNVLKSH--CS----FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVV- 112
A M DHP+V K V++PFM G L A+ +
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 113 ---IATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169
+ + ++ G++YL IHRD+ + N ++ + + DFG+S ++ ++
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 170 MRNTFVGTPC-WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMT 227
+ + P W+A E + + Y +D+W+FG+T E+ G P++ ++
Sbjct: 196 GCASKL--PVKWLALESL-ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
Query: 228 LQ--------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ + Y+ ++ C DP +RPS L
Sbjct: 253 IGGNRLKQPPECMEEV-YD-----------LMYQCWSADPKQRPSFTCLRME 292
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 58/300 (19%), Positives = 108/300 (36%), Gaps = 45/300 (15%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEI-------VAVKILDFERDNSDLSNISREA 60
I E E +GQG + + + + V +K+LD + + + A
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAA 63
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
M + H +++ ++ V +V F+ GS LK + + + +++
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQL 122
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGA--------IKLGDFGVSACLFDSGD-RQRMR 171
+ +L + IH +V + NIL+ IKL D G+S + ++R+
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN 230
W+ PE +E + D WSFG T E+ G P S + L
Sbjct: 183 --------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
Query: 231 ----APPGLD-YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIAR 285
AP + +I +C+ +P RPS + + + + + R
Sbjct: 235 HQLPAPKAAELA-----------NLINNCMDYEPDHRPSFRAI--IRDLNSLFTPDLVPR 281
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 75/304 (24%), Positives = 120/304 (39%), Gaps = 54/304 (17%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHP 69
+ Y VG G SV A+ E VA+K + + RE + + H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 70 N------VLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLK 122
N V S + ++ ++VMPFM + L I+ F E I ++ ++LK
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLK----FSEEKIQYLVYQMLK 137
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT----FVGTP 178
GL Y+H G +HRD+K GN+ ++ +K+ DFG++ R + +V T
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA----------RHADAEMTGYVVTR 187
Query: 179 CWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPP--- 233
+ APEV+ Y+ DIWS G E+ G F Y ++ + P
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247
Query: 234 --GLDYERDRKF--------SKSFKQMIAS-----------CLVKDPSKRPSAKKLLKHS 272
L+ + + + K F Q+ L D KR +A + L H
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307
Query: 273 FFKQ 276
FF+
Sbjct: 308 FFEP 311
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 76/288 (26%), Positives = 131/288 (45%), Gaps = 38/288 (13%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
+ E TL +E+G G V VAVK++ + + +EAQTM+ +
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMI--KEGSMSEDEFFQEAQTMMKLS 61
Query: 68 HPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
HP ++K + CS ++ +++V ++S G L+ L++ E + + +V +G+
Sbjct: 62 HPKLVKFYGVCS--KEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMA 118
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC-WMAPE 184
+L H IHRD+ + N L+D +K+ DFG++ + D + F P W APE
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF---PVKWSAPE 175
Query: 185 VMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NAPPG 234
V + Y K+D+W+FGI E+ G P+ Y +V+L Q A
Sbjct: 176 VF--HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT 233
Query: 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEY 282
+ Y Q++ SC + P KRP+ ++L S + R +
Sbjct: 234 I-Y-----------QIMYSCWHELPEKRPTFQQL--LSSIEPLREKDK 267
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 57/309 (18%), Positives = 117/309 (37%), Gaps = 49/309 (15%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
Y + +G G + V A+ ++ VA+K + D + + RE + + +DH
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHD 68
Query: 70 NVLK--------------SHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIA 114
N++K S +++++V +M + L +L+ E
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQ---GPLLEEHAR 123
Query: 115 TILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-AIKLGDFGVSACLFDSGDRQRMRNT 173
+ ++L+GL Y+H +HRD+K N+ I+ +K+GDFG++ + + +
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFG-ITALELAHGHAPF--SKY------------ 218
+ T + +P ++ + Y D+W+ G I A E+ G F +
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA-EMLTGKTLFAGAHELEQMQLILESIP 242
Query: 219 -PPMKVLLMTLQNAP---PGLDYERDRKFSKSFKQM-------IASCLVKDPSKRPSAKK 267
+ L P E + ++ + + L P R +A++
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302
Query: 268 LLKHSFFKQ 276
L H +
Sbjct: 303 ALSHPYMSI 311
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 68/323 (21%), Positives = 116/323 (35%), Gaps = 71/323 (21%)
Query: 17 EEVGQGVSASVHRALC--IPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKS 74
+VG+G V++A ++ A+K E +S RE + + HPNV+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALK--QIEGTGISMSAC-REIALLRELKHPNVISL 83
Query: 75 HCSFV--SDHNLWVVMPFMSG------GSCLHILKAAYPDGFEEVVIATILREVLKGLDY 126
F+ +D +W++ + P ++ ++L ++L G+ Y
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 127 LHHHGHIHRDVKSGNILIDV----RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM- 181
LH + +HRD+K NIL+ RG +K+ D G A LF+S + V W
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNSPLKPLADLDPVVVTFWYR 202
Query: 182 APEVMEQLHG---YDFKADIWSFG-ITALELAHGHAPF---------------------- 215
APE+ L G Y DIW+ G I A EL F
Sbjct: 203 APEL---LLGARHYTKAIDIWAIGCIFA-ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258
Query: 216 --------------SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM-------IASC 254
K P L+ + + + K + +
Sbjct: 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT-NCSLIKYMEKHKVKPDSKAFHLLQKL 317
Query: 255 LVKDPSKRPSAKKLLKHSFFKQA 277
L DP KR ++++ ++ +F +
Sbjct: 318 LTMDPIKRITSEQAMQDPYFLED 340
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 67/300 (22%), Positives = 116/300 (38%), Gaps = 41/300 (13%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHP 69
YT +G+G V A VA+K I FE + RE + ++ H
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHE 85
Query: 70 NVLK-----SHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKG 123
N++ + ++++V M + L+ +LK I L ++L+G
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKT---QHLSNDHICYFLYQILRG 140
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
L Y+H +HRD+K N+L++ +K+ DFG++ D +V T + AP
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPF--SKY------------PPMKVLLMTLQ 229
E+M GY DIWS G E+ F Y P + L +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 230 NAPPGLDY-----ERDRK-FSKSFKQM-------IASCLVKDPSKRPSAKKLLKHSFFKQ 276
N +Y +++ +++ F + L +P KR ++ L H + +Q
Sbjct: 261 N-LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 59/284 (20%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
+ + I + T +E+G G V VA+K++ + + EA
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMI--KEGSMSEDEFIEEA 70
Query: 61 QTMILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILR 118
+ M+ + H +++ + C+ ++++ +M+ G L+ L+ F+ + + +
Sbjct: 71 KVMMNLSHEKLVQLYGVCT--KQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCK 127
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
+V + ++YL +HRD+ + N L++ +G +K+ DFG+S + D + + F P
Sbjct: 128 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF---P 184
Query: 179 C-WMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ------ 229
W PEV+ ++ + K+DIW+FG+ E+ G P+ ++ + Q
Sbjct: 185 VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242
Query: 230 --NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
A + Y ++ SC + +RP+ K LL +
Sbjct: 243 PHLASEKV-Y-----------TIMYSCWHEKADERPTFKILLSN 274
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 45/300 (15%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHP 69
Y + VG G +V A+ VA+K + + RE + + + H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 70 N------VLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLK 122
N V + + ++VMPFM G+ L ++K + E I ++ ++LK
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH---EKLGEDRIQFLVYQMLK 139
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
GL Y+H G IHRD+K GN+ ++ +K+ DFG++ M +V T + A
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----M-TGYVVTRWYRA 193
Query: 183 PEVMEQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPP-----GL 235
PEV+ Y DIWS G E+ G F S + +M + PP L
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253
Query: 236 DYERDRKF--------SKSFKQMI--AS---------CLVKDPSKRPSAKKLLKHSFFKQ 276
+ + + K F ++ AS LV D +R +A + L H +F+
Sbjct: 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 59/283 (20%), Positives = 117/283 (41%), Gaps = 42/283 (14%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNISREAQTMILVDH 68
T+ E+GQG V+ + + VA+K ++ + EA M +
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 69 PNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT--------ILR 118
+V++ S V+M M+ G L++ P V+A +
Sbjct: 88 HHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 119 EVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
E+ G+ YL+ + +HRD+ + N ++ +K+GDFG++ ++++ ++ + P
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL--P 203
Query: 179 -CWMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ------- 229
WM+PE + + + +D+WSFG+ E+A P+ +VL ++
Sbjct: 204 VRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 262
Query: 230 -NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
N P L +E ++ C +P RPS +++
Sbjct: 263 DNCPDML-FE-----------LMRMCWQYNPKMRPSFLEIISS 293
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 74/305 (24%), Positives = 117/305 (38%), Gaps = 55/305 (18%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD--FERDNSDLSNISREAQTMILVDH 68
E Y VG G SV A VAVK L F+ RE + + + H
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKH 87
Query: 69 PN------VLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVL 121
N V S +++++V M G+ L+ I+K + + ++ ++L
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKC---QKLTDDHVQFLIYQIL 142
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF----VGT 177
+GL Y+H IHRD+K N+ ++ +K+ DFG++ R V T
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----------RHTADEMTGYVAT 192
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPP-- 233
+ APE+M Y+ DIWS G EL G F + + L++ L P
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 234 ---GLDYERDRKF--------SKSFKQMIAS-----------CLVKDPSKRPSAKKLLKH 271
+ E R + +F + LV D KR +A + L H
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312
Query: 272 SFFKQ 276
++F Q
Sbjct: 313 AYFAQ 317
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 59/345 (17%), Positives = 108/345 (31%), Gaps = 89/345 (25%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVK--ILDFERDNSDLSNISREAQTM 63
++ Y+L + +G G V I + A+K + D N RE M
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-------RELDIM 54
Query: 64 ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV--- 120
++DH N++K F + + P K + + VI +
Sbjct: 55 KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 121 ------------------------------------LKGLDYLHHHGHIHRDVKSGNILI 144
+ + ++H G HRD+K N+L+
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 145 DVR-GAIKLGDFGVSACLFDSGDRQRMRNT-FVGTPCWMAPEVMEQLHGYDFKADIWSFG 202
+ + +KL DFG SA + + ++ + + APE+M Y D+WS G
Sbjct: 175 NSKDNTLKLCDFG-SAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229
Query: 203 -ITALELAHGHAPFSKYPP-----------MKVL---------LMTLQNAPPGLDYERDR 241
+ EL G F ++++ M + +
Sbjct: 230 CVFG-ELILGKPLF----SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284
Query: 242 KFSKSFKQM--------IASCLVKDPSKRPSAKKLLKHSFFKQAR 278
+ K + + L +P R + + + H FF R
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR 329
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 77/340 (22%), Positives = 118/340 (34%), Gaps = 83/340 (24%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD-----------LSNISREAQ 61
Y L ++G G ++V A + N VA+KI+ R + L ++
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 62 T-MILVDHPNVLKSHCSFV-----SDHNLWVVMPFMSGGSCLHILKAAYPD-GFEEVVIA 114
T + ++LK F H VVM F G L L Y G + +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVH---VVMVFEVLGENLLALIKKYEHRGIPLIYVK 134
Query: 115 TILREVLKGLDYLH-HHGHIHRDVKSGNILID------VRGAIKLGDFGVSACLFDSGDR 167
I +++L GLDY+H G IH D+K N+L++ IK+ D G +AC +D
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWYD---- 189
Query: 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS----------- 216
+ T + +PEV+ + ADIWS EL G F
Sbjct: 190 -EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 217 ----------KYPPMKVL-----------------------LMTLQNAPPGLDYERDRKF 243
P +L L++ Y+ +
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK-YKFSKDE 306
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYI 283
+K ++ L DP KR A L+ H + K E I
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEI 346
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 69/249 (27%), Positives = 111/249 (44%), Gaps = 29/249 (11%)
Query: 36 NEIVAVKILDFERDNSDLSNISREAQT---MI-LVDHPNVLKSH-CSFVSDHNLWVVMPF 90
N VAVK L D + + ++ ++ H N+++ S D +V +
Sbjct: 54 NTTVAVKKLAAMVDITTE-ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLC-LVYVY 111
Query: 91 MSGGS---CLHILKAAYP-DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV 146
M GS L L P IA G+++LH + HIHRD+KS NIL+D
Sbjct: 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQ---GAANGINFLHENHHIHRDIKSANILLDE 168
Query: 147 RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGY-DFKADIWSFGITA 205
K+ DFG+ A + + M + VGT +MAPE + G K+DI+SFG+
Sbjct: 169 AFTAKISDFGL-ARASEKFAQTVMTSRIVGTTAYMAPEAL---RGEITPKSDIYSFGVVL 224
Query: 206 LELAHGHAPFSKYPPMKVLL---MTLQNAPPGLDYERDRKF----SKSFKQMIA---SCL 255
LE+ G ++ ++LL +++ ++ D+K S S + M + CL
Sbjct: 225 LEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCL 284
Query: 256 VKDPSKRPS 264
+ +KRP
Sbjct: 285 HEKKNKRPD 293
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 63/284 (22%), Positives = 109/284 (38%), Gaps = 44/284 (15%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNISREAQTMILVDH 68
TL +G G V+ VAVK L D + EA + +H
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 69 PNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT-----ILREVL 121
N+++ ++++ M+GG L+ P + +A + R++
Sbjct: 134 QNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
G YL + IHRD+ + N L+ G K+GDFG++ ++ +G ++ + P
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML--P 249
Query: 179 -CWMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ------ 229
WM PE + G + K D WSFG+ E+ G+ P+ +VL
Sbjct: 250 VKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP 307
Query: 230 --NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
N P + Y +++ C P RP+ +L+
Sbjct: 308 PKNCPGPV-Y-----------RIMTQCWQHQPEDRPNFAIILER 339
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 66/296 (22%), Positives = 113/296 (38%), Gaps = 46/296 (15%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNI 56
D K+ P ++ TL +G G V+ VAVK L D +
Sbjct: 23 DLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 80
Query: 57 SREAQTMILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIA 114
EA + +H N+++ +++M M+GG L+ P + +A
Sbjct: 81 LMEALIISKFNHQNIVRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 115 T-----ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA---IKLGDFGVSACLFDSGD 166
+ R++ G YL + IHRD+ + N L+ G K+GDFG++ ++ +
Sbjct: 139 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 167 RQRMRNTFVGTP-CWMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKV 223
++ + P WM PE + G + K D WSFG+ E+ G+ P+ +V
Sbjct: 199 YRKGGCAML--PVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
Query: 224 LLMTLQ--------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
L N P + Y ++ C P RP+ +L+
Sbjct: 255 LEFVTSGGRMDPPKNCPGPV-YR-----------IMTQCWQHQPEDRPNFAIILER 298
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 74/318 (23%), Positives = 122/318 (38%), Gaps = 49/318 (15%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
M K+ + + L +G+G V A P EIVA+K ++ RE
Sbjct: 1 MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 61 QTMILVDHPNVLKSH-----CSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIA 114
+ + H N++ SF + + ++++ M + LH ++ + I
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST---QMLSDDHIQ 115
Query: 115 TILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT- 173
+ + L+ + LH IHRD+K N+LI+ +K+ DFG+ A + D T
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL-ARIIDESAADNSEPTG 174
Query: 174 -------FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF--SKY------ 218
FV T + APEVM Y D+WS G EL F Y
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 219 -------PPMKVLLMTLQNAPPGLDY-----ERDRK-FSKSFKQM-------IASCLVKD 258
P L +++ P +Y K F ++ + LV D
Sbjct: 235 IFGIIGTPHSDNDLRCIES-PRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293
Query: 259 PSKRPSAKKLLKHSFFKQ 276
P+KR +AK+ L+H + +
Sbjct: 294 PAKRITAKEALEHPYLQT 311
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 67/312 (21%), Positives = 114/312 (36%), Gaps = 58/312 (18%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHP 69
+ Y + +G G V A VA+K + ++ + RE M V+H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 70 N------VLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLK 122
N V S ++++VM M + L +++ + ++ +L ++L
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELM--DANLCQVIQM----ELDHERMSYLLYQMLC 138
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
G+ +LH G IHRD+K NI++ +K+ DFG L + M +V T + A
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMTPYVVTRYYRA 194
Query: 183 PEVMEQLHGYDFKADIWSFGITALELAHGHAPF--------------------------- 215
PEV+ + Y DIWS G E+ G F
Sbjct: 195 PEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 216 -----------SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS 264
KY + D E ++ + + +++ LV D SKR S
Sbjct: 254 QPTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312
Query: 265 AKKLLKHSFFKQ 276
+ L+H +
Sbjct: 313 VDEALQHPYINV 324
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 69/317 (21%), Positives = 114/317 (35%), Gaps = 67/317 (21%)
Query: 11 EHYTLYEEVGQG----VSASVHRALCIPFNEIVAVKILDFERDNSDLSN----------I 56
YT+ + G V A V VA+K + + N +
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDSE-----GIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 57 SREAQTMILVDHPNVLK-----SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEV 111
RE + + HPN+L H + H L++V M + L +
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQ 134
Query: 112 VIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171
I + +L GL LH G +HRD+ GNIL+ I + DF ++ R+
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA--------REDTA 186
Query: 172 NTF----VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF--SKY------- 218
+ V + APE++ Q G+ D+WS G E+ + A F S +
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246
Query: 219 -----PPMKVLLMTLQNAPPGLDYERD-------RKFSKSFKQM-------IASCLVKDP 259
P ++ + P DY R+ R ++ IA L +P
Sbjct: 247 VEVVGTPKIEDVVMFSS-PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305
Query: 260 SKRPSAKKLLKHSFFKQ 276
+R S ++ L+H +F+
Sbjct: 306 QRRISTEQALRHPYFES 322
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 65/311 (20%), Positives = 116/311 (37%), Gaps = 56/311 (18%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHP 69
+ Y + +G G V A + VA+K + ++ + RE M V+H
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 70 N------VLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLK 122
N V + ++++VM M + L +++ + ++ +L ++L
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQM----ELDHERMSYLLYQMLC 175
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
G+ +LH G IHRD+K NI++ +K+ DFG L + M +V T + A
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMTPYVVTRYYRA 231
Query: 183 PEVMEQLHGYDFKADIWSFGITALELAHGHAPF--------------------------- 215
PEV+ + Y DIWS G E+ F
Sbjct: 232 PEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 216 --------SKYPPM-KVLLMTL-QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSA 265
P + L ++ D E ++ + + +++ LV DP+KR S
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 266 KKLLKHSFFKQ 276
L+H +
Sbjct: 351 DDALQHPYINV 361
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 68/293 (23%), Positives = 123/293 (41%), Gaps = 29/293 (9%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNI 56
D K+ + L + +G+G V A ++ VAVK+L +S+ +
Sbjct: 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77
Query: 57 SREAQTMILVD-HPNVLKSH-CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIA 114
E + +I + H NV+ L V++ F G+ L++ + V
Sbjct: 78 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 115 T--------------ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160
+V KG+++L IHRD+ + NIL+ + +K+ DFG++
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 161 LFDSGDRQRMRNTFVGTP-CWMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKY 218
++ D R + + P WMAPE + Y ++D+WSFG+ E+ G +P Y
Sbjct: 198 IYKDPDYVRKGDARL--PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASP---Y 251
Query: 219 PPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
P +K+ + G + Q + C +PS+RP+ +L++H
Sbjct: 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 8e-23
Identities = 65/356 (18%), Positives = 115/356 (32%), Gaps = 92/356 (25%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHP 69
+ Y + +G G V A +VA+K IL D D I RE + ++H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 70 NVLKSH-----CSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKG 123
+V+K L+VV+ S + + P E+ I T+L +L G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRT--PVYLTELHIKTLLYNLLVG 168
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM-- 181
+ Y+H G +HRD+K N L++ ++K+ DFG++ + +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 182 ----------------------APEVMEQLHGYDFKADIWSFG------ITALELAHGHA 213
APE++ Y D+WS G + ++ +
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 214 PFSK-------YPPMKVLLMTLQNAPPGLDYERD-------------------------R 241
P+ + RD +
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 242 KFSKSFKQM-------------------IASCLVKDPSKRPSAKKLLKHSFFKQAR 278
++ + F + + LV +P+KR + + L H FFK+ R
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 72/306 (23%), Positives = 132/306 (43%), Gaps = 53/306 (17%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE-------IVAVKILDFERDNSDLSNISREAQTMI-L 65
TL + +G+G V A + ++ VAVK+L + DLS++ E + M +
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 66 VDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATIL------ 117
H N++ C+ D L+V++ + S G+ L+A P G E +
Sbjct: 98 GKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 118 --------REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169
++ +G++YL IHRD+ + N+L+ +K+ DFG++ + + ++
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 170 MRNTFVGTPC-WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMT 227
N + P WMAPE + Y ++D+WSFG+ E+ G +P+ P ++ +
Sbjct: 216 TTNGRL--PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 228 LQ--------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQA 277
+ N L Y M+ C PS+RP+ K+L++
Sbjct: 273 KEGHRMDKPANCTNEL-YM-----------MMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320
Query: 278 RSNEYI 283
+ EY+
Sbjct: 321 TNEEYL 326
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 69/333 (20%), Positives = 122/333 (36%), Gaps = 72/333 (21%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISR-EAQTM-ILVD 67
A Y + + +G+G V +A ++ VA+K++ R+ + E + + L
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV---RNEKRFHRQAAEEIRILEHLRK 152
Query: 68 HPNVLKSHCSFVSDHNLW---VVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKG 123
+ + ++ + + M F L+ ++K GF ++ +L+
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 124 LDYLHHHGHIHRDVKSGNILI--DVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
LD LH + IH D+K NIL+ R IK+ DFG S+C + QR+ T++ + +
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCY----EHQRV-YTYIQSRFYR 266
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPF-------------------------- 215
APEV+ Y D+WS G EL G+
Sbjct: 267 APEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325
Query: 216 ---------SKYPPMKVLLMTLQNAPPGLDYERDRKFS-------------------KSF 247
SK P + TL + L+ R R+ F
Sbjct: 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280
+ CL DP+ R + + L+H + ++
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 65/289 (22%), Positives = 117/289 (40%), Gaps = 50/289 (17%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNISREAQTMILVDH 68
L E+G+G V A C +VAVK L E S + REA+ + ++ H
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQH 102
Query: 69 PNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT----------- 115
++++ C+ L +V +M G L++ PD
Sbjct: 103 QHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 116 --ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173
+ +V G+ YL +HRD+ + N L+ +K+GDFG+S ++ + + T
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 174 FVGTP-CWMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ- 229
+ P WM PE + L+ + ++D+WSFG+ E+ +G P+ + + + Q
Sbjct: 221 ML--PIRWMPPESI--LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276
Query: 230 -------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
PP + Y ++ C ++P +R S K +
Sbjct: 277 RELERPRACPPEV-Y-----------AIMRGCWQREPQQRHSIKDVHAR 313
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 65/301 (21%), Positives = 123/301 (40%), Gaps = 53/301 (17%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNI 56
+ L E+G+G V A C + +VAVK L + + +
Sbjct: 8 HVQHIK--RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDF 64
Query: 57 SREAQTMILVDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIA 114
REA+ + + H +++K + C L +V +M G L+A PD V
Sbjct: 65 QREAELLTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 115 T--------------ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160
I ++ G+ YL +HRD+ + N L+ +K+GDFG+S
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182
Query: 161 LFDSGDRQRMRNTFVGTP-CWMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSK 217
++ + + +T + P WM PE + ++ + ++D+WSFG+ E+ +G P+ +
Sbjct: 183 VYSTDYYRVGGHTML--PIRWMPPESI--MYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 238
Query: 218 YPPMKVLLMTLQ--------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLL 269
+V+ Q P + Y+ ++ C ++P +R + K++
Sbjct: 239 LSNTEVIECITQGRVLERPRVCPKEV-YD-----------VMLGCWQREPQQRLNIKEIY 286
Query: 270 K 270
K
Sbjct: 287 K 287
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 65/297 (21%), Positives = 116/297 (39%), Gaps = 36/297 (12%)
Query: 14 TLYEEVGQG-----VSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI-LVD 67
+ + +G G V A+ + + VAVK+L ++ + E + + L +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 68 HPNVLKSH-CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATIL--------- 117
H N++ + V+ + G L+ L+ I+
Sbjct: 86 HMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 118 -------REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170
+V KG+ +L IHRD+ + NIL+ K+ DFG++ + + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 171 RNTFVGTPC-WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTL 228
N + P WMAPE + Y F++D+WS+GI EL G +P YP M V
Sbjct: 205 GNARL--PVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSP---YPGMPVDSKFY 258
Query: 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ--ARSNEYI 283
+ G ++ +C DP KRP+ K++ ++ + S +I
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI--VQLIEKQISESTNHI 313
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 9e-22
Identities = 65/347 (18%), Positives = 111/347 (31%), Gaps = 86/347 (24%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMILVDHP 69
++Y + +G+G V+ A + VA+K + D D I RE + +
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 70 NVLKSH-----CSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKG 123
+++ + + L++V+ S L + K P E I TIL +L G
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKT--PIFLTEEHIKTILYNLLLG 141
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM-- 181
+++H G IHRD+K N L++ ++K+ DFG++ + D + +
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 182 -----------------APEVMEQLHGYDFKADIWSFG-ITALELAHGHAPFSKYPP--- 220
APE++ Y DIWS G I A EL + P
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA-ELLNMLQSHINDPTNRF 260
Query: 221 --------MKVLLMTLQNAPPGLDY------------------------ERDRKFSKSFK 248
+ K+ K F
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP 320
Query: 249 QM-------------------IASCLVKDPSKRPSAKKLLKHSFFKQ 276
+ S L +P+KR + + L H + K
Sbjct: 321 HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 62/296 (20%), Positives = 114/296 (38%), Gaps = 54/296 (18%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNISREAQTMILVDH 68
L + +G+G V +A VAVK+L S+L ++ E + V+H
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 69 PNVLKSH-CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATIL---------- 117
P+V+K + L +++ + GS L+ + G +
Sbjct: 86 PHVIKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 118 ------------REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165
++ +G+ YL +HRD+ + NIL+ +K+ DFG+S +++
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 166 DRQRMRNTFVGTPC-WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKV 223
+ + P WMA E + H Y ++D+WSFG+ E+ G P+ PP ++
Sbjct: 205 SYVKRSQGRI--PVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 224 LLMTLQ--------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ N + Y ++ C ++P KRP + K
Sbjct: 262 FNLLKTGHRMERPDNCSEEM-YR-----------LMLQCWKQEPDKRPVFADISKD 305
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 70/340 (20%), Positives = 117/340 (34%), Gaps = 87/340 (25%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISR-EAQTMIL--- 65
+ Y + +G+G V +A E VA+KI+ ++ N ++ E + +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVR--LLELM 107
Query: 66 -----VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILRE 119
++ F+ ++L +V +S L+ +L+ G + ++
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 120 VLKGLDYLHHH--GHIHRDVKSGNILI--DVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175
+ L +L IH D+K NIL+ R AIK+ DFG S+C + ++
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLG-----QRIYQYI 219
Query: 176 GTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS---------------KYPP 220
+ + +PEV+ + YD D+WS G +E+ G FS PP
Sbjct: 220 QSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278
Query: 221 MKVL-----------------------------------------LMTLQNAPPGLDY-- 237
+L L P G
Sbjct: 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGE 338
Query: 238 -ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
FK +I L DP R L+HSFFK+
Sbjct: 339 SGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 58/290 (20%), Positives = 112/290 (38%), Gaps = 50/290 (17%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNISREAQTMILVDH 68
EE+G+ V++ VA+K L + + EA + H
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 69 PNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT----------- 115
PNV+ + D L ++ + S G L P
Sbjct: 72 PNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 116 ---ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172
++ ++ G++YL H +H+D+ + N+L+ + +K+ D G+ ++ + + + N
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 173 TFVGTP-CWMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ 229
+ + P WMAPE + ++G + +DIWS+G+ E+ +G P+ Y V+ M
Sbjct: 190 SLL--PIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 245
Query: 230 --------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ P + Y ++ C + PS+RP K +
Sbjct: 246 RQVLPCPDDCPAWV-Y-----------ALMIECWNEFPSRRPRFKDIHSR 283
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 68/292 (23%), Positives = 126/292 (43%), Gaps = 51/292 (17%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE-------IVAVKILDFERDNSDLSNISREAQTMI-L 65
TL + +G+G V A + ++ VAVK+L + DLS++ E + M +
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 66 VDHPNVLKSH-CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVV------------ 112
H N++ L+V++ + S G+ L+A P G E
Sbjct: 144 GKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 113 --IATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170
+ + ++ +G++YL IHRD+ + N+L+ +K+ DFG++ + + ++
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 171 RNTFVGTPC-WMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMT 227
N + P WMAPE + Y ++D+WSFG+ E+ G +P+ P ++ +
Sbjct: 263 TNGRL--PVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318
Query: 228 LQ--------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ N L Y M+ C PS+RP+ K+L++
Sbjct: 319 KEGHRMDKPANCTNEL-YM-----------MMRDCWHAVPSQRPTFKQLVED 358
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 63/298 (21%), Positives = 116/298 (38%), Gaps = 58/298 (19%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNISREAQTMILVDH 68
++G+G V +A +VAVK+L E ++ REA M D+
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 69 PNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT----------- 115
PN++K C+ + ++ +M+ G L++ P + +
Sbjct: 110 PNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 116 -----------ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164
I R+V G+ YL +HRD+ + N L+ +K+ DFG+S ++ +
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 165 GDRQRMRNTFVGTP-CWMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPM 221
+ N + P WM PE + + Y ++D+W++G+ E+ +G P+
Sbjct: 228 DYYKADGNDAI--PIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 222 KVLLMTLQ--------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+V+ N P L Y ++ C K P+ RPS + +
Sbjct: 284 EVIYYVRDGNILACPENCPLEL-YN-----------LMRLCWSKLPADRPSFCSIHRI 329
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-21
Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 51/292 (17%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNEI-------VAVKILDFERDNSDLSNISREAQTMI-L 65
L + +G+G V A I ++ VAVK+L + DLS++ E + M +
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 66 VDHPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT-------- 115
H N++ C+ D L+V++ + S G+ L+A P G E +
Sbjct: 132 GKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 116 ------ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169
+V +G++YL IHRD+ + N+L+ +K+ DFG++ + ++
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 170 MRNTFVGTP-CWMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMT 227
N + P WMAPE + Y ++D+WSFG+ E+ G +P+ P ++ +
Sbjct: 250 TTNGRL--PVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
Query: 228 LQ--------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ N L Y M+ C PS+RP+ K+L++
Sbjct: 307 KEGHRMDKPSNCTNEL-YM-----------MMRDCWHAVPSQRPTFKQLVED 346
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 68/376 (18%), Positives = 118/376 (31%), Gaps = 125/376 (33%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL---- 65
Y + ++G G ++V + I + VA+K++ + E + +L
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHYTETALDEIR--LLKSVR 91
Query: 66 ---VDHPNVLKSHCSFVSDH---------NLWVVMPFMSGGSCLHILKAAYPD-GFEEVV 112
+ PN + + D ++ +V + G L G
Sbjct: 92 NSDPNDPN--REMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPC 147
Query: 113 IATILREVLKGLDYLHHHGH-IHRDVKSGNILIDV------------------------- 146
+ I+++VL+GLDYLH IH D+K NIL+ V
Sbjct: 148 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 147 ------------------------RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
+ +K+ D G +AC + T + +
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG-NACWVHKH-----FTEDIQTRQYRS 261
Query: 183 PEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKY---------------------PPM 221
EV+ GY+ ADIWS A ELA G F + P
Sbjct: 262 LEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPR 320
Query: 222 KVLLM------------TLQNAPPGLD----------YERDRKFSKSFKQMIASCLVKDP 259
K+++ L++ YE ++ + F + L P
Sbjct: 321 KLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIP 380
Query: 260 SKRPSAKKLLKHSFFK 275
KR +A + L+H +
Sbjct: 381 EKRATAAECLRHPWLN 396
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 56/291 (19%), Positives = 104/291 (35%), Gaps = 57/291 (19%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE--IVAVKILDFERDNSDLSNISREAQTMI-LVDHPN 70
+ +G+G V +A A+K + D + + E + + L HPN
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 71 VLKSH-CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT-------------- 115
++ + L++ + + G+ L L+ + +
Sbjct: 88 IINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV 175
+V +G+DYL IHRD+ + NIL+ K+ DFG+S R + +V
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----------RGQEVYV 196
Query: 176 GTPC------WMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTL 228
WMA E + Y +D+WS+G+ E+ G P+ ++
Sbjct: 197 KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 229 Q--------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
Q N + Y+ ++ C + P +RPS ++L
Sbjct: 256 QGYRLEKPLNCDDEV-YD-----------LMRQCWREKPYERPSFAQILVS 294
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 64/302 (21%), Positives = 120/302 (39%), Gaps = 39/302 (12%)
Query: 14 TLYEEVGQG-----VSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI-LVD 67
+ +G G ++A+ + + VAVK+L + D+S+ + E + M L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 68 HPNVLKSH-CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATIL--------- 117
H N++ +S ++++ + G L+ L++ E+ +
Sbjct: 108 HENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 118 ------------REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165
+V KG+++L +HRD+ + N+L+ +K+ DFG++ +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 166 DRQRMRNTFVGTP-CWMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKV 223
+ N + P WMAPE + + Y K+D+WS+GI E+ G P YP + V
Sbjct: 227 NYVVRGNARL--PVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNP---YPGIPV 280
Query: 224 LLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH--SFFKQARSNE 281
+ G ++ ++ ++ SC D KRPS L A
Sbjct: 281 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340
Query: 282 YI 283
Y
Sbjct: 341 YQ 342
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 71/334 (21%), Positives = 127/334 (38%), Gaps = 76/334 (22%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVK-ILDFERDNSDLSNISREAQTMIL---V 66
Y L +++G+G V +++ E+VAVK I D ++++D RE MIL
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE--IMILTELS 66
Query: 67 DHPNVLKSHCSFVSDHN--LWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLKG 123
H N++ +D++ +++V +M + LH +++A + E V ++ +++K
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRA---NILEPVHKQYVVYQLIKV 121
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM-- 181
+ YLH G +HRD+K NIL++ +K+ DFG+S + +
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 182 ----------------APEVMEQLHGYDFKADIWSFG-ITALELAHGHAPF--SKY---- 218
APE++ Y D+WS G I E+ G F S
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG-EILCGKPIFPGSSTMNQL 240
Query: 219 ---------PPMKVL-----------LMTLQNAPP-------GLDYERDRKFSKSFKQMI 251
P + + + +L+ + + K +
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300
Query: 252 AS---------CLVKDPSKRPSAKKLLKHSFFKQ 276
+ L +P+KR SA LKH F
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 60/281 (21%), Positives = 109/281 (38%), Gaps = 32/281 (11%)
Query: 14 TLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNISREAQTMI-LVD 67
+ +G G V A + VAVK+L + + E + M L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 68 HPNVLKSH--CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT---------- 115
H N++ C+ + V+ + G L+ L+ + A
Sbjct: 109 HENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 116 --ILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173
+V +G+ +L IHRDV + N+L+ K+GDFG++ + + + N
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 174 FVGTPC-WMAPEVMEQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN 230
+ P WMAPE + Y ++D+WS+GI E+ G P YP + V +
Sbjct: 227 RL--PVKWMAPESI--FDCVYTVQSDVWSYGILLWEIFSLGLNP---YPGILVNSKFYKL 279
Query: 231 APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
G + K+ ++ +C +P+ RP+ +++
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 77/280 (27%), Positives = 113/280 (40%), Gaps = 53/280 (18%)
Query: 19 VGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT---MI-LVDHPNVLKS 74
+G+G V++ + +VAVK L + QT MI + H N+L+
Sbjct: 38 LGRGGFGKVYKG-RLADGTLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLLRL 92
Query: 75 H--CSFVSDHNLWVVMPFMSGGS---CLHILKAAYP--DGFEEVVIATILREVLKGLDYL 127
C ++ +V P+M+ GS CL + P D + IA +GL YL
Sbjct: 93 RGFC--MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL---GSARGLAYL 147
Query: 128 HHHGH---IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV-----GTPC 179
H H IHRDVK+ NIL+D +GDFG+ A L D D T V GT
Sbjct: 148 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKD------THVTTAVRGTIG 200
Query: 180 WMAPEVMEQLHGY-DFKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTLQNAPPGLDY 237
+APE + G K D++ +G+ LEL G F +M L L
Sbjct: 201 HIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 238 ER-----DRKFSKSF-----KQMI---ASCLVKDPSKRPS 264
++ D ++ +Q+I C P +RP
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 71/339 (20%), Positives = 117/339 (34%), Gaps = 85/339 (25%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISR-EAQTMILVDH 68
+ + ++G G V I + AVK++ R+ + ++ EA + + +
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV---RNIKKYTRSAKIEADILKKIQN 90
Query: 69 PNVLKSHC-----SFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREVLK 122
++ ++ F+ ++ ++ + G L+ I+ +GF I E+LK
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPL--GPSLYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 123 GLDYLHHHGHIHRDVKSGNILI-------------------------DVRGAIKLGDFGV 157
L+YL H D+K NIL+ IKL DFG
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG- 207
Query: 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF-- 215
A + + T + APEV+ L G+D +D+WSFG EL G F
Sbjct: 208 CATF----KSDYH-GSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRT 261
Query: 216 ------------------------------SKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
SKY L + ++ + K
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321
Query: 246 S---------FKQMIASCLVKDPSKRPSAKKLLKHSFFK 275
F + S L DP+ RPS +LLKH F +
Sbjct: 322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 65/335 (19%), Positives = 109/335 (32%), Gaps = 81/335 (24%)
Query: 10 AEHYTLYEEVGQGVSASVHRALC-IPFNEIVAVKILDFERDNSDLSNISR-EAQTM-ILV 66
E Y + +G+G V L VA+KI+ R+ +R E + +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII---RNVGKYREAARLEINVLKKIK 74
Query: 67 DHPNVLKSHC-----SFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREV 120
+ K C F ++ + + G LK + + + ++
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELL--GKNTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 121 LKGLDYLHHHGHIHRDVKSGNILI-------------------DVRGAIKLGDFGVSACL 161
L +LH + H D+K NIL +I++ DFG SA
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATF 191
Query: 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPFS---- 216
D + T V T + PEV+ L G+ D+WS G E G F
Sbjct: 192 ----DHEHH-TTIVATRHYRPPEVI--LELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244
Query: 217 -----------KYPPMKVL-------------LMTLQNAPPGLDYERDRKFSKSFKQ--- 249
P ++ L+ +N+ G + + K KS+
Sbjct: 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 250 --------MIASCLVKDPSKRPSAKKLLKHSFFKQ 276
++ L DP++R + + L H FF
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 70/338 (20%), Positives = 118/338 (34%), Gaps = 79/338 (23%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFN-EIVAVKILDFERDNSDLSNISR-EAQTM-ILV 66
+ Y + + +G+G V + VAVKI+ ++ +R E Q + L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQVLEHLN 69
Query: 67 DHPNVLKSHC-----SFVSDHNLWVVMPFMSGGSCLH-ILKAAYPDGFEEVVIATILREV 120
C F ++ +V + G + +K F I + ++
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELL--GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 121 LKGLDYLHHHGHIHRDVKSGNILID-------------------VRGAIKLGDFGVSACL 161
K +++LH + H D+K NIL + IK+ DFG SA
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SAT- 185
Query: 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS----- 216
+D +T V T + APEV+ L G+ D+WS G +E G F
Sbjct: 186 YDD----EHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 217 ----------KYPPMKVLLMTLQN---APPGLDYERD-------RKFSKSFKQMIAS--- 253
P ++ T + LD++ + K K+ + S
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300
Query: 254 -----------CLVKDPSKRPSAKKLLKHSFFKQARSN 280
L DP+KR + ++ LKH FF + +
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 43/165 (26%), Positives = 65/165 (39%), Gaps = 34/165 (20%)
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFV-----G 176
+GL YLH IHRDVKS NIL+D K+ DFG+S D T + G
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK-KGTELD-----QTHLSTVVKG 203
Query: 177 TPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGL 235
T ++ PE + + K+D++SFG+ E+ + + P V L + A
Sbjct: 204 TLGYIDPEYFIKGRLTE-KSDVYSFGVVLFEVLCARSAIVQSLPREMVNL--AEWAVE-- 258
Query: 236 DYERDRKF-------------SKSFKQMIA---SCLVKDPSKRPS 264
+ + +S ++ CL RPS
Sbjct: 259 -SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 47/227 (20%), Positives = 84/227 (37%), Gaps = 23/227 (10%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
M + +G HY + +G+G + + N+ VA+K FE SD + E
Sbjct: 1 MSGQNNVVG-VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAPQLRDEY 56
Query: 61 QTM-ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILRE 119
+T +L + + + +V+ + G L L F +A ++
Sbjct: 57 RTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQ 114
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDVRGA-----IKLGDFGVSACLFDSGDRQ----RM 170
+L + +H ++RD+K N LI + I + DFG+ D +Q R
Sbjct: 115 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 171 RNTFVGTPCWM---APEVMEQLHGYDFKADIWSFGITALELAHGHAP 214
+ GT +M EQ + D+ + G + G P
Sbjct: 175 KKNLSGTARYMSINTHLGREQ----SRRDDLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 42/220 (19%), Positives = 80/220 (36%), Gaps = 22/220 (10%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM-ILV 66
+ ++ + +++G G + + NE VA+K E S + E + L
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLG 62
Query: 67 DHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDY 126
+ + + +V+ + G L L F + I +++ ++Y
Sbjct: 63 SGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 127 LHHHGHIHRDVKSGNILIDVRGA-----IKLGDFGVSACLFDSGDRQ----RMRNTFVGT 177
+H I+RDVK N LI G I + DF ++ D ++ R + GT
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 178 PCWMAPEV---MEQLHGYDFKADIWSFGITALELAHGHAP 214
+M+ EQ + D+ + G + G P
Sbjct: 181 ARYMSINTHLGKEQ----SRRDDLEALGHMFMYFLRGSLP 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 45/168 (26%), Positives = 80/168 (47%), Gaps = 32/168 (19%)
Query: 118 REVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177
+V KG+++L IHRD+ + NIL+ + +K+ DFG++ ++ D R + +
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-- 257
Query: 178 P-CWMAPEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKV---LLMTLQ--- 229
P WMAPE + Y ++D+WSFG+ E+ G +P YP +K+ L+
Sbjct: 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEEFCRRLKEGT 313
Query: 230 ------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
P + Y+ + C +PS+RP+ +L++H
Sbjct: 314 RMRAPDYTTPEM-YQ-----------TMLDCWHGEPSQRPTFSELVEH 349
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 25/147 (17%), Positives = 49/147 (33%), Gaps = 7/147 (4%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNI 56
D K+ + L + +G+G V A VAVK+L +S+ +
Sbjct: 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 72
Query: 57 SREAQTMILVD-HPNVLKSH-CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIA 114
E + +I + H NV+ L V++ F G+ L++ +
Sbjct: 73 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132
Query: 115 TILREVLKGLDYLHHHGHIHRDVKSGN 141
R+ + + D + +
Sbjct: 133 ARFRQGKDYVGAIPVDLKRRLDSITSS 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 42/216 (19%), Positives = 76/216 (35%), Gaps = 20/216 (9%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM-ILVDH 68
Y L ++G G ++ I E VA+K E + + E++ ++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK---LECVKTKHPQLHIESKIYKMMQGG 64
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
+ +VM + G L L F + + +++ ++Y+H
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 129 HHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQ----RMRNTFVGTPCWM 181
IHRDVK N L+ + + + DFG++ D+ Q R GT +
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 182 ---APEVMEQLHGYDFKADIWSFGITALELAHGHAP 214
+EQ + D+ S G + G P
Sbjct: 183 SINTHLGIEQ----SRRDDLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 41/216 (18%), Positives = 77/216 (35%), Gaps = 20/216 (9%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM-ILVDH 68
+ L ++G G ++ I NE VA+K E + + E++ IL
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKIYRILQGG 62
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
+ V +VM + G L L + + +++ ++++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 129 HHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFDSGDRQ----RMRNTFVGTPCWM 181
+HRD+K N L+ + + + DFG++ D+ Q R GT +
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 182 ---APEVMEQLHGYDFKADIWSFGITALELAHGHAP 214
+EQ + D+ S G + G P
Sbjct: 181 SVNTHLGIEQ----SRRDDLESLGYVLMYFLRGSLP 212
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 2e-12
Identities = 49/330 (14%), Positives = 92/330 (27%), Gaps = 77/330 (23%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-------SDLSNISREAQTM 63
E E++G+GV V + + + VA+KI+ E + I E
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 64 ---------ILVDHPNVLKSHCSFV------------------------------SDHNL 84
+ + + D L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNIL 143
++V+ F GG L ++ +IL ++ L HRD+ GN+L
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLAT---AKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 144 IDVRGAIKL-----------GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL-HG 191
+ KL G+ + D R G + + E L G
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLS---RLERDGIVVFCDVSMDEDLFTG 251
Query: 192 -YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVL---LMTLQNAPPGLDYERDRKFSKS 246
D++ DI+ + P+S + L ++ + ++ +
Sbjct: 252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRK 311
Query: 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
++ + L SA LL +
Sbjct: 312 IQEFHRTMLNFS-----SATDLLCQHSLFK 336
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 7e-08
Identities = 88/595 (14%), Positives = 165/595 (27%), Gaps = 223/595 (37%)
Query: 97 LHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFG 156
L + + A+ D F+ + + + +L + HI + S + V G ++L F
Sbjct: 22 LSVFEDAFVDNFDCKDVQDMPKSILSKEEI----DHI---IMSKD---AVSGTLRL--FW 69
Query: 157 VSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSF------GITAL---- 206
L + + FV EV+ Y F +T +
Sbjct: 70 ---TLLSKQEEMVQK--FVE-------EVLRI--NYKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 207 --ELAHGHAPFSKY-----PPMKVL---LMTLQNAP-------PGLDYERDRKFSKSFKQ 249
L + + F+KY P L L+ L+ A G K
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG--------SGK---- 163
Query: 250 MIASCLVKDPSKRPSAKKLLKHSF------FKQARSNEYIARTLLEGLPALGDRIKALKK 303
+ + D S K K F K S E T+LE L L +I
Sbjct: 164 ---TWVALDVCL--SYKVQCKMDFKIFWLNLKNCNSPE----TVLEMLQKLLYQIDPNWT 214
Query: 304 KEEDMLAQKKMPDGQKEEISQNEYKRGISGWNFN-----LEDVKAQASLIQDEDMISESN 358
D + K+ I Q E +R + + L +V+
Sbjct: 215 SRSDHSSNIKLR---IHSI-QAELRRLLKSKPYENCLLVLLNVQ---------------- 254
Query: 359 HGGSSSTLSSLEMQGKQSECQV-------AVLNQLPP----HI-LVESTMNITKLRCDKS 406
++ ++ + C++ V + L HI L +M +T D+
Sbjct: 255 ---NAKAWNAFNLS-----CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP---DEV 303
Query: 407 DDDSSVASPCFEQYTQLSSPCHDDRNQNNPSEKPSLEGTASPSHQRAGSTALSESIIAPV 466
+Y P + P T +P SIIA
Sbjct: 304 KS-------LLLKYLDCR-----------PQDLPREVLTTNP---------RRLSIIAES 336
Query: 467 NKESVTVAANSDELDEKAKPPVIQQKGRFKVTSENVCLEKVVPPTLQKS-HSMQVLSQSP 525
++ + N ++ +I+ L + P +K + V
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIE-----------SSLNVLEPAEYRKMFDRLSVFPP-- 383
Query: 526 AISSLVPSDTALSNLSGNSLFPMLCNVLQTNILQR--ESILNLMKQVSVGDCTANRLVDG 583
S+ +P+ L ++ ++++ ++N + +
Sbjct: 384 --SAHIPTIL-------------LS-LIWFDVIKSDVMVVVNKLHK-------------- 413
Query: 584 GGTPANTVTTEKSLLEAAHDREKDLLHEITDLQWRLMCAQDE--------LQKYK 630
SL+E + K+ I + L + + Y
Sbjct: 414 -----------YSLVEK---QPKESTISIPSIYLELKVKLENEYALHRSIVDHYN 454
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 30/199 (15%), Positives = 66/199 (33%), Gaps = 33/199 (16%)
Query: 11 EHYTLYEEVGQG--------VSASVHRALCIPFNEIVAVKILDFERDNSDLSNIS----R 58
+ L + S P + ++K+ + + L N R
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL---DAKDGRLFNEQNFFQR 98
Query: 59 EAQTMIL--------VDHPNVLKSHCSFV--SDHNLWVVMPFMSGGSCLHILKAAYPDGF 108
A+ + + + V + +V+P + G S L +
Sbjct: 99 AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSL-GRSLQSALDVSPKHVL 156
Query: 109 EEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV--RGAIKLGDFGVSACLFDSGD 166
E + + +L L++LH + ++H +V + NI +D + + L +G + SG
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 167 ----RQRMRNTFVGTPCWM 181
+ R+ G ++
Sbjct: 217 HVAYVEGSRSPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 19/73 (26%), Positives = 39/73 (53%), Gaps = 9/73 (12%)
Query: 115 TILR---EVLKGLDYLHHHGHIHRDVKSGNILIDVRGA--IKLGDFGVSACLFDSGD--- 166
T+L+ +L L+Y+H + ++H D+K+ N+L+ + + L D+G+S +G+
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 167 -RQRMRNTFVGTP 178
++ R GT
Sbjct: 212 YQENPRKGHNGTI 224
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 24/111 (21%), Positives = 52/111 (46%), Gaps = 14/111 (12%)
Query: 115 TILR---EVLKGLDYLHHHGHIHRDVKSGNILIDVRGA--IKLGDFGVSACLFDSGDRQ- 168
T+L+ +L L+Y+H H ++H D+K+ N+L++ + + L D+G++ G +
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 169 ---RMRNTFVGTPCWMAPEVMEQLHGYD--FKADIWSFGITALELAHGHAP 214
+ GT + + ++ +G + D+ G ++ GH P
Sbjct: 213 YAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 636 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.15 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.81 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.53 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.48 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.22 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.61 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.58 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.53 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.2 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.19 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.13 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.08 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.03 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.01 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.87 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.68 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.48 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.24 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.9 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.14 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-63 Score=521.80 Aligned_cols=264 Identities=26% Similarity=0.446 Sum_probs=235.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
..++|++++.||+|+||+||+|.++.+|+.||||++++.. .......+.+|+++|+.|+|||||+++++|.+++.+||
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3478999999999999999999999999999999997543 23356789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
|||||+||+|.+++++. +.++|..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 110 vmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~- 186 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES- 186 (311)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT-
T ss_pred EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC-
Confidence 99999999999999887 689999999999999999999999999999999999999999999999999998664322
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
......++||||.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..+..... ..+..+|++
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-----~~p~~~s~~ 260 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-----DFPEKFFPK 260 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----CCCTTCCHH
T ss_pred CcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----CCCcccCHH
Confidence 2234567899999999999987 7899999999999999999999999998888777776665432 234678999
Q ss_pred HHHHHHhhcccCCCCCCCHHH------HHhCcccccccChH
Q 006664 247 FKQMIASCLVKDPSKRPSAKK------LLKHSFFKQARSNE 281 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~e------lL~Hpffk~~~~~~ 281 (636)
+++||.+||.+||.+|||++| |++||||+.+.+..
T Consensus 261 ~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp HHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred HHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 999999999999999999887 68999999887754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-62 Score=523.08 Aligned_cols=261 Identities=35% Similarity=0.592 Sum_probs=234.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|+++++||+|+||+||+|.++.+|+.||||++++.... ..+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 36799999999999999999999999999999999865433 34568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 152 y~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~---~ 225 (346)
T 4fih_A 152 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---P 225 (346)
T ss_dssp CCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS---C
T ss_pred CCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC---C
Confidence 9999999999976 479999999999999999999999999999999999999999999999999998664332 2
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
...+++||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+....++.+ ..+..+|+++++
T Consensus 226 ~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~--~~~~~~s~~~~d 302 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL--KNLHKVSPSLKG 302 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC--SCGGGSCHHHHH
T ss_pred cccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC--CccccCCHHHHH
Confidence 3457899999999999976 6799999999999999999999999999988888777766554433 345679999999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
||.+||.+||.+|||+.|+|+||||++....
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 9999999999999999999999999876544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-62 Score=524.39 Aligned_cols=260 Identities=24% Similarity=0.460 Sum_probs=228.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
..++|++++.||+|+||+||+|.++.+|+.||||+++.... ....+.+.+|+.+|+.|+|||||+++++|.+++.+|||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 45899999999999999999999999999999999987653 34567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
||||+||+|.++|.......++|..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--- 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--- 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH---
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC---
Confidence 99999999999998765567899999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+.....+. .+..+|+++
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----~~~~~s~~~ 253 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP----VSLHYSYDL 253 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----CCTTSCHHH
T ss_pred cccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----CCccCCHHH
Confidence 123456799999999999987 689999999999999999999999999998888887777665432 346789999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
++||.+||.+||.+|||+.|+|+||||+.
T Consensus 254 ~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 99999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-61 Score=526.57 Aligned_cols=261 Identities=35% Similarity=0.592 Sum_probs=234.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|+++++||+|+||+||+|.++.+|+.||||+++..... ..+.+.+|+.+|+.++|||||++|++|.+++.+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 36799999999999999999999999999999999865433 45668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||+||+|.++++. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 229 y~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~---~ 302 (423)
T 4fie_A 229 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---P 302 (423)
T ss_dssp CCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC---C
T ss_pred CCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC---c
Confidence 9999999999976 469999999999999999999999999999999999999999999999999998664332 2
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
...+++||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+....++.+ ..+..+|+++++
T Consensus 303 ~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~--~~~~~~s~~~~d 379 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL--KNLHKVSPSLKG 379 (423)
T ss_dssp CBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTSSCHHHHH
T ss_pred cccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC--cccccCCHHHHH
Confidence 3457899999999999976 6799999999999999999999999999998888877776655433 345678999999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
||.+||.+||.+|||+.|+|+||||+.....
T Consensus 380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 9999999999999999999999999976544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-61 Score=499.14 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=211.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||+||+|.++.+|+.||||++++... ......+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999999976542 234667999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||| +|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---- 165 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC----
Confidence 999 67999999876 67999999999999999999999999999999999999999999999999999765322
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
....+.+||+.|||||++.+...++.++|||||||++|+|++|+.||.+.+.......+... .. ..+..+|++++
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~-~~----~~p~~~s~~~~ 240 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG-VY----TLPKFLSPGAA 240 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CC----CCCTTSCHHHH
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-CC----CCCCCCCHHHH
Confidence 22456899999999999987444578999999999999999999999987776665555443 22 23467899999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
+||.+||.+||.+|||++|+++||||+.
T Consensus 241 ~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 241 GLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHHcCccccc
Confidence 9999999999999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-62 Score=509.90 Aligned_cols=265 Identities=29% Similarity=0.459 Sum_probs=226.3
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCI---PFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
.+..++|++++.||+|+||+||+|++. .+++.||||+++.... ......+.+|+.+|+.++|||||+++++|.+++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 355689999999999999999999884 4688999999975532 223446789999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||+||+|.+++.+. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999999999887 679999999999999999999999999999999999999999999999999998653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
+.. ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+..... ..+..
T Consensus 178 ~~~---~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----~~p~~ 248 (304)
T 3ubd_A 178 DHE---KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-----GMPQF 248 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTT
T ss_pred CCC---ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----CCCCc
Confidence 322 23457899999999999987 7899999999999999999999999999888887777765432 23467
Q ss_pred hhHHHHHHHHhhcccCCCCCCC-----HHHHHhCcccccccChHH
Q 006664 243 FSKSFKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSNEY 282 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~~~ 282 (636)
+|+++++||.+||.+||.+||| ++|+++||||+.+.+...
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l 293 (304)
T 3ubd_A 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL 293 (304)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHH
Confidence 8999999999999999999998 589999999998876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-60 Score=494.44 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=221.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEe----CCeEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVS----DHNLW 85 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~----~~~l~ 85 (636)
..|++.++||+|+||+||+|.++.++..||||++.... .....+.+.+|+.+|+.|+|||||+++++|.+ +..+|
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 33588889999999999999999999999999997554 33456789999999999999999999999976 35689
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCcccEEEcc-CCcEEEeccCcccccc
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG--HIHRDVKSGNILIDV-RGAIKLGDFGVSACLF 162 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHRDLKP~NILld~-~g~vKL~DFGla~~~~ 162 (636)
||||||+||+|.+++.+. ..+++..++.|+.||+.||.|||++| ||||||||+||||+. +|.+||+|||+|+...
T Consensus 106 lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999999886 67999999999999999999999998 999999999999974 7999999999997432
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
. ....+.+|||.|||||++.+ .|+.++|||||||++|||++|++||.+......+...+...... ...+..
T Consensus 184 ~-----~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~ 254 (290)
T 3fpq_A 184 A-----SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKV 254 (290)
T ss_dssp T-----TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGC
T ss_pred C-----CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC--CCCCcc
Confidence 1 23457899999999999875 59999999999999999999999998776666665555543322 233456
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
+++++++||.+||.+||.+|||+.|+|+||||++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 7899999999999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=500.03 Aligned_cols=262 Identities=28% Similarity=0.345 Sum_probs=224.6
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|....++|++.++||+|+||+||+|.++.+|+.||||+++.+... .+|+.+|+.|+|||||++|++|.++..+|
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 344567899999999999999999999999999999999865432 47999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-cEEEeccCcccccccC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-AIKLGDFGVSACLFDS 164 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-~vKL~DFGla~~~~~~ 164 (636)
||||||+||+|.++|+.. +.+++..++.|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+.+...
T Consensus 127 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999999999887 6799999999999999999999999999999999999999887 6999999999876433
Q ss_pred CCcc--cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 165 GDRQ--RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 165 ~~~~--~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
+... ....+++||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.........+....++. ...+..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~ 281 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI--REIPPS 281 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG--GGSCTT
T ss_pred CcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc--hhcCcc
Confidence 2211 12345789999999999987 789999999999999999999999998877766666665543321 134567
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHH-------------HhCccccccc
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKL-------------LKHSFFKQAR 278 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~el-------------L~Hpffk~~~ 278 (636)
+++++++||.+||.+||.+|||+.|| ++|||+....
T Consensus 282 ~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 89999999999999999999999998 5699987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-58 Score=496.50 Aligned_cols=267 Identities=24% Similarity=0.363 Sum_probs=226.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEe------CC
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVS------DH 82 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~------~~ 82 (636)
.++|++++.||+|+||+||+|.++.+|+.||||+++.... ......+.+|+++|+.|+|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4789999999999999999999999999999999975543 3346678899999999999999999999764 36
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|||||||+ |+|.+++... +.+++..++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 7999999996 5799999765 689999999999999999999999999999999999999999999999999998664
Q ss_pred cCC-CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC-C----
Q 006664 163 DSG-DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-D---- 236 (636)
Q Consensus 163 ~~~-~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~-~---- 236 (636)
... .......+++||+.|||||++.+...|+.++||||+|||+|||++|++||.+.+..+.+..+........ .
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 332 1223356789999999999998867789999999999999999999999999888887766654211100 0
Q ss_pred --------------------c-ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 237 --------------------Y-ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 237 --------------------~-~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
+ .....+++++++||.+||.+||.+|||+.|+|+||||+....
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 0 011346899999999999999999999999999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-58 Score=479.18 Aligned_cols=262 Identities=21% Similarity=0.354 Sum_probs=206.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC--------
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH-------- 82 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~-------- 82 (636)
++|++++.||+|+||+||+|.++.+|+.||||+++........+.+.+|+.+|+.|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 479999999999999999999999999999999987766666778999999999999999999999997654
Q ss_pred ----eEEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCc
Q 006664 83 ----NLWVVMPFMSGGSCLHILKAAYP-DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 83 ----~l~iVmEy~~GGsL~~lL~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
.+|+|||||+||+|.+++..... ...++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 47999999999999999986522 1245677899999999999999999999999999999999999999999999
Q ss_pred ccccccCCCc---------ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 006664 158 SACLFDSGDR---------QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL 228 (636)
Q Consensus 158 a~~~~~~~~~---------~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~ 228 (636)
|+.+...... .....+.+||+.|||||++.+ ..|+.++|||||||++|||++ ||............+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~ 240 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence 9876432211 112345789999999999987 689999999999999999996 886533222222222
Q ss_pred hcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 229 ~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
.... + .+.....++.+++||.+||.+||.+|||+.|+++||||++..+
T Consensus 241 ~~~~--~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 241 RNLK--F-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HTTC--C-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred hcCC--C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 2221 1 1223456778899999999999999999999999999997654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=477.78 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=213.4
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCI---PFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l 84 (636)
..++|++++.||+|+||+||+|.++ .+++.||||++.... ...++.+|+++|+.+ +|||||+++++|.+++++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4578999999999999999999875 468899999986443 345688999999988 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC-CcEEEeccCccccccc
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR-GAIKLGDFGVSACLFD 163 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~-g~vKL~DFGla~~~~~ 163 (636)
|+|||||+||+|.+++. .+++..++.|++||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...+
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999983 48999999999999999999999999999999999999876 8999999999975432
Q ss_pred CCC-------------------------cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCC-
Q 006664 164 SGD-------------------------RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSK- 217 (636)
Q Consensus 164 ~~~-------------------------~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~- 217 (636)
... ......+.+||+.|||||++.+...|+.++||||+||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 011234568999999999998866799999999999999999999999954
Q ss_pred CChHHHHHHHHhcC---------------------CC----------------------------CCCcccchhhhHHHH
Q 006664 218 YPPMKVLLMTLQNA---------------------PP----------------------------GLDYERDRKFSKSFK 248 (636)
Q Consensus 218 ~~~~~~l~~~~~~~---------------------~~----------------------------~~~~~~~~~~S~~l~ 248 (636)
.+..+.+..+.... .+ ......+..+|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 34444433332100 00 001122356789999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+||.+||++||.+|||++|+|+||||+++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999865
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=510.79 Aligned_cols=265 Identities=24% Similarity=0.354 Sum_probs=225.3
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHH---HHHHHHHHhCCCCCcceeeeEEEe
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNI---SREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i---~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
..+..++|++++.||+|+||+||+|+++.+|+.||||++++... ......+ ++++.+++.++|||||+++++|.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 35667999999999999999999999999999999999975431 1122333 344666778899999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
+..+|+|||||.||+|.++|.+. +.|+|..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999999999887 6799999999999999999999999999999999999999999999999999986
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC---hHHHHHHHHhcCCCCCCc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP---PMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~---~~~~l~~~~~~~~~~~~~ 237 (636)
+... ...++||||.|||||++.+..+|+.++|||||||++|||++|.+||.+.. .......+.. .. .
T Consensus 342 ~~~~-----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-~~----~ 411 (689)
T 3v5w_A 342 FSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MA----V 411 (689)
T ss_dssp CSSC-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-CC----C
T ss_pred cCCC-----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-CC----C
Confidence 5322 24578999999999999755689999999999999999999999997532 2222333332 22 2
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHhCcccccccChHH
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSNEY 282 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~~~ 282 (636)
..+..+|+++++||.+||.+||.+|++ ++||++||||+.+.|...
T Consensus 412 ~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l 461 (689)
T 3v5w_A 412 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461 (689)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 234678999999999999999999998 799999999999876543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-56 Score=467.95 Aligned_cols=262 Identities=24% Similarity=0.416 Sum_probs=223.7
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
-..|..++|.+.+.||+|+||+||+|.+. .++..||||+++.. .....+.+.+|+++|++++|||||++++++.
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 34577899999999999999999999875 46889999999743 3345678999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAY-----------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG 148 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~-----------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g 148 (636)
+++.+|+|||||+||+|.++|.... ...+++..+..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 9999999999999999999998642 34699999999999999999999999999999999999999999
Q ss_pred cEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 006664 149 AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMT 227 (636)
Q Consensus 149 ~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~ 227 (636)
.+||+|||+|+...... ........+||+.|||||++.+ ..|+.++|||||||++|||++ |+.||.+....+.+..+
T Consensus 166 ~~Ki~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp CEEECCCSCHHHHTGGG-CEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred cEEECCcccceecCCCC-ceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999998653322 2223345679999999999987 679999999999999999998 99999998888777666
Q ss_pred HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 228 ~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
.....+ +.+..+++++.+||.+||.+||.+|||+.+| |+|++
T Consensus 244 ~~~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 244 TQGRVL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred HcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 654332 3356789999999999999999999999999 45654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-56 Score=466.55 Aligned_cols=262 Identities=26% Similarity=0.424 Sum_probs=217.0
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
..|+|..++|++.++||+|+||+||+|.+. ..||||+++... .....+.+.+|+.+|++++|||||++++++. ++
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~ 104 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KD 104 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CC
Confidence 468999999999999999999999999754 359999997544 3345678999999999999999999999875 45
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|||||||+||+|.++|... ...+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred eEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 689999999999999999764 3579999999999999999999999999999999999999999999999999997653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhc--cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC-ccc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQL--HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD-YER 239 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~--~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~-~~~ 239 (636)
... ......+.+||+.|||||++.+. ..|+.++|||||||++|||++|+.||.+......+...+........ ...
T Consensus 184 ~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 184 RWS-GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred cCC-cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 322 22234567999999999999752 35899999999999999999999999987776666655554322211 233
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
+..+++++++||.+||.+||.+|||+.+++++
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 46789999999999999999999999988753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=461.92 Aligned_cols=260 Identities=21% Similarity=0.347 Sum_probs=224.1
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
.++..++++++++||+|+||+||+|... .+++.||||+++........+.+.+|+.+|++++|||||++++++.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 4677889999999999999999999853 46789999999765555567789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAY--------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV 146 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~--------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~ 146 (636)
+..+|+|||||+||+|.++|.... ...+++..+..|+.||+.||.|||+++||||||||+||||+.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 999999999999999999997542 135899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHH
Q 006664 147 RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLL 225 (636)
Q Consensus 147 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~ 225 (636)
++.+||+|||+|+.+.... ........+||+.|||||++.+ ..|+.++|||||||++|||++ |..||.+....+...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAAD-YYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGCEEECCSCCBCGGGGGG-CBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCEEECCcccceeccCCC-ceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999998654332 2233456789999999999987 679999999999999999998 999999988877766
Q ss_pred HHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 226 MTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.+..... .+.+..++.++.+||.+||..||.+|||+.+|+++
T Consensus 259 ~i~~~~~----~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQV----LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCC----CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6554332 23456789999999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=465.08 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=216.4
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
.+.|..++|.+.++||+|+||+||+|.++ .++..||||+++.. .....+.+.+|+.+|++++|||||++++++.
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34577789999999999999999999865 46899999999643 3445678999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAY-------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV 146 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~-------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~ 146 (636)
++..+|||||||+||+|.+++.... ...+++..+..|+.||+.||.|||+++||||||||+||||+.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 9999999999999999999997642 245899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHH
Q 006664 147 RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLL 225 (636)
Q Consensus 147 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~ 225 (636)
++.+||+|||+|+.+.... ........+||+.|||||++.+ ..|+.++|||||||++|||++ |+.||.+....+.+.
T Consensus 194 ~~~~Ki~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp TTEEEECCCC-----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCcEEEcccccceeccCCC-cceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999998653332 2233446789999999999987 679999999999999999998 999999988877776
Q ss_pred HHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 226 MTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+..... .+.+..+++++.+||.+||.+||++|||+.||++
T Consensus 272 ~i~~g~~----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 272 CITQGRE----LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHHHTCC----CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HHHcCCC----CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 6655432 2345678999999999999999999999999976
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-55 Score=496.32 Aligned_cols=262 Identities=27% Similarity=0.419 Sum_probs=231.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++++.||+|+||+||+|.++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.++..+|+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 368999999999999999999999999999999997543 3346778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC--CcEEEeccCcccccccCCCc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR--GAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~--g~vKL~DFGla~~~~~~~~~ 167 (636)
||+||+|+++|... .+.|++..++.|++||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 235 ~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--- 310 (573)
T 3uto_A 235 FMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--- 310 (573)
T ss_dssp CCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT---
T ss_pred ecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC---
Confidence 99999999999653 2579999999999999999999999999999999999999854 89999999999876322
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
....+.+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+....+.+..+... ...+....+..+|+++
T Consensus 311 -~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNMDDSAFSGISEDG 387 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-CCCCCSGGGTTSCHHH
T ss_pred -CceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC-CCCCCcccccCCCHHH
Confidence 23456799999999999987 78999999999999999999999999998888777666543 3333444557799999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
++||.+||.+||.+|||+.|+|+||||+....
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99999999999999999999999999987544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-55 Score=469.63 Aligned_cols=264 Identities=23% Similarity=0.374 Sum_probs=226.4
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCC-----CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCC-CCcceeee
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPF-----NEIVAVKILDFERDNSDLSNISREAQTMILVDH-PNVLKSHC 76 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t-----g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~H-PNIVkl~~ 76 (636)
..+|+|..++|++++.||+|+||+||+|.+..+ ++.||||+++..........+.+|+.+|+.++| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 357999999999999999999999999998754 368999999866666667789999999999965 99999999
Q ss_pred EEEeC-CeEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCccc
Q 006664 77 SFVSD-HNLWVVMPFMSGGSCLHILKAAY--------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGN 141 (636)
Q Consensus 77 ~~~~~-~~l~iVmEy~~GGsL~~lL~~~~--------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~N 141 (636)
++... ..+|+|||||+||+|.++|+... ...+++..+..|+.||+.||.|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 98764 67999999999999999998642 2348999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCCh
Q 006664 142 ILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPP 220 (636)
Q Consensus 142 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~ 220 (636)
||++.++.+||+|||+|+.+..... .....+.+||+.|||||++.+ ..|+.++|||||||++|||++ |..||.+...
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred eeeCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999986643322 223456789999999999987 689999999999999999998 9999998776
Q ss_pred HHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 221 MKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 221 ~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
...+...+.... ....+..+++++.+||.+||..||.+|||+.+|++|
T Consensus 294 ~~~~~~~i~~g~---~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 294 DEEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp SHHHHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCC---CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 555555554432 223456789999999999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=433.53 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=229.4
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
..++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++.++..+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3478999999999999999999999999999999997654 334567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-- 168 (328)
T ss_dssp ECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred EECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence 9999999999999876 679999999999999999999999999999999999999999999999999997553221
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.........+..... ..+..+++++
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~~p~~~s~~~ 241 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----RIPFYMSTDC 241 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTSCHHH
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCCCCCHHH
Confidence 245678999999999998754456899999999999999999999998887776666655422 2345689999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.+||.+||..||.+|||++++++||||+...
T Consensus 242 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999999998643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=435.49 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=230.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
+..++|++++.||+|+||+||+|.++.+|+.||||+++... .......+.+|+.+|+.++||||++++++|.+...+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45689999999999999999999999999999999997542 2234667889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....+
T Consensus 82 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999999999999876 679999999999999999999999999999999999999999999999999987543222
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.........+..... ..+..+++
T Consensus 160 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s~ 230 (337)
T 1o6l_A 160 ---ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-----RFPRTLSP 230 (337)
T ss_dssp ---CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTSCH
T ss_pred ---CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----CCCCCCCH
Confidence 22456799999999999976 6799999999999999999999999998877666655554322 23457899
Q ss_pred HHHHHHHhhcccCCCCCC-----CHHHHHhCcccccccCh
Q 006664 246 SFKQMIASCLVKDPSKRP-----SAKKLLKHSFFKQARSN 280 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~ 280 (636)
++++||.+||.+||.+|| ++.++++||||+...+.
T Consensus 231 ~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999999999999999 89999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=440.12 Aligned_cols=263 Identities=27% Similarity=0.487 Sum_probs=225.6
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCe
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~ 83 (636)
.+..++|++++.||+|+||+||+|.++.+|+.||||++.... .......+.+|+.+++.+ +||||++++++|.+...
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 356689999999999999999999999999999999997542 223466788999999988 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999999886 6799999999999999999999999999999999999999999999999999875322
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.+ ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+....+....+..... ..+..+
T Consensus 177 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~ 247 (353)
T 3txo_A 177 NG---VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-----VYPTWL 247 (353)
T ss_dssp ------------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTS
T ss_pred CC---ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----CCCCCC
Confidence 22 23456799999999999987 5799999999999999999999999999888777776665432 223568
Q ss_pred hHHHHHHHHhhcccCCCCCCCH------HHHHhCcccccccCh
Q 006664 244 SKSFKQMIASCLVKDPSKRPSA------KKLLKHSFFKQARSN 280 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa------~elL~Hpffk~~~~~ 280 (636)
+.++++||.+||.+||.+||++ .++++||||+.+.+.
T Consensus 248 ~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 248 HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 9999999999999999999998 999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=420.32 Aligned_cols=261 Identities=37% Similarity=0.659 Sum_probs=231.2
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
..++|++++.||+|+||+||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||++++++|..+..+|+||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 357899999999999999999999999999999999765433 3567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
|||.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 170 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (297)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---
T ss_pred ECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc---
Confidence 999999999999874 69999999999999999999999999999999999999999999999999987653322
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+.....+.. ..+..++..++
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 247 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIFR 247 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--SCGGGSCHHHH
T ss_pred cccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCccccCHHHH
Confidence 22446789999999999987 6799999999999999999999999998888777766665544433 33567899999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
+||.+||..||.+|||+.++++||||+....
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 9999999999999999999999999987653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=434.47 Aligned_cols=266 Identities=25% Similarity=0.387 Sum_probs=231.4
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-----hhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-----SDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-----~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
....++|++++.||+|+||+||+|.++.+|+.||+|+++..... ...+.+.+|+.+|+.++||||++++++|.++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 34467899999999999999999999999999999999765432 2357889999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC----cEEEeccCc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG----AIKLGDFGV 157 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g----~vKL~DFGl 157 (636)
..+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999999764 6799999999999999999999999999999999999998776 799999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
+..+.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+......+..+... ...+..
T Consensus 166 a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~~~ 239 (361)
T 2yab_A 166 AHEIEDGV----EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-SYDFDE 239 (361)
T ss_dssp CEECCTTC----CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-CCCCCH
T ss_pred ceEcCCCC----ccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCc
Confidence 97653321 2346789999999999976 67999999999999999999999999988877766555443 333333
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
..+..++..+++||.+||.+||.+|||+.++++||||+...+.
T Consensus 240 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 282 (361)
T 2yab_A 240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ 282 (361)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHH
T ss_pred hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchh
Confidence 4456789999999999999999999999999999999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=440.39 Aligned_cols=265 Identities=26% Similarity=0.478 Sum_probs=224.8
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCC
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILV-DHPNVLKSHCSFVSDH 82 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~ 82 (636)
..+..++|++++.||+|+||+||+|.++.+++.||||+++.... ......+.+|..++..+ +||||++++++|.++.
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 45667899999999999999999999999999999999976542 23445688999999876 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||.||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999999999886 679999999999999999999999999999999999999999999999999997533
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC--------hHHHHHHHHhcCCCC
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP--------PMKVLLMTLQNAPPG 234 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~--------~~~~l~~~~~~~~~~ 234 (636)
..+ ....+++||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.... ....+...+.....
T Consensus 205 ~~~---~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 279 (396)
T 4dc2_A 205 RPG---DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 279 (396)
T ss_dssp CTT---CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-
T ss_pred cCC---CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-
Confidence 322 23457899999999999987 679999999999999999999999996421 12223333333222
Q ss_pred CCcccchhhhHHHHHHHHhhcccCCCCCCCH------HHHHhCcccccccCh
Q 006664 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSA------KKLLKHSFFKQARSN 280 (636)
Q Consensus 235 ~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa------~elL~Hpffk~~~~~ 280 (636)
..+..++.++++||.+||.+||.+||++ .+|++||||+.+.+.
T Consensus 280 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 280 ---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred ---CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 2345689999999999999999999984 899999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=426.45 Aligned_cols=261 Identities=27% Similarity=0.462 Sum_probs=231.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
+..++|++++.||+|+||+||+|.++.+|+.||||++..... ......+.+|+.+++.++||||++++++|.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 345899999999999999999999999999999999975421 234667889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999999999875 6799999999999999999999999999999999999999999999999999975422
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
...+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+..... ..+..++.
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~~p~~~~~ 228 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----RFPPFFNE 228 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----CCCTTSCH
T ss_pred ----ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCCCCCH
Confidence 2346789999999999986 6799999999999999999999999998888777766665432 22356899
Q ss_pred HHHHHHHhhcccCCCCCC-----CHHHHHhCcccccccChHH
Q 006664 246 SFKQMIASCLVKDPSKRP-----SAKKLLKHSFFKQARSNEY 282 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~~~ 282 (636)
++++||.+||.+||.+|| +++++++||||+.+.+...
T Consensus 229 ~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~ 270 (318)
T 1fot_A 229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 270 (318)
T ss_dssp HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred HHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHH
Confidence 999999999999999999 9999999999998776543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=433.09 Aligned_cols=266 Identities=27% Similarity=0.493 Sum_probs=230.5
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCC
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDH 82 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~ 82 (636)
..+..++|++++.||+|+||.||+|.++.+|+.||||+++... .......+.+|..++..+ +||||++++++|.+..
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3466799999999999999999999999999999999997542 123456788999999876 9999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 999999999999999999886 679999999999999999999999999999999999999999999999999987542
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
... ....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+....+ ..+..
T Consensus 170 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~~p~~ 240 (345)
T 1xjd_A 170 LGD---AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-----FYPRW 240 (345)
T ss_dssp CTT---CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTT
T ss_pred cCC---CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-----CCCcc
Confidence 221 22457799999999999987 6799999999999999999999999998887776665554422 12356
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHH-HHHhCcccccccChHH
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAK-KLLKHSFFKQARSNEY 282 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~-elL~Hpffk~~~~~~~ 282 (636)
+++++++||.+||..||.+||++. ++++||||+.+.+...
T Consensus 241 ~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l 281 (345)
T 1xjd_A 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 281 (345)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHH
Confidence 899999999999999999999998 9999999998876543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=426.93 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=196.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC----eEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH----NLW 85 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~----~l~ 85 (636)
+++|.+.++||+|+||+||+|.+ +|+.||||+++.... ......+|+..+..++|||||++++++.+++ .+|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 46899999999999999999987 589999999964321 1222345666667899999999999998764 689
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccccCcccEEEccCCcEEEeccCc
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH--------GHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~--------gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
||||||+||+|.++++. ..+++..+..++.|++.||.|||++ |||||||||+||||+.++.+||+|||+
T Consensus 78 lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999999986 4689999999999999999999987 999999999999999999999999999
Q ss_pred ccccccCCCcc-cccccccCCCCCCChhhhhhcc-----CCCcccchhhHHHHHHHHHcCCCCCCCC-------------
Q 006664 158 SACLFDSGDRQ-RMRNTFVGTPCWMAPEVMEQLH-----GYDFKADIWSFGITALELAHGHAPFSKY------------- 218 (636)
Q Consensus 158 a~~~~~~~~~~-~~~~~~~GT~~YmAPEvl~~~~-----~ys~ksDIWSLGiiLyeLltG~~PF~~~------------- 218 (636)
|+......... ......+||+.|||||++.+.. .|+.++|||||||++|||++|.+||...
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98664333221 2234568999999999997532 3678999999999999999998776321
Q ss_pred -ChHHHHHHHHhcCC--CCCC-cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 219 -PPMKVLLMTLQNAP--PGLD-YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 219 -~~~~~l~~~~~~~~--~~~~-~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.....+...+.... +.+. .......+..+.+|+.+||..||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11223333322211 1111 1112345678999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=432.63 Aligned_cols=275 Identities=38% Similarity=0.653 Sum_probs=229.3
Q ss_pred cccccCCCCeEEEeEEccc--CceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 4 KKYPIGAEHYTLYEEVGQG--VSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G--~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
..|....++|++++.||+| +||+||+|.++.+|+.||||+++.... ......+.+|+.+++.++|||||+++++|.+
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 97 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence 5677788999999999999 999999999999999999999986643 3345678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
++.+|+|||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999999999887667799999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCcc----cccccccCCCCCCChhhhhhc-cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-
Q 006664 161 LFDSGDRQ----RMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG- 234 (636)
Q Consensus 161 ~~~~~~~~----~~~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~- 234 (636)
....+... ......+||+.|+|||++.+. ..|+.++|||||||++|+|++|+.||.+......+...+....+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 54333221 122345899999999999763 468999999999999999999999998766555444333221110
Q ss_pred ----------------------------------------CCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 235 ----------------------------------------LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 235 ----------------------------------------~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
...+.+..+++++++||.+||..||.+|||+.++|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 0011234678899999999999999999999999999999
Q ss_pred cccc
Q 006664 275 KQAR 278 (636)
Q Consensus 275 k~~~ 278 (636)
+...
T Consensus 338 ~~~~ 341 (389)
T 3gni_B 338 KQIK 341 (389)
T ss_dssp GGC-
T ss_pred HHHh
Confidence 8764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=426.28 Aligned_cols=264 Identities=27% Similarity=0.502 Sum_probs=226.1
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCe
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~ 83 (636)
++..++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+.+++.+ +||||++++++|.++..
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 456689999999999999999999999999999999997654 233566788999999887 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999999999876 6799999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC--------hHHHHHHHHhcCCCCC
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP--------PMKVLLMTLQNAPPGL 235 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~--------~~~~l~~~~~~~~~~~ 235 (636)
.+ ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.... ....+...+.....
T Consensus 163 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 236 (345)
T 3a8x_A 163 PG---DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 236 (345)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--
T ss_pred CC---CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--
Confidence 22 22456799999999999987 679999999999999999999999996521 12222233333222
Q ss_pred CcccchhhhHHHHHHHHhhcccCCCCCCCH------HHHHhCcccccccCh
Q 006664 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSA------KKLLKHSFFKQARSN 280 (636)
Q Consensus 236 ~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa------~elL~Hpffk~~~~~ 280 (636)
..+..++.++++||.+||.+||.+||++ .++++||||+...+.
T Consensus 237 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 237 --RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred --CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 2345689999999999999999999995 899999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=430.30 Aligned_cols=265 Identities=25% Similarity=0.431 Sum_probs=230.4
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCe
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~ 83 (636)
.+..++|++++.||+|+||+||+|.++.+|+.||||+++... .......+.+|..++..+ +||||++++++|.+...
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 356689999999999999999999999999999999997543 223466788999999887 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999999876 5799999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.+ ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+..... ..+..+
T Consensus 174 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~ 244 (353)
T 2i0e_A 174 DG---VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----AYPKSM 244 (353)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTS
T ss_pred CC---cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-----CCCCCC
Confidence 22 22456799999999999976 6799999999999999999999999998887777666665432 223578
Q ss_pred hHHHHHHHHhhcccCCCCCCC-----HHHHHhCcccccccChHH
Q 006664 244 SKSFKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSNEY 282 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~~~ 282 (636)
+.++++||.+||.+||.+||+ +++|++||||+.+.+...
T Consensus 245 s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l 288 (353)
T 2i0e_A 245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 288 (353)
T ss_dssp CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHH
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHH
Confidence 999999999999999999994 799999999998766543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=427.44 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=230.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
...++|++++.||+|+||.||+|.++.+|+.||||+++... .......+.+|+.+|+.++||||++++++|.++..+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45689999999999999999999999999999999997543 1234667889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 118 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999999999886 57999999999999999999999999999999999999999999999999999765221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
..+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+..... ..+..++.
T Consensus 195 -----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~~~ 263 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSS 263 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTCCH
T ss_pred -----cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-----CCCCCCCH
Confidence 246789999999999986 6799999999999999999999999998887776666655422 22356899
Q ss_pred HHHHHHHhhcccCCCCCCC-----HHHHHhCcccccccCh
Q 006664 246 SFKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSN 280 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~ 280 (636)
++++||.+||..||.+||+ +++|++||||+...+.
T Consensus 264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 9999999999999999998 9999999999987654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=419.46 Aligned_cols=266 Identities=25% Similarity=0.421 Sum_probs=221.8
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeecCC---CchhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCI---PFNEIVAVKILDFER---DNSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~---~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
..+..++|++++.||+|+||.||+|.+. .+|+.||||+++... .......+.+|+.+|+.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 4567799999999999999999999985 689999999997543 2234556789999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.++.+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999999999876 679999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
.....+ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..... ..
T Consensus 170 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-----~~ 240 (327)
T 3a62_A 170 ESIHDG---TVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-----NL 240 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----CC
T ss_pred ccccCC---ccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-----CC
Confidence 543222 22346789999999999976 6789999999999999999999999998887776666655422 23
Q ss_pred chhhhHHHHHHHHhhcccCCCCCC-----CHHHHHhCcccccccChHH
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRP-----SAKKLLKHSFFKQARSNEY 282 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~~~ 282 (636)
+..++.++++||.+||..||.+|| ++.++++||||+...+...
T Consensus 241 p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~ 288 (327)
T 3a62_A 241 PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL 288 (327)
T ss_dssp CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHH
T ss_pred CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHH
Confidence 356889999999999999999999 8999999999998765543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=441.06 Aligned_cols=270 Identities=28% Similarity=0.456 Sum_probs=231.4
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
.+.+..++|++++.||+|+||+||+|.++.+++.||+|++..... ......+.+|+.+++.++||||++++++|.++.
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 345678999999999999999999999999999999999965321 112345789999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 99999999999999999976 469999999999999999999999999999999999999999999999999997653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccC---CCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHG---YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~---ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
..+ .....+.+||+.|+|||++.+... |+.++|||||||++|||++|..||.+.........++... ..+.++.
T Consensus 220 ~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~p~ 296 (410)
T 3v8s_A 220 KEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK-NSLTFPD 296 (410)
T ss_dssp TTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-HHCCCCT
T ss_pred cCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc-ccccCCC
Confidence 322 122347799999999999986322 7899999999999999999999999888877776665432 1123344
Q ss_pred chhhhHHHHHHHHhhcccCCCC--CCCHHHHHhCcccccccCh
Q 006664 240 DRKFSKSFKQMIASCLVKDPSK--RPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~k--Rpsa~elL~Hpffk~~~~~ 280 (636)
...+++++++||.+||..+|.+ ||++++|++||||+...+.
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 4578999999999999999998 9999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=408.93 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=218.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++++.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999999999999999999866533 345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||.| +|.+++... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP---VR 156 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC---CS
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc---cc
Confidence 9986 666666553 367999999999999999999999999999999999999999999999999999765322 22
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCC-CCCCChHHHHHHHHhcC--CCCCC----------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAP-FSKYPPMKVLLMTLQNA--PPGLD---------- 236 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~P-F~~~~~~~~l~~~~~~~--~~~~~---------- 236 (636)
.....+||+.|+|||++.+...|+.++|||||||++|+|++|..| |.+......+..+.... +....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 234568999999999998756689999999999999999987777 55555555544443311 11000
Q ss_pred ------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 237 ------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 237 ------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
......++.++++||.+||.+||.+|||++|+++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01123578999999999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=424.56 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=225.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++++.||+|+||.||+|.++.+|+.||+|+++.... ......+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 579999999999999999999999999999999986543 3456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC---CcEEEeccCcccccccCCC
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR---GAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~---g~vKL~DFGla~~~~~~~~ 166 (636)
||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 109 ~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~- 185 (362)
T 2bdw_A 109 LVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185 (362)
T ss_dssp CCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence 99999999998764 579999999999999999999999999999999999999754 459999999997653221
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.........+.... ..+....+..++++
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~ 260 (362)
T 2bdw_A 186 ---AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-YDYPSPEWDTVTPE 260 (362)
T ss_dssp ---SCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTGGGGSCHH
T ss_pred ---ccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCcccccCCCHH
Confidence 2345789999999999976 679999999999999999999999999887766665554432 23333445678999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
+++||.+||.+||.+||++.++|+||||..
T Consensus 261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 261 AKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=438.53 Aligned_cols=264 Identities=25% Similarity=0.429 Sum_probs=228.3
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
.....++|++++.||+|+||+||+|.++.+|+.||+|++...... .....+.+|+.+|+.++||||++++++|.+++.+
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 334457899999999999999999999999999999999866533 3456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc---cCCcEEEeccCccccc
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID---VRGAIKLGDFGVSACL 161 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld---~~g~vKL~DFGla~~~ 161 (636)
|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 86 ~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999999876 6799999999999999999999999999999999999998 4578999999999765
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.........+.... ..+..+.+.
T Consensus 164 ~~~~---~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~ 238 (444)
T 3soa_A 164 EGEQ---QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA-YDFPSPEWD 238 (444)
T ss_dssp CTTC---CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCTTTTT
T ss_pred cCCC---ceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-CCCCccccc
Confidence 3222 22346789999999999976 679999999999999999999999999888777666555443 333334456
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
.+++++++||.+||.+||.+|||+.++|+||||+.
T Consensus 239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 78999999999999999999999999999999974
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=417.37 Aligned_cols=268 Identities=25% Similarity=0.379 Sum_probs=212.7
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
..++|++++.||+|+||+||+|.++.+|+.||||+++..........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 45789999999999999999999999999999999987665555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 89 PFMSGGSCLHILKAAY----PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~----~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|||+ |+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9998 59999987642 235899999999999999999999999999999999999999999999999998765322
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CCCCC------
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLD------ 236 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~--~~~~~------ 236 (636)
. ......+||+.|+|||++.+...|+.++|||||||++|+|++|..||.+......+..+.... +....
T Consensus 162 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 162 V---NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp C---CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred c---ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 1 123456899999999999875678999999999999999999999999888777665554311 10000
Q ss_pred ---------------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 237 ---------------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 237 ---------------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
......++.++++||.+||..||.+|||+.++++||||++....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 00112578899999999999999999999999999999976543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=419.46 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=226.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++++.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+|+.++||||+++++++.+...+|+|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 57999999999999999999999999999999998643 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc--CCcEEEeccCcccccccCCCc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV--RGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~--~g~vKL~DFGla~~~~~~~~~ 167 (636)
||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+....
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-- 158 (321)
T 1tki_A 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred eCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence 99999999999653 246999999999999999999999999999999999999986 7899999999997653221
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+.... ..+....+..++.++
T Consensus 159 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE-YTFDEEAFKEISIEA 234 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCHHHHTTSCHHH
T ss_pred --ccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC-CCCChhhhccCCHHH
Confidence 2345689999999999976 568999999999999999999999999888777666555443 233333445789999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
++||.+||..||.+|||+.++++||||+..
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999999854
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=416.89 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=227.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-----hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-----SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-----~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+|+.++||||++++++|.++..+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 46799999999999999999999999999999999765432 2467899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC----cEEEeccCcccc
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG----AIKLGDFGVSAC 160 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g----~vKL~DFGla~~ 160 (636)
|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999999764 6799999999999999999999999999999999999998877 899999999976
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
+.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+......+..+.... ..+.....
T Consensus 168 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 241 (326)
T 2y0a_A 168 IDFGN----EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN-YEFEDEYF 241 (326)
T ss_dssp CCTTS----CCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC-CCCCHHHH
T ss_pred CCCCC----ccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC-CCcCcccc
Confidence 53221 2335689999999999976 679999999999999999999999999887766665544432 22333334
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
..++..+++||.+||..||.+|||+.++++||||+....
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 578899999999999999999999999999999986543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=429.92 Aligned_cols=264 Identities=27% Similarity=0.416 Sum_probs=222.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHH-HHhCCCCCcceeeeEEEeCCeE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQT-MILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~i-L~~L~HPNIVkl~~~~~~~~~l 84 (636)
+..++|++++.||+|+||.||+|.++.+++.||||+++.... ......+.+|..+ ++.++||||++++++|.+...+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 456899999999999999999999999999999999976542 2334566778777 4678999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999999886 67999999999999999999999999999999999999999999999999999754332
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
. ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.........++.... ..+..++
T Consensus 193 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~~ 263 (373)
T 2r5t_A 193 N---STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-----QLKPNIT 263 (373)
T ss_dssp C---CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-----CCCSSSC
T ss_pred C---CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-----CCCCCCC
Confidence 2 22457899999999999986 6799999999999999999999999998887777666665422 2235689
Q ss_pred HHHHHHHHhhcccCCCCCCCH----HHHHhCcccccccChHH
Q 006664 245 KSFKQMIASCLVKDPSKRPSA----KKLLKHSFFKQARSNEY 282 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa----~elL~Hpffk~~~~~~~ 282 (636)
.++++||.+||.+||.+||++ .++++||||+.+.+...
T Consensus 264 ~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l 305 (373)
T 2r5t_A 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL 305 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence 999999999999999999986 79999999998876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=422.79 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=222.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++++.||+|+||+||+|.+..+++.||||++.........+.+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 47999999999999999999999999999999999766554455678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ...
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-RER 162 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT-EEC
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC-ccc
Confidence 99999999998754 569999999999999999999999999999999999999999999999999997553222 223
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||.................. .......++..+.+
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 240 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLA 240 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TSTTGGGSCHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cCCccccCCHHHHH
Confidence 3456789999999999987444578999999999999999999999876554333333332221 22334678999999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
||.+||..||.+|||+.|+++||||+..
T Consensus 241 li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHccCChhhCcCHHHHhhChhhccc
Confidence 9999999999999999999999999854
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=413.64 Aligned_cols=266 Identities=27% Similarity=0.390 Sum_probs=219.6
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
....++|++++.||+|+||+||+|.+. +|+.||+|++...... .....+.+|+.+++.++||||+++++++.++..+|
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 345689999999999999999999985 5999999999755433 23567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+|||||.| +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 96 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 172 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP- 172 (311)
T ss_dssp EEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-
T ss_pred EEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-
Confidence 99999985 888888764 356999999999999999999999999999999999999999999999999999765322
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--CCCCCCc------
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN--APPGLDY------ 237 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~--~~~~~~~------ 237 (636)
.......+||+.|+|||++.+...|+.++|||||||++|+|++|..||.+....+.+..+... .+....+
T Consensus 173 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 --VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp --CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred --cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 122345689999999999987667899999999999999999999999877665555444331 1111110
Q ss_pred -----------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 238 -----------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 238 -----------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.....+++++++||.+||.+||.+|||+.|+++||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 01234678999999999999999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=430.88 Aligned_cols=268 Identities=25% Similarity=0.450 Sum_probs=229.3
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
...+..++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||++++++|.+..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45677899999999999999999999999999999999997543 2234677899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999999999875 679999999999999999999999999999999999999999999999999997653
Q ss_pred cCCCcccccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCCC--hHHHHHHHHhcCCCCCCcc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYP--PMKVLLMTLQNAPPGLDYE 238 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~--~~~~l~~~~~~~~~~~~~~ 238 (636)
.. ....+.+||+.|+|||++.+ ...|+.++|||||||++|+|++|..||.... ........+..... .
T Consensus 167 ~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----~ 238 (384)
T 4fr4_A 167 RE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV----T 238 (384)
T ss_dssp TT----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC----C
T ss_pred CC----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc----C
Confidence 22 22456799999999999964 2458999999999999999999999997432 22222233332222 2
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCC-HHHHHhCcccccccChHH
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPS-AKKLLKHSFFKQARSNEY 282 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRps-a~elL~Hpffk~~~~~~~ 282 (636)
.+..++..+.+||.+||.+||.+||+ ++++++||||+.+.+...
T Consensus 239 ~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~ 283 (384)
T 4fr4_A 239 YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV 283 (384)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHH
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHH
Confidence 34568999999999999999999998 999999999998876544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=423.63 Aligned_cols=262 Identities=28% Similarity=0.471 Sum_probs=221.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC----CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER----DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~----~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
.++|++++.||+|+||+||+|.++.+|+.||||+++... .....+.+.+|+.+++.++||||++++++|.+++.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 468999999999999999999999999999999996432 1224677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc---EEEeccCcccc
Q 006664 86 VVMPFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA---IKLGDFGVSAC 160 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~---vKL~DFGla~~ 160 (636)
+|||||+||+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999887653 2235899999999999999999999999999999999999986554 99999999976
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
+.... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.. ......+.. .........+
T Consensus 183 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~-~~~~~~~~~~ 256 (351)
T 3c0i_A 183 LGESG---LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIK-GKYKMNPRQW 256 (351)
T ss_dssp CCTTS---CBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHH-TCCCCCHHHH
T ss_pred ecCCC---eeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHc-CCCCCCcccc
Confidence 53322 22346689999999999986 578999999999999999999999998743 333333333 2223333334
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
..++.++++||.+||.+||.+|||+.++++||||+..
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 5789999999999999999999999999999999753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=407.26 Aligned_cols=260 Identities=26% Similarity=0.422 Sum_probs=217.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++++.||+|+||+||+|.+ .+|+.||+|++...... .....+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999998 68999999999765432 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~ 155 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---R 155 (288)
T ss_dssp CCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc---c
Confidence 9986 899988764 3579999999999999999999999999999999999999999999999999987542211 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CCCCCc----------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLDY---------- 237 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~--~~~~~~---------- 237 (636)
.....+||+.|+|||++.+...|+.++|||||||++|+|++|..||.+....+.+..+.... +....+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 23356899999999999875678999999999999999999999999888777665554321 100000
Q ss_pred ------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 238 ------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 238 ------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
.....++.++++||.+||..||.+|||+.++++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012357899999999999999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=436.70 Aligned_cols=264 Identities=27% Similarity=0.428 Sum_probs=221.1
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
..+..++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||++++++|.+.+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 4456689999999999999999999999999999999997542 23345667889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+...
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999999999876 679999999999999999999998 999999999999999999999999999987543
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+..... ..+..
T Consensus 301 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~~p~~ 371 (446)
T 4ejn_A 301 KDG---ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-----RFPRT 371 (446)
T ss_dssp C--------CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTT
T ss_pred CCC---cccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-----CCCcc
Confidence 222 22346789999999999976 6799999999999999999999999998887776666554432 23456
Q ss_pred hhHHHHHHHHhhcccCCCCCC-----CHHHHHhCcccccccCh
Q 006664 243 FSKSFKQMIASCLVKDPSKRP-----SAKKLLKHSFFKQARSN 280 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~ 280 (636)
+++++++||.+||.+||.+|| ++.++++||||....+.
T Consensus 372 ~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 899999999999999999999 99999999999987544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=440.58 Aligned_cols=272 Identities=24% Similarity=0.428 Sum_probs=231.1
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+.+..++|++++.||+|+||+||+|.++.+++.||||+++.... ......+.+|+.++..++||||++++++|.++..
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 34667899999999999999999999999999999999975321 1123347899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|||||.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 99999999999999999863 36799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCcccccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcc-
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE- 238 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~- 238 (636)
.+. ......+||+.|||||++.. ...|+.++|||||||++|||++|+.||.+....+....++.... .+.++
T Consensus 228 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~ 304 (437)
T 4aw2_A 228 DGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-RFQFPT 304 (437)
T ss_dssp TSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-HCCCCS
T ss_pred CCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc-cccCCc
Confidence 322 22345789999999999973 34589999999999999999999999999888777766654211 01111
Q ss_pred cchhhhHHHHHHHHhhcccCCCC--CCCHHHHHhCcccccccChH
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSK--RPSAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~k--Rpsa~elL~Hpffk~~~~~~ 281 (636)
....+++++++||.+||..+|++ |++++|+++||||+.+.+..
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 12458999999999999999988 99999999999999887653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=423.01 Aligned_cols=260 Identities=27% Similarity=0.377 Sum_probs=209.9
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
....++|++++.||+|+||+||+|.+..+|+.||||++..... ....+.+|+.+++.++||||+++++++.++..+|+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 4457899999999999999999999999999999999975433 23568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc--EEEeccCcccccccC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA--IKLGDFGVSACLFDS 164 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~--vKL~DFGla~~~~~~ 164 (636)
|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 94 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 94 IMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999999999876 67999999999999999999999999999999999999987665 999999998743221
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH----HHHHHHHhcCCCCCCcccc
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM----KVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~----~~l~~~~~~~~~~~~~~~~ 240 (636)
......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.... ..+..+... ....+..
T Consensus 172 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~ 244 (361)
T 3uc3_A 172 ----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV---KYSIPDD 244 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT---CCCCCTT
T ss_pred ----CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC---CCCCCCc
Confidence 12345689999999999987433344599999999999999999999864432 222222221 2233344
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
..+++++++||.+||.+||.+|||+.++++||||...
T Consensus 245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 5689999999999999999999999999999999654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=435.97 Aligned_cols=271 Identities=24% Similarity=0.399 Sum_probs=229.0
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+.+..++|++++.||+|+||+||+|.++.+|+.||||+++... .......+.+|+.++..++||||++++++|.++..
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 4567799999999999999999999999999999999997432 11234457899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|||||.||+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+..
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999999999999998752 4799999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccCCCCCCChhhhhh------ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQ------LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~------~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
.+. ......+||+.|+|||++.. ...|+.++|||||||++|||++|+.||.+....+....+...... +.+
T Consensus 215 ~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~~~ 291 (412)
T 2vd5_A 215 DGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH-LSL 291 (412)
T ss_dssp TSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-CCC
T ss_pred CCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-cCC
Confidence 221 12345789999999999974 245899999999999999999999999988877766666542110 111
Q ss_pred c-cchhhhHHHHHHHHhhcccCCCCC---CCHHHHHhCcccccccChH
Q 006664 238 E-RDRKFSKSFKQMIASCLVKDPSKR---PSAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 238 ~-~~~~~S~~l~dLI~~cL~~DP~kR---psa~elL~Hpffk~~~~~~ 281 (636)
+ ....+|.++++||.+||. +|.+| |+++++++||||+.+.+..
T Consensus 292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 1 135689999999999999 99998 5999999999999887653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=408.78 Aligned_cols=267 Identities=25% Similarity=0.377 Sum_probs=218.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
.++|++++.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 47899999999999999999999999999999998655433 23566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
|||.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--- 156 (311)
T ss_dssp ECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc---
Confidence 999999999888754 679999999999999999999999999999999999999999999999999997653222
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC---------------
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--------------- 233 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~--------------- 233 (636)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 12345689999999999987667899999999999999999999999988776665443321100
Q ss_pred -CCCc----------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccChH
Q 006664 234 -GLDY----------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 234 -~~~~----------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~ 281 (636)
.... .....++..+.+||.+||.+||.+|||+.++++||||++.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 0000 01145788999999999999999999999999999999876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=402.16 Aligned_cols=260 Identities=28% Similarity=0.480 Sum_probs=219.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|.+.+.||+|+||+||+|.+..++..||+|++...........+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 37899999999999999999999999999999999877666667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE---ccCCcEEEeccCcccccccC
Q 006664 90 FMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI---DVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 90 y~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl---d~~g~vKL~DFGla~~~~~~ 164 (636)
||+||+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999999988653 23569999999999999999999999999999999999999 45678999999999754322
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..............+ ... .....++
T Consensus 181 ----~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~-~~~~~~~ 252 (285)
T 3is5_A 181 ----EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP-NYA-VECRPLT 252 (285)
T ss_dssp ----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCC-C--CCCC
T ss_pred ----ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc-ccc-cccCcCC
Confidence 12345689999999999864 689999999999999999999999998877665554443322 221 1223478
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+++.+||.+||..||.+|||+.|+++||||+++
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 999999999999999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=425.34 Aligned_cols=265 Identities=25% Similarity=0.389 Sum_probs=212.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCC--eEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDH--NLW 85 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~--~l~ 85 (636)
.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.+. ||||++++++|..++ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 478999999999999999999999999999999986443 3345677889999999997 999999999998654 799
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+|||||. |+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 88 lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 9999998 589999976 479999999999999999999999999999999999999999999999999997653211
Q ss_pred ------------------CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 006664 166 ------------------DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT 227 (636)
Q Consensus 166 ------------------~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~ 227 (636)
.........+||+.|+|||++.+...|+.++|||||||++|||++|++||.+......+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 01122345789999999999987677999999999999999999999999998887777665
Q ss_pred HhcCCCCCC--------------------------------c----------ccchhhhHHHHHHHHhhcccCCCCCCCH
Q 006664 228 LQNAPPGLD--------------------------------Y----------ERDRKFSKSFKQMIASCLVKDPSKRPSA 265 (636)
Q Consensus 228 ~~~~~~~~~--------------------------------~----------~~~~~~S~~l~dLI~~cL~~DP~kRpsa 265 (636)
+........ + .....+++++.+||.+||.+||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 432111000 0 0011568899999999999999999999
Q ss_pred HHHHhCccccccc
Q 006664 266 KKLLKHSFFKQAR 278 (636)
Q Consensus 266 ~elL~Hpffk~~~ 278 (636)
.|+|+||||+...
T Consensus 324 ~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 324 NDALKHPFVSIFH 336 (388)
T ss_dssp HHHTTSTTTTTTC
T ss_pred HHHhCCHHHHHhc
Confidence 9999999998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=409.27 Aligned_cols=277 Identities=53% Similarity=0.954 Sum_probs=207.3
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
..|.+..++|++++.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.++||||+++++++..+..
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 35788899999999999999999999999999999999999766555556778899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCc
Q 006664 84 LWVVMPFMSGGSCLHILKAA------YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
.|+||||+.||+|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999999999752 235689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC--cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 006664 158 SACLFDSGD--RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 235 (636)
Q Consensus 158 a~~~~~~~~--~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~ 235 (636)
+......+. .........||+.|+|||++.+...++.++|||||||++|+|++|..||.................+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 876533221 112234568999999999997656789999999999999999999999998887776666655544332
Q ss_pred Cc-----ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 236 DY-----ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 236 ~~-----~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
.. .....++.++++||.+||..||.+||++.++++||||+.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 21 2235678999999999999999999999999999999876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=409.39 Aligned_cols=259 Identities=27% Similarity=0.455 Sum_probs=216.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-------------------------hhHHHHHHHHHH
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-------------------------SDLSNISREAQT 62 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-------------------------~~~~~i~rEi~i 62 (636)
+..++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 4568999999999999999999999999999999999754311 123568899999
Q ss_pred HHhCCCCCcceeeeEEEe--CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcc
Q 006664 63 MILVDHPNVLKSHCSFVS--DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSG 140 (636)
Q Consensus 63 L~~L~HPNIVkl~~~~~~--~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~ 140 (636)
++.++||||+++++++.+ +..+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999999987 5789999999999999876532 57999999999999999999999999999999999
Q ss_pred cEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccC--CCcccchhhHHHHHHHHHcCCCCCCCC
Q 006664 141 NILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHG--YDFKADIWSFGITALELAHGHAPFSKY 218 (636)
Q Consensus 141 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~--ys~ksDIWSLGiiLyeLltG~~PF~~~ 218 (636)
|||++.++.+||+|||++..+.... ......+||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HEEECCCCCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999997653322 12345689999999999976332 477899999999999999999999887
Q ss_pred ChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 219 PPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 219 ~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
........+.... ..++....+++++++||.+||.+||.+||++.++++||||+
T Consensus 244 ~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 244 RIMCLHSKIKSQA---LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SHHHHHHHHHHCC---CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred cHHHHHHHHhccc---CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 7665544443332 22333457899999999999999999999999999999996
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=413.58 Aligned_cols=265 Identities=21% Similarity=0.344 Sum_probs=216.0
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
..++|++++.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 457899999999999999999999999999999999765432 2345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc-----cCCcEEEeccCcccccc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID-----VRGAIKLGDFGVSACLF 162 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld-----~~g~vKL~DFGla~~~~ 162 (636)
||||.| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++..+.
T Consensus 112 ~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 999985 999999876 5699999999999999999999999999999999999994 45569999999987653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC--CCCCcc--
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP--PGLDYE-- 238 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~--~~~~~~-- 238 (636)
.. .......+||+.|+|||++.+...|+.++|||||||++|+|++|..||.+....+.+..+..... ....+.
T Consensus 189 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 189 IP---IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp --------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred Cc---ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 22 12234568999999999998766689999999999999999999999999888777766554211 110000
Q ss_pred ---------------------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 239 ---------------------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 239 ---------------------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
....++.++++||.+||.+||.+|||+.|+++||||+...+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 01227889999999999999999999999999999997654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=405.91 Aligned_cols=264 Identities=27% Similarity=0.381 Sum_probs=217.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC----chhHHHHHHHHHHHHhC---CCCCcceeeeEEEe
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD----NSDLSNISREAQTMILV---DHPNVLKSHCSFVS 80 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~----~~~~~~i~rEi~iL~~L---~HPNIVkl~~~~~~ 80 (636)
+..++|++++.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 456899999999999999999999999999999999975432 11234567888887766 49999999999988
Q ss_pred CC-----eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEecc
Q 006664 81 DH-----NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDF 155 (636)
Q Consensus 81 ~~-----~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DF 155 (636)
.. .+++||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 5899999997 59999998875556999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CC
Q 006664 156 GVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PP 233 (636)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~--~~ 233 (636)
|++...... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+......+..+.... ++
T Consensus 165 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 165 GLARIYSYQ----MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp SCTTTSTTC----CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccCCC----cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999754222 22346789999999999987 679999999999999999999999999988877766655421 11
Q ss_pred CCCc--------------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 234 GLDY--------------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 234 ~~~~--------------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
...+ .....++..+.+||.+||.+||.+|||+.++|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 1111 0123578899999999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=417.29 Aligned_cols=261 Identities=24% Similarity=0.403 Sum_probs=210.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
...++|++.+.||+|+||+||+|.+..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 34567999999999999999999999999999999997543 345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc---CCcEEEeccCcccccccC
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---RGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---~g~vKL~DFGla~~~~~~ 164 (636)
|||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 127 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp ECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999999764 56999999999999999999999999999999999999975 889999999998754221
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+..........+.........+.+..++
T Consensus 205 ----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 205 ----VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp ------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ----cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 12345789999999999986 5789999999999999999999999987766654444444443333333446789
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.++++||.+||..||.+|||+.++++||||....
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999999999998654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=420.73 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=218.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
.++|.+++.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3789999999999999999999999999999999974321 12345789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+ +|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--- 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--- 161 (336)
T ss_dssp ECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---
T ss_pred EECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC---
Confidence 9999 78999999876 67999999999999999999999999999999999999999999999999998765322
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
....+.+||+.|+|||++.+...+++++|||||||++|+|++|..||.+....... .......+..+..+++++
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----~~i~~~~~~~p~~~s~~~ 235 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----KKVNSCVYVMPDFLSPGA 235 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----CCCCSSCCCCCTTSCHHH
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----HHHHcCCCCCcccCCHHH
Confidence 22356789999999999987444578999999999999999999999764432211 111111233456789999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
++||.+||..||.+|||+.|+++||||+..
T Consensus 236 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 236 QSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 999999999999999999999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=395.49 Aligned_cols=262 Identities=26% Similarity=0.443 Sum_probs=228.0
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.++...|+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3589999999999999999999999999999999997654 334567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc---EEEeccCcccccccC
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA---IKLGDFGVSACLFDS 164 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~---vKL~DFGla~~~~~~ 164 (636)
|||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999998876 67999999999999999999999999999999999999976654 999999998755322
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.... ..........++
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (284)
T 3kk8_A 162 E----AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-YDYPSPEWDTVT 235 (284)
T ss_dssp C----BCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTTTTTSC
T ss_pred c----cccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc-ccCCchhhcccC
Confidence 1 2245689999999999986 678999999999999999999999999887766655554432 223333446789
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+++.+||.+||..||.+|||+.++++||||+...
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 9999999999999999999999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=431.41 Aligned_cols=268 Identities=25% Similarity=0.350 Sum_probs=203.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC-----Ce
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD-----HN 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-----~~ 83 (636)
.++|++++.||+|+||+||+|.++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999999999999999996543 234567889999999999999999999999543 57
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+..
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 999999985 6899999764 6799999999999999999999999999999999999999999999999999986532
Q ss_pred CCCc------------------------ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc---------
Q 006664 164 SGDR------------------------QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH--------- 210 (636)
Q Consensus 164 ~~~~------------------------~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt--------- 210 (636)
.... .......+||++|+|||++.....|+.++||||||||+|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 2110 1123567899999999988665779999999999999999998
Q ss_pred --CCCCCCCCCh--------------------HHHHHHHHh--cCC---------------------CC--C-Ccccchh
Q 006664 211 --GHAPFSKYPP--------------------MKVLLMTLQ--NAP---------------------PG--L-DYERDRK 242 (636)
Q Consensus 211 --G~~PF~~~~~--------------------~~~l~~~~~--~~~---------------------~~--~-~~~~~~~ 242 (636)
|.++|.+... .+.+..+.. ..+ .. . .......
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 7777766431 111111111 000 00 0 0112245
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
++.++++||.+||.+||.+|||++|+|+||||+.+...
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 68999999999999999999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=417.51 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=217.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVm 88 (636)
.++|++++.||+|+||.||+|.++.+|+.||||+++..... ..+|+.++..+ +||||++++++|.++..+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46799999999999999999999999999999999765432 34688888877 7999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC----CcEEEeccCcccccccC
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR----GAIKLGDFGVSACLFDS 164 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~----g~vKL~DFGla~~~~~~ 164 (636)
|||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+... +.+||+|||++..+...
T Consensus 96 E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 999999999999865 679999999999999999999999999999999999998432 35999999999765332
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC--hHHHHHHHHhcCCCCCCcccchh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP--PMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~--~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
. ....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.. ....+...+......+....+..
T Consensus 174 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 174 N---GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp T---CCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred C---CceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 2 12346789999999999986 568999999999999999999999997632 22233333333333333334567
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+++++++||.+||..||.+||++.++++||||...
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 89999999999999999999999999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=405.38 Aligned_cols=259 Identities=34% Similarity=0.582 Sum_probs=226.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEecc
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFM 91 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy~ 91 (636)
.|...+.||+|+||.||+|.+..+|+.||||+++.... ...+.+.+|+.+++.++||||+++++++..+..+|+||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 48899999999999999999999999999999975443 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccc
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 171 (636)
.||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 125 ~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~ 198 (321)
T 2c30_A 125 QGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---PKR 198 (321)
T ss_dssp CSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS---CCB
T ss_pred CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc---ccc
Confidence 99999999864 469999999999999999999999999999999999999999999999999987653322 123
Q ss_pred ccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHH
Q 006664 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251 (636)
Q Consensus 172 ~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI 251 (636)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....+.+ .....+++.+++||
T Consensus 199 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 275 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL--KNSHKVSPVLRDFL 275 (321)
T ss_dssp CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC--TTGGGSCHHHHHHH
T ss_pred ccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc--CccccCCHHHHHHH
Confidence 46789999999999976 6789999999999999999999999998887776665555443332 23456889999999
Q ss_pred HhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 252 ASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 252 ~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
.+||..||.+|||+.++++||||......
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 304 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHPFLLQTGLP 304 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred HHHccCChhhCcCHHHHhcChhhccCCCc
Confidence 99999999999999999999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=414.49 Aligned_cols=263 Identities=22% Similarity=0.371 Sum_probs=215.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
++|.+++.||+|+||+||+|.+..+++.||||++...........+.+|+.+++.++||||+++++++.++..+|+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999999999999999997554333333456799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
|.| +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~ 156 (324)
T 3mtl_A 82 LDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKT 156 (324)
T ss_dssp CSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred ccc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC---ccc
Confidence 985 899988775 356999999999999999999999999999999999999999999999999998754322 122
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CCCCCc-----------
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLDY----------- 237 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~--~~~~~~----------- 237 (636)
....+||+.|+|||++.+...|+.++|||||||++|+|++|..||.+....+.+..+.... +....+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 3456899999999999876678999999999999999999999999988777665554421 111100
Q ss_pred ------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 238 ------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 238 ------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.....++.++++||.+||.+||.+|||+.|+++||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 11235788999999999999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=405.20 Aligned_cols=266 Identities=28% Similarity=0.433 Sum_probs=214.4
Q ss_pred CCCeEEE-eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEE
Q 006664 10 AEHYTLY-EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 10 ~~~Y~l~-~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iV 87 (636)
.++|++. +.||+|+||+||+|.+..+++.||||++.... ......+.+|+.+++.+ +||||+++++++.+++.+|+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 4689995 78999999999999999999999999997543 33467789999999884 799999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc---EEEeccCcccccccC
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA---IKLGDFGVSACLFDS 164 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~---vKL~DFGla~~~~~~ 164 (636)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 9999999999999886 57999999999999999999999999999999999999987765 999999998755322
Q ss_pred CCc----ccccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCh--------------HH
Q 006664 165 GDR----QRMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPP--------------MK 222 (636)
Q Consensus 165 ~~~----~~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~--------------~~ 222 (636)
+.. .......+||+.|+|||++.+ ...|+.++|||||||++|+|++|..||.+... ..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 211 112235579999999999974 23488999999999999999999999976532 12
Q ss_pred HHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 223 VLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 223 ~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.+...+......+.......++..+++||.+||..||.+|||+.++++||||+...
T Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 23333333333333233356889999999999999999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=410.60 Aligned_cols=260 Identities=28% Similarity=0.377 Sum_probs=219.8
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-----CCCcceeeeEEEe
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-----HPNVLKSHCSFVS 80 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-----HPNIVkl~~~~~~ 80 (636)
..+..++|++++.||+|+||+||+|.+..+++.||||++.. .........+|+.+++.+. ||||+++++++..
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 34557899999999999999999999999999999999863 2334566788999999886 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc--------------
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-------------- 146 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-------------- 146 (636)
...+|+||||+ |++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 899999999876567999999999999999999999999999999999999975
Q ss_pred -----------CCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCC
Q 006664 147 -----------RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF 215 (636)
Q Consensus 147 -----------~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF 215 (636)
++.+||+|||++..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD------YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS------CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccCCCCEEEEeccCceecCC------CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCC
Confidence 78999999999975322 1245689999999999987 67999999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCC-----------------------cc------------------cchhhhHHHHHHHHhh
Q 006664 216 SKYPPMKVLLMTLQNAPPGLD-----------------------YE------------------RDRKFSKSFKQMIASC 254 (636)
Q Consensus 216 ~~~~~~~~l~~~~~~~~~~~~-----------------------~~------------------~~~~~S~~l~dLI~~c 254 (636)
......+.+..+.....+... ++ .....++.+.+||.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 987776665444332211100 00 0011237788999999
Q ss_pred cccCCCCCCCHHHHHhCcccc
Q 006664 255 LVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 255 L~~DP~kRpsa~elL~Hpffk 275 (636)
|..||.+|||+.|+|+||||+
T Consensus 340 L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCSSGGGSCCHHHHTTSGGGC
T ss_pred hcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999995
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=431.45 Aligned_cols=260 Identities=29% Similarity=0.472 Sum_probs=227.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
.++|++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 378999999999999999999999999999999996543 2234677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc---cCCcEEEeccCcccccccCC
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID---VRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld---~~g~vKL~DFGla~~~~~~~ 165 (636)
|||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+...
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 999999999999876 6799999999999999999999999999999999999995 4567999999999765322
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+....+.+..+... ...+..+.+..+|+
T Consensus 178 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 178 ---TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-KYAFDLPQWRTISD 251 (486)
T ss_dssp -------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCSCSGGGGGSCH
T ss_pred ---CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCcccCCCCH
Confidence 12345689999999999975 5999999999999999999999999988887766655543 33344556678999
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++++||.+||.+||.+|||+.++|+||||+...
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 999999999999999999999999999998654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=407.47 Aligned_cols=259 Identities=20% Similarity=0.344 Sum_probs=212.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC--------
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH-------- 82 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~-------- 82 (636)
++|++++.||+|+||.||+|.++.+|+.||||++.........+.+.+|+.+|+.++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 579999999999999999999999999999999987666666788999999999999999999999986643
Q ss_pred -------------------------------------------------eEEEEEeccCCCCHHHHHHHhCC-CCCCHHH
Q 006664 83 -------------------------------------------------NLWVVMPFMSGGSCLHILKAAYP-DGFEEVV 112 (636)
Q Consensus 83 -------------------------------------------------~l~iVmEy~~GGsL~~lL~~~~~-~~lse~~ 112 (636)
.+|+|||||+||+|.+++..... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 38999999999999999987532 2256667
Q ss_pred HHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc---------ccccccccCCCCCCCh
Q 006664 113 IATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR---------QRMRNTFVGTPCWMAP 183 (636)
Q Consensus 113 i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~---------~~~~~~~~GT~~YmAP 183 (636)
++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .......+||+.|+||
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 8999999999999999999999999999999999999999999999866433211 1223456899999999
Q ss_pred hhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCC
Q 006664 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRP 263 (636)
Q Consensus 184 Evl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRp 263 (636)
|++.+ ..|+.++|||||||++|+|++|..|+.. ............ ........++++++||.+||..||.+||
T Consensus 246 E~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 246 EQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLK---FPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp HHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTC---CCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred HHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccC---CCcccccCChhHHHHHHHHccCCCCcCC
Confidence 99986 6799999999999999999998777532 111122222211 1122356678899999999999999999
Q ss_pred CHHHHHhCccccc
Q 006664 264 SAKKLLKHSFFKQ 276 (636)
Q Consensus 264 sa~elL~Hpffk~ 276 (636)
|+.++++||||++
T Consensus 319 s~~~~l~~~~f~~ 331 (332)
T 3qd2_B 319 EATDIIENAIFEN 331 (332)
T ss_dssp CHHHHHHSTTCCC
T ss_pred CHHHHhhchhhhc
Confidence 9999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=429.30 Aligned_cols=261 Identities=28% Similarity=0.422 Sum_probs=230.5
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
..++|++++.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+|+.++||||++++++|.+...+|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34789999999999999999999999999999999976542 3456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE---ccCCcEEEeccCccccccc
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI---DVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl---d~~g~vKL~DFGla~~~~~ 163 (636)
|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+..
T Consensus 104 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999999765 679999999999999999999999999999999999999 4678999999999876532
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+......+..+... ...+..+.+..+
T Consensus 182 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 254 (484)
T 3nyv_A 182 SK----KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG-KYTFELPQWKKV 254 (484)
T ss_dssp CC----SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCSGGGGGS
T ss_pred cc----ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-CCCCCCcccccC
Confidence 21 2345689999999999976 6999999999999999999999999998887776665544 333445566789
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++++++||.+||.+||.+|||+.++|+||||+...
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 99999999999999999999999999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=405.44 Aligned_cols=264 Identities=25% Similarity=0.386 Sum_probs=228.5
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-----hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-----SDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-----~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
..++|++++.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||+++++++.++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 356899999999999999999999999999999999765432 136778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC----cEEEeccCccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG----AIKLGDFGVSA 159 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g----~vKL~DFGla~ 159 (636)
+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999764 6799999999999999999999999999999999999999887 79999999997
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+... ........
T Consensus 168 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~ 241 (321)
T 2a2a_A 168 EIEDGV----EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-SYDFDEEF 241 (321)
T ss_dssp ECCTTC----CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-CCCCCHHH
T ss_pred ecCccc----cccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-ccccChhh
Confidence 653321 2245679999999999976 67899999999999999999999999988776665554433 22233233
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
...++..+++||.+||..||.+|||+.++++||||......
T Consensus 242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~ 282 (321)
T 2a2a_A 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282 (321)
T ss_dssp HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence 45688999999999999999999999999999999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=396.96 Aligned_cols=258 Identities=25% Similarity=0.386 Sum_probs=222.7
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
....++|++++.||+|+||+||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 4456999999999999999999999999999999999964331 12356788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999999999886 67999999999999999999999999999999999999999999999999988543221
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+..... ..+..++
T Consensus 163 -----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~ 231 (279)
T 3fdn_A 163 -----RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVT 231 (279)
T ss_dssp ----------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----CCCTTSC
T ss_pred -----cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-----CCCCcCC
Confidence 2345689999999999976 6789999999999999999999999998777666555443321 2345688
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
..+++||.+||..||.+||++.++++||||+..
T Consensus 232 ~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 232 EGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 999999999999999999999999999999854
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=430.39 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=225.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc------------hhHHHHHHHHHHHHhCCCCCcceeeeE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN------------SDLSNISREAQTMILVDHPNVLKSHCS 77 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~------------~~~~~i~rEi~iL~~L~HPNIVkl~~~ 77 (636)
.++|.+++.||+|+||+||+|.++.+++.||||++...... .....+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 57899999999999999999999999999999999754321 335678999999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC---cEEEec
Q 006664 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGD 154 (636)
Q Consensus 78 ~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g---~vKL~D 154 (636)
|.++..+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999999876 6799999999999999999999999999999999999998776 699999
Q ss_pred cCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 006664 155 FGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 234 (636)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~ 234 (636)
||++..+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+......+..+... ...
T Consensus 193 fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~ 265 (504)
T 3q5i_A 193 FGLSSFFSKD----YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG-KYY 265 (504)
T ss_dssp CTTCEECCTT----SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCC
T ss_pred CCCCEEcCCC----CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCC
Confidence 9999765322 12345689999999999874 6899999999999999999999999998877766555543 333
Q ss_pred CCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 235 ~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+....+..+++++++||.+||.+||.+|||+.++|+||||+...
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 44455577899999999999999999999999999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=392.95 Aligned_cols=257 Identities=28% Similarity=0.409 Sum_probs=225.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3679999999999999999999999999999999975433 346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE---ccCCcEEEeccCcccccccCCC
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI---DVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl---d~~g~vKL~DFGla~~~~~~~~ 166 (636)
|++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 87 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 87 LCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp CCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred ccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 99999999999876 679999999999999999999999999999999999999 788999999999987653221
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+..... .........+++.
T Consensus 164 ---~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 164 ---MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF-TFPEKDWLNVSPQ 237 (277)
T ss_dssp ---CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCHHHHTTSCHH
T ss_pred ---chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCchhhhcCCHH
Confidence 2345689999999999875 489999999999999999999999998877766655554432 2222233468999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
+.+||.+||..||.+||++.++++||||+.
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 999999999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=430.29 Aligned_cols=258 Identities=30% Similarity=0.468 Sum_probs=222.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++++.||+|+||+||+|.++.++..||||++..... ......+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 479999999999999999999999999999999976542 2345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC---CcEEEeccCcccccccCCC
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR---GAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~---g~vKL~DFGla~~~~~~~~ 166 (636)
||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++..+...
T Consensus 117 ~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-- 192 (494)
T 3lij_A 117 CYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-- 192 (494)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--
Confidence 99999999999876 679999999999999999999999999999999999999754 55999999999765322
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+......+..+... ...+..+.+..+++.
T Consensus 193 --~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 193 --KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG-KYTFDSPEWKNVSEG 267 (494)
T ss_dssp --BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCCCSGGGTTSCHH
T ss_pred --ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCchhcccCCHH
Confidence 12346789999999999864 6999999999999999999999999998887766655544 333444556778999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+++||.+||.+||.+|||+.++|+||||+..
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 9999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=410.32 Aligned_cols=268 Identities=27% Similarity=0.421 Sum_probs=223.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC----CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER----DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~----~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
.++|++++.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.++..+|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 478999999999999999999999999999999997542 2345678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 006664 86 VVMPFMSGGSCLHILKAAY--------------------------------------PDGFEEVVIATILREVLKGLDYL 127 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~--------------------------------------~~~lse~~i~~i~~QIl~aL~yL 127 (636)
+|||||+||+|.+++.... ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999885210 11246788999999999999999
Q ss_pred HHCCCcccccCcccEEEccCC--cEEEeccCcccccccCCC-cccccccccCCCCCCChhhhhhc-cCCCcccchhhHHH
Q 006664 128 HHHGHIHRDVKSGNILIDVRG--AIKLGDFGVSACLFDSGD-RQRMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGI 203 (636)
Q Consensus 128 H~~gIvHRDLKP~NILld~~g--~vKL~DFGla~~~~~~~~-~~~~~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGi 203 (636)
|++||+||||||+|||++.++ .+||+|||++..+..... .........||+.|+|||++.+. ..|+.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998766 899999999986543221 11223466899999999999742 56899999999999
Q ss_pred HHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 204 TALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 204 iLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++|+|++|..||.+....+....+..... .+..+....+++.+++||.+||..||.+||++.++++||||+...
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKL-CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhccc-ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999888777766665433 233344556899999999999999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=432.98 Aligned_cols=260 Identities=28% Similarity=0.444 Sum_probs=227.2
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
.+..++|.+++.||+|+||.||+|.+..+|+.||||+++.... ......+.+|+.+|+.++||||+++++++.+...+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3556899999999999999999999999999999999975431 22456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999999999764 67999999999999999999999999999999999999999999999999999765322
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
....+.+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.........+.... +..+..++
T Consensus 170 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~p~~~s 240 (476)
T 2y94_A 170 ----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-----FYTPQYLN 240 (476)
T ss_dssp ----CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-----CCCCTTCC
T ss_pred ----ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----cCCCccCC
Confidence 123467899999999999874445789999999999999999999999877766655555432 22345688
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+++++||.+||..||.+|||+.++++||||+..
T Consensus 241 ~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 241 PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=428.02 Aligned_cols=260 Identities=24% Similarity=0.376 Sum_probs=213.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC------C
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD------H 82 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~------~ 82 (636)
.++|++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||++++++|... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999999999999999997543 334567789999999999999999999999755 4
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||+++ |.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 141 ~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred eEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 689999999875 666664 358999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC--------
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-------- 234 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~-------- 234 (636)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..++......
T Consensus 216 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 216 TS----FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -C----CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred CC----cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 21 23456799999999999987 679999999999999999999999999988777766554421110
Q ss_pred ----------------CCcc-------------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 235 ----------------LDYE-------------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 235 ----------------~~~~-------------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
..++ .....++++++||.+||.+||.+|||++|+|+||||+....
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 0000 00112678999999999999999999999999999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=422.06 Aligned_cols=269 Identities=24% Similarity=0.323 Sum_probs=214.9
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC-----C
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD-----H 82 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-----~ 82 (636)
..++|++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3689999999999999999999999999999999997543 234567889999999999999999999999876 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+||||+.| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 104 ~~~lv~e~~~~-~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECCSE-EHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecCCc-CHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 79999999974 999999764 679999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCc-------------------ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcC-----------C
Q 006664 163 DSGDR-------------------QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG-----------H 212 (636)
Q Consensus 163 ~~~~~-------------------~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG-----------~ 212 (636)
..... .......+||++|+|||++.....|+.++|||||||++|||++| .
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 32211 01235779999999999986657799999999999999999984 4
Q ss_pred CCCCCCCh-----------------HHHHHHHHh-----------------------cCCCCCCc---ccchhhhHHHHH
Q 006664 213 APFSKYPP-----------------MKVLLMTLQ-----------------------NAPPGLDY---ERDRKFSKSFKQ 249 (636)
Q Consensus 213 ~PF~~~~~-----------------~~~l~~~~~-----------------------~~~~~~~~---~~~~~~S~~l~d 249 (636)
++|.+... ..++..+.. ..+..... .....+++++++
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 44444321 122211111 11100000 112457999999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
||.+||.+||.+|||++|+|+||||+...+.
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 9999999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=417.98 Aligned_cols=261 Identities=24% Similarity=0.419 Sum_probs=226.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++++.||+|+||.||+|.++.+|+.||+|++.... ......+.+|+.+|+.++||||++++++|.++..+|+|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 368999999999999999999999999999999997543 2345578999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc--CCcEEEeccCcccccccCCCc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV--RGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~--~g~vKL~DFGla~~~~~~~~~ 167 (636)
||.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||++..+....
T Consensus 129 ~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-- 205 (387)
T 1kob_A 129 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 205 (387)
T ss_dssp CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred cCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc--
Confidence 99999999998754 246999999999999999999999999999999999999974 4789999999997653221
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+.... ..+.......+++++
T Consensus 206 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD-WEFDEDAFSSVSPEA 281 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC-CCCCSSTTTTSCHHH
T ss_pred --ceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccccccCCHHH
Confidence 2335689999999999976 678999999999999999999999999888777666555432 223333446789999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++||.+||..||.+|||+.++++||||+...
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 9999999999999999999999999998643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=393.08 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=224.3
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEe---
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVS--- 80 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~--- 80 (636)
........|.+.+.||+|+||+||+|.+..++..||+|++.... .......+.+|+.+++.++||||++++++|..
T Consensus 20 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred hcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 34566778999999999999999999999999999999997654 33456778999999999999999999999876
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCcccEEEc-cCCcEEEeccC
Q 006664 81 -DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG--HIHRDVKSGNILID-VRGAIKLGDFG 156 (636)
Q Consensus 81 -~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHRDLKP~NILld-~~g~vKL~DFG 156 (636)
+..+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred CCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 45699999999999999999886 67999999999999999999999999 99999999999997 78999999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 006664 157 VSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 236 (636)
Q Consensus 157 la~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~ 236 (636)
++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||............+..... .
T Consensus 178 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~ 248 (290)
T 1t4h_A 178 LATLKRA-----SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--P 248 (290)
T ss_dssp GGGGCCT-----TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--C
T ss_pred Ccccccc-----cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--c
Confidence 9864322 12345689999999999874 5899999999999999999999999887666665555544322 2
Q ss_pred cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 237 ~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
...+...++++.+||.+||..||.+|||+.++++||||++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 2334567789999999999999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=422.73 Aligned_cols=257 Identities=23% Similarity=0.383 Sum_probs=207.4
Q ss_pred CCCeEEE-eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHH-HhCCCCCcceeeeEEEe----CCe
Q 006664 10 AEHYTLY-EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM-ILVDHPNVLKSHCSFVS----DHN 83 (636)
Q Consensus 10 ~~~Y~l~-~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL-~~L~HPNIVkl~~~~~~----~~~ 83 (636)
.++|.+. +.||+|+||+||+|.++.+|+.||||+++. ...+.+|+.++ +.++||||++++++|.. ...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 3678776 789999999999999999999999999862 24567899987 45689999999999876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc---CCcEEEeccCcccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---RGAIKLGDFGVSAC 160 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---~g~vKL~DFGla~~ 160 (636)
+|+|||||.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999999998754456999999999999999999999999999999999999987 78999999999975
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHH---HHHHHhcCCCCCCc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV---LLMTLQNAPPGLDY 237 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~---l~~~~~~~~~~~~~ 237 (636)
.... ....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+...... ....+......+..
T Consensus 214 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 214 TTSH----NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp CC---------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cCCC----CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 4322 12346789999999999976 6799999999999999999999999976543211 11222222222233
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
..+..++.++++||.+||.+||.+|||+.++++||||...
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 3446789999999999999999999999999999999754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=410.52 Aligned_cols=265 Identities=22% Similarity=0.325 Sum_probs=225.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC-----CeE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD-----HNL 84 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-----~~l 84 (636)
..+|++++.||+|+||.||+|.+..++..||||++...........+.+|+.+++.++||||+++++++... ..+
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 479999999999999999999999999999999997655555567889999999999999999999999765 479
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||+.| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~iv~e~~~~-~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEEECCSE-EHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEcccCc-CHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 999999985 89999976 46999999999999999999999999999999999999999999999999999765433
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC----------
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG---------- 234 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~---------- 234 (636)
..........+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+.......
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 3322334567899999999998776779999999999999999999999999877766655543211100
Q ss_pred ---------------CC-cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 235 ---------------LD-YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 235 ---------------~~-~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.. ......++.++.+||.+||.+||.+|||+.++|+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00 011245688999999999999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=406.02 Aligned_cols=268 Identities=25% Similarity=0.368 Sum_probs=221.9
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
|-...++|++++.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.++..+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 344578999999999999999999999999999999998755433 2345678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 100 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999999888876654 67999999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC----------
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG---------- 234 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~---------- 234 (636)
. ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+.......
T Consensus 178 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 G---EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred c---cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 2 223456899999999999875578999999999999999999999999887766655443211100
Q ss_pred ------CC----------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 235 ------LD----------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 235 ------~~----------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.. ......+++.+.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 00 011235789999999999999999999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=408.16 Aligned_cols=261 Identities=34% Similarity=0.576 Sum_probs=223.6
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
..+..++|++++.||+|+||+||+|.+..+|..||+|++...........+.+|+.+++.++||||+++++++.+++.+|
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 35667899999999999999999999999999999999987666666778999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
+|||||+||+|.+++... ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++..+...
T Consensus 108 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999999999886 5799999999999999999999996 9999999999999999999999999998754322
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHH-----------------
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT----------------- 227 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~----------------- 227 (636)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||............
T Consensus 186 -----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 186 -----MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp -----C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred -----cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 2345689999999999987 67899999999999999999999999876554332111
Q ss_pred -------------------------HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 228 -------------------------LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 228 -------------------------~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.....+ ......++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPP---KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCC---CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCC---CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 111111 11123478899999999999999999999999999999854
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=394.87 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=225.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
++|++++.||+|+||.||+|.+..+++.||||+++........+.+.+|+.+++.++||||+++++++.++...|+||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 68999999999999999999999999999999998666555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+.... ....
T Consensus 87 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-RERL 163 (276)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT-EECC
T ss_pred cCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc-chhc
Confidence 9999999988654 569999999999999999999999999999999999999999999999999987553222 2223
Q ss_pred cccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHH
Q 006664 171 RNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dL 250 (636)
....+||+.|+|||++.+...++.++|||||||++|+|++|..||.................. .......++..+.+|
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLAL 241 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT--TSTTGGGSCHHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc--ccCchhhcCHHHHHH
Confidence 456789999999999976444578899999999999999999999876543333333332221 122345789999999
Q ss_pred HHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 251 IASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 251 I~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
|.+||..||.+|||+.++++||||+...
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHCCCCchhCCCHHHHhcCccccChh
Confidence 9999999999999999999999998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=448.84 Aligned_cols=264 Identities=25% Similarity=0.432 Sum_probs=231.7
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCe
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~ 83 (636)
.+..++|++++.||+|+||+||+|.++.+++.||||++.... .......+.+|..++..+ +||||++++++|.+...
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 355689999999999999999999999999999999997542 223456788999999887 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+||||+.||+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999999887 6799999999999999999999999999999999999999999999999999975433
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.+. ...+++||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+..... ..+..+
T Consensus 495 ~~~---~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~ 565 (674)
T 3pfq_A 495 DGV---TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----AYPKSM 565 (674)
T ss_dssp TTC---CBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-----CCCTTS
T ss_pred CCc---ccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-----CCCccC
Confidence 222 2457899999999999976 6799999999999999999999999999888777777665432 234578
Q ss_pred hHHHHHHHHhhcccCCCCCCCH-----HHHHhCcccccccChH
Q 006664 244 SKSFKQMIASCLVKDPSKRPSA-----KKLLKHSFFKQARSNE 281 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa-----~elL~Hpffk~~~~~~ 281 (636)
++++++||.+||.+||.+||++ ++|++||||+.+.+..
T Consensus 566 s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 9999999999999999999997 9999999999887653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=425.63 Aligned_cols=262 Identities=25% Similarity=0.434 Sum_probs=211.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-------chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-------NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-------~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
.++|.+.+.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++. ..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 4789999999999999999999999999999999975431 112335789999999999999999999975 45
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC---cEEEeccCccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSA 159 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g---~vKL~DFGla~ 159 (636)
.+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 689999999999999988754 6799999999999999999999999999999999999997544 59999999997
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
..... ....+.+||+.|+|||++.+ ...|+.++|||||||++|+|++|..||........+...+.........
T Consensus 291 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 291 ILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp SCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred ecCCC----ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 65322 22346789999999999853 3568889999999999999999999998765444444444444333333
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
..+..++..+.+||.+||..||.+||++.++++||||+...
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 34457899999999999999999999999999999998643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=440.03 Aligned_cols=266 Identities=25% Similarity=0.412 Sum_probs=229.0
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
++..++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+.+|+.++||||++++++|.++..+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 467789999999999999999999999999999999997542 123456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+|||||.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999999998765456999999999999999999999999999999999999999999999999999765322
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh---HHHHHHHHhcCCCCCCcccch
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~---~~~l~~~~~~~~~~~~~~~~~ 241 (636)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||..... ...+...+...+.. .+.
T Consensus 340 ~----~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~----~p~ 410 (576)
T 2acx_A 340 Q----TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE----YSE 410 (576)
T ss_dssp C----CEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC----CCT
T ss_pred c----cccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc----CCc
Confidence 1 2345689999999999986 5799999999999999999999999986532 23333333333322 236
Q ss_pred hhhHHHHHHHHhhcccCCCCCC-----CHHHHHhCcccccccChH
Q 006664 242 KFSKSFKQMIASCLVKDPSKRP-----SAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~~ 281 (636)
.+++++++||.+||.+||.+|| ++.++++||||+.+.+..
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~ 455 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKR 455 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHH
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHH
Confidence 7899999999999999999999 899999999999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=409.89 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=200.3
Q ss_pred CCeEEE---eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEE
Q 006664 11 EHYTLY---EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 11 ~~Y~l~---~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~i 86 (636)
++|++. +.||+|+||+||+|.++.+|+.||||++... ....+.+|+.+++.+. ||||+++++++.++...|+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 467775 7899999999999999999999999999643 3456789999999997 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC---cEEEeccCccccccc
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKLGDFGVSACLFD 163 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g---~vKL~DFGla~~~~~ 163 (636)
|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999999999875 6799999999999999999999999999999999999997665 899999999875432
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh------HHHHHHHHhcCCCCCCc
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP------MKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~------~~~l~~~~~~~~~~~~~ 237 (636)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||..... ...+...+......+..
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 162 DN---QPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237 (325)
T ss_dssp --------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred CC---CcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence 21 22346689999999999976 6799999999999999999999999976432 12233333333333343
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
..+..+++++++||.+||..||.+|||+.++++||||+..
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 4446789999999999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=397.67 Aligned_cols=258 Identities=46% Similarity=0.812 Sum_probs=229.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.+.|++++.||+|+||.||+|.+..+++.||||+++..........+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 46799999999999999999999999999999999877666667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+.... .
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---I 174 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB---C
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc---c
Confidence 9999999999864 579999999999999999999999999999999999999999999999999987653322 2
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....+. ....++..+.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~ 249 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKPLKE 249 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----CCSSCCHHHHH
T ss_pred ccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC----CccccCHHHHH
Confidence 2346689999999999976 678999999999999999999999999888777666555544332 23567899999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
||.+||..||.+|||+.++++||||....
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 99999999999999999999999997543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=411.64 Aligned_cols=260 Identities=27% Similarity=0.372 Sum_probs=216.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC------
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH------ 82 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~------ 82 (636)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 5789999999999999999999999999999999965432 334567899999999999999999999998763
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 8899999986 469999999999999999999999999999999999999999999999999997542
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC--------
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-------- 234 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~-------- 234 (636)
. .....+||+.|+|||++.+...|+.++|||||||++|+|++|+.||.+....+.+..+.......
T Consensus 180 ~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 180 S------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp S------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred c------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 1 13456899999999999876679999999999999999999999999888777665554321100
Q ss_pred -----------------CCc-ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 235 -----------------LDY-ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 235 -----------------~~~-~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
..+ ......++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 000 112356899999999999999999999999999999987643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=405.96 Aligned_cols=265 Identities=25% Similarity=0.402 Sum_probs=219.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC---
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH--- 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~--- 82 (636)
...++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 346899999999999999999999999999999999976532 234567899999999999999999999987654
Q ss_pred -eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 83 -NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 83 -~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 359999999999999999876 57999999999999999999999999999999999999999999999999999766
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
.............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+................. ......
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~ 244 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP-PSARHE 244 (311)
T ss_dssp ---------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-HHHHST
T ss_pred cccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-cccccC
Confidence 444333333445789999999999987 679999999999999999999999999888877766666543322 223345
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
.++.++.+||.+||.+||.+||++.+++.|+|++.
T Consensus 245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 68999999999999999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=405.90 Aligned_cols=270 Identities=22% Similarity=0.291 Sum_probs=222.1
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEe-------
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVS------- 80 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~------- 80 (636)
..++|++++.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 458999999999999999999999999999999999655432 234567899999999999999999999987
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 81 -DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 81 -~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
++.+|+|||||.| +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4579999999986 788877654 3569999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCC-cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CCCCC
Q 006664 160 CLFDSGD-RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLD 236 (636)
Q Consensus 160 ~~~~~~~-~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~--~~~~~ 236 (636)
.+..... ........+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+......+..+.... .+...
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 6542221 12223456899999999999876678999999999999999999999999888776665544321 11111
Q ss_pred cccc-------------------------hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 237 YERD-------------------------RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 237 ~~~~-------------------------~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
++.. ...++.+++||.+||.+||.+|||+.|+++||||+.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 1000 0126789999999999999999999999999999865443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=394.03 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=224.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
+..++|++++.||+|+||.||+|.+..++..||||++..... ......+.+|+.+++.++||||+++++++.++..+|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 445899999999999999999999999999999999965421 223467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 999999999999999876 57999999999999999999999999999999999999999999999999998654221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
.....+||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.... ...+..++.
T Consensus 168 ----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~ 237 (284)
T 2vgo_A 168 ----RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-----LKFPPFLSD 237 (284)
T ss_dssp ----CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----CCCCTTSCH
T ss_pred ----ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-----cCCCCcCCH
Confidence 1245689999999999986 678999999999999999999999999877766555544322 223456889
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.+++||.+||..||.+||++.++++||||+..
T Consensus 238 ~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 99999999999999999999999999999753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=397.21 Aligned_cols=263 Identities=23% Similarity=0.357 Sum_probs=222.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
+..++|++++.||+|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++.+++.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 446899999999999999999999999999999999965432 334677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 88 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999999999999887 579999999999999999999999999999999999999999999999999997653221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..........+....+.........++.
T Consensus 166 --~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 166 --LTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred --ccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 122345689999999999987 67899999999999999999999999998887777666666554443344567899
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
.+.++|.+||.+||.+||+..+.+.+.|..
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 999999999999999999666666666654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=434.34 Aligned_cols=265 Identities=25% Similarity=0.405 Sum_probs=227.1
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
.+..++|.+++.||+|+||.||+|.++.+|+.||||++..... ......+.+|+.+|+.++||||++++++|.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 4567899999999999999999999999999999999975432 23456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 85 WVVMPFMSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
|+|||||+||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999999997643 3469999999999999999999999999999999999999999999999999997653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC----hHHHHHHHHhcCCCCCCcc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP----PMKVLLMTLQNAPPGLDYE 238 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~----~~~~l~~~~~~~~~~~~~~ 238 (636)
... .....++||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.. .......+... .. .
T Consensus 341 ~~~---~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~~----~ 411 (543)
T 3c4z_A 341 AGQ---TKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AV----T 411 (543)
T ss_dssp TTC---CCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CC----C
T ss_pred CCC---cccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-cc----C
Confidence 322 12345699999999999987 679999999999999999999999997653 23333333332 22 2
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHhCcccccccCh
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSN 280 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~ 280 (636)
.+..++..+++||.+||.+||.+||+ +++|++||||+.+.+.
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 23678999999999999999999996 5899999999987654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=412.74 Aligned_cols=262 Identities=23% Similarity=0.337 Sum_probs=216.3
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe-----
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS----- 80 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~----- 80 (636)
++...++|++++.||+|+||+||+|.+..+|+.||||++...... ..+|+.+|+.++||||++++++|..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 456788999999999999999999999999999999998654332 2379999999999999999999954
Q ss_pred ---------------------------------CCeEEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHH
Q 006664 81 ---------------------------------DHNLWVVMPFMSGGSCLHILKA--AYPDGFEEVVIATILREVLKGLD 125 (636)
Q Consensus 81 ---------------------------------~~~l~iVmEy~~GGsL~~lL~~--~~~~~lse~~i~~i~~QIl~aL~ 125 (636)
+..+++|||||.| +|.+.+.. .....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999985 88877764 23467999999999999999999
Q ss_pred HHHHCCCcccccCcccEEEc-cCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHH
Q 006664 126 YLHHHGHIHRDVKSGNILID-VRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGIT 204 (636)
Q Consensus 126 yLH~~gIvHRDLKP~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGii 204 (636)
|||++||+||||||+|||++ .++.+||+|||++..+.... .....+||+.|+|||++.+...|+.++|||||||+
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC----CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999999999999999998 68899999999997653322 23456899999999999876679999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHhcCCCC--------------C----------CcccchhhhHHHHHHHHhhcccCCC
Q 006664 205 ALELAHGHAPFSKYPPMKVLLMTLQNAPPG--------------L----------DYERDRKFSKSFKQMIASCLVKDPS 260 (636)
Q Consensus 205 LyeLltG~~PF~~~~~~~~l~~~~~~~~~~--------------~----------~~~~~~~~S~~l~dLI~~cL~~DP~ 260 (636)
+|+|++|+.||.+....+.+..++...... . ....+..++.++++||.+||..||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999999988877776665421100 0 0012345788999999999999999
Q ss_pred CCCCHHHHHhCcccccc
Q 006664 261 KRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 261 kRpsa~elL~Hpffk~~ 277 (636)
+|||+.|+++||||+..
T Consensus 312 ~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHL 328 (383)
T ss_dssp GSCCHHHHHTSGGGHHH
T ss_pred hCCCHHHHhcCHHHHHH
Confidence 99999999999999854
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=392.62 Aligned_cols=263 Identities=30% Similarity=0.521 Sum_probs=208.9
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHH-HHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSN-ISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~-i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
+++..++|++++.||+|+||+||+|.+..+|+.||||++........... +.++...++.++||||+++++++.+++..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 67888999999999999999999999999999999999976544433333 44455557889999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 85 WVVMPFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
|+||||++| +|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999985 888877642 335799999999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCCcccccccccCCCCCCChhhhh---hccCCCcccchhhHHHHHHHHHcCCCCCCCC-ChHHHHHHHHhcCCCCCCc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVME---QLHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~---~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~-~~~~~l~~~~~~~~~~~~~ 237 (636)
.... ......||+.|+|||++. ....++.++|||||||++|+|++|..||... .....+........+..
T Consensus 161 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 234 (290)
T 3fme_A 161 VDDV----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL-- 234 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC--
T ss_pred cccc----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc--
Confidence 3321 223457999999999972 3356899999999999999999999999863 34444444444433322
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
....+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 235 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 235 -PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 23568999999999999999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=397.95 Aligned_cols=268 Identities=39% Similarity=0.674 Sum_probs=223.5
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEe---
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVS--- 80 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~--- 80 (636)
.+....++|++++.||+|+||.||+|.+..+|+.||||+++.... ....+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 445567899999999999999999999999999999999975432 356788999999998 89999999999987
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCc
Q 006664 81 ---DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 81 ---~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
...+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 56899999999999999999875445799999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~ 233 (636)
+....... ......+||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.........+.....+
T Consensus 176 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 176 SAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp TC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred ceecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 87553221 12345689999999999862 246889999999999999999999999988877766665554433
Q ss_pred CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 234 ~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
.. ....++..+++||.+||..||.+||++.++++||||+.....
T Consensus 253 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 253 RL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296 (326)
T ss_dssp CC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTH
T ss_pred cC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccc
Confidence 22 235678999999999999999999999999999999876543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=393.28 Aligned_cols=266 Identities=36% Similarity=0.649 Sum_probs=224.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 4578999999999999999999999999999999986543 335678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
|||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 96 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---L 171 (302)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH---H
T ss_pred EeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc---c
Confidence 999999999998764 356999999999999999999999999999999999999999999999999987543211 1
Q ss_pred cccccccCCCCCCChhhhh----hccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 169 RMRNTFVGTPCWMAPEVME----QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~----~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
.......||+.|+|||++. ....++.++|||||||++|+|++|..||.................+.. ..+..++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 249 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL--LTPSKWS 249 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SSGGGSC
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc--CCccccC
Confidence 1233568999999999985 235688999999999999999999999998888777666655544322 3346789
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhCcccccccChH
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~ 281 (636)
..+.+||.+||..||.+|||+.++++||||.......
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 286 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCH
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccch
Confidence 9999999999999999999999999999999876553
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=406.73 Aligned_cols=265 Identities=25% Similarity=0.354 Sum_probs=217.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch----hHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS----DLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~----~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
..++|++++.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.+++.++||||++++++|.+...+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4689999999999999999999999999999999997543221 234678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+...
T Consensus 88 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 999999986 888888654 346899999999999999999999999999999999999999999999999999765322
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CCCCCcc----
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLDYE---- 238 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~--~~~~~~~---- 238 (636)
. ......+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+....+.+..+.... +....++
T Consensus 166 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 166 N---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp C---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred c---ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 2 223456899999999999775678999999999999999999999999988877766655421 1111100
Q ss_pred -----------------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 239 -----------------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 239 -----------------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
....++.++++||.+||..||.+|||+.|+++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 1145678999999999999999999999999999998653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=412.77 Aligned_cols=260 Identities=27% Similarity=0.377 Sum_probs=219.1
Q ss_pred CCeEE--EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTL--YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l--~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
..|.+ .+.||+|+||.||+|.+..+|+.||+|+++... ......+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 34555 678999999999999999999999999997543 235667899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE--ccCCcEEEeccCcccccccCCC
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI--DVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl--d~~g~vKL~DFGla~~~~~~~~ 166 (636)
|||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 166 E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 166 EYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp ECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred eCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 999999999988764 2469999999999999999999999999999999999999 566899999999997653221
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+..... .+.......++++
T Consensus 244 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~ 318 (373)
T 2x4f_A 244 ---KLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW-DLEDEEFQDISEE 318 (373)
T ss_dssp ---BCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CSCSGGGTTSCHH
T ss_pred ---ccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCChhhhccCCHH
Confidence 2235679999999999976 6789999999999999999999999999888777766665433 2223344678999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+++||.+||..||.+||++.++++||||+...
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 99999999999999999999999999998653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=391.06 Aligned_cols=260 Identities=28% Similarity=0.431 Sum_probs=222.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-----hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-----SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-----~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
.++|++++.||+|+||.||+|.+..+|+.||+|+++..... ...+.+.+|+.+++.++||||+++++++.++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 46899999999999999999999999999999999765422 2367889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC----cEEEeccCcccc
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG----AIKLGDFGVSAC 160 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g----~vKL~DFGla~~ 160 (636)
|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999876 5799999999999999999999999999999999999998776 899999999876
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.. ..........
T Consensus 162 ~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (283)
T 3bhy_A 162 IEAGN----EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA-VNYDFDEEYF 235 (283)
T ss_dssp CC------------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-TCCCCCHHHH
T ss_pred ccCCC----cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh-cccCCcchhc
Confidence 53221 1235679999999999976 6789999999999999999999999998777665544433 3333333344
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
..++..+.+||.+||..||.+||++.++++||||+..
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 5678999999999999999999999999999999854
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=393.28 Aligned_cols=264 Identities=41% Similarity=0.730 Sum_probs=224.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
...++|++++.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.++||||+++++++..+..+|+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 45688999999999999999999999999999999997543 346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-- 179 (314)
T ss_dssp EECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred eecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence 9999999999999754 3579999999999999999999999999999999999999999999999999987653321
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................+.+ ..+..++..+
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 255 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF--RKPELWSDNF 255 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SSGGGSCHHH
T ss_pred -cccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc--CCcccCCHHH
Confidence 22345689999999999976 5789999999999999999999999998887766655555443332 3346689999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCcccccccChH
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~ 281 (636)
.+||.+||..||.+|||+.++++||||+......
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~ 289 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence 9999999999999999999999999999766443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=402.67 Aligned_cols=264 Identities=23% Similarity=0.396 Sum_probs=215.4
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCC--CCcceeeeEEEeC
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDH--PNVLKSHCSFVSD 81 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~H--PNIVkl~~~~~~~ 81 (636)
.+++..++|++++.||+|+||.||+|.+ .+++.||||++..... ......+.+|+.+|+.+.| |||+++++++.++
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 4567889999999999999999999987 4699999999986543 3345778999999999976 9999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+|+||| +.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred CEEEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99999999 5578999999875 6799999999999999999999999999999999999996 789999999999765
Q ss_pred ccCCCcccccccccCCCCCCChhhhhh----------ccCCCcccchhhHHHHHHHHHcCCCCCCCCChH-HHHHHHHhc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQ----------LHGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQN 230 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~----------~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~-~~l~~~~~~ 230 (636)
.... ........+||+.|+|||++.+ ...|+.++|||||||++|+|++|..||...... ..+...+.
T Consensus 158 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~- 235 (343)
T 3dbq_A 158 QPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID- 235 (343)
T ss_dssp -------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-
T ss_pred Cccc-ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc-
Confidence 3222 2223346789999999999964 246889999999999999999999999875443 22333322
Q ss_pred CCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 231 APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 231 ~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.. .....+...+.++.+||.+||..||.+|||+.++++||||+..
T Consensus 236 ~~--~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 236 PN--HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp TT--SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CC--cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 11 1223345567899999999999999999999999999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=403.85 Aligned_cols=258 Identities=37% Similarity=0.659 Sum_probs=225.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
+.|.+++.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.++...|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4599999999999999999999999999999999765432 34567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
|||. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 9998 5888888654 25799999999999999999999999999999999999999999999999999875421
Q ss_pred cccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
....+||+.|+|||++.+ ...|+.++|||||||++|+|++|..||.+......+..+.....+.. ....++..
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 281 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---QSGHWSEY 281 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---CCTTSCHH
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CCCCCCHH
Confidence 235689999999999863 35689999999999999999999999998888777766666544332 23568899
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
+++||.+||..||.+|||+.++++||||......
T Consensus 282 l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 9999999999999999999999999999865543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=402.86 Aligned_cols=261 Identities=26% Similarity=0.440 Sum_probs=215.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-------chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-------NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-------~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
.++|.+++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 4689999999999999999999999999999999965431 122345789999999999999999999987665
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc---EEEeccCccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA---IKLGDFGVSA 159 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~---vKL~DFGla~ 159 (636)
+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 89999999999999998764 67999999999999999999999999999999999999986654 9999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
..... ......+||+.|+|||++.+ ...|+.++|||||||++|+|++|..||........+...+.........
T Consensus 166 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T 2ycf_A 166 ILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241 (322)
T ss_dssp ECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred ecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence 65221 12335689999999999853 3568899999999999999999999997655433333333333322222
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
..+..++..+.+||.+||..||.+||++.++++||||+..
T Consensus 242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 3345688999999999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=388.92 Aligned_cols=262 Identities=27% Similarity=0.427 Sum_probs=216.8
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
...+..++|.+++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34456689999999999999999999999999999999996542 1234567899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999999999876 579999999999999999999999999999999999999999999999999987543
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.. ......+||+.|+|||++.+...++.++||||||+++|+|++|..||...........+..... ..+..
T Consensus 163 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~ 233 (276)
T 2h6d_A 163 DG----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-----YIPEY 233 (276)
T ss_dssp C-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTT
T ss_pred CC----cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----cCchh
Confidence 22 1233567999999999998744446899999999999999999999988776655544433321 22356
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
++..+.+||.+||..||.+|||+.++++||||++.
T Consensus 234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 78999999999999999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=393.85 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=222.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|.+++.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4689999999999999999999999999999999975432 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE---ccCCcEEEeccCcccccccCCC
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI---DVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl---d~~g~vKL~DFGla~~~~~~~~ 166 (636)
|++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--- 161 (304)
T 2jam_A 87 LVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--- 161 (304)
T ss_dssp CCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---
T ss_pred cCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---
Confidence 99999999999876 579999999999999999999999999999999999999 7788999999999864321
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ..+.......++..
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 162 --GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY-YEFESPFWDDISES 237 (304)
T ss_dssp --BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC-CCCCTTTTTTSCHH
T ss_pred --CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccccCCHH
Confidence 12345679999999999976 678999999999999999999999999877766655554432 22333344678999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+++||.+||..||.+||++.++++||||...
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=388.28 Aligned_cols=264 Identities=30% Similarity=0.443 Sum_probs=227.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--------hhHHHHHHHHHHHHhCC-CCCcceeeeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--------SDLSNISREAQTMILVD-HPNVLKSHCSF 78 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--------~~~~~i~rEi~iL~~L~-HPNIVkl~~~~ 78 (636)
.-.++|++.+.||+|+||.||+|.++.+|+.||||+++..... .....+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3468999999999999999999999999999999999765311 22456789999999995 99999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcc
Q 006664 79 VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158 (636)
Q Consensus 79 ~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla 158 (636)
..+...|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999999999876 57999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhh-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ-----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~-----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~ 233 (636)
..+.... .....+||+.|+|||++.+ ...++.++|||||||++|+|++|..||...........+.... .
T Consensus 172 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~ 246 (298)
T 1phk_A 172 CQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-Y 246 (298)
T ss_dssp EECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-C
T ss_pred hhcCCCc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC-c
Confidence 7653221 2345689999999999863 2457889999999999999999999999877766655554433 2
Q ss_pred CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 234 ~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
....+....++..+.+||.+||..||.+||++.++++||||++..
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 233344467899999999999999999999999999999998754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=387.47 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=213.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.++..+ +||||+++++++.++..+|+||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 689999999999999999999999999999999976533 33566788999999998 9999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC-------------------
Q 006664 89 PFMSGGSCLHILKAAYP--DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR------------------- 147 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~--~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~------------------- 147 (636)
|||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99999999999976422 568999999999999999999999999999999999999844
Q ss_pred CcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 006664 148 GAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT 227 (636)
Q Consensus 148 g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~ 227 (636)
+.+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+||..... ...+
T Consensus 171 ~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~ 240 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI 240 (289)
T ss_dssp CCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHH
T ss_pred eEEEEcccccccccCCc-------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHH
Confidence 47999999998765322 2346999999999998755677899999999999999999988765432 2233
Q ss_pred HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 228 ~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.....+ ..+..++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 241 ~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 241 RQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 332222 2235688999999999999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=389.97 Aligned_cols=259 Identities=27% Similarity=0.430 Sum_probs=226.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.++..+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34678999999999999999999999999999999997553 2345667889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......+
T Consensus 92 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999999999876 579999999999999999999999999999999999999999999999999987653222
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+.... ...+..++.
T Consensus 170 ~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 240 (294)
T 2rku_A 170 E---RKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-----YSIPKHINP 240 (294)
T ss_dssp C---CBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----CCCCTTSCH
T ss_pred c---ccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-----CCCccccCH
Confidence 1 2345689999999999976 668999999999999999999999999877766555444332 223456889
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.+.+||.+||..||.+||++.++++||||...
T Consensus 241 ~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 99999999999999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=394.19 Aligned_cols=273 Identities=26% Similarity=0.366 Sum_probs=224.1
Q ss_pred CCCcccccCCCCeEEEeEEcccCceEEEEEEEc-CCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhC---CCCCcceee
Q 006664 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCI-PFNEIVAVKILDFERDN-SDLSNISREAQTMILV---DHPNVLKSH 75 (636)
Q Consensus 1 ~~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L---~HPNIVkl~ 75 (636)
|++..+....++|++++.||+|+||.||+|.+. .+|+.||+|++...... .....+.+|+.+++.+ +||||++++
T Consensus 1 m~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp ----CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred CCCccccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 567777777899999999999999999999995 67899999999754422 2233466788877766 899999999
Q ss_pred eEEE-----eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcE
Q 006664 76 CSFV-----SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAI 150 (636)
Q Consensus 76 ~~~~-----~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~v 150 (636)
+++. ....+++||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCE
Confidence 9987 5577999999998 599999988755669999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhc
Q 006664 151 KLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN 230 (636)
Q Consensus 151 KL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~ 230 (636)
||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+...
T Consensus 160 kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 160 KLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp EECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEecCcccccccCC----CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 99999998754221 22345689999999999986 56899999999999999999999999988877766555432
Q ss_pred CC--CCCC--------------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 231 AP--PGLD--------------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 231 ~~--~~~~--------------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
.. .... ......++..+++||.+||..||.+||++.++++||||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 11 0000 0112457899999999999999999999999999999987653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=394.05 Aligned_cols=265 Identities=20% Similarity=0.322 Sum_probs=215.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE----------
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV---------- 79 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~---------- 79 (636)
.++|++++.||+|+||.||+|.+..+|+.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 57999999999999999999999999999999999754 3345677899999999999999999999874
Q ss_pred ----eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc-cCCcEEEec
Q 006664 80 ----SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID-VRGAIKLGD 154 (636)
Q Consensus 80 ----~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld-~~g~vKL~D 154 (636)
....+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4468999999998 599998864 5799999999999999999999999999999999999997 567999999
Q ss_pred cCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 006664 155 FGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 234 (636)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~ 234 (636)
||++.................||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+....+..
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99997653322222233456789999999998765679999999999999999999999999888777665555433211
Q ss_pred CC-------------------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 235 LD-------------------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 235 ~~-------------------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
.. ......++.++++||.+||..||.+|||+.++++||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 00 0112357899999999999999999999999999999986543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=404.09 Aligned_cols=258 Identities=28% Similarity=0.476 Sum_probs=223.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-------hhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCC
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-------SDLSNISREAQTMILV-DHPNVLKSHCSFVSDH 82 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-------~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~ 82 (636)
++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999999999999999765421 1245678999999998 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
..|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999999876 579999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhc-----cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQL-----HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~-----~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
... .....+||+.|+|||++.+. ..|+.++|||||||++|+|++|..||........+..+.... .....
T Consensus 252 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~ 326 (365)
T 2y7j_A 252 PGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ-YQFSS 326 (365)
T ss_dssp TTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCH
T ss_pred CCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCC
Confidence 221 23457899999999998742 358899999999999999999999998877766555544432 22333
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
+.+..++..+.+||.+||..||.+||++.++++||||+
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 34456789999999999999999999999999999996
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=399.31 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=226.9
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
..++|.+++.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.++..+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4578999999999999999999999999999999997553 23456678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
|||||.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 119 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 99999999999999876 6799999999999999999999999999999999999999999999999999976532221
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..... ..+..++..
T Consensus 197 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 267 (335)
T 2owb_A 197 ---RKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-----SIPKHINPV 267 (335)
T ss_dssp ---CBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----CCCTTSCHH
T ss_pred ---cccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC-----CCCccCCHH
Confidence 2345689999999999976 6789999999999999999999999998776665555444321 234568899
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+.+||.+||..||.+||++.++++||||...
T Consensus 268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 268 AASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999854
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=391.68 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=199.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 4789999999999999999999999999999999964421 12356789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE- 167 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-
Confidence 9999999999999864 35699999999999999999999999999999999999999999999999999876532221
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........+..... ..+..+..++.++
T Consensus 168 --~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 239 (278)
T 3cok_A 168 --KHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-----ADYEMPSFLSIEA 239 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----SCCCCCTTSCHHH
T ss_pred --cceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----cccCCccccCHHH
Confidence 2235689999999999976 5689999999999999999999999987554433322211 1223446689999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.+||.+||..||.+||++.++++||||...
T Consensus 240 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 999999999999999999999999999854
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=410.61 Aligned_cols=260 Identities=26% Similarity=0.379 Sum_probs=204.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC------C
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD------H 82 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~------~ 82 (636)
.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 378999999999999999999999999999999996543 234566788999999999999999999999764 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 689999999 6899998875 479999999999999999999999999999999999999999999999999987542
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC---------
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--------- 233 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~--------- 233 (636)
. .....+||+.|+|||++.+...|+.++|||||||++|+|++|+.||.+......+..+......
T Consensus 184 ~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 184 D------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred c------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 2 1345689999999999987567999999999999999999999999998877766555432110
Q ss_pred ----------------CCCc-ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 234 ----------------GLDY-ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 234 ----------------~~~~-~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
...+ ......++.+.+||.+||..||.+|||+.++|.||||.....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 0000 011346789999999999999999999999999999987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=399.05 Aligned_cols=268 Identities=24% Similarity=0.309 Sum_probs=221.9
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC-----
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD----- 81 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~----- 81 (636)
....++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.+++.++||||+++++++..+
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 345689999999999999999999999999999999997555555566788999999999999999999988764
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 67999999997 589999876 46999999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCcc-------cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--CC
Q 006664 162 FDSGDRQ-------RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN--AP 232 (636)
Q Consensus 162 ~~~~~~~-------~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~--~~ 232 (636)
....... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+... .+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 3321111 11234689999999999876567999999999999999999999999988766555443321 11
Q ss_pred CC---------------------C----CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 233 PG---------------------L----DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 233 ~~---------------------~----~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.. . .......+++++.+||.+||..||.+|||+.++++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00 0 0011236789999999999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=408.10 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=216.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-------hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-------SDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-------~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
++|++++.||+|+||+||+|.+..+|+.||||+++..... .....+.+|+.+++.++||||++++++|.++..
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 6899999999999999999999999999999999765421 133457789999999999999999999999999
Q ss_pred EEEEEeccCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 84 LWVVMPFMSGG-SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 84 l~iVmEy~~GG-sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
+|+||||+.+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999999776 999999875 579999999999999999999999999999999999999999999999999997653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.. ......+||+.|+|||++.+...++.++|||||||++|+|++|..||...... .. .....+..
T Consensus 182 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-----~~~~~~~~ 246 (335)
T 3dls_A 182 RG----KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-----AAIHPPYL 246 (335)
T ss_dssp TT----CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-----TCCCCSSC
T ss_pred CC----CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-----hccCCCcc
Confidence 22 22346789999999999987444588999999999999999999999763221 11 11223445
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+++++++||.+||.+||.+|||+.++++||||+..
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 88999999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=401.44 Aligned_cols=265 Identities=26% Similarity=0.415 Sum_probs=224.7
Q ss_pred CCCeEEE-eEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEE
Q 006664 10 AEHYTLY-EEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 10 ~~~Y~l~-~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~i 86 (636)
.++|.+. +.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+++.+ +||||++++++|.++..+|+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3568887 899999999999999999999999999976543 33467789999999998 56999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc---CCcEEEeccCccccccc
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---RGAIKLGDFGVSACLFD 163 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---~g~vKL~DFGla~~~~~ 163 (636)
|||||.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999999999986655567999999999999999999999999999999999999987 78999999999976532
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.... ..........+
T Consensus 187 ~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 260 (327)
T 3lm5_A 187 AC----ELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN-VDYSEETFSSV 260 (327)
T ss_dssp -----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTTTTTS
T ss_pred cc----ccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc-cccCchhhccc
Confidence 21 2245689999999999976 678999999999999999999999999887776665554432 23333445678
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
+..+++||.+||..||.+|||++++++||||+...+.
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 9999999999999999999999999999999977543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=396.69 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=207.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHh-CCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMIL-VDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~-L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||+||+|.+..+|+.||||++..... ........+|+..+.. .+||||+++++++.++..+|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 679999999999999999999999999999999865432 2333445556666554 49999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
||| +|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~---- 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA---- 210 (311)
T ss_dssp ECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred ecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC----
Confidence 999 67999988876 356999999999999999999999999999999999999999999999999998755322
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
.......||+.|+|||++.+ .++.++|||||||++|||++|..||.+..... .+.... ........++.++.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~~l~ 282 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ----QLRQGY--LPPEFTAGLSSELR 282 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH----HHTTTC--CCHHHHTTSCHHHH
T ss_pred CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----HHhccC--CCcccccCCCHHHH
Confidence 12345679999999999875 68999999999999999999977765432221 222111 12233456889999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
+||.+||.+||.+|||+.++++||||++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=397.31 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=213.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEe--CCeEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVS--DHNLWV 86 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~--~~~l~i 86 (636)
.++|++++.||+|+||+||+|.+..+++.||||+++.. ....+.+|+.+++.+. ||||+++++++.+ ....++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 47899999999999999999999999999999998632 3567899999999997 9999999999998 678999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-cEEEeccCcccccccCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-AIKLGDFGVSACLFDSG 165 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-~vKL~DFGla~~~~~~~ 165 (636)
||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 111 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999999999999874 388999999999999999999999999999999999999776 89999999997553222
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCC-ChHHHHHHHHh------------cCC
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQ------------NAP 232 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~-~~~~~l~~~~~------------~~~ 232 (636)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||... .....+..+.. ...
T Consensus 186 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 186 ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp ----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred ----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 2345689999999999987667999999999999999999999999543 33222222111 111
Q ss_pred CCC--------------------CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 233 PGL--------------------DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 233 ~~~--------------------~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
... .......+++++++||.+||.+||.+|||+.++|+||||+.+.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 000 01112337899999999999999999999999999999997653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=396.03 Aligned_cols=264 Identities=24% Similarity=0.385 Sum_probs=220.2
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC--e
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH--N 83 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~--~ 83 (636)
..+..++|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+|+.+++.++||||+++++++.... .
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 34667899999999999999999999999999999999976554455677889999999999999999999998765 7
Q ss_pred EEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE----ccCCcEEEeccCcc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYP-DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI----DVRGAIKLGDFGVS 158 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl----d~~g~vKL~DFGla 158 (636)
+|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999986532 239999999999999999999999999999999999999 77788999999999
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhh-------ccCCCcccchhhHHHHHHHHHcCCCCCCCCC----hHHHHHHH
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ-------LHGYDFKADIWSFGITALELAHGHAPFSKYP----PMKVLLMT 227 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~-------~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~----~~~~l~~~ 227 (636)
..+.... .....+||+.|+|||++.. ...|+.++|||||||++|+|++|..||.... .......+
T Consensus 164 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 164 RELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp EECCTTC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred eecCCCC----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 7653322 2335689999999999873 2568999999999999999999999996433 23334444
Q ss_pred HhcCCCC--------------------CCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcc
Q 006664 228 LQNAPPG--------------------LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273 (636)
Q Consensus 228 ~~~~~~~--------------------~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpf 273 (636)
+...+.. ........++..+.+||.+||.+||.+|||++|+++||-
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 4433321 011223567889999999999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=408.78 Aligned_cols=263 Identities=22% Similarity=0.399 Sum_probs=215.2
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCC--CCCcceeeeEEEeCC
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVD--HPNVLKSHCSFVSDH 82 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~--HPNIVkl~~~~~~~~ 82 (636)
..+...+|.+++.||+|+||+||+|.+.. ++.||||++..... ......+.+|+.+|+.+. ||||+++++++..+.
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 34556779999999999999999999865 99999999986543 345678899999999996 599999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+||| +.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+.
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9999999 5678999999876 5789999999999999999999999999999999999995 6899999999997653
Q ss_pred cCCCcccccccccCCCCCCChhhhhh----------ccCCCcccchhhHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcC
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQ----------LHGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQNA 231 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~----------~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~-~~l~~~~~~~ 231 (636)
... ........+||+.|+|||++.+ ...|+.++|||||||++|+|++|..||...... ..+..++. .
T Consensus 206 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~-~ 283 (390)
T 2zmd_A 206 PDT-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-P 283 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC-T
T ss_pred CCC-ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC-c
Confidence 221 1222346789999999999964 135899999999999999999999999875443 33333332 2
Q ss_pred CCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 232 ~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.. ....+...+.++++||.+||..||.+||++.++++||||+..
T Consensus 284 ~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 284 NH--EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp TS--CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cc--cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 21 222334558899999999999999999999999999999854
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=403.86 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=210.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC------
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH------ 82 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~------ 82 (636)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4789999999999999999999999999999999975433 344567889999999999999999999998765
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||+| +|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999986 7888885 358999999999999999999999999999999999999999999999999987542
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC-------
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL------- 235 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~------- 235 (636)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+......+..++.......
T Consensus 179 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 179 TS----FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ---------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cc----cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 21 12345789999999999987 6799999999999999999999999998887776665554321100
Q ss_pred -----------------C-------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 236 -----------------D-------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 236 -----------------~-------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
. .......+.++++||.+||..||.+|||+.++++||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 0 000112377899999999999999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=404.03 Aligned_cols=265 Identities=27% Similarity=0.460 Sum_probs=219.7
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeecCC---CchhHHHHHHHHHHHHhC-CCCCcceeeeEEE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCI---PFNEIVAVKILDFER---DNSDLSNISREAQTMILV-DHPNVLKSHCSFV 79 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~---~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~ 79 (636)
.+..++|++++.||+|+||.||+|.+. .+|+.||||+++... .......+.+|+.+++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 344589999999999999999999985 589999999996432 122345577899999999 6999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.+..+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999999999876 579999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhc-cCCCcccchhhHHHHHHHHHcCCCCCCCCC----hHHHHHHHHhcCCCC
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPFSKYP----PMKVLLMTLQNAPPG 234 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLltG~~PF~~~~----~~~~l~~~~~~~~~~ 234 (636)
.+.... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.... ........... .+
T Consensus 208 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~- 283 (355)
T 1vzo_A 208 EFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EP- 283 (355)
T ss_dssp ECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CC-
T ss_pred ecccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CC-
Confidence 653221 1223457899999999999752 357899999999999999999999996432 22222222222 22
Q ss_pred CCcccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHhCcccccccCh
Q 006664 235 LDYERDRKFSKSFKQMIASCLVKDPSKRP-----SAKKLLKHSFFKQARSN 280 (636)
Q Consensus 235 ~~~~~~~~~S~~l~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~ 280 (636)
..+..++..+++||.+||..||.+|| ++.++++||||....+.
T Consensus 284 ---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~ 331 (355)
T 1vzo_A 284 ---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331 (355)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred ---CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence 23456889999999999999999999 99999999999876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=404.58 Aligned_cols=261 Identities=24% Similarity=0.437 Sum_probs=223.1
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEc-------CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceee
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCI-------PFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSH 75 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-------~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~ 75 (636)
..|.+..++|++++.||+|+||+||+|.+. .++..||||+++..........+.+|+.+|+.+ +||||++++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 356778899999999999999999999875 356789999997665555677899999999999 899999999
Q ss_pred eEEEeCCeEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCccc
Q 006664 76 CSFVSDHNLWVVMPFMSGGSCLHILKAAYP--------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGN 141 (636)
Q Consensus 76 ~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~--------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~N 141 (636)
+++.+++.+|+|||||.||+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 999999999999999999999999987532 348899999999999999999999999999999999
Q ss_pred EEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCCh
Q 006664 142 ILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPP 220 (636)
Q Consensus 142 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~ 220 (636)
||++.++.+||+|||+++.+.... .........||+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+.
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCC-TTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEECCCCCEEEccccCCcccCccc-ceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999997653322 1122334568899999999986 679999999999999999999 9999998877
Q ss_pred HHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 221 MKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 221 ~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+....+..... ...+..++.++.+||.+||..||.+||++.++++
T Consensus 312 ~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 312 EELFKLLKEGHR----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp GGHHHHHHTTCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 665544443322 2334578899999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=386.23 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=211.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe----------
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS---------- 80 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~---------- 80 (636)
++|++++.||+|+||.||+|.+..+|+.||||++... ......+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 5799999999999999999999999999999999642 3346778999999999999999999999865
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCc
Q 006664 81 ---DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 81 ---~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
...+|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 45789999999999999999864 34688999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-----------cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHH
Q 006664 158 SACLFDSGD-----------RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLM 226 (636)
Q Consensus 158 a~~~~~~~~-----------~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~ 226 (636)
+........ .........||+.|+|||++.+...++.++|||||||++|+|++ ||...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 876532210 01123456899999999999865578999999999999999998 6654333333333
Q ss_pred HHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 227 TLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 227 ~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
.+......+........+..+++||.+||..||.+|||+.++++||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (303)
T 1zy4_A 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292 (303)
T ss_dssp HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence 44433333333344567888999999999999999999999999999986543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=411.59 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=213.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC------CeE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD------HNL 84 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~------~~l 84 (636)
.+|++++.||+|+||+||+|.+..+|+.||||++...... ..+|+.+|+.++|||||+++++|... .++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 4799999999999999999999999999999998654322 34799999999999999999998642 247
Q ss_pred EEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC-CcEEEeccCccccc
Q 006664 85 WVVMPFMSGGSCLHILKA--AYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR-GAIKLGDFGVSACL 161 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~--~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~-g~vKL~DFGla~~~ 161 (636)
++||||+.+ +|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.+
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 899999986 67666653 234679999999999999999999999999999999999999955 67899999999865
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC---------
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP--------- 232 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~--------- 232 (636)
.... .....+||+.|+|||++.+...|+.++|||||||++|||++|+.||.+....+.+..++....
T Consensus 208 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 208 VRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CTTC----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred ccCC----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3322 224568999999999998756799999999999999999999999999887777666554210
Q ss_pred -----CCCCcc----------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 233 -----PGLDYE----------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 233 -----~~~~~~----------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
..+.++ ....++.++++||.+||.+||.+||++.|+++||||+...
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 001111 1235688999999999999999999999999999998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=397.51 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=221.9
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNE---IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~---~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
..++..++|.+.+.||+|+||+||+|.+..+++ .||||++...........+.+|+.+++.++||||+++++++.++
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 346778999999999999999999999986555 59999998665656677899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999999999754 357999999999999999999999999999999999999999999999999999866
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
..............||+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.........+.... ..+.+
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----~~~~~ 276 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY----RLPAP 276 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----CCCCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----CCCCC
Confidence 443322223334567889999999976 578999999999999999999 999999888777666555432 22344
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..++..+.+||.+||..||.+||++.++++
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 678999999999999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=392.43 Aligned_cols=260 Identities=29% Similarity=0.451 Sum_probs=212.4
Q ss_pred CCcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 2 ~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
+...+.+...+|++.+.||+|+||+||+|.+ +|..||||++..... ......+.+|+.+++.++||||+++++++.+
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 4467888999999999999999999999986 588999999975543 3445678999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCcccEEEccCCcEEEeccCc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYP-DGFEEVVIATILREVLKGLDYLHHHG--HIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~g--IvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
...+|+|||||.||+|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999999986421 12899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
+...... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+............... ..
T Consensus 186 a~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---~~ 258 (309)
T 3p86_A 186 SRLKAST---FLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK---RL 258 (309)
T ss_dssp -------------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC---CC
T ss_pred Ccccccc---ccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---CC
Confidence 8754221 122345689999999999987 6789999999999999999999999998887766555433222 22
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+..+++++.+||.+||..||.+|||+.++++
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 344678999999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=409.09 Aligned_cols=260 Identities=27% Similarity=0.383 Sum_probs=211.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC------e
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH------N 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~------~ 83 (636)
..+|.+++.||+|+||+||+|.+..+++ ||+|++...... ..+|+.+|+.++||||++++++|.... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 4679999999999999999999987766 788877543322 237999999999999999999996544 3
Q ss_pred EEEEEeccCCCCHHHHHH-HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc-cCCcEEEeccCccccc
Q 006664 84 LWVVMPFMSGGSCLHILK-AAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID-VRGAIKLGDFGVSACL 161 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~-~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld-~~g~vKL~DFGla~~~ 161 (636)
+|+|||||.++.+..+.. ......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 899999998754333322 12246799999999999999999999999999999999999999 7899999999999765
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--------
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP-------- 233 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~-------- 233 (636)
.... .....+||+.|+|||++.+...|+.++|||||||++|+|++|+.||.+....+.+..++.....
T Consensus 193 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGE----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTC----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cCCC----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3322 2345689999999999987667999999999999999999999999998887777665542100
Q ss_pred -----------CC-----CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 234 -----------GL-----DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 234 -----------~~-----~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
.. .......+++++++||.+||.+||.+|||+.++++||||+..+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00 00112347889999999999999999999999999999987653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=410.75 Aligned_cols=259 Identities=23% Similarity=0.336 Sum_probs=217.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC------CCCCcceeeeEEEeCC
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV------DHPNVLKSHCSFVSDH 82 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L------~HPNIVkl~~~~~~~~ 82 (636)
...+|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+ +||||+++++++....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 356899999999999999999999999999999999642 23445678899998876 6789999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc--EEEeccCcccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA--IKLGDFGVSAC 160 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~--vKL~DFGla~~ 160 (636)
.+|+||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999999996 58999998876567999999999999999999999999999999999999998887 99999999864
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC----
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD---- 236 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~---- 236 (636)
... ...+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+....+.+..+.........
T Consensus 252 ~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 252 EHQ------RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp TTC------CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cCC------cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 321 2346789999999999987 57999999999999999999999999998877766555432110000
Q ss_pred -------------c-------------------------------------ccchhhhHHHHHHHHhhcccCCCCCCCHH
Q 006664 237 -------------Y-------------------------------------ERDRKFSKSFKQMIASCLVKDPSKRPSAK 266 (636)
Q Consensus 237 -------------~-------------------------------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~ 266 (636)
+ ......++.+.+||.+||.+||.+|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 0 00112378899999999999999999999
Q ss_pred HHHhCcccccc
Q 006664 267 KLLKHSFFKQA 277 (636)
Q Consensus 267 elL~Hpffk~~ 277 (636)
|+|+||||+..
T Consensus 405 e~L~Hpw~~~~ 415 (429)
T 3kvw_A 405 QALRHPWLRRR 415 (429)
T ss_dssp HHHTSTTTC--
T ss_pred HHhCChhhccC
Confidence 99999999854
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=402.82 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=223.1
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEE-----EcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeE
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRAL-----CIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCS 77 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~-----~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~ 77 (636)
..|++..++|++++.||+|+||.||+|. +..+++.||||+++..........+.+|+.+++.+ +||||++++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 4688999999999999999999999998 55677999999997665555677899999999999 79999999999
Q ss_pred EEeCC-eEEEEEeccCCCCHHHHHHHhCC---------------------------------------------------
Q 006664 78 FVSDH-NLWVVMPFMSGGSCLHILKAAYP--------------------------------------------------- 105 (636)
Q Consensus 78 ~~~~~-~l~iVmEy~~GGsL~~lL~~~~~--------------------------------------------------- 105 (636)
+.+.+ .+|+|||||.||+|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 98865 49999999999999999986531
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccc
Q 006664 106 -------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRN 172 (636)
Q Consensus 106 -------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 172 (636)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... .....
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 253 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 253 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC-
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhcc
Confidence 1289999999999999999999999999999999999999999999999999976533322 22334
Q ss_pred cccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHH
Q 006664 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMI 251 (636)
Q Consensus 173 ~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI 251 (636)
...||+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+......+...+..... ...+..+++++.++|
T Consensus 254 ~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li 329 (359)
T 3vhe_A 254 DARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR---MRAPDYTTPEMYQTM 329 (359)
T ss_dssp -CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC---CCCCTTCCHHHHHHH
T ss_pred ccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC---CCCCCCCCHHHHHHH
Confidence 5678999999999986 679999999999999999998 99999887655555555444321 233456889999999
Q ss_pred HhhcccCCCCCCCHHHHHhC
Q 006664 252 ASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 252 ~~cL~~DP~kRpsa~elL~H 271 (636)
.+||..||.+|||+.++++|
T Consensus 330 ~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHH
Confidence 99999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=381.50 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=221.3
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
..+|.+..++|++++.||+|+||+||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.++.
T Consensus 2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp ---CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4679999999999999999999999999986 578899999975432 3467899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred ceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence 999999999999999999764 3569999999999999999999999999999999999999999999999999987543
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
.. .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+..... ...+.
T Consensus 158 ~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~ 230 (269)
T 4hcu_A 158 DD--QYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----LYKPR 230 (269)
T ss_dssp CH--HHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----CCCCT
T ss_pred cc--ccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----CCCCC
Confidence 22 1122334567888999999976 679999999999999999999 9999998887776655554322 23345
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.++..+.+||.+||..||.+||++.++++|
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 678999999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=385.07 Aligned_cols=260 Identities=29% Similarity=0.475 Sum_probs=225.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
.++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 3689999999999999999999999999999999975432 345678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC---CcEEEeccCcccccccCC
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR---GAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~---g~vKL~DFGla~~~~~~~ 165 (636)
||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 101 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 999999999998876 579999999999999999999999999999999999999754 479999999987653221
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+... ......+....++.
T Consensus 179 ----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 179 ----KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-KYAFDLPQWRTISD 251 (287)
T ss_dssp ----SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCSGGGTTSCH
T ss_pred ----ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCchhhhhcCH
Confidence 1234578999999999975 4899999999999999999999999988776655544443 33334445567899
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++.+||.+||..||.+|||+.++++||||++..
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 999999999999999999999999999998654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=383.22 Aligned_cols=262 Identities=24% Similarity=0.435 Sum_probs=222.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEe--CCeE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVS--DHNL 84 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~--~~~l 84 (636)
-..++|++++.||+|+||.||+|.+..+|+.||+|+++.... ......+.+|+.+++.++||||+++++++.+ +..+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 346899999999999999999999999999999999986543 3456678999999999999999999998854 5789
Q ss_pred EEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccccCcccEEEccCCcEEEeccCc
Q 006664 85 WVVMPFMSGGSCLHILKAAY--PDGFEEVVIATILREVLKGLDYLHHHG-----HIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~g-----IvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999997642 234999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......
T Consensus 163 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--- 235 (279)
T 2w5a_A 163 ARILNHDT---SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--- 235 (279)
T ss_dssp HHHC---C---HHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---
T ss_pred heeecccc---ccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---
Confidence 87543221 12335689999999999986 578999999999999999999999999887766555554443322
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.+..++.++.+||.+||..||.+||++.++++|+|+...
T Consensus 236 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 236 -IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 235688999999999999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=390.04 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=218.0
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEE-cCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCC------CcceeeeEEE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALC-IPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP------NVLKSHCSFV 79 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~-~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HP------NIVkl~~~~~ 79 (636)
.+..++|++++.||+|+||+||+|.+ ..+|+.||||+++.. ......+.+|+.+++.++|+ +|+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 34568999999999999999999998 568999999998632 33456788999999988765 4999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-------------
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV------------- 146 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~------------- 146 (636)
..+.+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 889999998875557999999999999999999999999999999999999987
Q ss_pred ------CCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh
Q 006664 147 ------RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP 220 (636)
Q Consensus 147 ------~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~ 220 (636)
++.+||+|||++..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE------HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS------CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccCCCceEeeCcccccCcc------ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 66899999999875321 1235689999999999986 6799999999999999999999999998776
Q ss_pred HHHHHHHHhcCCCCC------------------C---------------------cccchhhhHHHHHHHHhhcccCCCC
Q 006664 221 MKVLLMTLQNAPPGL------------------D---------------------YERDRKFSKSFKQMIASCLVKDPSK 261 (636)
Q Consensus 221 ~~~l~~~~~~~~~~~------------------~---------------------~~~~~~~S~~l~dLI~~cL~~DP~k 261 (636)
.+..........+.. . .......++.+.+||.+||..||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 654433322110000 0 0011235678999999999999999
Q ss_pred CCCHHHHHhCccccccc
Q 006664 262 RPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 262 Rpsa~elL~Hpffk~~~ 278 (636)
|||+.|+++||||+..+
T Consensus 320 Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 320 RITLREALKHPFFDLLK 336 (339)
T ss_dssp SCCHHHHTTSGGGGGGG
T ss_pred ccCHHHHhcCHHHHHHh
Confidence 99999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=404.83 Aligned_cols=264 Identities=22% Similarity=0.382 Sum_probs=224.8
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEE-----EcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRAL-----CIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~-----~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
.++..++|++++.||+|+||+||+|. +..++..||||+++..........+.+|+.+++.++||||+++++++.+
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 35667899999999999999999999 5567889999999765555566778999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC---cEEE
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYP-----DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG---AIKL 152 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~-----~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g---~vKL 152 (636)
+...|+|||||.||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999999987632 3489999999999999999999999999999999999998555 5999
Q ss_pred eccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 006664 153 GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 231 (636)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~ 231 (636)
+|||+++.+..... ........||+.|+|||++.+ ..|+.++|||||||++|||++ |..||......+....+....
T Consensus 226 ~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 226 GDFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp CCCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred CCCccccccccccc-cccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999975533221 223345678999999999987 679999999999999999998 999999888777666555443
Q ss_pred CCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 232 ~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
.. ..+..++..+.+||.+||..||.+||++.+|++|.++-
T Consensus 304 ~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 RM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22 23467889999999999999999999999999988764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=390.20 Aligned_cols=264 Identities=24% Similarity=0.412 Sum_probs=226.1
Q ss_pred CCcccccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeee
Q 006664 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHC 76 (636)
Q Consensus 2 ~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~ 76 (636)
+...|.+..++|.+.+.||+|+||.||+|.+. .++..||||++...........+.+|+.+++.++||||+++++
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 45678899999999999999999999999984 4568999999986655666788999999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHHHhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 006664 77 SFVSDHNLWVVMPFMSGGSCLHILKAAYP----------------------DGFEEVVIATILREVLKGLDYLHHHGHIH 134 (636)
Q Consensus 77 ~~~~~~~l~iVmEy~~GGsL~~lL~~~~~----------------------~~lse~~i~~i~~QIl~aL~yLH~~gIvH 134 (636)
++.+++.+|+|||||.||+|.+++..... ..+++..++.++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999987532 23899999999999999999999999999
Q ss_pred cccCcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCC
Q 006664 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHA 213 (636)
Q Consensus 135 RDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~ 213 (636)
|||||+|||++.++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEED-SYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTS-CEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccchheEEEcCCCCEEEccccccccccccc-cceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999987654332 1222334568899999999987 668999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 214 PFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 214 PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
||.+............... ...+..++..+.+||.+||..||.+||++.+++++
T Consensus 252 p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHR----MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHhhcCCc----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9998777655544433322 23346789999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=399.34 Aligned_cols=263 Identities=28% Similarity=0.378 Sum_probs=218.4
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
.|++ .++|.+.+.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 37 ~~~l-~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 37 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred eecc-cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 3444 37999999999999999999999999999999999754432 345678899999999999999999999988765
Q ss_pred E------EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCc
Q 006664 84 L------WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 84 l------~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
. |+||||+. |+|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred cccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 4 99999998 57877763 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC---
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG--- 234 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~--- 234 (636)
+..... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+.......
T Consensus 191 a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 191 ARHADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp C--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccccc------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 875421 13456899999999999875679999999999999999999999999888776665554311110
Q ss_pred ----------------------CC-cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 235 ----------------------LD-YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 235 ----------------------~~-~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
.. ......+++.+++||.+||..||.+|||+.++++||||+....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 00 0112356899999999999999999999999999999986543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=391.17 Aligned_cols=269 Identities=24% Similarity=0.382 Sum_probs=204.9
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNE---IVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~---~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
+.+.+..++|++++.||+|+||+||+|.+..++. .||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 3567788999999999999999999999887775 89999997553 3345678999999999999999999999998
Q ss_pred eCCeE------EEEEeccCCCCHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc
Q 006664 80 SDHNL------WVVMPFMSGGSCLHILKAAYP----DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA 149 (636)
Q Consensus 80 ~~~~l------~iVmEy~~GGsL~~lL~~~~~----~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~ 149 (636)
..... |+||||+.||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 87665 999999999999999976421 25899999999999999999999999999999999999999999
Q ss_pred EEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 006664 150 IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTL 228 (636)
Q Consensus 150 vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~ 228 (636)
+||+|||++....... .........||+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.........+.
T Consensus 176 ~kl~Dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 176 VCVADFGLSRKIYSGD-YYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp EEECCCCC------------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred EEEeeccccccccccc-cccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 9999999997653322 2222334567889999999987 679999999999999999999 999999888777666555
Q ss_pred hcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCC-------HHHHHhCccccccc
Q 006664 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPS-------AKKLLKHSFFKQAR 278 (636)
Q Consensus 229 ~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRps-------a~elL~Hpffk~~~ 278 (636)
..... ..+..++.++.+||.+||..||.+||| +++++.|+|+....
T Consensus 254 ~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 254 GGNRL----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp TTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred cCCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 44322 234678899999999999999999999 78888999997643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=401.83 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=210.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC--------CCCcceeeeEEE--
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD--------HPNVLKSHCSFV-- 79 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~--------HPNIVkl~~~~~-- 79 (636)
.++|++++.||+|+||+||+|.+..+++.||||++.. .......+.+|+.+++.+. ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS--AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec--CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 5889999999999999999999999999999999963 2334567889999999885 788999999998
Q ss_pred --eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCC--------
Q 006664 80 --SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRG-------- 148 (636)
Q Consensus 80 --~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g-------- 148 (636)
.+..+|+||||+ +|+|.+.+.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 556899999999 66788777766556799999999999999999999998 999999999999998765
Q ss_pred -----------------------------------------cEEEeccCcccccccCCCcccccccccCCCCCCChhhhh
Q 006664 149 -----------------------------------------AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187 (636)
Q Consensus 149 -----------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~ 187 (636)
.+||+|||++...... ....+||+.|+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHHH
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhhc
Confidence 7999999998754221 23568999999999998
Q ss_pred hccCCCcccchhhHHHHHHHHHcCCCCCCCCCh------HHHHHHHHh--cCCCC---------------------C---
Q 006664 188 QLHGYDFKADIWSFGITALELAHGHAPFSKYPP------MKVLLMTLQ--NAPPG---------------------L--- 235 (636)
Q Consensus 188 ~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~------~~~l~~~~~--~~~~~---------------------~--- 235 (636)
+ ..|+.++|||||||++|+|++|..||..... ...+..+.. ...+. .
T Consensus 267 ~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 267 G-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp T-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred C-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 7 5699999999999999999999999975442 222222211 00000 0
Q ss_pred -----------CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 236 -----------DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 236 -----------~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
.+......+..+.+||.+||..||.+|||+.|+|+||||+
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0012345678899999999999999999999999999996
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=413.85 Aligned_cols=253 Identities=14% Similarity=0.148 Sum_probs=205.5
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHH---HHhCCCCCcceee-----
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQT---MILVDHPNVLKSH----- 75 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~i---L~~L~HPNIVkl~----- 75 (636)
|....++|++.+.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+ ++.++|||||+++
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 4445688999999999999999999999999999999997543 33456788999954 5556899999998
Q ss_pred --eEEEeCC-----------------eEEEEEeccCCCCHHHHHHHhCCCCCCH-------HHHHHHHHHHHHHHHHHHH
Q 006664 76 --CSFVSDH-----------------NLWVVMPFMSGGSCLHILKAAYPDGFEE-------VVIATILREVLKGLDYLHH 129 (636)
Q Consensus 76 --~~~~~~~-----------------~l~iVmEy~~GGsL~~lL~~~~~~~lse-------~~i~~i~~QIl~aL~yLH~ 129 (636)
+++.+.+ ..|+||||| +|+|.+++... ..+++ ..+..|+.||+.||.|||+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 6666554 289999999 67999999875 33444 7888899999999999999
Q ss_pred CCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhc----------cCCCcccchh
Q 006664 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL----------HGYDFKADIW 199 (636)
Q Consensus 130 ~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~----------~~ys~ksDIW 199 (636)
+||+||||||+|||++.++.+||+|||+++... ......+| +.|+|||++.+. ..|+.++|||
T Consensus 225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETT------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred CCeecCCCCHHHEEEcCCCCEEEEechhheecC------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 999999999999999999999999999987431 12345678 999999999874 2699999999
Q ss_pred hHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 200 SFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 200 SLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
||||++|+|++|+.||.+.........+ ......+++++++||.+||..||.+||++.++++||||+..
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGGSEWI---------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CCSGGG---------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHHHHCCCCCcccccccchhhh---------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 9999999999999999764432211111 11225678999999999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=391.67 Aligned_cols=260 Identities=22% Similarity=0.358 Sum_probs=222.8
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
.+.+..++|++++.||+|+||.||+|.+. .+++.||||+++..........+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 35677899999999999999999999987 4568999999976655556778999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccc
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYP----------------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDV 137 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~----------------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDL 137 (636)
++..+|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99999999999999999999987431 56899999999999999999999999999999
Q ss_pred CcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCC
Q 006664 138 KSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFS 216 (636)
Q Consensus 138 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~ 216 (636)
||+|||++.++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCc-cccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999987653221 1122345678999999999986 579999999999999999998 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 217 KYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 217 ~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+.........+...... ..+..++..+.+||.+||..||.+||++.++++
T Consensus 279 ~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TSCHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCChHHHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 88877666555544322 234578899999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=387.30 Aligned_cols=262 Identities=24% Similarity=0.407 Sum_probs=220.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC---CchhHHHHHHHHHHHHhCCCCCcceeeeEEE--eCCeE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER---DNSDLSNISREAQTMILVDHPNVLKSHCSFV--SDHNL 84 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~---~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~--~~~~l 84 (636)
.++|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++. +...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999996542 2234677899999999999999999999984 45689
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+|||||.+| |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999987 888888766677999999999999999999999999999999999999999999999999998765322
Q ss_pred CCcccccccccCCCCCCChhhhhhcc-CCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLH-GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~-~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
. .........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.........+..... ..+..+
T Consensus 163 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-----~~~~~~ 236 (305)
T 2wtk_C 163 A-ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-----AIPGDC 236 (305)
T ss_dssp C-SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-----CCCSSS
T ss_pred c-cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-----CCCCcc
Confidence 2 122234567999999999997532 247799999999999999999999998777665554444321 233567
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
+..+.+||.+||..||.+||++.++++||||+...
T Consensus 237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 89999999999999999999999999999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=398.24 Aligned_cols=264 Identities=24% Similarity=0.356 Sum_probs=220.9
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch----------------hHHHHHHHHHHHHhCCCCCcc
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS----------------DLSNISREAQTMILVDHPNVL 72 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~----------------~~~~i~rEi~iL~~L~HPNIV 72 (636)
..++|++++.||+|+||.||+|.+ +|+.||||++....... ....+.+|+.+++.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 357999999999999999999998 89999999997442111 127889999999999999999
Q ss_pred eeeeEEEeCCeEEEEEeccCCCCHHHH------HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEc
Q 006664 73 KSHCSFVSDHNLWVVMPFMSGGSCLHI------LKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILID 145 (636)
Q Consensus 73 kl~~~~~~~~~l~iVmEy~~GGsL~~l------L~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld 145 (636)
++++++.+++.+|+||||++||+|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999998 655435679999999999999999999999 9999999999999999
Q ss_pred cCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCc-ccchhhHHHHHHHHHcCCCCCCCCChHHHH
Q 006664 146 VRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDF-KADIWSFGITALELAHGHAPFSKYPPMKVL 224 (636)
Q Consensus 146 ~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~-ksDIWSLGiiLyeLltG~~PF~~~~~~~~l 224 (636)
.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||.........
T Consensus 187 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred CCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 9999999999998765322 2345689999999999987435666 999999999999999999999887663333
Q ss_pred HHHHhcCCCCCCcc---------------cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 225 LMTLQNAPPGLDYE---------------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 225 ~~~~~~~~~~~~~~---------------~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
...+......+... ....++.++.+||.+||..||.+||++.++++||||+....
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 33333332222110 01568899999999999999999999999999999987653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=395.50 Aligned_cols=267 Identities=22% Similarity=0.289 Sum_probs=213.1
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc----------hhHHHHHHHHHHHHhCCCCCcceeee
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN----------SDLSNISREAQTMILVDHPNVLKSHC 76 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~----------~~~~~i~rEi~iL~~L~HPNIVkl~~ 76 (636)
....++|.+++.||+|+||.||+|.+.. |..||||++...... .....+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 3456899999999999999999999864 999999999644321 12477899999999999999999999
Q ss_pred EEEe-----CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEE
Q 006664 77 SFVS-----DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIK 151 (636)
Q Consensus 77 ~~~~-----~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vK 151 (636)
++.. ...+|+||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence 9954 347899999998 5888888754 35699999999999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC
Q 006664 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA 231 (636)
Q Consensus 152 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~ 231 (636)
|+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+....
T Consensus 175 l~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 175 ICDFNLAREDTAD----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp ECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEecCcccccccc----cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 9999998743222 123456899999999999875679999999999999999999999999887766655543311
Q ss_pred CC-----------------------CCC----cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccCh
Q 006664 232 PP-----------------------GLD----YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280 (636)
Q Consensus 232 ~~-----------------------~~~----~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~ 280 (636)
.. ... ......+++.+.+||.+||..||.+|||+.++++||||+.....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 10 000 01123568889999999999999999999999999999976544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=406.84 Aligned_cols=264 Identities=24% Similarity=0.355 Sum_probs=197.0
Q ss_pred CCeEE-EeEEcccCceEEEEEEEc--CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe--CCeEE
Q 006664 11 EHYTL-YEEVGQGVSASVHRALCI--PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS--DHNLW 85 (636)
Q Consensus 11 ~~Y~l-~~~IG~G~fG~Vyka~~~--~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~--~~~l~ 85 (636)
+.|++ .++||+|+||+||+|.++ .+++.||||++..... ...+.+|+.+|+.++||||++++++|.. +..+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 45776 558999999999999976 5789999999964432 3467899999999999999999999965 67899
Q ss_pred EEEeccCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE----ccCCcEEEec
Q 006664 86 VVMPFMSGGSCLHILKAAY-------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI----DVRGAIKLGD 154 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~-------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl----d~~g~vKL~D 154 (636)
+||||+.| +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999975 8888876431 1249999999999999999999999999999999999999 6778999999
Q ss_pred cCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh---------HHHHH
Q 006664 155 FGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---------MKVLL 225 (636)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~---------~~~l~ 225 (636)
||+++.+.............+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+... .+.+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999986543322223345678999999999998756699999999999999999999999975443 23333
Q ss_pred HHHh--cCCCCCCcccc-------------------------------hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCc
Q 006664 226 MTLQ--NAPPGLDYERD-------------------------------RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHS 272 (636)
Q Consensus 226 ~~~~--~~~~~~~~~~~-------------------------------~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hp 272 (636)
.+.. ..+....+... ...+..+.+||.+||.+||.+|||+.|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 3222 11111111100 01267899999999999999999999999999
Q ss_pred cccccc
Q 006664 273 FFKQAR 278 (636)
Q Consensus 273 ffk~~~ 278 (636)
||....
T Consensus 336 ~f~~~~ 341 (405)
T 3rgf_A 336 YFLEDP 341 (405)
T ss_dssp GGTSSS
T ss_pred hhccCC
Confidence 998643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=397.08 Aligned_cols=264 Identities=21% Similarity=0.289 Sum_probs=205.3
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe-----
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN----- 83 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~----- 83 (636)
..++|++++.||+|+||+||+|.+..+|+.||||++..... ......+|+..++.++||||++++++|.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 34789999999999999999999999999999999864432 23355678888889999999999999976443
Q ss_pred --EEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCcccccCcccEEEcc-CCcEEEeccC
Q 006664 84 --LWVVMPFMSGGSCLHILKA--AYPDGFEEVVIATILREVLKGLDYLH--HHGHIHRDVKSGNILIDV-RGAIKLGDFG 156 (636)
Q Consensus 84 --l~iVmEy~~GGsL~~lL~~--~~~~~lse~~i~~i~~QIl~aL~yLH--~~gIvHRDLKP~NILld~-~g~vKL~DFG 156 (636)
+|+|||||.| +|...+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 8999999987 55554443 22356899999999999999999999 999999999999999996 8999999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC--
Q 006664 157 VSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-- 234 (636)
Q Consensus 157 la~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~-- 234 (636)
++..+.... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+.......
T Consensus 178 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 178 SAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp TCBCCCTTS----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CceecCCCC----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 997653322 23356899999999999775668999999999999999999999999888777666554321110
Q ss_pred ------------CCc-------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 235 ------------LDY-------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 235 ------------~~~-------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
... ......+.++++||.+||..||.+|||+.|+++||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 000 011225789999999999999999999999999999997643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=381.16 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=210.4
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPF---NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t---g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
...|++..++|++.+.||+|+||.||+|.+..+ +..||+|++.........+.+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 357899999999999999999999999998654 56799999876555556678899999999999999999999984
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
++..|+||||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred -cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 56789999999999999999865 3469999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYE 238 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~ 238 (636)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+...... .
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~----~ 237 (281)
T 1mp8_A 165 YMEDST--YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----P 237 (281)
T ss_dssp ----------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----C
T ss_pred ccCccc--ccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC----C
Confidence 653322 112234467889999999976 679999999999999999996 99999988776665555443322 2
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+..+++.+.+||.+||..||.+||++.++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 34678999999999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=384.61 Aligned_cols=263 Identities=21% Similarity=0.355 Sum_probs=225.8
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEE-----cCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeee
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALC-----IPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHC 76 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~-----~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~ 76 (636)
...|.+..++|.+.+.||+|+||.||+|.+ ..+++.||||++.........+.+.+|+.+++.+ +||||+++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 457889999999999999999999999985 4578899999998665555677899999999999 9999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHHHhCCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcc
Q 006664 77 SFVSDHNLWVVMPFMSGGSCLHILKAAYPD----------------GFEEVVIATILREVLKGLDYLHHHGHIHRDVKSG 140 (636)
Q Consensus 77 ~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~----------------~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~ 140 (636)
++.+++..|+|||||+||+|.+++...... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 999999999999999999999999875321 4899999999999999999999999999999999
Q ss_pred cEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCC
Q 006664 141 NILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYP 219 (636)
Q Consensus 141 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~ 219 (636)
|||++.++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eEEEcCCCCEEEccccccccccccc-cceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999987653322 2222345568899999999986 679999999999999999998 999998877
Q ss_pred hHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 220 ~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
........+..... ...+..++..+.+||.+||..||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 253 VDSKFYKMIKEGFR---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp SSHHHHHHHHHTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhHHHHHhccCCC---CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 65555555544322 2234568899999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=393.35 Aligned_cols=265 Identities=23% Similarity=0.355 Sum_probs=222.2
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeE
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCS 77 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~ 77 (636)
..|++..++|++++.||+|+||.||+|.+. .++..||||++...........+.+|+.+++.+ +||||++++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 367888999999999999999999999973 467789999997655555667899999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHHhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 006664 78 FVSDHNLWVVMPFMSGGSCLHILKAAYP---------------------DGFEEVVIATILREVLKGLDYLHHHGHIHRD 136 (636)
Q Consensus 78 ~~~~~~l~iVmEy~~GGsL~~lL~~~~~---------------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRD 136 (636)
+..++.+|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 9999999999999999999999986532 2378999999999999999999999999999
Q ss_pred cCcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCC
Q 006664 137 VKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPF 215 (636)
Q Consensus 137 LKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF 215 (636)
|||+|||++.++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCc-cceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999997654332 2223345678999999999987 679999999999999999998 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcc
Q 006664 216 SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273 (636)
Q Consensus 216 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpf 273 (636)
.+..........+.... ....+..+++++.+||.+||..||.+||++.++++|..
T Consensus 276 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGF---KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp TTCCCSHHHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCcHHHHHHHHhcCC---CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 88776555555554432 22334567899999999999999999999999997543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=381.18 Aligned_cols=264 Identities=28% Similarity=0.429 Sum_probs=215.0
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
....++|.....||+|+||.||+|.+..++..||||+++... ......+.+|+.+++.++||||+++++++...+.+++
T Consensus 18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 333445555569999999999999999999999999997543 3345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-CCcEEEeccCcccccccC
Q 006664 87 VMPFMSGGSCLHILKAAY-PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-~g~vKL~DFGla~~~~~~ 164 (636)
||||+.|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999999998753 234679999999999999999999999999999999999987 899999999998765322
Q ss_pred CCcccccccccCCCCCCChhhhhhc-cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHH-H-HHhcCCCCCCcccch
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL-M-TLQNAPPGLDYERDR 241 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~-~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~-~-~~~~~~~~~~~~~~~ 241 (636)
. .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.......... . ...... ...+.
T Consensus 177 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~ 249 (295)
T 2clq_A 177 N---PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH----PEIPE 249 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC----CCCCT
T ss_pred C---CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc----ccccc
Confidence 1 123456899999999999763 248899999999999999999999997644332221 1 111211 12346
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.++.++.+||.+||..||.+||++.++++||||+...
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 7889999999999999999999999999999998653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=396.18 Aligned_cols=263 Identities=24% Similarity=0.443 Sum_probs=226.2
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCC-------CcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCccee
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPF-------NEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKS 74 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t-------g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl 74 (636)
...|++..++|.+++.||+|+||+||+|.+..+ +..||||++...........+.+|+.+++.+ +||||+++
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 356889999999999999999999999997643 3689999998766666678899999999999 99999999
Q ss_pred eeEEEeCCeEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcc
Q 006664 75 HCSFVSDHNLWVVMPFMSGGSCLHILKAAYP--------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSG 140 (636)
Q Consensus 75 ~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~--------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~ 140 (636)
++++..++.+|+|||||.||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 9999999999999999999999999988642 35999999999999999999999999999999999
Q ss_pred cEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCC
Q 006664 141 NILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYP 219 (636)
Q Consensus 141 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~ 219 (636)
|||++.++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCC-TTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEEcCCCcEEEcccCccccccccc-ccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999997653322 1122344568899999999986 679999999999999999999 999999887
Q ss_pred hHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 220 ~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.......+..... ...+..++.++.+||.+||..||.+||++.+++++
T Consensus 299 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKEGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTTCC----CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCC----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7666555444322 22346788999999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=391.75 Aligned_cols=270 Identities=34% Similarity=0.552 Sum_probs=203.3
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHH-HHHhCCCCCcceeeeEEEeC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQ-TMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~-iL~~L~HPNIVkl~~~~~~~ 81 (636)
...|.+..++|++++.||+|+||.||+|.+..+|+.||||++...........+.+|+. +++.++||||+++++++..+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 45688999999999999999999999999999999999999986655555556666666 66788999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCc
Q 006664 82 HNLWVVMPFMSGGSCLHILKA---AYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
+..|+||||+.| +|.+++.. .....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 999999999986 78877764 2246799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhh---hccCCCcccchhhHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCC
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVME---QLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQNAPP 233 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~---~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~-~~l~~~~~~~~~ 233 (636)
+....... ......||+.|+|||++. ....++.++|||||||++|+|++|..||.+.... ..+........+
T Consensus 173 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3aln_A 173 SGQLVDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248 (327)
T ss_dssp SCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred ceeccccc----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence 87653221 123447999999999984 2256899999999999999999999999875432 212122222222
Q ss_pred CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 234 ~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.+.......++..+.+||.+||..||.+||++.++++||||...
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 23223335689999999999999999999999999999999753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=379.53 Aligned_cols=258 Identities=22% Similarity=0.415 Sum_probs=225.7
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
..|++..++|++.+.||+|+||+||+|.+..++..||+|++... ......+.+|+.+++.++||||+++++++.++..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 57999999999999999999999999999999999999999643 3356778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+||||+.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999999886656799999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.............. ....+..
T Consensus 164 ~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~ 236 (288)
T 3kfa_A 164 DT--YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----RMERPEG 236 (288)
T ss_dssp SS--SEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----CCCCCTT
T ss_pred Cc--cccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC----CCCCCCC
Confidence 22 222345568899999999986 678999999999999999999 999998877665554443332 2234467
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+++.+.+||.+||..||.+||++.++++
T Consensus 237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 237 CPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 8999999999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=377.91 Aligned_cols=258 Identities=22% Similarity=0.385 Sum_probs=219.4
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
...|.+..++|++++.||+|+||+||+|.+. ++..||||++..... ....+.+|+.+++.++||||+++++++.++.
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 3578999999999999999999999999875 678899999975432 3467889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+||||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999999999763 2569999999999999999999999999999999999999999999999999987553
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+..... ...+.
T Consensus 172 ~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----~~~~~ 244 (283)
T 3gen_A 172 DDE--YTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----LYRPH 244 (283)
T ss_dssp CHH--HHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----CCCCT
T ss_pred ccc--cccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC----CCCCC
Confidence 221 112234567888999999986 578999999999999999998 9999998887766655554322 23345
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.+++.+.+||.+||..||.+|||+.++++|
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 678999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=401.52 Aligned_cols=261 Identities=22% Similarity=0.372 Sum_probs=222.7
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+..|.+..++|.+.+.||+|+||.||+|.+..+++.||||+++..........+.+|+.+|+.++||||+++++++..+.
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 46789999999999999999999999999999999999999975544444566889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999999999865 2458999999999999999999999999999999999999999999999999987542
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
... .........+++.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.........+.... ..+.+.
T Consensus 265 ~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~ 338 (377)
T 3cbl_A 265 DGV-YAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG----RLPCPE 338 (377)
T ss_dssp TSE-EECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC----CCCCCT
T ss_pred CCc-eeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCC
Confidence 211 1111122345778999999986 568999999999999999998 999999887766554444332 223346
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.++..+.+||.+||..||.+|||+.++++
T Consensus 339 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 68899999999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=386.92 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=216.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCC-cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCC------cceeeeEEEeC
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFN-EIVAVKILDFERDNSDLSNISREAQTMILVDHPN------VLKSHCSFVSD 81 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg-~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPN------IVkl~~~~~~~ 81 (636)
..++|++++.||+|+||+||+|.+..++ ..||+|+++. .......+.+|+.+++.+.|++ |+.+++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc--cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 4589999999999999999999998777 7999999863 2334567889999999987665 89999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE-----------------
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI----------------- 144 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl----------------- 144 (636)
..+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999999 6688888877655679999999999999999999999999999999999999
Q ss_pred --ccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHH
Q 006664 145 --DVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 222 (636)
Q Consensus 145 --d~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~ 222 (636)
+.++.+||+|||++..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.......
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHE------HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp EEESCCCEEECCCTTCEETTS------CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccCCCcEEEeecCccccccc------cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5678999999999875322 1235689999999999986 679999999999999999999999999877665
Q ss_pred HHHHHHhcCCCCC---------------------------------------CcccchhhhHHHHHHHHhhcccCCCCCC
Q 006664 223 VLLMTLQNAPPGL---------------------------------------DYERDRKFSKSFKQMIASCLVKDPSKRP 263 (636)
Q Consensus 223 ~l~~~~~~~~~~~---------------------------------------~~~~~~~~S~~l~dLI~~cL~~DP~kRp 263 (636)
.+..+.....+.. ........+.++.+||.+||..||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 5443322111000 0001123466899999999999999999
Q ss_pred CHHHHHhCcccccccC
Q 006664 264 SAKKLLKHSFFKQARS 279 (636)
Q Consensus 264 sa~elL~Hpffk~~~~ 279 (636)
|+.++++||||+....
T Consensus 327 t~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 327 TLAEALLHPFFAGLTP 342 (355)
T ss_dssp CHHHHTTSGGGGGCCH
T ss_pred CHHHHhcChhhcCCCh
Confidence 9999999999997653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=374.17 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=220.2
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
.+++..++|++++.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++.++..+
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 46788999999999999999999999775 677899999965432 346789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999999999875 245999999999999999999999999999999999999999999999999998765333
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.................. ..+..+
T Consensus 158 ~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~ 230 (268)
T 3sxs_A 158 QY--VSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL----YRPHLA 230 (268)
T ss_dssp CE--EECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----CCCTTS
T ss_pred hh--hcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC----CCCCcC
Confidence 21 12234457788999999976 568999999999999999998 99999988877766555543322 234567
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
++.+.+||.+||..||.+|||+.++++|
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=405.46 Aligned_cols=262 Identities=15% Similarity=0.149 Sum_probs=198.4
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhC--CCCCcceee-------eE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILV--DHPNVLKSH-------CS 77 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L--~HPNIVkl~-------~~ 77 (636)
....|.+++.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+++.| +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 34569999999999999999999999999999999987653 23456778886655544 699988755 55
Q ss_pred EEeC-----------------CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHH------HHHHHHHHHHHHHHHHCCCcc
Q 006664 78 FVSD-----------------HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVI------ATILREVLKGLDYLHHHGHIH 134 (636)
Q Consensus 78 ~~~~-----------------~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i------~~i~~QIl~aL~yLH~~gIvH 134 (636)
+... ..+|+|||||+ |+|.+++.... ..+++... ..++.||+.||.|||++||+|
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 5443 34899999999 79999998752 23444444 577799999999999999999
Q ss_pred cccCcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhh-ccCCCcccchhhHHHHHHHHHcCCC
Q 006664 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ-LHGYDFKADIWSFGITALELAHGHA 213 (636)
Q Consensus 135 RDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~-~~~ys~ksDIWSLGiiLyeLltG~~ 213 (636)
|||||+|||++.+|.+||+|||+++.... ......||+.|+|||++.+ ...|+.++|||||||++|+|++|+.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999975421 1124567799999999964 2468999999999999999999999
Q ss_pred CCCCCChHHHH--H--HHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 214 PFSKYPPMKVL--L--MTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 214 PF~~~~~~~~l--~--~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
||.+..+.... . ...........++....+++.+++||.+||.+||.+|||+.++++||||+...
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 99875332100 0 00011112233344457899999999999999999999999999999998653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=385.53 Aligned_cols=262 Identities=20% Similarity=0.352 Sum_probs=224.9
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEE
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSF 78 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~ 78 (636)
..|++..++|++.+.||+|+||.||+|.+. .+++.||||++...........+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 467888999999999999999999999877 467899999997655555666789999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcE
Q 006664 79 VSDHNLWVVMPFMSGGSCLHILKAAY--------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAI 150 (636)
Q Consensus 79 ~~~~~l~iVmEy~~GGsL~~lL~~~~--------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~v 150 (636)
.++...|+|||||.||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 99999999999999999999997642 1357899999999999999999999999999999999999999999
Q ss_pred EEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 006664 151 KLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQ 229 (636)
Q Consensus 151 KL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~ 229 (636)
||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 178 kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 178 KIGDFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp EECCTTCCCGGGGGG-CEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EECcCcccccccccc-ccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 999999987653322 1122334578999999999986 678999999999999999999 8999998877666655554
Q ss_pred cCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 230 ~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.... ..+..++..+.+||.+||..||.+|||+.++++|
T Consensus 256 ~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 256 GGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3322 2345788999999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=378.93 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=223.5
Q ss_pred cccccCCCCeEEEe-EEcccCceEEEEEEEc--CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 4 KKYPIGAEHYTLYE-EVGQGVSASVHRALCI--PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~-~IG~G~fG~Vyka~~~--~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
+++.+..++|.+.+ .||+|+||.||+|.+. .++..||||+++..........+.+|+.+++.++||||+++++++ .
T Consensus 2 ~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred CcccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 46778889999988 9999999999999864 578899999998765556678899999999999999999999999 5
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
...+|+||||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 56799999999999999999653 35699999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
...............||+.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.....+ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~----~~ 234 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----EC 234 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC----CC
T ss_pred eccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC----CC
Confidence 5433322223344567899999999976 568999999999999999998 99999987776665554443322 23
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcc
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpf 273 (636)
+..++..+.+||.+||..||.+||++.++++|.+
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 4678999999999999999999999999997543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=391.23 Aligned_cols=258 Identities=28% Similarity=0.376 Sum_probs=214.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe-----
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHN----- 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~----- 83 (636)
.++|.+.+.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 47899999999999999999999999999999999754432 345678899999999999999999999987654
Q ss_pred -EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 84 -LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 84 -l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
+|+||||+. |+|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999998 47777663 359999999999999999999999999999999999999999999999999987542
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC----------
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP---------- 232 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~---------- 232 (636)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+.....
T Consensus 178 ~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 178 A------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred C------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 1 123568999999999997656789999999999999999999999998877665554433110
Q ss_pred -------------CC--CC-cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 233 -------------PG--LD-YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 233 -------------~~--~~-~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.. .. ......++.++++||.+||..||.+|||+.++++||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00 00 012246789999999999999999999999999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=394.74 Aligned_cols=258 Identities=25% Similarity=0.343 Sum_probs=214.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CC-----CcceeeeEEEeCCe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HP-----NVLKSHCSFVSDHN 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HP-----NIVkl~~~~~~~~~ 83 (636)
.++|++++.||+|+||+||+|.+..+++.||||+++.. ......+.+|+.+++.+. |+ +|+++++++.....
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 47899999999999999999999999999999999632 334566788999998875 55 49999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCcccccCcccEEEc--cCCcEEEeccCccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH--HHGHIHRDVKSGNILID--VRGAIKLGDFGVSA 159 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH--~~gIvHRDLKP~NILld--~~g~vKL~DFGla~ 159 (636)
+|+||||+.| +|.+++.......+++..++.++.||+.||.||| ..||+||||||+|||++ .++.+||+|||++.
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 9999999965 9999998875567999999999999999999999 57999999999999994 47889999999997
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC----
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL---- 235 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~---- 235 (636)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+....+.+..+........
T Consensus 210 ~~~~------~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 210 QLGQ------RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp ETTC------CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccc------ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 6522 1235689999999999987 5799999999999999999999999998887776655543211000
Q ss_pred ----------------Cc------------cc---------------------------chhhhHHHHHHHHhhcccCCC
Q 006664 236 ----------------DY------------ER---------------------------DRKFSKSFKQMIASCLVKDPS 260 (636)
Q Consensus 236 ----------------~~------------~~---------------------------~~~~S~~l~dLI~~cL~~DP~ 260 (636)
.+ .. ....++++++||.+||.+||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 00 00 001125789999999999999
Q ss_pred CCCCHHHHHhCcccccc
Q 006664 261 KRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 261 kRpsa~elL~Hpffk~~ 277 (636)
+|||+.|+|+||||+..
T Consensus 363 ~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSCCHHHHTTSGGGCC-
T ss_pred hCCCHHHHhcCcccccC
Confidence 99999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=381.48 Aligned_cols=267 Identities=31% Similarity=0.557 Sum_probs=207.2
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHH-HHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSN-ISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~-i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
...|.+..++|++++.||+|+||.||+|.+..+|+.||||++........... +.++..+++.++||||+++++++.++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 45788888999999999999999999999999999999999986654443333 44555567888999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
..+|+||||+ ++.+..+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred CcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 9999999999 55666665543 36799999999999999999999995 999999999999999999999999999875
Q ss_pred cccCCCcccccccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCCCC
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYP-PMKVLLMTLQNAPPGL 235 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~-~~~~l~~~~~~~~~~~ 235 (636)
+.... ......||+.|+|||++.. ...++.++|||||||++|+|++|..||.... ....+........+..
T Consensus 175 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 175 LVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC
T ss_pred ccCCc----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC
Confidence 53321 2235679999999999952 3468899999999999999999999998743 4444445554443322
Q ss_pred CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 236 ~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+....++.++.+||.+||..||.+||++.++++||||+..
T Consensus 251 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 251 --PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp --CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred --CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 2334688999999999999999999999999999999753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=386.84 Aligned_cols=256 Identities=16% Similarity=0.187 Sum_probs=210.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~i 86 (636)
+..++|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.+++.+ +||||+++++++..+...|+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 446899999999999999999999999999999999975533 23578999999999 99999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc-----EEEeccCccccc
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA-----IKLGDFGVSACL 161 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~-----vKL~DFGla~~~ 161 (636)
||||+ ||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++..+
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99999 99999999874 367999999999999999999999999999999999999998887 999999999865
Q ss_pred ccCCCcc----cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh---HHHHHHHHhcCCCC
Q 006664 162 FDSGDRQ----RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPPG 234 (636)
Q Consensus 162 ~~~~~~~----~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~---~~~l~~~~~~~~~~ 234 (636)
....... +.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 4432211 12346789999999999987 6789999999999999999999999987433 22222222111100
Q ss_pred CCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 235 ~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
........++ ++.+||.+||..||.+||++.+|++
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0001112345 9999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=387.92 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=213.9
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
+.+..++|.+++.||+|+||+||+|.+..+++.||+|++.. ........+.+|+.+++.++||||+++++++.++..+|
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 34567999999999999999999999999999999999843 34455678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+|||||.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999874 3579999999999999999999999999999999999999999999999999997653322
Q ss_pred Ccc-----------cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHH-----HHHHHh
Q 006664 166 DRQ-----------RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV-----LLMTLQ 229 (636)
Q Consensus 166 ~~~-----------~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~-----l~~~~~ 229 (636)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 111 11225689999999999987 6799999999999999999999999975432110 011111
Q ss_pred cCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 230 ~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
. ..+..+++.+.+||.+||..||.+|||+.++++
T Consensus 242 ~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 R-------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp H-------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c-------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 113557789999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=394.16 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=187.1
Q ss_pred CCCeEEEe-EEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe----CCeE
Q 006664 10 AEHYTLYE-EVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS----DHNL 84 (636)
Q Consensus 10 ~~~Y~l~~-~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~----~~~l 84 (636)
.++|.+++ .||+|+||+||+|.++.+|+.||||++... .....+....++.++||||++++++|.. +..+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 47788865 699999999999999999999999998632 1122233334577899999999999987 4568
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc---CCcEEEeccCccccc
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---RGAIKLGDFGVSACL 161 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---~g~vKL~DFGla~~~ 161 (636)
|+|||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999999998765557999999999999999999999999999999999999975 456999999998754
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHH---HHHhcCCCCCCcc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL---MTLQNAPPGLDYE 238 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~---~~~~~~~~~~~~~ 238 (636)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.......... ..+..........
T Consensus 182 ~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 182 TQN-----ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp ----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred ccc-----ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 221 2345689999999999865 568899999999999999999999997655433211 1111122222333
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.+..++.++++||.+||..||.+|||+.++++||||++.
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 346789999999999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=385.60 Aligned_cols=263 Identities=24% Similarity=0.433 Sum_probs=223.3
Q ss_pred CCcccccCCCCeEEEeEEcccCceEEEEEEEc-------CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcce
Q 006664 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCI-------PFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLK 73 (636)
Q Consensus 2 ~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-------~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVk 73 (636)
+...|++..++|++++.||+|+||.||+|.+. .++..||||+++..........+.+|+.+++.+ +||||++
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 34678999999999999999999999999986 467899999998665556677899999999999 8999999
Q ss_pred eeeEEEeCCeEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCc
Q 006664 74 SHCSFVSDHNLWVVMPFMSGGSCLHILKAAYP--------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKS 139 (636)
Q Consensus 74 l~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~--------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP 139 (636)
+++++.+++.+|+||||+.||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 99999999999999999999999999986532 2489999999999999999999999999999999
Q ss_pred ccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCC
Q 006664 140 GNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKY 218 (636)
Q Consensus 140 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~ 218 (636)
+|||++.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999999999999876533221 122334567889999999976 568999999999999999999 99999988
Q ss_pred ChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 219 PPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 219 ~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
........+...... ..+..++..+.+||.+||..||.+||++.++++
T Consensus 264 ~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 264 PVEELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp CHHHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHhcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 776655544443322 234568899999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=380.15 Aligned_cols=258 Identities=23% Similarity=0.364 Sum_probs=213.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEE----EcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRAL----CIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD-- 81 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~----~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-- 81 (636)
+...+|++++.||+|+||.||+|. +..+++.||||++...........+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 445779999999999999999998 56789999999998666555678899999999999999999999999887
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+|+||||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 67999999999999999997653 56999999999999999999999999999999999999999999999999999866
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCC--------------ChHHHHHHH
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKY--------------PPMKVLLMT 227 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~--------------~~~~~l~~~ 227 (636)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||... .....+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 444333334456678999999999987 56889999999999999999999986421 111122222
Q ss_pred HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 228 ~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+.. ......+..+++.+.+||.+||..||.+|||+.++++
T Consensus 256 ~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 256 LKE---GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHT---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred Hhc---cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 222 2223345678999999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=369.83 Aligned_cols=255 Identities=24% Similarity=0.403 Sum_probs=219.5
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
+|.+..++|++++.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.++..+
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 68899999999999999999999999986 678999999975432 346789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999999999875 356899999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.........||+.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+..... ...+..+
T Consensus 158 --~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~----~~~~~~~ 230 (267)
T 3t9t_A 158 --QYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----LYKPRLA 230 (267)
T ss_dssp --HHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----CCCCTTS
T ss_pred --cccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc----CCCCccC
Confidence 1112234567889999999986 678999999999999999999 9999998877666555544322 2234567
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+..+.+||.+||..||.+||++.++++
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 231 STHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 899999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=391.41 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=212.4
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-----------CCCcceee
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-----------HPNVLKSH 75 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-----------HPNIVkl~ 75 (636)
++..++|++++.||+|+||+||+|.+..+|+.||||++.. .......+.+|+.+++.+. ||||++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 4566899999999999999999999999999999999863 2334567889999998876 89999999
Q ss_pred eEEEeCC----eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccccCcccEEEcc----
Q 006664 76 CSFVSDH----NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH-GHIHRDVKSGNILIDV---- 146 (636)
Q Consensus 76 ~~~~~~~----~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHRDLKP~NILld~---- 146 (636)
+++.... .+++||||+ |++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9998754 799999999 89999999886656799999999999999999999998 9999999999999953
Q ss_pred --CCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh----
Q 006664 147 --RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---- 220 (636)
Q Consensus 147 --~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~---- 220 (636)
.+.+||+|||++...... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 348999999998754221 234589999999999987 5689999999999999999999999976431
Q ss_pred --HHHHHHHHhcC--CCC------------------------C-----------CcccchhhhHHHHHHHHhhcccCCCC
Q 006664 221 --MKVLLMTLQNA--PPG------------------------L-----------DYERDRKFSKSFKQMIASCLVKDPSK 261 (636)
Q Consensus 221 --~~~l~~~~~~~--~~~------------------------~-----------~~~~~~~~S~~l~dLI~~cL~~DP~k 261 (636)
...+..+.... .+. . .+..+..++.++.+||.+||..||.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 22222221100 000 0 01123467889999999999999999
Q ss_pred CCCHHHHHhCcccccc
Q 006664 262 RPSAKKLLKHSFFKQA 277 (636)
Q Consensus 262 Rpsa~elL~Hpffk~~ 277 (636)
|||+.++++||||+..
T Consensus 325 Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDT 340 (373)
T ss_dssp CBCHHHHHTCGGGTTC
T ss_pred cCCHHHHhhChhhhcc
Confidence 9999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=380.20 Aligned_cols=262 Identities=23% Similarity=0.385 Sum_probs=208.9
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEE----EcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRAL----CIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~----~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
..+..++|++++.||+|+||+||+|. +..+++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 45678999999999999999999998 5678999999998643 334567789999999999999999999998653
Q ss_pred --CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 82 --HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 82 --~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
..+|+|||||.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 5699999999999999999875 2459999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHH------------HHHHH
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK------------VLLMT 227 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~------------~l~~~ 227 (636)
.+..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 65433322233344567888999999987 679999999999999999999999986432110 00011
Q ss_pred HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 228 ~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..........+.+..+++++.+||.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111111223345678999999999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=374.47 Aligned_cols=259 Identities=17% Similarity=0.195 Sum_probs=213.9
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeE
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l 84 (636)
-.+..++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.+ +||||+++++++.++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 34667899999999999999999999999999999999865433 23478899999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc-----EEEeccCccc
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA-----IKLGDFGVSA 159 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~-----vKL~DFGla~ 159 (636)
|+||||+ |++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 9999999 99999999875 346999999999999999999999999999999999999987765 9999999998
Q ss_pred ccccCCCcc----cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC---hHHHHHHHHhcCC
Q 006664 160 CLFDSGDRQ----RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP---PMKVLLMTLQNAP 232 (636)
Q Consensus 160 ~~~~~~~~~----~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~---~~~~l~~~~~~~~ 232 (636)
......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. ....+..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 664432211 22356789999999999976 678999999999999999999999998743 2222222222111
Q ss_pred CCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 233 ~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..........+++++.+||.+||..||.+||++.+|++
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 11111223467899999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=386.44 Aligned_cols=262 Identities=20% Similarity=0.354 Sum_probs=224.1
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCc-----EEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeE
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCS 77 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~-----~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~ 77 (636)
..|++..++|++.+.||+|+||.||+|.+..++. .||+|++...........+.+|+.+++.+ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4688999999999999999999999999987665 79999997665555677899999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc
Q 006664 78 FVSDHNLWVVMPFMSGGSCLHILKAAY------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID 145 (636)
Q Consensus 78 ~~~~~~l~iVmEy~~GGsL~~lL~~~~------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld 145 (636)
+..+..+|+|||||+||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 999999999999999999999997642 24589999999999999999999999999999999999999
Q ss_pred cCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHH
Q 006664 146 VRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVL 224 (636)
Q Consensus 146 ~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l 224 (636)
.++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCT-TSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred CCCeEEECcccccccccccc-ceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999997654332 1222345567889999999986 679999999999999999998 99999887665555
Q ss_pred HHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 225 LMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
......... ...+..++..+.+||.+||..||.+|||+.++++
T Consensus 277 ~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 277 YKLVKDGYQ---MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCC---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 555544322 2234567899999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=383.11 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=221.7
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEE-----cCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeE
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALC-----IPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCS 77 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~-----~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~ 77 (636)
..|++..++|++.+.||+|+||+||+|.+ ..+++.||||++...........+.+|+.+++.+ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 35788889999999999999999999985 3577999999997665555667889999999999 79999999999
Q ss_pred EEeCC-eEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccE
Q 006664 78 FVSDH-NLWVVMPFMSGGSCLHILKAAYP--------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNI 142 (636)
Q Consensus 78 ~~~~~-~l~iVmEy~~GGsL~~lL~~~~~--------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NI 142 (636)
+...+ .+|+|||||.||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 88754 59999999999999999987532 1289999999999999999999999999999999999
Q ss_pred EEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChH
Q 006664 143 LIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPM 221 (636)
Q Consensus 143 Lld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~ 221 (636)
|++.++.+||+|||++..+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 999999999999999976543322 222345678999999999986 679999999999999999998 99999887655
Q ss_pred HHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 222 KVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 222 ~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
..+...+..... ...+..+++.+.++|.+||..||.+|||+.++++|
T Consensus 258 ~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 258 EEFCRRLKEGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHHTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhccCcc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 544444443321 22345678999999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=376.26 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=215.9
Q ss_pred CcccccCCCCeEEEe-EEcccCceEEEEEEE--cCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEE
Q 006664 3 KKKYPIGAEHYTLYE-EVGQGVSASVHRALC--IPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSF 78 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~-~IG~G~fG~Vyka~~--~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~ 78 (636)
...+.+..++|.+.+ .||+|+||+||+|.+ ..+++.||||++..... ......+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456778889999999 999999999999954 56789999999975543 23467789999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcc
Q 006664 79 VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158 (636)
Q Consensus 79 ~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla 158 (636)
....+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 667889999999999999999875 56999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCc
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY 237 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~ 237 (636)
.................||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---- 239 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---- 239 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----
T ss_pred eeeccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 765433322222334457889999999976 568899999999999999999 99999988776655554443322
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+..++..+.++|.+||..||.+||++.++++
T Consensus 240 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 234578999999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=387.52 Aligned_cols=259 Identities=23% Similarity=0.352 Sum_probs=218.6
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch-----hHHHHHHHHHHHHhCC--CCCcceeeeE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-----DLSNISREAQTMILVD--HPNVLKSHCS 77 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~-----~~~~i~rEi~iL~~L~--HPNIVkl~~~ 77 (636)
..+...++|++++.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.+++.+. ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 34566789999999999999999999999999999999997654221 2245678999999996 5999999999
Q ss_pred EEeCCeEEEEEeccCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc-cCCcEEEecc
Q 006664 78 FVSDHNLWVVMPFMSG-GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID-VRGAIKLGDF 155 (636)
Q Consensus 78 ~~~~~~l~iVmEy~~G-GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld-~~g~vKL~DF 155 (636)
+..+...++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 9999999999999987 8999999876 6799999999999999999999999999999999999998 7799999999
Q ss_pred CcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 006664 156 GVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 235 (636)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~ 235 (636)
|++...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.... ......
T Consensus 195 g~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~---- 259 (320)
T 3a99_A 195 GSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ---- 259 (320)
T ss_dssp TTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC----
T ss_pred ccccccccc-----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccc----
Confidence 998765322 23356799999999999875545788999999999999999999997532 112211
Q ss_pred CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccChH
Q 006664 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281 (636)
Q Consensus 236 ~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~~~ 281 (636)
......++.++.+||.+||..||.+||++.++++||||+......
T Consensus 260 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 260 -VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp -CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred -ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCcc
Confidence 122356789999999999999999999999999999999775443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=384.81 Aligned_cols=256 Identities=22% Similarity=0.375 Sum_probs=207.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEE----EEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIV----AVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~v----AIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+..++|++++.||+|+||+||+|.+..+++.+ |+|.+...........+.+|+.+++.++||||+++++++.++.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 55689999999999999999999998888765 7777754444456678999999999999999999999998765
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
.++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 78999999999999999874 35799999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.. .........||+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.............. ....+..
T Consensus 170 ~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~ 243 (327)
T 3poz_A 170 EE-KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQPPI 243 (327)
T ss_dssp TC-C-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----CCCCCTT
T ss_pred Cc-ccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC----CCCCCcc
Confidence 22 2222334567889999999987 679999999999999999999 999999877665544433322 2233466
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
++.++.+||.+||..||.+||++.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 88999999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=370.69 Aligned_cols=251 Identities=29% Similarity=0.502 Sum_probs=206.4
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC---chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD---NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~---~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
++..++|++.+.||+|+||.||+|.+. |..||||++..... ....+.+.+|+.+++.++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 567899999999999999999999974 89999999875432 2345778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccccCcccEEEcc--------CCcEEE
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG---HIHRDVKSGNILIDV--------RGAIKL 152 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g---IvHRDLKP~NILld~--------~g~vKL 152 (636)
+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999999854 57999999999999999999999999 899999999999985 678999
Q ss_pred eccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 006664 153 GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP 232 (636)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~ 232 (636)
+|||++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...............
T Consensus 158 ~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 231 (271)
T 3dtc_A 158 TDFGLAREWHRT-----TKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC
T ss_pred ccCCcccccccc-----cccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC
Confidence 999998754322 1235679999999999987 6789999999999999999999999998887766555544322
Q ss_pred CCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 233 ~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
....+..+++.+.+||.+||..||.+|||+.++++|
T Consensus 232 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 232 ---ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 223456788999999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=386.85 Aligned_cols=259 Identities=21% Similarity=0.378 Sum_probs=214.0
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcE----EEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEI----VAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~----vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
.-.+..++|++++.||+|+||+||+|.+..+++. ||+|++...........+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 3456779999999999999999999999888876 77777754443344456788999999999999999999886
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
+...++||||+.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 56799999999999999999764 35689999999999999999999999999999999999999999999999999986
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
+.... .........||+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.........+..... ...
T Consensus 165 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----~~~ 238 (325)
T 3kex_A 165 LPPDD-KQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER----LAQ 238 (325)
T ss_dssp SCCCT-TCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB----CCC
T ss_pred cCccc-ccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----CCC
Confidence 53332 2223345678899999999986 679999999999999999999 9999998776655544443322 223
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
+..++.++.+||.+||..||.+||++.++++|
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 239 PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 35578899999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=395.27 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=209.2
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCI---PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
..++..++|.+.+.||+|+||.||+|.+. .++..||||+++..........+.+|+.+|+.++||||+++++++.++
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 34567789999999999999999999887 567889999997665555667899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999999999764 356999999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
..............+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||......+....+.... ..+.+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~----~~~~~ 272 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY----RLPPP 272 (373)
T ss_dssp ----------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE----ECCCC
T ss_pred ccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCC
Confidence 433222222223356789999999986 679999999999999999997 999999887766655444321 12234
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..++..+.+||.+||..||.+||++.++++
T Consensus 273 ~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 567899999999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=384.38 Aligned_cols=263 Identities=22% Similarity=0.371 Sum_probs=218.9
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEE-----EcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRAL-----CIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~-----~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
++..++|++++.||+|+||.||+|. +..++..||||++...........+.+|+.+++.++||||+++++++..+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 5678999999999999999999998 56788999999997555555667889999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc---CCcEEEe
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYP-----DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---RGAIKLG 153 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~-----~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---~g~vKL~ 153 (636)
...|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999999987532 34899999999999999999999999999999999999984 4469999
Q ss_pred ccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCC
Q 006664 154 DFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAP 232 (636)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~ 232 (636)
|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.....
T Consensus 186 Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 186 DFGMARDIYRAS-YYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCHHHHHHHC-------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred cccccccccccc-ccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 999987543322 1222345678999999999976 678999999999999999998 9999998877666555544332
Q ss_pred CCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 233 ~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
. ..+..++..+.+||.+||..||.+||++.++++|.|+.
T Consensus 264 ~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 264 M----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2 23456889999999999999999999999999998874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=382.45 Aligned_cols=260 Identities=21% Similarity=0.339 Sum_probs=214.4
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCC----cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFN----EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg----~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
..++..++|.+.+.||+|+||+||+|.+..++ ..||||++...........+.+|+.+++.++||||+++++++..
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 45788899999999999999999999987654 46999999765555566678999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
...+|+||||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999999999764 35799999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
...............||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..... .+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~----~~~ 271 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR----LPT 271 (333)
T ss_dssp --------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----CCC
T ss_pred hccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc----CCC
Confidence 5433222222233457889999999976 678999999999999999998 9999998877666555543322 233
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+..++..+.+||.+||..||.+||++.++++
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4578899999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=372.76 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=217.8
Q ss_pred CCCcccccCCCCeEEEeEEcccCceEEEEEEEcC---CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeE
Q 006664 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIP---FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCS 77 (636)
Q Consensus 1 ~~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~---tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~ 77 (636)
|....|.+..++|.+.+.||+|+||+||+|.+.. ++..||+|++...........+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp --CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCCccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4456788999999999999999999999998754 3456999999866555667789999999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCc
Q 006664 78 FVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 78 ~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
+.+ ...|+||||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 82 IEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred EcC-CCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCC
Confidence 865 4568999999999999999875 25699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCC
Q 006664 158 SACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLD 236 (636)
Q Consensus 158 a~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~ 236 (636)
+....... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.................
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~---- 232 (281)
T 3cc6_A 160 SRYIEDED--YYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR---- 232 (281)
T ss_dssp GGCC-----------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC----
T ss_pred Cccccccc--ccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC----
Confidence 87653321 112234567889999999976 678999999999999999998 9999987666655544443322
Q ss_pred cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 237 ~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
...+..+++.+.+||.+||..||.+||++.+++++
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 22345688999999999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=370.38 Aligned_cols=254 Identities=18% Similarity=0.297 Sum_probs=217.8
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC-
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSD- 81 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~- 81 (636)
+.+.+..++|++.+.||+|+||+||+|.+. |..||||++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp -CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred CcCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 357788899999999999999999999984 89999999976543 34566789999999999999999999999887
Q ss_pred -CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCcccEEEccCCcEEEeccCcc
Q 006664 82 -HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG--HIHRDVKSGNILIDVRGAIKLGDFGVS 158 (636)
Q Consensus 82 -~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHRDLKP~NILld~~g~vKL~DFGla 158 (636)
..+|+||||++||+|.+++.......+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 78999999999999999998764446999999999999999999999999 999999999999999999999999886
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhhcc--CCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH--GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 236 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~--~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~ 236 (636)
... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+................
T Consensus 161 ~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--- 229 (271)
T 3kmu_A 161 FSF--------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR--- 229 (271)
T ss_dssp CTT--------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC---
T ss_pred eee--------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC---
Confidence 532 123457999999999997622 2334799999999999999999999988887766655544322
Q ss_pred cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 237 ~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
...+..++.++.+||.+||..||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2334678999999999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=377.31 Aligned_cols=265 Identities=23% Similarity=0.400 Sum_probs=214.7
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCC--CCCcceeeeEEEe
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVD--HPNVLKSHCSFVS 80 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~--HPNIVkl~~~~~~ 80 (636)
..+++..++|++++.||+|+||.||+|.+. +++.||||+++.... ......+.+|+.+++.+. ||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 456778899999999999999999999885 589999999976543 345678899999999997 5999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
+..+|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence 999999999 5678999999875 5799999999999999999999999999999999999996 58999999999976
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhc----------cCCCcccchhhHHHHHHHHHcCCCCCCCCChHH-HHHHHHh
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQL----------HGYDFKADIWSFGITALELAHGHAPFSKYPPMK-VLLMTLQ 229 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~----------~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~-~l~~~~~ 229 (636)
+.... ........+||+.|+|||++.+. ..++.++|||||||++|+|++|..||....... .+.....
T Consensus 176 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 176 MQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp ---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcc-ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 53322 11223456899999999998641 368889999999999999999999998754432 2222222
Q ss_pred cCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 230 ~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.. .....+...+.++.+||.+||..||.+||++.++++||||+..
T Consensus 255 -~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 255 -PN--HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp -TT--SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred -cc--cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 11 1222334568899999999999999999999999999999854
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=376.21 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=210.8
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCC-------cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFN-------EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg-------~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
.+..++|.+.+.||+|+||+||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 567899999999999999999999998877 479999986433 335677899999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc--------EE
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA--------IK 151 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~--------vK 151 (636)
++...|+|||||.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999875 234999999999999999999999999999999999999998887 99
Q ss_pred EeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc
Q 006664 152 LGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQN 230 (636)
Q Consensus 152 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~ 230 (636)
|+|||++..... .....||+.|+|||++.+...++.++|||||||++|+|++ |.+||......... .....
T Consensus 162 l~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~ 233 (289)
T 4fvq_A 162 LSDPGISITVLP-------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYED 233 (289)
T ss_dssp ECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHT
T ss_pred eccCcccccccC-------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhc
Confidence 999999864421 2345789999999999875679999999999999999999 55566555544433 33222
Q ss_pred CCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 231 APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 231 ~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.. ..+..++.++.+||.+||..||.+|||+.++++|
T Consensus 234 ~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RH-----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TC-----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11 1223457789999999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=380.57 Aligned_cols=259 Identities=21% Similarity=0.346 Sum_probs=215.7
Q ss_pred cccc-cCCCCeEEEeEEcccCceEEEEEEEcCCCcEE--EEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEE
Q 006664 4 KKYP-IGAEHYTLYEEVGQGVSASVHRALCIPFNEIV--AVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFV 79 (636)
Q Consensus 4 ~~~~-i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~v--AIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~ 79 (636)
..|+ +..++|++.+.||+|+||.||+|.+..+|..+ |+|.+...........+.+|+.+++.+ +||||+++++++.
T Consensus 17 ~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 17 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp CCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 4566 55689999999999999999999999999866 999987554445566789999999999 8999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAY--------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID 145 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~--------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld 145 (636)
+++.+|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 9999999999999999999998642 23699999999999999999999999999999999999999
Q ss_pred cCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHH
Q 006664 146 VRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVL 224 (636)
Q Consensus 146 ~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l 224 (636)
.++.+||+|||++..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.......
T Consensus 177 ~~~~~kL~Dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGGCEEECCTTCEESSCE----ECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCCeEEEcccCcCccccc----cccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 999999999999864311 112234567899999999976 568999999999999999998 99999988776655
Q ss_pred HHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 225 LMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
..+.... ....+..++..+.+||.+||..||.+||++.+++++
T Consensus 252 ~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 252 EKLPQGY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHGGGTC----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcCC----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4443332 223446788999999999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=404.86 Aligned_cols=258 Identities=22% Similarity=0.412 Sum_probs=224.1
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
..|++..++|++.+.||+|+||.||+|.++.++..||||+++.... ..+.+.+|+.+|+.++||||+++++++..+..
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 4688899999999999999999999999999999999999965432 46778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|||||.||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999999886556799999999999999999999999999999999999999999999999999976532
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.. ........+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.........+... .....+..
T Consensus 371 ~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~ 443 (495)
T 1opk_A 371 DT--YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----YRMERPEG 443 (495)
T ss_dssp CC--EECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT----CCCCCCTT
T ss_pred Cc--eeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----CCCCCCCC
Confidence 21 122234457788999999986 568999999999999999999 99999987766554443332 22334567
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++..+.+||.+||..||.+|||+.+|++
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 8999999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=381.24 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=206.1
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-----hhHHHHHHHHHHHHhC----CCCCcceee
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-----SDLSNISREAQTMILV----DHPNVLKSH 75 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-----~~~~~i~rEi~iL~~L----~HPNIVkl~ 75 (636)
..+...++|++++.||+|+||.||+|.+..+|+.||||+++..... .....+.+|+.+++.+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3455678999999999999999999999999999999999755322 1223456799999988 899999999
Q ss_pred eEEEeCCeEEEEEec-cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc-cCCcEEEe
Q 006664 76 CSFVSDHNLWVVMPF-MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID-VRGAIKLG 153 (636)
Q Consensus 76 ~~~~~~~~l~iVmEy-~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld-~~g~vKL~ 153 (636)
+++......++|||| +.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEE
Confidence 999999999999999 7899999999886 5799999999999999999999999999999999999998 78999999
Q ss_pred ccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 006664 154 DFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233 (636)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~ 233 (636)
|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.... ..... .
T Consensus 183 dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~-~- 249 (312)
T 2iwi_A 183 DFGSGALLHDE-----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA-E- 249 (312)
T ss_dssp CCSSCEECCSS-----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT-C-
T ss_pred EcchhhhcccC-----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh-c-
Confidence 99998765322 13456799999999999874444568999999999999999999997532 11211 1
Q ss_pred CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 234 ~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
...+..++..+.+||.+||..||.+||++.++++||||+...
T Consensus 250 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 250 ---LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ---cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 122356889999999999999999999999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=379.53 Aligned_cols=255 Identities=22% Similarity=0.375 Sum_probs=210.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEE----EEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIV----AVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~v----AIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
+..++|++++.||+|+||+||+|.+..+++.| |+|.+...........+.+|+.+++.++||||+++++++..+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 56789999999999999999999998888765 6666654444556778999999999999999999999998765
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
.++||+|+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 88999999999999999875 35799999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.. .........||+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.............. ....+..
T Consensus 170 ~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~ 243 (327)
T 3lzb_A 170 EE-KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQPPI 243 (327)
T ss_dssp -----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----CCCCCTT
T ss_pred cc-ccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----CCCCCcc
Confidence 22 2222334567889999999987 679999999999999999999 999999877766554444332 2233466
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++.++.+||.+||..||.+||++.++++
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8899999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=395.78 Aligned_cols=251 Identities=22% Similarity=0.386 Sum_probs=216.7
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC-
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH- 82 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~- 82 (636)
..|++..++|++++.||+|+||.||+|.+. |+.||||+++... ....+.+|+.+|+.++||||+++++++....
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 568899999999999999999999999874 7899999997543 4567899999999999999999999987765
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||.||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 79999999999999999998754458999999999999999999999999999999999999999999999999987432
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
.. .....+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+..+....+.... ....+.
T Consensus 341 ~~------~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~----~~~~p~ 409 (450)
T 1k9a_A 341 ST------QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----KMDAPD 409 (450)
T ss_dssp ------------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC----CCCCCT
T ss_pred cc------ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCC
Confidence 11 223468899999999986 679999999999999999998 999999877666655544332 233456
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+++.+.+||.+||..||.+|||+.+++.
T Consensus 410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 410 GCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=393.07 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=216.2
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC--e
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH--N 83 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~--~ 83 (636)
..+..++|.+.+.||+|+||+||+|.+..+|+.||||++.........+.+.+|+.+++.++||||+++++++.... .
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 34567899999999999999999999999999999999976554455677889999999999999999999998765 7
Q ss_pred EEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE----ccCCcEEEeccCcc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYP-DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI----DVRGAIKLGDFGVS 158 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl----d~~g~vKL~DFGla 158 (636)
.|+|||||.||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 8999999999999999976422 239999999999999999999999999999999999999 77788999999999
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhhc-------cCCCcccchhhHHHHHHHHHcCCCCCCCC----ChHHHHHHH
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL-------HGYDFKADIWSFGITALELAHGHAPFSKY----PPMKVLLMT 227 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~-------~~ys~ksDIWSLGiiLyeLltG~~PF~~~----~~~~~l~~~ 227 (636)
..+... ......+||+.|+|||++.+. ..|+.++|||||||++|+|++|..||... ...+.+..+
T Consensus 164 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 164 RELEDD----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp EECCCG----GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred eEccCC----CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 765322 123456899999999998652 45788999999999999999999999642 233444455
Q ss_pred HhcCCCCC--------------------CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 228 LQNAPPGL--------------------DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 228 ~~~~~~~~--------------------~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+...+... .......++..+.+||.+||.+||.+||++.++++
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 54433211 01122467788999999999999999999999865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=372.15 Aligned_cols=262 Identities=28% Similarity=0.455 Sum_probs=207.2
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
+..++|..++|++.+.||+|+||+||+|.+. ..||+|+++.... ......+.+|+.+++.++||||++++++ ...
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~ 91 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STA 91 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECS
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccC
Confidence 4578899999999999999999999999753 3599999976653 3456778999999999999999999995 456
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+++|||||.|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred CccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 6789999999999999999653 356999999999999999999999999999999999999999999999999998754
Q ss_pred ccCCCcccccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCc-c
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY-E 238 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~-~ 238 (636)
.... .........||+.|+|||++.. ...++.++|||||||++|+|++|..||.+......+...+......... .
T Consensus 171 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 171 SRWS-GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred cccc-ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 3221 1222345689999999999862 2568889999999999999999999998877766665555443322221 2
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
....+++.+.+||.+||..||.+||++.++++
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 23568899999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=397.56 Aligned_cols=257 Identities=23% Similarity=0.397 Sum_probs=220.2
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+..|++..++|++.+.||+|+||+||+|.+. ++..||||+++... ...+.+.+|+.+|+.++||||+++++++. +.
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 4678999999999999999999999999885 57889999997543 34678999999999999999999999986 66
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 79999999999999999986433468999999999999999999999999999999999999999999999999997653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
... ........+|+.|+|||++.. ..|+.++|||||||++|||++ |..||.+....+....+.... ..+.+.
T Consensus 336 ~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~----~~~~~~ 408 (454)
T 1qcf_A 336 DNE--YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY----RMPRPE 408 (454)
T ss_dssp CHH--HHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC----CCCCCT
T ss_pred CCc--eeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCC
Confidence 211 111234457888999999986 679999999999999999999 999999888777665554432 223456
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+++++.+||.+||..||.+|||+.+|+.
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 78999999999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=368.93 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=211.0
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchh------HHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD------LSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~------~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
.+..++|++.+.||+|+||+||+|.+..+++.||||++........ ...+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 4667999999999999999999999999999999999975543221 2678999999999999999999999977
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCcccEEEccCCc-----EEEe
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG--HIHRDVKSGNILIDVRGA-----IKLG 153 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHRDLKP~NILld~~g~-----vKL~ 153 (636)
.. ++||||+.||+|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 65 6999999999999988764 357999999999999999999999999 999999999999987776 9999
Q ss_pred ccCcccccccCCCcccccccccCCCCCCChhhhhh-ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHH--HHHHHhc
Q 006664 154 DFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ-LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV--LLMTLQN 230 (636)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~-~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~--l~~~~~~ 230 (636)
|||++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||........ .......
T Consensus 172 Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 172 DFGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp CCTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred CCCccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 9999874322 2345689999999999843 24578899999999999999999999987554333 2222222
Q ss_pred CCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 231 APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 231 ~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
. .....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 246 ~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 246 G---LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp C---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C---CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1 122334678999999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=380.05 Aligned_cols=259 Identities=24% Similarity=0.302 Sum_probs=208.7
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC-
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH- 82 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~- 82 (636)
.++.+..++|++++.||+|+||+||+|.+. ++.||||++... ........+|+.+++.++||||+++++++....
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 467788999999999999999999999875 899999999643 223445667999999999999999999998854
Q ss_pred ---eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCcccccCcccEEEccCCc
Q 006664 83 ---NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH----------GHIHRDVKSGNILIDVRGA 149 (636)
Q Consensus 83 ---~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~----------gIvHRDLKP~NILld~~g~ 149 (636)
.+|+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 47999999999999999987 3599999999999999999999999 9999999999999999999
Q ss_pred EEEeccCcccccccCCCcccccccccCCCCCCChhhhhhc----cCCCcccchhhHHHHHHHHHcCCCCCCCCC------
Q 006664 150 IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL----HGYDFKADIWSFGITALELAHGHAPFSKYP------ 219 (636)
Q Consensus 150 vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~----~~ys~ksDIWSLGiiLyeLltG~~PF~~~~------ 219 (636)
+||+|||+++.+..... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+..
T Consensus 170 ~kL~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 170 ACIADFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp EEECCCTTCEEECTTSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred EEEccCCcccccccccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 99999999976543322 2223456899999999999763 235668899999999999999999996532
Q ss_pred ---------hHHHHHHHHhcCCC--CC-CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 220 ---------PMKVLLMTLQNAPP--GL-DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 220 ---------~~~~l~~~~~~~~~--~~-~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
....+......... .+ ........+..+.+||.+||..||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12222222221111 11 11122345677999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=373.17 Aligned_cols=261 Identities=22% Similarity=0.355 Sum_probs=210.3
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcC---CCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIP---FNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~---tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
..+.+..++|.+.+.||+|+||.||+|.+.. ++..||+|+++.... ......+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 4677888999999999999999999998775 566899999976543 345677899999999999999999999998
Q ss_pred eCC-----eEEEEEeccCCCCHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcE
Q 006664 80 SDH-----NLWVVMPFMSGGSCLHILKAA----YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAI 150 (636)
Q Consensus 80 ~~~-----~l~iVmEy~~GGsL~~lL~~~----~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~v 150 (636)
+.. ..|+||||+.+|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 765 359999999999999998643 23569999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 006664 151 KLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQ 229 (636)
Q Consensus 151 KL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~ 229 (636)
||+|||++....... .........|++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+............
T Consensus 187 kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 187 CVADFGLSKKIYSGD-YYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp EECSCSCC-----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred EEeecCcceeccccc-ccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 999999987653322 1122334568889999999976 679999999999999999999 9999998877666555554
Q ss_pred cCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 230 ~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.... ..+..++..+.+||.+||..||.+||++.++++
T Consensus 265 ~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 265 GHRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp TCCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3322 234678899999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=367.03 Aligned_cols=256 Identities=22% Similarity=0.362 Sum_probs=217.5
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
..|++..++|++++.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 568899999999999999999999999875 67789999986543 245678999999999999999999998864 56
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
.|+||||+.||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 89999999999999999754223699999999999999999999999999999999999999999999999999876533
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+..... ...+..
T Consensus 162 ~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~ 234 (279)
T 1qpc_A 162 NE--YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----MVRPDN 234 (279)
T ss_dssp SC--EECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----CCCCTT
T ss_pred cc--cccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC----CCCccc
Confidence 22 122334567889999999976 568999999999999999999 9999998877665555443322 233467
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++..+.+||.+||..||.+|||+.++++
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 8899999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=381.35 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=215.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEE----EcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE--eC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRAL----CIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV--SD 81 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~----~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~--~~ 81 (636)
+..++|++++.||+|+||.||+|. +..+++.||||++... .......+.+|+.+++.++||||+++++++. +.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 567899999999999999999998 5678999999999644 3345567899999999999999999999987 45
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred ceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 67999999999999999998742 46999999999999999999999999999999999999999999999999999866
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH--------------HHHHHH
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM--------------KVLLMT 227 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~--------------~~l~~~ 227 (636)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 443333333445678999999999986 56899999999999999999999999643221 122222
Q ss_pred HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 228 ~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
+.. ......+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 257 ~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 257 LEE---GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhc---ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222 12233456789999999999999999999999999753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=372.32 Aligned_cols=255 Identities=26% Similarity=0.317 Sum_probs=206.3
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
..++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++..++.+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 35789999999999999999999999999999999975432 2335778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK- 188 (309)
T ss_dssp EEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-
Confidence 99999999999999876 579999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .+...+....+. .......++..
T Consensus 189 -~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~ 264 (309)
T 2h34_A 189 -LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPR-PSTVRPGIPVA 264 (309)
T ss_dssp ---------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCC-GGGTSTTCCTH
T ss_pred -cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCC-ccccCCCCCHH
Confidence 122345679999999999976 57899999999999999999999999876554 333333332221 22334678899
Q ss_pred HHHHHHhhcccCCCCCC-CHHHHHh
Q 006664 247 FKQMIASCLVKDPSKRP-SAKKLLK 270 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRp-sa~elL~ 270 (636)
+.+||.+||..||.+|| +++++++
T Consensus 265 l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999999 8888774
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=368.00 Aligned_cols=252 Identities=22% Similarity=0.384 Sum_probs=208.2
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC-
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD- 81 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~- 81 (636)
+..|.+..++|++++.||+|+||+||+|.+ +|+.||||+++... ..+.+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 457889999999999999999999999987 48999999986432 456789999999999999999999987654
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
+.+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 57999999999999999998753334899999999999999999999999999999999999999999999999998754
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
... .....|++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.... ....+
T Consensus 168 ~~~------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~ 236 (278)
T 1byg_A 168 SST------QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----KMDAP 236 (278)
T ss_dssp --------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----CCCCC
T ss_pred ccc------ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----CCCCc
Confidence 221 224468999999999976 678999999999999999998 999999877665554443322 22334
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+++.+.++|.+||..||.+||++.++++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 678999999999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=365.85 Aligned_cols=247 Identities=23% Similarity=0.400 Sum_probs=210.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe---------
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS--------- 80 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~--------- 80 (636)
..+|++++.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 367999999999999999999999999999999997543 246789999999999999999999865
Q ss_pred -------CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEe
Q 006664 81 -------DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLG 153 (636)
Q Consensus 81 -------~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~ 153 (636)
...+|+|||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 4568999999999999999987655679999999999999999999999999999999999999999999999
Q ss_pred ccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 006664 154 DFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233 (636)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~ 233 (636)
|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ......+....
T Consensus 165 Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~~~- 235 (284)
T 2a19_B 165 DFGLVTSLKNDG----KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLRDGI- 235 (284)
T ss_dssp CCTTCEESSCCS----CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHTTC-
T ss_pred cchhheeccccc----cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhccc-
Confidence 999987653322 2235679999999999986 67899999999999999999999987532 11222222211
Q ss_pred CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 234 GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 234 ~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
....++..+++||.+||..||.+||++.++++|.+..
T Consensus 236 -----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 236 -----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2245788999999999999999999999999988764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=369.74 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=211.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEE-EeCCeE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPF---NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSF-VSDHNL 84 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~t---g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~-~~~~~l 84 (636)
...+|++.+.||+|+||+||+|.+..+ +..||+|.+...........+.+|+.+++.++||||+++++++ ..++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 456799999999999999999987543 3468999997655656677899999999999999999999985 456788
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
|+||||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 103 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999999764 356899999999999999999999999999999999999999999999999999765432
Q ss_pred CC-cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 165 GD-RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 165 ~~-~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
.. .........||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+................ ..+..
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 256 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----LQPEY 256 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC----CCCTT
T ss_pred chhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC----CCCcc
Confidence 21 1122345578899999999977 679999999999999999999 77788777666655555443322 22456
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++..+.++|.+||..||.+||++.++++
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7899999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=395.01 Aligned_cols=266 Identities=25% Similarity=0.328 Sum_probs=206.1
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCe
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~ 83 (636)
.+.++..+|.+.+.||+|+||+||. ....+|+.||||++..... ..+.+|+.+|+.+ +|||||++++++.++..
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred cEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 3567778899999999999999764 4456899999999864322 2356899999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc---C--CcEEEeccCcc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---R--GAIKLGDFGVS 158 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---~--g~vKL~DFGla 158 (636)
+|+|||||. |+|.+++.... ..+.+..+..++.||+.||.|||++||+||||||+|||++. + ..+||+|||+|
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 999999997 59999998653 34566677899999999999999999999999999999953 2 36889999999
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhh--ccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCC
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ--LHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGL 235 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~--~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~ 235 (636)
..+.............+||+.|+|||++.+ ...++.++|||||||++|+|++ |..||......... ... ......
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~-~~~~~~ 248 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILL-GACSLD 248 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHT-TCCCCT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHh-ccCCcc
Confidence 865433222233456789999999999974 2457889999999999999999 99999765443322 222 211111
Q ss_pred CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 236 ~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
........+..+++||.+||..||.+|||+.++++||||+...+
T Consensus 249 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292 (432)
T ss_dssp TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence 12233556788999999999999999999999999999986543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=365.69 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=211.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE-EE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNE---IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL-WV 86 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~---~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l-~i 86 (636)
-.|.+.+.||+|+||+||+|.+..++. .||+|++.........+.+.+|+.+++.++||||+++++++.+.... ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 356678999999999999999766554 89999997655556677889999999999999999999999877665 99
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 101 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999763 35789999999999999999999999999999999999999999999999999975533221
Q ss_pred -cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 167 -RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 167 -~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
.........||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||................. ...+..++
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 254 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR----LPQPEYCP 254 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC----CCCCTTCC
T ss_pred cccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC----CCCCccch
Confidence 1122335578999999999976 678999999999999999999 5566666665555444443322 23346688
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+.+||.+||..||.+|||+.++++
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=378.16 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=210.7
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe----
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS---- 80 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~---- 80 (636)
-+.+..++|++++.||+|+||.||+|.+..+|+.||||++... .......+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 3557789999999999999999999999999999999998653 33456778999999999999999999999873
Q ss_pred CCeEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla 158 (636)
...+|+||||+.+|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 35789999999999999999763 2356999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcc------cccccccCCCCCCChhhhhhcc--CCCcccchhhHHHHHHHHHcCCCCCCCCChH-HHHHHHHh
Q 006664 159 ACLFDSGDRQ------RMRNTFVGTPCWMAPEVMEQLH--GYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQ 229 (636)
Q Consensus 159 ~~~~~~~~~~------~~~~~~~GT~~YmAPEvl~~~~--~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~-~~l~~~~~ 229 (636)
.......... .......||+.|+|||++.+.. .++.++|||||||++|+|++|..||...... ........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 6542111100 0112456899999999986522 2688999999999999999999999531100 01111222
Q ss_pred cCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 230 ~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
. ....+....++..+.+||.+||..||.+||++.+++++
T Consensus 262 ~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 262 N---QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp C---C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c---cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2 12223346788999999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=368.99 Aligned_cols=260 Identities=24% Similarity=0.401 Sum_probs=209.6
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcC-CCc--EEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIP-FNE--IVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~-tg~--~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
...+..++|++++.||+|+||+||+|.+.. ++. .||||+++... .......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 345678899999999999999999998653 333 68999987543 3345678899999999999999999999998
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.+. .++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccc
Confidence 765 89999999999999999875 2469999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYE 238 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~ 238 (636)
................||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..... ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~ 245 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---RLP 245 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC---CCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC---CCC
Confidence 66443332223345578889999999976 568999999999999999999 9999998887776655554332 223
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
....++..+.++|.+||..||.+||++.++++
T Consensus 246 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 44678999999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=393.71 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=215.2
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+..|++..++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 56789999999999999999999999999864 56799999975432 35678999999999999999999999876 6
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||.||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 78999999999999999976433569999999999999999999999999999999999999999999999999997653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
... ........||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+.... ..+.+.
T Consensus 332 ~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~----~~~~~~ 404 (452)
T 1fmk_A 332 DNE--YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----RMPCPP 404 (452)
T ss_dssp -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----CCCCCT
T ss_pred CCc--eecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCC
Confidence 221 112234567889999999986 579999999999999999999 999999888777665554432 223456
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.++..+.+||.+||..||.+|||+.+|+.
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 78999999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=364.28 Aligned_cols=255 Identities=16% Similarity=0.222 Sum_probs=206.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceee-eEEEeCCeEEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSH-CSFVSDHNLWVVM 88 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~-~~~~~~~~l~iVm 88 (636)
.++|++++.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.+.|++++..+ .++..+...|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 57999999999999999999999999999999998754432 3578999999999988866554 4446778899999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE---ccCCcEEEeccCcccccccCC
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI---DVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl---d~~g~vKL~DFGla~~~~~~~ 165 (636)
||+ |++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred Eec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 999 89999999754 3579999999999999999999999999999999999999 488999999999998654432
Q ss_pred Ccc----cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh---HHHHHHHHhcCCCCCCcc
Q 006664 166 DRQ----RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPPGLDYE 238 (636)
Q Consensus 166 ~~~----~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~---~~~l~~~~~~~~~~~~~~ 238 (636)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ...+..+...........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 211 12346689999999999987 5689999999999999999999999976432 111212211110000111
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
....+++++.+||.+||..||.+||++.++++
T Consensus 242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 22567899999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=377.21 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=210.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEE----cCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALC----IPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD-- 81 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~----~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-- 81 (636)
+....|++++.||+|+||+||++.. ..+|+.||||++...........+.+|+.+++.++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 3344459999999999999988754 4588999999998766556677899999999999999999999999984
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred ceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 6899999999999999999764 5999999999999999999999999999999999999999999999999999866
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHH--------------HHHHH
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK--------------VLLMT 227 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~--------------~l~~~ 227 (636)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 443332333445678999999999986 568899999999999999999999996532110 11111
Q ss_pred HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 228 LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 228 ~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+.. ......+..++.++.+||.+||..||.+|||+.++++
T Consensus 264 ~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 264 LER---GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hhc---ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 211 1223345678999999999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=391.43 Aligned_cols=260 Identities=25% Similarity=0.326 Sum_probs=198.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~iVm 88 (636)
.+.|.+.+.||+|+||+||.+ ...+|+.||||++..+ ..+.+.+|+.+++.+ +||||+++++++.++..+|+||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 455666789999999999875 4568999999998643 245678999999876 8999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC-------------CcE
Q 006664 89 PFMSGGSCLHILKAAYPDG-----FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR-------------GAI 150 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~-----lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~-------------g~v 150 (636)
|||. |+|.+++....... .++..++.++.||+.||.|||++||+||||||+|||++.+ +.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 9996 59999998642111 1233457899999999999999999999999999999754 489
Q ss_pred EEeccCcccccccCCCcc-cccccccCCCCCCChhhhhh------ccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHH
Q 006664 151 KLGDFGVSACLFDSGDRQ-RMRNTFVGTPCWMAPEVMEQ------LHGYDFKADIWSFGITALELAH-GHAPFSKYPPMK 222 (636)
Q Consensus 151 KL~DFGla~~~~~~~~~~-~~~~~~~GT~~YmAPEvl~~------~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~ 222 (636)
||+|||++..+....... ......+||+.|+|||++.+ ...++.++|||||||++|||++ |..||.+.....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999998654322111 12345689999999999965 2468999999999999999999 999997654433
Q ss_pred HHHHHHhcCC--CCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 223 VLLMTLQNAP--PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 223 ~l~~~~~~~~--~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
. .++.... +.........++.++++||.+||..||.+|||+.++++||||+..
T Consensus 248 ~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 248 S--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp H--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred H--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 2 2222221 122222345678999999999999999999999999999999753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=364.85 Aligned_cols=256 Identities=26% Similarity=0.486 Sum_probs=201.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++..+..+|+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4578999999999999999999999999999999997533 23456678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 87 VMPFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
||||+.||+|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999999998752 2356899999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh-HHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP-MKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~-~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...+...+.... ........+
T Consensus 190 ~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 263 (310)
T 2wqm_A 190 T---TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHY 263 (310)
T ss_dssp ------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCTTTS
T ss_pred C---ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCccccc
Confidence 1 12335679999999999976 6789999999999999999999999975432 122222222211 111223568
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+.++.+||.+||..||.+||++.++++
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 899999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=366.84 Aligned_cols=254 Identities=28% Similarity=0.379 Sum_probs=202.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHh--CCCCCcceeeeEEEeC----
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL--VDHPNVLKSHCSFVSD---- 81 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~--L~HPNIVkl~~~~~~~---- 81 (636)
+..++|++++.||+|+||+||+|.+ +|+.||||++... ....+.+|..++.. ++||||+++++++...
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 4568999999999999999999987 6999999998542 34556677777766 7999999999987653
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCcccccCcccEEEccCCcEEEe
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH--------HHGHIHRDVKSGNILIDVRGAIKLG 153 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH--------~~gIvHRDLKP~NILld~~g~vKL~ 153 (636)
..+|+||||++||+|.++++. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred ceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 568999999999999999954 57999999999999999999999 9999999999999999999999999
Q ss_pred ccCcccccccCCCcc-cccccccCCCCCCChhhhhhcc-----CCCcccchhhHHHHHHHHHcC----------CCCCCC
Q 006664 154 DFGVSACLFDSGDRQ-RMRNTFVGTPCWMAPEVMEQLH-----GYDFKADIWSFGITALELAHG----------HAPFSK 217 (636)
Q Consensus 154 DFGla~~~~~~~~~~-~~~~~~~GT~~YmAPEvl~~~~-----~ys~ksDIWSLGiiLyeLltG----------~~PF~~ 217 (636)
|||++.......... ......+||+.|+|||++.+.. .++.++|||||||++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997654332221 1133458999999999997632 244789999999999999999 889865
Q ss_pred CC----hHHHHHHHHhcCCCCCCcc---cchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 218 YP----PMKVLLMTLQNAPPGLDYE---RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 218 ~~----~~~~l~~~~~~~~~~~~~~---~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.. ..................+ ....++..+.+||.+||..||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 32 2223333222211111111 12357789999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=380.16 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=213.6
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
.+.+..++|.+.+.||+|+||+||+|.+ .+|+.||||++...........+.+|+.+++.++||||+++++++.++...
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 4567789999999999999999999974 479999999997655444444689999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccccCcccEEEccCCcEEEeccCccc
Q 006664 85 WVVMPFMSGGSCLHILKAAYP--DGFEEVVIATILREVLKGLDYLHHH---GHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~--~~lse~~i~~i~~QIl~aL~yLH~~---gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
++|||||.||+|.+++..... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 999999999999999986532 2499999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCC----ChHHHHHHHHhcCC---
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKY----PPMKVLLMTLQNAP--- 232 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~----~~~~~l~~~~~~~~--- 232 (636)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ..............
T Consensus 183 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 183 LMDYKD--THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp ECCSSS--SCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred ccCccc--ccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 653222 222345679999999999976 56899999999999999999999999521 00000111111110
Q ss_pred -------CCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 233 -------PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 233 -------~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
...........+..+.+||.+||..||.+|||+.++++|-.-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 011112234567889999999999999999999999987553
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=403.90 Aligned_cols=260 Identities=24% Similarity=0.383 Sum_probs=215.6
Q ss_pred cccccCCCCeEEEe-EEcccCceEEEEEEEc--CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 4 KKYPIGAEHYTLYE-EVGQGVSASVHRALCI--PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~-~IG~G~fG~Vyka~~~--~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
+.+.+..++|.+.+ .||+|+||.||+|.+. .++..||||+++........+.+.+|+.+|+.++|||||++++++..
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 35667778888887 8999999999999876 45678999999866555567889999999999999999999999976
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
..+|+|||||.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 5699999999999999999654 35699999999999999999999999999999999999999999999999999986
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
+..............+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+....+....+..... ...
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----~~~ 560 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----MEC 560 (613)
T ss_dssp CC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC----CCC
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----CCC
Confidence 5332222222233456789999999976 679999999999999999998 9999998887776655554332 233
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+..+++++.+||.+||..||.+||++.+|++
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 4678999999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=364.53 Aligned_cols=255 Identities=16% Similarity=0.221 Sum_probs=202.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeee-EEEeCCeEEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHC-SFVSDHNLWVVM 88 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~-~~~~~~~l~iVm 88 (636)
.++|++++.||+|+||+||+|.+..+++.||||++...... ..+.+|+.+++.+.|++++..+. ++..+...++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 57899999999999999999999999999999987654332 34788999999999887766554 457778899999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE---ccCCcEEEeccCcccccccCC
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI---DVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl---d~~g~vKL~DFGla~~~~~~~ 165 (636)
||+ ||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred Ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 999 99999999864 3579999999999999999999999999999999999999 788999999999998654332
Q ss_pred Ccc----cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH---HHHHHHHhcCCCCCCcc
Q 006664 166 DRQ----RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---KVLLMTLQNAPPGLDYE 238 (636)
Q Consensus 166 ~~~----~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~---~~l~~~~~~~~~~~~~~ 238 (636)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... .................
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 211 22346689999999999987 56899999999999999999999999764321 11111111110000111
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
....+++++.+||.+||..||.+||++.++++
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 22457899999999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=383.77 Aligned_cols=260 Identities=15% Similarity=0.180 Sum_probs=202.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCC-----CcEEEEEEeecCCCch----------hHHHHHHHHHHHHhCCCCCcc
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPF-----NEIVAVKILDFERDNS----------DLSNISREAQTMILVDHPNVL 72 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~t-----g~~vAIK~i~~~~~~~----------~~~~i~rEi~iL~~L~HPNIV 72 (636)
+..++|++++.||+|+||+||+|.+..+ ++.||||++....... ....+.+|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4567999999999999999999998764 5889999987543210 012234566667788899999
Q ss_pred eeeeEEEeC----CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc--c
Q 006664 73 KSHCSFVSD----HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID--V 146 (636)
Q Consensus 73 kl~~~~~~~----~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld--~ 146 (636)
++++++... ...|+||||| ||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999999875 5689999999 99999999874 35799999999999999999999999999999999999998 8
Q ss_pred CCcEEEeccCcccccccCCCc----ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHH
Q 006664 147 RGAIKLGDFGVSACLFDSGDR----QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 222 (636)
Q Consensus 147 ~g~vKL~DFGla~~~~~~~~~----~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~ 222 (636)
++.+||+|||+++.+...... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.....
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 899999999999765433211 112245679999999999987 569999999999999999999999998533222
Q ss_pred HHHHHHh-cCCCCCC-----cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 223 VLLMTLQ-NAPPGLD-----YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 223 ~l~~~~~-~~~~~~~-----~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
....... .....+. ......++.++.+||..||..||.+||++.+|++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 2211111 0000000 0011456889999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=379.61 Aligned_cols=259 Identities=16% Similarity=0.184 Sum_probs=202.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcC---CCcEEEEEEeecCCCch----------hHHHHHHHHHHHHhCCCCCccee
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIP---FNEIVAVKILDFERDNS----------DLSNISREAQTMILVDHPNVLKS 74 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~---tg~~vAIK~i~~~~~~~----------~~~~i~rEi~iL~~L~HPNIVkl 74 (636)
+..++|.+++.||+|+||.||+|.+.. ++..||||++....... ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 456899999999999999999999987 88999999997654321 12235678899999999999999
Q ss_pred eeEEEe----CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC--
Q 006664 75 HCSFVS----DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-- 148 (636)
Q Consensus 75 ~~~~~~----~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-- 148 (636)
++++.. +..+|+||||| |++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 999988 78899999999 99999999875 4799999999999999999999999999999999999998777
Q ss_pred cEEEeccCcccccccCCCc----ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh-HHH
Q 006664 149 AIKLGDFGVSACLFDSGDR----QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP-MKV 223 (636)
Q Consensus 149 ~vKL~DFGla~~~~~~~~~----~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~-~~~ 223 (636)
.+||+|||+++.+...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999765432211 112245689999999999987 5789999999999999999999999965221 111
Q ss_pred HHHHHhcCCCCCCc-----ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 224 LLMTLQNAPPGLDY-----ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 224 l~~~~~~~~~~~~~-----~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
...........+.. .....++.++.+||.+||..||.+||++.+|++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11111111111110 011267889999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=378.38 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=213.6
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
+...++|++.+.||+|+||+||+|.+ .+|+.||||++.... ......+.+|+.+++.++||||+++++++..++.+|+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34568999999999999999999986 479999999986543 3356788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 87 VMPFMSGGSCLHILKAAYP--DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~--~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
||||++||+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999998865421 24899999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHH------HHHHhcC------C
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL------LMTLQNA------P 232 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l------~~~~~~~------~ 232 (636)
. .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..+.... ....... .
T Consensus 193 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 193 D-QTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp S-CCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred c-ccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 2 2222345679999999999986 56899999999999999999999999764332110 1111111 0
Q ss_pred CCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCc
Q 006664 233 PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHS 272 (636)
Q Consensus 233 ~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hp 272 (636)
+.........++..+.++|.+||..||.+|||+.++++|.
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1111223456788999999999999999999999998753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=377.91 Aligned_cols=255 Identities=15% Similarity=0.220 Sum_probs=206.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCC--------CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcce------
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPF--------NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLK------ 73 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~t--------g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVk------ 73 (636)
...++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+++.++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3468999999999999999999999874 899999998743 35789999999999999998
Q ss_pred ---------eeeEEEe-CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEE
Q 006664 74 ---------SHCSFVS-DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNIL 143 (636)
Q Consensus 74 ---------l~~~~~~-~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NIL 143 (636)
+++++.. +..+|+||||| ||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5677766 78899999999 999999998754467999999999999999999999999999999999999
Q ss_pred EccCC--cEEEeccCcccccccCCCc----ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCC
Q 006664 144 IDVRG--AIKLGDFGVSACLFDSGDR----QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSK 217 (636)
Q Consensus 144 ld~~g--~vKL~DFGla~~~~~~~~~----~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~ 217 (636)
++.++ .+||+|||++..+...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99888 9999999999765432211 112245689999999999986 5799999999999999999999999987
Q ss_pred CC-hHHHHHHHH---hcCCCCCC--cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 218 YP-PMKVLLMTL---QNAPPGLD--YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 218 ~~-~~~~l~~~~---~~~~~~~~--~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.. ....+.... ......+. ...+..++.++.+||.+||..||.+||++.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 54 222222221 12111111 1112357899999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=372.50 Aligned_cols=260 Identities=20% Similarity=0.287 Sum_probs=193.9
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEE---
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFV--- 79 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~--- 79 (636)
..+++...+|++.+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.+++.+. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 45677888999999999999999999999999999999998543 3345567889999999995 999999999994
Q ss_pred -----eCCeEEEEEeccCCCCHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCcccEEEccCCcEE
Q 006664 80 -----SDHNLWVVMPFMSGGSCLHILKAA-YPDGFEEVVIATILREVLKGLDYLHHHG--HIHRDVKSGNILIDVRGAIK 151 (636)
Q Consensus 80 -----~~~~l~iVmEy~~GGsL~~lL~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHRDLKP~NILld~~g~vK 151 (636)
....+|+||||+. |+|.+++... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 3456899999996 6899988752 2356999999999999999999999999 99999999999999999999
Q ss_pred EeccCcccccccCCCcc---------cccccccCCCCCCChhhhh--hccCCCcccchhhHHHHHHHHHcCCCCCCCCCh
Q 006664 152 LGDFGVSACLFDSGDRQ---------RMRNTFVGTPCWMAPEVME--QLHGYDFKADIWSFGITALELAHGHAPFSKYPP 220 (636)
Q Consensus 152 L~DFGla~~~~~~~~~~---------~~~~~~~GT~~YmAPEvl~--~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~ 220 (636)
|+|||++.......... ......+||+.|+|||++. ....++.++|||||||++|+|++|..||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999997654322110 1112557999999999984 235688999999999999999999999976544
Q ss_pred HHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCc
Q 006664 221 MKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHS 272 (636)
Q Consensus 221 ~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hp 272 (636)
....... .........+..+.+||.+||..||.+||++.++++|-
T Consensus 259 ~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 259 LRIVNGK-------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp --------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHhhcCc-------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 3322211 12223345667899999999999999999999999753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=369.37 Aligned_cols=237 Identities=22% Similarity=0.353 Sum_probs=194.1
Q ss_pred CCCeEEE-eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHH-HhCCCCCcceeeeEEEe----CCe
Q 006664 10 AEHYTLY-EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM-ILVDHPNVLKSHCSFVS----DHN 83 (636)
Q Consensus 10 ~~~Y~l~-~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL-~~L~HPNIVkl~~~~~~----~~~ 83 (636)
.++|.++ +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +.++||||++++++|.. +..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 3667777 789999999999999999999999999853 24567899988 66799999999999987 678
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc---CCcEEEeccCcccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---RGAIKLGDFGVSAC 160 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---~g~vKL~DFGla~~ 160 (636)
+|+|||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 999999999999999999875567999999999999999999999999999999999999997 78999999999864
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC---CCCCCc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA---PPGLDY 237 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~---~~~~~~ 237 (636)
.. ...|+.++|||||||++|+|++|..||................ ...+..
T Consensus 170 ~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 170 TT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp CT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred cc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 31 1346788999999999999999999997654433211111111 111111
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.....++.++++||.+||..||.+|||+.++++||||++..
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 12256899999999999999999999999999999998653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=403.21 Aligned_cols=259 Identities=22% Similarity=0.335 Sum_probs=213.1
Q ss_pred cccccCCCCeEEEe-EEcccCceEEEEEEE--cCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 4 KKYPIGAEHYTLYE-EVGQGVSASVHRALC--IPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~-~IG~G~fG~Vyka~~--~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
+.+.+..+.+.+.. .||+|+||+||+|.+ ..+++.||||+++.... ......+.+|+.+|+.++|||||++++++.
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 440 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34566666777754 899999999999955 46778999999975433 334678999999999999999999999986
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
. ..+++|||||.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 517 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK 517 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHH
T ss_pred c-CCEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcc
Confidence 4 5689999999999999999865 679999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYE 238 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~ 238 (636)
.+..............||+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+....+....+...... .
T Consensus 518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~----~ 592 (635)
T 4fl3_A 518 ALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----G 592 (635)
T ss_dssp HTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----C
T ss_pred ccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----C
Confidence 65433322222334567889999999976 679999999999999999998 99999998887766555544322 3
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+..++.++.+||.+||..||.+||++.+|++
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 34678999999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=377.65 Aligned_cols=253 Identities=14% Similarity=0.126 Sum_probs=205.0
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEE-----EEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC---CCCcceee
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRA-----LCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD---HPNVLKSH 75 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka-----~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~---HPNIVkl~ 75 (636)
..+.+..++|.+.+.||+|+||+||+| .+..+++.||||++... ....+.+|+.+++.++ ||||++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 456788899999999999999999999 46788999999998643 3456788888888887 99999999
Q ss_pred eEEEeCCeEEEEEeccCCCCHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc------
Q 006664 76 CSFVSDHNLWVVMPFMSGGSCLHILKAA---YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV------ 146 (636)
Q Consensus 76 ~~~~~~~~l~iVmEy~~GGsL~~lL~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~------ 146 (636)
+++..++..|+|||||+||+|.+++... ....+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 9999999999999999999999999753 2356999999999999999999999999999999999999998
Q ss_pred -----CCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH
Q 006664 147 -----RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM 221 (636)
Q Consensus 147 -----~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~ 221 (636)
++.+||+|||+|+.+.... ........+||+.|||||++.+ ..|+.++|||||||++|||++|+.||......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFP-KGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSC-TTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccCCEEEeeCchhhhhhccC-CCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999997543222 1223456789999999999987 56999999999999999999999999643221
Q ss_pred HHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 222 KVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 222 ~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
. ... ... ......++.+.+++..||+.+|.+|++..+.+.+
T Consensus 292 ~-----~~~-~~~---~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 292 E-----CKP-EGL---FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp E-----EEE-CSC---CTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred c-----eee-chh---ccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0 000 000 0112347789999999999999999765544443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=381.41 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=202.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCC---cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE-eCCeEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFN---EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV-SDHNLWV 86 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg---~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~-~~~~l~i 86 (636)
..|++.+.||+|+||+||+|.+..++ ..||+|.++..........+.+|+.+|+.++||||+++++++. .++..|+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 45889999999999999999876433 4689999876555566788999999999999999999999865 4568899
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
||||+.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 169 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999999999999764 35689999999999999999999999999999999999999999999999999976533221
Q ss_pred c-ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhh
Q 006664 167 R-QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244 (636)
Q Consensus 167 ~-~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S 244 (636)
. ........||+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+....+.......... ...+..++
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~----~~~p~~~~ 322 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----LLQPEYCP 322 (373)
T ss_dssp ----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC----CCCCTTCC
T ss_pred ccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC----CCCCCCCC
Confidence 1 112234568889999999986 679999999999999999999 7889987666555544443322 22345688
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 245 KSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 245 ~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..+.++|.+||..||.+||++.++++
T Consensus 323 ~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 323 DPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=397.63 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=219.6
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
+..|++..++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 56799999999999999999999999999864 56799999975432 35678999999999999999999999876 6
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||.||+|.+++.......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 79999999999999999976433569999999999999999999999999999999999999999999999999997553
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
.. .........+++.|+|||++.+ ..|+.++|||||||++|||++ |..||.+....+.+..+.... ....+.
T Consensus 415 ~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~----~~~~~~ 487 (535)
T 2h8h_A 415 DN--EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----RMPCPP 487 (535)
T ss_dssp CH--HHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC----CCCCCT
T ss_pred CC--ceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCC
Confidence 21 1112234457889999999986 579999999999999999999 999999888776665554332 223446
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.++..+.+||.+||..||.+|||+.+|+.
T Consensus 488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 488 ECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=369.77 Aligned_cols=260 Identities=24% Similarity=0.399 Sum_probs=211.7
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEE----EcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRAL----CIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~----~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
...+..++|++++.||+|+||.||+|. +..+|+.||||++... .......+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 345667889999999999999999998 4678999999999753 33456778999999999999999999999876
Q ss_pred CC--eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcc
Q 006664 81 DH--NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158 (636)
Q Consensus 81 ~~--~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla 158 (636)
.. .+++||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 54 789999999999999999875 346999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH------------H---H
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM------------K---V 223 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~------------~---~ 223 (636)
.................||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... . .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 865433322222344568888999999986 56899999999999999999999998642110 0 1
Q ss_pred HHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 224 LLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 224 l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+...+... ...+.+..++.++.+||.+||..||.+||++.++++
T Consensus 272 ~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNN---GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTT---CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcC---CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11122211 122334678899999999999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.11 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=198.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHh--CCCCCcceeeeEEEeC----Ce
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL--VDHPNVLKSHCSFVSD----HN 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~--L~HPNIVkl~~~~~~~----~~ 83 (636)
.++|++++.||+|+||.||+|.+. |+.||||++... ......+|..++.. ++||||+++++++... ..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 468999999999999999999874 899999998533 23344556666654 4999999999999987 78
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccccCcccEEEccCCcEEEecc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH--------GHIHRDVKSGNILIDVRGAIKLGDF 155 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~--------gIvHRDLKP~NILld~~g~vKL~DF 155 (636)
+|+|||||+||+|.++++. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 9999999999999999976 3699999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCc-ccccccccCCCCCCChhhhhhccCCCcc------cchhhHHHHHHHHHcC----------CCCCCCC
Q 006664 156 GVSACLFDSGDR-QRMRNTFVGTPCWMAPEVMEQLHGYDFK------ADIWSFGITALELAHG----------HAPFSKY 218 (636)
Q Consensus 156 Gla~~~~~~~~~-~~~~~~~~GT~~YmAPEvl~~~~~ys~k------sDIWSLGiiLyeLltG----------~~PF~~~ 218 (636)
|++..+...... .......+||+.|+|||++.+ ..+... +|||||||++|||++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999765433221 112235689999999999976 334443 9999999999999999 7777543
Q ss_pred C----hHHHHHHHHhcCCCCCCcc---cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 219 P----PMKVLLMTLQNAPPGLDYE---RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 219 ~----~~~~l~~~~~~~~~~~~~~---~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
. ..................+ ....++.++.+||.+||..||.+|||+.++++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2 2223333322211111111 123678889999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=362.92 Aligned_cols=246 Identities=28% Similarity=0.469 Sum_probs=199.9
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
.+..++|++.+.||+|+||+||+|.+. ++.||||++... .....+.+|+.+++.++||||+++++++.+ ..|+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence 467789999999999999999999874 789999998532 345678999999999999999999998774 4799
Q ss_pred EEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccccCcccEEEccCCc-EEEeccCccccc
Q 006664 87 VMPFMSGGSCLHILKAAYP-DGFEEVVIATILREVLKGLDYLHH---HGHIHRDVKSGNILIDVRGA-IKLGDFGVSACL 161 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~-~~lse~~i~~i~~QIl~aL~yLH~---~gIvHRDLKP~NILld~~g~-vKL~DFGla~~~ 161 (636)
||||++||+|.+++..... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999999999999986422 237899999999999999999999 89999999999999988886 799999998654
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH--HHHHHHHhcCCCCCCccc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM--KVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~--~~l~~~~~~~~~~~~~~~ 239 (636)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ........... ...
T Consensus 157 ~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~ 225 (307)
T 2eva_A 157 QTH------MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR----PPL 225 (307)
T ss_dssp --------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC----CCC
T ss_pred ccc------cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC----CCc
Confidence 221 234579999999999976 67899999999999999999999999864332 22222222222 223
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
...++..+.+||.+||..||.+|||+.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4568899999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=369.21 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=213.7
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
.+.|++..++|++.+.||+|+||.||+|.+.. .||+|+++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 36789999999999999999999999998853 499999976543 22345677899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+++||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 9999999999999999999764 34699999999999999999999999999999999999998 789999999998654
Q ss_pred ccCC--CcccccccccCCCCCCChhhhhh--------ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC
Q 006664 162 FDSG--DRQRMRNTFVGTPCWMAPEVMEQ--------LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA 231 (636)
Q Consensus 162 ~~~~--~~~~~~~~~~GT~~YmAPEvl~~--------~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~ 231 (636)
.... ..........||+.|+|||++.+ ...|+.++|||||||++|+|++|..||................
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 2111 11122334579999999999974 2357899999999999999999999999887776665554443
Q ss_pred CCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 232 PPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 232 ~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+.. ....++.++.+||.+||..||.+|||+.++++
T Consensus 260 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 260 KPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3222 22357889999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=381.41 Aligned_cols=248 Identities=21% Similarity=0.256 Sum_probs=197.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-------chhHHHHHHHHHHHHhCC---------CCCc
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-------NSDLSNISREAQTMILVD---------HPNV 71 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-------~~~~~~i~rEi~iL~~L~---------HPNI 71 (636)
+..++|++++.||+|+||+||+|.+ +|+.||||++..... ......+.+|+.+|+.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4457899999999999999999998 789999999986532 234578899999999886 6666
Q ss_pred ceeeeEE-----------------Ee-------------CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHH
Q 006664 72 LKSHCSF-----------------VS-------------DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121 (636)
Q Consensus 72 Vkl~~~~-----------------~~-------------~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl 121 (636)
+++++++ .+ +..+|+|||||.||++.+.+.+ ..+++..++.++.||+
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLT 171 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHH
Confidence 6665554 33 6889999999999987776643 5689999999999999
Q ss_pred HHHHHHH-HCCCcccccCcccEEEccCC--------------------cEEEeccCcccccccCCCcccccccccCCCCC
Q 006664 122 KGLDYLH-HHGHIHRDVKSGNILIDVRG--------------------AIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180 (636)
Q Consensus 122 ~aL~yLH-~~gIvHRDLKP~NILld~~g--------------------~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~Y 180 (636)
.||.||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y 243 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCT
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecc
Confidence 9999999 99999999999999999887 899999999976522 245899999
Q ss_pred CChhhhhhccCCCcccchhhHHHH-HHHHHcCCCCCCCCChHHHHH-HHHhcC--CCCCCcccchhhhHHHHHHHHhhcc
Q 006664 181 MAPEVMEQLHGYDFKADIWSFGIT-ALELAHGHAPFSKYPPMKVLL-MTLQNA--PPGLDYERDRKFSKSFKQMIASCLV 256 (636)
Q Consensus 181 mAPEvl~~~~~ys~ksDIWSLGii-LyeLltG~~PF~~~~~~~~l~-~~~~~~--~~~~~~~~~~~~S~~l~dLI~~cL~ 256 (636)
||||++.+. .+.++||||||++ .++++.|..||.+........ ...... ........+..+++++++||.+||.
T Consensus 244 ~aPE~~~g~--~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 321 (336)
T 2vuw_A 244 MDEDLFTGD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLN 321 (336)
T ss_dssp TCSGGGCCC--SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGG
T ss_pred cChhhhcCC--CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhc
Confidence 999999863 3889999998777 778888999985422111121 222111 1111223345789999999999999
Q ss_pred cCCCCCCCHHHHH-hCcccc
Q 006664 257 KDPSKRPSAKKLL-KHSFFK 275 (636)
Q Consensus 257 ~DP~kRpsa~elL-~Hpffk 275 (636)
+| |+.|+| +||||+
T Consensus 322 ~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 322 FS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SS-----SHHHHHHHCGGGC
T ss_pred cC-----CHHHHHhcCCCcC
Confidence 87 999999 999995
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.43 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=195.9
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHH--HHhCCCCCcceeeeEEEe--
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT--MILVDHPNVLKSHCSFVS-- 80 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~i--L~~L~HPNIVkl~~~~~~-- 80 (636)
...+..++|++++.||+|+||.||+|.+ +++.||||++.... ......|..+ +..++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 4567889999999999999999999976 68999999996432 2334444444 456899999999986543
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCcccccCcccEEEccCC
Q 006664 81 ---DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH---------GHIHRDVKSGNILIDVRG 148 (636)
Q Consensus 81 ---~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~---------gIvHRDLKP~NILld~~g 148 (636)
...+|+|||||+||+|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 23689999999999999999774 568999999999999999999999 999999999999999999
Q ss_pred cEEEeccCcccccccCC-----CcccccccccCCCCCCChhhhhhc------cCCCcccchhhHHHHHHHHHcCCCCCCC
Q 006664 149 AIKLGDFGVSACLFDSG-----DRQRMRNTFVGTPCWMAPEVMEQL------HGYDFKADIWSFGITALELAHGHAPFSK 217 (636)
Q Consensus 149 ~vKL~DFGla~~~~~~~-----~~~~~~~~~~GT~~YmAPEvl~~~------~~ys~ksDIWSLGiiLyeLltG~~PF~~ 217 (636)
.+||+|||++..+.... .........+||+.|+|||++.+. ..++.++|||||||++|||++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999999997654321 111223356899999999999752 3466789999999999999999777632
Q ss_pred CC-----------------hHHHHHHHHhcCC--CCC--CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 218 YP-----------------PMKVLLMTLQNAP--PGL--DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 218 ~~-----------------~~~~l~~~~~~~~--~~~--~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.. ............. +.+ .+.....+++.+.+||.+||..||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 11 1111112221111 111 11223457789999999999999999999999964
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=361.56 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=205.4
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC---CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER---DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~---~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
|...+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44558999999999999985 68899999996543 22346778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 90 FMSGGSCLHILKAAY-PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 90 y~~GGsL~~lL~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
|+.||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA-QT 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS-SC
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc-cc
Confidence 999999999997532 2459999999999999999999999999999999999999999999999999987543322 12
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHH---HHHHHhcCCCC-------CCcc
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV---LLMTLQNAPPG-------LDYE 238 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~---l~~~~~~~~~~-------~~~~ 238 (636)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||........ +...+...... ....
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 22345689999999999875 478999999999999999999999976443221 11111111110 0012
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.....+..+.++|.+||..||.+||++.++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 23567788999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=395.29 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=217.7
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPF---NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t---g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
..|++..++|++++.||+|+||.||+|.+..+ +..||||++.........+.+.+|+.+|+.++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 45778889999999999999999999998653 56799999876555555678999999999999999999999985
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
++.+|+|||||.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 56789999999999999999864 34689999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
..... ........||+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+....+....+...... ..
T Consensus 541 ~~~~~--~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----~~ 613 (656)
T 2j0j_A 541 MEDST--YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----PM 613 (656)
T ss_dssp CCC------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC----CC
T ss_pred cCCCc--ceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----CC
Confidence 53322 112234567889999999976 679999999999999999997 99999998887776666554332 23
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+..+++.+.+||.+||..||.+||++.++++
T Consensus 614 ~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 4578899999999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=358.27 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=204.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHh--CCCCCcceeeeEEEeCC----e
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMIL--VDHPNVLKSHCSFVSDH----N 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~--L~HPNIVkl~~~~~~~~----~ 83 (636)
.++|++.+.||+|+||.||+|.+ +|+.||||++... ....+.+|+.++.. ++||||+++++++.... .
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 36899999999999999999987 5999999998532 34567889999987 79999999999998876 8
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCcccccCcccEEEccCCcEEEecc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH--------HHGHIHRDVKSGNILIDVRGAIKLGDF 155 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH--------~~gIvHRDLKP~NILld~~g~vKL~DF 155 (636)
+|+||||+.+|+|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 9999999999999999976 36999999999999999999999 899999999999999999999999999
Q ss_pred CcccccccCCCcc-cccccccCCCCCCChhhhhhccC-----CCcccchhhHHHHHHHHHcC----------CCCCCCCC
Q 006664 156 GVSACLFDSGDRQ-RMRNTFVGTPCWMAPEVMEQLHG-----YDFKADIWSFGITALELAHG----------HAPFSKYP 219 (636)
Q Consensus 156 Gla~~~~~~~~~~-~~~~~~~GT~~YmAPEvl~~~~~-----ys~ksDIWSLGiiLyeLltG----------~~PF~~~~ 219 (636)
|++.......... ......+||+.|+|||++.+... ++.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9997654332211 12345689999999999976322 23689999999999999999 78986542
Q ss_pred ----hHHHHHHHHhcCCCCCCcc---cchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 220 ----PMKVLLMTLQNAPPGLDYE---RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 220 ----~~~~l~~~~~~~~~~~~~~---~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
....+...+.........+ .....+..+.+||.+||..||.+|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2233333332221111111 123566789999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=381.12 Aligned_cols=257 Identities=16% Similarity=0.229 Sum_probs=209.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCC-CCcceeeeEEEeCCeEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDH-PNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~H-PNIVkl~~~~~~~~~l~i 86 (636)
...++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+.| ++|..+..++......|+
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 3468999999999999999999999999999999998755433 247789999999987 556667777788899999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEE---ccCCcEEEeccCccccccc
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILI---DVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILl---d~~g~vKL~DFGla~~~~~ 163 (636)
||||| |++|.+++... ...+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.+..
T Consensus 81 vme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99999 99999999864 3579999999999999999999999999999999999999 6889999999999987644
Q ss_pred CCCcc----cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh---HHHHHHHHhcCCCCCC
Q 006664 164 SGDRQ----RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPPGLD 236 (636)
Q Consensus 164 ~~~~~----~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~---~~~l~~~~~~~~~~~~ 236 (636)
..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+... ...+..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 33211 12336789999999999987 6799999999999999999999999987543 2222222211111111
Q ss_pred cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 237 ~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
......++.++.+||.+||..||.+||++.+|++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1222467899999999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=377.23 Aligned_cols=252 Identities=14% Similarity=0.151 Sum_probs=196.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--hhHHHHHHHHHHHHhCCC-CCcce------------
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--SDLSNISREAQTMILVDH-PNVLK------------ 73 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--~~~~~i~rEi~iL~~L~H-PNIVk------------ 73 (636)
....|.+.+.||+|+||+||+|.+..+|+.||||++...... ...+.+.+|+.+++.+.| +|+..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345688999999999999999999999999999999744332 346789999999999987 32211
Q ss_pred ---------eeeEEEe-----CCeEEEEEeccCCCCHHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 006664 74 ---------SHCSFVS-----DHNLWVVMPFMSGGSCLHILKAA-----YPDGFEEVVIATILREVLKGLDYLHHHGHIH 134 (636)
Q Consensus 74 ---------l~~~~~~-----~~~l~iVmEy~~GGsL~~lL~~~-----~~~~lse~~i~~i~~QIl~aL~yLH~~gIvH 134 (636)
++.++.. ...++++|+++ +++|.+++... ....+++..+..++.||+.||.|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1111111 22467788876 57999988622 2234778889999999999999999999999
Q ss_pred cccCcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhh---------hccCCCcccchhhHHHHH
Q 006664 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME---------QLHGYDFKADIWSFGITA 205 (636)
Q Consensus 135 RDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~---------~~~~ys~ksDIWSLGiiL 205 (636)
|||||+||||+.++.+||+|||+++..... ..+.+| +.|+|||++. ....|+.++|||||||++
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999998754211 346688 9999999994 224478899999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 206 LELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 206 yeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
|+|++|+.||...........+ +.....+++.+++||.+||.+||.+||++.++++||||+..
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEWI---------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGGG---------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHCCCCCCCcchhhhHHHH---------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 9999999999875543221111 12234678999999999999999999999999999999754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=400.57 Aligned_cols=263 Identities=24% Similarity=0.316 Sum_probs=211.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe------CCe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS------DHN 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~------~~~ 83 (636)
.++|++.+.||+|+||+||+|.+..+|+.||||++...........+.+|+.+++.++||||+++++++.. +..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999999999999999999766555667789999999999999999999998765 677
Q ss_pred EEEEEeccCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc---EEEeccCccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAY-PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA---IKLGDFGVSA 159 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~---vKL~DFGla~ 159 (636)
.|+|||||+||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999999999999998742 225899999999999999999999999999999999999987664 9999999997
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHh----------
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ---------- 229 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~---------- 229 (636)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||............+.
T Consensus 173 ~~~~~----~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 173 ELDQG----ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp BTTSC----CCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccc----cccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 65322 12345789999999999976 6799999999999999999999999976433221100000
Q ss_pred -cCCCCC--------CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 230 -NAPPGL--------DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 230 -~~~~~~--------~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
...... .......+++.+.+||.+||.+||.+|||+.++++||||+..
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 000000 011234578999999999999999999999999999999853
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=387.84 Aligned_cols=243 Identities=22% Similarity=0.254 Sum_probs=204.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcC-CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe---
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIP-FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN--- 83 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~-tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~--- 83 (636)
+..++|++++.||+|+||+||+|.+.. +|+.||||++...........+.+|+.+++.++||||+++++++.....
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 345899999999999999999999986 7999999998755555556678999999999999999999999988665
Q ss_pred --EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 84 --LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 84 --l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
.|+|||||+|++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++. +.+||+|||++...
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~-~~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-SCEEECCCTTCEET
T ss_pred ceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC-CcEEEEecccchhc
Confidence 7999999999999887753 6999999999999999999999999999999999999986 49999999998765
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
... ...+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.... ..+ ......
T Consensus 232 ~~~-------~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~---~~~~~~ 291 (681)
T 2pzi_A 232 NSF-------GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLP---EDDPVL 291 (681)
T ss_dssp TCC-------SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCC---TTCHHH
T ss_pred ccC-------CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc--------ccc---cccccc
Confidence 221 35689999999999976 4589999999999999999999998752110 001 111223
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
..++.+.+||.+||.+||.+||+..+.+.|+|+.
T Consensus 292 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 292 KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 4578899999999999999999999999998875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.90 Aligned_cols=227 Identities=18% Similarity=0.172 Sum_probs=188.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
+..++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.+++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 445789999999999999999999999999999999976543 234577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+|||||+|++|.++++. +.....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999999999999853 34666788999999999999999999999999999999999999998554
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--CCCCCCcccchhh
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN--APPGLDYERDRKF 243 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~--~~~~~~~~~~~~~ 243 (636)
|++ .++.++|||||||++|+|++|+.||.+......+...... ............+
T Consensus 175 --------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T 3uqc_A 175 --------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232 (286)
T ss_dssp --------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred --------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence 333 2688899999999999999999999875543211000000 0000111223568
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+.++.+||.+||.+||.+| |+.++++
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 8999999999999999999 9999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=325.97 Aligned_cols=231 Identities=16% Similarity=0.185 Sum_probs=160.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCC---------chhHHHHHHHHHHHHhC-CCCCcceeeeEEEeCCeEEE
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERD---------NSDLSNISREAQTMILV-DHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~---------~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~~~~l~i 86 (636)
...+.|+.|.+..+...-+|+.||+|++..... ......+.+|+++|+++ .||||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346778888888888778899999999975531 12356789999999999 69999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
|||||+||+|.++|... +.+++. .|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~- 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC- 393 (569)
T ss_dssp EEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence 99999999999999875 567764 589999999999999999999999999999999999999999998653322
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
....+.+||+.|||||++.+ .+..++|+||+|+++|+|.+|..+|. ..+...+. ....
T Consensus 394 --~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~~~---------~~l~~~~~---------~~~~ 451 (569)
T 4azs_A 394 --SWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSNWL---------YAVWQEPV---------ERWN 451 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH---------HHHHTSCG---------GGCS
T ss_pred --ccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccchhH---------HHhhcCCC---------CCCc
Confidence 23457899999999999976 46778999999999998876644431 11111111 1113
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
+..+...++..+|..|+.......|+|..
T Consensus 452 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 452 FVLLLALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HHHHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCChhhhccchhHH
Confidence 45667777788888888777666666654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=277.72 Aligned_cols=189 Identities=20% Similarity=0.238 Sum_probs=146.6
Q ss_pred EEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-h------hHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 14 TLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-S------DLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 14 ~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~------~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
...+.||+|+||+||+| ...+..+|+|........ . ..+++.+|+.+|+.++||||+++..++......|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34668999999999999 446888999987543221 1 23457999999999999999966666667778899
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
|||||+||+|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999999865 5689999999999999999999999999999987 999999999986532211
Q ss_pred cc----cccccccCCCCCCChhhhhh-ccCCCcccchhhHHHHHHHHHcCCCCCC
Q 006664 167 RQ----RMRNTFVGTPCWMAPEVMEQ-LHGYDFKADIWSFGITALELAHGHAPFS 216 (636)
Q Consensus 167 ~~----~~~~~~~GT~~YmAPEvl~~-~~~ys~ksDIWSLGiiLyeLltG~~PF~ 216 (636)
.. ....+++||+.|||||++.. ...|+..+|+|+.++-..+.+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 10 02346799999999999975 2458888999999999888888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-25 Score=228.69 Aligned_cols=148 Identities=16% Similarity=0.176 Sum_probs=119.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-----------------hhHHHHHHHHHHHHhCCCCCcc
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-----------------SDLSNISREAQTMILVDHPNVL 72 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-----------------~~~~~i~rEi~iL~~L~HPNIV 72 (636)
...|.+++.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+|+.++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 34566779999999999999999 88999999999643311 13456889999999999 4 5
Q ss_pred eeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEE
Q 006664 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKL 152 (636)
Q Consensus 73 kl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL 152 (636)
++++++.. +..|+|||||+||+|.+ +. . .....++.||+.||.|||++||+||||||+|||++ +|.+||
T Consensus 165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 165 AVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp SSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEE
T ss_pred CcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEE
Confidence 55555544 45699999999999987 41 1 23457999999999999999999999999999999 999999
Q ss_pred eccCcccccccCCCcccccccccCCCCCCChhhhhh
Q 006664 153 GDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188 (636)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~ 188 (636)
+|||+|+ ++..|+|||++..
T Consensus 234 ~DFG~a~----------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 234 IDFPQSV----------------EVGEEGWREILER 253 (282)
T ss_dssp CCCTTCE----------------ETTSTTHHHHHHH
T ss_pred EECCCCe----------------ECCCCCHHHHHHH
Confidence 9999985 2456899999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.8e-21 Score=195.99 Aligned_cols=139 Identities=17% Similarity=0.173 Sum_probs=109.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcE--EEEEEeecCCCc-----------------------hhHHHHHHHHHHHHh
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEI--VAVKILDFERDN-----------------------SDLSNISREAQTMIL 65 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~--vAIK~i~~~~~~-----------------------~~~~~i~rEi~iL~~ 65 (636)
.-|.+.+.||+|+||.||+|.+..+|+. ||||+++..... .....+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3488999999999999999999788999 999997543211 011357899999999
Q ss_pred CCCCCc--ceeeeEEEeCCeEEEEEeccCC-C----CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccc
Q 006664 66 VDHPNV--LKSHCSFVSDHNLWVVMPFMSG-G----SCLHILKAAYPDGFEEVVIATILREVLKGLDYLH-HHGHIHRDV 137 (636)
Q Consensus 66 L~HPNI--Vkl~~~~~~~~~l~iVmEy~~G-G----sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH-~~gIvHRDL 137 (636)
+.|++| ..+++. ...++||||+.+ | +|.++... .++..+..++.||+.||.||| ++||+||||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 988865 334432 356899999942 3 66665432 235567899999999999999 999999999
Q ss_pred CcccEEEccCCcEEEeccCcccc
Q 006664 138 KSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 138 KP~NILld~~g~vKL~DFGla~~ 160 (636)
||+|||++. .++|+|||+|..
T Consensus 198 kp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEE
T ss_pred CHHHEEEcC--cEEEEECccccc
Confidence 999999987 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=8.7e-18 Score=181.13 Aligned_cols=137 Identities=17% Similarity=0.111 Sum_probs=100.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-------------hhHH--------HHHHHHHHHHhCCCCC
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-------------SDLS--------NISREAQTMILVDHPN 70 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-------------~~~~--------~i~rEi~iL~~L~HPN 70 (636)
-|.++..||.|+||.||+|.+ .+|+.||||+++..... .... ...+|...|.++.+++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 399999999999999999987 47999999998532100 0011 1245777777776555
Q ss_pred cceeeeEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC--
Q 006664 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-- 148 (636)
Q Consensus 71 IVkl~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-- 148 (636)
+.-..-+.... .++||||++|++|..+. ....+..++.||+.+|.|||++|||||||||.|||++.+|
T Consensus 175 v~vp~p~~~~~--~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQSR--HTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEEET--TEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeeccC--ceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 43222222222 37999999998875432 1224567889999999999999999999999999998776
Q ss_pred --------cEEEeccCccc
Q 006664 149 --------AIKLGDFGVSA 159 (636)
Q Consensus 149 --------~vKL~DFGla~ 159 (636)
.+.|+||+-+.
T Consensus 245 ~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SCTTSEEEEEEECCCTTCE
T ss_pred ccccccccceEEEEeCCcc
Confidence 38999999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.7e-12 Score=129.50 Aligned_cols=139 Identities=19% Similarity=0.175 Sum_probs=111.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~iVmE 89 (636)
..|.+...+|.|+.+.||++.. .+..+++|+...... .....+.+|+.+++.+. +..+.++++++.+.+..|+|||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 4689999999999999999974 378999999864211 12335889999999884 6778899999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH---------------------------------------- 129 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~---------------------------------------- 129 (636)
|++|.+|.+.+. +......++.++..+|..||+
T Consensus 91 ~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999876521 112234788899999999998
Q ss_pred -------------------CCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 130 -------------------HGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 130 -------------------~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999865566799999864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=2.2e-11 Score=121.48 Aligned_cols=134 Identities=16% Similarity=0.103 Sum_probs=99.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCC--cceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN--VLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPN--IVkl~~~~~~~~~l~iVm 88 (636)
..|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+.+.+ +.++++++..++..|+||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 4566655445667799999954 56788999997533 2245788999999886544 456888888888899999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG------------------------------------- 131 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g------------------------------------- 131 (636)
||++|.+|. . .... ...++.++...|..||+..
T Consensus 95 e~i~G~~l~--~-----~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 95 GEVPGQDLL--S-----SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp ECCSSEETT--T-----SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EecCCcccC--c-----CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 999998773 1 1112 1256667777777777643
Q ss_pred ---------------------CcccccCcccEEEccCCcEEEeccCccc
Q 006664 132 ---------------------HIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 132 ---------------------IvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
++|+|++|.||+++.++.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 8999999999999866667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.15 E-value=8.1e-11 Score=124.60 Aligned_cols=142 Identities=15% Similarity=0.164 Sum_probs=106.5
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEee--cCCCchhHHHHHHHHHHHHhCC--CCCcceeeeEEEeC---CeEE
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILD--FERDNSDLSNISREAQTMILVD--HPNVLKSHCSFVSD---HNLW 85 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~--~~~~~~~~~~i~rEi~iL~~L~--HPNIVkl~~~~~~~---~~l~ 85 (636)
..-++.|+.|.++.||++... +..+++|+.. ..........+.+|+.+++.|. +..+.+++.++.+. +..|
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 445788999999999998753 5678889875 3322223456889999999987 45578888887766 4589
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH------------------------------------ 129 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~------------------------------------ 129 (636)
+||||++|..+.+. ....+++.....++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 99999999876431 11346788888999999999999997
Q ss_pred ----------------------CCCcccccCcccEEEccCCc--EEEeccCcccc
Q 006664 130 ----------------------HGHIHRDVKSGNILIDVRGA--IKLGDFGVSAC 160 (636)
Q Consensus 130 ----------------------~gIvHRDLKP~NILld~~g~--vKL~DFGla~~ 160 (636)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999987653 69999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.99 E-value=5e-10 Score=115.84 Aligned_cols=182 Identities=18% Similarity=0.200 Sum_probs=121.5
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCc--ceeeeEEEeCC---eEEEEEe
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNV--LKSHCSFVSDH---NLWVVMP 89 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNI--Vkl~~~~~~~~---~l~iVmE 89 (636)
++.++.|.+..||++. ..+++|+.. .......+.+|+.+|+.+ .+..| .+++.....+. ..|+||+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~---~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPK---HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEES---SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecC---CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4569999999999873 458889854 223456789999999887 44333 34444333332 3489999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH---------------------------------------- 129 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~---------------------------------------- 129 (636)
|++|.+|...... .++......++.++...|..||+
T Consensus 97 ~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 97 KIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred ccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9999887654332 36777778888888888888886
Q ss_pred ------------------CCCcccccCcccEEEcc--CCcEEEeccCcccccccCCCcccccccccCCCCC---CChhhh
Q 006664 130 ------------------HGHIHRDVKSGNILIDV--RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW---MAPEVM 186 (636)
Q Consensus 130 ------------------~gIvHRDLKP~NILld~--~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~Y---mAPEvl 186 (636)
..++|+|++|.||+++. ++.+.|+||+.+... +.. ........+ ..|+..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~-~~~------~Dl~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS-DPD------NDFISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE-CTT------HHHHTTCCTTTSCCHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC-ChH------HHHHHHHhhccccCHHHH
Confidence 13699999999999987 456889999987542 110 011111111 233322
Q ss_pred hh-ccCCC------------cccchhhHHHHHHHHHcCCCCCC
Q 006664 187 EQ-LHGYD------------FKADIWSFGITALELAHGHAPFS 216 (636)
Q Consensus 187 ~~-~~~ys------------~ksDIWSLGiiLyeLltG~~PF~ 216 (636)
.. ...|. ...+.|++|.++|.+.+|..+|.
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 00111 22589999999999999988763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=7.2e-07 Score=92.55 Aligned_cols=132 Identities=17% Similarity=0.127 Sum_probs=92.3
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCC---CcceeeeEEE-eCCeEEEEEecc
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP---NVLKSHCSFV-SDHNLWVVMPFM 91 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HP---NIVkl~~~~~-~~~~l~iVmEy~ 91 (636)
++.++.|....||+. |..+++|+-. .......+.+|+.+|+.+.+. .|.+.+.+.. ..+..|+||+|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 566899999999988 5668888842 233456789999999998752 2455665553 345678999999
Q ss_pred CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 006664 92 SGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH----------------------------------------- 130 (636)
Q Consensus 92 ~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~----------------------------------------- 130 (636)
+|..+....- ..++......++.++...|..||+.
T Consensus 96 ~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 96 QGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred CCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9987765321 1234444455555555555555532
Q ss_pred -------------------CCcccccCcccEEEcc---CCc-EEEeccCccc
Q 006664 131 -------------------GHIHRDVKSGNILIDV---RGA-IKLGDFGVSA 159 (636)
Q Consensus 131 -------------------gIvHRDLKP~NILld~---~g~-vKL~DFGla~ 159 (636)
.++|+|++|.|||++. ++. +.|+||+.+.
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3589999999999987 355 5899999875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.2e-06 Score=88.24 Aligned_cols=132 Identities=16% Similarity=0.135 Sum_probs=97.8
Q ss_pred EEcccCce-EEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEEEEeccCCCC
Q 006664 18 EVGQGVSA-SVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWVVMPFMSGGS 95 (636)
Q Consensus 18 ~IG~G~fG-~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~iVmEy~~GGs 95 (636)
.+..|..| .||+......+..+++|+-.. .....+.+|..+|+.+. +--|.+++.+..+++..|+|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 45556655 699988777788899998642 24556889999998874 3236678888889999999999999988
Q ss_pred HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 006664 96 CLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH--------------------------------------------- 130 (636)
Q Consensus 96 L~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~--------------------------------------------- 130 (636)
+.+..... ......+..++...|..||..
T Consensus 107 ~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 87765432 122234556666666666631
Q ss_pred -------------CCcccccCcccEEEccCCcEEEeccCccc
Q 006664 131 -------------GHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 131 -------------gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 15899999999999877777899999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=4.2e-06 Score=89.53 Aligned_cols=78 Identities=15% Similarity=0.100 Sum_probs=51.8
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC------chhHHHHHHHHHHHHhCCC--CCc-ceeeeEEEeCCeEE
Q 006664 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD------NSDLSNISREAQTMILVDH--PNV-LKSHCSFVSDHNLW 85 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~------~~~~~~i~rEi~iL~~L~H--PNI-Vkl~~~~~~~~~l~ 85 (636)
-++.||.|.++.||++....++..|++|....... .....++.+|..+|+.+.. |.. .+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997655678899998642211 1234567889999987742 443 455543 445568
Q ss_pred EEEeccCCC
Q 006664 86 VVMPFMSGG 94 (636)
Q Consensus 86 iVmEy~~GG 94 (636)
+||||+.|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.13 E-value=3.1e-05 Score=80.02 Aligned_cols=138 Identities=18% Similarity=0.169 Sum_probs=80.0
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-----CCCcceee-e--EEEeCCeEEE
Q 006664 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-----HPNVLKSH-C--SFVSDHNLWV 86 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-----HPNIVkl~-~--~~~~~~~l~i 86 (636)
-++.|+.|..+.||++... +..+++|+.... ...+..|+.+++.|. .|.++... + +...++..|+
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 3456777889999998753 345899998641 234445666665442 34444311 0 2235678899
Q ss_pred EEeccCCCCHH--------------HHHHHh---C--CCCC-------CHH--------H--------------------
Q 006664 87 VMPFMSGGSCL--------------HILKAA---Y--PDGF-------EEV--------V-------------------- 112 (636)
Q Consensus 87 VmEy~~GGsL~--------------~lL~~~---~--~~~l-------se~--------~-------------------- 112 (636)
||+|++|..+. ..+... . +... ... .
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999986431 111111 0 1000 010 0
Q ss_pred ---HHHHHHHHHHHHHHHHH-------------CCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 113 ---IATILREVLKGLDYLHH-------------HGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 113 ---i~~i~~QIl~aL~yLH~-------------~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
+..+..++..++.+|+. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234445666652 579999999999999878899999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=3.2e-06 Score=88.86 Aligned_cols=84 Identities=12% Similarity=0.105 Sum_probs=56.6
Q ss_pred eEEEeEE-cccCceEEEEEEEc--C----CCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCC-C--CCcceeeeEEEe
Q 006664 13 YTLYEEV-GQGVSASVHRALCI--P----FNEIVAVKILDFERD--NSDLSNISREAQTMILVD-H--PNVLKSHCSFVS 80 (636)
Q Consensus 13 Y~l~~~I-G~G~fG~Vyka~~~--~----tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~-H--PNIVkl~~~~~~ 80 (636)
...++.| +.|....+|++... . ++..+++|+...... ......+.+|+.+|+.|. + ..+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456788 89999999998653 1 266789998643220 001245788999998774 2 346677777655
Q ss_pred C---CeEEEEEeccCCCCH
Q 006664 81 D---HNLWVVMPFMSGGSC 96 (636)
Q Consensus 81 ~---~~l~iVmEy~~GGsL 96 (636)
. +..|+||||++|..+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 4 356899999998653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.0002 Score=77.21 Aligned_cols=75 Identities=15% Similarity=-0.005 Sum_probs=45.9
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeecC-----CC-chhHHHHHHHHHHHHhC---CCCCcceeeeEEEeCCeEE
Q 006664 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFE-----RD-NSDLSNISREAQTMILV---DHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~-----~~-~~~~~~i~rEi~iL~~L---~HPNIVkl~~~~~~~~~l~ 85 (636)
-++.||.|..+.||++.. ++..++||..... .. .........|..++..+ .+..+.+++.+. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 467899999999999953 5678999943211 11 11112223344443322 234566666654 56779
Q ss_pred EEEecc-CC
Q 006664 86 VVMPFM-SG 93 (636)
Q Consensus 86 iVmEy~-~G 93 (636)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00044 Score=72.10 Aligned_cols=77 Identities=17% Similarity=0.016 Sum_probs=61.3
Q ss_pred EEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC---CCCcceeeeEEEeCCeEEEEEec
Q 006664 14 TLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD---HPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 14 ~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~---HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
.-.+.|+.|.+..+|++.. ++..+++|+.... ....+.+|...|+.|. ...+.+++.+....+..|+||||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 4467899999999999874 4678889987532 3567889999998874 35677888888878899999999
Q ss_pred cCCCCH
Q 006664 91 MSGGSC 96 (636)
Q Consensus 91 ~~GGsL 96 (636)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 999753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00015 Score=74.38 Aligned_cols=133 Identities=18% Similarity=0.146 Sum_probs=74.9
Q ss_pred EeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCc-ceeeeEEEeCCeEEEEEecc-CC
Q 006664 16 YEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNV-LKSHCSFVSDHNLWVVMPFM-SG 93 (636)
Q Consensus 16 ~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNI-Vkl~~~~~~~~~l~iVmEy~-~G 93 (636)
++.|+.|....+|++ ..+++|+...... ..-...+|+.+++.+..-++ .+++.. +...-++|+||+ +|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 788999999999999 4588898753211 11123568888877643233 345443 344457899999 66
Q ss_pred CCHHH---------------HHHHhCCCC--C----C-HHHHHHHHHH--------------HHHHHHHHH----H----
Q 006664 94 GSCLH---------------ILKAAYPDG--F----E-EVVIATILRE--------------VLKGLDYLH----H---- 129 (636)
Q Consensus 94 GsL~~---------------lL~~~~~~~--l----s-e~~i~~i~~Q--------------Il~aL~yLH----~---- 129 (636)
.+|.. .|.+-+... + . ...+..+... +...+..+. .
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 44321 111111110 1 1 1111111111 111122111 1
Q ss_pred CCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 130 ~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
..++|+|+.|.||+ ..++.+.|+||..+.
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 23799999999999 457788999999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0012 Score=65.24 Aligned_cols=135 Identities=19% Similarity=0.107 Sum_probs=92.6
Q ss_pred CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccccccc
Q 006664 95 SCLHILKAAYPDGFEEVVIATILREVLKGLDYLH-HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT 173 (636)
Q Consensus 95 sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH-~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 173 (636)
+|.++|+.. ..+++|.++|.++.|.+.+|.-+- +..-..+=+-|..|+|..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 789999876 478999999999999999988762 22223444567999999999988764 2211
Q ss_pred ccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHh
Q 006664 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253 (636)
Q Consensus 174 ~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~ 253 (636)
.....+.|||... ...+.+.=|||||+++|.-+--..| -..+..+|+.+..||..
T Consensus 98 -~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~----------------------e~eE~eLS~~LE~LL~~ 152 (229)
T 2yle_A 98 -AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK----------------------ENEERELSPPLEQLIDH 152 (229)
T ss_dssp ----------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC----------------------TTEEECCCHHHHHHHHH
T ss_pred -ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC----------------------cccchhhCHHHHHHHHH
Confidence 1123466888753 3456778899999999988752222 13346789999999999
Q ss_pred hcccC-------------------------CCCCCCHHHHHh
Q 006664 254 CLVKD-------------------------PSKRPSAKKLLK 270 (636)
Q Consensus 254 cL~~D-------------------------P~kRpsa~elL~ 270 (636)
|..-. +..|.+.+++++
T Consensus 153 Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 153 MANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp HTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred HHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 98662 357788888875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.001 Score=69.04 Aligned_cols=137 Identities=8% Similarity=0.059 Sum_probs=72.0
Q ss_pred EeEEcccCceE-EEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCC--CCcceeeeEEEeCCeEEEEEeccC
Q 006664 16 YEEVGQGVSAS-VHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDH--PNVLKSHCSFVSDHNLWVVMPFMS 92 (636)
Q Consensus 16 ~~~IG~G~fG~-Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~H--PNIVkl~~~~~~~~~l~iVmEy~~ 92 (636)
++.|+.|.... +|+... .+|..+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||++.
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG 95 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence 45566665554 667642 2366777776543211 234567787776642 23455665432333 78999998
Q ss_pred CCCHHHHHHHhC---------------------C---CCCCHHHHH-------H-HH------------HHHHHHHHHH-
Q 006664 93 GGSCLHILKAAY---------------------P---DGFEEVVIA-------T-IL------------REVLKGLDYL- 127 (636)
Q Consensus 93 GGsL~~lL~~~~---------------------~---~~lse~~i~-------~-i~------------~QIl~aL~yL- 127 (636)
|..+.+.+.... . ..+...... . +. ..+...+..+
T Consensus 96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~ 175 (333)
T 3csv_A 96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL 175 (333)
T ss_dssp SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 777655443210 0 112221111 0 00 0111222333
Q ss_pred -----HHCCCcccccCcccEEEccC----CcEEEeccCccc
Q 006664 128 -----HHHGHIHRDVKSGNILIDVR----GAIKLGDFGVSA 159 (636)
Q Consensus 128 -----H~~gIvHRDLKP~NILld~~----g~vKL~DFGla~ 159 (636)
+...++|||+.+.||+++.+ +.+.|+||+.+.
T Consensus 176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 23469999999999999864 689999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0021 Score=65.37 Aligned_cols=80 Identities=14% Similarity=0.001 Sum_probs=56.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-C--CCcceeeeEEEeCCeEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-H--PNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-H--PNIVkl~~~~~~~~~l~i 86 (636)
..+..-++.+|.|..+.||++.. .+|+.|++|+..... ......+.+|+..|+.|. . --+.+.+++ ++ -++
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l 87 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL 87 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence 45667789999999999999975 578999999865332 222345788999999884 2 123445443 22 378
Q ss_pred EEeccCCCC
Q 006664 87 VMPFMSGGS 95 (636)
Q Consensus 87 VmEy~~GGs 95 (636)
||||+.++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0042 Score=63.73 Aligned_cols=143 Identities=16% Similarity=0.108 Sum_probs=80.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-----CCCcceee-e--EEEeCCe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-----HPNVLKSH-C--SFVSDHN 83 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-----HPNIVkl~-~--~~~~~~~ 83 (636)
...-++.|+.|....||++... .| .+++|+..... ....+..|+.++..|. -|.++... + +...++.
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 3445678889999999998753 33 68899886421 2234567888877653 23333211 0 1223467
Q ss_pred EEEEEeccCCCCHH-----------H---HHHHhC---CCC----CCHHHHHHH---------------HHHHHHHHHHH
Q 006664 84 LWVVMPFMSGGSCL-----------H---ILKAAY---PDG----FEEVVIATI---------------LREVLKGLDYL 127 (636)
Q Consensus 84 l~iVmEy~~GGsL~-----------~---lL~~~~---~~~----lse~~i~~i---------------~~QIl~aL~yL 127 (636)
.+++|+|++|..+. . .+.... ... .....-... -..+...+.++
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 89999999986421 0 111111 000 010000000 01134445555
Q ss_pred HH-------CCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 128 HH-------HGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 128 H~-------~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
+. .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 53 368999999999999876666899999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0041 Score=64.02 Aligned_cols=75 Identities=16% Similarity=0.082 Sum_probs=48.5
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCC--cceeeeE-----EEeCCeEEEEEe
Q 006664 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN--VLKSHCS-----FVSDHNLWVVMP 89 (636)
Q Consensus 17 ~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPN--IVkl~~~-----~~~~~~l~iVmE 89 (636)
..++ |....||++.. .+|+.+++|+...... ....+..|+.++..|.... +.+++.. ...++..++||+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 88889998754 3466799999853221 3456777888887764212 3333332 233567789999
Q ss_pred ccCCCC
Q 006664 90 FMSGGS 95 (636)
Q Consensus 90 y~~GGs 95 (636)
|++|..
T Consensus 108 ~i~G~~ 113 (328)
T 1zyl_A 108 SVGGRQ 113 (328)
T ss_dssp CCCCEE
T ss_pred ecCCCC
Confidence 998843
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0034 Score=68.09 Aligned_cols=74 Identities=11% Similarity=0.048 Sum_probs=50.9
Q ss_pred EEEeEEcccCceEEEEEEEcC-------CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCc-ceeeeEEEeCCeEE
Q 006664 14 TLYEEVGQGVSASVHRALCIP-------FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNV-LKSHCSFVSDHNLW 85 (636)
Q Consensus 14 ~l~~~IG~G~fG~Vyka~~~~-------tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNI-Vkl~~~~~~~~~l~ 85 (636)
.-++.|+.|....||++.... .+..+++|+.... .....+.+|..+++.|...++ .++++.+.+ .
T Consensus 76 ~~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 76 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred eEEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 346789999999999997642 2578999987321 112455689999988753344 566665542 3
Q ss_pred EEEeccCCC
Q 006664 86 VVMPFMSGG 94 (636)
Q Consensus 86 iVmEy~~GG 94 (636)
+|+||++|.
T Consensus 149 ~v~e~l~G~ 157 (429)
T 1nw1_A 149 RLEEYIPSR 157 (429)
T ss_dssp EEECCCCEE
T ss_pred EEEEEeCCc
Confidence 899999873
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0017 Score=69.53 Aligned_cols=142 Identities=14% Similarity=0.104 Sum_probs=85.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcC-------CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCC
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIP-------FNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDH 82 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~-------tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~ 82 (636)
+... ++.|..|-...+|++.... .+..|++|+... .......+.+|..+++.|. +.-..++++.+.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-- 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE-- 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--
Confidence 4444 4678889999999987632 357899998632 1123556679999998774 3223556666543
Q ss_pred eEEEEEeccCCCCHH--------------HHHHHhCCC------CCC--HHHHHHHHHHHHH------------------
Q 006664 83 NLWVVMPFMSGGSCL--------------HILKAAYPD------GFE--EVVIATILREVLK------------------ 122 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~--------------~lL~~~~~~------~ls--e~~i~~i~~QIl~------------------ 122 (636)
.+||||++|..|. ..|.+.+.. ... ...+..++.++-.
T Consensus 126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 2999999985431 222222111 122 3455666655422
Q ss_pred -HHHHHH----H----CCCcccccCcccEEEccC----CcEEEeccCccc
Q 006664 123 -GLDYLH----H----HGHIHRDVKSGNILIDVR----GAIKLGDFGVSA 159 (636)
Q Consensus 123 -aL~yLH----~----~gIvHRDLKP~NILld~~----g~vKL~DFGla~ 159 (636)
.+..|. . ..++|+|+.+.||+++.+ +.+.|+||..|.
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 2 258999999999999876 789999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0019 Score=68.09 Aligned_cols=75 Identities=11% Similarity=0.079 Sum_probs=45.4
Q ss_pred EEeEEcccCceEEEEEEEcC--------CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCC-cceeeeEEEeCCeEE
Q 006664 15 LYEEVGQGVSASVHRALCIP--------FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN-VLKSHCSFVSDHNLW 85 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~--------tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPN-IVkl~~~~~~~~~l~ 85 (636)
-++.|+.|....||++.... .+..+++|+..... .......+|..+++.+...+ +.++++.+ . -+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 45678899999999997642 13688999864321 11222467888888775333 34666544 2 27
Q ss_pred EEEeccCCCC
Q 006664 86 VVMPFMSGGS 95 (636)
Q Consensus 86 iVmEy~~GGs 95 (636)
+||+|++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998853
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.013 Score=64.25 Aligned_cols=75 Identities=15% Similarity=0.224 Sum_probs=49.5
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCc-ceeeeEEEeCCeEEEEEeccCC
Q 006664 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNV-LKSHCSFVSDHNLWVVMPFMSG 93 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNI-Vkl~~~~~~~~~l~iVmEy~~G 93 (636)
-++.|+.|-...+|++.....+..+++|+...... ..-...+|..+++.|...++ .++++.+. + .+||||++|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 45779999999999998754457899998743221 11112689999998875555 46776663 2 259999988
Q ss_pred CC
Q 006664 94 GS 95 (636)
Q Consensus 94 Gs 95 (636)
..
T Consensus 186 ~~ 187 (458)
T 2qg7_A 186 YA 187 (458)
T ss_dssp EE
T ss_pred cc
Confidence 43
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.017 Score=60.28 Aligned_cols=30 Identities=23% Similarity=0.361 Sum_probs=26.8
Q ss_pred CCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 130 ~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 368999999999999887889999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.90 E-value=0.046 Score=59.27 Aligned_cols=75 Identities=9% Similarity=0.094 Sum_probs=49.5
Q ss_pred EEeEEcccCceEEEEEEEcCC-------CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCC-cceeeeEEEeCCeEEE
Q 006664 15 LYEEVGQGVSASVHRALCIPF-------NEIVAVKILDFERDNSDLSNISREAQTMILVDHPN-VLKSHCSFVSDHNLWV 86 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~t-------g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPN-IVkl~~~~~~~~~l~i 86 (636)
-++.|..|-...+|++..... +..|++|+..... ...-...+|..+++.+.--+ ..++++.+ . -++
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 456788899999999986421 5789999864322 11223467999988775323 34555533 2 278
Q ss_pred EEeccCCCC
Q 006664 87 VMPFMSGGS 95 (636)
Q Consensus 87 VmEy~~GGs 95 (636)
||+|++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.14 E-value=0.54 Score=50.03 Aligned_cols=28 Identities=36% Similarity=0.555 Sum_probs=24.2
Q ss_pred CcccccCcccEEE------ccCCcEEEeccCccc
Q 006664 132 HIHRDVKSGNILI------DVRGAIKLGDFGVSA 159 (636)
Q Consensus 132 IvHRDLKP~NILl------d~~g~vKL~DFGla~ 159 (636)
++|+|+.+.|||+ +.++.+.++||-+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 345789999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 636 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-76 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-75 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-74 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-72 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-68 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-68 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-68 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-68 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-66 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-66 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-65 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-65 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-63 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-61 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-60 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-59 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-57 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-56 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-56 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-56 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-55 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-55 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-54 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-54 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-52 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-52 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-50 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-50 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-49 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-48 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-48 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-47 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-44 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-35 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-16 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 8e-76
Identities = 96/283 (33%), Positives = 155/283 (54%), Gaps = 12/283 (4%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ + + E+G G V++A + + A K++D + +L + E + DHPN
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-TKSEEELEDYMVEIDILASCDHPN 70
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++K +F ++NLW+++ F +GG+ + + E I + ++ L L+YLH +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGA-VDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM---- 186
IHRD+K+GNIL + G IKL DFGVSA + R R++F+GTP WMAPEV+
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVVMCET 186
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246
+ YD+KAD+WS GIT +E+A P + PM+VLL ++ PP L + ++S +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL--AQPSRWSSN 244
Query: 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLE 289
FK + CL K+ R + +LL+H F SN+ I + E
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVD-SNKPIRELIAE 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 4e-75
Identities = 68/266 (25%), Positives = 126/266 (47%), Gaps = 5/266 (1%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E + L + +G+G V A+ E VAVKI+D +R NI +E +++H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
V+K + + ++ + + SGG ++ G E +++ G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
G HRD+K N+L+D R +K+ DFG+ A +F +R+R+ N GT ++APE++++
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGL-ATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
+ D+WS GI + G P+ + + L+ +K + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLAL 239
Query: 251 IASCLVKDPSKRPSAKKLLKHSFFKQ 276
+ LV++PS R + + K ++ +
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNK 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 239 bits (611), Expect = 1e-74
Identities = 100/306 (32%), Positives = 157/306 (51%), Gaps = 16/306 (5%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFE--RDNSDLSNISREAQTMILVDH 68
+ ++ E+G G +V+ A + +E+VA+K + + + N +I +E + + + H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
PN ++ ++ +H W+VM + G + + P +EV IA + L+GL YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLH 132
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
H IHRDVK+GNIL+ G +KLGDFG ++ + + N+FVGTP WMAPEV+
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILA 185
Query: 189 LH--GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246
+ YD K D+WS GIT +ELA P M L QN P L +S+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ---SGHWSEY 242
Query: 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKEE 306
F+ + SCL K P RP+++ LLKH F + R I + A+ + +K +
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMK 302
Query: 307 DMLAQK 312
+L Q+
Sbjct: 303 KILFQE 308
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 2e-73
Identities = 96/274 (35%), Positives = 150/274 (54%), Gaps = 10/274 (3%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ YT +E++GQG S +V+ A+ + + VA++ ++ ++ I E M +PN
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPN 78
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ S++ LWVVM +++GGS ++ +E IA + RE L+ L++LH +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 131 GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLH 190
IHRD+KS NIL+ + G++KL DFG A + Q R+T VGTP WMAPEV+ +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTR-K 191
Query: 191 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
Y K DIWS GI A+E+ G P+ P++ L + N P + + K S F+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--ELQNPEKLSAIFRDF 249
Query: 251 IASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIA 284
+ CL D KR SAK+LL+H F K A+ +
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 9e-72
Identities = 90/322 (27%), Positives = 144/322 (44%), Gaps = 53/322 (16%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ + E+G G V + P ++A K++ E + + I RE Q + + P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH- 129
++ + +F SD + + M M GGS +LK A E ++ + V+KGL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK 123
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
H +HRDVK NIL++ RG IKL DFGVS L DS M N+FVGT +M+PE ++
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG- 177
Query: 190 HGYDFKADIWSFGITALELAHGHAPF---------------------------------- 215
Y ++DIWS G++ +E+A G P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 216 -----SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
PPM + + FS F+ + CL+K+P++R K+L+
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 271 HSFFKQARSNE-----YIARTL 287
H+F K++ + E ++ T+
Sbjct: 298 HAFIKRSDAEEVDFAGWLCSTI 319
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 1e-68
Identities = 74/271 (27%), Positives = 122/271 (45%), Gaps = 10/271 (3%)
Query: 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTM 63
+ I T+ + +G G +V++ ++ VAVK+L+ L E +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 64 ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
H N+L + + L +V + G S H L FE + + I R+ +G
Sbjct: 59 RKTRHVNILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQG 116
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
+DYLH IHRD+KS NI + +K+GDFG+ A + G+ WMAP
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGL-ATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 184 EV--MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
EV M+ + Y F++D+++FGI EL G P+S ++ + D + R
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 242 -KFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
K+ K+++A CL K +RP ++L
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 3e-68
Identities = 62/274 (22%), Positives = 120/274 (43%), Gaps = 18/274 (6%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDH 68
AE Y + +G G + +I+ K LD+ ++ + E + + H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 69 PNVLKSHCSFV--SDHNLWVVMPFMSGGSCLHILKAAYPDG--FEEVVIATILREVLKGL 124
PN+++ + + ++ L++VM + GG ++ + +E + ++ ++ L
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 125 DYLHHHGH-----IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPC 179
H +HRD+K N+ +D + +KLGDFG++ L FVGTP
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKAFVGTPY 179
Query: 180 WMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239
+M+PE M + Y+ K+DIWS G EL PF+ + ++ + + Y
Sbjct: 180 YMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY-- 236
Query: 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
++S ++I L RPS +++L++
Sbjct: 237 --RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 3e-68
Identities = 65/274 (23%), Positives = 125/274 (45%), Gaps = 17/274 (6%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQ 61
+++ + E + + +G+G +V+ A I+A+K+L + + RE +
Sbjct: 1 RQWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 58
Query: 62 TMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
+ HPN+L+ + F +++++ + G+ L+ F+E AT + E+
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELA 116
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
L Y H IHRD+K N+L+ G +K+ DFG S S R T GT ++
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTTLCGTLDYL 171
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
PE++E +D K D+WS G+ E G PF + + +++
Sbjct: 172 PPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-----VEFTFPD 225
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275
++ + +I+ L +PS+RP +++L+H +
Sbjct: 226 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 223 bits (570), Expect = 4e-68
Identities = 73/268 (27%), Positives = 126/268 (47%), Gaps = 10/268 (3%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+HY ++EE+G G VHR A K + + SD + +E QTM ++ HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPT 84
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ H +F D+ + ++ FMSGG + + + E +R+V KGL ++H +
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 131 GHIHRDVKSGNILIDVR--GAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
++H D+K NI+ + +KL DFG++A L D ++ GT + APEV E
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL----DPKQSVKVTTGTAEFAAPEVAEG 199
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
+ D+WS G+ + L G +PF + L +++ +D S+ K
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
I L+ DP+ R + + L+H +
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTP 285
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 2e-67
Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 19/271 (7%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNV 71
E+G+G +V++ L VA L + S+ EA+ + + HPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 72 LKSHCSFVS----DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYL 127
++ + S+ S + +V M+ G+ LK + V+ + R++LKGL +L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFL 128
Query: 128 HHHGH--IHRDVKSGNILIDVR-GAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
H IHRD+K NI I G++K+GD G++ R +GTP +MAPE
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVIGTPEFMAPE 183
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFS 244
+ E+ YD D+++FG+ LE+A P+S+ + + + + D+
Sbjct: 184 MYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF--DKVAI 239
Query: 245 KSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275
K++I C+ ++ +R S K LL H+FF+
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 217 bits (553), Expect = 2e-66
Identities = 80/280 (28%), Positives = 124/280 (44%), Gaps = 21/280 (7%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD--------LSNISREAQT 62
E+Y E +G+GVS+ V R + P + AVKI+D S +E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 63 M-ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
+ + HPN+++ ++ ++ ++V M G L E I+R +L
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
+ + LH +HRD+K NIL+D IKL DFG S L D GTP ++
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL----DPGEKLREVCGTPSYL 176
Query: 182 APEVMEQLH-----GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 236
APE++E GY + D+WS G+ L G PF M +L M +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ-FG 235
Query: 237 YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
+S + K +++ LV P KR +A++ L H FF+Q
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 219 bits (558), Expect = 2e-66
Identities = 64/272 (23%), Positives = 121/272 (44%), Gaps = 10/272 (3%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
++Y + EE+G G VHR + + K ++ D + E M + HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPK 87
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ H +F + + +++ F+SGG + A E + +R+ +GL ++H H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 131 GHIHRDVKSGNILIDVR--GAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
+H D+K NI+ + + ++K+ DFG++ L + + T + APE++++
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKL----NPDEIVKVTTATAEFAAPEIVDR 202
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
F D+W+ G+ L G +PF+ ++ L + D + S K
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-FDEDAFSSVSPEAK 260
Query: 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQARSN 280
I + L K+P KR + L+H + K SN
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 1e-65
Identities = 73/281 (25%), Positives = 131/281 (46%), Gaps = 20/281 (7%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREA 60
+KK P E + + +G+G ++V A + + A+KIL+ + + ++RE
Sbjct: 3 RKKRP---EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
M +DHP +K + +F D L+ + + G L ++ F+E E+
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEI 117
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
+ L+YLH G IHRD+K NIL++ I++ DFG A + +Q N+FVGT +
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANSFVGTAQY 176
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
++PE++ + +D+W+ G +L G PF + ++ L+Y+
Sbjct: 177 VSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-----LEYDFP 230
Query: 241 RKFSKSFKQMIASCLVKDPSKRPSAKK------LLKHSFFK 275
KF + ++ LV D +KR ++ L H FF+
Sbjct: 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (546), Expect = 5e-65
Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 11/274 (4%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
+ Y + +G G + V A ++VA+K + + ++ E + + HPN
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
++ + S +L+++M +SGG + + E + ++ +VL + YLH
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDL 126
Query: 131 GHIHRDVKSGNILI---DVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187
G +HRD+K N+L D I + DFG+S D + +T GTP ++APEV+
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME----DPGSVLSTACGTPGYVAPEVLA 182
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247
Q Y D WS G+ A L G+ PF K+ L A D S S
Sbjct: 183 Q-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL-KAEYEFDSPYWDDISDSA 240
Query: 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
K I + KDP KR + ++ L+H + + +
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-63
Identities = 71/311 (22%), Positives = 125/311 (40%), Gaps = 13/311 (4%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN 70
E Y + E++G+G VHR + + K + +D + +E + + H N
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRN 62
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHH 130
+L H SF S L ++ F+SG + E I + + +V + L +LH H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 131 GHIHRDVKSGNILIDVRGA--IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
H D++ NI+ R + IK+ +FG + L P + APEV +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL----KPGDNFRLLFTAPEYYAPEVHQH 177
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
D+WS G L G PF + ++ + NA D E ++ S
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYTFDEEAFKEISIEAM 235
Query: 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALKKKEEDM 308
+ LVK+ R +A + L+H + KQ E ++ ++ L +KK +
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQ--KIERVSTKVIRTLKHRRYYHTLIKKDLNMV 293
Query: 309 LAQKKMPDGQK 319
++ ++ G
Sbjct: 294 VSAARISCGGA 304
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 201 bits (513), Expect = 8e-61
Identities = 69/272 (25%), Positives = 123/272 (45%), Gaps = 10/272 (3%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKIL--DFERDNSDLSNISREAQTMILVD 67
++ Y L E +G G + VH A + + VAVK+L D RD S REAQ ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 68 HPNVLKSHCSFVSDHN----LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
HP ++ + + ++ ++VM ++ G + I+ P ++ + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
L++ H +G IHRDVK NI+I A+K+ DFG++ + DSG+ +GT +++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243
E D ++D++S G E+ G PF+ P+ V ++ P R
Sbjct: 184 EQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-PPSARHEGL 241
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275
S ++ L K+P R ++ +
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-60
Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 15/270 (5%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKIL--DFERDNSDLSNISREAQTMILV-D 67
E + L++ +G+G V A N+ A+K L D + D+ E + + L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYL 127
HP + C+F + NL+ VM +++GG ++ +++ + F+ E++ GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL 119
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187
H G ++RD+K NIL+D G IK+ DFG+ ++ NTF GTP ++APE++
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 188 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247
Y+ D WSFG+ E+ G +PF ++ + P R K
Sbjct: 177 G-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF-----YPRWLEKEA 230
Query: 248 KQMIASCLVKDPSKRPSAKK-LLKHSFFKQ 276
K ++ V++P KR + + +H F++
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-60
Identities = 68/337 (20%), Positives = 126/337 (37%), Gaps = 22/337 (6%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
+ KK I ++ + +G G++ V + E A+K+L D RE
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREV 55
Query: 61 QTMI-LVDHPNVLKSHCSF----VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIAT 115
+ P++++ + L +VM + GG ++ F E +
Sbjct: 56 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115
Query: 116 ILREVLKGLDYLHHHGHIHRDVKSGNILID---VRGAIKLGDFGVSACLFDSGDRQRMRN 172
I++ + + + YLH HRDVK N+L +KL DFG +
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLT 171
Query: 173 TFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN-- 230
T TP ++APEV+ YD D+WS G+ L G+ PF + +
Sbjct: 172 TPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230
Query: 231 -APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLE 289
+ S+ K +I + L +P++R + + + H + Q+
Sbjct: 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 290
Query: 290 GLPALGDRIKALKKKEEDMLAQKKMPDGQKEEISQNE 326
L +R + +K++ LA ++ Q + +
Sbjct: 291 VLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIED 327
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 5e-59
Identities = 67/285 (23%), Positives = 122/285 (42%), Gaps = 14/285 (4%)
Query: 4 KKYPIGAEHYTLYE-EVGQGVSASVHRALCIPFNE--IVAVKILDFERDNSDLSNISREA 60
KK + ++ + + E+G G SV + + + VA+K+L + +D + REA
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
Q M +D+P +++ L +VM GG LH + +A +L +V
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVAELLHQV 118
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
G+ YL +HRD+ + N+L+ R K+ DFG+S L R+ W
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239
APE + + ++D+WS+G+T E L++G P+ K +V+ Q E
Sbjct: 179 YAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----EC 233
Query: 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKL---LKHSFFKQARSNE 281
+ +++ C + RP + ++ ++ A E
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 8e-59
Identities = 57/276 (20%), Positives = 118/276 (42%), Gaps = 20/276 (7%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
+ + L + +G+G V VAVK + ++++ EA M +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCI---KNDATAQAFLAEASVMTQLR 58
Query: 68 HPNVLKSHCSFV-SDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDY 126
H N+++ V L++V +M+ GS + L++ + +V + ++Y
Sbjct: 59 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 127 LHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM 186
L + +HRD+ + N+L+ K+ DFG++ + ++T W APE +
Sbjct: 119 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPEAL 172
Query: 187 EQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
+ + K+D+WSFGI E + G P+ + P V+ + G +
Sbjct: 173 RE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----GYKMDAPDGCPP 227
Query: 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNE 281
+ +++ +C D + RPS +L + + +++E
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQ--LEHIKTHE 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 197 bits (502), Expect = 1e-58
Identities = 71/284 (25%), Positives = 126/284 (44%), Gaps = 21/284 (7%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDH 68
+ + + +G G VH A+K+L E + + + E + +V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
P +++ +F ++++M ++ GG +L+ + F V EV L+YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLH 121
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
I+RD+K NIL+D G IK+ DFG + + D + T GTP ++APEV+
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTPDYIAPEVVST 175
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
Y+ D WSFGI E+ G+ PF MK L + F++ K
Sbjct: 176 -KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-----ELRFPPFFNEDVK 229
Query: 249 QMIASCLVKDPSKR-----PSAKKLLKHSFFKQARSNEYIARTL 287
+++ + +D S+R + + H +FK+ + ++R +
Sbjct: 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 273
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (495), Expect = 5e-58
Identities = 63/286 (22%), Positives = 130/286 (45%), Gaps = 12/286 (4%)
Query: 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI 64
K+ + T+ ++G G V+ + ++ VAVK L D ++ +EA M
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMK 68
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGL 124
+ HPN+++ + +++ FM+ G+ L L+ VV+ + ++ +
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
+YL IHRD+ + N L+ +K+ DFG+S + +GD W APE
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE 186
Query: 185 VMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243
+ + + K+D+W+FG+ E+A +G +P+ +V + ER
Sbjct: 187 SLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----YELLEKDYRMERPEGC 241
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLK--HSFFKQARSNEYIARTL 287
+ +++ +C +PS RPS ++ + + F+++ ++ + + L
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 287
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 7e-58
Identities = 65/296 (21%), Positives = 118/296 (39%), Gaps = 33/296 (11%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEI-----VAVKILDFERDNSDLSNISR 58
K+ E+ + +G G V A ++ VAVK+L + D+S+ +
Sbjct: 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS 89
Query: 59 EAQTMI-LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVV----- 112
E + M L H N++ + ++++ + G L+ L++ E+ +
Sbjct: 90 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 149
Query: 113 ----------------IATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFG 156
+ +V KG+++L +HRD+ + N+L+ +K+ DFG
Sbjct: 150 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 157 VSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALE-LAHGHAPF 215
+ A S +R WMAPE + + Y K+D+WS+GI E + G P+
Sbjct: 210 L-ARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 216 SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
P +QN G ++ ++ ++ SC D KRPS L
Sbjct: 268 PGIPVDANFYKLIQN---GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-57
Identities = 62/275 (22%), Positives = 114/275 (41%), Gaps = 14/275 (5%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT 62
+ ++ + E L E +G G V + VAVK L + + EA
Sbjct: 5 EDEWEVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLK--QGSMSPDAFLAEANL 61
Query: 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
M + H +++ + V+ ++++ +M GS + LK + + ++ +
Sbjct: 62 MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
G+ ++ +IHRD+++ NIL+ + K+ DFG++ + + R W A
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTA 178
Query: 183 PEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
PE + + K+D+WSFGI E+ HG P+ +V +QN G R
Sbjct: 179 PEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV----IQNLERGYRMVRPD 233
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLK--HSFF 274
+ Q++ C + P RP+ L FF
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-56
Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 17/284 (5%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILD-----FERDNSDLSNISREAQTMIL 65
++Y EE+G G A V + A K + R +I RE +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
+ HPNV+ H + + ++ +++ ++GG L + E L+++L G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVY 127
Query: 126 YLHHHGHIHRDVKSGNILIDVRGA----IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWM 181
YLH H D+K NI++ R IK+ DFG++ + D GTP ++
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFGNEFKNIFGTPEFV 183
Query: 182 APEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
APE++ +AD+WS G+ L G +PF + L + + E
Sbjct: 184 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFS 241
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIAR 285
S K I LVKDP KR + + L+H + K + + ++
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 285
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-56
Identities = 59/299 (19%), Positives = 104/299 (34%), Gaps = 33/299 (11%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
YT +G+G V A VA+K + + RE + ++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 70 NVLKSHCSFVS----DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
N++ + + ++ + G +LK I L ++L+GL
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLK 123
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
Y+H +HRD+K N+L++ +K+ DFG++ D +V T + APE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYERDR-- 241
M GY DIWS G E+ F + L ++ + +P D
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 242 ----------------------KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278
++ L +P KR ++ L H + +Q
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 193 bits (490), Expect = 2e-56
Identities = 64/275 (23%), Positives = 122/275 (44%), Gaps = 19/275 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSD-----LSNISREAQTMIL 65
++++ +G+G V+ ++ A+K LD +R N +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 66 VDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
D P ++ +F + L ++ M+GG + L F E + E++ GL+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLE 121
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEV 185
++H+ ++RD+K NIL+D G +++ D G+ AC F + VGT +MAPEV
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGL-ACDFSKK----KPHASVGTHGYMAPEV 176
Query: 186 MEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245
+++ YD AD +S G +L GH+PF ++ + + E FS
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVELPDSFSP 234
Query: 246 SFKQMIASCLVKDPSKRPS-----AKKLLKHSFFK 275
+ ++ L +D ++R A+++ + FF+
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-56
Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 12/265 (4%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
I T +E+G G VH + + VA+K + + EA+ M+ +
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIR--EGAMSEEDFIEEAEVMMKLS 58
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYL 127
HP +++ + + + +V FM G L+ E ++ + +V +G+ YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG-MCLDVCEGMAYL 117
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187
IHRD+ + N L+ IK+ DFG++ + D D+ W +PEV
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVFS 175
Query: 188 QLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246
Y K+D+WSFG+ E + G P+ +V +++ G + R S
Sbjct: 176 F-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----VEDISTGFRLYKPRLASTH 230
Query: 247 FKQMIASCLVKDPSKRPSAKKLLKH 271
Q++ C + P RP+ +LL+
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-56
Identities = 66/277 (23%), Positives = 110/277 (39%), Gaps = 14/277 (5%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFN---EIVAVKIL--DFERDNSDLSNISREAQT 62
IG + L E++G G V R + VAVK L D + + RE
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
M +DH N+++ + + +V GS L + F ++ +V +
Sbjct: 65 MHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGS-LLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
G+ YL IHRD+ + N+L+ R +K+GDFG+ L + D M+ W A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 183 PEVMEQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
PE ++ + +D W FG+T E +G P+ ++L + G R
Sbjct: 183 PESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---GERLPRPE 238
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278
+ ++ C P RP+ L F +A+
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-56
Identities = 62/278 (22%), Positives = 114/278 (41%), Gaps = 26/278 (9%)
Query: 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS-----DLSNISREAQ 61
P+ Y + +G G SV+ + + N VA+K ++ +R + + + + E
Sbjct: 1 PL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 59
Query: 62 TMILVD--HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILRE 119
+ V V++ F + +++ L +E + + +
Sbjct: 60 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQ 118
Query: 120 VLKGLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTP 178
VL+ + + H+ G +HRD+K NILID+ RG +KL DFG A L D+ + F GT
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTR 173
Query: 179 CWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 238
+ PE + + A +WS GI ++ G PF +
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-----------GQVF 222
Query: 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
++ S + +I CL PS RP+ +++ H + +
Sbjct: 223 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 5e-56
Identities = 59/265 (22%), Positives = 117/265 (44%), Gaps = 12/265 (4%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD 67
I + T +E+G G V VA+K++ + EA+ M+ +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLS 57
Query: 68 HPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYL 127
H +++ + ++++ +M+ G L+ L+ F+ + + ++V + ++YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYL 116
Query: 128 HHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVME 187
+HRD+ + N L++ +G +K+ DFG+S + D D W PEV+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLM 174
Query: 188 QLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246
+ K+DIW+FG+ E+ + G P+ ++ + Q GL R S+
Sbjct: 175 Y-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ----GLRLYRPHLASEK 229
Query: 247 FKQMIASCLVKDPSKRPSAKKLLKH 271
++ SC + +RP+ K LL +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 5e-56
Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 18/284 (6%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDH 68
+ + +G+G V A+KIL E ++++ E++ + H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
P + +F + L VM + +GG L F E E++ L+YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLH 122
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
++RD+K N+++D G IK+ DFG+ G + F GTP ++APEV+E
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVLED 179
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
+ Y D W G+ E+ G PF ++ + L + R S K
Sbjct: 180 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----EIRFPRTLSPEAK 233
Query: 249 QMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSNEYIARTL 287
++A L KDP +R AK++++H FF + + + L
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-56
Identities = 57/272 (20%), Positives = 112/272 (41%), Gaps = 15/272 (5%)
Query: 18 EVGQGVSASVHRALCI--PFNEIVAVKILDFERDNSDLSN-ISREAQTMILVDHPNVLKS 74
E+G G +V + + VAVKIL E ++ L + + EA M +D+P +++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 75 HCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIH 134
++ + +VM G L+ ++ I ++ +V G+ YL +H
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 135 RDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDF 194
RD+ + N+L+ + K+ DFG+S L + + + W APE + + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSS 189
Query: 195 KADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIAS 253
K+D+WSFG+ E ++G P+ +V M + + ++
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----GCPAGCPREMYDLMNL 245
Query: 254 CLVKDPSKRPSAKKL---LKHSFFKQARSNEY 282
C D RP + L++ ++ +
Sbjct: 246 CWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 277
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (481), Expect = 6e-56
Identities = 60/270 (22%), Positives = 103/270 (38%), Gaps = 12/270 (4%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE---IVAVKILDFERDNSDLSNISREAQTMI 64
I + + +G G V + VA+K L + EA M
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 82
Query: 65 LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGL 124
DHPNV+ + ++ FM GS L F + + +LR + G+
Sbjct: 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGS-LDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 125 DYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT--FVGTPCWMA 182
YL ++HRD+ + NIL++ K+ DFG+S L D + W A
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 183 PEVMEQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
PE ++ + +D+WS+GI E +++G P+ V+ Q+
Sbjct: 202 PEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL----PPPM 256
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ Q++ C KD + RP +++
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-55
Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 14/276 (5%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQT 62
K + I E L ++GQG V VA+K L +EAQ
Sbjct: 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK--PGTMSPEAFLQEAQV 65
Query: 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
M + H +++ + VS+ +++V +MS GS L LK + + ++
Sbjct: 66 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
G+ Y+ ++HRD+++ NIL+ K+ DFG++ + D + R W A
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTA 182
Query: 183 PEVMEQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
PE + K+D+WSFGI EL G P+ +VL + G
Sbjct: 183 PEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPP 237
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLK--HSFFK 275
+ +S ++ C K+P +RP+ + L +F
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-55
Identities = 66/287 (22%), Positives = 113/287 (39%), Gaps = 32/287 (11%)
Query: 17 EEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNIS----REAQTMILVDHPNVL 72
+ +G+G A+V++A N+IVA+K + + I+ RE + + + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 73 KSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH 132
+F N+ +V FM + I + I + L+GL+YLH H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 133 IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGY 192
+HRD+K N+L+D G +KL DFG++ G R V T + APE++ Y
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 193 DFKADIWSFGITALELAHGHAPFSKYPPMKVL-----------------------LMTLQ 229
D+W+ G EL + L +T +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 230 NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
+ P + +I + +P R +A + LK +F
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-54
Identities = 77/293 (26%), Positives = 129/293 (44%), Gaps = 29/293 (9%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDL-SNISREAQTMILVDHP 69
E++ E++G+G V++A E+VA+K + + + + S RE + ++HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N++K +++ L++V F+ + A+ G +I + L ++L+GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
H +HRD+K N+LI+ GAIKL DFG++ G R V T + APE++
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 190 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-------PGLDYERDRK 242
Y DIWS G E+ A F + L + PG+ D K
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 243 -----------------FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278
+ + +++ L DP+KR SAK L H FF+
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 5e-54
Identities = 66/326 (20%), Positives = 126/326 (38%), Gaps = 22/326 (6%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTM 63
+ + + +G G +V++ L IP E VA+K L I EA M
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 64 ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
VD+P+V + ++ + M G L + D + ++ KG
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKG 123
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
++YL +HRD+ + N+L+ +K+ DFG++ L + +++ WMA
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 184 EVMEQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242
E + Y ++D+WS+G+T EL G P+ P ++ + + +
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----PQPPI 237
Query: 243 FSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIARTLLEGLPALGDRIKALK 302
+ ++ C + D RP ++L+ +AR L GD L
Sbjct: 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEF--------SKMARDPQRYLVIQGDERMHLP 289
Query: 303 KKEEDMLAQKKMPDGQKEEISQ-NEY 327
+ + M + +++ +EY
Sbjct: 290 SPTDSNFYRALMDEEDMDDVVDADEY 315
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 183 bits (466), Expect = 6e-54
Identities = 67/291 (23%), Positives = 121/291 (41%), Gaps = 31/291 (10%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDL-SNISREAQTMILVDHP 69
E Y E++G+G V++A + E A+K + E+++ + S RE + + H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N++K + + L +V + + G E V + L ++L G+ Y H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
+HRD+K N+LI+ G +K+ DFG++ G R + T + AP+V+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 190 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ-------------------- 229
Y DIWS G E+ +G F L+ +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 230 ----NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276
P + +S +++ L DP++R +AK+ L+H++FK+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 9e-54
Identities = 60/303 (19%), Positives = 102/303 (33%), Gaps = 39/303 (12%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLS-NISREAQTMILVDHP 69
Y ++GQG V +A + VA+K + E + RE + + L+ H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 70 NVLKSHCSF--------VSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVL 121
NV+ ++++V F + E I +++ +L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLL 127
Query: 122 KGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL-FDSGDRQRMRNTFVGTPCW 180
GL Y+H + +HRD+K+ N+LI G +KL DFG++ + V T +
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPF------------------------- 215
PE++ Y D+W G E+
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 216 --SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
Y + L + D + +I LV DP++R + L H F
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307
Query: 274 FKQ 276
F
Sbjct: 308 FWS 310
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-53
Identities = 64/270 (23%), Positives = 107/270 (39%), Gaps = 13/270 (4%)
Query: 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNE---IVAVKILDFERDNSDLSNISREAQT 62
Y I E L +G+G VH+ + + VA+K +S +EA T
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 63 MILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLK 122
M DHP+++K +++ +W++M + G L + + ++
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGE-LRSFLQVRKYSLDLASLILYAYQLST 119
Query: 123 GLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMA 182
L YL +HRD+ + N+L+ +KLGDFG+S + DS + + WMA
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK--ASKGKLPIKWMA 177
Query: 183 PEVMEQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241
PE + + +D+W FG+ E L HG PF V+
Sbjct: 178 PESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----PMPP 232
Query: 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+ ++ C DPS+RP +L
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 3e-53
Identities = 59/295 (20%), Positives = 107/295 (36%), Gaps = 34/295 (11%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRA-----LCIPFNEIVAVKILDFERDNSDLSNISR 58
+ ++G+G V +A L +VAVK+L E ++ R
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 59 EAQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILK----------------- 101
EA M D+PN++K + ++ +M+ G L+
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 102 -----AAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFG 156
+ P I R+V G+ YL +HRD+ + N L+ +K+ DFG
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 157 VSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALE-LAHGHAPF 215
+S + S D + WM PE + + Y ++D+W++G+ E ++G P+
Sbjct: 186 LSRNI-YSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 216 SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
+V+ ++ C K P+ RPS + +
Sbjct: 244 YGMAHEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 6e-53
Identities = 52/267 (19%), Positives = 104/267 (38%), Gaps = 9/267 (3%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTM 63
I T + +G G V++ + + VA+K L + EA M
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 64 ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
H N+++ + ++ +M G+ L+ + F + + +LR + G
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAG 122
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
+ YL + ++HRD+ + NIL++ K+ DFG+S L D + + W AP
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243
E + + +D+WSFGI E+ ++ + + G
Sbjct: 183 EAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFRLPTPMDC 238
Query: 244 SKSFKQMIASCLVKDPSKRPSAKKLLK 270
+ Q++ C ++ ++RP ++
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-52
Identities = 66/291 (22%), Positives = 125/291 (42%), Gaps = 29/291 (9%)
Query: 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNE-------IVAVKILDFERDNSDLSNI 56
++ + + L + +G+G V A I ++ VAVK+L + DLS++
Sbjct: 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 65
Query: 57 SREAQTM-ILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG-------- 107
E + M ++ H N++ + D L+V++ + S G+ L+A P G
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 108 ------FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161
+ + +V +G++YL IHRD+ + N+L+ +K+ DFG+ A
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL-ARD 184
Query: 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPP 220
D + WMAPE + Y ++D+WSFG+ E G +P+ P
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 221 MKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
++ + + ++ + M+ C PS+RP+ K+L++
Sbjct: 244 EELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 6e-52
Identities = 67/294 (22%), Positives = 122/294 (41%), Gaps = 31/294 (10%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDL-SNISREAQTMILVDHP 69
+ Y E++G+G +V +A +EIVA+K + + D+ + S+ RE + + H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
N+++ H SD L +V F L + + ++ + L ++LKGL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD--QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 130 HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQL 189
+HRD+K N+LI+ G +KL +FG++ R + V T + P+V+
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVVTLWYRPPDVLFGA 176
Query: 190 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE----------- 238
Y D+WS G ELA+ P + L + E
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 239 --------------RDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278
K + + + ++ + L +P +R SA++ L+H +F
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-51
Identities = 67/292 (22%), Positives = 126/292 (43%), Gaps = 16/292 (5%)
Query: 8 IGAEHYTLYEEVGQGVSASVHRALCI---PFNEIVAVKILD---FERDNSDLSNISREAQ 61
+G E++ L + +G G V I ++ A+K+L + + E Q
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 62 TMILVDH-PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
+ + P ++ H +F ++ L +++ +++GG L F E + + E+
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEI 138
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
+ L++LH G I+RD+K NIL+D G + L DFG+ + F + + +R +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL-SKEFVADETERAYDFCGTIEYM 197
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240
V G+D D WS G+ EL G +PF+ + +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYP 256
Query: 241 RKFSKSFKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSNEYIARTL 287
++ S K +I L+KDP KR A ++ +H FF++ ++ A+ +
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKV 308
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (449), Expect = 2e-51
Identities = 49/296 (16%), Positives = 107/296 (36%), Gaps = 22/296 (7%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREA 60
M+ + +G Y L ++G G ++ I E VA+K+ + + L E+
Sbjct: 1 MELR---VG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH---IES 53
Query: 61 QTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
+ ++ + + ++ + V++ + G S L L F + + ++
Sbjct: 54 KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPS-LEDLFNFCSRKFSLKTVLLLADQM 112
Query: 121 LKGLDYLHHHGHIHRDVKSGNILI---DVRGAIKLGDFGVSACLFDSGDRQRM----RNT 173
+ ++Y+H IHRDVK N L+ + + DFG++ D+ Q +
Sbjct: 113 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 174 FVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 233
GT + + + D+ S G + G P+ + +
Sbjct: 173 LTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231
Query: 234 GLDY---ERDRKFSKSFKQMIASCLVKDPSKRPSA---KKLLKHSFFKQARSNEYI 283
+ + + F + C +P ++L ++ F +Q S +Y+
Sbjct: 232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 3e-51
Identities = 74/297 (24%), Positives = 118/297 (39%), Gaps = 38/297 (12%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIP-FNEIVAVKILDFERDNSDLS-NISREAQTMIL--- 65
+ Y E+G+G V +A + VA+K + + + + RE +
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 66 VDHPNVLKSHCSFVSDHN-----LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREV 120
+HPNV++ L +V + ++ K P G I ++ ++
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-GVPTETIKDMMFQL 125
Query: 121 LKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCW 180
L+GLD+LH H +HRD+K NIL+ G IKL DFG L Q + V T +
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG----LARIYSFQMALTSVVVTLWY 181
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYE 238
APEV+ Q Y D+WS G E+ F + L ++ + P D+
Sbjct: 182 RAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 239 RD--------------------RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275
RD + K ++ CL +P+KR SA L H +F+
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 4e-51
Identities = 55/292 (18%), Positives = 113/292 (38%), Gaps = 26/292 (8%)
Query: 5 KYPIGAEHYTLYEEVGQGVSASVHRALC-----IPFNEIVAVKILDFERDNSDLSNISRE 59
++ + E T+ E+GQG V+ + VA+K ++ + E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 60 AQTMILVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDG--------FEEV 111
A M + +V++ V+M M+ G L++ P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 112 VIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR 171
+ + E+ G+ YL+ + +HRD+ + N ++ +K+GDFG++ D R
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT-RDIYETDYYRKG 192
Query: 172 NTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLLMTLQN 230
+ WM+PE ++ + +D+WSFG+ E+A P+ +VL ++
Sbjct: 193 GKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251
Query: 231 APPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK------HSFFKQ 276
++ +++ C +P RPS +++ F++
Sbjct: 252 GLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-50
Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 25/291 (8%)
Query: 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALC-----IPFNEIVAVKILDFERDNSDLSNI 56
D K+ + L + +G+G V A VAVK+L +S+ +
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 63
Query: 57 SREAQTMILVDHPN--VLKSHCSFVSDHNLWVVMPFMSGGSCLHILK------------- 101
E + +I + H V L V++ F G+ L+
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123
Query: 102 -AAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160
Y D + +V KG+++L IHRD+ + NIL+ + +K+ DFG+ A
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL-AR 182
Query: 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP 220
+ WMAPE + Y ++D+WSFG+ E+ A YP
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASP--YPG 239
Query: 221 MKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271
+K+ + G + Q + C +PS+RP+ +L++H
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-50
Identities = 57/290 (19%), Positives = 105/290 (36%), Gaps = 26/290 (8%)
Query: 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPF-----NEIVAVKILDFERDNSDLSNIS 57
K+ + + +G G V A VAVK+L ++ +
Sbjct: 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 58 REAQTMI-LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPD---------- 106
E + + L +H N++ + V+ + G L+ L+
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 107 ------GFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160
+ + + +V KG+ +L IHRD+ + NIL+ K+ DFG+ A
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL-AR 193
Query: 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP 220
+ ++ WMAPE + Y F++D+WS+GI EL + P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 221 MKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
+ + G ++ +C DP KRP+ K++++
Sbjct: 253 VDSKFYKMIK--EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-50
Identities = 60/303 (19%), Positives = 110/303 (36%), Gaps = 28/303 (9%)
Query: 6 YP-IGAEHYTLYEEVGQGVSASVHRALCIPFNEI--VAVKILDFERDNSDLSNISREAQT 62
YP + + +G+G V +A A+K + D + + E +
Sbjct: 4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 63
Query: 63 MI-LVDHPNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYP--------------DG 107
+ L HPN++ + L++ + + G+ L L+ +
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 108 FEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167
+ +V +G+DYL IHRD+ + NIL+ K+ DFG+S +
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEV 179
Query: 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLM 226
+ WMA E + Y +D+WS+G+ E+ G P+ ++
Sbjct: 180 YVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--- 235
Query: 227 TLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSNEYIART 286
+ P G E+ ++ C + P +RPS ++L Y+ T
Sbjct: 236 -YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 294
Query: 287 LLE 289
L E
Sbjct: 295 LYE 297
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (442), Expect = 9e-50
Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 21/272 (7%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDH 68
+ + + +G G V A+KILD ++ + + E + + V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 69 PNVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLH 128
P ++K SF + NL++VM +++GG L+ F E +++ +YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
I+RD+K N+LID +G I++ DFG + + T GTP +APE++
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEIILS 212
Query: 189 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248
GY+ D W+ G+ E+A G+ PF P+++ + FS K
Sbjct: 213 -KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-----KVRFPSHFSSDLK 266
Query: 249 QMIASCLVKDPSKR-----PSAKKLLKHSFFK 275
++ + L D +KR + H +F
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 173 bits (440), Expect = 9e-50
Identities = 64/302 (21%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTM-ILVDHP 69
+ Y L ++G+G + V A+ I NE V VKIL I RE + + L P
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGP 90
Query: 70 NVLKSHCSFVS--DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYL 127
N++ +V ++ + + + I + E+LK LDY
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYC 145
Query: 128 HHHGHIHRDVKSGNILIDVRGA-IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVM 186
H G +HRDVK N++ID ++L D+G+ A + G +R V + + PE++
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-AEFYHPGQEYNVR---VASRYFKGPELL 201
Query: 187 EQLHGYDFKADIWSFGITALELAHGHAPF------------------SKYPPMKVLLMTL 228
YD+ D+WS G + PF ++ + +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 229 QNAP---------------PGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSF 273
+ P + E S + L D R +A++ ++H +
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
Query: 274 FK 275
F
Sbjct: 322 FY 323
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-49
Identities = 61/275 (22%), Positives = 107/275 (38%), Gaps = 14/275 (5%)
Query: 17 EEVGQGVSASVHRALCIPFN---EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLK 73
E +G+G V+ + + AVK L+ D ++S E M HPNVL
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 74 SH-CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGH 132
S+ + VV+P+M G L + +V KG+ +L
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGD-LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 133 IHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNT-FVGTPCWMAPEVMEQLHG 191
+HRD+ + N ++D + +K+ DFG++ ++D T WMA E ++
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QK 210
Query: 192 YDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQM 250
+ K+D+WSFG+ E + G P+ + + LQ + ++
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----LQPEYCPDPLYEV 266
Query: 251 IASCLVKDPSKRPSAKKLLKH--SFFKQARSNEYI 283
+ C RPS +L+ + F Y+
Sbjct: 267 MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 301
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 6e-49
Identities = 62/298 (20%), Positives = 110/298 (36%), Gaps = 41/298 (13%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
YT + +G G V++A E+VA+K + D +RE Q M +DH N++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 73 KSHCSFVS------DHNLWVVMPFMSGGSCLHILKAAYPDG-FEEVVIATILREVLKGLD 125
+ F S + L +V+ ++ + + + + ++ + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 126 YLHHHGHIHRDVKSGNILIDVRGAI-KLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPE 184
Y+H G HRD+K N+L+D A+ KL DFG + L +++ + + APE
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICSRYYRAPE 192
Query: 185 VMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL---------------- 228
++ Y D+WS G EL G F + L+ +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 229 --------QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278
Q + + + L P+ R + + HSFF + R
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-48
Identities = 62/296 (20%), Positives = 110/296 (37%), Gaps = 42/296 (14%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
A L E +G+G V R E VAVKI + S E +++ H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHE 57
Query: 70 NVLKSHCSFVSDHN----LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLD 125
N+L + D+ LW+V + GS L + + GL
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLA 114
Query: 126 YLHHH--------GHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMR-NTFVG 176
+LH HRD+KS NIL+ G + D G++ + D + N VG
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 177 TPCWMAPEVME-----QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA 231
T +MAPEV++ + +ADI++ G+ E+A + + ++ L +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 232 PPGL-----------------DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
P + + + + + +++ C + + R +A ++ K
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 168 bits (425), Expect = 6e-48
Identities = 42/273 (15%), Positives = 83/273 (30%), Gaps = 17/273 (6%)
Query: 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHP 69
HY + +G+G + + N+ VA+K D L + R + +L
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYK--LLAGCT 61
Query: 70 NVLKSHCSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH 129
+ + + +V+ + + F +A +++L + +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHE 119
Query: 130 HGHIHRDVKSGNILID-----VRGAIKLGDFGVSACLFDSGDRQ----RMRNTFVGTPCW 180
++RD+K N LI I + DFG+ D +Q R + GT +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 181 MAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT---LQNAPPGLDY 237
M+ + D+ + G + G P+ +
Sbjct: 180 MSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270
E F + F + + P L
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 6e-48
Identities = 73/304 (24%), Positives = 117/304 (38%), Gaps = 43/304 (14%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHP 69
Y + VG G +V A+ VA+K L + RE + + + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 70 NVLKSHCSFVSDH------NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
NV+ F D + ++VMPFM G ++K + E I ++ ++LKG
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKG 133
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
L Y+H G IHRD+K GN+ ++ +K+ DFG++ +V T + AP
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAP 187
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV--LLMTLQNAPPGLDYERDR 241
EV+ Y DIWS G E+ G F + +M + PP +R +
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 242 ------------------------KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277
S ++ LV D +R +A + L H +F+
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307
Query: 278 RSNE 281
E
Sbjct: 308 HDTE 311
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 2e-47
Identities = 68/310 (21%), Positives = 113/310 (36%), Gaps = 42/310 (13%)
Query: 1 MDKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISRE 59
++K + + E Y VG G SV A VAVK L + RE
Sbjct: 9 LNKTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 60 AQTMILVDHPNVLKSHCSFVS-----DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIA 114
+ + + H NV+ F + N ++ + G +I+K + +
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 124
Query: 115 TILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTF 174
++ ++L+GL Y+H IHRD+K N+ ++ +K+ DFG++ +
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT------DDEMTGY 178
Query: 175 VGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL---------- 224
V T + APE+M Y+ DIWS G EL G F + L
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238
Query: 225 ----------------LMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKL 268
+ +L P + ++ LV D KR +A +
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
Query: 269 LKHSFFKQAR 278
L H++F Q
Sbjct: 299 LAHAYFAQYH 308
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-44
Identities = 67/312 (21%), Positives = 113/312 (36%), Gaps = 54/312 (17%)
Query: 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHP 69
+ Y + +G G V A + VA+K L N + RE M V+H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 70 NVLKSHCSFVSD------HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKG 123
N++ F ++++VM M C I + ++ +L ++L G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQMLCG 131
Query: 124 LDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAP 183
+ +LH G IHRD+K NI++ +K+ DFG L + M +V T + AP
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMTPYVVTRYYRAP 187
Query: 184 EVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ-------------- 229
EV+ GY DIWS G E+ F + ++
Sbjct: 188 EVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 230 -----------------------NAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAK 266
++ D E ++ + + +++ LV DP+KR S
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 267 KLLKHSFFKQAR 278
L+H +
Sbjct: 307 DALQHPYINVWY 318
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 135 bits (341), Expect = 1e-35
Identities = 68/329 (20%), Positives = 114/329 (34%), Gaps = 61/329 (18%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVL 72
Y L ++G G ++V A + N VA+KI+ D E + + V+ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 73 KS-------------HCSFVSDHNLWVVMPFM-SGGSCLHILKAAYPDGFEEVVIATILR 118
K H + + + VVM F G + L ++K G + + I +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 119 EVLKGLDYLH-HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGT 177
++L GLDY+H G IH D+K N+L+++ + + A L ++ + T
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 178 PCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSK-------------------- 217
+ +PEV+ + ADIWS EL G F
Sbjct: 193 REYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 218 YPPMKVLLMTLQNAPPGLD-----------------------YERDRKFSKSFKQMIASC 254
LL + + Y+ + +K ++
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 255 LVKDPSKRPSAKKLLKHSFFKQARSNEYI 283
L DP KR A L+ H + K E I
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTLGMEEI 340
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.0 bits (181), Expect = 7e-16
Identities = 30/199 (15%), Positives = 64/199 (32%), Gaps = 13/199 (6%)
Query: 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD--HPN 70
+ + +G+G ++V VK + R+ + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 71 VLKSHCSFVSDHNLWVVMPFMSGGSCL--HILKAAYPDGFEEVVIATILREVLKGLDYLH 128
+ L V + G+ + ++ A +L +L+ + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 129 HHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQ 188
H G +H D+ N+L+ G I + DF S + + G R+ + + +
Sbjct: 121 HRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT---- 175
Query: 189 LHGYDFKADIWSFGITALE 207
Y + DI S L+
Sbjct: 176 ---YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 636 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.26 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.99 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.67 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.5 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.2 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.48 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-61 Score=494.21 Aligned_cols=262 Identities=25% Similarity=0.399 Sum_probs=223.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++++.||+|+||+||+|.++.+|+.||||+++........+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 47899999999999999999999999999999999876655556678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.... ...
T Consensus 84 y~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-RER 160 (271)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT-EEC
T ss_pred ccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC-ccc
Confidence 99999999999754 679999999999999999999999999999999999999999999999999998654332 233
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
...+.+||+.|||||++.+...++.++|||||||++|+|++|++||.................. ....+..+|+++++
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLA 238 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT--TSTTGGGSCHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCCHHHHH
Confidence 4457799999999999987444578899999999999999999999876554444344433322 22334678999999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
||.+||..||.+|||++|+++||||++
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-60 Score=486.25 Aligned_cols=258 Identities=25% Similarity=0.425 Sum_probs=229.4
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
++|.+ ++|++++.||+|+||+||+|.++.+|+.||||++.... .......+.+|+.+|+.++|||||++++++.++
T Consensus 1 r~~~l--~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 1 RQWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp CCCCG--GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCcch--hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence 46776 79999999999999999999999999999999997543 223456789999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
+.+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred CEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999999999999886 67999999999999999999999999999999999999999999999999999754
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
... .....+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.... +..+.
T Consensus 157 ~~~-----~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-----~~~p~ 225 (263)
T d2j4za1 157 PSS-----RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----FTFPD 225 (263)
T ss_dssp CCC-----CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----CCCCT
T ss_pred CCC-----cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----CCCCc
Confidence 322 2346789999999999987 679999999999999999999999999888777665555432 22345
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
.+|+++++||.+||.+||.+|||++|+|+||||..
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 226 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 68999999999999999999999999999999963
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=488.68 Aligned_cols=260 Identities=37% Similarity=0.662 Sum_probs=232.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++++.||+|+||+||+|.++.+|+.||||+++..... ..+.+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 46899999999999999999999999999999999765433 45678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||+||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+.... .
T Consensus 98 y~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~---~ 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---S 171 (293)
T ss_dssp CCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---C
T ss_pred ecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc---c
Confidence 9999999998876 469999999999999999999999999999999999999999999999999998653322 2
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQ 249 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~d 249 (636)
.....+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+......+..+.....+.+ ..+..+|+++++
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~ 248 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIFRD 248 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--SSGGGSCHHHHH
T ss_pred cccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC--CCcccCCHHHHH
Confidence 3456789999999999987 6799999999999999999999999999888888777776655443 345678999999
Q ss_pred HHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 250 MIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 250 LI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
||.+||.+||.+|||+.|+|+||||+....
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~~~ 278 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCCC
Confidence 999999999999999999999999986543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-59 Score=491.68 Aligned_cols=260 Identities=34% Similarity=0.592 Sum_probs=223.2
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
++..++|++++.||+|+||+||+|.++.+|+.||||+++..........+.+|+.+|+.++|||||+++++|.++..+|+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778999999999999999999999999999999999876666667789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
|||||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.+.+.
T Consensus 82 VmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 99999999999999876 679999999999999999999997 59999999999999999999999999999865322
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHH------------------
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT------------------ 227 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~------------------ 227 (636)
...+++||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+..........
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred ----ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 2356799999999999987 67999999999999999999999999765432221110
Q ss_pred ------------------------HhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 228 ------------------------LQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 228 ------------------------~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
....++. .....+|.++++||.+||.+||++|||++|+|+||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCC---CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCcc---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000000 1123468999999999999999999999999999999854
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-59 Score=486.01 Aligned_cols=263 Identities=26% Similarity=0.450 Sum_probs=228.9
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
..++|++++.||+|+||+||+|.++.+|+.||||+++... .......+.+|+++|++++|||||+++++|.+++.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999997543 22346779999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
|||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 86 vmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~- 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES- 162 (288)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC-
Confidence 99999999999999887 689999999999999999999999999999999999999999999999999998653322
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
......+.+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+..... ..+..++++
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s~~ 236 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPK 236 (288)
T ss_dssp -------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-----CCCTTCCHH
T ss_pred cccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC-----CCCccCCHH
Confidence 2223456789999999999987 6799999999999999999999999999888777766654422 234678999
Q ss_pred HHHHHHhhcccCCCCCCCHHH------HHhCcccccccCh
Q 006664 247 FKQMIASCLVKDPSKRPSAKK------LLKHSFFKQARSN 280 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~e------lL~Hpffk~~~~~ 280 (636)
+++||.+||++||.+|||++| +++||||+.+.+.
T Consensus 237 ~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp HHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 999999999999999999987 6889999988765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-59 Score=481.78 Aligned_cols=260 Identities=35% Similarity=0.640 Sum_probs=230.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
+.|++++.||+|+||+||+|.++.+|+.||||+++... ....+.+.+|+++|+.++|||||+++++|.+++.+|+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 57999999999999999999999999999999997543 34567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcccc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRM 170 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 170 (636)
|+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 91 ~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---~~~ 166 (288)
T d2jfla1 91 CAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---IQR 166 (288)
T ss_dssp CTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH---HHH
T ss_pred CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC---ccc
Confidence 9999999998765 256999999999999999999999999999999999999999999999999999754322 122
Q ss_pred cccccCCCCCCChhhhhh----ccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 171 RNTFVGTPCWMAPEVMEQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 171 ~~~~~GT~~YmAPEvl~~----~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
..+.+||+.|||||++.. ...|+.++|||||||++|+|++|+.||.+....+.+..+....++.+ ..+..+|++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~s~~ 244 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL--AQPSRWSSN 244 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC--SSGGGSCHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC--CccccCCHH
Confidence 346789999999999852 35689999999999999999999999999888888877777655443 334678999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+++||.+||++||.+|||+.|+++||||+..
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999743
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=490.93 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=233.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLW 85 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~ 85 (636)
|..++|++++.||+|+||+||+|+++.+|+.||||++++.. .......+.+|+.+|+.++||||++++++|.++..+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45689999999999999999999999999999999997543 2335678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCC
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 165 (636)
+|||||.||+|.+++... +.++|..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....+
T Consensus 82 iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999999999887 689999999999999999999999999999999999999999999999999998654332
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+.......+..... ..+..+|+
T Consensus 160 ---~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~-----~~p~~~s~ 230 (337)
T d1o6la_ 160 ---ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-----RFPRTLSP 230 (337)
T ss_dssp ---CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTSCH
T ss_pred ---cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC-----CCCccCCH
Confidence 23457899999999999987 6899999999999999999999999999888776665555432 23467899
Q ss_pred HHHHHHHhhcccCCCCCCC-----HHHHHhCcccccccCh
Q 006664 246 SFKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSN 280 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~ 280 (636)
++++||.+||++||.+|++ ++++++||||+.+.+.
T Consensus 231 ~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence 9999999999999999994 9999999999877544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-59 Score=486.78 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=213.5
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
..++|++++.||+|+||+||+|.++.+|+.||||+++..........+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35779999999999999999999999999999999987665555567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc---cCCcEEEeccCcccccccCC
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID---VRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld---~~g~vKL~DFGla~~~~~~~ 165 (636)
|||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp CCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred eccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 999999999999764 6799999999999999999999999999999999999994 5789999999999754222
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
....+.+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+.........+.... ..+..+....+|+
T Consensus 164 ---~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~ 238 (307)
T d1a06a_ 164 ---SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE-YEFDSPYWDDISD 238 (307)
T ss_dssp ------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC-CCCCTTTTTTSCH
T ss_pred ---CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCCCccccCCCH
Confidence 22356789999999999987 679999999999999999999999999888777666665543 3334445568999
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
++++||.+||.+||.+|||+.|+++||||++
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 9999999999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-58 Score=470.38 Aligned_cols=256 Identities=28% Similarity=0.454 Sum_probs=221.4
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC-CchhHHHHHHHHHHHHhCCCCCcceeeeEEEe----CCe
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER-DNSDLSNISREAQTMILVDHPNVLKSHCSFVS----DHN 83 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~-~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~----~~~ 83 (636)
+...|++.++||+|+||+||+|.++.+++.||+|++.... .....+.+.+|+++|+.++|||||+++++|.+ +..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 4445688889999999999999999999999999997654 33456778999999999999999999999976 356
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccccCcccEEEc-cCCcEEEeccCcccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHG--HIHRDVKSGNILID-VRGAIKLGDFGVSAC 160 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHRDLKP~NILld-~~g~vKL~DFGla~~ 160 (636)
+|+|||||+||+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|+.
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 89999999999999999886 67999999999999999999999998 99999999999996 578999999999975
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
... ....+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+......+...+...... ...+
T Consensus 165 ~~~-----~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~--~~~~ 235 (270)
T d1t4ha_ 165 KRA-----SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFD 235 (270)
T ss_dssp CCT-----TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGG
T ss_pred ccC-----CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC--cccC
Confidence 321 12346789999999999975 59999999999999999999999998876666665555443322 2334
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccc
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFK 275 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk 275 (636)
..+++++++||.+||.+||++|||+.|+|+||||+
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 56789999999999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=475.11 Aligned_cols=257 Identities=24% Similarity=0.445 Sum_probs=214.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEe--CCeEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVS--DHNLWV 86 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~--~~~l~i 86 (636)
+++|++++.||+|+||+||+|.++.+|+.||||+++.... ....+.+.+|+++|+.++|||||++++++.+ +..+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 5899999999999999999999999999999999976653 3456778999999999999999999999965 467999
Q ss_pred EEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccccCcccEEEccCCcEEEeccCccc
Q 006664 87 VMPFMSGGSCLHILKAA--YPDGFEEVVIATILREVLKGLDYLHHHG-----HIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~g-----IvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
|||||+||+|.+++.+. ....+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998653 2356999999999999999999999976 9999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
.+.... ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+....+.....+. .
T Consensus 163 ~~~~~~---~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~----~ 234 (269)
T d2java1 163 ILNHDT---SFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR----I 234 (269)
T ss_dssp HC--------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----C
T ss_pred ecccCC---CccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC----C
Confidence 653322 22346799999999999976 679999999999999999999999999988877666665544332 3
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccc
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFF 274 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpff 274 (636)
+..+|+++++||.+||..||.+|||+.||++|||+
T Consensus 235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 45789999999999999999999999999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.3e-58 Score=478.11 Aligned_cols=255 Identities=36% Similarity=0.654 Sum_probs=227.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc--hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN--SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~--~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.|++++.||+|+||+||+|.++.+|+.||||+++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 499999999999999999999999999999999865432 345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||.||+|..++... ..+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|.....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------
Confidence 99999987766654 6799999999999999999999999999999999999999999999999999975422
Q ss_pred ccccccCCCCCCChhhhhhc--cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 170 MRNTFVGTPCWMAPEVMEQL--HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~--~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
....+||+.|||||++.+. ..|+.++|||||||++|||++|..||.+......+..+.....+.+ ....+|+++
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~s~~~ 243 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---QSGHWSEYF 243 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---SCTTSCHHH
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC---CCCCCCHHH
Confidence 2356899999999999642 3589999999999999999999999999888888877777655443 245789999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++||.+||.+||.+|||++|+|+||||....
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 9999999999999999999999999997644
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=472.86 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=229.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-----hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-----SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-----~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
.++|++++.||+|+||+||+|.++.+|+.||||++++.... ...+.+.+|+.+|+.++|||||+++++|.++..+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 47899999999999999999999999999999999765422 2467899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC----cEEEeccCcccc
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG----AIKLGDFGVSAC 160 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g----~vKL~DFGla~~ 160 (636)
|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..
T Consensus 89 ~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999999886 6799999999999999999999999999999999999998776 599999999976
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
.... ....+.+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+... ...+....+
T Consensus 167 ~~~~----~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 240 (293)
T d1jksa_ 167 IDFG----NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFEDEYF 240 (293)
T ss_dssp CTTS----CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-CCCCCHHHH
T ss_pred cCCC----ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCchhc
Confidence 5322 12346789999999999986 67999999999999999999999999998887776655543 333333445
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
..+|+++++||.+||.+||.+|||++|+++||||+...+
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 678999999999999999999999999999999986543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-57 Score=478.73 Aligned_cols=256 Identities=27% Similarity=0.471 Sum_probs=230.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVm 88 (636)
++|++++.||+|+||+||+|.++.+|+.||||+++... .....+.+.+|+.+|+.++|||||+++++|.++..+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 78999999999999999999999999999999997543 2234678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCcc
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
|||.||+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred eecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 999999999999876 67899999999999999999999999999999999999999999999999999865322
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
..+.+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+..... ..+..++++++
T Consensus 158 --~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s~~~~ 229 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----RFPPFFNEDVK 229 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----CCCTTSCHHHH
T ss_pred --cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----CCCCCCCHHHH
Confidence 346799999999999986 6799999999999999999999999999888877776665432 23467899999
Q ss_pred HHHHhhcccCCCCCC-----CHHHHHhCcccccccCh
Q 006664 249 QMIASCLVKDPSKRP-----SAKKLLKHSFFKQARSN 280 (636)
Q Consensus 249 dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~ 280 (636)
++|.+||.+||.+|+ |+++|++||||+++.+.
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 999999999999996 99999999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4e-57 Score=481.15 Aligned_cols=261 Identities=28% Similarity=0.414 Sum_probs=229.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++++.||+|+||+||+|.++.+|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 368999999999999999999999999999999996543 3456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc--cCCcEEEeccCcccccccCCCc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID--VRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld--~~g~vKL~DFGla~~~~~~~~~ 167 (636)
||+||+|.+++... .+.+++..++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+.+...
T Consensus 104 ~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--- 179 (350)
T d1koaa2 104 FMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--- 179 (350)
T ss_dssp CCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---
T ss_pred cCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc---
Confidence 99999999998653 25699999999999999999999999999999999999995 4688999999999865322
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
....+.+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.... ..+.......+|+++
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD-WNMDDSAFSGISEDG 256 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCSCCGGGGGCCHHH
T ss_pred -cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCcccccCCCHHH
Confidence 23356799999999999987 679999999999999999999999999888877766665433 333344456789999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
++||.+||.+||.+|||+.|+|+||||+...
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999998654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.2e-57 Score=480.66 Aligned_cols=259 Identities=24% Similarity=0.424 Sum_probs=228.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEec
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMPF 90 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmEy 90 (636)
++|++++.||+|+||+||+|.++.+|+.||||+++... ......+.+|+.+|+.++|||||+++++|.+++.+|+||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 67999999999999999999999999999999997543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc--cCCcEEEeccCcccccccCCCcc
Q 006664 91 MSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID--VRGAIKLGDFGVSACLFDSGDRQ 168 (636)
Q Consensus 91 ~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld--~~g~vKL~DFGla~~~~~~~~~~ 168 (636)
|+||+|.+++... ...+++..++.|+.||+.||.|||++|||||||||+||||+ .+|.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~---- 182 (352)
T d1koba_ 108 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---- 182 (352)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT----
T ss_pred CCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC----
Confidence 9999999987654 34699999999999999999999999999999999999997 5689999999999865322
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFK 248 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~ 248 (636)
....+.+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+......+..+..... .+.......+|++++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW-EFDEDAFSSVSPEAK 260 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC-CCCSSTTTTSCHHHH
T ss_pred CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCcccccCCCHHHH
Confidence 23456789999999999987 6799999999999999999999999999888877766655432 233344567999999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 249 QMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 249 dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
+||.+||.+||.+|||+.|+|+||||+..
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-57 Score=478.62 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=229.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
.++|++++.||+|+||+||+|.++.+|+.||||+++... .....+.+.+|+++|+.++|||||+++++|.+...+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 478999999999999999999999999999999997543 223467789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
|||+.||+|..++... +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 120 ~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 9999999999999887 6799999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
...+.+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+......+..+..... ..+..+++++
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s~~~ 265 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDL 265 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTCCHHH
T ss_pred --ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-----CCCccCCHHH
Confidence 1346789999999999987 6799999999999999999999999998888777766665432 2346789999
Q ss_pred HHHHHhhcccCCCCCC-----CHHHHHhCcccccccC
Q 006664 248 KQMIASCLVKDPSKRP-----SAKKLLKHSFFKQARS 279 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~ 279 (636)
.+||.+||.+||.+|+ |+++|++||||+.+.+
T Consensus 266 ~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 9999999999999995 8999999999997754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-56 Score=479.15 Aligned_cols=264 Identities=23% Similarity=0.331 Sum_probs=222.1
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHH---HHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNI---SREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i---~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
..++|++++.||+|+||+||+|.++.+|+.||||+++.... ......+ .+|+.+++.++|||||+++++|.+++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 46899999999999999999999999999999999965431 1112223 345677778899999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999999887 6799999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
. .....+||+.|||||++.....|+.++|||||||++|||++|+.||.+........ +.... .......+..+
T Consensus 160 ~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~-~~~~~~~~~~~ 232 (364)
T d1omwa3 160 K-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMT-LTMAVELPDSF 232 (364)
T ss_dssp S-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHS-SSCCCCCCSSS
T ss_pred C-----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhc-ccCCCCCCCCC
Confidence 2 23467899999999999765779999999999999999999999998754432221 11111 11123345678
Q ss_pred hHHHHHHHHhhcccCCCCCCC-----HHHHHhCcccccccChH
Q 006664 244 SKSFKQMIASCLVKDPSKRPS-----AKKLLKHSFFKQARSNE 281 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRps-----a~elL~Hpffk~~~~~~ 281 (636)
|+++++||.+||.+||.+||| ++++++||||+.+.+..
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~ 275 (364)
T d1omwa3 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275 (364)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHH
Confidence 999999999999999999999 79999999999876553
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-56 Score=458.46 Aligned_cols=260 Identities=31% Similarity=0.470 Sum_probs=228.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch--------hHHHHHHHHHHHHhCC-CCCcceeeeEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS--------DLSNISREAQTMILVD-HPNVLKSHCSFVS 80 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~--------~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~ 80 (636)
.++|++.+.||+|+||+||+|.++.+|+.||||+++...... ..+.+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 479999999999999999999999999999999997654321 2346789999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
++.+|+|||||+||+|.++++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999999876 6799999999999999999999999999999999999999999999999999986
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhc-----cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQL-----HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 235 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~-----~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~ 235 (636)
+.... .....+||+.|+|||++.+. ..|+.++||||+||++|+|++|+.||.+.+.......+.... ..+
T Consensus 160 ~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~-~~~ 234 (277)
T d1phka_ 160 LDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-YQF 234 (277)
T ss_dssp CCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCC
T ss_pred ccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC-CCC
Confidence 53321 23457899999999999742 347889999999999999999999999988877766666543 233
Q ss_pred CcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 236 DYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 236 ~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
..+....+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 44455689999999999999999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=471.64 Aligned_cols=259 Identities=27% Similarity=0.493 Sum_probs=227.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCC--CchhHHHHHHHHHHHH-hCCCCCcceeeeEEEeCCeEEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFER--DNSDLSNISREAQTMI-LVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~--~~~~~~~i~rEi~iL~-~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
++|++++.||+|+||+||+|.++.+|+.||||++++.. .......+.+|+.++. .++|||||+++++|.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 78999999999999999999999999999999997543 2234566677777765 78999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--- 156 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT---
T ss_pred EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc---
Confidence 9999999999999887 67999999999999999999999999999999999999999999999999999765322
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.......+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+....+ ..+..+|+++
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----~~p~~~s~~~ 230 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-----FYPRWLEKEA 230 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTSCHHH
T ss_pred cccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----CCCccCCHHH
Confidence 223446789999999999987 6799999999999999999999999998887776666554422 2346789999
Q ss_pred HHHHHhhcccCCCCCCCHH-HHHhCcccccccCh
Q 006664 248 KQMIASCLVKDPSKRPSAK-KLLKHSFFKQARSN 280 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~-elL~Hpffk~~~~~ 280 (636)
++||.+||.+||.+||++. ++++||||++..+.
T Consensus 231 ~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 264 (320)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred HHHHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence 9999999999999999995 89999999987543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=458.00 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=223.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++++.||+|+||+||+|.++.+|+.||||+++..... .....+.+|+++|+.++|||||+++++|.++..+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 7999999999999999999999999999999999765432 346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||.| .+.+++......++++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...... .
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~---~ 157 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---R 157 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS---B
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc---c
Confidence 9976 46666665556789999999999999999999999999999999999999999999999999997653322 2
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--CCCc----------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--GLDY---------- 237 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~--~~~~---------- 237 (636)
.....+||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+..+...... ...+
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 3456789999999999987666789999999999999999999999988887777665432111 0000
Q ss_pred ------------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 238 ------------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 238 ------------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.....+|+++++||.+||.+||++|||+.||++||||+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 01235688999999999999999999999999999998764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-56 Score=467.88 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=227.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
.++|++++.||+|+||+||+|.++.+|+.||||+++... .+...+.+|+++|+.++|||||+++++|.+++.+|+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 478999999999999999999999999999999997543 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccC--CcEEEeccCcccccccCCCc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVR--GAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~--g~vKL~DFGla~~~~~~~~~ 167 (636)
||+||+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--- 157 (321)
T d1tkia_ 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--- 157 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---
T ss_pred cCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC---
Confidence 99999999999764 2469999999999999999999999999999999999999854 58999999999765222
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+....+.+..+.... ..+....+..+|+++
T Consensus 158 -~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE-YTFDEEAFKEISIEA 234 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCHHHHTTSCHHH
T ss_pred -CcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCChhhccCCCHHH
Confidence 22456789999999999976 679999999999999999999999999988877776666543 333444456789999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
++||.+||.+||.+|||++|+++||||++
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 99999999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-56 Score=462.64 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=217.2
Q ss_pred EEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCch----hHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 14 TLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNS----DLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 14 ~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~----~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
+.++.||+|+||+||+|.++.+|+.||||+++...... ....+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 35789999999999999999999999999997654321 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
||.|+++..++.. ...+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... .
T Consensus 81 ~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~---~ 155 (299)
T d1ua2a_ 81 FMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---R 155 (299)
T ss_dssp CCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC---C
T ss_pred hhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc---c
Confidence 9999877666543 3679999999999999999999999999999999999999999999999999997653322 2
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CCCCCc----------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLDY---------- 237 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~--~~~~~~---------- 237 (636)
...+.+||+.|||||++.+...|+.++|||||||++|||++|.+||.+....+.+..+.... +....+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 33467899999999999876779999999999999999999999999988888776655421 100000
Q ss_pred -----------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 238 -----------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 238 -----------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
.....+++++++||.+||++||++|||++|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 01235689999999999999999999999999999998643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-55 Score=456.48 Aligned_cols=259 Identities=22% Similarity=0.372 Sum_probs=223.8
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
.+|+|..++|++.+.||+|+||+||+|.++.+|+.||||+++.+. ...+.+.+|+.+|+.++|||||+++++|.++..
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 359999999999999999999999999999999999999986543 346679999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999999887667899999999999999999999999999999999999999999999999999986533
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.. ........||+.|||||++.+ ..|+.++|||||||++|||++|..||........+...+.... ..+.+..+
T Consensus 168 ~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~---~~~~~~~~ 241 (287)
T d1opja_ 168 DT--YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGC 241 (287)
T ss_dssp SS--SEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---CCCCCTTC
T ss_pred CC--ceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC---CCCCCccc
Confidence 22 222334568999999999987 6799999999999999999996666544444444444444322 23445678
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
++++++||.+||..||.+|||+.++++
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-56 Score=470.60 Aligned_cols=257 Identities=23% Similarity=0.365 Sum_probs=213.8
Q ss_pred CCCeEEEe-EEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHH-hCCCCCcceeeeEEEe----CCe
Q 006664 10 AEHYTLYE-EVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMI-LVDHPNVLKSHCSFVS----DHN 83 (636)
Q Consensus 10 ~~~Y~l~~-~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~-~L~HPNIVkl~~~~~~----~~~ 83 (636)
.++|.++. .||+|+||+||+|.++.+|+.||||+++. ...+.+|+.++. .++|||||+++++|.+ +..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 46899875 59999999999999999999999999853 346789999975 4589999999999976 467
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc---CCcEEEeccCcccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV---RGAIKLGDFGVSAC 160 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~---~g~vKL~DFGla~~ 160 (636)
+|+|||||+||+|.++|.......|++..++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 999999999999999998764567999999999999999999999999999999999999975 56799999999986
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC---CCCCCc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA---PPGLDY 237 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~---~~~~~~ 237 (636)
..... ...+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.............. ...+..
T Consensus 164 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 164 TTSHN----SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp CCCCC----CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred ccCCC----ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 54322 2346789999999999986 679999999999999999999999997765544333322221 112222
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 238 ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 238 ~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
..+..+|+++++||.+||++||.+|||+.|+++||||.+.
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 3345789999999999999999999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-55 Score=448.94 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=216.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-----hhHHHHHHHHHHHHhCC--CCCcceeeeEEEeCC
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-----SDLSNISREAQTMILVD--HPNVLKSHCSFVSDH 82 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-----~~~~~i~rEi~iL~~L~--HPNIVkl~~~~~~~~ 82 (636)
.++|++++.||+|+||+||+|.++.+|+.||||+++..... ....++.+|+.+|++++ |||||+++++|.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36899999999999999999999999999999999765422 12234678999999986 899999999999999
Q ss_pred eEEEEEeccCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-CCcEEEeccCcccc
Q 006664 83 NLWVVMPFMSG-GSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-RGAIKLGDFGVSAC 160 (636)
Q Consensus 83 ~l~iVmEy~~G-GsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-~g~vKL~DFGla~~ 160 (636)
.+|+||||+.| +++.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 99999999986 6888888876 67999999999999999999999999999999999999985 47999999999975
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
... ....+.+||+.|||||++.+...++.++|||||||++|+|++|+.||.+.. .+... . ...+
T Consensus 161 ~~~-----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-~----~~~~ 224 (273)
T d1xwsa_ 161 LKD-----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-Q----VFFR 224 (273)
T ss_dssp CCS-----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-C----CCCS
T ss_pred ccc-----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-c----cCCC
Confidence 422 123567899999999999875556788999999999999999999997632 12222 1 1234
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
..+|+++++||.+||.+||.+|||++|+++||||++...
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 568999999999999999999999999999999987643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-55 Score=459.05 Aligned_cols=263 Identities=23% Similarity=0.373 Sum_probs=224.0
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCc-----EEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeE
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNE-----IVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCS 77 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~-----~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~ 77 (636)
.+|+|..++|++++.||+|+||+||+|.+..+++ .||+|++...........+.+|+.+|+++ +|||||+++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 4688999999999999999999999999876554 69999997655555667889999999988 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHHhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 006664 78 FVSDHNLWVVMPFMSGGSCLHILKAAYP---------------------DGFEEVVIATILREVLKGLDYLHHHGHIHRD 136 (636)
Q Consensus 78 ~~~~~~l~iVmEy~~GGsL~~lL~~~~~---------------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRD 136 (636)
+.+.+.+|+|||||+||+|.++|..... ..+++..+..|+.||+.||+|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 9999999999999999999999976421 3489999999999999999999999999999
Q ss_pred cCcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCC
Q 006664 137 VKSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPF 215 (636)
Q Consensus 137 LKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF 215 (636)
|||+|||++.++.+||+|||+|+...... ......+.+||+.|||||++.+ ..|+.++|||||||++|||++ |.+||
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CchhccccccCCeEEEeeccccccccCCC-ceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999998654332 2223346679999999999987 679999999999999999997 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 216 SKYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 216 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.+.+....+..++.... ..+.+..+++++++||.+||..||++|||++||++|
T Consensus 268 ~~~~~~~~~~~~~~~~~---~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGF---KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCSHHHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCC---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 98877776666665532 234456789999999999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=446.86 Aligned_cols=263 Identities=26% Similarity=0.368 Sum_probs=216.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCC-CcEEEEEEeecCCCc-hhHHHHHHHHHHHHhC---CCCCcceeeeEEEe----
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPF-NEIVAVKILDFERDN-SDLSNISREAQTMILV---DHPNVLKSHCSFVS---- 80 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~t-g~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L---~HPNIVkl~~~~~~---- 80 (636)
.++|++++.||+|+||+||+|.+..+ ++.||||+++..... .....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 37899999999999999999999765 678999999765432 2233466788887665 89999999999864
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 81 -DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 81 -~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
...+|++||||.||.+.... ......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 35789999999987655443 3445679999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--CCC-
Q 006664 160 CLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--GLD- 236 (636)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~--~~~- 236 (636)
.... .......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+....+.+..+...... ...
T Consensus 165 ~~~~----~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 165 IYSF----QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCG----GGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhcc----cccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 5422 223457799999999999987 67999999999999999999999999998888777665432110 000
Q ss_pred -------------------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 237 -------------------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 237 -------------------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
......+++.+++||.+||.+||.+|||+.|+|+||||+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 011245789999999999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=447.31 Aligned_cols=262 Identities=27% Similarity=0.444 Sum_probs=217.8
Q ss_pred cccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 4 KKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
.+|+|..++|++++.||+|+||+||+|.. +..||||+++.... ....+.+.+|+.+|++++|||||++++++. +.
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence 36999999999999999999999999974 34699999976543 345678999999999999999999999764 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+|+|||||+||+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 789999999999999999764 3569999999999999999999999999999999999999999999999999997653
Q ss_pred cCCCcccccccccCCCCCCChhhhhhc--cCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC-ccc
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQL--HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD-YER 239 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~--~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~-~~~ 239 (636)
... ......+..||+.|||||++.+. ..|+.++|||||||++|||++|+.||.+......+...+........ ...
T Consensus 156 ~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 156 RWS-GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred ccC-CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 322 22234567899999999999752 34899999999999999999999999988777666666554432222 233
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
+..+++++++||.+||..||++|||+.+|+++
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 56789999999999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.3e-54 Score=443.32 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=218.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++++.||+|+||+||+|.++ +|+.||||+++.... ......+.+|+.+|+.++|||||+++++|.+++..|++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 79999999999999999999985 889999999976543 2346789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.|+.+..+.... +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|....... .
T Consensus 81 ~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~---~ 155 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---R 155 (286)
T ss_dssp CCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred eehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc---c
Confidence 99987766665544 679999999999999999999999999999999999999999999999999987653322 1
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CCCCC-----------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLD----------- 236 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~--~~~~~----------- 236 (636)
.....+|++.|+|||++.+...++.++|||||||++|||++|++||.+....+.+..+.... +....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 23456899999999999876778999999999999999999999999888777665544311 00000
Q ss_pred -----------cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccc
Q 006664 237 -----------YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQ 276 (636)
Q Consensus 237 -----------~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~ 276 (636)
......+++++++||.+||++||++|||+.|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0112457889999999999999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.5e-54 Score=442.60 Aligned_cols=261 Identities=25% Similarity=0.437 Sum_probs=216.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC--chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC----e
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD--NSDLSNISREAQTMILVDHPNVLKSHCSFVSDH----N 83 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~--~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~----~ 83 (636)
.++|++++.||+|+||+||+|.+..+|+.||||+++.... ......+.+|+.+|+.++|||||++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 5789999999999999999999999999999999976543 344667899999999999999999999998754 4
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 89999999999999999887 6799999999999999999999999999999999999999999999999999876544
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
.........+.+||+.|||||++.+ ..|++++|||||||++|+|++|++||.+....+....++...+.. .......+
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 241 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP-PSARHEGL 241 (277)
T ss_dssp ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-GGGTSSSC
T ss_pred ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC-CchhccCC
Confidence 4333344557789999999999976 679999999999999999999999999998888887777665432 23445678
Q ss_pred hHHHHHHHHhhcccCCCCCC-CHHHHHhCcccc
Q 006664 244 SKSFKQMIASCLVKDPSKRP-SAKKLLKHSFFK 275 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRp-sa~elL~Hpffk 275 (636)
|+++++||.+||.+||.+|| |++++ .|+|.+
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 99999999999999999999 55554 566654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=445.91 Aligned_cols=265 Identities=23% Similarity=0.389 Sum_probs=225.9
Q ss_pred cccccCCCCeEEEeE-EcccCceEEEEEEEcC--CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe
Q 006664 4 KKYPIGAEHYTLYEE-VGQGVSASVHRALCIP--FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS 80 (636)
Q Consensus 4 ~~~~i~~~~Y~l~~~-IG~G~fG~Vyka~~~~--tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~ 80 (636)
++|-+..++|.+.+. ||+|+||+||+|.++. ++..||||+++........+.+.+|+++|++++|||||++++++.+
T Consensus 1 k~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred CceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 456788899999995 9999999999998764 4568999999876666677889999999999999999999999865
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
+.+|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -CeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 4689999999999999988653 35799999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
+.............+||+.|||||++.+ ..|+.++|||||||++|||++ |..||.+....+....+..... .+.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~----~~~ 233 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----MEC 233 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----CCC
T ss_pred ccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----CCC
Confidence 6544433334456689999999999986 579999999999999999998 9999998887766555544332 234
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHH---HhCcccc
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRPSAKKL---LKHSFFK 275 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRpsa~el---L~Hpffk 275 (636)
+..+++++.+||.+||..||++|||+.+| |+|+|+.
T Consensus 234 p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 56789999999999999999999999888 5566664
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=442.42 Aligned_cols=263 Identities=22% Similarity=0.356 Sum_probs=222.3
Q ss_pred CCcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 2 ~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
.+..|+|..++|++++.||+|+||+||+|.++ ++..||||+++.... ..+.+.+|+.+|++++|||||++++++. +
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~ 79 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeec-c
Confidence 46789999999999999999999999999975 678999999975433 4567899999999999999999999875 4
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
+.+|+|||||++|+|.+++.......+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 56799999999999999876554346999999999999999999999999999999999999999999999999999866
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcC-CCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG-~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
.... ........||+.|||||++.+ ..|+.++|||||||++|||++| .+||......+.+..+.... ....+
T Consensus 160 ~~~~--~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~----~~~~p 232 (272)
T d1qpca_ 160 EDNE--YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY----RMVRP 232 (272)
T ss_dssp SSSC--EECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----CCCCC
T ss_pred cCCc--cccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----CCCCc
Confidence 4332 223345689999999999986 5699999999999999999995 55566655555544443322 23345
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHh--Ccccc
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLK--HSFFK 275 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~--Hpffk 275 (636)
..+++++++||.+||..||++|||++++++ |+||.
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 678999999999999999999999999998 78885
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-53 Score=444.44 Aligned_cols=259 Identities=23% Similarity=0.362 Sum_probs=211.6
Q ss_pred ccCCCCeEEEeEEcccCceEEEEEEEcCCCc---EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCe
Q 006664 7 PIGAEHYTLYEEVGQGVSASVHRALCIPFNE---IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHN 83 (636)
Q Consensus 7 ~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~---~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~ 83 (636)
++..++|++.+.||+|+||+||+|.++.+|+ .||||.+.........+.+.+|+.+|++++|||||++++++.+++.
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 4677899999999999999999999987765 6899998766666667789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|||||+||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999988764 35699999999999999999999999999999999999999999999999999986643
Q ss_pred CCCccc--ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 164 SGDRQR--MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 164 ~~~~~~--~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
...... ......||+.|||||++.+ ..|+.++|||||||++|||++ |.+||.+....+.+..+..... .+.+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~----~~~~ 255 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR----LPPP 255 (299)
T ss_dssp ---------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----CCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----CCCC
Confidence 322111 1223568999999999986 679999999999999999997 8999999888776665554332 2345
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
..++.++.+||.+||..||.+|||+.+|+++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 6789999999999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=449.96 Aligned_cols=265 Identities=27% Similarity=0.368 Sum_probs=218.5
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
+..|++ .++|++++.||+|+||+||+|.++.+|+.||||+++.... ....+.+.+|+++|+.++|||||+++++|...
T Consensus 11 ~~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 11 KTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 89 (346)
T ss_dssp SSEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred Cceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence 445665 6899999999999999999999999999999999976543 34567789999999999999999999999876
Q ss_pred C------eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEecc
Q 006664 82 H------NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDF 155 (636)
Q Consensus 82 ~------~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DF 155 (636)
+ .+|+||||| |++|..+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccc
Confidence 4 579999999 6678887765 57999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--
Q 006664 156 GVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP-- 233 (636)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~-- 233 (636)
|+|+.... .....+||+.|+|||++.+...++.++||||+||++|+|++|++||.+......+.........
T Consensus 166 g~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 166 GLARQADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp TTCEECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cceeccCC------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 99975422 2346789999999999987667899999999999999999999999988776665443321110
Q ss_pred --------------------C---CC-cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 234 --------------------G---LD-YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 234 --------------------~---~~-~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
. .. ......+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 00 011245789999999999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=432.58 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=207.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
|..++|++++.||+|+||+||+|.++ +++.||||+++.... ..+.+.+|+++++.++|||||++++++..++.+|+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 56789999999999999999999975 578899999875433 346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 79 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~- 156 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 156 (263)
T ss_dssp EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-
Confidence 9999999999998764 35689999999999999999999999999999999999999999999999999986543322
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
.......||+.|||||++.+ ..|+.++|||||||++|||++ |.+||........+..+..... ...+..++++
T Consensus 157 -~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~----~~~p~~~~~~ 230 (263)
T d1sm2a_ 157 -TSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----LYKPRLASTH 230 (263)
T ss_dssp ---------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC----CCCCTTSCHH
T ss_pred -eeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC----CCCccccCHH
Confidence 22335679999999999987 679999999999999999999 5777776666655554444322 2334677899
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
+.+||.+||..||.+|||+++|++|
T Consensus 231 l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=438.09 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=211.9
Q ss_pred CCeEEE-eEEcccCceEEEEEEEc--CCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEE
Q 006664 11 EHYTLY-EEVGQGVSASVHRALCI--PFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 11 ~~Y~l~-~~IG~G~fG~Vyka~~~--~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~i 86 (636)
+.+.+. ++||+|+||+||+|.+. .+++.||||+++.... ....+.+.+|+.+|++++|||||++++++.+ ...|+
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 334443 46999999999999865 4568999999975433 3345679999999999999999999999865 45789
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGD 166 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 166 (636)
|||||+||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 85 vmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999999999999875 6799999999999999999999999999999999999999999999999999987654433
Q ss_pred cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhH
Q 006664 167 RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSK 245 (636)
Q Consensus 167 ~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~ 245 (636)
.........||+.|||||++.+ ..|+.++|||||||++|||++ |+.||.+....+....+..... .+.+..+++
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~----~~~p~~~~~ 237 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----MGCPAGCPR 237 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----CCCCTTCCH
T ss_pred ccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC----CCCCcccCH
Confidence 3333445689999999999987 568999999999999999997 9999998887766555544332 233467899
Q ss_pred HHHHHHHhhcccCCCCCCCHHHH---HhCcccc
Q 006664 246 SFKQMIASCLVKDPSKRPSAKKL---LKHSFFK 275 (636)
Q Consensus 246 ~l~dLI~~cL~~DP~kRpsa~el---L~Hpffk 275 (636)
++++||.+||..||++|||+.+| |+|+|+.
T Consensus 238 ~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 99999999999999999999998 4566654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=448.32 Aligned_cols=269 Identities=22% Similarity=0.328 Sum_probs=221.5
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC---
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH--- 82 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~--- 82 (636)
|+|+ ++|++++.||+|+||+||+|.++.+|+.||||+++........+.+.+|+.+|+.++||||+++++++....
T Consensus 4 ~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 4 FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 4443 469999999999999999999999999999999986666666778999999999999999999999997653
Q ss_pred -eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 83 -NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 83 -~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+++|+|+.||+|.+++.. .++++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|...
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 23455566679999999976 47999999999999999999999999999999999999999999999999999866
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC--------
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP-------- 233 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~-------- 233 (636)
.............+||+.|+|||++.....|+.++||||+||++|+|++|+.||.+....+...........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 444333334556789999999999977677899999999999999999999999887766555443321100
Q ss_pred ---------------C--CCc-ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 234 ---------------G--LDY-ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 234 ---------------~--~~~-~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
. ..+ .....++.++++||.+||.+||.+|||+.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0 000 11235678999999999999999999999999999998654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=435.01 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=213.5
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCC---CcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPF---NEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~t---g~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
.|+|..++|++++.||+|+||+||+|.+..+ +..||||.++..........+.+|+.+|+.++|||||++++++. +
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 5899999999999999999999999998754 35689999876555666778999999999999999999999985 5
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
+.+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 6789999999999999988764 357999999999999999999999999999999999999999999999999999865
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
.... ........||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+....+....+.....+ +.+
T Consensus 159 ~~~~--~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~----~~~ 231 (273)
T d1mp8a_ 159 EDST--YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----PMP 231 (273)
T ss_dssp --------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----CCC
T ss_pred cCCc--ceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----CCC
Confidence 3322 122345678999999999986 679999999999999999997 99999998887776666544332 345
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
..+|+++++||.+||..||.+|||+.+|++|
T Consensus 232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 6789999999999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=443.96 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=213.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC------CeEE
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD------HNLW 85 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~------~~l~ 85 (636)
+|+.+++||+|+||+||+|+++.+|+.||||++..+... ..+|+.+|+.++||||++++++|... .++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 699999999999999999999999999999999765432 24799999999999999999999643 3589
Q ss_pred EEEeccCCCCHHHHHH-HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-cEEEeccCccccccc
Q 006664 86 VVMPFMSGGSCLHILK-AAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-AIKLGDFGVSACLFD 163 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~-~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-~vKL~DFGla~~~~~ 163 (636)
+|||||.+|.+..+.. ......+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||++..+..
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 9999998764444332 22345799999999999999999999999999999999999999775 899999999876533
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC----------
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP---------- 233 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~---------- 233 (636)
. ....+.+||+.|+|||++.+...|+.++|||||||++|||++|++||......+.+..+......
T Consensus 176 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 176 G----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp T----SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred C----cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 2 22346789999999999987678999999999999999999999999988877766555431100
Q ss_pred ----CCCc----------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 234 ----GLDY----------ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 234 ----~~~~----------~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
...+ .....+++++++||.+||.+||++|||+.|+|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000 11245789999999999999999999999999999998653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=430.37 Aligned_cols=259 Identities=20% Similarity=0.327 Sum_probs=210.7
Q ss_pred cccCCCCeEEEeEEcccCceEEEEEEEcCCC----cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 6 YPIGAEHYTLYEEVGQGVSASVHRALCIPFN----EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 6 ~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg----~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
-+|.++.|++.+.||+|+||+||+|.++.++ ..||||+++..........+.+|+.+|+.++|||||++++++.+.
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 3688899999999999999999999987655 479999997666666667789999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
..+++|||||.+|++.+++... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999999999988765 357999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcC-CCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG-~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
..............||+.|||||++.+ ..|+.++|||||||++|||++| .+||.+....+....+.... ..+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~----~~~~~ 235 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF----RLPTP 235 (283)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----CCCCC
T ss_pred cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC----CCCCc
Confidence 444333333345678999999999986 6799999999999999999995 55555555554444333322 22344
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
..++..+++||.+||..||++|||+.+|++
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 236 MDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 678899999999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=438.34 Aligned_cols=266 Identities=22% Similarity=0.293 Sum_probs=214.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-hhHHHHHHHHHHHHhCCCCCcceeeeEEEe--------
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-SDLSNISREAQTMILVDHPNVLKSHCSFVS-------- 80 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~-------- 80 (636)
.++|+++++||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47999999999999999999999999999999999765433 345678899999999999999999999865
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
+..+|+|||||.++.+..+... ...+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 3468999999988765544332 36799999999999999999999999999999999999999999999999999975
Q ss_pred cccCCC-cccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC--CCCCc
Q 006664 161 LFDSGD-RQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP--PGLDY 237 (636)
Q Consensus 161 ~~~~~~-~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~--~~~~~ 237 (636)
...... ......+.+||+.|+|||++.+...|+.++|||||||++|||++|+.||.+......+..+..... .....
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 532221 122344578999999999998767899999999999999999999999998887776554433111 00000
Q ss_pred --------------------cc-----chhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 238 --------------------ER-----DRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 238 --------------------~~-----~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
.. ....++++++||.+||++||++|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 00 01246788999999999999999999999999999853
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=433.89 Aligned_cols=265 Identities=24% Similarity=0.366 Sum_probs=218.6
Q ss_pred CCcccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeC
Q 006664 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSD 81 (636)
Q Consensus 2 ~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~ 81 (636)
.|..|+|..++|++++.||+|+||+||+|.++.+ ..||||+++.... ..+.+.+|+.+|++++|||||++++++. +
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~ 83 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 83 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence 4778999999999999999999999999998654 6799999975433 3567899999999999999999999985 4
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccc
Q 006664 82 HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACL 161 (636)
Q Consensus 82 ~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~ 161 (636)
+.+|+|||||.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 56899999999999999887654467999999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcC-CCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 006664 162 FDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLLMTLQNAPPGLDYERD 240 (636)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG-~~PF~~~~~~~~l~~~~~~~~~~~~~~~~ 240 (636)
.... ........||+.|+|||++.. ..++.++|||||||++|||++| .+||......+.+..+.... ..+.+
T Consensus 164 ~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~----~~~~~ 236 (285)
T d1fmka3 164 EDNE--YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----RMPCP 236 (285)
T ss_dssp --------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----CCCCC
T ss_pred cCCC--ceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----CCCCC
Confidence 3322 122345679999999999986 6799999999999999999995 55556666555554444332 22345
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHh--Ccccccc
Q 006664 241 RKFSKSFKQMIASCLVKDPSKRPSAKKLLK--HSFFKQA 277 (636)
Q Consensus 241 ~~~S~~l~dLI~~cL~~DP~kRpsa~elL~--Hpffk~~ 277 (636)
..+++++++||.+||..||++||++++|+. |+||...
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 678999999999999999999999999988 8888654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=426.81 Aligned_cols=262 Identities=25% Similarity=0.342 Sum_probs=221.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iVmE 89 (636)
++|++++.||+|+||+||+|.++.+|+.||||+++.... ......+.+|+.+|+.++||||++++++|.+...+++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 689999999999999999999999999999999976653 3456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCccc
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDRQR 169 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 169 (636)
|+.|++|..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|....... .
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~---~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---R 156 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC---S
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC---c
Confidence 99999988887654 679999999999999999999999999999999999999999999999999997653322 2
Q ss_pred ccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCC-CCChHHHHHHHHhcCC--CC------------
Q 006664 170 MRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFS-KYPPMKVLLMTLQNAP--PG------------ 234 (636)
Q Consensus 170 ~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~-~~~~~~~l~~~~~~~~--~~------------ 234 (636)
......+++.|+|||++.+...++.++|||||||++|||++|+.||. +.+..+.+..+..... ..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 23455788999999999876678999999999999999999999864 4444444433322110 00
Q ss_pred ----------CCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccc
Q 006664 235 ----------LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQA 277 (636)
Q Consensus 235 ----------~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~ 277 (636)
........+++.+++||.+||.+||.+|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 0011224678899999999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=426.16 Aligned_cols=253 Identities=22% Similarity=0.392 Sum_probs=220.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeEEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l~iV 87 (636)
++.++|+++++||+|+||+||+|++ +++..||||+++.... ..+.+.+|+.++++++|||||++++++.+++.+|+|
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 4678999999999999999999997 4788999999986543 346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc
Q 006664 88 MPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR 167 (636)
Q Consensus 88 mEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 167 (636)
||||++|+|.+++.... ..+++..+.+++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 155 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 155 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-
Confidence 99999999999876642 5689999999999999999999999999999999999999999999999999986543322
Q ss_pred ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhhhHH
Q 006664 168 QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKFSKS 246 (636)
Q Consensus 168 ~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~ 246 (636)
.......||+.|||||++.+ ..|+.++|||||||++|||++ |+.||.+....+....+.... ....+..++++
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~----~~~~p~~~~~~ 229 (258)
T d1k2pa_ 156 -TSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----RLYRPHLASEK 229 (258)
T ss_dssp -CCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----CCCCCTTCCHH
T ss_pred -eeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC----CCCCcccccHH
Confidence 22335679999999999987 679999999999999999998 899999988777665554432 22345678899
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 247 FKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 247 l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
+++||.+||+.||.+|||+++|++|
T Consensus 230 l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 230 VYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=434.78 Aligned_cols=265 Identities=23% Similarity=0.361 Sum_probs=214.3
Q ss_pred CCcccccCCCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceee
Q 006664 2 DKKKYPIGAEHYTLYEEVGQGVSASVHRALCIP-----FNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSH 75 (636)
Q Consensus 2 ~k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~-----tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~ 75 (636)
+..+|+|..++|++++.||+|+||+||+|.+.. +++.||||+++..........+.+|..++.++ +||||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 346899999999999999999999999999764 45789999997666666667788888888766 689999999
Q ss_pred eEEEeC-CeEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcc
Q 006664 76 CSFVSD-HNLWVVMPFMSGGSCLHILKAAY--------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSG 140 (636)
Q Consensus 76 ~~~~~~-~~l~iVmEy~~GGsL~~lL~~~~--------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~ 140 (636)
+++..+ ..+|+|||||+||+|.+++.... ...+++..+..++.||+.||.|||++|||||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 987664 56899999999999999997642 234899999999999999999999999999999999
Q ss_pred cEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcC-CCCCCCCC
Q 006664 141 NILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG-HAPFSKYP 219 (636)
Q Consensus 141 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG-~~PF~~~~ 219 (636)
||||+.++.+||+|||+|+....... .....+.+||+.|||||++.+ ..|+.++|||||||++|||++| .+||.+..
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeECCCCcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999986543322 223446789999999999987 6799999999999999999985 67898776
Q ss_pred hHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 220 ~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
....+...+.... ....+..+++++++||.+||..||++|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 242 IDEEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CSHHHHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCC---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6665555554432 223456789999999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-53 Score=443.61 Aligned_cols=268 Identities=26% Similarity=0.426 Sum_probs=222.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEc---CCCcEEEEEEeecCC---CchhHHHHHHHHHHHHhCCC-CCcceeeeEEEe
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCI---PFNEIVAVKILDFER---DNSDLSNISREAQTMILVDH-PNVLKSHCSFVS 80 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~---~tg~~vAIK~i~~~~---~~~~~~~i~rEi~iL~~L~H-PNIVkl~~~~~~ 80 (636)
++.++|++++.||+|+||+||+|.+. .+|+.||||+++... .....+.+.+|+++|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 55689999999999999999999874 478999999997543 22345678899999999976 899999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSAC 160 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~ 160 (636)
...+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999887 6789999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCcccccccccCCCCCCChhhhhhcc-CCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 006664 161 LFDSGDRQRMRNTFVGTPCWMAPEVMEQLH-GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 239 (636)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~-~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~~~~~~ 239 (636)
+.... .....+..||+.|+|||.+.+.. .++.++|||||||+||+|++|..||.+.........+..... ......
T Consensus 179 ~~~~~--~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~-~~~~~~ 255 (322)
T d1vzoa_ 179 FVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPY 255 (322)
T ss_dssp CCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-HCCCCC
T ss_pred hcccc--cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-cCCCCC
Confidence 53322 22345678999999999997643 478899999999999999999999976543333222222110 011223
Q ss_pred chhhhHHHHHHHHhhcccCCCCCC-----CHHHHHhCcccccccCh
Q 006664 240 DRKFSKSFKQMIASCLVKDPSKRP-----SAKKLLKHSFFKQARSN 280 (636)
Q Consensus 240 ~~~~S~~l~dLI~~cL~~DP~kRp-----sa~elL~Hpffk~~~~~ 280 (636)
+..+|+++++||.+||.+||.+|| |++|+++||||+.+.+.
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence 457899999999999999999999 58999999999987644
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-52 Score=437.45 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=212.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeC--CeEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSD--HNLWV 86 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~--~~l~i 86 (636)
.++|++++.||+|+||+||+|.++.+|+.||||+++.. ....+.+|+.+|+.+. ||||++++++|... ..+|+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 47899999999999999999999999999999998643 3567889999999995 99999999999854 56999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCC-cEEEeccCcccccccCC
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRG-AIKLGDFGVSACLFDSG 165 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g-~vKL~DFGla~~~~~~~ 165 (636)
|||||.+|+|..+. ..+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 110 v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp EEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred EEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 99999999987653 4699999999999999999999999999999999999998655 6999999999765322
Q ss_pred CcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH-HHHHHHHh------------cCC
Q 006664 166 DRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQ------------NAP 232 (636)
Q Consensus 166 ~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~-~~l~~~~~------------~~~ 232 (636)
......+||+.|+|||++.+...|+.++||||+||++|+|++|..||...... .....+.. ...
T Consensus 184 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred ---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 12356789999999999988677899999999999999999999999765432 22111110 000
Q ss_pred CC--------------------CCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCcccccccC
Q 006664 233 PG--------------------LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARS 279 (636)
Q Consensus 233 ~~--------------------~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~~ 279 (636)
.. ........+++++++||.+||.+||.+|||++|+|+||||+.+.+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 00 001122457899999999999999999999999999999997654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=440.15 Aligned_cols=264 Identities=25% Similarity=0.346 Sum_probs=219.2
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEeC--
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVSD-- 81 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~-- 81 (636)
.|++ .++|++++.||+|+||+||+|.++.+|+.||||+++.... ......+.+|+.+|+.++|||||+++++|...
T Consensus 13 ~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 13 IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp EEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 4555 5889999999999999999999999999999999976543 34566789999999999999999999999643
Q ss_pred ---CeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcc
Q 006664 82 ---HNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVS 158 (636)
Q Consensus 82 ---~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla 158 (636)
...++||+|+.||+|.+++.. .++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred cccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence 345677788889999999854 57999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC----
Q 006664 159 ACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG---- 234 (636)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~~---- 234 (636)
.... ....+..||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.......
T Consensus 169 ~~~~------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 169 RHTD------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp -CCT------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccC------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 6532 223467899999999998876678999999999999999999999999887766655554321110
Q ss_pred ---------------------CCc-ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 235 ---------------------LDY-ERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 235 ---------------------~~~-~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
..+ .....+++++++||.+||..||.+|||+.|+|+||||++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000 01235789999999999999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=429.42 Aligned_cols=255 Identities=22% Similarity=0.373 Sum_probs=210.2
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCc----EEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCCeE
Q 006664 9 GAEHYTLYEEVGQGVSASVHRALCIPFNE----IVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDHNL 84 (636)
Q Consensus 9 ~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~----~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~~l 84 (636)
..++|++++.||+|+||+||+|.+..+|+ .||+|.++........+.+.+|+.+|++++|||||++++++.++ ..
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 34689999999999999999999988886 58888886555555677899999999999999999999999864 57
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccC
Q 006664 85 WVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDS 164 (636)
Q Consensus 85 ~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 164 (636)
+++|||+.+|+|.+++... ...+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 8889999999999988775 367999999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchhh
Q 006664 165 GDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRKF 243 (636)
Q Consensus 165 ~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 243 (636)
. .........||+.|||||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+....+..... .+.+..+
T Consensus 165 ~-~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~----~~~p~~~ 238 (317)
T d1xkka_ 165 E-KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----LPQPPIC 238 (317)
T ss_dssp C-C--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC----CCCCTTB
T ss_pred c-ccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----CCCCccc
Confidence 2 2223345579999999999987 679999999999999999998 8999998777665544443322 2345678
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 244 SKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 244 S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
++++.+||.+||..||.+|||+.+|+.|
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=425.36 Aligned_cols=262 Identities=24% Similarity=0.450 Sum_probs=221.2
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcCCC-------cEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCccee
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIPFN-------EIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKS 74 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg-------~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl 74 (636)
-.+|+|..++|++++.||+|+||.||+|.+..++ ..||||+++.+........+.+|...+.++ +|||||++
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 4569999999999999999999999999987655 479999998776666677888999999888 89999999
Q ss_pred eeEEEeCCeEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcc
Q 006664 75 HCSFVSDHNLWVVMPFMSGGSCLHILKAAYP--------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSG 140 (636)
Q Consensus 75 ~~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~--------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~ 140 (636)
++++.++..+|+|||||++|+|.++|..... ..+++..+..++.||+.||+|||++|||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 9999999999999999999999999976532 35899999999999999999999999999999999
Q ss_pred cEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCC
Q 006664 141 NILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYP 219 (636)
Q Consensus 141 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~ 219 (636)
|||++.++.+||+|||+++....... .......+||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCT-TCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeecCCCCeEeccchhhcccccccc-ccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999999986644332 223445689999999999987 689999999999999999997 799999888
Q ss_pred hHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 220 ~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.......+.... ....+..+++++++||.+||++||.+|||+.|+++
T Consensus 243 ~~~~~~~i~~~~----~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGH----RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTC----CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCC----CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 776554443322 22345678999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-51 Score=432.50 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=206.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCC-chhHHHHHHHHHHHHhCCCCCcceeeeEEEe------CCe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERD-NSDLSNISREAQTMILVDHPNVLKSHCSFVS------DHN 83 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~-~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~------~~~ 83 (636)
++|+++++||+|+||+||+|.++.+|+.||||+++.... ......+.+|+.+|+.++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 689999999999999999999999999999999976543 3445678999999999999999999999964 368
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|||||.|+ +...+. ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+|++|||+++....
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 99999999775 444442 4699999999999999999999999999999999999999999999999999875422
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC----------
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP---------- 233 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~~---------- 233 (636)
. ......+||+.|+|||++.+ ..|++++||||+||++|+|++|++||.+.+.......++.....
T Consensus 172 ~----~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 172 S----FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred c----cccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 2 23346689999999999987 67999999999999999999999999887766655444321110
Q ss_pred ---------------------------CCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhCccccccc
Q 006664 234 ---------------------------GLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQAR 278 (636)
Q Consensus 234 ---------------------------~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~Hpffk~~~ 278 (636)
..........++++++||.+||.+||++|||++|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 001111234688999999999999999999999999999998643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-51 Score=424.01 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=222.3
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFV 79 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~ 79 (636)
.|++..++|++++.||+|+||+||+|.++ .++..||||+++..........+.+|+.+|+.++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 47788899999999999999999999876 3568999999986655556778999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHHhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccc
Q 006664 80 SDHNLWVVMPFMSGGSCLHILKAAY----------------------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDV 137 (636)
Q Consensus 80 ~~~~l~iVmEy~~GGsL~~lL~~~~----------------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDL 137 (636)
+.+.+++|||||.+|+|.+++.... ...+++..+..|+.||+.||+|||++|||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 9999999999999999999997532 124889999999999999999999999999999
Q ss_pred CcccEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCC-CCCC
Q 006664 138 KSGNILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGH-APFS 216 (636)
Q Consensus 138 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~-~PF~ 216 (636)
||+||||+.++.+||+|||+|+.+... .......+.+||+.|||||++.+ ..|+.++|||||||++|||++|. +||.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSA-DYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGG-GCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cccceEECCCCcEEEccchhheeccCC-ccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999765333 22233456789999999999987 67999999999999999999984 7898
Q ss_pred CCChHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 217 KYPPMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 217 ~~~~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+.+..+....+..... ...+..+++++.+||.+||..||.+|||+.||++
T Consensus 245 ~~~~~e~~~~v~~~~~----~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGNI----LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TSCHHHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCC----CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8888776665544332 2335678999999999999999999999999964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=418.64 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=209.6
Q ss_pred ccccCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe-CCe
Q 006664 5 KYPIGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS-DHN 83 (636)
Q Consensus 5 ~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~-~~~ 83 (636)
.|+|..++|++++.||+|+||.||+|.+ .|..||||+++.+. ..+.+.+|++++++++||||+++++++.+ ++.
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence 4999999999999999999999999998 47899999996433 45678999999999999999999998865 466
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCccccccc
Q 006664 84 LWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFD 163 (636)
Q Consensus 84 l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~ 163 (636)
+|+|||||++|+|.+++.......+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 89999999999999999765334589999999999999999999999999999999999999999999999999875422
Q ss_pred CCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccchh
Q 006664 164 SGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDRK 242 (636)
Q Consensus 164 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~~ 242 (636)
......||+.|+|||++.+ ..|+.++|||||||++|||++ |++||...+..+....+..... .+.+..
T Consensus 156 ------~~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~----~~~~~~ 224 (262)
T d1byga_ 156 ------TQDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----MDAPDG 224 (262)
T ss_dssp ------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC----CCCCTT
T ss_pred ------CCccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----CCCCcc
Confidence 2345678999999999987 679999999999999999998 7999988777666655543322 234567
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 243 FSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 243 ~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
+++++++||.+||..||.+|||+.++++
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 8899999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=421.17 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=210.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcC-CC--cEEEEEEeecCC--CchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIP-FN--EIVAVKILDFER--DNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH 82 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~-tg--~~vAIK~i~~~~--~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~ 82 (636)
|..++|++++.||+|+||+||+|.+.. ++ ..||||+++... .....+.+.+|+.+|+.++|||||++|+++.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 667899999999999999999998653 33 468999987553 23446789999999999999999999999976 4
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccc
Q 006664 83 NLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLF 162 (636)
Q Consensus 83 ~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~ 162 (636)
.+++|||||++|++.+++.... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 6789999999999999887652 569999999999999999999999999999999999999999999999999998775
Q ss_pred cCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCcccch
Q 006664 163 DSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDR 241 (636)
Q Consensus 163 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~~~~~l~~~~~~~~~~~~~~~~~ 241 (636)
.............||+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+..+....+..... ..+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~ 238 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---RLPRPE 238 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC---CCCCCT
T ss_pred cCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC---CCCCcc
Confidence 55444444445678889999999987 679999999999999999997 8999999988887776665432 234456
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 242 KFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 242 ~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
.+++++++||.+||..||++|||+.+|++
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999999999999999999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=423.26 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=215.4
Q ss_pred ccc-cCCCCeEEEeEEcccCceEEEEEEEcCCCcE--EEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeeeEEEe
Q 006664 5 KYP-IGAEHYTLYEEVGQGVSASVHRALCIPFNEI--VAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHCSFVS 80 (636)
Q Consensus 5 ~~~-i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~--vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~~~~~ 80 (636)
.|+ |..++|++.+.||+|+||+||+|.++.+|.. ||||.++........+.+.+|+++|+.+ +|||||++++++.+
T Consensus 3 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 3 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred CCCccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 465 7889999999999999999999999988875 6777776544445566789999999998 79999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc
Q 006664 81 DHNLWVVMPFMSGGSCLHILKAA--------------YPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV 146 (636)
Q Consensus 81 ~~~l~iVmEy~~GGsL~~lL~~~--------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~ 146 (636)
++.+|+|||||+||+|.++|... ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence 99999999999999999999753 2356999999999999999999999999999999999999999
Q ss_pred CCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcC-CCCCCCCChHHHHH
Q 006664 147 RGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLL 225 (636)
Q Consensus 147 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG-~~PF~~~~~~~~l~ 225 (636)
++.+||+|||+|+..... .......||+.|+|||.+.+ ..|+.++|||||||++|||++| .+||.+.+..+...
T Consensus 163 ~~~~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp GGCEEECCTTCEESSCEE----CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CCceEEcccccccccccc----ccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999998754222 12235679999999999987 6799999999999999999996 56788877777655
Q ss_pred HHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHhC
Q 006664 226 MTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.+.... ....+..+++++++||.+||..||++|||+.+|++|
T Consensus 238 ~i~~~~----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 238 KLPQGY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HGGGTC----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcC----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 544432 234456789999999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=422.49 Aligned_cols=267 Identities=20% Similarity=0.346 Sum_probs=228.9
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEcC-----CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeE
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCIP-----FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCS 77 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~~-----tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~ 77 (636)
+..|+|..++|++++.||+|+||+||+|.++. ++..||||+++..........+.+|+.++++++|||||+++++
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 45799999999999999999999999998753 4678999999866555566778999999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCc
Q 006664 78 FVSDHNLWVVMPFMSGGSCLHILKAAY--------PDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGA 149 (636)
Q Consensus 78 ~~~~~~l~iVmEy~~GGsL~~lL~~~~--------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~ 149 (636)
+..+..+++|||||.+|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|||++.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 999999999999999999999887531 124688999999999999999999999999999999999999999
Q ss_pred EEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcC-CCCCCCCChHHHHHHHH
Q 006664 150 IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLLMTL 228 (636)
Q Consensus 150 vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG-~~PF~~~~~~~~l~~~~ 228 (636)
+||+|||+|+.+..... .......+||+.|+|||.+.+ ..|+.++|||||||++|||++| .+||.+.+....+..+.
T Consensus 172 ~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp EEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EEEeecccceeccCCcc-eeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999986644332 223445679999999999987 6789999999999999999997 58898888777766555
Q ss_pred hcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh------Ccccc
Q 006664 229 QNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK------HSFFK 275 (636)
Q Consensus 229 ~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~------Hpffk 275 (636)
.... .+.+..+++.+++||.+||+.||.+|||+.+|++ +|+|+
T Consensus 250 ~~~~----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 250 EGGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp TTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred hCCC----CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 4332 2334678899999999999999999999999997 56554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=421.19 Aligned_cols=263 Identities=21% Similarity=0.351 Sum_probs=227.2
Q ss_pred CcccccCCCCeEEEeEEcccCceEEEEEEEc-----CCCcEEEEEEeecCCCchhHHHHHHHHHHHHhC-CCCCcceeee
Q 006664 3 KKKYPIGAEHYTLYEEVGQGVSASVHRALCI-----PFNEIVAVKILDFERDNSDLSNISREAQTMILV-DHPNVLKSHC 76 (636)
Q Consensus 3 k~~~~i~~~~Y~l~~~IG~G~fG~Vyka~~~-----~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L-~HPNIVkl~~ 76 (636)
..+|+|..++|++++.||+|+||.||+|.+. .+++.||||+++..........+.+|+.+++.+ +|||||++++
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3579999999999999999999999999864 467899999998777666777899999999998 6999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHHHhCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcc
Q 006664 77 SFVSDHNLWVVMPFMSGGSCLHILKAAYP----------------DGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSG 140 (636)
Q Consensus 77 ~~~~~~~l~iVmEy~~GGsL~~lL~~~~~----------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~ 140 (636)
++.++..+|+|||||+||+|.+++..... ..+++..+..++.||+.||+|||++|||||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 99999999999999999999999986531 25899999999999999999999999999999999
Q ss_pred cEEEccCCcEEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHc-CCCCCCCCC
Q 006664 141 NILIDVRGAIKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAH-GHAPFSKYP 219 (636)
Q Consensus 141 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLlt-G~~PF~~~~ 219 (636)
|||++.++.+||+|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccCcccccccchheeccCCC-cceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999998654332 2233445789999999999986 679999999999999999998 777787777
Q ss_pred hHHHHHHHHhcCCCCCCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 220 PMKVLLMTLQNAPPGLDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 220 ~~~~l~~~~~~~~~~~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
....+..++.... ....+..+++++++||.+||..||.+|||+.+|++
T Consensus 253 ~~~~~~~~i~~~~---~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKEGF---RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHHTC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCC---CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6666666655433 22334678999999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=406.15 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=206.5
Q ss_pred EEEeEEcccCceEEEEEEEcCCC---cEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEe-CCeEEEEEe
Q 006664 14 TLYEEVGQGVSASVHRALCIPFN---EIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVS-DHNLWVVMP 89 (636)
Q Consensus 14 ~l~~~IG~G~fG~Vyka~~~~tg---~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~-~~~l~iVmE 89 (636)
.+.++||+|+||+||+|.+..++ ..||||+++........+.+.+|+++|++++|||||++++++.. ++.+|+|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 34789999999999999987543 36999999766666677889999999999999999999999775 568999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEeccCcccccccCCCc-c
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDFGVSACLFDSGDR-Q 168 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~-~ 168 (636)
||++|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 110 ~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp CCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99999999998764 356788899999999999999999999999999999999999999999999999866433222 1
Q ss_pred cccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCCCCCcccchhhhHHH
Q 006664 169 RMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYP-PMKVLLMTLQNAPPGLDYERDRKFSKSF 247 (636)
Q Consensus 169 ~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~-~~~~l~~~~~~~~~~~~~~~~~~~S~~l 247 (636)
.......||+.|+|||++.. ..|+.++|||||||++|||++|..||.... ..+....+..... ...+..+++++
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~----~~~p~~~~~~l 263 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----LLQPEYCPDPL 263 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC----CCCCTTCCHHH
T ss_pred eecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----CCCcccCcHHH
Confidence 22334579999999999987 679999999999999999999777775543 3333333333322 23346788999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhC
Q 006664 248 KQMIASCLVKDPSKRPSAKKLLKH 271 (636)
Q Consensus 248 ~dLI~~cL~~DP~kRpsa~elL~H 271 (636)
.+||.+||..||++||++.|+++|
T Consensus 264 ~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 264 YEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-48 Score=399.19 Aligned_cols=260 Identities=16% Similarity=0.219 Sum_probs=203.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCC-cceeeeEEEeCCeEEEEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPN-VLKSHCSFVSDHNLWVVM 88 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPN-IVkl~~~~~~~~~l~iVm 88 (636)
+++|++++.||+|+||+||+|.+..+|+.||||++...... ..+.+|+++++.++|+| |+.+++++.++...++||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999998765433 34678999999998766 555677778889999999
Q ss_pred eccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEc---cCCcEEEeccCcccccccCC
Q 006664 89 PFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILID---VRGAIKLGDFGVSACLFDSG 165 (636)
Q Consensus 89 Ey~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld---~~g~vKL~DFGla~~~~~~~ 165 (636)
|||. |+|.+.+... ...+++..+..++.|++.||+|||++||+||||||+|||++ .+..+||+|||+|+.+.+..
T Consensus 83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 83 ELLG-PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp ECCC-CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEcC-Cchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9995 5677666543 36799999999999999999999999999999999999985 35579999999998765433
Q ss_pred Cc----ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC---CCCCcc
Q 006664 166 DR----QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP---PGLDYE 238 (636)
Q Consensus 166 ~~----~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~~~l~~~~~~~~---~~~~~~ 238 (636)
.. .+...+.+||+.|||||++.+ ..|+.++|||||||++|||++|..||................. ......
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 21 123456789999999999987 6799999999999999999999999987655443322211100 000111
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHH---HhCcccc
Q 006664 239 RDRKFSKSFKQMIASCLVKDPSKRPSAKKL---LKHSFFK 275 (636)
Q Consensus 239 ~~~~~S~~l~dLI~~cL~~DP~kRpsa~el---L~Hpffk 275 (636)
....+|+++.+||.+||..||++||++.+| |+|+|.+
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 234688999999999999999999998755 5555543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-46 Score=390.23 Aligned_cols=256 Identities=17% Similarity=0.197 Sum_probs=209.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCC-CCcceeeeEEEeCCeEEE
Q 006664 8 IGAEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDH-PNVLKSHCSFVSDHNLWV 86 (636)
Q Consensus 8 i~~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~H-PNIVkl~~~~~~~~~l~i 86 (636)
|..++|++++.||+|+||+||+|.+..+|+.||||+++..... ..+.+|+++++.|.| +||+.+++++..+...|+
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4468999999999999999999999999999999998654432 346789999999975 899999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEcc-----CCcEEEeccCccccc
Q 006664 87 VMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDV-----RGAIKLGDFGVSACL 161 (636)
Q Consensus 87 VmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~-----~g~vKL~DFGla~~~ 161 (636)
||||| ||+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.+
T Consensus 79 vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99999 68999988764 357999999999999999999999999999999999999964 578999999999876
Q ss_pred ccCCCc----ccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCChH---HHHHHHHhcCCCC
Q 006664 162 FDSGDR----QRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---KVLLMTLQNAPPG 234 (636)
Q Consensus 162 ~~~~~~----~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~~---~~l~~~~~~~~~~ 234 (636)
.+.... .....+++||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.... .....+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 443221 123456789999999999987 67999999999999999999999999754332 2222221111111
Q ss_pred CCcccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 006664 235 LDYERDRKFSKSFKQMIASCLVKDPSKRPSAKKLL 269 (636)
Q Consensus 235 ~~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL 269 (636)
........+++++.+++..|+..+|++||+.+.+.
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 11122356789999999999999999999987654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=392.92 Aligned_cols=254 Identities=24% Similarity=0.293 Sum_probs=195.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCcceeeeEEEeCC----eEE
Q 006664 10 AEHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNVLKSHCSFVSDH----NLW 85 (636)
Q Consensus 10 ~~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNIVkl~~~~~~~~----~l~ 85 (636)
+.+|.+.+.||+|+||+||+|++ +|+.||||+++.... ......+|+..++.++|||||++++++.+++ .+|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 47899999999999999999986 689999999864321 1122234555556789999999999998754 689
Q ss_pred EEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCcccccCcccEEEccCCcEEEeccCc
Q 006664 86 VVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH--------HGHIHRDVKSGNILIDVRGAIKLGDFGV 157 (636)
Q Consensus 86 iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~--------~gIvHRDLKP~NILld~~g~vKL~DFGl 157 (636)
+|||||++|+|.+++++. .+++.....++.|++.||.|||. +|||||||||+||||+.++.+||+|||+
T Consensus 78 lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999999874 68999999999999999999996 5999999999999999999999999999
Q ss_pred ccccccCCCcc-cccccccCCCCCCChhhhhhcc-----CCCcccchhhHHHHHHHHHcCCCCCCCCC------------
Q 006664 158 SACLFDSGDRQ-RMRNTFVGTPCWMAPEVMEQLH-----GYDFKADIWSFGITALELAHGHAPFSKYP------------ 219 (636)
Q Consensus 158 a~~~~~~~~~~-~~~~~~~GT~~YmAPEvl~~~~-----~ys~ksDIWSLGiiLyeLltG~~PF~~~~------------ 219 (636)
++......... ......+||+.|||||++.+.. .|+.++|||||||++|||++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 98765443222 2234578999999999987532 25778999999999999999988874211
Q ss_pred --hHHHHHHHHhcCC--CCCC-cccchhhhHHHHHHHHhhcccCCCCCCCHHHHHh
Q 006664 220 --PMKVLLMTLQNAP--PGLD-YERDRKFSKSFKQMIASCLVKDPSKRPSAKKLLK 270 (636)
Q Consensus 220 --~~~~l~~~~~~~~--~~~~-~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~elL~ 270 (636)
............. +.+. ..........+.+|+.+||+.||.+|||+.||++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1122222222111 1111 1112334567999999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-44 Score=379.24 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=201.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-----------CCCcceeeeEEE
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-----------HPNVLKSHCSFV 79 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-----------HPNIVkl~~~~~ 79 (636)
.+|+++++||+|+||+||+|+++.+|+.||||+++.+ ....+.+.+|+++++.++ ||||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 5699999999999999999999999999999999643 233456788999998775 578999998886
Q ss_pred e--CCeEEEEEeccCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccccCcccEEEccCC------c
Q 006664 80 S--DHNLWVVMPFMSGG-SCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH-HGHIHRDVKSGNILIDVRG------A 149 (636)
Q Consensus 80 ~--~~~l~iVmEy~~GG-sL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHRDLKP~NILld~~g------~ 149 (636)
. ....+++|+++.++ +............+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 4 35677777776554 34444555555779999999999999999999998 8999999999999998665 3
Q ss_pred EEEeccCcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHHHHHHHcCCCCCCCCCh------HHH
Q 006664 150 IKLGDFGVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGITALELAHGHAPFSKYPP------MKV 223 (636)
Q Consensus 150 vKL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGiiLyeLltG~~PF~~~~~------~~~ 223 (636)
+||+|||.+..... .....+||+.|+|||++.+ ..|+.++||||+||++++|++|+.||..... .+.
T Consensus 171 ~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 171 IKIADLGNACWYDE------HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred eeEeeccccccccc------ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 99999999875422 2346789999999999986 6799999999999999999999999964322 111
Q ss_pred HHHHHh--cCC------------------------CCC-----------CcccchhhhHHHHHHHHhhcccCCCCCCCHH
Q 006664 224 LLMTLQ--NAP------------------------PGL-----------DYERDRKFSKSFKQMIASCLVKDPSKRPSAK 266 (636)
Q Consensus 224 l~~~~~--~~~------------------------~~~-----------~~~~~~~~S~~l~dLI~~cL~~DP~kRpsa~ 266 (636)
+...+. ... ... ........++++++||.+||.+||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111110 000 000 0011245688999999999999999999999
Q ss_pred HHHhCcccccc
Q 006664 267 KLLKHSFFKQA 277 (636)
Q Consensus 267 elL~Hpffk~~ 277 (636)
|+|+||||+..
T Consensus 324 e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 324 GLVNHPWLKDT 334 (362)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhcCcccCCC
Confidence 99999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=6e-25 Score=211.69 Aligned_cols=170 Identities=17% Similarity=0.110 Sum_probs=121.5
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCc-----------------hhHHHHHHHHHHHHhCCCCCcceee
Q 006664 13 YTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDN-----------------SDLSNISREAQTMILVDHPNVLKSH 75 (636)
Q Consensus 13 Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~-----------------~~~~~i~rEi~iL~~L~HPNIVkl~ 75 (636)
|.+++.||+|+||+||+|.+. +|+.||||+++..... .....+.+|..++..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999984 7999999987532110 0123456789999999999999987
Q ss_pred eEEEeCCeEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccccCcccEEEccCCcEEEecc
Q 006664 76 CSFVSDHNLWVVMPFMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHHHGHIHRDVKSGNILIDVRGAIKLGDF 155 (636)
Q Consensus 76 ~~~~~~~~l~iVmEy~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHRDLKP~NILld~~g~vKL~DF 155 (636)
++.. .+++|||++++.+. .+++..+..++.||+.+|.|||++||+||||||+|||++. +.++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-TEEEECCC
T ss_pred EecC----CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-CCEEEEEC
Confidence 6532 37999999986532 2455667789999999999999999999999999999985 45899999
Q ss_pred CcccccccCCCcccccccccCCCCCCChhhhhhccCCCcccchhhHHHH
Q 006664 156 GVSACLFDSGDRQRMRNTFVGTPCWMAPEVMEQLHGYDFKADIWSFGIT 204 (636)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~ys~ksDIWSLGii 204 (636)
|.|.............. .+. .-.+.+. +.|+.++|+||+.--
T Consensus 147 G~a~~~~~~~~~~~l~r-d~~----~~~~~f~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 147 PQSVEVGEEGWREILER-DVR----NIITYFS--RTYRTEKDINSAIDR 188 (191)
T ss_dssp TTCEETTSTTHHHHHHH-HHH----HHHHHHH--HHHCCCCCHHHHHHH
T ss_pred CCcccCCCCCcHHHHHH-HHH----HHHHHHc--CCCCCcccHHHHHHH
Confidence 99865422211100000 000 0012221 458899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.26 E-value=2.1e-06 Score=83.43 Aligned_cols=139 Identities=19% Similarity=0.161 Sum_probs=92.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-CCCcceeeeEEEeCCeEEEEEe
Q 006664 11 EHYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-HPNVLKSHCSFVSDHNLWVVMP 89 (636)
Q Consensus 11 ~~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-HPNIVkl~~~~~~~~~l~iVmE 89 (636)
+.|...+..+-|+.+.||+.. ..+..+++|+...... .....+.+|...+..+. +--+.+++.+...++..|+||+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 467777765556667999885 4567788888753321 12335678998887764 3335677888888899999999
Q ss_pred ccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 006664 90 FMSGGSCLHILKAAYPDGFEEVVIATILREVLKGLDYLHH---------------------------------------- 129 (636)
Q Consensus 90 y~~GGsL~~lL~~~~~~~lse~~i~~i~~QIl~aL~yLH~---------------------------------------- 129 (636)
+++|.++...... .. ....++.++...+..||+
T Consensus 91 ~l~G~~~~~~~~~----~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 91 EADGVLCSEEYED----EQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHTTT----CS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred ecccccccccccc----cc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9999877543311 01 112233333344444442
Q ss_pred -------------C------CCcccccCcccEEEccCCcEEEeccCccc
Q 006664 130 -------------H------GHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 130 -------------~------gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
. .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 26899999999999876666799999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.99 E-value=1.1e-05 Score=84.31 Aligned_cols=79 Identities=16% Similarity=0.076 Sum_probs=52.3
Q ss_pred EEeEEcccCceEEEEEEEcCCCcEEEEEEeecC------CCchhHHHHHHHHHHHHhCC-C-C-CcceeeeEEEeCCeEE
Q 006664 15 LYEEVGQGVSASVHRALCIPFNEIVAVKILDFE------RDNSDLSNISREAQTMILVD-H-P-NVLKSHCSFVSDHNLW 85 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~------~~~~~~~~i~rEi~iL~~L~-H-P-NIVkl~~~~~~~~~l~ 85 (636)
-.+.||.|....||++.+..+++.|++|.-... .-+...++..+|+..|+.+. + | .+.+++. .++...+
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~ 107 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAV 107 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTE
T ss_pred eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCE
Confidence 366899999999999988777889999975321 11224566778999987663 2 3 3455554 3555668
Q ss_pred EEEeccCCCC
Q 006664 86 VVMPFMSGGS 95 (636)
Q Consensus 86 iVmEy~~GGs 95 (636)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 8999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.67 E-value=8.3e-05 Score=71.36 Aligned_cols=80 Identities=16% Similarity=0.119 Sum_probs=55.0
Q ss_pred CCeEEEeEEcccCc-eEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCC--CCcceeeeEEEeCCeEEEE
Q 006664 11 EHYTLYEEVGQGVS-ASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDH--PNVLKSHCSFVSDHNLWVV 87 (636)
Q Consensus 11 ~~Y~l~~~IG~G~f-G~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~H--PNIVkl~~~~~~~~~l~iV 87 (636)
..+.+ +.+..|.. +.||+... ..+..+++|...... ...+.+|...++.+.. -.+.+++.+..+++..|+|
T Consensus 11 ~g~~~-~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 11 FGYDW-AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp TTCEE-EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCce-EEcCCcccCCeEEEEEe-CCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 33444 34555654 68999874 457778889864322 2346788888877643 2356778888888899999
Q ss_pred EeccCCCCH
Q 006664 88 MPFMSGGSC 96 (636)
Q Consensus 88 mEy~~GGsL 96 (636)
|+|++|.++
T Consensus 85 ~~~i~G~~~ 93 (255)
T d1nd4a_ 85 LGEVPGQDL 93 (255)
T ss_dssp EECCSSEET
T ss_pred EEeeecccc
Confidence 999988654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.50 E-value=0.0054 Score=62.92 Aligned_cols=74 Identities=11% Similarity=0.072 Sum_probs=51.5
Q ss_pred EEeEEcccCceEEEEEEEcC-------CCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCc-ceeeeEEEeCCeEEE
Q 006664 15 LYEEVGQGVSASVHRALCIP-------FNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNV-LKSHCSFVSDHNLWV 86 (636)
Q Consensus 15 l~~~IG~G~fG~Vyka~~~~-------tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNI-Vkl~~~~~~~~~l~i 86 (636)
-++.|+-|-.-.+|++.... ..+.|.+++.- .. ...-...+|..+++.+.--++ .++++++.+ ++
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 35789999999999997642 34678888764 21 223456789999998853344 467776643 68
Q ss_pred EEeccCCCC
Q 006664 87 VMPFMSGGS 95 (636)
Q Consensus 87 VmEy~~GGs 95 (636)
||||++|..
T Consensus 119 I~efi~g~~ 127 (395)
T d1nw1a_ 119 LEEYIPSRP 127 (395)
T ss_dssp EECCCCEEE
T ss_pred EEEEecccc
Confidence 999998753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.20 E-value=0.009 Score=59.52 Aligned_cols=68 Identities=18% Similarity=0.098 Sum_probs=45.1
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCCCCCc-----cee--eeEEEeCCeEEEEEeccCCC
Q 006664 24 SASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVDHPNV-----LKS--HCSFVSDHNLWVVMPFMSGG 94 (636)
Q Consensus 24 fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~HPNI-----Vkl--~~~~~~~~~l~iVmEy~~GG 94 (636)
--.||++.. .+|..|++|+...... ..+.+..|+..|..|..-+| +.. -..+..++..+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999975 5788899999854322 35668889998877642221 111 12334567789999999874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.48 E-value=0.049 Score=53.19 Aligned_cols=143 Identities=15% Similarity=0.068 Sum_probs=75.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCcEEEEEEeecCCCchhHHHHHHHHHHHHhCC-----CCCcceee---eEEEeCCe
Q 006664 12 HYTLYEEVGQGVSASVHRALCIPFNEIVAVKILDFERDNSDLSNISREAQTMILVD-----HPNVLKSH---CSFVSDHN 83 (636)
Q Consensus 12 ~Y~l~~~IG~G~fG~Vyka~~~~tg~~vAIK~i~~~~~~~~~~~i~rEi~iL~~L~-----HPNIVkl~---~~~~~~~~ 83 (636)
...-++.|..|---+.|++... .| .+++|++..... ...+..|+.+|..|. .|..+... .+..-...
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~ 93 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 93 (316)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred CceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCC---HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecc
Confidence 3455666778888899998753 34 589999854322 234566777776653 23332211 11223455
Q ss_pred EEEEEeccCCCCHH--------------HHHHHhC---CC----CCCHH------------------HHHHHHHHHHHHH
Q 006664 84 LWVVMPFMSGGSCL--------------HILKAAY---PD----GFEEV------------------VIATILREVLKGL 124 (636)
Q Consensus 84 l~iVmEy~~GGsL~--------------~lL~~~~---~~----~lse~------------------~i~~i~~QIl~aL 124 (636)
.+.++.+..|.... ..+.... .. ..... .....+..+...+
T Consensus 94 ~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 173 (316)
T d2ppqa1 94 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 173 (316)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred cceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhh
Confidence 66677776663221 0111100 00 00000 1112222222223
Q ss_pred HHHH----HCCCcccccCcccEEEccCCcEEEeccCccc
Q 006664 125 DYLH----HHGHIHRDVKSGNILIDVRGAIKLGDFGVSA 159 (636)
Q Consensus 125 ~yLH----~~gIvHRDLKP~NILld~~g~vKL~DFGla~ 159 (636)
.-.+ ..|+||+|+.++||+++.+...-|.||+.|.
T Consensus 174 ~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 174 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 3222 2479999999999999987777899999875
|